



Generation of myeloid derived suppressor cells during the progression of murine 
RET melanoma
Taku F1, Mahnke K1, Ring S1, Umansky V2, Aiba S3, Enk AH1 1University of Heidelberg, 
Heidelberg, Germany 2German Cancer Research Center, Heidelberg, Germany 
3Tohoku University, Graduate School of Medicine, Sendai, Japan
Myeloid derived suppressor cells (MDSC) comprise a phenotypically heterogeneous 
population of cells (CD11b+, Gr-1+, Ly6G+, Ly6C+), which can be found in tumor 
bearing mice and in patients with cancer. Though there are several reports, which 
suggest that MDSC suppress the activity of T cells during tumor growth, the exact 
mechanism of their suppressive function is still unclear. To investigate the expression 
of suppressive molecules (B7H1, B7H3, B7H4) by MDSC during melanoma growth, 
we injected RET melanoma cells into C57BL/6 mice. After tumors had reached 
defi ned sizes, mice were sacrifi ced and single cell suspensions of tumors and spleens 
were prepared. FACS analysis revealed signifi cant numbers of Ly6C+CD124+ MDSC 
within the CD11b+ cells in the tumor. Interestingly, there were almost no Ly6G+ 
cells within the CD11b+ population in the tumor. Moreover, the CD11b+Ly6C+ 
cells initially upregulated the expression of B7H1, B7H3 and B7H4, whereas these 
molecules were gradually downregulated during tumor growth. When CD11b+ 
cells were isolated by MACS and co-cultivated with syngeneic CD4+ T cells and 
anti-CD3 antibodies, tumor-derived CD11b+ cells suppressed the proliferation 
of CD4+ T cells by NO production. In contrast, splenic CD11b+ cells from tumor 
bearing mice or control mice did not upregulate suppressive molecules in both 
Ly6G+ or Ly6C+ populations. As expected from FACS data, splenic CD11b did 
not suppress the proliferation of syngeneic CD4+ T cells. Our results suggest that 
the main population of tumor infi ltrating CD11b+ cells were Ly6C+Ly6G- cells, 
which suppress T cell proliferation by upregulation of suppressive molecules.
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Vaccination against autoimmune disease through in vivo silencing of dendritic 
cells with a specifi c IL-12/IL23p40 si-RNA
Brück J1, Weigert C1, Pascolo C2, Glocova I1, Fuchs K1, Ghashghaeinia M1, Hötzenecker 
W1, Ghoreschi K1, Röcken M1 1Department of Dermatology, Tübingen, Germany 
2University Hospital of Zürich, Oncology, Zürich, Switzerland
Experimental autoimmune encephalomyelitis (EAE) is a prototypic organ-specifi c autoimmune disease, 
mediated by infl ammatory myelin-specifi c T helper (Th) cells. Destructive infl ammation within the 
central nervous system -producing Th1 cells is initiated by the infi ltration of IFN-g-producing Th1 cells 
and IL-17-producing Th17 cells. CFA stimulates dendritic cells (DC) through Toll-like receptors (TLR), 
and induces infl ammatory mediators such as IL-12, IL-23 and IL-6 that promote the differentiation of 
naïve Th cells into Th1 or Th17 cells respectively. IL-12 and IL-23 are heterodimers sharing the IL-12/
IL-23p40 subunit. Experiments with knockout mice or therapies with antibodies revealed that the IL-
12/-23p40 subunit is crucial for the development of EAE and other autoimmune diseases. Antibodies 
against IL-12/IL-23p40 improve EAE and psoriasis but bear the risk of severe infections, due to the 
polyclonal neutralization of the IL-12/IL-23p40 molecule. In contrast to antibodies, siRNA is short 
lived and interferes with immune responses for very limited periods of time. We therefore asked, 
whether siRNA allows establishing protective immunity when applied at the time of DC activation. 
We synthesized various siRNA directed against IL-12/IL-23p40 and identifi ed one candidate siRNA 
capable to inhibit IL-12/IL-23p40 production by DC in vitro after TLR-stimulation. Naïve SJL-mice 
were immunized with PLP in CFA and received either IL-12/IL-23p40 or control siRNA. In the 
presence of IL-12/IL-23p40 siRNA IL-12/IL-23p40 production by DC was impaired in vitro and in 
vivo. Vaccination of mice with IL-12/IL-23p40 siRNA during immunization signifi cantly improved the 
clinical course of EAE (20% with clinical symptoms in the siRNA group vs 100%  in the control). Our 
results may provide the basis for new vaccination strategies with IL-12/IL-23p40 siRNA establishing 
protective immunity against organ-specifi c infl ammatory autoimmune diseases, including psoriasis.
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Essential roles of actin cytoskeleton formation through mDia1 in skin dendritic cell 
functions
Hideaki T, Gyohei E, Shuh N, Yoshiki M, Kenji K Kyoto University, Kyoto, Japan
Antigen acquisition, migration, maturation, and T cell stimulation of cutaneous 
dendritic cells (DCs) are essential to initiate acquired cutaneous immune responses. 
The critical mechanism for cell machinery is formation of actin nucleation and 
polymerization, which are facilitated by two groups of proteins, the mDia family 
of formins and Wiskott-Aldrich syndrome protein (WASP). Although WASP is 
known to be important for immunological synapse formation, the role of mDia 
remains unknown. Initially, we found that mDia1 mRNA was dominantly expressed 
among three isotypes, mDia1-3 in bone marrow-derived dendritic cells (BMDCs) 
and Langerhans cells (LCs) by quantitative PCR. To evaluate its roles, we generated 
mDia1-defi cient mice and backcrossed 10 times to C57BL/6 mice . Although the 
proliferation and maturation of BMDCs were comparable between wild-type 
mice and mDia1-defi cient mice, phagocytosis of FITC-dextran and FITC-induced 
cutaneous DC migration were signifi cantly impaired in mDia1-defi cient mice. In 
addition, immunofl uorescent staining with phalloidin showed incomplete actin 
bundle and podosome formation in mDia1-defi cient mice. Moreover, two-photon 
microscopy for three-dimensional time-lapse imaging revealed that immunological 
synapse formation of mDia1-defi cient DCs to OT-II CD4+ T cell were impaired. We 
also observed OT-II CD4 and OT-I CD8 T cell proliferation was attenuated by OVA-
exposed mDia-defi cient BMDC. Consistently, DNFB-induced contact hypersensitivity 
and OVA-induced delayed-type hypersensitivity responses were impaired in mDia1-
defi cient mice.  These results suggest that actin polymerization through mDia1 is 
essential for cutaneous DC functions to initiate acquired cutaneous immune responses.
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Adenosine produced by CD4+CD25+ regulatory T cells suppresses contact 
hypersensitivity reactions by engaging the A1 adenosine receptor on vascular 
endothelium
Ring S1, Oliver S2, Cronstein B2, Enk AH1, Mahnke K1 1University Hospital Heidelberg, 
Heidelberg, Germany 2New York University School of Medicine, New York, USA
Injection of adenosine or its agonist NECA into TNCB sensitized mice abrogates the 
elicitation phase of contact hypersensitivity (CHS) reactions by blocking the adherence 
of leukocytes to vascular endothelium. Since Treg express the ectonucleosidases CD39/
CD73, which degrade ATP into adenosine, we set out to investigated the role of Treg derived 
adenosine in the suppression of the T cell - endothelial cell (EC) interaction. In initial in vitro 
experiments we superfused activated EC with T cells and detected substantial adherence of 
T cells to the EC. In contrast, pretreatment of the EC with Treg or adenosine, respectively, 
reduced the number of adherent T cells by 80% as compared to untreated controls. 
Furthermore we show that these effects are mediated by the adenosine receptor A1, since 
blocking of the A1 receptor restores the adherence of the T cells to the EC. Likewise in vivo, 
we could show that adenosine is essential for the Treg mediated anti-infl ammatory effect 
in CHS responses, since Treg isolated from CD39 defi cient mice failed to prevent adhesion 
of leukocytes to the endothelium as compared to wt Treg. Injection of the A1 adenosine 
receptor antagonist CPCPX before treatment with wt Treg abrogated their suppressive 
function and an ear swelling reaction was recorded. When analysing the effects of Treg on 
adhesion molecules involved in mediating adherence of effector cells to EC we found, that 
the expression of E- and P-selectin by the vascular endothelium was downregulated by Treg 
in vivo and in vitro.  In aggregate our data indicate that CD39-driven adenosine release by 
Treg downregulates expression of adhesion molecules by EC via the A1 adenosine receptor 
providing a novel mechanism by which Treg mediate suppression of CHS responses in vivo.
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The RhoA effector mDia1 regulate motility and function in T lymphocytes
Egawa G1, Tanizaki H1, Okada T2, Narumiya S1, Miyacchi Y1, Kabashima K1 1Kyoto 
University, Kyoto, Japan 2RIKEN, Yokohama, Japan
Lymphocytes, which are the most motile cells in whole body, exhibit dynamic change 
in their receptor expression, cell polarity, and constitution of cytoskeleton to reach its 
destination. Rho-GTPase (Rho, Cdc42, Rac) play a central role in the modulation of 
cytoskeleton, and it is known that genetic deletion of WASP, the effector of Cdc42, induce 
atopic dermatitis like skin infl ammation and autoimmunity. Moreover, we recently 
reported that mDia1, one of the effectors of RhoA, is essential for thymocytes egress 
and T lymphocytes entry into the lymph nodes. These reports indicate a close relation 
between the actin dymamics of T lymphocytes and its immunological function.To this 
end, we examined T lymphocytes motility in ex vivo lymph nodes using two-photon 
microscope and found that mDia1-defi cient T lymphocyte appeared round shape and 
mobility impairment. Additionally, treatment of Y-27632, a specifi c inhibitor of other 
RhoA effectors, ROCK1/2, resulted in further T lymphocytes dysmotility, suggesting 
adequate actin nucleation by RhoA family molecules are essential for normal T 
lymphocytes motility in lymph nodes. We also characterized chemotactic and homing 
ability of mDia1-defi cient T lymphocytes and found that defect of actin regulation 
resulted in impairment of immunological response formation. Our fi ndings indicate 
that regulation of cytoskeleton is fundamental mechanism for T lymphocytes function.
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Local UVB-induced immunosuppression is mediated by IL-10-produing and 
OX40L-positive mature Langerhans cells
Yoshiki R1, Kabashima K2, Sugita K1, Nakamura M1, Tokura Y1 1University of 
Occupational and Environmental Health, Kitakyushu, Japan 2Kyoto University, Kyoto, 
Japan
The mechanism underlying the local UVB-induced immunosuppression is a central 
issue to be clarifi ed in photoimmunology. There have been reported a considerable 
number of cells and factors that participate in the sensitization phase-dependent 
suppression, including Langerhans cells (LCs), T regulatory cells (Tregs), IL-10, and 
TNF-a. The recent surprising fi nding that LC-depleted mice rather exhibit an increased 
contact hypersensitivity (CHS) response urges us to re-evaluate the LC-related 
mechanism of UVB-induced immunosuppression. We studied the surface expression 
of OX40L and the intracellular expression of IL-10 in LCs and dermal dendritic cells 
(dDCs) from UVB (300 mJ/cm2)-irradiated mouse skin and those migrating to the 
regional lymph nodes from UVB-irradiated, FITC-painted mice. In suspensions of 
epidermal and dermal cells prepared from UVB-irradiated ears, Langerin+ MHC 
class II+ cutaneous DCs expressed OX40L as well as CD86 and produced IL-10 
at higher levels than Langerin- MHC class II+ cells, suggesting that LCs in UVB-
irradiated skin elaborate the immmunoregulatory surface molecule and cytokine. 
When freshly isolated epidermal cells were cultured with RANKL, whose production 
by UVB-exposed kertinocytes was confi rmed by fl ow cytometry, the IL-10 production 
by LCs was increased. In mice sensitized with FITC on the UVB-preirradiated skin, 
antigen-specifi c CD4+CD25+ Tregs capable of suppressing CHS to FITC were 
induced. In the UVB and FITC-treated mice, Langerin+ LCs migrating from the skin 
to the regional lymph nodes produced a high amount of IL-10 compared to Langerin- 
DCs. These fi ndings suggest that IL-10-producing mature LCs induced by RANKL 
are responsible for the induction of Tregs and the resultant immunosuppression.
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The role of mast cells in contact hypersensitivity using newly-generated mast cell-
specifi c conditional depletion model
Otsuka A, Miyachi Y, Kabashima K Kyoto University, Kyoto, Japan
The role of mast cells in contact hypersensitivity (CHS) response is controversial 
because some studies have shown that mast cell-defi cient mice have intact CHS 
responses whereas others have shown defective elicitation of CHS.  In those studies, 
W/Wv mice containing a point mutation in stem cell factor (SCF) receptor (c-Kit), 
were used as mast cell-defi ciency model. However, W/Wv mice were not only lack 
of mast cells but also anemic and melanocyte defi cient. Therefore, to evaluate the 
role of mast cells during CHS, pure mast cell defi cient mice model are required. 
A recent study indicated that conserved noncoding sequence 2 (CNS-2) is an 
essential enhancer for interleukin 4 gene transcription specifi c in mast cells. CNS-
2-defi cient mice could not produce IL-4 or IL-13 in both the connective tissue-
type and immature-type of mast cells but not in basophils. Taking advantage of 
this system, mast cell specifi c–diphtheria toxin receptor mediated conditional cell 
knock out (MaS TRECK) mice were newly generated. In this mouse, mast cells in 
the peritoneal cavity, skin, and stomach were completely depleted after injection 
of diphtheria toxin and recovered within 7 days. On the other hand, the numbers 
of CD4, CD8 NKT cells were not altered. We used these mice to address the roles 
of mast cell in the CHS response. When mast cells were depleted during both 
sensitization and elicitation, or only during sensitization phase or elicitation phase 
in CHS, the extent of ear thickness change was attenuated. Consistently, mast cell 
depletion suppressed edema and infl ammatory cell infi ltration, especially CD4+ 
cells, in the dermis. Therefore, MasTRECK mice are valuable system to evaluate the 
mast cell functions at each time point in vivo, and the above results suggest that mast 
cells play an essential role in CHS during both sensitization and elicitation phase.
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Surgical denervation of skin in the KC-Tie2 mouse model of psoriasis eliminates 
dendritic cell infi ltrate, decreases IL-23 protein expression and improves acanthosis
Ostrowski SM, Belkadi AM, Matheny C, Diaconu D, Wolfram JA, Hatala DA, Ward 
NL Case Western Reserve University, Cleveland, USA
A role for the nervous system in psoriasis is evidenced by increases in the number of nerve fi bers 
and neuropeptides in psoriatic skin, the symmetrical distribution of plaque, and disease exacerbation 
related to stress. Most interestingly may be the clinical fi nding that following accidental denervation 
psoriatic plaques have been reported to clear. Although many hypotheses have been proposed, the 
mechanisms underlying these observations remain unclear.  We recently generated the KC-Tie2 mouse, 
a new murine model of human psoriasis. Using this model system, we observed a ~2.5-fold increase 
in the number of  PGP9.5+ nerve fi bers in KC-Tie2 mouse back skin compared with littermate controls 
(p=0.0001) and a 4.1 and 9.2 fold increase in substance P (SP) and neuropeptide Y (NPY), respectively. 
To examine the infl uence of nerves and nerve-derived factors on psoriasis maintenance, we unilaterally 
surgically denervated the dorsal cutaneous nerves at their anatomical entry into back skin of KC-Tie2 
animals. Ten days post-surgery, denervation was confi rmed using PGP9.5 immunohistochemistry and 
measurement of protein expression of PGP9.5. We also determined that the nerve derived molecules 
SP and NPY were decreased in denervated compared with innervated skin. Interestingly, histological 
examination of the psoriasiform phenotype following cutaneous denervation revealed a a 34% decrease 
in acanthosis (p=0.014).  CD4+ T cells and Th1 and Th17 cytokine expression remained unchanged 
as did the number of F4/80+ macrophages, however, the number of CD11c+ dermal DCs decreased 
signifi cantly in denervated skin (50%, p=0.002), returning to control mouse levels.  In addition, IL-
23 protein expression decreased by 33% in denervated compared with innervated skin. These data 
provide experimental evidence suggesting that nerves and their derived factors infl uence DCs and KCs 
and contribute to infl ammation and acanthosis observed in psoriasis. Elucidation of the mechanisms 
underlying these fi ndings may lead to novel therapeutic approaches for the treatment of psoriasis.
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Alteration of the migratory behavior of UV-induced regulatory T cells in vivo
Schwarz A, Schuller W, Schwarz T University of Kiel, Kiel, Germany
UV-induced regulatory T cells (UV-Treg) inhibit the sensitization but not the elicitation 
of contact hypersensitivity when injected i.v, since UV-Treg express lymph node 
homing, but not skin homing receptors and migrate into the lymph nodes but not 
the skin. We demonstrated that the migration and the homing receptor expression of 
UV-Treg can be altered by tissue-specifi c antigen presenting cells (APC) in vitro. To 
prove whether this phenomenon can also be observed in vivo, we obtained UV-Treg 
from mice which were sensitized against dinitrofl uorobencene (DNFB) through UV-
exposed skin. UV-Treg were injected i.v. into mice which were DNFB-sensitized 5 days 
earlier. To activate the i.v. injected UV-Treg in the lymph nodes with DNFB-bearing 
skin-derived APC, recipient mice were boosted with DNFB on the abdomen and ear 
challenged 24 hours later. Sensitized but unboosted mice were not suppressed in their 
challenge despite the injection of UV-Treg. When mice were boosted with DNFB 24 
hours after injection of UV-Treg, the ear swelling response was suppressed, suggesting 
that UV-Treg upon the DNFB boost through the skin migrate into the periphery. The 
experiment was repeated but UV-Treg were labelled with CFSE. Ears were cut and 
analyzed by fl uorescence microscopy. In mice which were not boosted with DNFB 
after injection of UV-Treg no CFSE-labelled cells were detected in the ears. In contrast, 
CFSE-positive cells were found in the ears of mice which were DNFB-boosted after 
injection. In turn, CFSE-labelled cells were detected in the lymph nodes of unboosted 
mice, but absent in boosted mice. This indicates a fi rst option to alter the migratory 
behavior of Treg in vivo and thus may have input on strategies trying to utilize Treg 
not only for the prevention but also for the treatment of immune-mediated disorders.
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IL-4 therapy of psoriasis selectively abrogates IL-23 and TH17 immune responses 
in humans
Guenova E1, Ghoreschi K1, Hötzenecker W1, Sauer K1, Weindl G2, Tham M1, Schäkel K3, 
Schaller M1, Röcken M1, Biedermann T1 1Eberhard Karls University Tübingen, Germany 
2 Freie Universität Berlin, Germany 3Technische Universität Dresden, Germany
Over the last decade, psoriasis was characterized as prototypic Th1 disease mediated by IFN-γ 
producing Th cells. More recent data suggested that also Th17 cells and the Th17 driving cytokines 
such as IL-23 are involved. Consequently, targeting the IL-12/23p40 subunit improved psoriasis. 
Systemic IL-4 therapy also signifi cantly improved psoriasis as shown in a dose escalation study. 
This IL-4 treatment induced intra-lesional IL-4 expression, but did not signifi cantly suppress IL-12 
or IFN-γ. Therefore, we investigated the in vivo effects of IL-4 therapy on the IL-23/Th17 pathway in 
psoriasis. While IL-12p35 mRNA was rather increased following IL-4 therapy, this treatment dose 
dependently suppressed cutaneous IL-23p19 and IL-17 mRNA expression to <10%. Accordingly, 
immunohistology revealed IL-23+ APC and IL-17+ T cells in psoriasis skin prior to therapy, whereas 
following 6 weeks of IL-4 therapy, IL-23 and IL-17 became almost undetectable. To uncover underlying 
mechanisms, we studied the effects of IL-4 on IL-12 and IL-23 production in human dendritic cells 
(DC). In line with our previous data, IL-4 promoted IL-12p70 production, but in sharp contrast 
signifi cantly suppressed the central Th17 inducing cytokines IL-1β, IL-6, and IL-23. Consequently, 
this IL 4 treatment allowed DC to prime Th cells for IFN-γ production, while it strongly inhibited their 
capacity to induce Th17 cells. In contrast to priming with conventional DC, Th cells primed with 
IL-4-DC failed to produce IL-17 and IL-22. Thus, we show that IL-4 ameliorates psoriasis by acting 
on the level of DC to selectively suppress IL-23 and consequently Th17 cells but not by regulating 
IL-12 and IFN-γ. These data demonstrate the dominant role of the Th17 pathway in psoriasis and, 
consequently, that IL-4 treatment of psoriasis provides the unique opportunity to suppress harmful 
IL-23/Th17 responses while preserving the IL 12/IFN-γ responses for antimicrobial defenses.
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Th22 cells represent a distinct human T lymphocyte subset of tissue-signaling 
leukocytes
Eyerich K1, Foerster S2, Pennino D3, Carbone T3, Cianferani F4, Odorisio T4, Traidl-
Hoffmann C1, Durham S5, Schmidt-Weber C2, Cavani A3 1ZAUM – Center for 
Allergy & Environment, Div of Environmental Dermatology & Allergy HHZ/TUM, 
Munich, Germany 2Molecular Immunology, Dept of Allergy & Clinical Immunology, 
NHLI, Imperial College, London, UK 3Lab of Immunology, Istituto Dermopatico 
dell’Immacolata, IRCCS, Rome, Italy 4Lab of Cellular & Molecular Biology, Istituto 
Dermopatico dell’Immacolata, IRCCS, Rome, Italy 5Upper Respiratory Medicine, 
Dept of Allergy & Clinical Immunology, NHLI, Imperial College, London, UK
T helper subsets are usually defi ned according to their production of lineage-
indicating cytokines. The present study identifi es a novel subset of T lymphocytes 
– Th22 cells – that preferentially infi ltrate the epidermis in infl ammatory skin 
disorders and are characterized by the secretion of IL-22 and TNF-alpha, but lack 
IFN-gamma, IL-4 and IL-17. Th22 clones are stable in culture and reveal a clearly 
separate transcriptome profi le compared to Th1, Th2 and Th17 cells that includes 
tissue remodeling genes like Fibroblast growth factors and chemokines involved 
in angiogenesis and fi brosis. Keratinocytes exposed to Th22 supernatants express a 
specifi c, novel response profi le that combines innate immune pathways (induction 
of TLR3, complement cascade and defensins) as well as recruitment (CXCL 
chemokines) and modulation (IL-7, IL-15) of adaptive immunity as a consequence 
of synergistic effects of TNF-alpha and IL-22, thus demonstrating the functional 
identity of Th22 cells. Furthermore, Th22 supernatant IL-22 dependently enhanced 
rapid and complete wound healing in an in vitro injury model. In conclusion, 
we report a human Th22 subset with distinct identity for gene expression and 
function, present within the epidermal layer in infl ammatory skin diseases.
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The functional spectrum of cytotoxic DCs: different roles of IFN and MHC I in 
pDCs and mDCs
Kalb M, Stary G, Koszik F, Stingl G Department of Dermatology, DIAID, Medical 
University of Vienna, Vienna, Austria
Dendritic cells (DCs) do not only exhibit the unique capacity to evoke primary immune 
responses by presenting antigens to naïve T cells, but may also acquire subtype-
specifi c cytotoxic molecules in response to stimulation with intracellular, but not 
extracellular Toll-like receptor (TLR) agonists. We have previously shown that TLR7/8 
and -9 stimulated plasmacytoid DCs (pDCs) express tumor necrosis factor-related 
apoptosis-inducing ligand (TRAIL), while TLR7/8-stimulated myeloid DCs (mDCs) 
express perforin and granzyme B, but not TRAIL. To gain a better understanding of the 
mechanisms through which cytotoxic DCs elicit their killer activity, pDCs and mDCs 
isolated from peripheral human blood were stimulated with a TLR7/8 agonist in the 
presence of IFNα/β antibodies. Under these conditions the expression of TRAIL on 
TLR7/8-stimulated pDCs, but not granzyme B and perforin on mDCs was completely 
abolished. Also, freshly isolated pDCs, but not mDCs, that had been stimulated 
with IFNα alone expressed TRAIL and the mean fl uorescence intensity of TRAIL 
expression correlated with the dose of IFNα used. At a functional level both TLR7/8- 
and IFNα-stimulated pDCs killed the tumor cell line Jurkat in a TRAIL-dependent 
fashion, while tumor cell lysis was abolished in the presence of neutralizing IFNα/β 
antibodies. In contrast, TLR7/8-stimulated mDCs lysed the MHC I low tumor cell 
line K562 and much less effi ciently their HLA-A*0201-transfected counterpart in a 
granzyme B- and perforin-dependent but IFNa-independent fashion. Despite this 
killing pattern, TLR7/8-stimulated mDCs did not display the phenotypic profi le of 
natural killer (NK) cells.  In conclusion our data demonstrate two distinct mechanisms 
by which pDCs and mDCs elicit their tumoricidal activity, pointing to an as yet 
underappreciated powerful innate defense line in infectious and tumor immunity.




UVB irradiation for suppression of virus mimicking-induced RIG-I gene expression
Kimura K, Matsuzaki Y, Nishikawa Y, Kitamura H, Akasaka E, Rokunohe D, Nakano H, 
Imaizumi T, Satoh K, Sawamura D Hirosaki University Graduate School of Medicine, 
Hirosaki, Japan
Retinoic acid-inducible gene-I (RIG-I) is a cytoplasmic protein that recognizes 
viral double-stranded RNA (dsRNA) to induce the type I interferon (IFN) response. 
In human keratinocytes, RIG-I is induced by IFN-β and TNF-α stimulation, and is 
abundantly expressed in psoriatic keratinocytes of the spinous and basal layers. This 
study investigated the effects of extraneous stimuli including viral infection and UVB 
exposure on RIG-I expression in human keratinocytes. Polyinosinic-polycytidylic 
acid (poly(I:C)), which mimics viral infection, signifi cantly induced RIG-I expression, 
while UVB inhibited basal RIG-I expression and the poly(I:C)-induced RIG-I 
overexpression in cultured human keratinocytes (HaCaT). IFN-regulatory factor 
(IRF)-1, which binds to a regulatory element located on the RIG-I gene promoter, 
was required for both inductions of RIG-I expression. IRF-1 expression was enhanced 
three hours after the poly(I:C) stimulation, consistent with the RIG-I response 
to poly(I:C), and thereafter was suppressed. Moreover, UVB exposure promptly 
decreased IRF-1 expression, resulting in decreased IRF-1 protein binding to the RIG-I 
promoter, and consequently, decreased RIG-I expression. Thus, suppression of RIG-I 
and IRF-1 expression caused by UVB exposure may partly explain the inhibition 
of skin-based immune responses, leading to viral infection and recrudescence.
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A Novel Anti-infl ammatory Effect of Epigallocatechin-3-gallate on Keratinocytes by 
Suppressing Steroid-induced MIF Expression in vitro
Park Y, Kang H Department of Dermatology, College of Medicine, The Catholic 
University of Korea, Seoul, Republic of Korea
Epigallocatechin-3-gallate (EGCG) is well known with its anti-infl ammatory effects on chronic 
infl ammatory skin conditions such as atopic dermatitis (AD). In our previous study, we found that the 
topical application of EGCG could improve AD-like skin lesions of NC/Nga mice by suppressing the 
macrophage migration inhibitory factor (MIF) and other Th1-related cytokines. To our surprise, the 
suppressive effect of EGCG on MIF was not limited to the AD-like skin lesions but was observed in the 
serum as well. MIF has been reported to be one of the most crucial immunoregulatory cytokines in the 
pathogenesis of AD. Moreover, there is evidence that steroids up-regulate MIF. However, so far, few 
experiments have assessed the effect of EGCG on MIF in keratinocytes in vitro. In this study, we aimed to 
ascertain the anti-infl ammatory effect of EGCG in vitro and clarify whether steroids cause the up-regulation 
of MIF. HaCaT cell growth induced by various concentrations of EGCG treatment was monitored using the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide colorimetric assay. To determine the anti-
infl ammatory effect of EGCG on MIF and other cytokines, HaCaT cells were stimulated with recombinant 
TNF-α, lipopolysaccharide, dexamethasone or recombinant MIF with or without adding various 
concentrations of EGCG. RNA and protein levels of IL-6, IL-8, MIF, toll-like receptor (TLR) 2, TLR4, and 
tumor growth factor (TGF)-?of cells were measured by using RT-PCR, Western blot and ELISA, respectively. 
EGCG treatment did not signifi cantly affect cell viability, and was not cytotoxic to the HaCaT cells. EGCG 
suppressed recombinant TNF-α-induced MIF and IL-8 expression on HaCaT cells in a dose-dependent 
fashion (P<0.05). Interestingly, MIF expression on HaCaT cells was signifi cantly up-regulated when treated 
with 10-3 uM dexamethasone, compared to the group without steroid (P<0.05). On the other hand, 
IL-8 expression was not affected by dexamethasone (1 - 10-4 uM). EGCG suppressed dexamethasone-
induced MIF expression of HaCaT cells in a dose-dependent manner. These results indicate that ECGC 
has a novel anti-infl ammatory effect on keratinocytes by suppressing steroid-induced MIF expression.
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Abscence of CCR4 Exacerbates Skin Infl ammation in the Oxazolone Induced 
Contact Hypersensitivity Model
Lehtimäki S1, Tillander S1, Puustinen A1, Matikainen S1, Nyman T2, Wolff H1, Alenius 
H1, Lauerma A1 1Finnish Institute of Occupational Health, Helsinki, Finland 2Institute 
of Biotechnology, University of Helsinki, Finland
Chemokine receptor CCR4 is highly expressed by Th2 cells and involved in the 
recruitment of infl ammatory cells into the skin. We studied the effects of CCR4 defi ciency 
in the murine model of oxazolone induced contact hypersensitivity in CCR4-/- and WT 
mice. In the skin draining lymph nodes, the mRNA expression levels of Th2 cytokines, 
IL-4, IL-5 and IL-13, are attenuated in oxazolone sensitized CCR4-/- mice compared to 
wild type, whereas the expression level of Th1 cytokine, IFN-gamma, is at comparable 
level. However, in the skin, the infl ammatory response is stronger in CCR4-/- mice 
compared to wild type, evidenced by increased ear swelling and infl ammatory cell 
infi ltration. In addition, the mRNA expression levels of Th1 and Th2 cytokines, several 
chemokines, chemokine receptors and selectins in the skin of CCR4-/- mice are 
signifi cantly elevated compared to wild type. These data demonstrate that absence of 
CCR4 results in deregulated immune response during the allergic skin infl ammation.
016
Activating Transcription Factor 3 (ATF3) Critically Determines Susceptibility to 
Bacterial Toxins vs. Systemic Bacterial Infections
Hoetzenecker W1, Guenova E1, Echtenacher B2, Woelbing F1, Brück J1, Glocova I1, 
Biedermann T1, Ghoreschi K3, Röcken M1 1Universitiy of Tuebingen, Germany 2Universitiy 
of Regensburg, Germany 3 NIH, Bethesda, USA
Systemic bacterial infections such as cellulitis activate the innate immune system and may result in severe shock, 
including fever, tachycardia and hypotension. These symptoms result from TLR-signals like lipopolisacharide 
(LPS) released during bacterial infections. Recent data revealed that activation of the transcription factor ATF3 
provides protection against the toxicity resulting from innate immune activation by LPS and protects from LPS-
induced death, by initiating a negative feedback loop in the NFkB signal pathway. Here, we found that stimulation 
of dendritic cells (DC) or peritoneal macrophages (PM) with LPS increased expression of ATF3. Moreover, stress 
signals such as reactive oxygen species (ROS) or glutathione depletion as they occur during sepsis induce ATF3, 
suppress the in vivo release of infl ammatory cytokines, namely IL-6, and protect from LPS-induced shock and 
mortality. In consequence, glutathione depletion, as it is occurs during sepsis, enhanced LPS-induced ATF3 
4fold, signifi cantly inhibited IL-6 mRNA and protein > 90% in vivo, and signifi cantly decreases the risk of LPS-
induced lethality. Comparing ATF3.WT with ATF3.KO mice, we found that glutathione-depletion regulates IL-6 
through a strictly ATF3-dependent signalling cascade, as cells from ATF3.KO mice produced normal amounts 
of IL-6, even at sub-lethally low glutathione levels and mice remained fully susceptible to LPS-induced lethality. 
Next we addressed, whether the increased awareness of ATF3.KO mice to innate signals such as LPS might, 
inversely, promote the protection against systemic infection. We therefore compared bacterial infection after 
coecal perforation in ATF3.WT and ATF3.KO mice. In WT mice bacterial infection resulted in glutathione 
depletion, high ATF-3 mRNA levels, low IL-6 and high mortality. In sharp contrast in ATF3.KO mice infection-
induced glutathione depletion did not suppress the IL-6-mediated protection of mice from sepsis-induced 
mortality. As ATF3 is induced within minutes following innate immune activation, it abrogates susceptibility 
to LPS-induced immune activation. Thus, induction of ATF3 induces an immune paralysis protective against 
bacterial toxins, while ATF3 dramatically increases susceptibility to bacteria through inhibition of IL-6.
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Anti-phospholipids in leukocytoclastic vasculitis
Barnadas M, Borrell M, Vallvé C, Gich I, Alomar A Hospital Sta. Creu i St. Pau, 
Barcelona, Spain
To clarify the role of antiphospholipid antibodies in leukocytoclastic vasculitis 
(LV) we carried out a study: fi rst, to elucidate the specifi city of circulating anti-
phospholipid antibodies in LV; second, to investigate the relationship between 
the different  immunoglobulin (Ig) class of anti-phospholipid antibodies with the Ig 
class deposited in skin vessels; and third, to evaluate the connection between anti-
phospholipids and kidney damage. A prospective study was carried out in 69 patients 
with histopathologically proven LV and  a control group of  27 patients with palpable 
purpura on legs who did not fulfi ll the histopathologic diagnosis of LV. The levels of IgG, 
IgM, IgA anti-cardiolipin, anti-phosphatidylserine and IgG, IgM anti-beta2 glycoprotein 
antibodies were studied by means of an ELISA test.  We did not fi nd a statistically 
signifi cant relationship between the elevation of any type of antiphospholipids 
with the diagnosis of LV. In the LV group we did not fi nd any relationship between 
each immunoglobulin class deposited in the skin and the class of anti-phospholipid 
antibodies detected in plasma. We only observed a signifi cant relationship between the 
level of IgA anti-cardiolipin and IgA skin deposits in the control group, p=0.002. In the 
LV group we found a tendency between haematuria and IgA anti-phosphatidylserine 
p=0.06 and a relationship between proteinuria  and IgM anti-cardiolipin (p=0.042) 
We were unable  to confi rm a pathogenic role of  any class of anti-phospholipids 
antibodies in development of LV skin lesions. The relationship between elevation of IgA 
anti-cardiolipin and cutaneous IgA deposits in the control group suggests that it may 
represent an epiphenomenon of vessel damage. The relationship between haematuria 
and  IgM anti-cardiolipin and proteinuria with IgA anti-phosphatidylserine indicates a 
possible role of anti-phospholipid antibodies in kidney damage.  
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ATP is a tissue site specifi c activator of the suppressive capacity of naïve regulatory 
T cells during contact hypersensitivity reactions
Ring S, Enk AH, Mahnke K University Hospital Heidelberg, Heidelberg, Germany
Adoptively transferred naïve CD4+CD25+Foxp3+ regulatory T cells (Treg) suppress 
both phases (sensitization and elicitation) of the murine contact hypersensitivity 
reaction (CHS). Since it has been established that Treg require activation in order 
to convey their suppressive capacity, we tracked the activation status of adoptively 
transferred Treg after injection in vivo. We labelled freshly isolated naïve Treg 
with fl uorescent dyes and injected them into mice either 2h before sensitization 
or 15 min before challenging. CD4+ cells were injected as controls. 24h after 
sensitization or challenging with hapten, the re-isolated fl uorescent Treg showed 
a signifi cant increase of the activation markers CD69, Foxp3 and CD44 whereas 
CD62L decreased. Moreover, the activation was dependent on the site of hapten 
treatment, i.e. Treg became activated in the draining lymph node after sensitization, 
and in the blood during the elicitation phase. Because the suppressive function of 
Treg is partly mediated by adenosine generated by degradation of ATP via the CD39/
CD73 ectonucleotidase pathway, we hypothesized that ATP in addition to serving as 
substrate for adenosine production, might also act as an activator for Treg. In in vitro 
experiments we demonstrated that ATP indeed induced the activation of naïve Treg as 
indicated by upregulation of CD69. Moreover, ATP-activated Treg showed increased 
suppressive capacity, comparable to results obtained with anti-CD3/CD28 activated 
Treg. Finally, in vivo the application of hapten augmented the ATP concentration 
tissue specifi c, i.e. during sensitization ATP was increased only in the draining LN 
whereas challenge elevated ATP selectively in the serum. These data strictly correlate 
with the observed pattern of Treg activation in vivo and suggest a novel role of ATP 
in tissue specifi c activation of Treg during allergic and infl ammatory reactions.
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ATP released by B16 melanomas upregulate the expression of the ectonucleotidase 
CD39 on Treg
Kretz M, Ring S, Mahnke K University Hospital Heidelberg, Heidelberg, Germany
Tumor-resident CD4+CD25+FoxP3+ regulatory T cells (Treg) contribute to the 
immunosuppressive environment of tumors through different pathways, e.g. by 
blocking the priming of T-cells and by suppressing the function of tumor-specifi c 
CD8+ T cells. Recently it was shown that Treg, via the ectonucleotidases CD39 
and CD73, cleave ATP into adenosine, which exerts immunosuppressive effects. 
Therefore we started to investigate whether production of adenosine by Treg 
contributes to the immunosuppressive environment created by tumors. In the murine 
B16 melanoma model we analyzed the Adenosinetriphosphate (ATP) turnover, the 
number and the activation status of the Treg and the activation status of the tumor-
resident CD8+ T cells in different lymphoid organs and in the tumor itself. Mice were 
sacrifi ced after the tumors reached a volume of 300-400mm3, and spleens, non-
draining lymphnodes (ndLN), draining lymphnodes (dLN) and tumors were isolated. 
Lymphoid organs of naïve mice were used as controls. Using ATP-luminescence 
assays for the detection of the ATP-release, we showed an approximately 100-
fold higher concentration of ATP in the supernatant of tumor cells as compared 
to the supernatant of cells from the lymphoid organs. Also, in the tumor we 
found signifi cantly elevated numbers of Treg showing increased expression of the 
characteristic activation marker CD69 in comparison to spleens and LN. These 
tumor-resident Treg strongly up-regulated the ectonucleotidase CD39, which is the 
key enzyme for the production of immunosuppressive adenosine. Thus these data 
suggest that the increased levels of ATP released by the tumor, activate the tumor-
resident regulatory T cells. The up-regulated CD39 degrades the ATP into adenosine 
which is then contributing to the immunosuppressive environment of the tumor.
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Avena sativa aerial part extract regulates skin immunoinfl ammatory disorders as 
atopic dermatitis pathology
Aries M, Vaissiere C, Charveron M, Castex-Rizzi N Pierre Fabre Dermocosmetique, 
Toulouse, France
Atopic dermatitis (AD) is a chronic infl ammatory disease hypothesized to be the 
product of complex interactions among the host’s environment, susceptibility genes, 
skin barrier dysfunction, and immune system dysregulation. Th1 and Th2 cells 
which differ in their secretory patterns of cytokines are postulated in the disease 
process and immunosuppressive agents are the foundation for the pharmacologic 
treatment of fl ares; emollient applications is a very benefi cial complement and 
make the use of topical potent immunomodulatory agents logical therapeutic 
considerations. The aim of the present study was to evaluate the activity of Avena 
sativa (Avena Rhealba®) aerial plant extract (leaves and stems without fl ower nor 
fruit) (3-30µg/ml) on 1- cutaneous infl ammatory response through the prostacyclin 
(PGI2, COX-2 mediator) production by human keratinocytes 2- immune cellular 
response through the production by human peripheral blood mononuclear 
cells (PBMC) of interleukine 2 (Th1 cytokine) and interleukine 4, 5, and 13 (Th2 
cytokines) which are up-regulated in atopic dermatitis. extract decreased signifi cantly 
(p<0.001) the A23187-induced PGI2 production (-57% with 30µg/ml extract 
concentration). Avena sativa aerial plant extract also signifi cantly down-regulated 
Th1 and Th2 cytokines : -27% on CD4+ IL2+ cells (p<0.001); -21%, -17%, -26% 
on IL4, IL5, IL13 production respectively (with 10µg/ml extract concentration). Our 
results demonstrate that Avena sativa aerial plant extract is a potent regulator of 
immunoinfl ammatory response showing, therefore, a real interest of this Avena sativa 
aerial plant extract topical preparations in atopic dermatitis infl ammatory pathology.
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Bet v 1-specifi c immune responses in specifi c immunotherapy-treated birch pollen 
allergic individuals during seasonal pollen exposure
Möbs C1, Slotosch C1, Löffl er H2, Hertl M1, Pfützner W1 1Philipps University, Marburg, 
Germany 2SLK-Clinics, Heilbronn, Germany
In the present study we investigated the impact of specifi c immunotherapy (SIT) 
on Bet v 1-specifi c cellular and humoral profi les in birch pollen allergic patients 
(n=15) compared to birch pollen allergic subjects treated only symptomatically 
(n=7) and healthy controls (n=8) during environmental birch pollen exposure. 
Birch pollen allergen (Bet v 1)-specifi c T helper (Th) 1, Th2, and type 1 regulatory 
(Tr1) cell subsets were quantifi ed both within and outside birch pollen season on 
the basis of their characteristic cytokine profi les by ELISPOT analysis of peripheral 
blood mononuclear cells. At the same time points, titers of birch pollen allergen-
specifi c IgG4 and IgE antibodies were assessed. In contrast to healthy controls, both 
birch pollen allergic subjects treated by SIT and those treated only symptomatically 
showed a signifi cantly increased Th2-driven immune response during birch pollen 
season, characterized by enhanced numbers of Bet v 1-specifi c, IL-5-producing 
Th2 cells. However, only patients on SIT developed a simultaneous increase of 
Bet v 1-specifi c, IL-10-secreting Tr1 cells, which correlated with a signifi cant 
reduction of clinical symptoms. Unlike both birch pollen allergic cohorts, healthy 
individuals were characterized by enhanced numbers of Bet v 1-specifi c, IFNgamma-
producing Th1 cells, while alterations in the frequencies of Th2 and Tr1 cells were 
not observed. While there were no substantial changes of allergen-specifi c IgE titers 
during birch pollen season in all three groups, elevated titers of allergen-specifi c 
IgG4 antibodies were only detectable in patients receiving SIT. These data show 
that allergen tolerance induced by SIT is accompanied by an increase of allergen-
specifi c Tr1 cells and IgG4 antibodies, pointing to the protection of birch pollen 
allergic patients through both cellular and humoral immunoregulatory mechanisms.
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Biological treatment targeting tumour necrosis factor-alpha in experimental 
epidermolysis bullosa acquisita
Hirose M1, Recke A2, Fritag M2, Ishii N3, Mueller RS4, Zillikens D2, Ludwig RJ2 1Dept 
of Dermatology, Univ of Lübeck / Medizinische Tierklinik, Ludwig Maximillan Univ, 
Lübeck/Muenchen, Germany 2Dept of Dermatology, Univ of Lübeck, Germany 
3Dept of Dermatology, Kurume Univ Medical School/Dept of Dermatology, Lübeck, 
Fukuoka, Japan/Lübeck, Germany, Japan 4Medizinische Tierklinik, Ludwig Maximillan 
Univ, Munich, Germany
Epidermolysis bullosa acquisita (EBA) is a diffi cult to treat subepidermal autoimmune skin blistering 
disease with circulating and tissue-bound anti-type VII collagen antibodies. Several reports demonstrated 
an increased expression of tumour necrosis factor-alpha (TNFa) in the serum and blister fl uid of patients 
with other subepidermal autoimmune blistering skin diseases. In addition, some individual patients 
have been reported to be successfully treated with TNFa inhibition. We here show, that induction of 
experimental EBA in mice by repetitive injection of rabbit-anti mouse type VII collagen antibodies, leads 
to an increased expression of TNFa in the skin as determined by PCR and immunohistochemistry. In 
addition, increased levels of TNFa were detected in the serum of injected mice in contrast to mice 
treated with normal rabbit IgG. Therefore, in a next series of experiments, the effects of TNFa defi ciency 
in this EBA animal model were evaluated. Interestingly, after injection of antibodies to murine type 
VII collagen, no difference in disease severity was observed in TNFa-defi cient mice compared to 
wild type mice. Subsequently, we inhibited TNFa functions using a pharmacologic approach: Along 
with injection of antibodies to type VII collagen, mice were treated prophylactically with etanercept 
or an antibody directed to murine TNFa. However, both treatments did not signifi cantly alter the 
blistering phenotype clinically or histologically compared to treatment with a control monoclonal 
antibody. In conclusion, although TNFa is detected at increased levels in both skin and serum of 
EBA mice, inhibition of the TNFa function appears to have no effect on the blistering phenotype.
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Calcitonin Gene-Related Peptide modulates IL-13 in circulating CLA+ T cells in 
atopic dermatitis patients
Santamaria-Babi L1, Antunez C2, Torres M2, Lopez S2, Rodriguez R2, Blanca M2, 
Mayorga C2 1Institute of  Research in Biomedicine. University of Barcelona, Barcelona, 
Spain 2Allergy Service. Carlos Haya Hospital, Malaga, Spain
Neuropeptides may play an important role in the pathogenesis of atopic dermatitis 
by regulating immune responses and contributing to neurogenic infl ammation. The 
purpose of this study was to assess the ability of neuropeptides to infl uence IL-13 and 
IFN-gamma production in circulating skin memory T cells (CLA+/CLA- T cells) from 
atopic dermatitis patients with severe, chronic lesions and intense pruritus, and from 
non-atopic controls. Cells were cultured in the presence and absence of different NP, 
Calcitonin Gene Related Peptide (CGRP), Somatostatin (SOM) and Substance-P (SP). 
IL-13 and IFN-gamma production and HLA-DR expression were measured in both 
CLA+ and CLA- T cell subsets by fl ow cytometry. CGRP increased IL-13 production in 
PBMC from atopic dermatitis patients (p<0.05), with no changes detected in presence 
of SOM or SP. Memory T cells incubated with CGRP also showed an increase in IL-
13 (p=0.029), and in the T-cell activation marker, HLA-DR (p=0.028) in CLA+ T cells 
from atopic dermatitis patients compared to controls, but not in CLA- T cells. Patients 
with a higher production of IL-13 were those with higher total IgE and percentage 
of skin area involved. Furthermore, the IL-13/IFN-gamma ratio was increased in AD 
patients after cells were cultured with CGRP (p=0.043). Our results suggest a specifi c 
immunomodulatory role of CGRP towards a Th2 pattern in CLA+ memory T cells, 
which may contribute to exacerbating clinical symptoms in atopic dermatitis patients.
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Ceramide defi ciency in epidermis results in development of dermatitis through 
Langerhans cell maturation and expansion of IL-17-producing gd T cells
Sano S1, Nakajima K1, Terao M2, Takaishi M1, Azukizawa H2, Katayama I2, Takeda 
J2 1Kochi Medical School, Kochi University, Nankoku, Japan 2Osaka University 
Graduate School of Medicine, Suita, Japan
Ceramides in the stratum corneum are essential for skin barrier function to prevent 
skin infl ammation, but the underlying mechanism still remains elusive. Here, we 
generated Sptlc2 targeted mice under the keratin 5 promoter, whose keratinocytes 
were devoid of serine palmitoyltransferase (SPT), the rate-limiting enzyme for de 
novo synthesis of sphigolipids. Ceramide levels were reduced in the cornifi ed layer 
of newborn K5-SPT-KO mice and proinfl ammatory cytokines from their keratinocytes 
were upregulated. From 2 weeks after birth, barrier disruption and spontaneous 
dermatitis developed, with histologic aberration such as hyperkeratosis, acanthosis 
and the infi ltration of infl ammatory cells in the dermis. Langerhans cells (LCs) in the 
epidermis of K5-SPT-KO mice appeared mature and there were increased numbers 
of langerin+ dendritic cells (DCs) in the skin-draining lymph nodes compared with 
control mice. In the skin-draining lymph nodes of these mice, there were increased 
IL-17-producing gd T cells and, to a lesser extent, Th17 cells. Furthermore, IL-
17 and IL-22 mRNAs in the lesional skin of K5-SPT-KO mice were increased. 
We concluded that defi ciency in de novo ceramide synthesis of keratinocytes 
resulted in increase of proinfl amatory signals in epidermis and subsequent barrier 
disruption, that promoted aberrant maturation and migration of LCs, followed 
by expansion of IL-17-producing gd T cells and development of dermatitis. 
This animal model may represent an ‘innate dermatitis’ initiated by an aberrant 
keratinocyte-LC crosstalk and help to understand the relationship between reduced 
epidermal ceramides and infl ammatory skin disease, such as atopic dermatitis.




CGRP induces ex vivo upregulation of epidermal TLR9 expression and LL37 gene-
expression
Baerveldt EM, Kant M, De Vries K, Florencia EF, Von Bergh A, Neumann HA, Laman 
JD, Prens EP Erasmus Medical Centre, Rotterdam, Netherlands
During wound healing and in psoriasis calcitonin gene-related peptide (CGRP) 
and vasoactive intestinal peptide (VIP) are upregulated. This occurs parallel with 
epidermal enhancement of the innate antigen receptor TLR9 and the antimicrobial 
peptides cathelicidin (LL37) plus ß-Defensin 2 (hBD2). All components of the 
innate immune barrier are regarded as interdependable and co-regulated. Next to 
their roles as immunomodulators, both CGRP and VIP are considered a functional 
part of the innate immune barrier as they exert antimicrobial activity. We therefore 
investigated their impact on TLR9, LL37 and hBD2 mRNA and protein expression. 
Skin biopsies from 9 healthy donors and primary keratinocytes were stimulated 
with CGRP, VIP and their co-transmitter acetylcholine (ACh) up to 1, 2, 4, 8, 
16 and 24 h. mRNA was extracted from epidermal sheets and analysed using 
quantitative PCR. CGRP induced signifi cant upregulation of TLR9 mRNA expression. 
Immunohistochemical analysis showed enhanced TLR9 protein expression in the 
basal epidermal layer. CGRP induced a signifi cant, up to 200 fold, upregulation 
of LL37 mRNA expression. These results were paralleled by upregulation of 
Nerve Growth Factor without affecting TLR7 or hBD2 expression. Both VIP and 
ACh induced TLR9 and LL37 only to a modest degree. Combined upregulation 
of TLR9 and LL37 can kick-off innate skin infl ammation and strongly support a 
functional role for CGRP in regulation of the epidermal antimicrobial barrier. 
026
Characterization of in vitro generated mast cell from different origin
Kaesler S1, Schmidt U1, Wölbing F1, Scholten J2, Hartmann K2, Shumilina E1, Matzner 
N1, Roers A3, Lang F1, Biedermann T1 1Eberhard-Karls University Tuebingen, Germany 
2University of Koeln, Germany 3Technical University of Dresden, Germany
Mast cells (MC) are not only key effector cells in immediate type I reactions but also play a crucial 
role in innate and adaptive immunity. Consequently, MC investigations in vitro and in vivo steadily 
increase. As it is diffi cult to obtain primary MC in large numbers, it is well accepted to work 
with in vitro generated MC. The classical way to generate MC is from bone marrow (BMMC), 
alternatively MC can be obtained from fetal skin (FSMC) or from fetal liver (FLMC). As these cultures 
may differ and analyses about the infl uence of the MC source on quantity and quality of the in 
vitro induced cells have not been done, we established the side-by-side culture and generation 
of these MC types and performed comparative studies in respect of morphology, surface marker 
expression, and release of mediators in immediate, intermediate, and late responses. While all 
three cell types were clearly identifi ed as MC by different means, we found several differences 
concerning proliferation, lifespan and maturation. FSMC seem to be more mature and/or more 
responsive, as they show a higher granule content and mediator release but lower proliferation 
capacity than BMMC and FLMC. Most interesting, temporal dynamics of the MC-specifi c marker 
gene Mcpt5 revealed two subpopulations only in BMMC but not in FLMC and FSMC cultures, 
indicating incomplete or delayed maturation of BMMC. Functional analyses with IgE-DNP revealed 
for all three MC types unequivocal immediate Ca2+-infl ux and identical sustained activation as 
detected by patch-clamp experiments for the K-channel SK4. Finally, investigating the innate 
immune response by TLR stimulation we found for all three MC types the same results for several 
parameters on RNA and protein level except for IL-10 release, which was high for BMMC, low 
for FLMC and undetectable for FSMC. These investigations are most helpful to generate large 
quantities of well characterized MC, but also indicate that there may be peculiar differences 
that need to be addressed especially when MC functions as immune regulators are studied.
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Comparison of the Expression Profi le of JunB, c-Jun, and S100A8 (Calgranulin A)
Chul Jong P, Tae Wook K, Young Min P, Kyung Ho L Bucheonsi Kyunggido, Republic 
of Korea
Psoriasis is a chronic, infl ammatory, immune-mediated skin disease. Recently, several 
psoriasis-linked genetic loci have been reported. Among them, PSORS4 contains 
S100A8 (Calgranulin A) and PSOR6 (19p13) locus harbors JunB (19p13.2). S100A8 
proteins are considered to be markers of infl ammation in a variety of diseases. It 
was reported that the expressions of JunB and c-Jun reduced in psoriatic lesions. 
We attempted to assess the roles and correlations of S100A8, JunB, and c-Jun in 
the pathogenesis of guttate psoriasis and psoriasis vulgaris, by studying whether any 
differences in S100A8, JunB, and c-Jun positive cell expression could be detected 
in guttate psoriasis and psoriasis vulgaris, as compared to normal skin. Skin biopsy 
specimens from patients with psoriasis vulgaris (n=37), patients with guttate psoriasis 
(n=17), and a normal skin control (n=9) were utilized in the study. Formalin-fi xed 
and paraffi n-embedded tissue sections were prepared and JunB, c-Jun, and S100A8 
were immunohistochemically stained in order to compare the expressions of those 
three proteins in each group.Reduced JunB and c-Jun expressions in the psoriasis 
vulgaris and guttate psoriasis groups were observed as compared to those of the 
control groups. Increased S100A8 expressions were detected in the psoriasis group 
as compared to the control groups. In addition, the expression of S100A8 differed 
between the psoriasis vulgaris and guttate psoriasis group, and was expressed more 
profoundly in the guttate psoriasis group (p<0.05). Our results indicate that S100A8 
proteins can contribute to the pathogenesis of guttate psoriasis, and this may eventually 
become a good target for therapies for psoriasis provoked by microorganisms.
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Cytotoxic activity of invariant NKT cells in human allergic contact dermatitis
Balato A1, Fishelevich R2, Zhao Y2, Gaspari A2 1University of Naples Federico II, 
Napoli, Italy 2University of Maryland - School of Medicine, Baltimore, USA
The role of cytotoxicity of NKT-cells in the skin is not defi ned. There are two prototypic 
skin diseases in which epidermal Keratinocytes (KC) over-express CD1d, a MHC 
class-I-like molecule that present antigens to NKT-cells, in all layers of the epidermis 
and which there is infi ltration of NKT-cells into the skin: allergic contact dermatitis 
(ACD) and psoriasis. In both diseases, NKT-cells are found within skin lesions, and 
within the epidermis in close apposition to CD1d bearing KC.  This suggests that 
there may be direct KC-NKT-cell interactions that can affect the ongoing immune 
mediated infl ammatory response. Our purpose was to investigate the cytotoxic 
activity of invariant NKT cells in the skin and in human allergic contact dermatitis. 
Paired skin biopsies from patch test reaction and normal skin were used for qPCR and 
immunohistochemistry. 51Cr release assay was performed with NKT-cells as effector 
cells and KC as target cells. Invariant NKT-cells are enriched in ACD reactions, but 
not in normal skin. Gene expression of cytotoxic effector molecules (perforin and 
granzymes) was higher in ACD lesions compared to normal skin (qPCR). Perforin and 
granzymes were found in invariant NKT-cells in patch test reactions, where as these 
molecules were also expressed by other cells, such as CD8+ conventional T-cells and 
NK-cells. Invariant gene expression of cytotoxic effector molecules is increased when 
these cells are activated in vitro by glycolipid and potent APC such as CD1d bearing 
monocytes, and KC in some cases as well.  Human NKT-cells are in an activated 
state in ACD, and contribute to the tissue damage of allergic infl ammation. These 
fi ndings indicate that innate immunity plays an important role in the elicitation phase 
of ACD, and may represent a novel therapeutic target in allergic skin infl ammation.
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Decreased Levels of Autoantibody against Histone Deacetylase 3 in Patients with 
Systemic Sclerosis
Yutaka K1, Fumihide O1, Eiji M1, Motoi T1, Kazuhiro S1, Minoru H2, Manabu F2, 
Shinichi S1 1Nagasaki University, Japan 2Kanazawa University, Japan
Systemic sclerosis (SSc) is characterized by immunological abnormalities, especially the production 
of autoantibodies against various cellular components. HDACs play a key role in the regulation of 
gene transcription. Recent studies show that HDAC inhibitors have anti-infl ammatory effects in 
autoimmune diseases. HDAC inhibitor treatment prevents collagen accumulation in a mouse SSc 
model. Autoantibody to HDAC-3 is produced in colon cancer patients, while HDAC-1 and HDAC-2 
do not elicit such autoantibody response. Therefore, we hypothesized that autoimmune background 
in SSc induced the production of autoantibody to HDAC-3. Therefore, to test this hypothesis, the 
presence or levels of anti-HDAC-3 antibody (Ab) in SSc patients were investigated. Anti-HDAC-3 Ab 
was examined by enzyme-linked immunosorbent assay (ELISA) and immunoblotting using human 
recombinant HDAC-3. The HDAC-3 activity was evaluated by ELISA using the fl uorimetric histone 
deacetylase lysyl substrate that comprises an acetylated lysine side chain. Contrary to our hypothesis, 
IgG and IgM anti-HDAC-3 Ab levels in SSc patients were signifi cantly lower than in normal controls 
(p<0.0005 and p<0.001, respectively). Furthermore, decreased levels of IgG anti-HDAC-3 Ab were 
specifi c to SSc, since IgG anti-HDAC-3 Ab levels in patients with dermatomyositis (DM) and those 
with systemic lupus erythematosus (SLE) were similar and slightly increased relative to normal 
controls, respectively. Immunoblotting analysis showed that anti-HDAC-3 Ab was detected in 
normal controls and patients with DM or SLE, while it was absent in SSc patients. The HDAC-3 
activity was signifi cantly inhibited by IgG isolated from sera of normal controls, whereas such 
inhibitory effect was not observed by IgG isolated from sera of SSc patients. These results indicate 
the lack of anti-HDAC-3 autoantibody in SSc patients, which is produced in healthy individuals 
as well as DM and SLE patients, suggesting that this autoantibody might function as protective Ab.
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Early events involved in dendritic cell activation induced by contact sensitizers: role 
of oxidative stress, celium infl ux and MAPKs
Migdal C1, Foggia L1, Ferrer A1, Tailhardat M2, Courtellemont P2, Haftek M1, Serres M1 
1EA 41-69 Université C. Bernard, Lyon1, Lyon, France 2LVMH Recherche, Saint Jean 
de Braye, France
Allergic Contact Dermatitis (ACD) resulting from skin sensitization is a common occupational 
and environmental health problem. Given the importance of epidermal dendritic cells 
(DCs) in the initiation of skin sensitization, the aim of this study is to better understand the 
mechanisms by which sensitizers modulate the immune system and to identify the early 
events implicated in DC activation induced after exposure to sensitizers. DCs derived from 
monocytes (mono-DCs) were used to explore chemical-induced changes in the phenotype 
of these cells (CD86, CD54 and HLA-DR). But as one major limitation of these studies is 
related to inter-donors variability, a human monocytic cell line (U937) was used as a DC 
surrogate. This cell line responds to sensitizers similarly to mono-DCs with an up-regulation 
of CD86 expression and IL-8 secretion, whereas non sensitizers and irritants have no effect. 
In order to identify the intracellular pathways leading to DC activation, the role of oxidative 
stress was evaluated by pre-treating cells with antioxidants such as glutathione (GSH) or 
N-acetyl-cysteine (NAC) before chemical exposure. Our data show that these antioxidants 
inhibit CD86 expression and IL-8 secretion induced by several sensitizers of various 
chemical structures (DNCB, nickel, MCI/MI, citral, cinnamaldehyde, mercury compounds 
etc…). These sensitizers induce a direct oxidative stress and a perturbation of mitochondrial 
potential assessed with fl uorescent probes, associated with GSH depletion, an increase of 
apoptosis using annexin V staining and the detection of activated caspases. Moreover, these 
sensitizers modulate MAPKs pathways and an intracellular calcium infl ux is detected. All 
these data support the concept that oxidative stress plays a central role in DC activation and 
that ROS production can act as second messengers in the pathways leading to DC activation.
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Efalizumab induces hyporesponsiveness in T cells
Koszik F, Stary G, Selenko-Gebauer N, Stingl G Medical University of Vienna, Vienna, 
Austria
The use of the lymphocyte function associated-molecule-1 (LFA-1) alpha-chain 
(CD11a)-binding monoclonal antibody (mAb) efalizumab (E) is a treatment option in 
moderate to severe psoriasis. Even though LFA-1 is universally expressed on leukocytes 
of the peripheral blood, the general opinion holds that E exerts its effects essentially 
on T lymphocytes by blocking their migration and by perturbing the immunological 
synapse. To test the validity of the latter assumption, we asked whether E could interfere 
with T cell proliferation induced by qualitatively and quantitatively different stimuli. 
Using PBMC of E-treated patients, we observed that E, while unable to interfere with 
T cell proliferation under optimal stimulation conditions (PHA), effectively blocks 
the allogeneic mixed leukocyte reaction and anti-CD3-driven T cell proliferation 
induced under suboptimal conditions. To understand the mechanism(s) underlying 
this phenomenon we exposed normal PBMC to E under various conditions. Cells 
were subsequently stimulated via CD3. Whereas addition of E to the medium alone 
did not modify the reactivity of PBMC to plate bound anti CD3, crosslinking via 
an anti-E antibody rendered T cells less reactive to a following anti-CD3 stimulus. 
Our fi ndings suggest that binding of E to CD11a can induce molecular events 
that downmodulate T cell responsiveness/threshold to a T cell receptor-mediated 
stimulus. This may also provide an explanation as to why E is highly effective in 
patients with stable psoriasis, but often fails to control disease fl ares. These fi ndings 
may further deliver insights into the immunosuppressive potential of E-treatment.
032
Effects of activated T cells on multinucleated giant cells depend on how they are 
activated
Mizuno K, Iwasaka K, Okamoto H Kansai Medical University, Moriguchi, Japan
Since activated T cells predominantly infi ltrated in sarcoidal lesions, T cells are emerging as 
important regulators of granuloma formation.  Multinucleated giant cells (MGCs) in various 
types of granulomas are originated from the fusion of monocyte-macrophage lineage cells. 
Osteoclasts are also MGCs of which precursor cells are monocyte-macrophage lineage 
cells.  Co-cultures of mitogen-activated T cells with osteoclast precursors result in the 
formation of multiple functional osteoclasts.  Here we examined the role of activated T 
cells in granulomas using in vitro MGC formation model from human monocytes.  T cells of 
healthy controls were stimulated for 3 days by concanavalin A (Con A), phytohemagglutinin 
(PHA), or propionibacterium acnes (P. acnes).  Cultured supernatants were used as 
conditioned medium for the induction of MGC formation.  We have previously reported 
that conditioned medium from Con A-stimulated peripheral blood mononuclear cells had 
an ability to generate MGCs from monocytes.  Conditioned medium from P. acnes- but 
not PHA-stimulated T cells induced MGC formation.  Co-cultures of activated T cells by 
Con A or P. acnes with monocytes also induced MGC formation.  There was no difference 
in the formation rate between CD4+- and CD8+- T cells activated by Con A or P. acnes. 
In contrast, co-cultures of PHA-stimulated or freshly-isolated T cells with monocytes did 
not induce MGC formation.  IFN-β neutralizing antibody completely blocked the MGC 
formation.  On the other hand, GM-CSF or IL-3 neutralizing antibody slightly inhibited the 
formation.  T cells activated by P. acnes, a possible etiological bacterium in sarcoidosis, as 
well as a particular lectin thus play an important role in granuloma formation and IFN-β 
is a main responsible factor for the induction of MGC formation by activated T cells.
033
Effects of chronic mild stress on the expression of serotonergic markers in the 
eczematous skin of atopic mice
Rasul A, Norlind K, Lonne-Rahm SB, El-Nuor H Karolinska University Hospital, 
Stockholm, Sweden
The impact of chronic mild stress on the expression of serotonin (5-hydroxytryptamin; 
5-HT), 5-HT1A, 5-HT2A receptors (R) and serotonin transporter protein (SERT) in 
eczematous skin of atopic mice, was studied. Twenty-four NC/Nga atopic mice were 
subject to chronic mild stress for 12 weeks, and eczema was induced by applying a 
mite antigen (Dermatophagoids pteronyssinus) on the ears for the last four weeks. The 
mice were divided in to three groups, 8 per group, stressed eczema (SE), non stressed 
eczema (NSE) and stress control (SC). Biopsies were obtained from the mice sensitized 
with the mite antigen on their ears in parallel to the chronic mild stress procedure. The 
biopsies were fi xed with 4% formalin and 0.2% picric acid for immunohistochemistry, 
using a streptavidin-biotinylated technique.There was an increased (p<0.01) number 
of 5-HT containing cells in the mice with eczema (SE and NSE, respectively) 
compared with the SC, while a tendency (p=0.09) to more 5-HT positive cells in the 
SE compared with the NSE. Besides that there was an epidermal immunoreactivity for 
5-HT1AR and 5-HT2AR, which was highest in the SE and NSE, 5-HT2AR expression 
was also seen on nerve bundles, their number being decreased (p<0.01) in the SE (6.3 
immunoreactive bundles/section) compared to the NSE (11.3). The staining intensity 
of the nerve bundles for 5-HT2AR was lower in the SE compared with the NSE and CS. 
SERT expression was seen in the epidermis of all groups, but also on nerve bundles 
with a decreased (p<0.001) number in the SE (5.9) compared to the NSE (11.9) and 
also SC (9.5; p<0.05). There is a modulation of the expression of 5-HT, 5-HT2AR 
and SERT in the eczematous skin of the atopic mouse during chronic mild stress. 
034
Enhanced IL-13 Expression in the Skin of STAT6-/- Mice in the Murine Model of 
Atopic Dermatitis
Savinko T, Lehtimäki S, Fyhrquist N, Karisola P, Majuri M, Matikainen S, Wolff H, 
Lauerma A, Alenius H Finnish Institute of Occupational Health 1, Helsinki, Finland
Atopic dermatitis (AD) is an allergic skin disease characterized by elevated serum IgE 
levels, Th2-type lesions and Th1-type chronic lesions, and may lead to other allergic 
disorders. To assess the role of signal transducer and activator of transcription (STAT) 
4 and STAT6, two major mediators of Th1 and Th2 signalling in the pathogenesis 
of AD, wild type, STAT4-/- and STAT6-/- mice were epicutaneously sensitized and 
challenged with ovalbumin. Skin infl ammation was determined examining mRNA 
expression and cell infi ltration. To study systemic effects, serum antibody levels and 
cytokine production from draining lymph nodes were determined.  STAT4-/- mice 
showed attenuated Th1 responses whereas STAT6-/- mice responded with diminished 
systemic Th2 responses. In contrast, local responses within the skin of STAT6-/- mice 
showed markedly increased expression of Th2 cytokines IL-5 and IL-13, which 
was accompanied by signifi cantly elevated T cell numbers and IL-2, IL-33, E- and 
P-selectin transcripts. Both STAT4 and STAT6 play a critical role in AD by affecting 
cellular infi ltration as well as cytokine and antibody production. The effects of STAT6 
defi ciency are very different within the local skin microenvironment compared to 
the systemic level within the circulation as well as in lymphoid organs. Although 
blockage of STAT6 signalling has been shown to attenuate systemic Th2-type 
immunological responses, special attention should be paid to the effects within the 
local tissue microenvironment when considering STAT6 as a therapeutic target for AD.
035
Exploring the Immunologic Synapse in Allergic Contact Dermatitis by Modelling the 
T-Cell Receptor-Major Histocompatibility-Peptide-Complex
Ahlfors S, Sundin A, Hansson C University of Lund, Lund, Sweden
Based on experimental data of T-cell responses to contact allergenic peptides we 
have constructed a model of the immunological synapse associated with allergic 
contact dermatitis (ACD). This was done in order to provide a detailed understanding 
of the structures associated with dinitrophenyl (Dnp) antigen recognition by T-cells. 
The model of the synapse is composed of three parts, a model peptide antigen 
carrying a strong contact allergenic hapten, a comparative homology model of 
the major histocompatibility complex (MHC) class II (H-2Aq), and, in complex 
with this, a T-cell receptor (TCR). The structure of the energy-minimized H-2Aq 
model corresponded well with crystal data from other MHC class II molecules. A 
conformational search was performed for all of the Dnp-modifi ed peptide antigens in 
complex with the MHC model to fi nd the low-energy conformations for each of the 
antigens. Also, calculations of the dynamics of the antigen models (in water) showed 
that our models corresponded well with experimental data. Furthermore, to gain 
insight into the structural features of the complete H-2Aq immunological synapse, 
the MHC-peptide complexes were combined with crystal data of CDR3 loops 
(TCRs) from several immunological synapses. Based on our model, we can explain 
why some antigens gave a T-cell response and why some show no T-cell response 
at all. A specifi c orientation in space of the Dnp towards the TCR could explain 
the observed experimental T-cell responses. This detailed structural explanation 
of experimental T-cell response data provides a better understanding of the 
immunological synapse and of antigen structures associated with ACD. Our approach 
can also be rewarding to use in other T-cell mediated hypersensitivities in humans.
036
Expression of molecules involved in the innate immunity is strongly enhanced 
during lactation in mammary epithelial cells
Mildner M1, Abtin A1, Gläser R2, Schröder JM2, Pammer J1, Mlitz V1, Schmidt M1, 
Tschachler E1 1Medical University of Vienna, Vienna, Austria 2University Hospital 
Schleswig-Holstein, Kiel, Germany
Mastitis of the mammary tissue in response to invading bacteria is a serious problem in breast-
feeding women, and the innate immune system is of particular importance for rapid elimination 
of pathogens in this setting. Toll-like receptors (TLRs) have been shown to be important and 
suffi cient to mediate the induction of microbial peptides (AMPs) which represent a crucial part 
of the innate immune response. In the present study we have investigated the expression and 
regulation of AMPs and TLRs in non-lactating versus lactating human mammary epithelial cells in 
vitro and in vivo. We could demonstrate that during lactation the protein production of S100A7, 
calprotectin (S100A8 and S100A9), human beta-defensin (HBD)-1 as well as RNase 5 and RNase 7 
were strongly up-regulated in human mammary epithelial cells, whereas HBD-2 was not induced. 
We could further show that high amounts of S100A7 (up to 400 ng/ml), HBD1 (up to 150 ng/ml), 
calprotectin (up to 15 ng/ml), RNAase 5 up to 3 ng/ml) and RNase 7 (up to 1.5 ng/ml) were present 
in human breast milk. In addition, the exposure of human mammary epithelial cells in monolayer 
culture to a cocktail inducing lactation sensitized these cells to TLR-mediated up-regulation of 
AMPs by both TLR-agonists and heat-inactivated bacterial cultures. We therefore investigated 
whether TLRs were also regulated by lactation. Western blot analysis of human primary mammary 
epithelial cells in vitro and immuno-histochemical stainings of non-lactating and lactating breast 
biopsy specimens revealed that TLR-1, -3, -6, -7, -8 and -9 were signifi cantly up-regulated during 
lactation. We conclude that an enhanced secretion of AMPs as well as an enhanced production 
of TLRs by lactating mammary glands might represent an important step for rapid elimination of 
invading pathogenic bacteria from the breast. Furthermore, the high concentrations of some AMPs 
in human breast milk might also represent an important protective factor for breastfed babies.




Flow cytometric analysis of peripheral invariant NKT cells in patients with atopic 
dermatitis
Gyimesi E1, Sipka S1, Szarazne Sz. M1, Zeher M1, Gaspar K2, Remenyik E2, Szegedi 
A2 1University of Debrecen, Medical and Health Science Centre, 3rd Department of 
Internal Medicine, Debrecen, Hungary 2University of Debrecen, Medical and Health 
Science Centre, Department of Dermatology, Debrecen, Hungary
In this study we investigated whether peripheral invariant NKT cells (iNKT) can be involved in 
the pathogenesis of atopic dermatitis (AD). The frequency and absolute number of iNKT cells in 
mononuclear cells of peripheral blood of patients with AD (n=43) and healthy controls (n=15) 
were measured by fl ow cytometry using anti-CD3 and monoclonal antibody specifi c for the 
CDR3 loop of the invariant TCR a-chain of iNKT cells (clone: 6B11). The CD4/CD8 subsets of 
iNKT cells were also determined. Furthermore, after PMA/ionomycin stimulation for 4 hours, 
intracellular IFNg and IL-4 cytokines were detected in CD4+CD8-, CD4-CD8- (DN) and CD4-
CD8+ subsets of iNKT cells by fi ve colour fl ow cytometry in patients with AD (n=10) and healthy 
controls (n=10). Both the percentage and absolute number of iNKT cells were signifi cantly lower 
in patients with AD (P< 0.05) compared to healthy controls. The frequency of DN  and CD4-CD8+ 
subpopulation was signifi cantly lower in AD patient (P< 0.05). There was a positive correlation 
between the absolute number of DN cells and iNKT cells both in AD patients (R=938 and P< 
0.001) and healthy controls (R=0.921 and P< 0.0001). The intracellular IFNg level signifi cantly 
decreased in DN CD4/CD8 iNKT subsets of AD patients (P<0.05), however the intracellular IL-4 
level was signifi cantly increased (P< 0.05). According to these results the percentage and the 
number of iNKT cells and also the cytokine producing capacity of the CD4/CD8 iNKT subsets 
are different in peripheral blood obtained from AD patients compared to healthy controls. These 
observations suggest that the DN iNKT cell subset can serve as a source of IL-4 that promotes 
the Th2 differentiation in AD patients and might play a role in the pathogenesis of this disease.
038
FOXP3+ T regulatory cells are present in all stages of cutaneous squamous cell 
carcinoma development
August S1, Pickard C1, Dixon S1, Theaker J2, Gadola S3, Healy E1 1 Dermatopharmacology, 
Univ of Southampton, UK 2Dept of Histopathology, Southampton Gen Hosp,UK 3Div 
of Infection, Infl ammation & Immunity, Univ of Southampton, UK
Squamous cell carcinoma (SCC) of the skin continues to increase in incidence, with fair-skinned 
individuals at higher risk. The propensity for SCCs to arise on patients receiving immunosuppressive 
therapy demonstrates the crucial role of the immune system in preventing skin cancer. The tendency of 
the tumour to grow despite the presence of a peritumoral immune cell infi ltrate in most cases implies 
that this local immune response is insuffi cient to eradicate the lesion. It is now established that FOXP3+ 
T regulatory cells (Tregs) are present in other types of cancer and that these cells can suppress anti-
tumour immune responses. We hypothesised that Tregs play a role in permitting the progression from 
normal keratinocytes through to cutaneous SCC by inhibiting immune-mediated clearance of malignant 
and/or dysplastic cells. A combination of immunohistochemistry/ image analysis and fl uorescence 
activated cell sorting analysis was employed to investigate for CD3, CD4, CD8, CD25 and FOXP3 
expression in SCCs (n=24) and the pre-cancerous lesions, actinic keratosis (AK, n=16) and Bowen’s 
disease (BD, n=18). All lesions (AK, BD and SCC) contained numerous peritumoral FOXP3+ Tregs, 
constituting a mean of 11.9% (SD±5.6%) of the total immune cell infi ltrate. Double immunostaining 
experiments showed that the majority of these FOXP3+ cells co-expressed CD25. Furthermore, the 
mean ratio of Tregs to CD8+ T cells was 1:2 in skin SCC, suggesting that Tregs constitute a substantial 
proportion of the immune cell infi ltrate compared to cytotoxic T cells. There was no signifi cant 
difference in the numbers of Tregs in AK and BD compared to skin SCC, indicating that the infl ux of 
Tregs may represent an early step in carcinogenesis. In addition, fl ow cytometric data demonstrated 
that there is marked enrichment of Tregs in the peritumoural infi ltrate compared to peripheral blood 
in SCC patients, implying that there is a preferential accumulation or expansion of Tregs within 
the tumour microenvironment and that this enrichment is important for tumour development.
039
Generation of a DEC-205 specifi c single chain fragment variable (ScFv) toxin for 
ablation of dendritic cells in vivo
Maas M1, Johnson TS1, Enk AH1, Nettelbeck DM2, Mahnke K1 1University Hospital 
Heidelberg, Germany 2Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, 
Germany
Dendritic cells (DC) are divided into two major subsets. One is characterized by 
being CD8+ DCIR+, whereas the other is expressing DEC205. It has been shown 
that CD8- DEC205+ DC but not CD8+ DCIR+ DC are able to induce FoxP3+Treg 
in the absence of exogenous IL-2 or TGF-â. To minimize tolerogenic effects of 
DEC-205+ DC during cancer therapy, we devised a novel method to eliminate this 
tolerogenic DC subset in vivo. We generated a single-chain fragment variable (scFv) 
that is specifi c for DEC205+ based on a monoclonal murine anti-DEC205 antibody. 
This scFv was fused to Pseudomonas aeruginosa Exotoxin A, which is a toxin that 
inhibits cellular protein synthesis by ADP-ribosylation of elongation-factor-2 of the 
ribosomes. The DNA sequences of both, the scFv and ETA were cloned into an 
expression vector fused to a 6xHis tag and a c-myc tag. We cloned two variants of 
this construct, fusing ETA at the 5`-end or at the 3`-end of the scFv. The expression 
of the recombinant proteins was performed in the E.coli strain TG1 using IPTG 
induction, followed by purifi cation with affi nity chromatography and subsequent 
dialysis. To address whether scFv bind to DC, bone marrow derived DC (BMDC) 
were incubated with scFv-ETA and subsequently stained with a c-myc specifi c 
antibodies. FACS analysis revealed effective binding to the DEC205 receptor of both 
of the constructs. To test whether the scFv-ETA is functional we incubated BMDC 
with graded doses of scFv-ETA and subsequently analyzed induction of apoptosis 
by Annexin-V/PI staining. These results show that scFv-ETA is able to specifi cally 
kill DC. Thus, scFv-ETA is an effi cient tool to eliminate DEC205+ DC and further 
experiments will reveal the role of DEC205+ DC in tolerance and immunity.
040
Generation of Increased Numbers of IgG Plasma Cells in Bullous Pemphigoid: 
NC16a specifi c cells belong to the short-lived Plasma blast population
László S, Neumann S, Hunzelmann N Uniklinik Köln, Köln, Germany
Bullous pemphigoid (BP) is characterized by the presence of circulating 
immunoglobulin G (IgG) autoantibodies directed against the 180 kDa 
bullous pemphigoid antigen (BP180), also known as collagen XVII. The major 
immunodominant site of BP180 is located within the noncollagenous (NC16a) 
domain. In this study we analyzed frequency and phenotype of antigen (NC16a)-
specifi c plasma cells in BP. The enrichment of plasma cells from the peripheral 
blood of patients and healthy individuals was performed using CD138 microbeads. 
CD138+ plasma cells were stained for different surface molecules as well 
intracellularly for immunoglobulin G (icIgG). 50 % (+/- 8.8 %) of the CD138 positive 
cells of BP patients  expressed icIgG, while in control persons an icIgG expression 
was only found in about 24 % (+/- 7.9 %; p < 0.0001). Additionally, on average 
72.5 % (+/- 7.0 %) of the CD138+ IgG-secreting cells of BP patients showed a high 
expression for HLA-DR (CD138+HLA-DRhigh) whereas in healthy donors only 50 
% (+/- 9.3 %) of these cells expressed this surface marker (p < 0.0001). NC16a 
specifi c cells were only detected in the HLA-DRhigh population (1.07 % +/- 0.66 
%) and identifi ed as short-lived plasma blasts. In the cell population representing 
mature long-lived plasma cells, expressing low amounts of HLA-DR (CD138+HLA-
DRlow), no NC16a specifi c cells were detected.  These data indicate that in BP a 
broad autoantigen-independent activation of the plasma cell system occurs. Antigen 
specifi c autoreactive plasma cells belong to the short-lived plasma blast subset 
which could play a role in the immunopathology of BP being prone to remission. 
041
Glutathione Concentrations Regulate Innate Immunity in Septic Patients via 
Modulation of ATF3 (Activating Transcription Factor 3)
Hoetzenecker W1, Guenova E1, Echtenacher B2, Woelbing F1, Hoetzenecker K3, Brueck J1, 
Glocova I1, Biedermann T1, Ghoreschi K4, Röcken M1 1Univ of Tübingen, Germany 2Univ 
of Regensburg, Germany 3Medical Univ of Vienna, Austria 4NIH, Bethesda, USA
ATF3 a stress-regulated transcription factor, is activated in response to TLR-mediated signalling and initiates 
a central negative feedback loop in the NFkB signal pathway. As we found that glutathione depletion, as 
it occurs during systemic infectious diseases, increases susceptibility to bacterial infections in mice, we 
analyzed the effects of ATF3 on human immune cells and the production of IL-6 under conditions of 
sepsis. Stimulation of peripheral blood mononuclear cell (PBMC) and CD14+ monocytes with LPS slightly 
increases ATF3; glutathione depletion, as it occurs during sepsis condition increased expression of ATF3 
5fold. This increase in ATF-3 resulted in signifi cant inhibition of IL-6, IL-12p40, IL-1b and TNF mRNA 
and protein expression by human PBMC and monocytes. Interestingly, restoration of glutathione with 
N-acetly-cysteine impaired ATF3-induction and restored cytokine secretion to control values. Inhibition 
of cytokine secretion was ATF-3-dependent, as blocking of ATF3 induction with specifi c siRNA fully 
restored cytokine production at sub-lethally low glutathione levels. To correlate these fi ndings with the 
in vivo situation, as it occurs during sepsis in humans, we analyzed ATF3, IL-6, TNF expression and 
glutathione levels in the blood of septic patients around day 4 and at the time of recovery. We compared 
the data to those of healthy controls. Surprisingly, both glutathione and ATF3 expression were decreased 
at the beginning of sepsis. Yet, further analysis revealed that in the course of disease glutathione continued 
to decrease, while the ATF3 mRNA was restored to normal levels. IL-6 levels in the serum correlated 
negatively with ATF3 expression: being high at the beginning they declined with increasing ATF3 levels, 
down to levels found in healthy controls. Thus, glutathione levels regulate innate immunity during sepsis, 
by determining IL-6 production through the induction of ATF3. The fi ndings explain why therapeutic 
restoration of glutathione during early phases of sepsis improve the outcome of sepsis; they also predict 
that exaggerated glutathione restoration may increases the susceptibility to bacterial toxins, such as LPS.
042
Histone H4 is a major component of the antimicrobial action of human sebocytes
Lee DY1, Huang CM2, Nakatsuji T2, Thiboutot D3, Monestier M4, Gallo RL2 
1Dermatology, Sungkyunkwan University Samsung Medical Center, Seoul, Republic 
of Korea 2Dermatology, University of California San Diego, San Diego, USA 
3Dermatology, Pennsylvania State University, Milton S. Hershey Medical Center, 
Hershey, USA 4 Microbiology & Immunology, Temple University, Philadelphia, USA
Antimicrobial peptides, such as cathelicidin and β defensins, directly kill microbes 
and have been detected in human sebaceous glands and cell lines. Despite the 
presence of several such peptides, the apparent abundance of these is insuffi cient 
for direct killing of most skin pathogens. In this study we sought to determine 
what molecules provide the majority of antimicrobial peptide activity in human 
sebocytes. Acid soluble protein extracts of SEB-1 sebocytes were separated by 
reversed-phase high performance liquid chromatography and assayed for capacity 
to inhibit the growth of Staphylococcus aureus. Antimicrobial activity was isolated 
in a single major fraction and identifi ed to be histone H4 by mass spectrometry 
and Western blot analysis. The importance of histone H4 to the antimicrobial 
activity of sebocytes was confi rmed by specifi c neutralizing antibody and by 
direct demonstration that recombinant histone H4 had antimicrobial activity 
against Staphylococcus aureus and Propionibacterium acnes. In addition, histone 
H4 enhanced the antimicrobial action of free fatty acids in human sebum. Taken 
together, these results indicate that the release of the histone H4 by holocrine 
secretion from the sebaceous gland may play an important role in innate immunity.
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Human IgG1 and IgG3, but not IgG2 or IgG4, directed against type VII collagen 
cause the pathophysiological features associated with autoimmune blistering 
diseases
Recke A1, Sitaru C2, Vidarsson G3, Evensen M1, Chiriac MT1, Ludwig RJ1, Zillikens D1
1Dept of Dermatology, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, 
Lübeck, Germany 2Dept of Dermatology, University of Freiburg, Freiburg, Germany 
3Dept of Exp. Immunohematology, Sanquin Research and Landsteiner Laboratory, 
University of Amsterdam, Amsterdam, Netherlands
Autoimmunity to type VII collagen, a major hemidesmosomal skin constituent, is 
associated with epidermolysis bullosa acquisita and bullous lupus erythematosus, 
which are subepidermal blistering diseases of skin and mucous membranes. 
Tissue damage induced by these autoantibodies is mediated by their Fc portion 
and is associated with an activation of both complement and leukocytes, leading 
to separation within the dermal-epidermal junction. The autoantibodies belong to 
all four human IgG subclasses; however, the specifi c contribution of each subclass 
in the pathogenesis of autoimmunity to type VII collagen is still controversial. To 
elucidate their pathogenic relevance, we generated a unique set of chimeric anti-
type VII collagen autoantibodies of the four IgG subclasses derived from identical 
V genes, i.e. a set of full-length disease-related recombinant human autoantibodies. 
All four autoantibodies had the same binding specifi city and a similar avidity 
of about 7 nM in surface plasmon resonance analysis (Biacore). Using ex vivo 
models, we demonstrate that a monoclonal autoantibody against type VII collagen 
is suffi cient to activate complement and to induce dermal-epidermal separation. 
However, this ability was restricted to IgG1 and IgG3, and was dose-dependent. 
These fi ndings may eventually contribute to the development of novel therapeutic 
strategies for autoimmune diseases, e.g. isotype-specifi c immunoadsorption.
044
IL-17 and IL-22 producing Th17 cells induce protein contact dermatitis
Glocova I, Yazdi A, Brück J, Röcken M, Ghoreschi K Department of Dermatology, 
Tübingen, Germany
The Th17 cytokines interleukin (IL-)17 and IL-22 are crucial in the pathogenesis of psoriasis. 
Recent fi ndings suggest that Th17 cells are also involved in the pathogenesis of atopic 
and contact dermatitis. During the chronic phase of these diseases the eczematous skin is 
characterized by the presence of Th17 cells and interferon gamma (IFN-g) producing Th1 
cells. Yet, it is still unclear which Th cell subset is responsible for eczema development. 
Therefore, we studied the key mediators induced in response to epicutaneous peptide 
exposure. Ovalbumin (OVA)-specifi c T cell-receptor transgenic mice were epicutaneously 
sensitized with OVA to prime skin-derived peptide specifi c T cells. Gut-primed T cells 
were generated by feeding OVA. We analyzed the cytokine pattern of OVA-specifi c T 
cells activated by skin or gut antigen exposure. After priming, OVA-specifi c T cells from 
skin- or gut-primed donors were transferred into naïve BALB/c mice. Recipient mice 
were challenged epicutaneously with OVA and analyzed for migration of OVA-specifi c 
T cells, eczema development and local cytokine expression. Skin-primed OVA T cells of 
epicutaneously primed donor mice were characterized by high expression of IL-17, IL-22 
and IFN-g˜. In contrast gut-primed OVA T cells showed a Th1 phenotype. After transfer 
in naïve BALB/c mice and epicutaneous OVA challenge, eczema development was only 
observed in mice that had received skin-primed OVA T cells. Skin-primed OVA T cells 
as well as gut-primed OVA T cells migrate with similar frequency into the skin-draining 
lymph nodes of OVA-challenged mice, but only skin-primed OVA T cells were pathogenic. 
Whereas IFN-g was induced in both groups of OVA-challenged mice, only mice that 
received skin-primed OVA T cells showed high levels of IL-17 and IL-22 in the skin-draining 
lymph nodes. The Th17 cytokines IL-17 and IL-22 rather than IFN-g or IL-4 seem to be 
responsible in regulating local tissue infl ammation and causing protein contact-dermatitis.
045
Impaired allergic contact dermatitis response to DNCB in atopic dermatitis (AD) is 
enhanced by fi laggrin loss of function variants
Newell L, Polak M, Pickard C, Owen C, Holloway J, Healy E, Ardern-Jones M 
University of Southampton, United Kingdom
The association of fi laggrin (FLG) loss-of-function variants with atopic dermatitis (AD) has 
highlighted the importance of barrier function in the disease pathogenesis. However, not all 
individuals with AD have FLG mutations and vice versa.  The Th2 skewing in AD skin may 
suggest simultaneous intrinsically defective immunological function. Dinitrochlorobenzene 
(DNCB), a highly lipophilic molecule was found to effi ciently penetrate FLG wild type 
(wt) and defi cient skin to the basement membrane. We utilised contact sensitisation to 
DNCB to examine whether FLG status was associated with an enhanced defect in the 
epithelial immune system in AD as represented by Th2-specifi c responses. Individuals 
with AD (n=9) were screened for R501x and 2204del4 FLG mutations. AD and controls 
(n=9) were sensitised then re-challenged with DNCB. Clinical responses were quantifi ed 
by erythema and skinfold thickness measurements. DNCB-specifi c PBMCs were identifi ed 
by assay of IFN-gamma and IL-4 production with ex vivo and cultured ELISpot. There was 
no signifi cant difference in oSCORAD between FLG variant and wt groups.  All individuals 
with AD showed attenuated clinical responses as measured by skinfold thickness (p<0.05) 
and skin erythema (p<0.05). FLG variants demonstrated further impaired responses 
compared to FLG wt AD. Ex vivo and after short-term culture, antigen-specifi c Th1 cells 
were identifi ed in all groups, only AD made antigen-specifi c Th2 responses (p=0.001). 
Individuals with FLG mutations demonstrated increased IL-4 production.These data suggest 
that immunological priming through the skin with a barrier independent novel antigen 
induces Th2/Tc2 responses in AD irrespective of FLG status, but that loss of fi laggrin 
enhances the immunological Th2 skewing. This supports the possibility that genetic control 
of epidermal integrity determines the threshold for the altered (Th2) immune responses 
associated with AD but that a second immunological abnormality may also be required. 
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Impaired anaphylaxis and mast cell degranulation in mice lacking serum- and 
glucocorticoid-inducible kinase 1
Wölbing F1, Sobiesiak M2, Shumilina E2, Kaesler S1, Lam RS2, Matzner N2, Zemtsova IM2, Kuhl 
D3, Lang F2, Biedermann T1 1Univ of Tübingen, Dept of Derm, Germany 2Univ of Tübingen, 
Dept of Physiol, Germany 3Free Univ Berlin, Dept of Biol, Chem & Pharm, Germany
Allergen and IgE-mediated crosslinking of FcεRI receptors on mast cells initiates several proinfl ammatory 
signalling pathways. Among them, the phosphoinositol-3 (PI3)-kinase pathway plays a pivotal role. A kinase 
activated by the PI3-kinase pathway is the serum- and glucocorticoid-inducible kinase 1 (SGK1), known to 
regulate a variety of ion channels involved in controlling membrane potential. Since the regulation of membrane 
potential plays an important role in governing mast cell degranulation by determinating Calcium infl ux, we 
wanted to elucidate whether SGK1 activation is involved in mast cell degranulation and in vivo anaphylaxis. To 
this end, mice were sensitized with Dinitrophenol (DNP)-specifi c IgE and 24h later these mice were challenged 
with different doses of DNP to determine the threshold dose of DNP eliciting systemic anaphylaxis. Anaphylaxis 
read out was the decrease of core body temperature as detected by measuring rectal temperature every 7 min. 
SGK1 knockout mice (sgk1-/-) and their SGK1 wild-type littermates (sgk1+/+) were challenged with 120µg DNP 
and core body temperature was monitored for one hour. Full-blown anaphylaxis with a fast decline in body 
temperature resulting in a signifi cant temperature drop with a maximum of 1,74±0,41 C after 21 minutes was 
detected only in sgk1+/+ mice, while sgk1-/- mice showed no anaphylactic reaction. To analyze whether the 
strong impairment of anaphylaxis depended on the absence of SGK1 in mast cells, bone marrow derived mast 
cells (BMMC) of sgk1-/- and sgk1+/+  mice were generated showing unequivocal phenotypes after 4 weeks of 
culture with IL-3 and SCF (CD117+, CD34+, FceRI+). In vitro degranulation of mast cells as detected by release of 
ß-hexosaminidase was signifi cantly reduced in BMMC from sgk1-/- mice. To identify the role of SGK1 precisely, 
patch clamping was performed. In contrast to sgk1+/+ BMMC cell membrane hyperpolarisation following 
allergen specifi c activation was reduced in sgk1-/- BMMC secondary due to impaired Ca2+ infl ux. Our data 
demonstrate that SGK1 is required for ion channel regulation in the process of mast cell degranulation and 
systemic anaphylaxis and further indicate that therapeutic targeting of the SGK1 pathway may be highly promising.
047
Improvement of dendritic cells vaccinotherapy by using imiquimod
Buche S1, Charbonnier-Hatzfeld AS2, Lassalle P3, Marchetti P2, Mortier L1 1Hôpital 
Claude Huriez, Lille, France 2Inserm U837, Lille, France 3Inserm U774, Lille, France
Melanoma represents a real problem of public health. Its incidence doubles in France every 10 years 
and it is responsible for 5 deaths per day. The usual treatment, the dacarbazine, has a low effi cacy 
with only 20% response among patients. Thus new therapeutic approaches must be developed to 
treat melanoma. As antigen presenting cells, dendritic cells should be a good candidate to stimulate 
specifi cally immune response against tumors. For 15 years, numerous vaccinotherapy using dendritic 
cells (DC) have been developed and display promising result. Nevertheless, this strategy should 
be optimized in order to increase successful response. One way to increase effect of dendritic cell 
injection is to couple it with other treatment. In this context, imiquimod appears to be an interesting 
molecule. Imiquimod is an imidazo-quinoline which binds TLR-7. TLR-7 binding induces synthesis 
and release of cytokines such as IFNα, TNFα and IL 6/8/12. In vivo, imiquimod topic application 
induces DC maturation, particularly Langherhans cells maturation which then migrate into lymph 
nodes. DC generated in vitro from monocytes in the presence of IL-3 and IFNβ (DCI3) could be a 
good candidate in a melanoma treatment in association with imiquimod. Indeed, DCI3 display some 
characteristics of plasmacytoïd DC which express TLR-7. First, a TLR encoding mRNA expression of 
DCI3 was established by RT-PCR. Then imiquimod effect on DCI3 phenotype and on in vitro migration 
capacity was studied. Finaly, a human melanoma xenograft SCID mouse model was established to 
estimate the effect of imiquimod on the DCI3 in vivo migration capacity and survival. Interestingly, the 
both mature and immature DCI3 highly expressed TLR7. Imiquimod increases the CD123 expression 
(receptor of IL3 and survival marker). Preliminary results suggest that imiquimod would increase the 
DCI3 migration against CCL19 in vitro. This last result was confi rmed in vivo. Tumor pretreatment by 
imiquimod induces a higher migration of DC injected in this tumor into spleens and lymph nodes. Thus 
these results show that intratumoral injection of DCI3 in association with imiquimod topic application 
should be a good strategy in order to improve the effi cacy of immunotherapy in melanoma patients.
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Induced in vivo expression and secretion of beta defensins, RNase 7 and psoriasin 
in patients with atopic dermatitis independently of S. aureus
Gläser R, Dressel S, Meyer-Hoffert U, Fölster-Holst R, Schröder JM, Schwarz T, Harder 
J University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany
Human skin has the ability to produce highly effective antimicrobial peptides (AMP) 
against potentially invading microorganisms. Recently, reduced expression of AMP 
in patients with atopic dermatitis (AD) compared to psoriasis vulgaris has been shown 
and discussed as a possible explanation for the high infection rate of AD patients. Aim 
of our study was to analyze comparatively the in vivo expression and secretion of 
different AMP in AD patients and healthy controls. Standardized skin derived washing 
fl uids from lesional and non-lesional skin as well as nasal swabs were collected 
from untreated AD-patients (n=38) and matched controls (n=25). Qualitative and 
(semi-)quantitative analysis of microbial colonization with Staphylococcus aureus 
(SA) and coagulase negative Staphylococci was performed. The release of human 
beta defensin (hBD)-2, hBD-3, RNase 7 and psoriasin (S100A7) was determined by 
ELISA. In addition, biopsies were taken from AD patients and controls to investigate 
AMP expression by immunohistochemistry. Colonization with SA was observed in 
87% of AD patients and 32% of healthy controls. Immunohistochemistry revealed 
an induced expression level for all AMP in lesional and partly in non lesional skin. 
The median AMP-release in lesional skin of AD patients was signifi cantly higher 
for hBD-2, RNase 7 and psoriasin when compared to non lesional skin and healthy 
controls. No correlations between SA colonization and individual AMP levels were 
observed, whereas SA colonisation was positively correlated with the severity of AD 
as determined by the “scoring of atopic dermatitis” (SCORAD). Nasal fl uids of AD 
patients and controls showed no signifi cant differences in hBD-2 and -3, RNase7 
and psoriasin levels. This study indicates that the antimicrobial response in AD is not 
generally impaired, but greatly differs according to the type of AMP produced by skin.




Induction of Multinucleated Giant Cell In vitro by high dose glucose density of 
conditioned medium
Iwasaka H, Mizuno K, Okamoto H Kansai Medical University, Moriguchi,Osaka, 
Japan
Multinucleated giant cells (MGCs) are seen in granuloma and considered to origi-
nate from the fusion of monocyte-macrophage lineage cells.
Langhans-type giant cells are seen in many infectious granulomatous disorders such 
as tuberculosis and leprosy or in unknown pathological infl ammatory granulomatous 
disorders such as sarcoidosis and granuloma annulare, whereas foreign-body-
type giant cells are characteristic in foreign-body granulomas. It is known that 
granuloma annulare is associated with diabetes mellitus. In the present study we 
examined the in vitro effects of glucose on the formation of MGCs. The supernatant of 
concanavalin A-stimulated human peripheral blood mononucrear cells (conditioned 
medium) produced MGCs from monocytes on day 1 with a maximal desity on day3. 
Immunocytochemical staining showed that MGCs expressed CD14, CD54, and CD68. 
While CD14 and CD54 were stained on the cell membrane, CD68 and angiotensin 
converting enzyme were detected in the cytoplasm of MGCs. The fusion rate of MGC 
at culture medium with 0.45% glucose was signifi cantly higher than that with 0% or 
0.25% glucose. The expression of CD54 on monocytes cultured in 0.45% glucose 
medium for 1 day was higher than that in 0% or 0.25% glucose culture medium, 
while there was no difference in CD11a expression.These results suggest that glucose 
concentration infl uenced the rate of MGC formation through the expression of CD54.
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Induction of regulatory T cells by immature epidermal Langerhans cells upon oral 
glucocorticosteroid treatment
Stary G1, Klein I1, Kohlhofer S1, Skvara H1, Jung T2, Stingl G1 1Medical University of 
Vienna, Department of Dermatology, DIAID, Vienna, Austria 2Institute for Biomedical 
Research and Institute for Exploratory Development, Novartis, Basel, Switzerland
Although glucocorticosteroids have been used for many decades in autoimmune 
diseases and transplantation, the exact mechanisms responsible for their 
immunosuppressive properties are not fully understood. We therefore undertook 
a study with 24 nickel-allergic patients, performed epicutaneous patch tests (EPT) 
prior and after oral steroid or placebo treatment and took skin biopsies 72 hours 
after patch test application for immunofl uorescence analysis. Expectedly, oral steroid 
treatment led to a substantial reduction of clinical symptoms that was paralleled by 
a sizeable decrease of infi ltrating T cells. To our surprise, however, we found an 
absolute and, even more pronounced, a relative increase of FoxP3+CD25+CD4+ 
T cells in the dermis of post-steroid ECT as compared to the placebo control group. 
In addition, higher numbers of epidermal Langerhans cells (LC) were observed 
after oral steroid treatment in comparison to pre-steroid lesions or the placebo 
group. In contrast to LC from pre-steroid patch tests, those after steroid had an 
immature phenotype. Interestingly, increased numbers of epidermal LC and 
dermal regulatory T cells were associated with upregulated expression of TGF-beta 
in skin biopsies after steroid treatment. Functional in vitro experiments showed a 
dose-dependent increase of FoxP3+CD4+ T cells upon incubation of peripheral 
blood mononuclear cells with dexamethasone. Our data support the concept that 
corticosteroid can promote the generation of regulatory T cells and, thus, shed new 
light on the mechanisms of glucocorticosteroid-mediated immunosuppression.
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Initiation of cutaneous skin responses by promoting Th differentiation through 
prostaglandin I receptor IP
Nakajima S, Honda T, Tanizaki H, Egawa G, Narumiya S, Miyachi Y, Kabashima K 
Kyoto University Graduate School of Medicine, Kyoto, Japan
It has been demonstrated that a large amount of prostaglandin I2 (PGI2), which exerts 
its actions via its specifi c receptor IP (Ptgir), is detected in the infl ammatory sites, 
such as asthma and atopic dermatitis. However, the roles of PGI2 in the cutaneous 
immune responses remain to be elucidated. Therefore, we sought to address this 
issue by generating Ptgir-/- mice and using an IP agonist. Previous reports suggested 
that PGI2 might suppress infl ammation, we expected the contact hypersensitivity 
(CHS) response to be enhanced in Ptgir-/- mice. However, Ptgir-/- mice exhibited 
signifi cantly attenuated CHS response induced by dinitrofl uorobenzene (DNFB). 
This phenotype was recapitulated in wild-type mice by adoptive transfer of T cells 
from sensitized Ptgir-/- mice. In addition, decreased amounts of IFN-gamma in 
the culture supernatant of DNFB-sensitized lymph node cells after re-stimulation 
were observed in Ptgir-/- mice. We then purifi ed naEe T cells and incubated them 
with Th skewing condition for Th differentiation in vitro. An IP selective agonist 
facilitated Th1 differentiation from naEe T cells in cAMP and PI3 kinase dependent 
manners. Lastly, we detected PGI synthase in dendritic cells and its receptor IP in 
T cells abundantly by real time PCR analysis. Taken together, our data implicate 
that PGI2 produced by dendritic cells in the lymph nodes act on IP in naEe T cells 
to promote Th differentiation to initiate acquired cutaneous immune responses.
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Interleukin (IL)-31 induces pro-infl ammatory cytokines in human monocytes and 
macrophages following stimulation with staphylococcal exotoxins
Kasraie S, Niebuhr M, Werfel T Department of Immunodermatology & Allergy 
Research, Hannover Medical School, Hannover, Germany
IL-31 is a cytokine expressed by T cells following activation with cytokines or staphylococcal 
exotoxins. A major function of IL-31 in atopic dermatitis (AD) is the induction of pruritus 
in the skin via the IL-31 receptor on sensory nerve cells. However, the regulation of 
the IL-31 receptor and pro-infl ammatory functions of IL-31 in human monocytes and 
monocyte derived cells have yet to be studied in detail. Objective was to investigate the 
regulation and function of IL-31 receptors in resting and activated human monocytes, 
macrophages and dendritic cells. Human monocytes, macrophages and dendritic cells 
were stimulated with staphylococcal exotoxins (SEB, a-toxin) or cytokines (IFN-γ, IL-13). 
IL-31RA expression and regulation were then investigated at both the mRNA and protein 
level. Subsequently, functional effects of IL-31 stimulation on cytokine secretion were 
measured at the protein level. Staphylococal exotoxins signifi cantly up-regulated IL-31RA 
expression on monocytes and macrophages but not on dendritic cells at both the mRNA 
and protein level. IL-31 enhanced the secretion of IL-1b, IL-6 and IL-18 and up-regulated 
CD86 and HLA-DR expression. In AD patients functional IL-31RA was also detected 
following stimulation of PBMC with IFN-γ.  However, this was not observed in healthy 
individuals. IL-31 induces pro-infl ammatory effects in activated human monocytes and 
macrophages. This may have implications for cutaneous infl ammation in eczema where 
an over-expression of IL-31 has been described previously. Our fi ndings provide a new link 
between staphylococcal colonization and the worsening of infl ammation via IL-31. Further 
therapeutic considerations may include the TH2 cytokine IL-31 as a target molecule in AD. 
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Lack of PPAR-alpha aggravates skin contact hypersensitivity by triggering regulatory 
T cells
Dubrac S1, Elentner A1, Schoonjans K2, Auwerx J2, Schmuth M1 1Medical School, 
Innsbruck, Austria 2EPFL, Lausanne, Switzerland
PPAR-alpha is strongly linked to infl ammation. Whereas PPAR-alpha defi ciency 
was previously shown to be pro-infl ammatory, the underlying mechanism remains 
unknown. Therefore, the aim of our work was to dissect the cellular basis of the pro-
infl ammatory effects of PPAR-alpha defi ciency in skin. We found that, after challenge 
with a contact allergen, cutaneous hypersensitivity reactions were increased in PPAR-
alpha defi cient mice when compared to wild type animals. The number of T-lymphocytes 
was increased in the hypersensitivity reaction and predominantly consisted of CD4+ 
T-lymphocytes. These lymphocytes displayed increased expression of the activation 
marker CD25 in PPAR-alpha defi cient mice compared to wild type animals. Upon 
allergen challenge, the percentage of regulatory T-cells (Treg) was decreased in the 
skin draining lymph nodes, whereas the amount of Treg remained unchanged in the 
skin of PPAR-alpha defi cient mice compared to wild type animals. Lack of Foxp3 up-
regulation in lymph nodes of PPAR-alpha defi cient mice upon allergen challenge did 
not result from an intrinsic unability to express Foxp3 but rather from a lack of IL-2 
production by PPAR-alpha defi cient T-lymphocytes, TGF-beta remained unchanged. 
In addition, PPAR-alpha defi cient Treg exhibited intrinsic dysfunction since their 
suppressive capacity was impaired when compared to wild type cells. In conclusion, 
PPAR-alpha defi ciency aggravates skin contact hypersensitivity by triggering Treg.
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Lactoferrin is expressed in eccrine glands of the skin and exists in sweat
Pakr J, Park G, Yang J Sungkyunkwan University Samsung Medical Center, Seoul, 
Republic of Korea
The eccrine gland is a major appendage and exocrine gland in the skin. Its main 
function has been considered to be thermoregulation. Recently, it has been reported 
that antimicrobial peptides including cathelicidin and dermcidin exist in the sweat, 
suggesting that sweat may play a role in skin defense. Lactoferrin is a non-haem iron-
binding protein that is part of the transferrin protein family. It is found in tears, saliva, 
vaginal fl uids, nasal and bronchial secretions, most highly in milk. It has been known 
as a component of host defense against infection and infl ammation. In this study, we 
determined if lactoferrin is produced by eccrine glands, thereby establishing its potential 
to add to defense of the skin. Lactoferrin was detected in eccrine glands of normal human 
skin by immunohistochemistry. In addition, lactoferrin was found in sweat obtained 
from normal volunteers by Western blot analysis. These fi ndings suggest that lactoferrin 
may contribute to skin defense against infection through the secretion of sweat.
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Langerhans cells are critical in the development of atopic dermatitis-like 
infl ammation and symptoms in mice
Elentner A1, Finke D2, Schmuth M1, Chappaz S2, Ebner S1, Malissen B3, Kissenpfennig 
A4, Romani N1, Dubrac S1 1Medical School, Innsbruck, Austria 2Medical University, 
Basel, Switzerland 3Université de la Méditerrannée, Marseille, France 4Queen´s 
University, Belfast, Ireland
Genetic or vitamin D3-induced overexpression of TSLP by keratinocytes results in an 
atopic dermatitis (AD)-like infl ammatory phenotype in mice echoing the discovery of 
high thymic stromal lymphopoietin (TSLP) expression in epidermis from AD patients. 
Although skin dendritic cells (DC) are suspected to be involved in AD, direct evidence 
of a pathogenetic role for skin DC in TSLP-induced skin infl ammation has not yet been 
demonstrated. In a mouse model of AD i. e. mice treated with the low-calcemic vitamin 
D3 analogue, MC903, we show that epidermal Langerhans cells (LC)-depleted mice 
treated with MC903 do neither develop AD-like infl ammation nor increased serum IgE 
as compared to vitamin D3 analogue-treated control mice. Accordingly, we show that, 
in mice treated with MC903 or in K14-TSLP transgenic mice, expression of maturation 
markers by LC is increased whereas maturation of dermal DC is not altered. Moreover, 
only LC are responsible for the polarization of naïve CD4+ T cells to a Th2 phenotype i. e., 
decrease in IFN-gamma and increase in IL-13 production by CD4+ T cells. This effect of 
LC on T-lymphocytes does not require OX40-L/CD134 and is mediated by a concomitant 
downregulation of IL-12 and CD70. While it was previously stated that TSLP up-regulates 
the production of TARC/CCL17 and MDC/CCL22 by human LC in vitro, our work shows 
that production of these Th2- cell attracting chemokines is increased only in keratinocytes 
in response to TSLP overexpression. These results demonstrate that LC are required for the 
development of AD in mouse models of AD involving epidermal TSLP overexpression.
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Langerhans’ cells are more effi cient than dermal dendritic cells at activating CD8 
T cells
Polak ME, Newell L, Healy E, Ardern-Jones MR School of Medicine, University of 
Southampton, UK
Cutaneous dendritic cells are the critical regulators of adaptive immune responses to antigens 
entering the organisms via skin. We sought to investigate the potential of human skin migratory 
Langerhan’s cells (smiLCs) and dermal dendritic cells (smiDDCs) to activate antigen-specifi c T 
lymphocytes. We optimised isolation of functional human smiLCs and smiDDCs, assessing yield, 
viability and phenotype of epidermal and dermal migratory cells, following enrichment on the 
density gradient (n=25). Subsequently, we tested the potential of smiLCs and smiDDCs to stimulate 
the antigen-specifi c HLA-matched T lymphocytes by measuring the secretion of cytokines and 
the proliferation of T lymphocytes subpopulations with fl ow cytometry and in the ELISpot assay. 
To assess the activation status of smiDCs we analysed the expression of HLA-class I, HLA-DR, 
CD86, CD40, CD70 and CD83 prior and post culture with TNF-α. Migratory epidermal and 
dermal cells comprised mixed populations of cells, differing in expression of CD1a, CD11c and 
HLA-DR. SmiLCs expressed high levels of CD1a and HLA-DR and no CD11c, while smiDDCs 
co-expressed all three markers. HLA-A2 smiLCs pulsed with an A2 EBV epitope activated Tc1 
EBV-specifi c HLA-A2-restricted T lymphocytes more effi ciently than smiDDCs (P<0.05). Moreover, 
smiLCs were better able to stimulate the proliferation of CD8+ T cells (p<0.05). Analysis with fl ow 
cytometry demonstrated that fresh smiLCs expressed higher levels of CD70, CD86 and CD83 than 
smiDDCs (p<0.05) and up-regulated them more strongly after maturation with TNF-α (p<0.05), 
which may explain their stronger stimulatory ability. The higher potential of smiLCs to stimulate 
CD8+ T lymphocytes suggests that tissue localisation may determine the outcome of DC-T cell 
interaction. Further understanding of the differential functions of skin DCs may indicate future 
targets for immune therapy of skin disease and help to develop new strategies for vaccinations.
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Macrophages express IL-12 and IL-23 in lesions of Hidradenitis suppurativa
Schlapbach C, Hänni T, Yawalkar N, Hunger R University of Bern, Bern, Switzerland
Hidradenitis suppurativa (HS) is a chronic infl ammatory disorder of the apocrine 
gland-bearing skin. The pathophysiology of HS is still poorly understood and the 
role of the immune system therein is unclear. The cytokines IL-12 and IL-23 are 
important in bridging the innate and adaptive immune system and may contribute 
to the genesis of infl ammatory diseases. Classically activated macrophages 
(M1) are an important source of IL-12 and IL-23.The expression of macrophage 
markers were analyzed by immunohistochemistry in lesional skin from patients 
with HS and compared to normal skin. IL-12 and IL-23 expression was analyzed 
on both mRNA and protein level.We found a signifi cant up-regulation of different 
macrophage markers, predominantly of the M1 subset, in HS. Both IL-12 and 
IL-23 were found the be over-expressed on the mRNA and the protein level and 
produced by macrophages. The over-expression of IL-12 and IL-23 in lesions 
of HS further points to a crucial role of the innate immune system in HS and 
provides evidence for the use of anti-IL-12/23 antibodies in the treatment of HS.
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MAPK pathways regulate B7-H1 expression in dendritic cell (DC) subpopulations
Karakhanova S, Mahnke K University of Heidelberg, Heidelberg, Germany
B7-H molecules, expressed by DC, play an important role in immune regulation, but 
the control of their expression during DC maturation is not clear yet. We investigated 
the expression of B7-H1 during DC maturation in monocyte derived DC (MoDC) and 
genuine DC (gDC), isolated from blood of healthy donors. Stimulation of MoDC as 
well as gDC with a cytokine cocktail and TLR-ligands resulted in enhanced expression 
of classical costimulatory molecules like CD86 and increased T-cell stimulatory 
capacity. However this activation was also accompanied by upregulation of B7-H1. 
While MoDC represent a homogenous myeloid population, gDC consist of mixed 
populations of myeloid DC and plasmacytoid DC expressing different TLR receptor 
repertoires. To analyse the B7-H1 expression in these individual subpopulations we 
isolated and stimulated enriched mDC and pDC with TLR ligands and cytokines and 
performed FACS analysis and functional assays. LPS, Poly I:C and cytokines enhanced 
the expression of B7-H1 in mDC. In contrast, in pDC CpG and cytokines induced 
upregulation of B7-H1 surface expression, although to a lesser extend as compared to 
mDC. The B7-H1 up-regulation was accompanied by the activation of the ERK and p38 
MAPK-kinase pathways in DC and specifi c inhibitors downregulated B7-H1 expression. 
To induce upregulation of B7-H1 in gDC simultaneous activation of both, ERK and p38 
molecules, was necessary. Functionally the B7-H1 expression by DC was involved in 
silencing the IFN-gamma production by T cells, since blockage of B7-H1 on the DC 
in DC-T cells cocultures increased the amount of produced IFN-gamma. Our result 
indicate that B7-H1 expression is upregulated during maturation of MoDC and freshly 
isolated peripheral blood DC, involving the ERK/p38 MAPK kinase pathways, and 
functionally B7-H1 may serve to control IFN-gamma cytokine production from T-cells.
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Neurogenic signals are required for the induction of contact hypersensitivity but 
not for low zone tolerance to type IV allergens
Trosien JA, Maurer M Charité - Universitätsmedizin Berlin, Berlin, Germany
Allergic contact dermatitis due to contact hypersensitivity (CHS) reactions is one 
of the major occupational dermatologic problems. The induction of low dose 
tolerance (LZT) may be a promising strategy to prevent harmful allergic reactions 
to type IV allergens. Nerves have been shown to participate in the pathophysiology 
of a diverse spectrum of dermatologic disorders, including contact dermatitis. 
Here, we investigated the role of cutaneous sensory nerves in the induction phase 
of CHS and LZT in a mouse model. We generated sensory nerve-defi cient skin by 
unilateral surgical denervation of a defi ned region of back skin in female C57BL/6 
mice. Animals sensitized to TNCB on the denervated skin area showed markedly 
reduced CHS reactions (decreased ear swelling up to 70%, p < 0.0001, and hapten-
specifi c T cell proliferation) when compared to sham-operated mice. In contrast, LZT 
induction was not affected by the absence of skin sensory nerves as CHS responses 
were signifi cantly diminished by repeated topical low dose application of TNCB on 
either the denervated or the sham-operated back skin. Our data show that sensory 
nerves are required for a normal sensitization to contact allergens, allergen-driven 
skin infl ammation and T cell responses, but not for the induction of low dose 
tolerance. The most likely explanation for the different role of sensory nerves in these 
two T cell driven responses is that neuropeptides released from cutaneous nerves 
are involved in the activation of CHS- but not LZT-inducing antigen-presenting cells. 
The identifi cation of specifi c neurogenic signals that facilitate sensitization to contact 
allergens may provide novel targets for the prevention of allergic contact dermatitis.
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Oxidized fragrance terpenes are common allergens in consecutive dermatitis 
patients. Overview of different clinical studies over an 18 years period
Matura M1, Sköld M2, Bråred-Christensson J2, Karlberg AT2 1Institute of Environmental 
Medicine, Karolinska Institutet, Stockholm, Sweden 2Dermatochemistry and Skin 
Allergy, Department of Chemistry, University of Gothenburg, Gothenburg, Sweden
Limonene and linalool are common fragrance terpenes which are found in perfumes 
and household products often in considerably high concentration. Both terpenes 
autoxidize on air exposure in normal room temperature and handling. The pure 
compounds are not allergenic but the oxidation products have been found to cause 
contact allergy. The aim of different clinical studies conducted through 18 years (1991-
2009) was to investigate the frequency of contact allergy to oxidized R-limonene and 
linalool. We also aimed to study concomitant positive test reactions in the study 
group. Patch testing with oxidized limonene and oxidized linalool was performed 
in all together 9296 and 4929 (resp.) patients in several dermatologic clinics. All 
together 2.2% of the patients tested showed positive reactions to oxidized R-limonene 
and 2.7% to oxidized linalool (cases). Contact allergy to Fragrance mix was observed 
in 20-41%, to Myroxylon Pereirae in 20-33% and to colophony in 12-32% of cases 
compared to 6%, 5%, and 3% (resp.) frequencies in patients without contact allergy 
to oxidized fragrance terpenes. None of the cases tested with non-oxidized fragrance 
terpenes showed positive reactions. Oxidized fragrance terpenes are common contact 
allergens in contrast to non-oxidized fragrance terpenes, intended to apply into 
products at manufacturing. Contact allergy to the oxidized terpenes was observed with 
a signifi cantly high frequency of contact allergy to other fragrance allergy markers. 
The results emphasize the need of testing patients with the compounds they actually 
come in contact with and not only with the compounds given on ingredient labels.




Participation of newly-identifi ed IL-1 family members in the pathogenesis of 
psoriasis
Johnston A, Xing X, Riblett M, Voorhees JJ, Elder JT, Gudjonsson JE University of 
Michigan, Ann Arbor, USA
The IL-1 cytokine family consists of 11 members, the best characterized of which are IL-1a, IL-1b, 
IL-RA and IL-18.  Seven novel members have recently been identifi ed: IL-1F5, which antagonizes 
the pro-infl ammatory cytokines IL-1F6, F8 and F9; IL-1F7, an attenuator of IL-18 activity; IL-1F10 of 
unknown function, and IL-F11 (IL-33) a Th2-inducing cytokine. The regulation and function of these 
new cytokines in the skin is poorly understood.  Recently, overexpression of IL-1F6 in IL-1F5 knockout 
mice was shown to lead to a psoriasiform phenotype; expression of these two cytokines is elevated 
in psoriatic skin.  To better defi ne the role of this family in psoriasis pathogenesis, we assessed the 
expression of all known IL-1 family ligands and their receptors in healthy controls, symptomless psoriasis 
and psoriatic plaques by QRT-PCR.  Expression of the IL1B, IL1RA, IL1F5, -F6, -F8, and -F9 genes was 
signifi cantly increased in plaque versus symptomless skin, whereas expression of the anti-infl ammatory 
IL1F7 gene was decreased.  This was supported immunohistologically, with IL-1F5, -F6, -F8 and -F9 
being up-regulated and IL-1F7 being down-regulated in psoriasis plaques. IL-1F6 was up-regulated at 
the mRNA level to a much greater degree than its antagonist cytokine IL1F5.  To begin to understand 
the induction of IL-1 cytokines in psoriasis skin, we treated normal human keratinocytes (NHK) with 
IL-1a, IL-17A, IL-22 and TNF-a. Stimulation of NHK with IL-1a increased expression of IL-1a and 1b, 
IL-1F5, -F6, -F8, -F9, -F10 and -F11. IL-17A induced IL-1F6 and -F9 expression. While IL-22 alone 
was ineffective, it potentiated the effects of IL-17A. TNF-a dose-dependently induced IL1RA, -F5, -F7, 
-F8 and -F9 expression, while IL-1F7 was suppressed by IL-1a, IL-17A and IL-22. With regard to IL-1 
family effector function, treatment of NHK with IL-1F9 dose-dependently induced the expression of 
hCAP18/LL-37, an antimicrobial peptide overexpressed in psoriasis epidermis. While these results 
suggest important participation of newly-identifi ed IL-1 family members in the pathogenesis of psoriasis, 
the exact interactions and roles of these novel cytokines in skin infl ammation remains to be elucidated.
062
Platelet P-selectin as a biomarker of infl ammation in psoriasis
Garbaraviciene J, Diehl S, Ludwig RJ, Boehncke WH Clinic of Johann Wolfgang 
Goethe University, Frankfurt, Germany
In addition to their role in hemostasis, platelets are also recognised as important modulators in 
the regulation of immune response. Activated platelets expressing P-selectin (CD62P) increase 
cell interactions and are involved in the extravasation of leukocytes into the infl ammed tissue. 
Considering P-selectin as a possible general indicator of infl ammation, we investigated its 
expression in psoriasis and other infl ammatory skin diseases. Platelet activation measured as 
P-selectin expression was assessed by fl ow cytometry in 46 patients suffering from psoriasis, 
admitted for in-patient treatment to our dermatological department. 41 healthy volunteers served 
as controls. Increased median P-selectin expression on the platelets was observed in patients with 
psoriasis before treatment, compared to the control group of healthy persons (3.61% vs. 1.46%, 
p<0.001). The successful anti-psoriatic therapy was followed by decrease in the median PASI from 
17.2 to 5.45, as well as in levels of median P-Selectin from 3.61% to 1.48%, p<0.01. Changes in the 
PASI evaluated for psoriasis patients before and after the successful anti-psoriatic therapy correlated 
with changes in P-selectin expression, r=0.31, p<0.05. In addition we investigated P-Selectin 
correlation with separate PASI components: erythema, infi ltration and scaling. These analyses 
documented an even better correlation with PASI components refl ecting infl ammation,- erythema 
and infi ltration (r=0.52, p<0.01 and r=0.35, p<0.05 respectively), but not with a scaling (r=0.04, 
p=0.98). Successful therapy resulted also in a marked decrease of median P-selectin expression in 
cases of other infl ammatory skin diseases (n=100, from 2.52% to 1.41%, p<0.001).Taken together, 
patients with infl ammatory skin diseases exhibit increased platelet activation as documented 
by elevated P-selectin expression. Successful anti-infl ammatory treatment results in reduced 
P-selectin expression. In the case of psoriasis, the change in P-selectin values correlates with the 
PASI, particularly with erythema and infi ltration which refl ect infl ammation. Platelet P-selectin 
expression may therefore be a potential biomarker for the severity of psoriatic infl ammation.
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Polymorphisms of IL-4, IL-10 and IL-13 genes in Polish population of atopic 
dermatitis patients
Narbutt J, Przybylowska K, Kuna P, Stelmach I, Slowik-Rylska M, Lesiak A Medical 
University of Lodz, Lodz, Poland
Atopic dermatitis (AD) is a chronic infl ammatory skin disease. Genetic background 
of AD  probably contains highly interactive and polygenetic components. The results 
obtained in various centers on the occurrence and role of gene  polymorphisms, 
including IL-4, IL-10 and IL-13, are unequivocal. It can result from genetic differences 
in various populations.  These discrepancies were the reason why we examined IL-4, 
IL-10  and IL-13 genes polymorphisms in Polish AD patients group where AD severity 
assessed by SCORAD system was defi ned as mild.  The study group consisted of 166 
AD patients and 205 healthy controls, living in the same central region of Poland 
with negative allergy history. AD was diagnosed according to criteria proposed by 
Hanifi n and Rajka . Blood samples were taken to analyze IL-4 , -10 and -13 gene 
polymorphisms by RFLP-PCR technique. The following polymorphisms were examined: 
for IL-4 gene(- 590 T/C) , for IL-10 gen (-1082 G/A) and for IL-13 gene (-1055 C/T). 
Analysis of-1055 C/T IL-13 gene polymorphisms revealed  signifi cantly decreased 
risk of AD development  in the carriers of genotype C/C (OR=0,59 (0,39;0,92), while 
signifi cantly increased risk for AD development was observed among C/T genotype 
carriers (OR=1,59 (1,03;2,46). Similar tendency was observed in allele frequency: for 
allele C, OR was 0,64 (CI 95% 0,44;0,93) and for allele T,  OR = 1,55 (1,07;2,25). 
No statistical signifi cances was found for -590 C/T IL-4 and -1082 G/A IL-10 gene 
polymorphisms. Based on obtained results we conclude that -1055 C/T IL-13 gene 
polymorphisms may be involved in AD pathogenesis in AD Polish population.
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Production of Tolerance-Inducing Molecules for Type XVII Collagen for Gene 
Therapy in Junctional Epidermolysis Bullosa Patients
Ettinger M1, Gratz IK1, Schwarzenbacher R2, Thalhamer J3, Hintner H4, Bauer JW1 
1eb-house Austria, University Hospital Salzburg, Austria 2Dept of Molecular Biology, 
University of Salzburg, Austria 3Christian Doppler Laboratory of Allergy Diagnostics 
and Therapy, University Salzburg, Austria 4eb-house austria, Dept of Dematology 
University Hospital Salzburg, Austria
The immune system is constantly confronted with antigens (proteins) and has to 
discriminate between self (harmless) and non-self (potentially harmful). Several mechanisms 
act together to ensure self-tolerance. Immune responses to the therapeutic gene product 
are potentially serious complications in treatment of genetic diseases by gene therapy. 
Especially in treatment of junctional Epidermolysis bullosa, an autosomal heritable skin 
blistering disease, the induction and maintenance of tolerance is critical to the success of 
the treatment, due to the lack of type XVII collagen in these patients and also because of 
its general immunogenicity. Aim of this study was to create tolerance-inducing molecules 
and explore their functionality and their ability to induce tolerance. Antigen presentation 
by immature (non-activated) dendritic cells (DC) results in generation of regulatory T 
cells. We want to modulate the activation status of DC via application of the suppressive 
cytokine IL-10. Therefore, we generated fusion proteins of IL-10 and the antigen human 
NC16A, the immunodominant domain of type XVII collagen. These proteins have been 
successfully expressed in the baculovirus insect cell expression system and subsequently 
purifi ed. The biological functionality of IL-10 in fusion with antigen will be proven by 
its stimulating effect on the growth of a mast cell line, MC/9. The potential ability of the 
cytokine fusion proteins to induce antigen specifi c immune tolerance will be examined 
in further experiments using a mouse model, which mimics ex vivo gene therapy.
065
Regulatory T cells in atopic dermatitis – epidermal dendritic cell clusters may 
contribute to their local expansion
Nagy G1, Baráth S1, Szodoray P2, Gáspár K1, Sipka S1, Bagdi E3, Banham AH4, Krenács 
L3, Szegedi A1 1Univ of Debrecen, Hungary 2Univ of Oslo, Norway 3Laboratory of 
Tumour Pathology & Molecular Diagnostics, Szeged, Hungary 4Univ of Oxford, UK
Regulatory T cells (Tregs) have an essential role in tolerance and immune regulation. However, 
there is only a small quantity of controversial data published thus far on the role and number 
of these cells in atopic dermatitis (AD). The aim of the study was to investigate the number of 
CD4+CD25+FOXP3+ Tregs in patients with AD. Peripheral blood and skin biopsy samples 
from atopy patch test (APT)-positive acute and chronic phase AD patients were investigated. 
Immunohistochemistry was applied to identify CD4+CD25+FOXP3+ Tregs in the skin, while 
fl ow cytometry was utilised to detect CD4+CD25highFOXP3+ Tregs in the peripheral blood. 
In the peripheral blood of patients with AD, neither the absolute number nor the percentage of 
CD4+CD25highFOXP3+ Tregs showed signifi cant alteration. Increased numbers of FOXP3+ Tregs 
were detected in skin biopsy specimens. Skin samples from acute phase AD patients showed a 
moderate to marked morphologically non-specifi c dermal perivascular mononuclear cell infi ltrate 
of which 80% are CD4+ cells and 10-30% of these demonstrated CD25 and FOXP3 expression. 
About 90% of intraepidermal lymphocytes proved to be CD4+ T-cells and most of them (usually 
more than 60%) expressed CD25 and FOXP3. Skin biopsy samples of the chronic phase AD patient 
concurred with the above fi ndings. We observed epidermal DC aggregates – appear to be equivalent 
with so-called Langerhans cell microgranulomas (LCMs) – uniformly present in APT-positive skin 
samples, which also contained intermingled FOXP3+ Tregs. We demonstrated that patients with 
AD have elevated number of CD4+CD25+FOXP3+ Tregs in lesional skin. We also established 
that IDEC-like epidermal DC aggregates are uniformly present in APT-positive skin lesions, and 
most of these aggregates contained FOXP3+ Treg cells showing close contact with DC elements.
066
Retinoic X Receptor Antagonism Stimulates Filaggrin and Represses Thymic Stromal 
Lymphopoietin
Fontao L, Grand D, Carraux P, Saurat JH University Hospital of Geneva, Switzerland
Recent genetic studies disclosed loss of function mutations in the gene encoding fi laggrin 
as a major risk factor for the development of atopic dermatitis (AD). Thymic stromal 
lymphopoietin (TSLP), a cytokine produced by epithelial cells is involved in allergic 
diseases such as AD. Although a clear relationship between TSLP expression and fi laggrin 
defi ciency in AD is still missing, it is likely that barrier abnormalities in fi laggrin defi cient 
individuals facilitate cutaneous allergens penetration and thereby TSLP production which 
may ultimately led to allergic skin infl ammation. Retinoic Acid (RAR), Retinoid X (RXR), 
Peroxysome Proliferator Activated (PPAR) nuclear hormone Receptors regulate fi laggrin 
or TSLP genes expression. Therefore, we tested whether ligands to those receptors could 
modulate TSLP and fi laggrin genes expressions both in vitro and in vivo as a therapeutic 
approach for treating AD. First, quantitative RT-PCR and/or western blot were used to assess 
the impact of RAR, RXR, PPAR agonists and/or antagonists on the expression of fi laggrin and 
TSLP expression in cultured human keratinocytes. Next, the impact of compounds capable 
of modulating fi laggrin and TSLP expression in vitro was further investigated in vivo using 
wild type and fi laggrin defi cient mice. We found that among the 10 compounds tested 
in vitro, BAL10092 and BAL16513 signifi cantly increase fi laggrin expression in cultured 
keratinocytes. Both compounds were RXR antagonists and differ slightly in their ability to 
reduce TSLP transcript in cultured keratinocytes. When the ears of wild type and fi laggrin 
defi cient mice were treated daily by topical application of 1% BAL10092 or 1% BAL 16513 
solutions, both compounds increase fi laggrin expression at the protein level. Of interest, 
both compound also signifi cantly reduced the spontaneous ear swelling of fi laggrin defi cient 
mice which TSLP dependency mechanism still remains to be established. Altogether our 
fi ndings suggest that RXR antagonists may represent new alternative for AD therapy.
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Reverse signalling of IFN-gamma-producing Th1 cells drives antigen-presenting 
cells into apoptosis
Wieder T, Braumüller H, Bauer N, Röcken M University Medical Center Tübingen, 
Tübingen, Germany
MHC class II-expressing antigen-presenting cells (APC) interact with T helper cells thereby 
differentiating them into Th1, Th2 or Th17 lymphocytes. Despite the importance of these interactions 
and the extensive knowlegdge about the effects that APC exert on T cell differentiation and 
functioning, surprisingly little is known about the reverse signalling, i. e. the instruction of APC by T 
cell signalling. As this situation is of special relevance for the instruction of APC by tumor-specifi c T 
lymphocytes in tumor-draining lymph nodes, we used interferon-gamma (IFN-γ)-producing Th1 cells 
specifi c for the tumor-associated antigen Tag and either total APC (mainly B cells and macrophages/
monocytes) or purifi ed DC in an in vitro restimulation assay. Then, we analyzed the expression and 
posttranscriptional regulation of cell cycle- and cell death-associated genes and gene products. 
As Th1 cells can arrest tumor growth or proliferation of intracellular pathogens, we fi rst used gene 
arrays focussing on pro- and anti-apoptotic, and on pro- and anti-proliferative candidate genes to 
analyze APC death signalling after restimulation. A cluster of pro-apoptotic genes, i.e. Bax, caspase 
2 or death associated protein kinase 1, and multiple anti-proliferative genes, i.e. cyclin-dependent 
kinase inhibitor 2A and Reprimo, were highly (>20-fold) up-regulated in restimulated APC. On the 
other hand, proto-tumorigenic genes, i.e. c-myc or early growth response 1, were down-regulated. 
Consistent with these results, Western blot analysis of purifi ed APC showed a dramatic (>90%) and 
fast decline of c-myc phosphorylation after restimulation. Furthermore, apoptosis induction in APC 
after incubation with Th1 cells was confi rmed by Annexin V- and TUNEL-staining. In conclusion, 
peptide-specifi c Th1 cells exert a strong negative signalling on APC. This feedback loop may 
arrest APC-driven T cell proliferation thus contributing to the termination of immune responses.
068
Solvents infl uence T cell fate in contact hypersensitivity to weak haptens
Schuepbach-Mallepell S, Roques S, Caillon A, Gaide O Geneva University Hospital, 
Geneva, Switzerland
Sensitizing molecules like di-nitro-fl uoro-benzene (DNFB) activate the infl ammasome, 
thus driving an Il-1beta mediated Th1 and Th17 response. Di-nitro-thoyciano-
benzene (DNTB) is very similar in structure yet does not activate the infl ammasome, 
thus favoring a Treg response, in a mouse model of contact dermatitis. We used, 
as one of our controls, fl uorescein isothiocyanate (FITC), which is widely reported 
to be a Th2 inducer. However, FITC failed to induce any reaction when dissolved 
in our classical solvent, acetone olive oil. However, when dissolved in acetone 
di-butyl-phtalate (DBP), it induced a strong Th2 response, as reported. Based on a 
previous observation that DBP alone can induce an up-regulation of thymic stromal 
lymphopoietin (TSLP), we investigated the role of this Th2-promoting cytokine in this 
system. We found that DBP could up-regulate TSLP independently of the presence 
of an hapten, be it FITC or DNTB. Hence, DBP provides a strong Th2-inducing 
signal. Accordingly, DNTB dissolved in DBP induced a strong Th2 reaction in the 
skin. However, when dissolved in acetone olive oil, it induced a Treg response. 
And when dissolved in acetone olive-oil together with an irritant such as sodium-
dodecyl-sulfate (SDS), it triggered a Th1 response. Taken together, our results strongly 
suggest that T helper fate depends on the type of solvent used (the solution) during 
experimental contact and atopic dermatitis. The hapten on the contrary has little 
effect, except when it has a direct effect on danger signaling, as is the case with 
DNFB. The sensitizing potential of weak haptens such as perfumes may thus strongly 
depend on the context in which they are presented, and may challenge our way of 
looking at the sensitizing power of weak haptens, as the solution is in the solution.
069
Susceptibility to experimental Epidermolysis Bullosa Acquisita (EBA) is correlated 
with expression of Th1 cytokines
Hammers CM1, Bieber K1, Ludwig RJ2, Zillikens D2, Westermann J1 1Institute of 
Anatomy, Luebeck, Germany 2Department of Dermatology, Luebeck, Germany
The immune system recognizes and eliminates foreign antigens. Under certain 
circumstances B and T lymphocytes can also react to self-components and initiate 
autoimmune diseases. One example is the generation of autoantibodies against type 
VII collagen, which are deposited at the dermal-epidermal junction (DEJ) and induce 
severe blistering of skin and mucous membranes, a disease called Epidermolysis 
Bullosa Acquisita (EBA). We have previously established an active disease model of 
EBA by immunizing mice with recombinant murine type VII collagen. In this model, 
immunization of different mouse strains leads to different disease activities. In the 
present study we demonstrate that susceptible SJL mice show an increased T cell 
proliferation and expression of Th1-specifi c cytokines as IL-27 and IFN-gamma in 
the draining lymph nodes of the skin. However, resistant BALB/c mice feature lesser 
expression of these cytokines, whereas IL-17 is signifi cantly increased. In line with 
these observations we found signifi cantly higher levels of IgG2b in the serum of SJL 
mice, which has previously been shown to be the most pathogenic antibody subclass 
in murine EBA because of its complement-fi xing abilities. Binding of IgG2b to the DEJ 
was also signifi cantly increased in SJL compared to BALB/cmice. Our results provide a 
basis for new strategies to treat EBA, i.e. by applying appropriate cytokines that shift the 
autoimmune response to the production of non-pathogenic type VII collagen antibodies.
070
Syndecan-4 regulates Dendritic cell motility and podosome formation via 
PKCalpha
Averbeck M, Bühligen J, Gebhardt C, Himmel M, Ziegler W, Simon JC Universität 
Leipzig, Leipzig, Germany
Dendritic cells (DC) in tissues act as surveillors of the immune system. Their maturation and 
migration into lymphatic tissues following antigen contact play a crucial role in developing 
immune responses as well as in maintaining tolerance. Hence, the understanding of 
the control of DC migration is therefore important in developing strategies to modulate 
immune responses. Lysophosphatidylcholine (LysoPC) functions as an endogenous 
danger signal for DC. LysoPC is generated during apoptosis, acts as “fi nd-” and “eat me” 
signal and is thought to prevent autoimmunity. Moreover, LysoPC activates PKCdelta and 
initiates a signalling cascade in which Syndecan-4 (SDC), a heparansulfate proteoglycan, 
is phosphorylated. We recently demonstrated that SDC4 in human monocyte derived DC 
is upregulated during DC maturation and infl uences DC motility. Therefore, we wanted 
to explore whether LysoPC modulates DC motility and adhesion and whether SDC4 
regulates DC motility by PKCdelta phosphorylation dependent PKCalpha binding. Using 
videomicroscopy and static adhesion assay we show that LysoPC inhibits DC adhesion to 
fi bronectin and DC motility by decreased podosome formation. LysoPC upregulates MHC 
and costimulatory molecules in DC, however, fails to induce increased SDC4 expression. 
Moreover, Lyso PC induced SDC4 phosphorylation prevents PKCalpha binding to SDC-4. 
We conclude, in DC, SDC4 regulate DC motility and podosome formation via PKCalpha 
binding. This binding is controlled by PKCdelta dependent phosphorylation of SDC4. 
Since Lyso PC matured DC are defective in motility and adhesion future experiments need 
to show that LysoPC released during programmed cell death might delay DC migration 
to lymphoid tissues and thus might prevent premature immune responses against self.
071
Targeting of a MOG-single chain fusion protein to DEC205+  dendritic cells in vivo 
ameliorates experimental autoimmune encephalomyelitis in BL/6 mice
Schmitt S, Johnson T, Ring S, Storn V, Enk AH, Mahnke K University Hospital 
Heidelberg, Heidelberg, Germany
For the purpose of tolerance induction, we have recently established a novel method to 
load steady state dendritic cells (DC) in vivo with antigens, using biochemical coupling 
of antigens to DC-specifi c anti-DEC205 antibodies. The biochemical coupling is time 
consuming and not precise, as different conjugation products may occur. Thus we aimed at 
generating recombinant fusion proteins, containing a DEC205-specifi c single chain fragment 
variable (ScFv) fused to the autoantigen MOG. The respective DNA sequences were cloned 
into His-Tag and Myc-Tag containing vectors and the recombinant ScFvMOG fusion protein 
was purifi ed. To assess its targeting capabilities, cultivated DC were incubated with graded 
doses of ScFvMOG and stained thereafter with Myc-Tag specifi c antibodies. Examination 
via fl uorescence microscopy revealed effective loading of MHC class II compartments with 
ScFvMOG. Likewise in vivo, we show that after injection of ScFvMOG exclusively DC in 
the draining lymph nodes (LN) stained positive for Myc-Tag antibodies. When analysing 
the T cell populations of ScFvMOG injected mice we detected increasing numbers of 
CD4+CD25+FoxP3+ T cells in the LN. To test whether these Treg are able to protect mice from 
MOG-induced experimental autoimmune encephalomyelitis (EAE), we injected ScFvMOG 
conjugates into the footpads of BL/6 mice, induced EAE 2 weeks later and assessed the course 
of the disease. We found that in mice treated with ScFvMOG the onset of EAE was delayed and 
only 20 % of the ScFvMOG treated mice developed symptoms. In contrast, in PBS-injected 
or MOG peptide-injected groups 80% of the animals developed clinical signs of EAE. Thus, 
our data show that specifi c targeting of steady state DC by DEC-specifi c ScFv fusionproteins, 
leads to induction of Treg and serves as a novel strategy to prevent autoimmunity.
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T-cell mediated auto- and cross-reactivity between Human and Malassezia 
sympodialis thioredoxin(s) in adult patients with atopic dermatitis
Balaji H1, Heratizadeh A1, Wichmann K1, Scheynius A2, Crameri R3, Werfel T1 
1Medizinische Hochschule Hannover, Hannover, Germany 2Karolinska Institutet, 
Stockholm, Sweden 3Swiss Institute of Allergy and Asthma Research, Davos, 
Switzerland
Atopic dermatitis (AD) represents a chronic relapsing skin manifestation of atopy. 
Recent studies have established the cross-reactivity at the IgE level between fungal 
and human allergens. The T-cell mediated cross-reactivity between these human 
and fungal allergens remains to be elucidated. Our objective was to demonstrate 
the T-cell mediated auto- and cross-reactivity between the human (Hu TRX) and 
M.sympodialis (Mala s 13) thioredoxins.TCLs and TCCs specifi c for Mala s 13 and 
HuTRX were generated from the blood and skin compartment and assessed for their 
specifi city and cross-reactivity. Cytokine profi le of the TCC were assessed following 
restimulation with Hu TRX and Mala s 13. Cell surface expression of markers such 
as CD4, CD8 and CLA on the TCC were analysed by fl ow cytometry.TCL and TCC 
specifi c for Mala s 13 were also cross-reactive with HuTRX (proliferation assessed by 
incorporation of (3H) thymidine.  Blocking antibody against HLA-DR abrogated this 
proliferation, suggesting the involvement of MHC class II antigen presentation.  Most 
of the TCC were CD4+ and co-expressed the skin homing receptor CLA. Majority 
of the Mala s 13 specifi c TCC produced IFN-g when restimulated with Hu TRX . 
Interestingly, some TCC also produced IL-17. Mala s 13 and Hu TRX specifi c TCC 
could not be generated from the peripheral blood of healthy persons. The non-
reactive TCC predominantly produced IFN-γ and IL-10 when stimulated with Con 
A. (Thioredoxin)- auto-reactive skin homing T-cells secreting infl ammatory cytokines 
such as IFN-γ and IL-17 may have relevance for cutaneous infl ammation in AD.




Th1 cells induce tumor dormancy and preserve cellular differentiation in a model 
of multistage carcinogenesis
Braumüller H, Wieder W, Bauer N, Röcken M Univ Tübingen, Germany
CD4+-interferon-gamma (IFN-γ)+ T lymphocytes (Th1 cells) are able to cause severe destructive 
autoimmune diseases such as experimental encephalitis. Despite this, little attention has been given 
to the tumor-modulating capacity of Th1 cells. We analyzed the capacity of tumor-specifi c Th1 
lymphocytes in multistage carcinogenesis using RIP1-Tag2 mice that develop islet carcinomas due 
to the transgenic expression of the oncoprotein T antigen (Tag) in all insulin-producing beta cells. 
At 4-5 weeks of age the mice develop hyperplastic islets, at 8 weeks adenomas and at 12-14 weeks 
carcinomas, and the mice die of hypoglycemia. We have previously shown that Tag-Th1 cells 
arrest tumor growth and angiogenesis without evidence of either killing or islet destruction. To 
elucidate the underlying mechanisms we characterized the expression of differentiation antigens 
during the development of multistage carcinogenesis. In untreated mice growing tumors started 
around week 7 loosing fi rst the glucose transporter (Glut2), a differentiation antigen expressed 
in the late embryogenic islet development.  After week 8 mice started to loose the insulin 
producing capacity, and their ability to respond to glucose. Insulin is expressed at mid-term of 
islet embroyogeneis. In contrast, all cells continued to express the earliest differentiation antigen, 
synaptophysin and Tag, the tumor antigen, showing that multistage carcinogenesis lead to a 
coordinated loss of differentiation antigens. In sharp contrast, when treated with Tag-Th1 cells, 
islets did not only keep their normal shape, they also remained fully differentiated expressing 
Glut2 and insulin and responded normally to high glucose. Induction of tumor dormancy strictly 
required cytokine-signaling through TNFR1 as in double transgenic TNFR1.KOxRIP1-Tag2 mice 
the Tag-Th1 cells did not only fail to prevent tumor development; in TNFR1.KOxRIP1-Tag2 
mice the Tag-Th1 cells even accelerated tumor growth, antigen loss and tumor-related death.
074
Th1/TH17 cells amplify human contact hypersensitivity by licensing Th1to kill 
autologous keratinocytes in a ICAM-1 dependent antigen non specifi c manner
Pennino D1, Eyerich K1, Scarponi C1, Carbone T1, Foerster S2, Nasorri F1, Garcovich 
S3, Traidl-Hoffmann C2, Albanesi C1, Cavani A1 1IDI-IRCCS, Roma, Italy 2ZAUM – 
Center for Allergy and Environment Dermatology and Allergy Helmholtz Zentrum/
TUM, Munich, Germany 3Università S.Cuore, Roma, Italy
Th17 is a newly identifi ed lineage of effector T cells involved in autoimmunity 
and immune responses to pathogens. We demonstrate here the pathogenetic role 
of IL-17-producing CD4+ T lymphocytes in allergic contact dermatitis (ACD) to 
skin-applied chemicals. IL-17+ T cells infi ltrate ACD reactions and predominantly 
distribute at the site of heavy spongiosis. Skin IL-17+ T cells were functionally and 
phenotypically heterogeneous: pure Th17 prevailed in ACD skin. However, hapten 
responsiveness was restricted to Th1/IL-17 (IFN-γ+IL-17+), Th0/IL-17 (IFN-γ+IL-
17+IL-4+) fractions, and, to less extent, Th2/IL-17 cells. In the IFN-γ-dominated 
ACD environment, IL-17-releasing T cells affect immune function of keratinocytes 
by promoting CXCL-8, IL-6, and HBD-2 production. In addition, compared to 
Th1, supernatants from Th1/IL-17 T cells were much more effi cient in inducing 
ICAM-1 expression on keratinocytes, and keratinocyte-T cell adhesiveness in vitro. 
As a consequence, exposure to combined IFN-γ and IL-17 rendered keratinocytes 
susceptible to ICAM-1-dependent antigen non-specifi c T cell killing. This fi nding, 
together with the observation that hapten-specifi c T lymphocytes represent a 
minor fraction of ACD infi ltrating T cells, demonstrated that IL-17 effi ciently 
amplifi es the allergic reaction by rendering virtually all T lymphocytes recruited 
at the site of skin infl ammation capable to directly contribute to tissue damage.
075
The characterisation of regulatory and effector FOXP3 expressing T cell populations 
during a human cutaneous antigen-specifi c memory response in vivo
Vukmanovic-Stejic M1, Agius E1, Booth N1, Dunne PJ1, Lacy KE1, Reed JR1, Sobande 
TO1, Kissane S1, Rustin MH2, Akbar AN1 1University College London, London, United 
Kingdom 2The Royal Free Hospital, London, United Kingdom
FOXP3 and CD25 expression have been used as specifi c markers to distinguish 
regulatory from non-regulatory T cells in mice. However non-regulatory T cells in 
humans can also upregulate these molecules after activation. The kinetics and function 
of CD4+CD25hiFOXP3+T cell accumulation and proliferation in humans during a 
localised antigen-specifi c T cell response is currently unknown. We therefore injected 
tuberculin PPD into the skin of seventy-eight healthy human volunteers to generate 
a secondary immune response and sampled the cutaneous lesions at different times 
after injection. We found that skin CD4+CD25hiFOXP3+T cells expressed typical 
regulatory T cell(Treg) markers (i.e., they were CD25hi, CD127lo, CD27+, and 
CD39+) and did not behave like effector T cells in that they failed to synthesise IL-2 
and IFN-gamma upon re-stimulation in vitro. The numbers of both CD4+FOXP3-
(memory) and CD4+ FOXP3+ (putative natural Tregs) T cells increased in parallel 
with the two groups expressing similar proportions of Ki67+ cells. Our data therefore 
demonstrate that memory and CD4+ Treg populations are regulated in tandem during 
a secondary antigenic response. Experiments using suction blister technology to 
harvest cells from the site of the immune response in the skin were also carried out 
to determine whether memory CD4+ T cells from skin could be manipulated in vitro 
to produce CD4+FOXP3+ T with regulatory function. We show that it is possible to 
isolate effector CD4+ T cell populations from infl amed skin and manipulate them 
in vitro to generate Tregs with the potential to suppress infl ammatory responses. 
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The effect of proopiomelanocortin-derived peptides on the immune system of 
human hair follicles
Park YL1, Whang KU1, Lee WS2 1Soonchunhyang University, Bucheon, Republic of 
Korea 2Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
Neuropeptides derived from proopiomelanocortin (POMC) are produced by many 
organs including skin, and display various immune regulation effects. A hair follicle 
is a mini-organ with a peculiar immune system, and the proximal (lower) part of an 
anagen hair follicle is recognized as an immune-privileged area. There are various 
factors that regulate the generation, maintenance, and collapse of hair follicle immune 
privilege (IP). The purpose of this study was to investigate the effect of POMC-derived 
peptides such as adrenocorticotropic hormone (ACTH), α-melanocyte stimulating 
hormone (α-MSH), and β-endorphin on the immune privilege of human hair 
follicles. We used a low dose of interferon (IFN)-γ, which is a potent upregulator 
of major histocompatibility(MHC) class expression in cultured human anagen hair 
follicles. Then, we examined the effects of POMC-derived peptides on the regulation 
of ectopic MHC class expression using semiquantitative Reverase Transcriptase-
Polymerase Chain Reaction (RT-PCR) and immunohistochemical staining. ACTH, 
α-MSH, and β-endorphin downregulated INF-γ induced ectopic human leukocyte 
antigen (HLA) class I expression in organ-cultured human angen hair bulbs.
These results of our study indicate that POMC-derived peptides (α-MSH, ACTH, 
and β-endorphin) may be immune modulators of hair follicle immune privilege.
077
The enviromental contaminant, benzo(a)pyrene induced Interleukin-8 by normal 
human keratinocytes
Tsuji G, Takahara M, Hiroshi U, Satoshi T, Yoichi Y, Masutaka F Kyushu University, 
Fukuoka, Japan
Dioxins affect immune functions such as tumor immunity, auto immune disease 
and allergic disease. However, the effects of dioxins toxicity especially to skin 
immune function are still poorly understood. Benzo(a)pyrene (BaP) is a kind of 
dioxins and is environmental contaminant contained in exhaust gas from diesel 
cars and cigarette smokes. To examine effects of BaP to human skin, we treated 
normal human keratinocytes with BaP and measured the production of Interleukin-8 
(IL-8), well established cutaneous infl ammatory cytokine. BaP was shown to induce 
IL-8 expression at both mRNA and secretion levels in a dose-dependent manner. 
Because BaP-mediated IL-8 induction was reduced after treatment with resveratrol 
which is a selective antagonist of aryl hydrocarbon receptor (AhR), IL-8 induction 
was likely linked to AhR-activation. Overall, these data highlight an AhR-dependent 
regulation of IL-8 on noremal human keratinocytes in response to BaP, which may 
contributes to the cutaneous infl ammatory effects of this environmental contaminant.
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The role of interleukin-1 and the interleukin-1 receptors in regulatory T cell 
functions
Kovács-Sólyom F, Prihoda J, Kemény L, Gyulai R University of Szeged, Szeged, 
Hungary
We could show previously, that dysfunction of regulatory T cells (Treg) may play 
a role in the pathogenesis of psoriasis. The cause of Treg dysfunction, however, is 
currently unknown.The aim of this study was to analyze the possible role of the 
interleukin-1 (IL-1) pathway in regulatory T cell dysfunction. CD4+CD25- (effector) 
and CD4+CD25+CD127- (Treg) cells were isolated from peripheral blood of normal 
volunteers and psoriatic patients.  Expression of IL-1 and the IL-1 receptors was 
determined on the mRNA and protein level by quantitative RT-PCR and by fl ow 
cytometry and ELISA, respectively. Expression of the interleukin-1 receptor I (IL-1RI) 
which transmit the interleukin-1 (IL-1) signal, increased after CD3/CD28 activation 
in both effector and Treg cells. This increase was more than two hundred fold higher 
in CD4+CD25- T cells than in Tregs. On the other hand, the steady-state expression 
of the decoy IL-1 receptors (IL-1RII and soluble IL-1RII) and the IL-1 antagonist 
(IL-1N) were higher in Tregs compared to CD4+CD25- T cells. After activation, 
IL-1RII mRNA expression was about forty-fi ve fold increased above baseline level 
in Tregs, whereas, it remained unchanged in CD4+CD25- T cells. The difference 
was twenty-six fold in case of sIL-1RII and about ten fold in case of IL-1RN. Upon 
activation cell surface IL-1RII protein expression increased two times in CD4+CD25- 
T cells and ten times in Tregs. Our results demonstrate that after activation Tregs 
upregulate the expression of the IL-1 decoy receptors and the IL-1 antagonist 
strikingly more than the effector T cells, while the signal transmitting IL-1 receptor 
expression increases signifi cantly more on effector T cells. These mechanisms might 
provide protection for Tregs against the infl ammatory effects of IL-1. Dysfunctions 
of this pathway may be responsible for infl ammatory disease development.
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The Role Of PARP-1 And PARP-2 In Contact Hypersensitivity Reaction
Brunyanszki A, Hegedu C, Szanto M, Gergely P, Virag L, Bai P University of Debrecen, 
Medical and Health Science Center, Dept. Medical Chemistry, Debrecen, Hungary
Our aim was to give evidence whether poly(ADP-ribose) polymerase-1 or -2 
(PARP-1 and -2) may have role in the elicitation phase of the contact hypersensitivity 
reaction (CHS).Oxazolone (4-ethoxymethylene-2-phenyloxazol-5-one, OXA) was 
used to sensitize PARP-1-/- and -2-/- mice with the respective controls, then allergic 
infl ammation was elicited in the ears.When comparing the extent of edema formation 
upon OXA challenge PARP-1-/- mice are protected against the allergic infl ammation 
in contrast to the PARP-2-/- mice. Since the lack of effect PARP-2 mice were 
omitted them from further examination. The suppression of allergic infl ammation 
in the PARP-1-/- mice was typifi ed by weaker infl ammatory cell immigration, 
myeloperoxidase activity and furthermore lower expression of proinfl ammatory 
kemokines, cell adhesion molecules and matrix metalloproteinase-9. On the course 
of the infl ammatory process we have shown the bulk production of peroxynitrtie 
in concordance with an immense iNOS expression in the infi ltrating cells that 
were abrupt in the PARP-1-/- mice. Peroxynitrite-induced DNA damage induced 
PARP-1 activation and PAR formation that was clearly missing in the PARP-1-/- 
mice. Our previous data indicated that similar changes can be observed by the 
systemic administration of PJ34, a PARP inhibitor.Our results suggest PARP-1 
has a crucial role in CHS that can be infl uenced pharmacologically by PARP 
inhibitors. Since PARP-1 is an important cofactor of NFkB, a proinfl ammatory 
transcription factor, our future experiments will focus on NFkB function.
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The stratum corneum contains a biochemical redox barrier which protects against 
sensitisation by highly reactive environmental chemicals
Pickard C1, Louafi  F1, Lowings K1, Dearman R2, Kimber I2, Healy E1, Friedmann PS1 
1University of Southampton, UK 2University of Manchester, UK
Occupational dermatitis, caused by small molecular weight chemicals, results in a signifi cant 
morbidity. It is unclear why some chemicals are potent sensitisers, others weak sensitisers and 
others tolerisers. The model hapten dinitrochlorobenzene(DNCB) is a potent sensitizer in both 
animals and humans, whilst dinitrothiocyanobenzene(DNTB) has been reported to induce 
immunological tolerance. We have previously demonstrated DNTB to be a weak sensitizer 
(although not a toleriser) in humans, a difference not related to the cytokine profi les following 
epicutaneous application. To further explore the sensitization potential of these two chemicals, 
we have employed in vitro and ex vivo models to examine their reactivity with free-thiols, and 
their ability to penetrate the stratum corneum. Our results demonstrate that DNTB binds rapidly 
to reduced glutathione, with a peak absorption at 405nm (n=3). By contrast, DNCB binds slowly 
to glutathione with a peak absorption at 340nm, the kinetics of which were augmented by the 
addition of glutathione-S-transferase (n=3). In addition, using a fl ow cytometric method, we showed 
that DNTB caused a signifi cantly greater depletion of free thiols in human monocytes compared to 
DNCB (n =3; p = < 0.05). Application of DNCB to normal human skin mounted in Franz diffusion 
chambers, revealed a dramatic depletion of free thiols (n=3) and an extensive dinitrophenylation of 
proteins throughout the viable epidermis (n=10). By contrast, DNTB did not cause an appreciable 
thiol depletion or protein dinitrophenylation in the epidermis, binding instead to a thiol rich 
layer in the stratum corneum. Thus, differences in the sensitisation potential of the two chemicals 
relate to their ability to penetrate into the epidermis and indicate that a thiol rich region in the 
stratum corneum acts as an important biochemical redox barrier against highly reactive chemicals.
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The synergistic action of Interferon-gamma and Interleukin-17 increases cutaneous 
innate immunity by the induction of antimicrobial proteins
Simanski M, Schumacher H, Harder J University Hospital of Schleswig-Holstein, 
Campus Kiel, Germany
The synergistic action of Interferon-gamma and Interleukin-17 increases cutaneous 
innate immunity by the induction of antimicrobial proteins. Human skin is in 
permanent contact with microorganisms usually without getting infected. This is 
in part due to the antimicrobial proteins which are expressed by keratinocytes. The 
expression of most of these antimicrobial proteins in keratinocytes can be induced 
by stimulation with bacterial products or cytokines. To gain more insight into the 
regulation of antimicrobial proteins we stimulated primary keratinocytes with several 
combinations of cytokines and analysed gene and protein expression of the principal 
skin-derived antimicrobial proteins (RNase-7, psoriasin, hBD-2 and hBD-3) using real-
time PCR and ELISA. These experiments identifi ed the synergistic action of IFN-gamma 
and IL-17 as strong inducer of gene and protein expression of all tested antimicrobial 
proteins. Even picogram amounts of the combination of IFN-gamma and IL-17 induced 
an expression of antimicrobial proteins in primary keratinocytes which revealed this 
cytokine combination among various other cytokines as one of the most powerful 
inducer of antimicrobial proteins in keratinocytes known so far. To assess the functional 
signifi cance of these fi ndings we incubated IFN-gamma/IL-17-treated primary 
keratinocytes and skin explants with bacteria. IFN-gamma/IL-17-treated keratinocytes 
exhibited higher bactericidal activity compared to the unstimulated control cells. In 
addition, the ex vivo induction of antimicrobial proteins in skin explants through 
IFN-gamma/IL-17 increased the bactericidal activity of these skin explants. Together, 
these results indicate an important role of the synergistic action of IFN-gamma/IL-
17 for cutaneous defense through the induction of various antimicrobial proteins.
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Thermosensitive transient receptor potential vanilloid ion channels regulate human 
dendritic cell functions
Tóth BI1, Szöllõsi AG1, Benkõ S2, Rajnavölgyi É2, Kovács L1, Bíró T1 1Dept of Physilology, 
Univ of Debrecen, Hungary 2Dept of Immunology, Univ of Debrecen, Hungary
We have previously shown that transient receptor potential vanilloid-1 (TRPV1, the 
“capsaicin receptor“) is expressed on human epidermal Langerhans cells in situ. In 
the current study, we investigated the expression and function of TRPV1 and other 
thermosensitive TRPV channels on human cultured monocyte-derived dendritic cells 
(DCs).The presence of TRPV1 was identifi ed both at the protein (immunolabeling) and 
gene (real-time Q-PCR) levels on human DCs. Moreover, the prototypic TRPV1 agonist 
capsaicin specifi cally (i.e. via TRPV1) and dose-dependently inhibited cytokine-induced 
DC differentiation (fl ow cytometry analysis of DC-SIGN expression), phagocytosis of 
bacteria (quantitative fl uorimetry), activation of DCs (fl ow cytometry analysis of various 
maturation markers) and pro-infl ammatory cytokine secretion (ELISA). These effects were 
most probably mediated by TRPV1-mediated infl ux of Ca2+ to the DCs (quantitative 
fl uo 4-based fl uorimetry). In addition, we have also identifi ed the expression of TRPV2 
and TRPV4 (but not TRPV3), other heat-sensitive members of the TRPV channel family, 
on DCs. Accordingly, plant-derived TRPV4 activators (thymol, carvacol) – but not the 
TRPV3 agonist eugenol – evoked a transient increase of intracellular Ca2+ levels, similar 
to the action of capsaicin. Furthermore, activation of TRPV4 also inhibited phagocytotic 
activity of immature DCs and suppressed their activation and maturation.These data 
provide evidence that human DCs express various heat-activated TRPV ion channels. In 
addition, our fi ndings introduce TRPV-coupled signaling mechanisms as novel players 
in human DC biology with potential anti-infl ammatory actions. Therefore, further studies 
are invited to explore the importance of DC-localized TRPVs in cutaneous immunology.
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THP-1 cells induce infl ammatory reaction in epidermal keratinocytes via contact 
dependent and independent ways
Karakawa M1, Komine M2, Tamaki K1, Ohtsuki M1 1University of Tokyo, Tokyo, Japan 
2Jichi Medical University, Shimotsuke, Japan
Dendritic cells (DCs) play important roles in educating T cells in infl ammatory skin diseases 
especially psoriasis, but no evidence has been reported on direct effects on keratinocytes 
(KCs). We have previously demonstrated that peripheral normal appearing skin of psoriatic 
plaques contained DCs along the epidermal-dermal junction, where infl ammatory changes 
were observed in the epidermis without lymphocyte infi ltration. We speculated that DCs 
might induce early infl ammatory changes without T-cells, directly affecting epidermal 
KCs. We used Transwell™ chambers to co-culture HaCaT KCs with THP-1 cells, one of 
monocyte cell lines induced to DC-like cells by stimulation with TPA, with or without direct 
contact. HaCaT KCs without THP-1 cells were used as a control. CCL27 concentration in 
the culture supernatant was measured with ELISA. RNA levels of CCL27 and keratins K1, 
K6A, K14, K16 and K17 were evaluated using real-time RT-PCR. NFkB- and AP-1- luciferase 
constructs together with thymidine kinase- renilla luciferase construct were transfected to 
HaCaT KCs, co-cultured with THP-1 cells, and double luciferase assay was performed.
CCL27 in supernatant was up-regulated in the co-culture group with direct contact with 
THP-1 cells. RNA levels of CCL27, K6A, and K16 were increased in the co-culture group 
with direct contact. K14 and K17 remain unchanged. K1 was decreased in the co-culture 
group with or without direct contact. Activities of NFkB- or AP-1-driven luciferase construct 
in HaCaT KCs were up-regulated in the co-culture groups with our without direct contact 
with THP-1 cells.These results suggested that DCs can induce infl ammatory reaction in 
epidermal KCs without T-cell involvement, partly through NFkB and AP-1 activation.
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Thymic stromal lymphopoietin contributes to the different immune response 
between BALB/c and C57BL/6 strains
Watanabe H, Katakuse M, Shigeno T, Mukoyama Y Maruho co., Ltd., Kyoto, Japan
BALB/c mouse is more susceptible to certain kind of bacterial or viral infection than 
C57BL/6 mouse. This different susceptibility is regarded as their different preferential 
immune response such as Th2/Th1, respectively. Previously, we reported that thymic 
stromal lymphopoietin (TSLP) was an important cytokine skewing the immune 
response to Th2 in fl uorescein isothiocyanate (FITC)-induced contact hypersensitivity 
(CHS) in BALB/c mice. In the present study, we investigate contribution of TSLP to 
the different immune property between these strains. FITC-CHS was carried out as 
described previously. Briefl y, the mice were sensitized with 400 micro liter of 0.5% 
FITC in acetone:dibutylphthalate (DBP) (1:1) on day 0 and 1, and then their ears were 
challenged on >5 days. The ear edema and the mRNA expression of cytokines in 
the ear were determined 24 hours after the challenge. The level of TSLP expression 
was determined 24 hours after the second sensitization. Considerable ear swelling in 
FITC-CHS was observed in BLAB/c mice. However C57BL/6 mice showed clearly less 
swelling than BALB/c, which was just detectable level. The mRNA expression of a Th2 
cytokine, interleukin-4, and a pro-infl ammatory cytokine, tumor necrosis factor, levels 
in ear were higher in BALB/c mice than C57BL/6 mice. As we reported previously, 
the solvent for FITC, DBP, is an inducer of TSLP and acts as an indispensable adjuvant 
in the model. Interestingly, the level of TSLP expression in the ear during sensitization 
phase was obviously less in C57BL6 mice than BLAB/c mice. In conclusion, these 
results suggest that TSLP is one of the modulators to characterize the preferential 
immune response or the predisposition between BALB/c and C57BL/6 mouse.




Time dependent expression of caspase-3 positive cells in human allergic contact 
eczema: a kinetic study
El-Nour H, Jagerfeld J, Nordlind K Karolinska Institutet, Stockholm, Sweden
Our aim was to investigate the expression of the apoptotic marker caspase-3 in 
the skin of nickel-allergic patients (n= 10), using skin biopsies from epicutaneous 
patch test reactions to nickel sulphate, obtained at different time points (0, 
6, 24, 48, and 72 h) after application of the antigen. Also we studied a possible 
colocalization of caspase-3 with the serotonin transporter protein SERT, which has 
a role in apoptosis.   The skin biopsies were fi xed in a mixture of 4% formalin with 
0.2% picric acid, and rinsed in 0.1 M phosphate buffer containing 10% sucrose 
for at least 24 h, before being cut into 14 µm thick sections and stained using 
immunohistochemistry and a streptavidin-biotin technique. Caspase-3 expression 
was observed on mononuclear cells in the epidermis and dermis. The numbers of 
caspase-3 immunoreactive cells were altered in a time-dependant manner reaching 
the highest at 48 h. The numbers of these cells at 0 and 6 h were 21 (mean) cells/
section and 19.7, respectively; and at 24 and 48 h the numbers were increased 
(p<0.01) to 53.1 and 105.4, respectively. At 72 h, a dramatic decline (p<0.05) in 
the number of caspase-3 positive cells (62.9 cells/section) was noted in contrast to 
their number at 48 h. Double staining of SERT with the apoptosis marker caspase-3 
revealed a colocalization on immune cells that were numerous on the later time 
points compared to 0 and 6 h. At 48 and 72 h coexpression of SERT and caspase-3 
was seen on 60% of the immune cells. The present fi ndings suggest that the majority 
of immune cells in allergic contact eczema go through apoptosis at 48 h after 
antigen application, and that apoptosis of these cells might be regulated by SERT.
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Tolerance to contact allergens: CD4+CD25+ regulatory T cells exhibit non-specifi c 
suppressor activity but induce hapten-specifi c CD8+ suppressor T cells via IL-10 
production
Frankenberg U, Lorenz N, Schmidt T, Steinbrink K University of Mainz, Germany
The induction of tolerance may represent a strategy aiming at preventing harmful immune responses. 
Low zone tolerance (LZT), induced by epicutaneous application of low doses of contact allergens, 
requires the generation of CD8+ suppressor T cells that inhibit the development of Tc1-mediated 
contact hypersensitivity (CHS). In this study, we analyzed the role and function of naturally occurring 
CD4+CD25+FOXP3+ regulatory T cells (nTregs) in LZT. We observed increased numbers of nTregs 
during the induction of LZT. Furthermore, depletion of CD4+CD25+ Tregs during tolerization (by 
anti-CD25-Ab or cyclophosphamide) induced an elevated CHS response as revealed by a signifi cant 
ear swelling, hapten-specifi c T cell proliferation and Tc1 cytokine pattern. Notably, transfer 
experiments revealed that CD8+ T cells purifi ed from these Treg-depleted and tolerized mice totally 
lost their capacity to act as suppressor T cells in LZT, demonstrating an abrogated development of 
CD8+ suppressor T cells in the absence of CD4+CD25+ T cells. Adoptive transfer experiments of 
CD4+CD25+ Tregs obtained from tolerized animals into naïve mice that are subsequently sensitized 
clearly showed that CD4+CD25+ T cells exhibited regulatory functions for the transfer of LZT to 
allergens. In addition, sensitization of recipients of CD4+CD25+ Tregs with a second, unrelated 
hapten, was followed by a tolerance development, indicating a non-specifi c suppressor activity of 
CD4+CD25+ Tregs in LZT. ELISPOT analysis showed that CD4+CD25+ nTregs produce IL-10 in 
signifi cant amounts during induction of LZT. IL-10+CD4+CD25+ nTregs derived from WT mice, 
but not IL-10- nTregs allowed for the induction of LZT in adoptively transferred T cell-defi cient 
mice, indicating that IL-10-producing Tregs are required during the induction phase of LZT. Our 
data demonstrate that  IL-10-secreting CD4+CD25+ Tregs play a privotal role in tolerance to 
contact allergens as important modulators in the network of CD8+ T cell-related immune responses. 
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Toll-like receptors 2, 4, 7 and 9 expression in CD30+ cutaneous T-cell lymphoma
Knol A1, Dompmartin A2, Quereux G3, Comoz F4, Renaut J5, Khammari A3, Dreno B3 
1INSERM, U892, CHU Hôtel-Dieu, Nantes, France 2Clinique dermatologique, CHU 
Côte de Nacre, Caen, France 3Clinique dermatologique, CHU Hôtel-Dieu, Nantes, 
France 4Service d’anatomie pathologique, CHU Côte de Nacre, Caen, France 5Institut 
d’histo-pathologie, Nantes, France
CD30+ anaplastic large cell lymphoma is a primary cutaneous lymphoproliferative 
disorder with a high rate of spontaneous regression (approximately 25%) whose 
pathogenesis remains unclear, making the association with viruses suspected. The 
aim of the present study was to assess TLR-2, -4, -7 and -9 expression in cutaneous 
biopsies from patients with CD30+ anaplastic large cell lymphoma and type C 
lymphomatoid papulosis. Immunohistochemical analysis of TLR-2, -4, -7 and -9 was 
conducted on paraffi n-embedded sections of cutaneous biopsies obtained from 12 
patients with CD30+ T-cell lymphoma (n=9) and type C lymphomatoid papulosis 
(n=3). Five healthy skins were used as controls. We observed that TLR-2, TLR-4, 
TLR-7 were weakly expressed in the epidermis of each normal skin, whereas no 
immunoreactivity was detected for TLR-9. In cutaneous lesions of CD30+ T-cell 
lymphoma and type C lymphomatoid papulosis, we observed a moderate (42%) 
to strong (33%) intensity of labeling with TLR-2, TLR-4 (moderate : 50% to strong 
: 25%) and TLR-7 (moderate: 33% to strong: 42%) in the epidermis, and in 25% 
of cases, we detected an expression of TLR-7 within the lymphocytic infi ltrate. 
Regarding TLR-9, we observed a weak (25%) to moderate (25%) expression in 
the epidermis. The development of cutaneous lesions in CD30+ T-cell lymphoma 
appears to be associated with an increased expression of TLR-2, -4, -7 and -9 by 
keratinocytes and of TLR-7 by T lymphocytes, perhaps induced by a virus and thus 
contributing to the maintenance of the lymphocytic infi ltrate in cutaneous lesions.
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Urticarial Vasculitis
Benea V1, Georgescu SR1, Benea EO2, Ilie AE1, Muresian D1, Rusu A1, Grigore M1, 
Malin AM1, Macavei I1 1Scarlat Longhin Clinical Hospital for Dermatology, Bucharest, 
Romania 2Matei Bals Institute for Infectious Diseases, Bucharest, Romania
The aim of the study was to evaluate the main aspects of urticarial vasculitis. The study 
group included 100 patients who attended the Allergy Unit for urticarial vasculitis. 
It was performed a full physical examination, hematological, immunologic, and 
allergologic investigations and was followed the therapeutically response. The mean 
age of patients was 41.2 years; 72% of these were women.  The individual lesions 
last for 24 hours at least in all cases. The episodes of urticaria were recurrent and 
ranged in duration from months (60%) to years (28%). Other skin manifestations were 
angioedema (43%), physical urticaria (8%) and livedo reticularis (1%). Extracutaneous 
manifestations were malaise (27%), fever (6%), myalgia (4%), arthralgia (30%), 
gastrointestinal troubles (11%), headache (15%), and glomerulonephritis (2%). The 
main laboratory fi ndings observed were an elevated erythrocytes sedimentation rate 
(55%), a reduced level of serum complement (12%) and of C3 (6%), the presence 
of circulating immune complexes (24%), of cryoglobulins (12%) and of ANF (4%). 
The therapeutic approaches were represented by H1 antihistamines (100%), triciclic 
antidepressants (22%), NSAINS (15%), dapsone (29%), pentoxifi line (31%), colchicine 
(5%) and systemic corticosteroids (15%).These fi ndings confi rm that urticarial vasculitis 
is a form of chronic urticaria with clinical, laboratory and therapeutic particularities.
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Vitreoscilla Filiformis Lysate, A Probiotic Profi le For Topical Skin Care
Gueniche A, Breton L L’Oreal Recherche, Clichy Cedex, France
Probiotics stabilize the gut microfl ora and can modulate the function of immune 
cells. A large body of evidence now demonstrates that Treg cells are critically 
involved in controlling immunopathology in a wide variety of infl ammatory diseases. 
Therefore, one may propose that probiotics redress the imbalances of a disordered 
immune system. The same way of thinking may be applied to the skin. Human skin 
is endowed with innate immune defense mechanisms against infection. As in the gut, 
where probiotics improve relationship between microfl ora and mucosal homeostasis, 
a non-pathogenic bacteria may have the potential to alleviate reactions in skin surface 
by restoring the balance between immune signals of pathogenic and non-pathogenic 
microfl ora. Vitreoscilla fi liformis is a non-pathogenic bacterium and we have shown 
that ointment containing 5% of bacterial lysate signifi cantly improved atopic dermatitis 
and seborrheic dermatitis skin symptoms versus placebo.Vitreoscilla fi liformis lysate 
improve protection of skin homeostasis through T-regulatory cell induction and 
the release of IL-10 which allows optimal Th1/Th2 balance. Vitreoscilla fi liformis 
lysate is also, able to induce directly the release of cationic antimicrobial peptides 
probably, through TLR2 pathway. Thus, similar to the local infl uence of probiotics 
in the digestive system, microorganism’s lysates display it’s locally effects on the 
skin by improving innate immune system function and skin microfl ora equilibrium.
090 [Oral 034]
The effects of fi laggrin mutations on barrier function in eczema patients
Abdul Ghaffar S1, Tan SP1, Campbell LE2, Lee LH1, Sergeant A1, McLean WI1, Weller 
R1 1The University of Edinburgh, UK 2University of Dundee, UK
Mutations in fi laggrin are strongly associated with atopic dermatitis (AD). A functional 
barrier defect is thought to be a key mechanism underlying eczema. Our aim was to 
determine whether fi laggrin mutations correlate with altered skin barrier function in 
AD.  58 mild to moderate AD patients were recruited and screened for the common 
European fi laggrin null variants. 45 were wild type; 12 were heterozygous carriers (9x 
2282del4, 3x R501X, 1x S3247X); and 1 was a compound heterozygote (2282del4/
R501X). Age, sex and SASSAD scores were similar between the fi laggrin wild-type and 
heterozygote groups (11.6 ± 9.3 vs 11.4 ± 7.5).  Hay fever (22/45 versus 11/13) was 
signifi cantly higher in heterozygotes but not asthma. Functional measurements were 
performed on uninvolved fl exor forearm skin. Trans-epidermal water loss (TEWL) 
was slightly elevated in heterozygotes (8.4± 0.6) versus wild-type (8.1 ± 0.9 g/m2/h 
p<0.05). The number of tape strips required to reach TEWL >20 gm-2 per hour was 
signifi cantly less in the fi laggrin-related AD group (13.9 ±5.7) versus  wild-type (11 ± 
1.7, p=0.002). TEWL rose in a dose-dependent manner following 24 hour application 
of SLS (0.06 to 4%) and this was signifi cantly more marked in heterozygotes than wild-
type AD patients at concentrations of SLS above 0.5%.  In a cohort of patients patch 
tested to the European standard allergen battery, 1 of 25 wild-type subjects developed 
>5 positive reactions compared to 3 of 7 heterozygotes (p<0.05). The results support 
an underlying functional skin barrier defect in the pathogenesis of fi laggrin-related 
AD. Filaggrin mutations are particularly associated with defects in the integrity of the 
epidermal barrier at rest and appear to enhance breakdown in response to irritants. 
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Are the superantigens producing Staphylococcus aureus strains more resistant to 
antimicrobial peptides?
Baranska-Rybak W1, Szultka L1, Sokolowska-Wojdylo M1, Naumiuk L2, Nowicki R1, 
Kamysz W1, Roszkiewicz J1 1Med Univ, Gdansk, Poland 2Lipopharm, Zblewo, Poland
Superantigens are high-molecular-weight proteins comprising a group of molecules produced by 
various microorganisms.They are involved in pathogenesis of several human diseases. Staphylococcal 
(SA) superantigens can penetrate the epidermis and dermis, react with many cells of immunological 
system of the skin stimulating infl ammatory reactions, inducing infl ammation in the place of 
application and stimulating IgE production against particular superantigens.Twenty eight patients 
with erythrodermia were  enrolled in the study. From the each patient skin swabs were taken. 
Susceptibility to antibiotics (rifampicin, vancomicin, ciprofl oksacin, chloramphenicol, clindamycin, 
erythromycin and piperacillin) was determined by disk diffusion method and microdilution assay as 
recommended by CLSI. Staphylococcal Enterotoxin  and TSST1 Test Kits (SET-RPLA and TST-RPLA) 
were used for detection of staphylococcal superantigens. MIC of AMPs (Aurein 1.2, Citropin 1.1, 
lipopeptide Palm-KK-NH2, Protegrin 1, Tachyphelasin 3, Temporin A, Uperin 3.6) was determined 
using a microbroth dilution method. In the group of the  total 28 of the patients with erythrodermia 
the presence of SA was confi rmed in 24 cases.The total of 14 strains of SA excreted enerotoxines 
SEA (8 strains), SEC (3 strains) and/or SED (5 strains) and only one TSST-1 in the group of 24. 
We did not observe that superantigen producing strains were less susceptible to AMPs than non 
producing ones. The opposite situation was observed in conventional antibiotics. SA strains excreting 
superantigens had higher MICs and MBCs.There is no evidence of development of the AMP 
resistance in relation to antibiotic susceptibility, likely refl ecting the fact that the mode of action of 
the antibiotics investigated herein is not shared with AMPs. The interesting fi nding considering the 
high effi cacy of AMPs, especially lipopeptides, against superantigen-producing and superantigen-
non-producing strains of SA makes them attractive candidates for therapeutic implication. 
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The use of Sulfasalazine and Pentoxiphylline as an adjuvant therapy for the treatment 
of Pemphigus Vulgaris: A comparative study
El Darouti M, Marzouk S, Abdel Hay R, El Tawdy A, Fawzy M, Leheta T, Gammaz H, 
Al Gendy N Faculty of Medicine, Cairo University, Cairo, Egypt
Pemphigus Vulgaris (PV) represents a potentially life threatening autoimmune 
blistering disease. Tumor necrosis factor (TNF-α) has been implicated as a possible 
mechanism underlying acantholysis. This comparative double blinded study was 
carried out to estimate the use of both sulfasalazine (SSZ) and pentoxiphylline (PTX) 
(cheap anti-TNF drugs) as an adjuvant therapy for PV. This study included 64 PV 
patients; 42 patients received the full treatment regimen (with SSZ and PTX) and 22 
patients followed the same regimen except they received placebo instead of PTX and 
SSZ. Five healthy subjects were included as control. Serum samples were taken to 
measure TNF-α in the control group and before starting treatment in all patients and 
this were repeated every 2 weeks for 8 weeks and clinical assessment was made every 
week for all patients. The level of TNF-α was statistically higher in all patients than in 
healthy individuals. There was a statistically signifi cant decrease in the level of TNF-α 
in patients in group 1 compared to those in group 2, in the serum samples at 6 (P value 
<0.001) and 8 weeks (P value <0.001). There was a signifi cant clinical improvement 
in patients group 1 compared to those in group 2 (P value <0.001). There was a highly 
statistically signifi cant correlation between clinical improvement and the lowering of 
the level of TNF-α after 8 weeks of treatment in patients in group 1 (P-value <0.001) 
and in patients in group 2 (P-value 0.008). As a conclusion, the use of PTX and SSZ as 
adjuvant therapy in treatment of PV gave a faster and more signifi cant decrease in the 
level of TNF-α, and this decrease was associated with rapid clinical improvement. 
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Switching azathioprine to mycophenolate reduces UVA photosensitivity in renal 
transplant recipients
Hofbauer G1, Straub G1, Meyer R1, Karran P2, Attard N2, French L3, Wüthrich R3, Serra 
A3 1Univ Hosp Zurich, Dept of Derm, Switzerland 2Cancer Res UK London Res Inst, 
Clare Hall Labs, Herts, UK 3Univ Hosp Zurich, Div of Nephrology, Switzerland
Squamous cell carcinoma of the skin (SCC) is very frequent in organ transplant recipients. Azathioprine 
(AZA) – a standard immunosuppressant - causes selective UVA (320-400nm) photosensitivity with 
6-thioguanine (6-TG) DNA incorporation. DNA 6-TG absorbs UVA to produce reactive oxygen species 
(ROS) with resulting DNA damage. UVA and UVB photosensitivity in renal transplant recipients on 
AZA or mycophenolate mofetil (MMF) and in renal transplant recipients switched from AZA to MMF. 
Skin photosensitivity was assessed by minimal erythema dose (MED) for 16 renal transplant recipients 
on AZA and 17 on MMF. Mean UVA MED was lower in the AZA (21.3) versus MMF group (34.0J/
cm2; p=0.021). MED UVB, immediate and delayed pigmentation were unchanged. Subsequently, we 
identifi ed 25 (18 male) renal transplant recipients on AZA (mean age 55.6±12.5 yrs; mean duration 
of transplant 14.5±4.2 yrs, AZA 57.0±18.4 mg/day) and switched them to MMF (1084.0±361.3 mg/
day). 3 months after the switch, UVA MED increased from 16.0±7.2 to 25.4±11.5 J/cm2 (p<0.00001), 
independent of gender, age and duration of immunosuppression. MED UVB, immediate and delayed 
pigmentation were unaffected. The glomerular fi ltration rate (GFR) (49.0±16.5 before; 48.8±16.7 
ml/min/1.73m2 after) and urine protein to creatinine ratio (0.036±0.063 before and 0.045±0.079 
mg/mmol after) were not affected. In 7 patients, 6TG DNA in peripheral blood mononuclear cells 
measured by high performance liquid chromatography at 98.6±27.8 on AZA declined to 43.3±15.0 
pmol 6-TG/mg total DNA after 3 months on MMF, correlating to diminished UVA photosensitivity. 
Our data shows selective UVA photosensitivity on AZA which was reduced by switching from AZA to 
MMF. The decrease in DNA 6-TG in white blood cells likely refl ects similar, if not greater reductions 
in keratinocyte DNA 6-TG, suggesting a causal relationship between DNA 6-TG in skin and UVA 
photosensitivity. As DNA 6-TG and UVA interact to form DNA damaging ROS, elimination of DNA 
6-TG by switching from AZA to MMF might reduce the risk of SCC in renal transplant recipients.
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Expression of epidermal differentiation and antimicrobial proteins after treatment 
with pimecrolimus versus betamethasone in atopic dermatitis
Jensen J1, Scherer A2, Bräutigam M2, Gläser R1, Witt M1, Fölster-Holst R1, Proksch E1 
1University of Kiel, Kiel, Germany 2Novartis Pharma, Basel, Switzerland
An impaired epidermal skin barrier function is a hallmark of atopic dermatitis. The disturbed 
epidermal barrier alleviates the entry of allergens into the skin resulting in allergic reactions and 
infl ammation. Also, microbes may penetrate into the skin resulting in skin infection. Standard 
treatments by corticosteroids or calcineurin inhibitors are regarded to be anti-infl ammatory. 
The effect of the drugs on skin barrier related epidermal proteins is unknown. We examined 
the infl uence of either pimecrolimus (PIM) or betamethasone (BMV) on the expression of 
epidermal differentiation and antimicrobial proteins (AMP) by gene arrays and immunochemistry 
in 15 patients. Epidermal proliferation, keratins, and involucrin were more suppressed after 
treatments with BMV then PIM. Filaggrin, known to aggregate keratin fi laments during epidermal 
differentiation and to bind water in the stratum corneum, showed increased RNA expression 
and protein expression after treatment with both drugs. Expression of fi laggrin was slightly more 
pronounced after PIM than after BMV treatment. BMV treatment led to a signifi cant reduction in 
psoriasin expression, whereas PIM led to only a slight reduction. The AMPs HBD2, HBD3, and 
RNase7 showed a weak to moderate staining in lesional AD epidermis. After treatment with BMV, 
staining intensity was reduced or disappeared, whereas PIM treatment led to only slightly reduced 
staining. We did not fi nd a signifi cant immunoreactivity for LL37 and HNP1-3 in AD before or 
after treatment. We conclude that treatment of AD with BMV, in contrast to PIM, results in a 
reduction of epidermal and antimicrobial proteins. This may be related to a broad BMV induced 
reduction in protein synthesis, which increases the risk allergic reaction and skin infections. In 
contrast, pimecrolimus seems to sustain the skin’s physical and antimicrobial skin barrier.
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A Risk-Benefi t Assessment of Adalimumab, Etanercept, and Infl iximab in Psoriasis
Strober B1, Langley R2, Rozzo S3 1New York University School of Medicine, New 
York, New York, USA 2Dalhousie University, Halifax, Nova Scotia, Canada 3Abbott 
Laboratories, Abbott Park, Illinois, USA
Risk-benefi t was assessed for anti-tumor necrosis factor (anti TNF) treatment of psoriasis (Ps). 
Number needed to treat (NNT) [to observe a 75% or 90% reduction in Psoriasis Area and Severity 
Index (PASI 75/90) in 1 additional patient], and number needed to harm (NNH) [number to observe 
an additional adverse event (AE)], relative to placebo, were calculated from placebo-controlled 
periods of published Ps trials of adalimumab (ADA), etanercept (ETN), and infl iximab (IFX). Pooling 
long-term safety results, number of patient-years of treatment (NPY) expected for observation 
of an additional case of serious infection, malignancy (nonmelanoma skin cancer [NMSC] and 
lymphoma calculated separately), tuberculosis, congestive heart failure, demyelinating disease/
peripheral neuropathy, lupus/lupus-like syndrome were calculated. NNT point estimates for 
PASI 75 were 1.4, 1.6, 2.3, and 3.2 for IFX 5 mg/kg every 8 weeks (Express and Express II, each), 
ADA 40 mg every other week, ETN 50 mg twice weekly, and ETN 50 mg weekly or 25 mg twice 
weekly, respectively; those for PASI 90 NNT were 1.9/2.2, 2.3, and 5.0/9.2, for IFX, ADA and 
ETN, respectively. The 95% confi dence interval (CI) lower limit for ETN PASI 90 NNT was greater 
than the CI upper limits for ADA and IFX, suggesting less PASI 90 effi cacy with ETN. NNH were 
often >/=100-fold greater than NNT, with broad and overlapping CIs, indicating large benefi t 
risk ratios for anti-TNFs in Ps. For each drug, NPY for serious infections was >50 patient-years; 
for NMSC, was >60 patient-years; for malignancies (excluding NMSCs and lymphomas) >150 
patient-years; and for tuberculosis >429 patient-years. CI for available NPY for “any AE of interest” 
overlapped. Overall, NNH for each serious AE was typically >/=100-fold greater than NNT for 
the same drug, indicating large benefi t-risk ratio for anti-TNFs in controlled clinical trials of Ps.
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2,3,7,8-Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in 
vitro
Fimmel S2, Hinz N3, Stahlmann R3, Wang X1, Zhao J4, Zouboulis CC6 1Shanghai Slin 
Diesease and STD Hospital, China 2Charité Universitaetsmedizin Berlin, Germany 
3Universitaetsmedizin Berlin, Germany 4Xuzhou No1 People’s Hospital, Xhzhou, 
China 5Chinese Academy of Medical Sciences & Peking Union Medical College, 
Nanjing, China 6Dessau Medical Center, Germany
Chloracne is a characteristic marker of intoxication by 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) or other compounds. Decreased lipogenesis is one of the most 
prominent clinical characteristics in this disease. However, the activity of dioxins 
on human sebaceous glands is still unclear. We studied the effects of TCDD on 
sebaceous gland differentiation both in cultured SZ95 sebocytes and human skin 
samples maintained ex vivo. We detected arylhydrocarbon receptor (AHR) protein 
expression, the receptor for dioxin, in SZ95 seboyctes. Its expression was markedly 
inhibited by TCDD (10-8 M). Furthermore, reduced production/expression of 
specifi c markers of sebaceous differentiation, such as release of neutral lipids (10-
10 M-10-8 M) (p<0.001, respectively), epithelial membrane antigen and keratin 
(K) 7 and markedly increased expression of keratinocyte differentiation markers, 
such as K10 and peroxisome proliferators-activated receptor-a, were assessed 
in SZ95 sebocytes treated with TCDD (10-8M). To corroborate these in vitro data 
a new ex vivo model was administered, namely a sebaceous gland-rich skin 
culture. Obvious shrinkage of sebaceous glands with sebaceous duct hyperplasia 
and increased expression of K10 and involucrin in the atrophic sebaceous glands 
were observed on the 5th day of TCDD treatment. In conclusion, TCDD affects the 
differentiation of sebaceous gland cells probably by switching human sebaceous into 
keratinocyte differentiation, which may be regulated by the AHR signal pathway.




A highly specifi c and sensitive in vitro assay for Para-Phenylenediamine (PPD) 
allergy diagnosis: PPD-specifi c lymphocyte activation test (LAT)
Kneilling M, Caroli U, Grimmel C, Fischer J, Wieder T, Eichner M, Röcken M, 
Biedermann T Eberhard Karls University Tübingen, Tübingen, Germany
Patients sensitized to para-phenylenediamine (PPD) increasingly develop increasingly 
severe delayed type hypersensitivity reactions presenting with massive lymph node 
hyperplasia and edema of the head and neck in response to black hair dye. PPD 
allergy is usually diagnosed by performing epicutaneous patch tests, but severe test 
reactions and iatrogenic sensitizations are considerable drawbacks. We examined 
nine patients with severe allergic reactions in response to permanent hair dyes. Patch 
tests using the standard concentration of 1% PPD resulted in severe and sometimes 
even bullous reactions in all eight patients responsive to PPD (8/9). Titration revealed 
that at 1% of the standard concentration (0.01% PPD), patch test sensitivity decreased 
and only 50% of patients responded. Consequently, we established an in vitro assay 
to diagnose PPD allergy. Peripheral blood mononuclear cells (PBMC) were cultured 
with titrated concentrations of PPD with or without IL-2 supplementation, and T cell 
proliferation was determined by [3H]-thymidine incorporation. This lymphocyte 
activation test (LAT) detected T cell proliferation specifi c to PPD, with at least 3.5-
fold increase in [3H]-thymidine uptake in all PPD allergic patients. LAT with PPD 
remained positive for at least 10 months, indicating long-lasting T cell memory. Most 
importantly, in tolerant controls and in one patient sensitive to p-toluylendiamine 
(PTD) and dispers orange 3 (DO3), but not PPD, LAT with PPD remained unresponsive. 
These data demonstrate that LAT with PPD is both highly sensitive and specifi c 
and can be used to detect PPD sensitization to avoid patch test-associated risks.
098
A novel preclinical approach to predict skin drug levels and systemic exposure in 
patients after topical treatment
Meingassner J, Aschauer H, Fahrngruber H, Kowalsky E, Stuchlik P, Heiling R, Stuetz A 
Novartis Institutes for BioMedical Research, Vienna, Austria
Whereas bio-analytical assessment of dermal drug levels after systemic treatment 
is relatively simple, reliable drug level determination in topically treated skin is 
challenging, in particular in a clinical setting. Exact determinations of drug levels 
in living skin layers is almost impossible due to the high risk of contamination of 
the analytes with non-absorbed drug present on the treated skin surface or trapped 
in the superfi cial stratum corneum. We have developed a short-term, pre-clinical 
4-component approach for prediction of drug levels in man after topical application. 
First, drug penetration into and permeation through skin are determined in vitro using 
both human and pig skin. Second, under in vivo conditions, drug penetration into the 
dermis of pigs is determined in small areas (4 cm2) on the back at different post-treatment 
times. The superfi cial skin layers are removed from the dissected skin samples by heat 
separation prior to analysis of the dermal tissue. This procedure avoids contamination 
which otherwise results in artifactually high tissue concentrations. Third, in vivo 
time-dependent permeation of the drug through the skin into the systemic circulation 
is determined over 24 hrs in pigs treated on 10% of their body surface area. In the 
fourth step, the compounds are investigated in vitro and in vivo using infl amed / 
irritated pig skin to mimic diseased skin, which is usually associated with increased 
skin permeability and higher systemic exposure. By evaluation of all the data a skin 
pharmacokinetic profi le considered to be predictive for the human situation, is obtained. 
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A Retrospective Cohort Study of the Impact of Biological Therapy Initiation on 
Medical Resource Use, Costs and Outcomes in Patients with Psoriasis
Fonia A1, Le Ruen C2, Grant D3, Hemmett L4, Barker J1, Smith C1 1St.John Institute of 
Dermatology, London, United Kingdom 2IMS World, Ireland, United Kingdom 3MS 
World, London, United Kingdom 4Janssen-Cilag, London, United Kingdom
Our aim was to describe the impact on use of medical resource use costs and outcomes 
associated with the introduction of biologic therapies in patients with moderate to severe 
psoriasis. Data were extracted from case notes of a sequential patient cohort with psoriasis 
attending a tertiary referral severe psoriasis service and initiated on biologics (adalimumab, 
efalizumab, etanercept or infl iximab) for treatment of their psoriasis. Data were collected 
for 12 months prior to, and at least six months following initiation of biologic therapy, 
on hospital resource use (inpatient, outpatient, day ward, A&E visits and phototherapy 
sessions) and drug usage (systemic non-biologic and biologic psoriasis therapies and 
supportive drugs). Outcomes were measured using Psoriasis Area and Severity Index (PASI). 
Differences in resource use and associated costs and outcomes, between 12 months pre- 
and post-initiation of  biologic therapy, were tested using Wilcoxon paired sign tests for 
numeric data and McNemar test for proportions. Confi dence intervals around treatment 
costs were constructed using a 5000-sample bootstrap analysis.The analysis  comprised 76 
patients completing 12 months’ of biologic therapy; 68% males; mean age at time of study: 
47 years (range 23-74); mean duration of psoriasis: 26 years (range: 2.7-62.8). Signifi cant 
reductions (p<0.05) in the year following initiation of biologic therapy were observed for 
all hospital RU categories, with mean annual costs reduced by £1,682 (95%CI: -3,182, 
-182.2); P=0.028). Mean annual drug costs increased by £9,456 (95%CI: 8,732, 10,182; 
p<0.001). Mean PASI fell by 8.9 points from 18.7 to 9.8 (95%CI: -10.8, -7.1; p<0.001).While 
initiation of biologic therapies for psoriasis increases total costs, they are partially offset by 
substantial reductions in hospital RU and result in signifi cantly improved patient outcomes.
100
A unique case of an erythrodermic TCR gamma delta(+) peripheral T cell lymphoma 
with TH2 phenpotype
Bauer W, Spazierer D, Klein I, Stary G, Woehrl S, Wagner SN, Muellauer L, Stingl G 
Medical University of Vienna, Vienna, Austria
Peripheral T cell lymphomas expressing the gamma delta TCR represent rare cases 
of non-Hodgkin lymphomas and most often originate at extranodal sites.We report 
on a 78-year old patient with a peripheral TCR gamma delta+ T cell lymphoma 
who initially presented with a sudden onset of erythroderma, massive pruritus and 
eosinophilia. Within one month the patient developed generalized lymphadenopathy 
with the presence of tumor cells staining positive for CD3, CD4, CD5 and TCRVd1 and 
lacking expression of CD2, CD7, CD8, CD30 and of cytotoxic molecules (granzyme 
B, perforin). These cells were also present in the peripheral blood (CD4/CD8 ratio up 
to 12) whereas involvement of liver or spleen could not be observed. Upon in vitro 
stimulation these cells readily produced IL4, IL5 and IL13, thus displaying a TH2 
phenotype. This is in sharp contrast to the vast majority of TCR gamma delta+ lymphomas 
showing a cytotoxic phenotype. The disease was not associated with HTLV1 or EBV 
infection. Due to the known aggressive course of gamma delta T cell lymphomas 
we initiated systemic chemotherapy with CHOP, which was complicated by severe 
recurrent infections and stopped after fi ve cycles because of disease progression. After 
short stabilization with extracorporeal photopheresis and systemic glucocorticoids 
the patient died 8 months after initial diagnosis due to disease progression.To the 
best of our knowledge this TCR gamma delta+ peripheral T cell lymphoma is unique 
for the expression of a TH2 phenotype and its clinical presentation as erythrodermia.
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An imbalance of protease and antiprotease activities in the skin of eczema patients
Tan SP1, Abdul Ghaffar S1, Campbell LE2, McLean I2, Weller R1, Brown S1 1The 
University of Edinburgh, UK2University of Dundee, UK
Compromised skin barrier function in about 40% of severe eczema patients can be explained 
by truncating mutations in the fi laggrin gene. We hypothesized that the remaining 60% of 
eczema cases are caused by downregulation of protease inhibitors, such that an excess of 
proteolytic activity within the skin was responsible for barrier dysfunction. We therefore tested 
for differences in skin protease inhibition between eczema and healthy subjects which we 
correlated to their fi laggrin status.Suction blisters were induced in 10 eczema subjects and 
11 healthy controls. Inhibitory activities of blister fl uid against cysteine and serine proteases 
were measured using enzyme kinetic assays. The anti-elastases (elafi n and secretory 
leukocyte protease inhibitor, SLPI) were quantifi ed using ELISA. Blister cap sections were 
stained for fi laggrin, CD1a, and CD68. Subjects were screened for fi laggrin gene mutations 
(2282del4, R501X, S3247X, R2447X). 4 of 10 eczema subjects and 1 of 11 healthy controls 
had an abnormal fi laggrin gene. Interestingly, compared to controls, eczema subjects showed 
higher inhibitory activity towards trypsin (p<0.05), papain (p<0.03), and possibly elastase 
(p<0.16). No difference in chymotrypsin inhibition was found. Following precipitation and 
removal of high molecular weight proteins from the blister fl uid, higher elastase (p<0.02) and 
trypsin (p<0.03), but lower papain inhibition (p<0.005) were demonstrated in the eczema 
subjects. Apart from a higher elastase inhibition (p<0.03) seen in the heterozygotes, we 
detected no other correlation between fi laggrin genotype and protease inhibitor activities. 
Eczema subjects, irrespective of fi laggrin status, had a reduced average level of SLPI in their 
skin (p<0.09). Our pilot data confi rmed an altered protease: antiprotease balance in the skin 
of eczema patients and may offer pathomechanistic insights into the aetiology of eczema.
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Anti TNF-alfa drugs in the treatment of Pityriasis Rubra Pylaris of adult (type I and 
II)
Didona B1, Giampetruzzi A1, Garcovich A2, Antonelli G1, Garcovich S2, Tonanzi T1 
1Istituto Dermopatico dell’Immacolata, Rome, Italy 2Catholic University of Sacred 
Heart, Rome, Italy
PRP is a rare chronic disease of unknown cause characterized by erythematous-
scaly plaques arising  on the face and scalp with typical cephalo-caudal progression 
and follicular hyperkeratotic papules. The brigth orange colour of the lesions and 
the sparing areas are  typical clinical aspects together with possible complications 
consistent with erythroderma, palmo-plantar keratoderma and onychodystrophy. 
The refractoriness to conventional therapies (retinoids, methotrexate, cyclosporine, 
phototherapy) get us to investigate new drugs for its management. Because PRP 
shares clinical and histological features with psoriasis the use of anti TNF alfa drugs 
is considered helpful, as mentioned in some papers of the dermatological literature. 
We managed seven cases whose six of classical PRP (type I) with acute onset and the 
last one of type II with a very long history of disease. Two patients  have been treated 
by infl iximab (5mg/Kg) alone, one case by the association infl iximab and acitretin (25 
mg /day) and the other ones by the combination etanercept (50 mg subcutaneoulsly 
at week) and acitretin (25 mg/day). The cases managed by infl iximab alone improved 
within one and two weeks after the fi rst infusion, while one case received benefi t 
only after the combination infl iximab and acitretin, the other ones achieved a good 
result after six-seven weeks. One year after the initiation of the therapy a complete 
clearing  reached  in the cases treated with infl iximab alone while the others cases 
obtained about 85-90 % of resolution of skin lesions. The results obtained with the 
anti-TNF alfa agents in our patients affected by PRP represent a valid therapeutic 
approach in this dermatologic condition and justifi e their use as fi rst-line option. 
jid2009232.indd   Sec1:17 7/31/2009   6:36:11 PM
ABSTRACTS
S18  Journal of Investigative Dermatology (2009), Volume 129 
103
Antibacterial activity of a new lipophilic derivatives of teicoplanin
Ostorházi E1, Pintér G2, Herczegh P2, Kárpáti S1, Rozgonyi F1 1Dept of Dermatology, 
Venerology & Dermatooncology, Budapest, Hungary 2Dept of Pharmaceutical 
Chemistry, Debrecen, Hungary
In the framework of a systemic study on the synthesis of lipophilic derivatives of 
glycopeptide antibiotic aglycons we prepared a series of teicoplanin aglycon 
derivatives each pocessing a lypophilic side chain. The latter moiety was introduced 
using a diazo-transfer-1,3-dipolar cycloaddition reaction seqence. Minimal inhibitory 
concentration (MIC) and minimal bactericidal concentration (MBC) of ten derivatives 
were measured compared to those of vancomycin and teicoplanin on ATCC reference 
stains of Bacillus subtilis, methicillin-sensitive and- resistant Staphylococcus aureus 
(MRSA), biofi lm producing and non-producing Staphylococcus epidermidis, 
vancomycin-sensitive and-resistant Enterococcus faecalis (VRE), respectively. Ten wild-
type clinical isolates of each of MRSA and VRE strains were also involved in the study. 
Two of the ten derivatives had similar MICs and MBCs as those of teicoplanin and two 
showed MICs and MBCs comparable to those of vancomycin. Further two derivatives 
needed extremely low concentrations to expert both bacteriostatic and bactericidal 
effects on all bacterial strains tested regardless of their resistance to methicillin or 
vancomycin. Some derivatives possessed post antibiotic effect as well. It is concluded 
that the lipophilic nature at certain structure of these derivatives probably facilitate 
their penetration through the lipid rich cell walls and membranes of MRSA and VRE, 
too, thus they can easily reach and access their target even in MRSA and VRE as well.
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Antibiotics used for Rosacea modify Sebum Production:  In-vitro studies
Ni Raghallaigh S1, Lacey N1, Zouboulis CC2, Powell FC1 1Mater Misericordiae 
University Hospital, Dublin, Ireland 2Dessau Medical Center, Dessau, Germany
Preliminary studies suggest that sebum secretion is abnormal in patients with papulopustular rosacea 
(PPR).  Tetracyclines and trimethoprim are used to treat PPR. To ascertain if sebum modifi cation plays 
a role in the mechanism of action of these antibiotics, their in-vitro effect on the proliferation and 
lipogenesis of SZ95 human sebocytes was examined. The antibiotics examined were minocycline, 
doxycycline and trimethoprim. Concentrations (mcg/ml) ranged as follows: minocycline 0.3 - 5.0; 
doxycycline 0.025 - 4; trimethoprim 0.25 - 5. 96-well cell culture plates were seeded with SZ95 
sebocytes. 16-cell wells were evaluated for each concentration. The amount of neutral and polar 
lipids produced by the sebocytes at each concentration was measured by fl uorescence after staining 
with Nile red. Cell growth was assessed by staining with crystal violet. There was reduced cell 
proliferation at all minocycline and doxycycline concentrations. With minocycline, cell growth 
was maximal at 0.6 mcg/ml, after which there followed a linear reduction in cell proliferation with 
increasing concentrations. Production of neutral and polar lipids showed a corresponding decline 
with increasing doses. Although cell growth was reduced with higher concentrations of doxycycline, 
there was an increase in lipogenesis. At a dose of 2 mcg/ml cell growth reduced by 40.3%, 
while neutral lipids increased by 231% and polar by 102%. Trimethoprim inhibited cell growth 
maximally at a concentration of 1 mcg/ml. However, at higher concentrations there was a marked 
proliferation of cells, with growth of 106% at 5mcg/ml, and an increase in lipogenesis.Antibiotics 
used in the management of rosacea affect the proliferation and lipogenesis of sebocytes. Cell growth 
decreased at higher concentrations of both minocycline and doxycycline. At higher concentrations 
of minocycline lipogenesis decreased, but increased with higher concentrations of doxycycline. 
Trimethoprim had a biphasic effect on proliferation and lipogenesis. The effects of antibiotics on 
lipogenesis may be a factor in the response of both rosacea and acne vulgaris to antibiotic therapies.
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Antimicrobial activity of Vitreoscilla fi liformis lysate: Results from a randomized, 
double-blind, vehicle-controlled study and in vitro study
Gueniche A1, Bastien P1, Mahe Y1, Billoni N1, Knaudt B2, Piche E2, Voltz T2, Rocken 
M2, Biedermann T2, Breton L1 1LOREAL Recherche, Clichy Cedex, France 2University 
of Tübingen, Tübingen, Germany
Atopic dermatitis is a chronic and relapsing infl ammatory skin disease that is treated with immuno-
suppressants in acute phases and with emollients to stabilize the skin barrier thereafter. Novel 
treatments for AD focusing on establishing the physical and immunological barrier are needed. 
Directly applying non-pathogenic bacterial extracts to the skin of AD patients could be such a 
new therapeutic rationale to not only treat, but also stabilize AD skin. Therefore, we designed a 
study to investigate the effects of non pathogenic bacterial lysate Vitreoscilla fi liformis strain at 5% 
v/v on atopic probands with mild AD. As demonstrated by the study’s data, Vf is highly effective 
in AD signifi cantly improving not only SCORAD but also reducing “pruritus” and consequently 
“loss of sleep”. There is a better clearance of pathogenic bacteria in the group using the verum. 
After fi nishing treatment on day 29, Staphylococuus aureus was reduced on skin of 29.6% (n=8) 
volunteers, when treated with bacterial lysate. These differences between the two groups may be 
related to the stimulation of antimicrobial defense proteins seen by in vitro approach using proteomic 
and genomic in air exposed skin. One interpretation could be that Vitreoscilla fi liformis lysates 
improves AD skin by immuno-modulation and anti-infl ammatory effects. Changes of bacterial 
colonization such as decrease of Staphylococcus aureus colonization could be a direct effect of 
Vitreoscilla fi liformis bacterial extract and an indirect effect secondary due to the anti-infl ammatory 
properties resulting in less auto-inoculation of bacteria due to reduced scratching and changing 
the basic conditions for bacterial growth by restoring the skin barrier. The direct application of 
non-pathogenic bacteria to atopic dermatitis skin offers a totally new concept of product, effective 
through local innate immuno-modulatory mechanisms. Further steps should include clinical studies 
with Vitreoscilla fi liformis application to AD skin that include the study of biomarkers in the skin.
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Assessment of disease activity and damage in discoid lupus erythematosus
Wahie S, McColl E, Reynolds NJ Newcastle University, Newcastle upon Tyne, UK
Clinical studies assessing response of discoid lupus erythematosus (DLE) to new therapies require 
a validated measure to assess activity that takes into account the varied clinical signs including 
infl ammation, scarring and dyspigmentation.  Recently, a disease activity score for cutaneous lupus 
(CLASI) has been developed but this was not designed specifi cally for DLE. This aim of this study 
was to formulate a clinical instrument incorporating all the key features required for measuring 
activity and severity of DLE and to test inter and intra-rater reliability.The content of a ‘sign score’ 
was determined by dermatologists with clinical and research expertise in both DLE and clinical 
scores of infl ammatory skin disease. Several options were then peer reviewed and assessed in 
patients.The ‘sign score’ developed measures both severity and extent of erythema, scale, induration 
(comprising activity) and scarring/atrophy and dyspigmentation (comprising damage) caused by 
DLE. The body sites assessed refl ect the predilection of DLE to affect sun-exposed skin. A pilot 
study of the scoring instrument in 10 patients demonstrated good inter and intra-rater reliability 
with intra-class correlation co-effi cients (ICCs) of 0.85 (95%CI 0.66-0.96) for the summed activity 
and damage severity scores. A few minor modifi cations resulted in the ‘Score of Activity and 
Damage in DLE’ (SADDLE).To further test reliability of SADDLE, nine patients with biopsy-proven 
DLE were recruited with a wide range of disease severity.  Six assessors independently performed 
SADDLE in all patients and were then asked to re-measure the second patient seen, in order to 
investigate intra-rater reliability. The ICC for the summed activity and damage severity scores was 
0.82 (95% CI, 0.61-0.95) indicating good inter-rater reliability. However, measuring extent of DLE 
was less reliable than measuring severity, particularly for sun-exposed sites. The SADDLE has been 
tested on a total of 19 patients with DLE on two separate occasions, consistently demonstrating 
good reliability. Further studies are required to investigate SADDLE’s correlation with global 
assessments of disease activity, quality of life scores and its responsiveness to change with therapy.
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Assessment of Foregoing Life-Events, Quality of Life, Self/Body Image and Future-
Image In Patients with Chronic Skin Diseases and the Hungarian Adaptation of the 
Skindex-29 Questionnaire
Német B1, Holló P2, Kása M3, Kárpáti S2, Bagdy E1 1Károli Gáspár Univ, Inst of 
Psychology, Budapest, Hungary 2Semmelweis Medical Univ, Dept of Dermatology, 
Budapest, Hungary 3Tomesa Psoriasis Treatment Center, Budapest, Hungary
Our primary aim was to assess the relation of foregoing life events, quality of life, self-
and body- image and future-image of sine morbo persons and patients with excema and 
psoriasis. Our second aim was to translate and validate the Skindex-29, one of the most 
frequently used skin disease-specifi c HRQOL questionnaires developed in English for the 
Hungarian language area.We measured our research and control groups with DLQI Quality 
of Life Questionnaire and the trial version of Hungarian Skindex-29, Foregoing Life Events 
Questionnaire by Peykel, Self- and Body-Image Questionnaire by Pressing, and the “After 
ten years” projective compositional test.In case of Skindex-29, forward and backward 
translations were carried out, and for doubtful items the process was repeated until a 
satisfactory agreement with the original version of Skindex-29 was achieved. More than two 
hundred adult persons (patients and healthy people) responded to our questionnaires. We 
found signifi cant correlation between the Skindex-29 trial version and the DLQI (r=0,8364; 
p=0,00). Our results also show signifi cant connection between skin problems and the 
number of answers to different future-image categories (p=0,00). We found signifi cant 
correlation between the skin problem and the quality of life (p=0,00) and no signifi cant 
correlation between foregoing life events, and self-, body-image. We have developed a 
semantically equivalent translation of Skindex-29 into Hungarian that is is a comprehensible, 
useable, reliable and valid measure of quality-of-life for Hungarian dermatological patients.
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Assessment of the skin’s parameters: moisture, melanin content, intensity of 
erythema, transepidermal water loss,  pH and production of sebum by patients 
treated oral isotretinoine
Bergler-Czop B, Brzezinska-Wcislo L, Lis-Swiety A Silesian Medical University, 
Katowice, Poland
Common acne (acne vulgaris) is an illness affecting seborrhoeic areas (mainly: chest, face, back), 
characterized among others, by the presence of comedoes (comedones), cutaneous and pustular 
eruptions, purulent cysts and scars. Severe forms of acne are indication for general treatment with 
retinoids, such as: focused, inverted, fulminant, intensifi ed pustular-papulous. Bibliography notes 
many adverse reactions found during therapy. Most frequently described adverse reactions affect 
skin and mucosa, such as: cheilitis, dryness of nasal, oral and throat  mucosa, conjunctivitis and 
infl ammation of palpebral marigin, reversible opacifi cation of cornea, characteristics of eczema 
and general skin dryness. The aim of research was to assess skin parameters in patients orally treated 
with isotretinoine. The assessment included: moisture, melanin content, intensity of erythema, 
transepidermal water loss, pH and production of sebum. The tests will be carried out using MPA5 
apparatus. Diagnostic equipment MPA 5 includes: Tewameter TM300 (assessment of transepidermal 
water loss), Skin-pH-Meter PH 905 (assessment of skin’s pH), Mexameter MX18 (assessment of 
melanin content and intensity of erythema), Corneometer CM825 (assessment of skin’s moisture).
The tested material were the 15 patients  (11 females, 4 males) of the Dermatological Clinics, who 
were qualifi ed to oral treatment with isotretinoine due to severe forms of acne. The parameters 
were determined before oral isotretinoine was included and after 3 and 6 months of treatment. The 
medium dose was 51,42 mg/ kg b. m. after 3 months and 77,13 mg/kg b.m. after 6 months.The tests 
showed in most patients a statistically signifi cant decrease in sebum production and skin’s moisture 
as well as an increase in the intensity of erythema. However, the therapy had no statistical signifi cant 
infl uence upon the skin’s ph, melanin content and transepidermal water loss. These tests were 
preliminary. It is planned to assess the above mentioned parameters 6 months after the end of therapy.




Association between serum IL-16 level and the degree of sensitization in patients 
with atopic dermatitis
Gáspár K1, Nagy G1, Irinyi B1, Tumpek J1, Sipka S1, Remenyik É1, Szodoray P2, Szegedi 
A1 1University of Debrecen, Debrecen, Hungary 2University of Oslo, Oslo, Norway
At the site of infl ammation infi ltrating CD4+ helper T cells play a pivotal role in the 
pathogenesis of atopic dermatitis (AD). IL-16 has been previously characterized as an 
immunomodulatory cytokine. Besides its chemotactic properties, IL-16 is able to trigger 
IL-2 receptor alpha chain expression and to activate CD4+ T cells, in synergy with IL-2 
or IL-15. In addition, IL-16 amplifi es the infl ammatory processes by stimulating cytokine 
production in monocytes and contributes to T cell activation. Our aim was to investigate 
the association between serum IL-16 level and sensitisation in patients with AD. Overall 85 
patients with AD were studied. Serum level of IL-16 was measured by immunoenzymatic 
assay in patients with AD and serum IgE, and specifi c IgE levels were also assessed. Based 
on specifi c IgE levels and Prick-test results, we divided AD patients into subgroups, and 
examined serum IL-16 and total IgE levels. Thirty-six healthy, aged-matched volunteers 
and 20 psoriasis patients served as controls.Compared to healthy individuals and patients 
with psoriasis, we found signifi cantly higher levels of IL-16 in sera of patients with AD. A 
signifi cant correlation was apparent between serum levels of IL-16 and the serum levels of 
IgE (r= 0.408; P=0.004). IL-16 levels were signifi cantly elevated in those subgroups, where 
specifi c IgE were detected against 1-5 or more than 5 antigens. Although the levels of IL-16 
were also elevated in the Prick-test positive group, compared to Prick-test negative subjects, 
the difference was not signifi cant. IL-16 correlates with the degree of sensitization, but the 
association is not as strong as in the case of serum IgE. We assume that the role of IL-16 is 
complex in the pathogenesis of AD, both in the initiation and the perpetuation of the disease.
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Calmodulin-like skin protein increases in the differentiated epidermal layers in 
Atopic Dermatitis
Donovan M1, Ambach A2, Thomas-Collignon A1, Prado C1, Bernard D1, Jammayrac 
O1, Gollnick H2, de Lacharriere O1 1L’Oréal R&D, Clichy, France 2Otto-von-Guericke 
University, Magdeburg, Germany
In atopic dermatitis (AD), the skin barrier is defective, resulting in dry skin and an 
increased trans-epidermal water loss. These changes are associated with decreased 
expression of key epidermal proteins, such as fi laggrin, which are involved in the 
formation of a functional bar-rier, a process which is calcium dependent. The calcium 
binding protein, Calmodulin-like skin protein (CLSP), which is expressed in the 
stratum granulosum and lower layers of the stratum corneum, has been postulated 
to play a role in modulating the function of calcium binding proteins involved 
in barrier formation.  The objective of this study was to determine if the levels of 
CLSP were altered in the epidermis in AD. The expression of CLSP was analyzed 
by immunohistochemistry, western blot and ELISA in skin biopsies taken from 
patients with exacerbated (n = 9) and non-exacerbated (n = 7) AD (as determined 
by   SCORAD and IgE serum levels) as well as from healthy control subjects (n = 7). 
Immunohistochemical analysis showed a strong and signifi cant increase of CLSP in 
the stratum granulosum in acute AD compared to non acute AD and normal skin. 
Western blot and ELISA analysis of total protein extracts from the same biopsies 
confi rmed that CLSP and particularly the mature non-degraded 16 kDa form of the 
protein was signifi cantly increased in acute AD compared  to non acute and normal 
skin (p < 0.02).  The increased expression of CLSP in acute AD could be involved in the 
dysfunction of calcium dependent proteins which are essential for the for-mation of a 
functional barrier.  Thus, CLSP should be considered as a new target for AD therapies.
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Chronic lithium impairs skin tolerance to ischemia in random-pattern skin fl ap of 
rats
Nezami BG, Rahimpour S, Sadeghi M, Sianati S, Kalbasi anaraki D, Rasooli A, 
Dehpour AR Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
Despite its apparent anti apoptotic effect, lithium impairs endothelium-dependent 
vasorelaxation in various tissues. In this study we assessed the effect of lithium 
treatment on ischemic skin fl ap survival and its interaction with nitric oxide (NO) 
pathway. Seventy-six male Sprague-Dawley rats were randomly assigned into 13 
groups. Animals in the chronic lithium group received lithium chloride in tap water 
for 4 weeks and seven postoperative days. Acute lithium groups received 3nmol, 
10 nmol and 3 µmol/fl ap lithium locally. In another experiment interaction with 
NO synthase inhibitor L-NAME as well as NO precursor L-arginine was studied. 
For skin fl ap surgery, bipedicled dorsal skin fl ap measuring 8×2 cm was elevated 
on the midline and the cranial pedicle was cut after 2 hours. Chronic lithium 
treatment signifi cantly decreased skin fl ap survival while acute local lithium had no 
effect. Chronic lithium group had mean fl ap survival value of 42.9 ± 3.5%, which 
was signifi cantly lower than Normal subjects (60.5 ± 4.5%, P < 0.05). Systemic 
L-NAME (10 mg/kg, 30 min before fl ap elevation) failed to signifi cantly decrease 
the survival, while effective systemic L-arginine (300mg/kg) signifi cantly increased 
fl ap survival in lithium treated animals (P < 0.001). Long-term lithium treatment 
impairs the skin tolerance to ischemia in rats, which seems to be NO mediated. 
This effect can be reversed by L-arginine treatment. The results warrant special 
attention in patients on chronic lithium treatment who undergo skin surgeries.
 
112
Clinical improvement of dissecting folliculitis of the scalp with adalimumab: control 
of infl ammation within residual structural pathology
Navarini AA, Trüeb RM University Hospital Zurich, Zurich, Switzerland
Dissecting folliculitis of the scalp (DF) is an infl ammatory, suppurative process 
involving the scalp, eventually resulting in extensive scarring and irreversible alopecia. 
Together with hidradenitis suppurativa and acne conglobata, DF constitutes a follicular 
occlusion disorder with accumulation of sebaceous and keratinous material inside 
the dilated pilosebaceous unit with subsequent burst and a neutrophilic infl ammatory 
reaction resulting in abscess formation. Generally, response to systemic retinoids, 
antibiotics, and intralesional steroids is unpredictable, and surgical resection remains 
the single defi nitive treatment. There is a need for effective anti-infl ammatory therapy 
to control the disease process. Since hidradenitis suppurativa has been shown to 
respond favourably to TNF targeted-therapy, we decided to treat 3 cases of DF with 
adalimumab. In all cases, response to therapy was rapid and favourable, though 
relapse followed soon upon discontinuation of adalimumab. Clinical examination 
demonstrated suppression of TNF dependent infl ammation but histopathological 
studies showed only partial resolution of structural pathology in severe cases. Taken 
together, although treatment of DF with the TNF antagonist adalimumab can lead to 
clinical improvement of infl ammation, in severe cases residual structural pathology 
can remain unchanged and is a focus for relapse upon discontinuation of therapy.
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Comparison of apoptosis-inducing factor (AIF) expression in keratoacanthomas and 
squamous cell carcinomas of the skin
Bassukas I1, Skyrlas A2, Passa V2, Gaitanis G1, Hantschke M3, Malamou-Mitsi V2 1Dept 
Skin & Venereal Diseases, Univ Ioannina Medical School, Greece 2Dept Pathol, Univ 
Ioannina Medical School, Greece 3Dermatopathologie, Friedrichshafen, Germany
Although almost identical at the histopathological level accumulating evidence suggests that the 
proapoptotic tissue status is a distinguishing feature of keratoacanthomas (KA) compared to squamous 
cell carcinomas of the skin (SCC). Apoptosis-inducing factor (AIF) plays an important role in several 
“caspase-independent” cell death scenarios. Evidence for bidirectional effects (pro-apoptotic or 
pro-survival) of AIF in epidermal keratinocytes led us to compare its expression in KA and SCC.The 
expression of AIF in formalin-fi xed, paraffi n embedded archival material of 52 neoplasms (29 KA, 
23 SCC) was evaluated by immunohistochemistry, two-color immunofl uorescence to colocalize 
AIF to DNA fragmentation (TUNEL) at the cellular level and by western blot analysis of laser 
tissue microdissection-selected tumor probes. We could show that AIF, in a predominantly diffuse 
cytoplasmic pattern, is widely present in either tumor, yet immunohistochemical expression is more 
prominent in SCC (10-90% AIF+ cells) than in KA (5-60% AIF+ cells; P<0.01), a fi nding that was 
further confi rmed by western blot AIF quantifi cation (six-fold increased AIF titers in SCC compared 
to KA). Moreover, in neither malignancy total AIF expression corresponds to overall apoptotic tumor 
stage, however colocalization of apoptosis-related nuclear AIF pattern and overt DNA fragmentation 
(TUNEL) in the same cell is more frequent event in KA compared to SCC (50% vs. 20% of apoptotic 
nuclei; P<0.01). In conclusion, although there are no vast immunohistochemical pattern differences 
in AIF expression between SCC and KA, at the protein level AIF is overexpressed in SCC. Yet AIF 
contribution to apoptosis seems to be more important in KA than in SCC, a fi nding that indicates 
to a complex involvement of AIF in the process of keratinocyte tumor progression. Finally, based 
on our present fi ndings we suggest that future studies should also evaluate AIF modulating 
treatment modalities for their therapeutic potential against keratinocyte-derived skin tumors.
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Cutaneous lymphoma in gluten sensitive diseases
Erõs N, Marschalkó M, Hársing J, Silló P, Preisz K, Blazsek A, Nagy E, Csomor J, 
Matolcsy A, Kárpáti S Semmelweis University, Budapest, Hungary
Gluten sensitive diseases (GSD), like celiac disease and dermatitis herpetiformis (DH) have a 
signifi cantly increased risk for non-Hodgkin lymphoma (NHL), most commonly for enteropathy-
type T-cell lymphoma, but B-cell lymphoma of the gut or lymph nodes and extraintestinal B- and 
T-cell lymphomas have been also reported. The association of cutaneous lymphomas and GSD is 
not well established. The aim of our study was to investigate GSD markers in cutaneous lymphoma 
patients as well as to survey data of DH patients for cutaneous lymphomas. Forty-nine cutaneous 
lymphoma patients and 179 DH patients were enrolled in this study, including 40 patients with 
cutaneous T-cell lymphoma (mycosis fungoides (MF): 30, Sézary syndrome: 5, peripheral T-cell 
lymphoma: 3, subcutaneous panniculitis like T-cell lymphoma: 1, lymphomatoid papulosis:1), 7 
patients with cutaneous B-cell lymphoma (follicle center lymphoma: 4, marginal zone lymphoma: 
3) and 2 patients with double lymphoid malignancies (B-CLL and marginal zone lymphoma: 1, 
B-CLL and mycosis fungoides: 1). All patients were screened for GSD by IgA antibody against 
tissue transglutaminase (tTG) by ELISA as well as by IgA anti-endomysium antibodies (EMA). 
DH was diagnosed by skin histology and direct immunofl uorescence analysis and the patients’ 
data were reviewed for the development of cutaneous lymphoma and for other NHLs. One out 
of the 179 DH patients developed MALT lymphoma in the parotis. This patient also had skin 
symptoms and serological markers characteristic both for DH and lupus erythematosus. A further 
DH patient had MF stage II/A and an underlying gluten sensitive enteropathy (GSE).  His both 
skin disorders responded well to PUVA treatment and gluten free diet respectively, but a fatal 
outcome for different reasons terminated our observation. We found EMA/tTG positivity only 
in the latter DH-GSE-MF patient out of the 49 cutaneous lymphoma cases. Otherwise just one 
case out of the 179 patients with DH developed MALT lymphoma. Since we have demonstrated 
that DH could be associated with cutaneous lymphomas, and cutaneous lymphoma can present 
serological markers of GSD, cutaneous lymphoma also should be screened for gluten sensitivity. 
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Dermal Exposure to Pyrethroids Leads to Behavioral Changes in the Mouse
Sadeghi Hashjin G, Fallah F, Koohi MK University of Tehran, Islamic Republic of 
Iran 
Permethrin and Cypermethrin are synthetic pyrethroids, belonging to a group of 
insecticides with low mammalian toxicity and high insecticidal activity. The present 
study was undertaken to evaluate sub-acute toxicity of permethrin and cypermethrin 
after dermal exposure in mice based on behavioral examination such as lethality, 
weight gain, grooming, analgesymetry, anxiety, grasping at an inclined screen, 
activity, and despairing in fl oating on water. The study was conducted on 70 adult 
male mice, which were exposed dermally by whole tail zone in 10 sec once daily 
for 28 consecutive days to concentrations of 0%, 0.1%, 1% and 10%. In this study, 
there were no signifi cant changes in body weight gain, grooming behavior and pain 
sensation among treated and control groups. However, these chemicals caused the 
following effects in the experimental groups: a tendency to increased motor activity 
in most cases (47% in P0.1% group, P  = 0.025), a tendency to lose grasping faster 
than controls (48% and 40% decreased in P10% and C1% groups, respectively, (P 
< 0.05), shorter stay in the long arms and longer stay in the short arms (up to 84% 
difference with the controls, P < 0.05), and failure in the fl oating behavior (500% 
and 900% increase in interruption times in P10% and C10% groups, respectively, 
P < 0.05). In conclusion, upon long-term dermal exposure, synthetic pyrethroids 
may lead to increased motor activity, decreased grasping tendency and/or ability, 
increased apathy, and increased despairing in the mouse as an animal model.
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Development of a New Immunotherapy Strategy Against Melanoma Based on the 
Use of Artifi cial Antigen-Presenting Cells
Chatillon JF1, Fauquembergue E2, Bayeux F1, Drouet A2, Musette P1, Latouche JB2 
1INSERM U905, Rouen, France 2INSERM U614, Rouen, France
Adoptive immunotherapy based on in vitro activation and expansion of tumor antigen-
specifi c cytotoxic T lymphocytes (CTLs) is a very promising approach against cancer. 
Numerous techniques have been proposed to activate such CTLs, including the culture of 
peripheral T lymphocytes with allogeneic tumor cells. Our team has developed a strategy 
based on the use of artifi cial antigen-presenting cells (AAPCs) co-cultured with peripheral 
T lymphocytes. These AAPCs have been transduced to express molecules involved in the 
immunological synapse, restricted to the HLA-A2.1 molecule, and essential to activate CTLs 
against MART-1, auto-antigen which is overexpressed in melanoma. We defi ned, starting 
from the peripheral blood lymphocytes of 6 A2.1+ healthy donors, the optimal conditions 
for proliferation and purifi cation of MART-1-specifi c CTLs, using AAPCs and anti-MART-1 
phycoerythrin (PE)-coupled pentamer staining. After one round of a 2 to 3 week co-culture, 
we obtained 3 to 25% of specifi c CD8+ T cells, depending on the donor. A cytotoxic assay 
showed the capacity of these cells to specifi cally lyse MART-1-pulsed T2 cells and A2.1+ 
melanoma cells. Flow cytometry staining revealed a high potency to produce mainly TNF-α, 
IFN-γ and Granzyme B. By sorting anti-MART-1 PE-coupled pentamer stained cells with 
anti-PE magnetic beads, we highly purifi ed specifi c CD8+ T lymphocytes which were then 
co-cultured with AAPCs to expand them.We will now apply this strategy to expand MART-
1-specifi c CTLs from stage II, III or IV melanoma patients, and precisely study expansion, 
phenotype (IFN-γ, TNF-α, IL-2 production and Vβ T Cell Receptor repertoire) and function 
(cytotoxic assays against MART-1-pulsed or melanoma-derived cell lines) of the obtained CTLs. 
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Development of a skin substitute for therapeutic use, based on human amnion
Tauzin H1, Rolin G1, Viennet C1, Goydadin Ac1, Binda D1, Robin S2, Tiberghien 
P3, Humbert P1 1Cutaneous Engineering and Biology Team,  Besançon, France 
2Bioexigence, France 3French Blood Establishment of Bourgogne Franche-Comté
Human amniotic membrane (HAM), derived from fœtal membranes, is composed of three 
layers: an epithelial layer, a basement membrane and a nonvascular stroma containing 
fi broblasts. It’s a pool of growth factors, mitogenic and angiogenic factors and cytokines 
which are known to act during wound healing: IL-6, IL-8, FGF, EGF... A clinical prospective 
study, carried out in Besançon CHU, in collaboration with French Blood establishment 
of Bourgogne Franche-Comté, showed that HAM is an excellent biologic dressing for 
leg ulcers treatment: its application signifi cantly enhances granulation tissue formation, 
decreases fi brin clots and improves wound healing. Our project is to develop a new skin 
substitute based on HAM, which could be a new therapeutic way for venous leg ulcers. 
Considering that HAM epithelial cells are immunogenic by expressing CMH I antigens, 
experimentations are realised with a desepithelialized HAM by an enzymatic action. 
After desepithelialization, it’s essential to verify basement membrane presence, using 
immunohistochemistry for collagen IV, VII and laminin 5. Then,  autologous keratinocytes 
are seeded on the desepithelialized HAM and cultured for 21 days (fi rst in immersion 
then at air-liquid interface) in order to obtain a reconstructed epidermis. Epidermic 
differentiation state characterization (histology and immunohistochemistry) is required 
in order to validate this new skin substitute. Validated desepithelialization method is 
incubation with a 1,2U/ml dispase solution in PBS, for 30 minutes at room temperature. 
The basement membrane of desepithelialized HAM is still intact and is a good substrate 
for keratinocytes growth. A stratifi ed structure is obtained after 21 days and has to be 
characterized. The next important step is to obtain a fully differentiated epidermis on 
desepithelialized HAM. An initial phase of clinical feasibility is expected to be carried out.
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Dysregulation of retinoid-metabolism in human atopic dermatitis
Mihály J1, Gamlieli A1, Rasche C2, Worm M2, Rühl R1 1University of Debrecen, 
Debrecen, Hungary 2Charité –Universitätsmedizin Berlin, Berlin, Germany
Atopic dermatitis (AD) is one of the most common skin diseases and is characterized 
by features like chronic infl ammation, reduced rate of apoptosis, bacterial 
colonialisation, epidermal hyperproliferation, eosinophilia, permeability dysfunction 
as well as severe pruritus. Vitamin A derivatives (retinoids) have been shown to be 
responsible for a variety of physiological processes in the skin, like the control of 
differentiation, apoptosis and proliferation. Human skin biopsies were obtained 
from healthy human volunteers (HS) (n=6) and AD patients (n=6), with both affected 
(AS) and non-affected (NAS) skin. RT-QPCR analysis was performed and the gene 
expression of all known retinoid receptors, retinoid-binding proteins and retinoid-
metabolizing enzymes was investigated. Our results show that the target gene 
expression of retinoid receptor regulated pathways is signifi cantly down-regulated in 
both the affected and non-affected skin of AD patients. CYP26 decreased to 12% in 
NAS and 17% in AS in comparison to 100% set for HS, transglutaminase (TG) 2 to 26% 
NAS and 7% AS, retinoic acid receptor responder (RARRES) 1 to 3% NAS and 2% AS, 
cellular retinol-binding protein (CRBP) 1 to 0% NAS and 0% AS, but no signifi cant 
decrease was found for cellular retinoic acid binding protein (CRABP) 2 and retinoic 
acid receptor (RAR) â. Additionally, the main retinoic acid synthesizing enzyme, 
retinal-dehydrogenase (RALDH) 1, is signifi cantly down-regulated to 0,1% NAS and 
1% AS in AD patients. Analysis of serum and skin retinoid concentration via HPLC-
MS is performed to validate these fi ndings. We conclude that in AD patients retinoid 
regulation is deviated which might contribute to the various clinical features of AD.
119
Ecthyma gangrenosum-like bullous pemphigoid
Geiss Steiner J, Trüeb RM, Mühleisen B, Kerl K, French LE, Hofbauer GF University 
Hospital, Zurich, Switzerland
Bullous pemphigoid (BP) is a chronic, autoimmune, subepidermal blistering skin 
disease with varied clinical presentations. Diagnosis is based on the clinical picture, 
histopathological fi ndings, direct and indirect immunofl uorescence studies. In unclear 
cases, ELISA or western blot analysis helps to establish a defi nite diagnosis through 
detection of immunoglobulin G autoantibodies specifi c for the hemidesmosomal BP 
antigens BP230 and BP180. We report 6 cases of BP with an as yet not characterized, 
distinctive ecthyma-gangrenosum like presentation. Patients were female, above 80 
years of age, physically immobile, and skin lesions showed truncal localization, 
and bacterial colonization. Factors contributing to physical immobility were a high 
body mass index, psychiatric disease, sedative medication, and rheumatic disease. 
The clinical picture resembled ecthyma gangrenosum, but lacked systemic infection 
with p. aeruginosa. Lesional bacteriological studies revealed staph. aureus and/or p. 
aeruginosa. Diagnosis proved challenging in all cases. Suspicion has to be high, and 
repeated diagnostic procedures and additional laboratory studies may be necessary 
to establish a defi nitive diagnosis of BP. In summary, we propose this combination of 
truncal ecthyma gangrenosum-like lesions with bacterial colonization in the context 
of older age and immobility as a clinically distinct presentation or variant of BP.
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Effect of a new compound, inducer of GLUT1 expression:  GC-glucoside, on 
experimental atrophic skin model
Demaude J1, Dalko M2, Duranton A1, Breton L1 1L’Oréal  Research, Clichy 92583, 
France 2L’Oréal  Research, Aulnay/bois 93600, France
Severe structural and functional changes, including deterioration of epidermal homeostasis (i.e. 
equilibrium between proliferative and differentiation), occur during skin aging. To improve this 
homeostasis, we promote a protection against age-related alterations of epidermal components 
by controlling glycolysis. Thus, in epidermal basal layer, glucose transporter GLUT-1, is only 
expressed during proliferation and disappears in suprabasal layers.  Normal human skin fragments 
are obtained from plastic surgery, and used to realize an atrophic skin model. In this model, 
metabolism alteration is induced with dermocorticoïds at 2mg/cm² (Diprosone®) to mimic the 
phenotypic characteristic of skin aging.GC-glucoside (1mM) was evaluated versus retinoic acid 
(positive control at 10-7M) in this atrophic skin model on 3 markers: Ki67 (proliferative index) and 
2 functional proteoglycans: syndecan-1 and CD44.Compared to normal skin, atrophic skin model 
showed decrease i) in mitotic index value (3.4% of proliferating cell Ki-67+ in atrophic conditions 
versus 7.5% for the control), ii) in syndecan-1 expression (2.5 in atrophic conditions versus 3.3 for 
the control) iii) and in CD44 expression (1.68 in atrophic conditions versus 2.9 for the control), 
hallmarks of skin aging. When GC-glucoside was applied onto atrophic skin samples, a strong 
stimulation of regeneration stimulation was observed (14.6% of Ki-67+ cells) against 6.07% for 
samples treated with retinoic acid as positive control. Syndecan-1 immunohistochemical evaluation 
after GC-glucoside treatment showed similar values to retinoic acid treatment (3.1 vs 3.6) indicating 
a potential return to normal or basal level (3.3). Moreover, GC-glucoside signifi cantly increased 
CD44 staining with 2.4 (p=0.036) versus dermocorticoïds treated skin (1.68), similar to retinoic acid 
treatment: 2.66 (p=0.02). In conclusion, GC-glucoside may improve epidermal homeostasis via a 
better cellular renewal. Moreover, the cohesion between the epidermis and the dermal-epidermal 
junction was strengthened as demonstrated by the increase of syndecan-1 and CD44 expression. 




Elevated MMP-7 levels in patients with Systemic sclerosis: correlation with skin and 
lung involvement
Moinzadeh P1, Hellmich M1, Brinckmann J2, Krieg T1, Neumann E3, Müller-Ladner U3, 
Hunzelmann N1 1University of Cologne, Cologne, Germany 2University of Lübeck, 
Lübeck, Germany 3University of Gießen, Bad Nauheim, Germany
Recent data indicate that fi brotic processes characterized by increased deposition 
of extracellular matrix proteins are accompanied by a remodelling of the affected 
tissue. Matrix metalloproteinase-7 (MMP-7, Matrilysin) is a protease synthesized by 
epithelial and mesenchymal cells and has been shown to degrade a broad range of 
ECM proteins. For MMP-7 an important role in tissue remodelling associated e.g. 
with tumor invasion and lung fi brosis has recently been demonstrated. MMP-7 serum 
levels were determined in 125 patients with SSc and 25 age matched healthy controls. 
In systemic sclerosis (SSc) patients, an increased serum MMP-7 level of 4.9 µg/ml 
was found (p< 0.0001) when compared to controls (2.5 µg/ml). SSc patients with 
a modifi ed Rodnan skin score below 7 had a mean value of 3.1 µg/ml, while those 
above 7 had a mean value of 5.2 µg/ml (P< 0.003). Interestingly, the clinical diagnosis 
of pulmonary fi brosis did not correlate with MMP-7 levels, whereas pulmonary 
hypertension did signifi cantly correlate (p<0.008). Furthermore, lung involvement (as 
determined by DLCO) correlated negatively with the MMP-7 serum levels (p<0.02).
These data suggest that in SSc the fi brotic process, particularly of the skin and lung, 
is accompanied by an ongoing aberrant remodelling process involving MMP-7.
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Factors  modulating depression in psoriatic patients
Kanikowska A1, Pawlaczyk M1, Michalak M2 1Department of Biology and 
Environmental Studies, Poznan, Poland 2Department of Computer Sciences and 
Statistics, Poznan, Poland
The aim of the study was to evaluate factors predisposing patients with psoriasis 
to depression. The study included 120 patients suffering from  plaque psoriasis, 
aged from 16 to 75 (mean 45). The patients underwent a clinical assessment of 
psoriasis severity measured  by Psoriasis Area and Severity Index (PASI). Intensity 
of pruritus was evaluated with a single item visual analogue scale (VAS). Patients 
quality of life was assessed by the Dermatology Life Quality Index (DLQI). Patients 
completed also Beck Depression Inventory (BDI)  as a screening tool for depressive 
symptoms  and answered additional questions concerning personal data, the disease 
history, therapy and their everyday problems.  Depressive symptoms were present 
in 22% of patients with psoriasis. Women (p =0,04), singles (p=0,001), unemployed 
(p=0,02), suffering from severe physical symptoms of psoriasis (p=0,01), with  more 
acute course of the disease (p=0,02), impaired social relationships (p <0,001) 
and low self-esteem (p<0,001) were more likely to have depressive symptoms. 
Low quality of life measured by DLQI in psoriatic patients was usually associated 
with depressive symptoms (p<0,001). Family support, religion, age and duration 
of the disease did not have statistically signifi cant infl uence on the BDI outcomes 
among the studied patients. There are many factors that may lead to depression or 
aggravate its course. It is important to screen for depression all the patients with 
psoriasis especially those with low quality of life and impaired social relationships. 
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Gravitational Eczema Does Not Adversely Affect Venous Leg Ulcer Healing
Patel GK, Ruge FS, Price P, Harding KG School of Medicine, Cardiff University, 
Cardiff, United Kingdom
Venous leg ulceration (VLU) is a common and chronic condition that places a burden 
on the healthcare system, added to which there is the frustration, economic loss, 
and impaired quality of life experienced by the patients. Up to 60% of venous leg 
ulcers develop gravitational eczema, often leading to a change in therapy such as 
topical corticosteroid application. But it is not known if or how gravitational eczema 
infl uences venous ulcer healing? The aim of the study was to determine the prevalence 
of gravitational eczema, its effect on local immune milieu and consequence for ulcer 
healing. Of the 680 new referrals to the Dept. of Wound Healing over a period of 
24 months, 45% had VLU with a mean age of 69 yrs (range 25 to 96) and 66% were 
female. The mean wound area was 20.1 cm2 (range 0.04cm2 to 448cm2). Healing 
occurred in 199 (65%), mean = 23 weeks (range 1 to 107). Of these VLU 41% 
developed gravitational eczema. Multivariate analysis revealed that gravitational 
eczema development led to greater B cell numbers and CD4:CD8 ratio, but was not 
associated with age, sex, ulcer location or size. In most cases gravitational eczema 
resolved within 30 weeks. Intriguingly, 74.6% gravitational eczema healed compared 
to 62.9% in those without (p= 0.03), leading us to conclude that gravitational 
eczema does change the local immune environment but not impair VLU healing.
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The effect of intense pulsed light on T-cell infi ltration in acne vulgaris
Taylor M, Gonzalez M Cardiff University, Cardiff, United Kingdom
Currently, it is unclear whether yellow light improves acne vulgaris and if its coagulative 
vascular properties confer specifi c activity against infl ammatory cells and/or sebaceous 
glands. A previous report showed that T-lymphocytes not only predominated in lesions less 
than 6 hours old but were also signifi cantly increased in non-lesional skin of acne patients 
when compared to unaffected controls.Consequently, this study was designed to clinically and 
histochemically investigate whether yellow intense pulsed light (IPL) had anti-infl ammatory 
or anti-sebocytic effects on non-lesional skin of patients with mild to moderate acne vulgaris. 
Twenty-seven volunteers with mild to moderate acne were eligible for analysis. Their mean 
age was 24.8 years. Clinical assessments included lesion counts, sebumeter readings and 
Leeds assessments before and after the course of IPL.  Punch biopsies of non-lesional skin 
were taken at baseline, 48 hours after the fi rst IPL session and 7 days after the 4th treatment. 
Quantifi cation of CD3 (pan T cell marker) infi ltrate involving pilosebaceous units in a small 
cohort of these biopsies (18) was performed by a single blinded assessor. The numbers of 
CD3+ve cells trended downwards after 4 IPL treatments with an apparent increase noted in 
the 48-hour biopsies. This mirrors the observed percentage reduction of 11.2 ± 18.3 (mean 
± sd) in the number of infl ammatory lesions at the end of the trial. CD3+ve cells were found 
in the infrainfundibular, peri-sebaceous and peri-follicular regions of the follicle. Therefore, 
yellow broad-spectrum IPL may infl uence acne vulgaris through an anti-infl ammatory effect. 
However, characterisation of the T-cell infi ltrate using CD4 and CD8 markers along with 
study of the changes in the enzymatic profi le of the sebaceous glands using PPAR-gamma 
and CEPB are indicated. In addition examination of vascular changes using E-selectin and 
VCAM will further elucidate any potential role for IPL in the treatment of acne vulgaris.
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IL-17 polarization in mycosis fungoides-type cutaneous T-cell lymphoma associated 
with neutrophilic infi ltration of the skin
Fontao L1, Jaunin F1, Prins C1, Dupin N2, Kaya G1, Saurat JH1, Piguet V1 1University 
Hospital of Geneva, Geneva, Switzerland 2Hospital Tarnier-Cochin, Paris, France
Mycosis fungoides (MF), the most frequent form of cutaneous T cell lymphoma is characterized 
by atypical CD4+ lymphocytes infi ltrating the skin. MF is generally associated with a TH2 bias 
and in some instances complicated by a neutrophilic dermatosis that is associated with a poor 
prognosis. The mechanisms underlying MF with a neutrophilic reaction are unclear. Recently, TH17 
cytokines have been implicated in the regulation of autoimmunity or infl ammation, and are major 
regulator of neutrophils. Therefore, we investigated whether TH17 cytokines were implicated in 
MF with neutrophilic infi ltration of the skin. Three MF were investigated by immunohistochemistry 
and qRT-PCR. Histological skin sections showed exocytosis of CD4 T lymphocyte with spongiosis 
that was associated in one case with a neutrophilic infi ltrate in the superfi cial dermis and within 
sub-corneal pustules. qRT-PCR revealed that IL-4, IL-5 were not detected in either the normal 
skin or the pathological skin whereas IL-13, IL-31 and IL-10 transcript were found in the tested 
MF. Strikingly, IL-17 transcripts were specifi cally identifi ed in the MF with Neutrophilic reaction 
whereas TNF-alpha, and IFN-gamma were predominantly found in typical MF. In the MF with 
neutrophilic reaction but not in others, the infi ltrate contains neutrophils that were IL-17 
positive. Double immunofl uorescence stainings indicate that CD3 + positive cells were mostly 
IL-17 negative suggesting that IL-17 positives cells were not T lymphocytes. In conclusion, we 
show that MF with neutrophilic infi ltration of the skin correlates with the presence of IL-17+ 
neutrophils along the typical CD4+ lymphocytes. Recently, it has been suggested that TH-17 
differentiation is promoted by phagocytosis of apoptotic cells via the release of TH-17 promoting 
cytokines produced by neutrophils and dendritic cells. Future studies will establish the exact 
origin of the TH17 polarization in the skin of patients with MF with neutrophilic infi ltration 
and potentially reveal therapeutic opportunities in this subset of MF with poor prognosis.
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Immature B lymphocytes predict the response to extracorporeal photopheresis in 
patients with chronic graft-versus-host disease
Knobler R, Kuzmina Z, Pickl W, Worel N, Greinix H Medical University of Vienna, 
Vienna, Austria
Chronic graft-versus-host disease (GVHD) is a serious complication of allogeneic hematopoietic 
stem cell transplantation (HCT) affecting 30 to 80% of patients. The clinical signs of chronic GVHD 
can resemble those seen in autoimmune disorders and autoantibody production has been frequently 
observed leading to autoimmune-like conditions.  During the last years a substantial number of 
patients with steroid-refractory chronic GVHD have been treated with  and have responded to ECP. 
So far, no biomarkers are known predictors of response. Therefore, we investigated the distribution 
of B cell subpopulations such as immature CD19+/CD21- B cells serially at defi ned time points 
in patients with chronic GVHD  under ECP treatment. Since a perturbation of circulating B cell 
compartments has been associated with active chronic GVHD and its impact on the immune 
system, we hypothesized that elevated numbers of immature B lymphocytes prior to ECP could 
predict response to ECP. ECP Patients were treated initially on two consecutive days every two weeks 
(1 cycle) until improvement and then monthly until complete resolution. It was found that immature 
B cells were signifi cantly elevated during active cGVHD.We thus investigated the distribution of 
immature CD19+CD21- B-cells in peripheral blood (PB)  prior to ECP (n=19), 6 (n=28), 12 (n=34), 
and 21 months (n=33) after start of ECP in 49 patients (28 male, 21 female) with moderate (n=25) 
or severe (n=24) cGVHD  and correlated results with clinical response. ECP-nonresponders at 6 
months had a signifi cantly higher (p=0.02) percentage of immature CD19+CD21- B-lymphocytes 
(mean 22%, range 4-52%) in PB prior to start of ECP compared to CR (mean 8%; range 1.3-
29%) and PR (mean 16%; range 1.6-55%) patients. Percentages of immature CD19+CD21- 
B-lymphocytes were signifi cantly  lower in CR patients compared with ECP-nonresponders at 6 
(mean 5% vs 25%; range 1-15% vs 14-43%), 12 (mean 6% vs 24%, range 1.2-16 vs 1.5-58%), 
and 21 (mean 6% vs 26%; range 1-21% vs 2-60%) months after start of ECP. In conclusion, B cell 
subsets serially assessed could serve as possible biomarkers of response to ECP in cGVHD patients. 
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Immunogenicity of Rituximab in Patients with Severe Pemphigus
Schmidt E1, Hennig K2, Mengede C3, Zillikens D1, Kromminga A2 1Department of 
Dermatology, University of Lübeck, Lübeck, Germany 2IPM Biotech, Hamburg, 
Germany 3Squarix Biotechnology, Marl, Germany
Pemphigus is a life-threatening autoimmune bullous disease associated with 
autoantibodies to desmoglein 1 and/or 3. The anti-CD20 chimeric mouse monoclonal 
antibody rituximab has previously been successfully applied in more than 130 
reported pemphigus patients with severe and/or refractory disease. Since antibodies 
against other therapeutics such as IFN alpha and beta, erythropoietin, and TNF alpha 
antagonists had led to decreased effi cacy of these drugs, we determined anti-rituximab 
antibodies in 11 patients with pemphigus before rituximab administration as well as 
3, 9, and 15 months thereafter. For this purpose, a novel, affi nity capture elution 
assay was established using rabbit IgG against the F(ab)2 fragment of rituximab. In 
addition, serum levels of rituximab were determined by a competition ELISA. In 2 of 
11 pemphigus patients, antibodies to rituximab were detected. In both patients, only 
a partial remission was observed under treatment. In addition, when followed over 
a longer period of time, the occurrence of anti-rituximab antibodies paralleled an 
increase in disease activity. Of the 9 patients without development of antiantibodies 
to rituximab, in 5, all lesions healed and in 4, partial remissions were seen. These 
observations show that antibodies to rituximab are generated in some patients during 
rituximab treatment and may be associated with a less favourable response to treatment.
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In vivo refl ectance confocal microscopy imaging of psoriasis: correlation with 
routine histology
Wolberink EA, van Erp PE, Teussink MM, van de Kerkhof PC, Gerritsen MJ Radboud 
University Nijmegen Medical Center, Nijmegen, Netherlands
In vivo refl ectance confocal microscopy (RCM) is an exciting new option for imaging skin. It provides 
real-time, noninvasive imaging with nuclear and cellular details. Because images are viewed 
in horizontal (en face) sections instead of the traditional vertical way, it is possible to recognize 
features that are unique to RCM and can’t be readily recognized by conventional histopathology. 
Our objective was to establish features of stable plaque psoriasis vulgaris, using RCM and its 
correlation with routine and en face haematoxylin-eosin (HE) histology.After pre-treatment with 
salicylic acid in petrolatum, lesional and non-lesional sites of eight patients with stable plaque 
psoriasis were studied using dermatoscopy, RCM and  histology. Based on histological criteria for 
psoriasis, we evaluated RCM images for the presence of nine histological features: parakeratosis, 
epidermal infl ammatory infi ltrate, diminished or absent stratum granulosum, epidermal thickening 
(acanthosis), decreased  thickness of suprapapillary epidermal plate, increase in height of papillary 
dermis, increase in number of papillae, dilated and increased number of vessels, and presence 
of dermal infl ammatory infi ltrate. Determination and quantifi cation of psoriatic characteristics by 
RCM and its correlation with routine and en face HE histology fi ndings.Parakeratosis, acanthosis, 
elongated rete ridges, thinning of the suprapapillary plate, absence of granular layer, infl ammatory 
infi ltrate in epidermis, increase in papillary number, increase in number and volume of papillary 
capillaries could be easily determined. Correlation between RCM images and HE histology 
was high. These features differed signifi cantly from the ones observed in uninvolved skin. At 
dermatoscopy pink-red dots were seen, which correlate well with the number of papillae seen 
at RCM and HE histology. We established distinct morphologic features used for histological 
diagnosis in psoriasis with RCM. These features differed signifi cantly from non-involved skin.
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In vivo study of the protection of the skin from UV damage by ubiquitin-proteasome 
system activation
Guérif Y1, Oberto G1, Gondran C2, Garcia N1, Bauza E1, Botto JM1, Berghi A1, Cucumel 
K1, Dal Farra C2, Domloge N1 1ISP Vincience Global Skin Research Center, Sophia-
Antipolis, France 2ISP Corporate Research Center, Wayne, USA
The ubiquitin-proteasome system is an essential mechanism for maintaining cell integrity, due to its 
role in eliminating abnormal and damaged cell proteins. Through aging, the synthesis and activity 
of this system decrease, leading to the accumulation of damaged proteins that impair cell function, 
which accelerates aging. In this study, we evaluated the benefi cial effects of activating the ubiquitin-
proteasome system, using a previously described inducer (IV08.013).12 volunteers participated 
in this double-blind study. They applied, twice a day, the inducer-containing cream, or placebo, 
on a defi ned zone of the thigh for a week, followed by full solar spectrum irradiation of 2 MED. 
Volunteers continued to apply creams for 3 more weeks. Skin condition was evaluated by TEWL, 
in vivo confocal microscopy (vivascope) assessment, and by clinical examination. From day 8 on 
the induced side, TEWL studies revealed a signifi cant decrease of TEWL measures (p = 0.0323), 
indicating better barrier function. Interestingly, this effect was also seen after UV stress. TEWL 
was signifi cantly reduced on the irradiated-induced side (p = 0.0113) at D16 and (p = 0.0225) at 
D23, suggesting signifi cant UV protection of epidermal functions and integrity on the ubiquitin-
proteasome activated side. Vivascope study revealed that UV damage was remarkably reduced on 
the induced side at all time points, as demonstrated by stratum corneum thickness, and stratum 
granulosum cell shape and morphology. Observation and quantifi cation of sunburn cells showed 
signifi cant reduction on the induced side, and similar results were obtained with other signs of UV 
damage, such as vacuoles and oedema, which were signifi cantly reduced. Clinical examination 
revealed a signifi cant increase in the healthy appearance of the skin, as well as hydration 
and radiance, which were visible after 2 weeks of study on 83% of volunteers.These results 
confi rm the ubiquitin-proteasome system’s key protective roles in skin biology and photoaging. 
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Increased serum levels of soluble CD163 in patients with scleroderma
Shimizu K, Ogawa F, Takenaka M, Sato S Nagasaki University, Nagasaki, Japan
CD163 is a 130 kDa, type I transmembrane protein belonging to group B of the 
cysteine-rich scavenger receptor family. Expression of CD163 is constitutive and/or 
induced by some stimuli on circulating monocytes and most tissue macrophages. 
An approximately 130 kDa soluble form of human CD163 is released from the 
cell surface by proteolysis after oxidative stress or infl ammatory stimuli. Thus, 
elevated level of circulating soluble CD163 (sCD163) has been reported in diabetes 
mellitus, which is one of oxidative conditions. We have already acknowledged 
that scleroderma (SSc) is one of oxidative conditions. Therefore, we conducted to 
measure serum sCD163 in SSc patients. After receiving the informed consents, 56 SSc 
patients were examined and 40 persons were used as healthy controls. Blood samples 
were collected and the concentration of serum sCD163 was measured by ELISA 
(Human CD163, R&D Systems). Other parameters in blood of SSc patients were also 
examined. Statistical analyses were performed using Mann-Whitney’s U-test and the 
relationship between parameters was statistically examined by Spearman’s rank test. 
Serum sCD163 levels were elevated in SSc patients compared with normal controls 
(P<0.01), with similar levels between limited SSc and diffuse SSc patients. SSc 
patients with pulmonary fi brosis had increased serum levels of sCD163 than those 
without pulmonary fi brosis (P<0.05). SSc patients with elevated sCD163 levels had 
increased serum levels of IgG than those with normal sCD163 levels (P<0.05). Serum 
sCD163 levels correlated positively with pulsatility index in SSc patients (p=0.0009, 
r=0.534). These results suggest that the oxidative stress may play an important role 
in immunological abnormalities, renal circulation and pulmonary fi brosis of SSc.
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Infl iximab Correlates with an Increase in Polyclonality of CD4+CD25highCD127-
Foxp3+ Regulatory T Cells in Psoriasis
Diluvio L1, Romiti ML2, Pacciani V2, Angelini F2, Campione E1, Prinz JC3, Chimenti 
S1, Lamioni A4 1Policlinico Tor Vergata, Rome, Italy 2Tor Vergata University, Rome, 
Italy 3Ludwig-Maximilians University, Munich, Germany 4Associazione Nazionale 
Microcitemie Italia, Rome, Italy
The exaggerated immune response in psoriasis vulgaris indicates that proliferative 
and functional defi ciencies of CD4+CD25highCD127-Foxp3+ Treg may be involved 
in Tumor Necrosis Factor-alpha (TNF)-α-driven infl ammation. Infl iximab is a chimeric 
monoclonal antibody, which blocks TNF-α and is highly effective in psoriasis 
treatment.The aim of this work was to evaluate infl iximab infl uence on frequency 
and TCR variability of T regulatory cells (Treg) in psoriasis patients. Peripheral 
blood mononuclear cells from untreated, infl iximab patients and healthy volunteers 
were analyzed by fl ow cytometry and TCR-Vβ-chain (TCRBV) fragment length 
spectratyping. In both healthy individuals and untreated psoriasis patients, TCRBV 
gene families of Treg showed a greater bias in fragment lengths than in the infl iximab-
treated patients, with expansions of particular TCR fragments indicating oligoclonal 
T cell expansions. Furthermore, in treated patients a decrease in CD45RO+ memory 
CD4+CD25highCD69- T cells and a corresponding increased frequency of naïve 
compartment was observed. These results suggest that downregulation of infl ammation 
by infl iximab in psoriasis has profound effects on the spectrum, variability, distribution 
and phenotype of the peripheral compartment of CD4+CD25highCD127- Foxp3+ Treg. 
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Infl iximab infusion for Netherton syndrome: Sustained clinical improvement 
correlated with a reduction of thymic stromal lymphopoietin levels in skin
Laffi tte E, Fontao L, Kaya G, Khelifa E, Luebbe J, Saurat JH Geneva University Hospital, 
Geneva, Switzerland
Netherton syndrome (NS) is a skin disorder caused by mutations in SPINK5, a gene 
encoding the protease inhibitor lymphoepithelial Kazal-type¡Vrelated inhibitor (LEKTI). 
It has been recently shown that the pro-Th2 cytokine thymic stromal lymphopoietin 
(TSLP) and pro-infl ammatory cytokine such as TNF-α are overexpressed in LEKTI 
defi cient epidermis. We report the case of a 25-year old woman with a typical clinical 
NS, confi rmed by the absence of LEKTI expression in the epidermis. She presented 
with recurrent severe infl ammatory vesiculopustular cutaneous fl ares, unresponsive 
to therapy with systemic dapsone, topical steroids, tacrolimus and pimecrolimus. 
Thus, we initiated infl iximab (monoclonal antibody against TNF-α) infusions 
at 5mg/kg with an induction therapy (week 0-2-6), followed by a maintenance 
therapy every other month. After the second infusion, a dramatic improvement was 
observed and after one year of therapy the skin was nearly clear of infl ammatory 
lesion; however the ichtiosis was not improved. TSLP expression was assessed by 
ELISA and quantitative RT-PCR in skin biopsies obtained from infl ammatory and non 
infl ammatory lesions before and after infl iximab therapy. ELISA performed on skin 
protein extracts revealed an elevated TSLP production in infl ammatory skin lesion 
before and after infl iximab therapy. Of note, after one year of anti-TNF, a reduction 
by 4 of TSLP production was observed both in infl ammatory and non infl ammatory 
skin lesions. Quantitative RT-PCR performed on total RNA isolated from skin biopsies 
gave similar results for TSLP and reveals a strong expression of TNF-α in both lesional 
and non lesional skin that was not modulated by infl iximab therapy. Our data suggest 
that TNF may play a crucial role in NS and in the infl ammatory cascade driven by 
TSLP, and that an anti-TNF should be considered as  a therapeutic approach for NS.




Infl uence of different solvents on the vitality and capacity of cytokine production 
in human keratinocytes
Strelow IF, Mrowietz U, Gläser R Univ Hospital of Schleswig-Holstein, Kiel, Germany
The antipsoriatic effect of fumaric acid esters (FAE) has been demonstrated in several clinical 
studies and in 1994 Fumaderm®, containing dimethylfumarate (DMF) as main ingredient, 
achieved approval in Germany. Because the mode of action of DMF still remains unclear, 
further in vitro experiments are mandatory. While DMF is not soluble in water, the aim 
of this study was to systematically analyse different solvents regarding their possible 
infl uence on viability and cytokine production in human keratinocytes.Human primary 
keratinocytes were cultivated with different concentrations (0.2-10% v/v) of methanol, 
ethanol, dimethylsulfoxide (DMSO) and dimethylisosorbitol (DMI) for 24 hours. Viability 
of keratinocytes was determined using the neutral red uptake assay. In addition, after 24 
hours treatment of keratinocytes with the solvents, stimulation with tumor necrosis factor 
(TNF)-alpha was performed for 2 hours. Relative expression levels of interleukin (IL)-8 were 
determined by realtime RT-PCR. Minimal cytotoxic effects were demonstrated for methanol, 
where the median effective toxic concentration (EC50) was not reached in all tested 
concentrations. Calculated median toxic EC50 were 5.5 % for DMSO, 2.5 % for ethanol and 
1.5 % for DMI. Induction of IL-8-mRNA expression was observed in keratinocytes cultured 
with 1 and 10 % methanol as well as 1 % DMSO and 0,2 % DMI, whereas incubation 
with ethanol or all other concentrations of the solvents resulted in an inhibition of TNF-
alpha induced IL-8-expression. In summary, our results demonstrate that the selection of 
the optimal solvent is essential for planning in vitro experiments with fumaric acid esters or 
other substances in human keratinocytes. Out of the different solvents investigated in this 
study, we recommend the use of methanol in a concentration of 1 % combining optimal 
viability of the cells with highest reliability for functional m-RNA expression analyses. 
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Light fractionation increases the effi cacy of ALA-PDT but not of MAL-PDT; what is 
the role of (vascular) endothelial cells?
de Vijlder HC, de Bruijn HS, de Haas ER, van de Ploeg-van den Heuvel A, Kruijt B, 
Poel-Dirks D, Sterenborg HJ, Neumann HA, ten Hagen TL, Robinson DJ Erasmus MC 
Rotterdam, 3000 CA Rotterdam, Netherlands
Photodynamic therapy (PDT) using protoporpyrin IX (PpIX) precursors like 
5-aminolevulinic acid (ALA) or methyl-aminolevulinate (MAL) has shown to be effective 
in the treatment of various skin diseases. Using ALA we have shown in numerous studies 
that the effi cacy is signifi cantly improved by applying light fractionation with a long 
dark interval. In contrast, in the hairless mouse model, the PDT effi cacy using MAL is 
unaffected by adopting this approach. Our previous results show that the formation of 
acute edema is much greater following ALA-PDT suggesting that there is a difference 
in response of endothelial cells to PDT.Cryo-sections of hairless mouse skin after 4 
hours of topical MAL or ALA application were stained with a fl uorescent endothelial 
cell marker (CD31). Co-localization of this marker with the PpIX fl uorescence was 
investigated using the spectral imaging function of the confocal microscope. Images 
were analyzed using the single value decomposition algorithm to prove we are really 
investigating PpIX fl uorescence. The same approach was used to analyze the intra-
vital confocal microscopy images of mouse skin chambers. In these chambers we 
investigated the PpIX fl uorescence distribution in the vasculature of live skin pre and 
post PDT after both MAL and ALA application. Our results show PpIX fl uorescence 
at depth in cryo-sections of mouse skin after 4 hours of topical application. Intra-vital 
microscopy shows PpIX fl uorescence in tissue and endothelial cells/vasculature deep 
in mouse skin (even below the cutaneous muscularis). Differences in distribution 
after MAL or ALA application or in response to PDT will be presented and discussed.
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LXR agonists activate the sebaceous gland function in vivo
Rossio P, Spiesse D, Van Der Cruyssen G, Boiteau Jg, Colette P, Jomard A Galderma 
R & D, Sophia Antipolis, France
Liver X receptors (LXR) play a key role in cholesterol homeostasis and triglyceride 
metabolism with a major activity in liver and intestine. Sub-types LXRa and LXRb 
are expressed in human skin. The effect of LXR modulators on keratinocytes and 
sebocytes was shown in vitro, but very little information has been obtained from in 
vivo experiments. Thus, the purpose of this study was to investigate the in vivo effect 
of LXR agonists on the sebaceous gland function following topical application in 
a rat model. Rats (Hsd:FUZZY-fz) received a 4-week topical treatment either with 
vehicle or with LXR agonists (TO901317 or CD-A at 0.001, 0.01 and 0.1%). LXR 
activity on sebaceous glands was assessed by measuring the sebum excretion rate 
(SER) and the 14C acetate incorporation. Furthermore, the effect of T0901317 on 
gene transcription involved in lipid metabolism was studied in the epidermal split by 
qRT-PCR after an 8-day treatment. The differential expression of these genes between 
sebaceous glands and the epidermis was assessed using a laser microdissection 
method. The new compound entity CD-A induced a gradual and dose-dependent 
increase of SER over 4 weeks. An increase of lipid synthesis was also revealed. As 
expected regarding the potency of both LXR agonists in the transactivation assay, 
CD-A and TO901317 at 0.01% displayed the same level of effects in vivo. Activity on 
lipid metabolism in the skin was confi rmed by highlighting the modulation of gene 
transcription involved either in cholesterol homeostasis or in triglyceride metabolism 
after an 8-day treatment with TO901317. Interestingly, a differential modulation was 
shown between sebaceous glands and the epidermis. In conclusion, these results 
indicate that LXR agonists are able to stimulate the sebaceous gland function in vivo 
and suggest that LXR modulators might be of interest in sebaceous gland diseases.
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Lymph Node Metastasis can effectively be reduced by a novel Combinatory Therapy 
in a metastasizing Mouse Melanoma Model
Valero T, Steele S, Petzelbauer P, Loewe R Medical University of Vienna, Vienna, 
Austria
We have recently established a spontaneously metastasizing mouse melanoma 
model to demonstrate that dimethylfumarate (DMF) reduces melanoma growth 
and lymph node metastasis. We have now used this model to compare the 
effects of DMF to therapeutic effects of dacarbazine (DTIC) as well as to effects 
of a combination of DMF and DTIC on melanoma growth and metastasis. Most 
importantly, lymph node metastases, as analyzed by immunohistochemistry, were 
most effectively and signifi  cantly reduced by a combination of DTIC and DMF. 
These results correlated with reduced lymph vessel angiogenesis in primary and 
metastatic tumor sites. In summary, the combination of DTIC with DMF might be 
an appropriate adjuvant in the treatment of advanced stage melanoma in humans.
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Narrow-band UVB treatment increases effectively vitamin D levels in patients with 
psoriasis and atopic dermatitis
Vähävihu K1, Ala-Houhala M1, Hasan T1, Kautiainen H2, Snellman E3, Reunala T4 
1Tampere University Hospital, Tampere, Finland 2Orton Rehabilitation Unit, Helsinki, 
Finland 3Ministry of Social Affairs and Health, Helsinki, Finland 4Tampere University, 
Tampere, Finland
Vitamin D insuffi ciency is common in winter in the Nordic countries. Narrow-band 
UVB (NB-UVB) is a routine treatment for psoriasis (PS) and atopic dermatitis (AD) but 
its effect on vitamin D balance is not known. Our objectives were to study vitamin 
D levels in patients with PS and AD during NB-UVB treatment in winter. 36 adult 
patients with PS and AD received a total of 15 NB-UVB treatments three times a 
week in a Waldman UV 7001 cabin during January-March. Serum calcidiol (25-
hydroxyvitamin D) was measured by radioimmunoassay. At onset 16/18 patients 
with psoriasis and 17/18 patients with AD had vitamin D insuffi ciency (calcidiol 
< 50 nmol L-1). Mean serum calcidiol was 36.8±12.5 nmol L-1 in psoriasis and 
32.2±12.2 nmol L-1 in AD. NB-UVB treatment course signifi cantly (p<0.001) 
increased serum calcidiol in PS by 59.9 nmol L-1 (95% CI 53.5 to 66.9) and in AD 
by 68.2 nmol L-1 (95% CI: 55.4 to 80.1). One month after NB-UVB treatments serum 
calcidiol levels still were nearly at the same level. NB-UVB treatments improved 
signifi cantly (p<0.001) both PASI (from 8.0 to 3.8) and SCORAD (from 37.1 to 
22.9). No correlation was found between changes in serum calcidiol and PASI 
(p=0.43) or serum calcidiol and SCORAD (p=0.08).  The present study shows that 
in addition to the clinical response NB-UVB treatment effectively corrects vitamin D 
insuffi ciency in winter both in PS and AD. Increased serum calcidiol levels persisted 
one month after the NB-UVB course suggesting that the effect is long-lasting. 
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Nitric Oxide donor PAPA NONOate improves wound healing by increasing col-
lagen synthesis
Dashti N1, Zarebavani M2 1Faculty of Allied Medicine, Tehran University of Medical 
Sciences, Tehran, Islamic Republic of Iran 2Faculty of Allied Medicine, Tehran, Islamic 
Republic of Iran
Wound healing is an orchestrated sequence of biochemical changes which results in 
tissue repair. Nitric Oxide (NO) is formed from the amino acid L-arginine by three 
distinct isoforms of nitric oxide synthase. Nitric Oxide plays an important role in wound 
healing by increasing the rate of collagen synthesis in fi broblasts and accelerates 
wound closure when applied topically at the wound site. Because of the limited utility 
of authentic NO gas and short half-life of NO in vivo, NONOates have been widely 
used as NO donor drugs. In this study PAPA NONOate was applied on full thickness 
thermal wound and its effect on wound fl uid collagen synthesis was investigated 
.Twelve Sprague-Dawley  rats were transferred to separate metabolic cages and the 
dorsal surface of each rat was given full thickness thermal wound. During wound 
healing (21 days) the test wounds (n==6) were treated with 100 micromol PAPA 
NONOate in phosphate buffer on the day of wounding and every 3 days. Wound fl uid 
was collected using circular sponges. The rate of collagen synthesis was determined 
by quantitative estimation of hydroxyproline .Phenyl isothiocyanate (PTC) was used 
for derivetization of amino acids from wound fl uid collagen hydrolysate followed by 
HPLC analysis. The rate of wound healing was determined by video image analysis. 
The results of this assay indicate nitric oxide can increase the rate of collagen synthesis 
in the test group (1.17+/- 0.11 mg vs. 0.12 +/- 0.011 mg for controls, P<0.005).  There 
is also a signifi cant difference (P<0.001) in wound closure profi les between the test 
and control groups. These experiments indicate nitric oxide can increase the rate 
of wound healing by increasing the rate of collagen synthesis at the wound site.
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Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
Gisondi P, Targher G, Zoppini G, Girolomoni G University of Verona, Verona, Italy
Non-alcoholic fatty liver disease (NAFLD) and chronic plaque psoriasis are both 
associated with the metabolic syndrome and increased risk of incident cardiovascular 
disease. We assessed the frequency and characteristics of NAFLD in patients with 
chronic plaque psoriasis. 130 consecutive patients with chronic plaque psoriasis 
and 260 apparently healthy controls matched for age, sex and body mass index 
were enrolled. NAFLD was diagnosed by abdominal ultrasound after excluding 
other secondary causes of chronic liver disease. The frequency of NAFLD was 
remarkably greater in psoriasis patients than in controls (47% vs. 28%; p<0.0001). 
Patients with psoriasis and NAFLD (n=61) were more likely to have the metabolic 
syndrome, and had higher serum C-reactive protein and interleukin-6 levels, and 
lower serum adiponectin than those with psoriasis alone (n=69; p„T0.003). They 
also had greater severity of psoriasis according to the Psoriasis Area and Severity 
Index (PASI) score (14.2 ± 12.6 vs. 9.6 ± 7.4; p<0.01). In multivariate regression 
analysis, NAFLD was associated with higher PASI score independently of age, 
gender, body mass index, psoriasis duration, and alcohol consumption. NAFLD is 
frequent in patients with chronic plaque psoriasis - affecting up to nearly half of 
these patients - and is strongly associated with psoriasis severity. Early recognition 
of NAFLD in this group of patients is very important for better management.
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Not all intravenous immunoglobulin preparations are equally well tolerated
Feldmeyer L, Boehler A, Irani S, Speich R, French LE, Hofbauer GF University Hospital 
Zurich, Zurich, Switzerland
The range of diseases in which intravenous immunoglobulin (IVIG) is used has 
increased rapidly since its initial use in primary antibody defi ciency. Despite many 
years of safe use, side effects and adverse reactions still occur. Whereas many reports 
concentrated on the description of adverse reactions following IVIG infusions, few 
have compared the adverse reactions of the different available IVIG preparations. 
In the course of our clinical practice, we have observed different IVIG formulations 
to be of different tolerability in our patients. We report on adverse events following 
IVIG infusion for different indications in 40 patients in our dermatology department 
between May 2001 and December 2008. 13 patients (31.7 %) experienced mild and 
moderate adverse reactions during or within 48 hours of the standard administered 
IVIG preparation (Redimune) which did not recur after switching to an alternative 
preparation (Octagam or Endobulin). These adverse reactions included headache (7 
cases), fever (5), chills (3), nausea (3), emesis (3), hypotension (1), and muscle cramps 
(1). In four cases, the presence of predisposing conditions was identifi ed: one patient 
experiencing severe headache had a history of migraine; in three cases the presence 
of a concomitant infection was identifi ed. Except for two cases, adverse events 
occurred during the fi rst or the second infusion of a given preparation. No patient 
experienced severe adverse reactions. Among the 16 patients that received Octagam 
in the fi rst place, no one experienced adverse reactions. Our study shows that IVIG 
preparations are not all equally well tolerated in patients. Beside common prophylactic 
measures we recommend switching IVIG formulation in case of side effects.
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Oxidative stress in the pathogenesis of vitiligo
Pescitelli L, Prignano F, Fiorillo C, Becatti M, Taddei N, Lotti T Florence University, 
Florence, Italy
Vitiligo is a chronic acquired hypomelanotic disorder affecting 0,5%-2% of the world 
population with a complex and uncleared pathogenesis. Recently, oxidative stress 
has been invoked as the initial pathogenetic event in melanocyte: an alteration in 
the antioxidant pattern, with a signifi cant reduction in catalase activity, has been 
demonstrated in both lesional and non lesional epidermis of patients, as well as 
in melanocytes. The antioxidant imbalance has been confi rmed also in peripheral 
blood mononuclear cells of active vitiligo patients; it was correlated to an increased 
intracellular production of reactive oxygen species (ROS) and appeared to be 
consequent to a mitochondrial impairment. In order to demonstrated the involvement 
of oxidative stress in the pathogenesis of vitiligo, we have grown primary keratinocytes 
from lesional, perilesional and healthy skin, evaluating intracellular ROS generation, 
lipid peroxidation, total antioxidant capacity, mithocondrial activity and apoptosis in 
the presence or in the absence of curcumin and capsaicin.The results indicate that 
keratinocytes from perilesional skin show the features of damaged cells. Pretreatment 
with antioxidants inhibited caspase activation, increased total antioxidant capacity, 
repressed intracellular ROS generation, lipid peroxidation and ameliorated 
mitochondrial activity. Our data give to keratinocytes a role of primary importance in 
vitiligo development and support the concept that free radical-mediated damage may 
be the initial pathogenic event in melanocyte degeneration in generalized vitiligo. 
These results also suggest that antioxidants might represent an alternative approach 
to limit mitochondrial damage and oxidative stress in perilesional vitiligo skin.
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Pharmacologic Preconditioning of Random-Pattern Skin Flap in Rats Using Local 
Captopril: Interaction with Nitric Oxide System
Nezami BG, Assa S, Shafaat Talab S, Emami H, Dehpour AR Tehran University of 
Medical Sciences, Tehran, Islamic Republic of Iran
ACE inhibitors have been implicated in modulation of ischemia/ reperfusion events in different 
organs. However, its mechanism of action is a place of controversy. The aim of this study was to 
investigate the effect of captopril preconditioning on skin fl ap survival in a rat model of random 
pattern skin fl ap and evaluating its mechanism of action. Eighty Sprague-Dawley rats were randomly 
divided into either control or treatment groups (n = 8 each). Bipedicled dorsal skin fl aps (2 x 8 cm) 
were elevated at the midline. In fi rst three groups, pharmacologic preconditioning was induced by 
local injection of captopril (25, 50 and 200 mol/fl ap) prior to cutting the cranial pedicle and inducing 
permanent ischemia. At the seventh postoperative day, the survival of the fl aps was measured. In 
control group 1 milliliter of saline was administered locally in the fl ap. Next three groups received 
1 ml of losartan, an angiotensin receptor type 1 antagonist, with different doses (10, 50, 100 and 
200 micromol/fl ap) to investigate the involvement of renin angiotensin system and the outcome was 
compared with that of captopril and control group. The role of nitric oxide system was evaluated by 
interaperitoneal administration of nitric oxide synthase inhibitor, N omega-nitro-l-arginine methyl 
ester hydrochloride (L-NAME) (10 mg/kg), 30 min before treatment with effective dose of captopril.
Signifi cant increase in fl ap survival was obtained with 200 mmol/fl ap captopril compared to control 
group (65.2±5 vs. 49.5±3.3, P<0.05) while no signifi cant improvement was observed with losartan 
administration(48.5±8.8). Co-administration of L-NAME and effective dose of captopril (200 mmol/
fl ap) reversed its protective effect to the level of control group.  Pharmacologic preconditioning 
with local captopril can signifi cantly improve skin fl ap tolerance to ischemia. Although being an 
ACE inhibitor, the protective effect of captopril is not mediated through renin angiotensin pathway 
and nitric oxide system seems to be the alternative proposed mechanism in this phenomenon.
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Photodamaging effects of porphyrins on primary human keratinocytes and carci-
noma cell cultures. The evaluation of cytotoxic and phototoxic effect of chitosan 
on cell cultures
Cosgarea R1, Susan M1, Senila S1, Baldea I1, Macovei V1, Dreve S2 1University of 
Medicine, Cluj-Napoca, Romania 2National Institute of Research for Development 
of Isotopic and Molecular Technologies, Cluj-Napoca, Romania 3Chemical Research 
Institute ICECHIM, Bucuresti, Romania
Photodynamic therapy (PDT) is a nonsurgical method for treating non melanoma skin cancer 
and precancerous lesions which consists in a combination between a topical photosensitizer 
substance and exposure to red light.The aim of  the study was to test the effect of PDT on the 
normal and tumoral cell cultures, obtained by biopsy of normal skin and small fragments of 
basal cell carcinoma. The photosensitizer substances were: 5,10,15,20-tetra-(p-methoxyphenil) 
porphyrin (TMP) and its component with zinc (Zn-TMP). The effects of PDT were assessed using 
a MTS cell-proliferation assay and an immunocitochemical method with annexin V– FITC for the 
detection of apoptosis. We observed the effects of concomitent exposure of the cells to the chitosan, 
photosensitizer substances and red light. Both tested substances, TMP and Zn-TMP, had a cytotoxic 
effect for a concentration more than 100 µg/ml; these substances had a phototoxic effect on primary 
human carcinoma cell cultures less then 100 µg/ml. The number of viable cells in carcinoma cell 
cultures photosensitized with TMP and Zn-TMP, then irradiated with red light was signifi cantly 
reduced, depending on the concentration of photosensitizer, compared to control groups. We 
didn’t obtain phototoxic effect on primary keratinocytes, probably due to preferential accumulation 
of photosensitizer substances in tumoral cells. Associated administration of chitosan with 
photosensitizer substances produced an increased cell viability with 20% after exposure to red light 
compared with the same concentrations of photosensitizer without chitosan (cytoprotective effect).
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Polyunsaturated fatty acids upregulate lipid synthesis and infl ammatory signalling 
in SZ95 sebocytes by inducing the expression of the fatty acid synthesis enzymes 
SCD and FADS2
Angres S1, Seltmann H2, Zouboulis CC2 1Charité Universitaetsmedizin Berlin, Berlin, 
Germany 2Dessau Medical Center, Dessau, Germany
Biosynthesis of monounsaturated and polyunsaturated fatty acids (PUFA), which are 
contained in human sebum, is an enzymatic process. Previous studies have shown 
that treatment of SZ95 sebocytes with the PUFA linoleic acid and arachidonic 
acid leads to a specifi c lipid accumulation. In this study, a possible mechanism 
by which treatment with PUFA may increase sebaceous lipids could be identifi ed, 
namely the regulation of the expression of stearoyl-CoA desaturase (SCD) and fatty 
acid desaturase 2 (FADS2), two major enzymes of PUFA biosynthesis. Linoleic 
acid treatment induced a short-term early increase of SCD and FADS2 at mRNA 
and protein levels in SZ95 sebocytes. Treatment with arachidonic acid led to an 
increase of SCD and to a decrease of FADS2 mRNA levels. Linoleic acid/testosterone 
stimulated lipogenesis in SZ95 sebocytes. A distinct proinfl ammatory PUFA pattern 
was registered; while LA strongly upregulated IL-6 secretion only and AA induced a 
mild level of release of both IL-6 and IL-8 from SZ95 sebocytes. Treatment with the 
SCD inhibitor FPCA reduced the LA-upregulated SCD and FADS2 mRNA levels and 
exhibited anti-infl ammatory properties. In conclusion, SCD and FADS2 expression 
in human sebocytes is associated with both lipogenesis and infl ammatory signalling.




Problems in the use of Refl ectance Confocal Microscopy (RCM) to measure stratum 
corneum (SC) thickness
Robertson K, Rees JL The University of Edinburgh, Edinburgh, United Kingdom
We have compared 2 different methods for measuring stratum corneum (SC) thickness 
using Refl ectance Confocal Microscopy (RCM); the fi rst suggested by Lucid, the microscope 
manufacturer, the second consisting of simple visual analysis of confocal images. In brief, the fi rst 
is based on the fact that the concentration of confocally bright keratin in SC causes a signifi cant 
increase in image brightness, so SC images can be separated from those of living epidermis using 
image processing software based on analysis of the fi rst differential. Visual analysis is a simple 
determination by the observer as to the depth (µm) of the fi rst image to show the presence of 
granular layer cells.We collected vertical (z-axis) ‘stacks’ of images at 1µm intervals from SC 
surface to 50µm depth (51 images) at 11 body sites (including palm), and measured SC thickness 
using both methods. Excluding the palm, thickness values were not signifi cantly different (p=0.40, 
student t-test). Values for the palm, however, were signifi cantly different: 7µm for Lucid’s method, 
89µm for visual analysis. This large discrepancy caused us to suspect there was another reason 
for the increased brightness of images close to the skin surface. We found that the known artifact 
of the RCM imaging process which causes a bright ‘fl are’ of light at the skin surface leads to the 
incorrect differential being used. The same anomaly was noted when we tested Lucid’s method by 
measuring high-density matt black paper, which generated a ‘SC thickness’ value of 14µm despite 
the paper having no apparent change in structure visually. We were therefore unable to conclude 
that Lucid’s method was measuring brightness purely due to keratin, and now suspect that this 
method may be unsatisfactory. We compared visually analysed SC thickness results between 3 
observers; one experienced in RCM, 1 experienced in light microscopy, and 1 with no microscopy 
experience. There was little difference in measurements (p=0.9859) between the 3 investigators. 
We consider simple visual analysis to be the most appropriate method of measuring SC using RCM.
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Prognostic value of Hutchinson’s sign in acute herpes zoster ophthalmicus
Natsuaki Y, Saruta H, Yasumoto S, Hashimoto T, Nakamura S, Ishii Y, Teshima Y Dept 
of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Herpes zoster ophthalmicus occurs when varicella zoster virus reactivates in the 
ophthalmic division of the trigeminal nerve. The ophthalmic division is further divided 
into the nasociliary nerve, frontal nerve and lacrimal nerve. The nasociliary nerve is 
also divided into the infratrochlear nerve and external nasal branch. Hutchinson?Œs 
sign is defi ned as the appearance of skin lesions on the tip, side or root of the nose, 
representing the dermatome of the nasociliary nerve. The purpose of this study was 
to determine the prognostic value of the nasociliary nerve skin lesions for ocular 
infl ammation. Age, sex, acute pain, rash duration, rash severity, rash extent of the 
individual patients, development of ocular complications and postherpetic neuralgia 
were assessed. 41 patients (mean age: 68 years, range: 24-102) presenting with acute 
herpes zoster in the fi rst branch of the trigeminal nerve were followed up for six 
months. All patients were treated with antiviral drugs, as soon as the diagnosis of 
herpes zoster was made. 16 of 41 patients developed ocular complications in the acute 
phase. Conjunctivitis was most commonly, observed in 16 patients, keratitis was seen 
in 7 patients, iritis was seen in 2 patients and external ocular motor palsies occurred 
in 2 patients. Statistical analysis between the presence of ocular complications and 
the symptoms of herpes zoster ophthalmicus showed that the severity of acute pain 
(p<0.01) and the distribution of nasociliary nerve dermatome (p<0.001) were the 
major prognostic factors of subsequent ocular infl ammation. Dermatologists should 
be alert for early skin lesions on the nasociliary nerve dermatome, because this is a 
reliable prognostic sign of ocular complications in herpes zoster ophthalmicus.
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Pulse Corticosteroid Therapy in Pemphigus
Kanwar A PGIMER, Chandigarh, India
Dexamethasone cyclophosphamide pulse therapy in pemphigus was pioneered by earlier 
researchers. This regimen has been used with success in nearly thousand patients in our 
centre. Initially proposed regimen of dexamethasone- cyclophosphamide pulse therapy 
(DCP) consisted of 100 mg dexamethasone dissolved in 500 mL of 5% glucose as a slow 
intravenous drip over 2 hours repeated on 3 consecutive days. On the second day, the patient 
is also given 500 mg cyclophosphamide in the same drip. The pulses are repeated at exactly 
28 day intervals counted from the fi rst day of the pulse. In between the DCPs the patient 
receives only 50 mg cyclophosphamide orally. DCP therapy has been divided in four phases. 
The phase 1 refers to the phase in which recurrences of clinical lesions in between the DCPs 
occur and therefore additional treatment (conventional daily doses of oral corticosteroids 
or additional dexamethasone pulses) can be given to achieve quicker clinical recovery, and 
these are as a rule withdrawn step-wise during the subsequent DCPs. In phase 2, the patient 
remains completely alright clinically but receives 6 more DCPs at exactly 28 day cycles 
along with 50 mg cyclophosphamide orally per day. In phase 3, the DCPs are stopped and 
the patient receives only 50 mg cyclophosphamide orally per day for the next 12 months. In 
phase 4, the treatment for pemphigus is withdrawn completely and the patient is followed 
up to look for a relapse if any. According to recent recommendations, both phase 2 and 3 
persists for 9 months. In our centre, we use DCP at an interval of 3 weeks initially in patients 
with severe pemphigus. Dose of dexamethasone used in 136 mg/day (equivalent to 1000 
mg of nethylprednisolone) instead of 100 mg/day. DCP has been found to be extremely 
safe and effective in pemphigus.  In view of long-lasting remission ranging from 6 months 
to 12 years, we have proposed that a cure for pemphigus may be possible with DCP.
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Quality of life and optimism in psoriasis patients
Zalewska A1, Miniszewska J2, Chodkiewicz J2 1Psychodermatology Department, 
Medical University of Lodz, Lodz, Poland 2Health Psychology Department, University 
of Lodz, Lodz, Poland
Numerous literature data point out at highly impaired quality of life In psoriatic 
patients. The aim of the study was to assess impact of personal resources such as 
optimism, health locus of control and self-effi cacy on health related quality of life 
(HRQL). Detailed sociodemographic data and severity of psoriasis were taken into 
account. The study group comprised of 168 (56 women, 112 men; mean and SD age 
39.8 and 13.0 years, range 17-70 years; mean  and SD disease duration 15.2 and 
11.9 years, range 1-52 years) psoriasis vulgaris in-patients from the Dermatology and 
Venereology Department, Medical University of Lodz.  Disease severity was evaluated 
by PASI score (Psoriasis Area and Severity Index). The following psychological 
questionnaires were employed: to evaluate HRQL - SKINDEX-29, Life Orientation 
Test (LOT-R), Multidimenstional Health Locus of Control Scale (MHLC), Self-Effi cacy 
Scale (GSES). Statistically signifi cant positive correlation was observed between level 
of optimism and self-effi cacy and higher HRQL. Furthermore, conviction that other 
people infl uence our health status signifi cantly correlated with worse HRQL. Moreover, 
the older the patients the worse there HRQL was.The obtained results point out at the 
importance of psychological intervention e.g. psychotherapy which should be focused 
on improvement of self-effi cacy and optimism, employment in psoriatic patients.
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Red ginseng root extract-containing herbal mixture improves facial wrinkles and 
increases type I procollagen synthesis in human skin in vivo:  a randomized, double-
blind, placebo-controlled study
Cho S1, Won CH2, Lee DH3, Lee MJ4, Lee SK5, Koo BS5, Kim NM5, Chung JH3 1Seoul 
National Univ Boramae Hospital, Republic of Korea 2Ulsan Univ Asan Medical 
Center, Seoul, Republic of Korea 3Seoul National Univ College of Medicine, Republic 
of Korea, 4Institute of Dermatological Science, Seoul National Univ, Republic of 
Korea 5KT&G Central Research Institute, Daejeon, Republic of Korea
Red ginseng contains many bioactive constituents including various ginsenosides which claim to 
have anti-oxidant, immunostimulatory and anti-aging activities.  Yet, no controlled human study 
explored its effects on photoaged skin.  The objective of this study was to determine whether long-
term intake of red ginseng extract mixture reduces facial wrinkles and increases collagen synthesis 
in human skin in vivo.  Healthy female volunteers over 40 years of age were randomized in a 
double-blind fashion to receive 3 g/day of either red ginseng extract-containing herbal mixture 
or placebo for 24 weeks. Facial wrinkles, elasticity, epidermal water content, erythema, and 
pigmentation were measured objectively.  Facial skin samples were taken before and after intake 
of study substance, and real-time PCR and immunohistochemical analyses were undertaken for 
type I procollagen, MMP-9 and fi brillin-1 expression.  In the 82 subjects who completed the study, 
facial wrinkles were signifi cantly improved, type I procollagen gene and protein expression was 
increased, and fi brillin-1 fi ber length was elongated only in the treatment group. No changes 
were seen in the facial elasticity, epidermal water content, erythema and pigmentation in either 
group.  In conclusion, red ginseng extract-containing mixture improves facial wrinkles, a clinical 
sign of photoaging, and this improvement is associated with biochemical and histological 
evidence of increased collagen synthesis in the dermis.  These results substantiate the alleged 
benefi cial effects of red ginseng on photoaging and support its use as an effective “beauty food”.
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Resveratrol Protects Keratinocytes Cells Against Nitric Oxide-Induced Toxicity
Bastianeto S1, Duranton A2, Dumont Y1, Breton L2, Quirion R1 1McGill University, 
Montreal, Canada 2L’Oréal  Research, Clichy, France
A growing number of studies suggest that natural extracts and phytochemicals have a 
positive impact on brain aging. This can be evidenced by exposure of  hippocampal 
cells to the nitric oxide (NO) donor sodium nitroprusside (SNP) which resulted in 
a decrease in cell survival and the protection by natural polyphenols against these 
events. More recently, it has been reported that neuroprotective effects of one of 
these compounds, resveratrol, may be mediated by specifi c binding sites in the 
brain. In this work we have  transposed to skin these results. Using immortalized 
keratinocytes cell lines HaCAT, we have here studied the effect of resveratrol in a 
model of toxicity induced by the nitric oxide (NO) donor, sodium nitroprusside 
(SNP). A 24-hour exposure SNP (0.3-10 mM) caused a concentration-dependent 
decrease of cell survival, as revealed by the MTT and calcein assays. A treatment with 
resveratrol (1-30 μM) inhibited the toxic effect of SNP, the effect being signifi cant 
from 10 μM. Moroever, resveratrol reduced the increased activity of caspase-3 
and the number of apoptotic cells, as estimated by the SYTO 16, suggesting that 
it protects keratinocytes cells through its anti-apoptotic action. Finally, we have 
identifi ed [3H]-resveratrol binding sites in HaCAT as well as in human skin sections. 
Taken together, these data suggest that as for brain resveratrol is a potent agent that 
offers anti-aging effetcs for human skin. Moreover a similar mechanism could be 
involved to explain the benefi cial effects resveratrol in skin and brain. This can be 
connected with the hormonal prevention of aging which has also been described 
to have benefi cial effects against age-induced damage in the CNS the liver and 
the skin through molecular mechanisms reducing oxidative stress and apoptosis.
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Risk-Benefi t Analysis of Adalimumab Versus Methotrexate and Placebo for the 
Treatment of Moderate to Severe Psoriasis: Comparison of Adverse Event-Free 
Response Days in the CHAMPION Trial
Reich K1, Signorovitch J2, Ramakrishnan K2, Gupta S3, Mulani P3 1Georg-August-
University, Göttingen, Germany 2Analysis Group,, Boston, USA 3Abbott Laboratories, 
Abbott Park, USA
CHAMPION was the fi rst randomized trial to demonstrate the superiority of a biologic versus 
nonbiologic therapy for treatment of psoriasis (Ps). This study compared adverse event (AE)-free 
response days for adalimumab (ADA) vs. methotrexate (MTX) and placebo. In CHAMPION, a Phase 
III, DBPC trial, patients with moderate to severe chronic plaque Ps were randomized to receive 
placebo (N=53), MTX (N=110), or ADA (N=107). Clinical effi cacy was measured by the PASI and 
safety was measured by AE rates. The study applied a composite risk-benefi t measure: the total number 
of AE-free response days, (ie, number of days with ≥75% improvement in PASI from baseline (PASI 
75 response) and freedom from any AEs). Patients were followed for 17 weeks from their baseline 
visit. The cumulative number of AE-free response days was evaluated over the entire study period 
and during the fi rst 30 days. Outcomes were compared across treatment groups using Wilcoxon 
rank sum tests. Over 17 weeks, ADA-treated patients experienced signifi cantly more any-AE-free 
response days (36.9 days) than patients treated with MTX (8.3 days; p<0.0001) or placebo (6.7 days; 
p<0.0001). ADA also provided more AE-free response (1.05 days) during the fi rst 30 days compared 
with both MTX (0.03 days; p<0.0001) and placebo (0.08 days; p=0.013). MTX did not provide a 
statistically signifi cant difference in number of response days vs. placebo during either time period 
evaluated. With substantially more AE-free response days than MTX and placebo, ADA treatment 
for Ps had a superior risk-benefi t profi le, even within the fi rst month of treatment. MTX did not show 
a statistically signifi cant risk-benefi t advantage over placebo in terms of any-AE-free response days.
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Simple method of constructing living skin equivalent using human amnion as dermal 
matrix
Shirakata Y, Yang L, Sayama K, Hashimoto K Ehime University Graduate School of 
Medicine, Toon City, Japan
Living skin equivalents (LSE), containing well-differentiated keratinocytes cultivated on fi broblasts-
populated dermal substitutes have been used to treat burn wounds, skin defects and chronic 
wounds and ulcers. The dermal matrix and the fi broblasts in LSE modulate epidermal growth and 
differentiation through dynamic interaction. A variety of biomaterials are being employed as dermal 
substitutes, including type I collagen, acellular human dermis, collagen-glycosaminoglycane matrix, 
human plasma, fi brin glue and so on. However, it has not been widely used because of complicated 
procedures for making LSE. To develop a simple method for constructing LSE, we focused human 
amnion (AM) as dermal matrix. Human AM was de-epithelialized and investigated whether it well 
supported the keratinocytes adherence and proliferation or the fi broblasts ingrowth and proliferation. 
The new LSE was constructed by seeding keratinocytes on the epithelial side of the fi broblasts-
populated de-epithelialized AM and was investigated morphologically, immunohistochemically 
and with electronic microscope. The LSE was transplanted onto a full-thickness wound of a nude 
mouse and the histological morphology of harvested sample was observed. The de-epithelialized 
AM well supported the adherence and proliferation of keratinocytes and the ingrowth of fi broblasts. 
The new LSE showed good mechanical property and revealed good morphology with well 
differentiated epidermis and well developed basement membrane. The LSE grafts survived well on 
nude mice with good morphogenesis. In conclusion, the LSE with amnion as the dermal matrix 
presented various advantages such as simple cultivating procedures, low cost, good mechanical and 
handling properties and it is devoid of the matrix of animal products. The good epidermogenesis 
in vivo or in vitro study confi rmed it as a good skin substitute in future clinical application.
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Study of the distribution and biological effects of cross-linked hyaluronic acid fi llers 
injected in human dermis
Tran C, Micheels P, Grand D, Carraux P, Kaya G, Sorg O, Salomon D Geneva 
University Hospital, Geneva, Switzerland
Hyaluronic acid (HA) fi llers are biodegradable hydrogels made of cross-linked hyaluronic 
acid used for soft tissue augmentation. Their dermal distribution, resorption, and potential 
to induce infl ammation and dermal remodelling has not been extensively studied. Esthélis 
Basic®, Juvederm Ultra® and Restylane® fi llers have been injected in the dermis of 15 
healthy volunteers. The dermal distribution of the fi llers was assessed by histology and 
electron microscopy after one week, 3 months and one year. Various immunostainings (CD3, 
CD20, CD68, alpha actin, procollagen I) have been performed. A quantitative PCR analysis 
for collagen I and III, elastin, HAS1, HAS2, HAS3, Hyal2, CD44, has also been conducted. 
The major difference between the three HA fi llers was the dermal distribution. Esthélis 
was homogeneously distributed throughout the dermis, spreading between the collagen 
bundles. Restylane disrupted the collagen network due to his structure: a biphasic HA gel. 
The distribution of Juvederm was in between. A discreet dermal infl ammatory infi ltrate at the 
injection site has been observed in the three conditions at one week, 3 months and one year, 
without a granulomatous reaction. After one year, the 3 fi llers persisted in the dermis, suggesting 
a slow resorption process.There was no structural or cellular alterations visible in electron 
microscopy. Extensive rough endoplasmic reticulum and Golgi apparatus in the cytoplasm of 
fi broblasts suggested an increased metabolic activity. Nevertheless, the results of quantitative 
PCR did not demonstrate, for both Esthélis and Restylane, an up-regulation of collagen I 
and III at one week.The monophasic cross-linked HA fi llers display a more homogeneous 
distribution in human dermis as compared to biphasic gels. None of the products induced 
a pathological infl ammatory response up to one year, suggesting and excellent tolerance.
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Systemic profi le of psoriasis: the effects of ustekinumab and etanercept following 
12 weeks of treatment
Brodmerkel C1, Kikuchi T2, Fidelus-Gort R3, Khatcherian A2, Novitskaya I2, Baribaud 
F1, Krueger J2 1Centocor Research and Development, Inc, Malvern, USA 2Rockefeller 
University, New York, USA 3Incyte Corporation, Wilmington, USA
Serum proteins and subsets of infl ammatory cells are potential biomarkers associated 
with psoriasis and its comorbidities, and variation in these may correlate with response 
to biologic therapy. Blood samples from patients (n=145) in ACCEPT, which compared 
the effi cacy of etanercept (ETA) and ustekinumab(UST) in moderate-to-severe psoriasis, 
were analyzed for a panel of 91 proteins using a Luminex-based-platform. Serum CCL22, 
a chemokine produced by macrophages and dendritic cells, signifi cantly correlated with 
disease severity based on the Psoriasis Area and Severity Index (PASI) and body surface area 
(BSA) of involvement (r>0.5, p<0.001). Serum leptin signifi cantly correlated with BMI (r>0.7, 
p<0.001). No consistent changes in normalized serum protein profi les were identifi ed based 
on treatment response (PASI 75) at wk4 or wk12 across all groups. Signifi cantly reduced 
serum IL-8, CRP and CCL4 levels were observed for ETA-treated patients. UST had minimal 
impact on serum CCL4; trends for decreased serum levels of IL-8 and CRP were noted. 
Median numbers of circulating lymphocytes remained unchanged across all groups (n=69). 
There were no signifi cant changes in percentages of CD4+ T-cells (naïve and memory); 
CD8+ T-cells (naïve, memory, and effector), regulatory T-cells; CLA+ cells; NK cells; NKT 
cells following 12 wks of UST or ETA; or in cytokine production (IFNγ, TNF, IL-17, and IL-22) 
in response to CD3:CD28 stimulation ex vivo following UST or ETA. In summary, these data 
demonstrate limited effects on the circulating serum protein profi le as well as the normal 
complement of circulating immune cells after 12 wks of treatment with either UST or ETA.
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The effect of Phenytoin on melanocyte cultures
Stefanescu D, Baldea I, Cosgarea R University of Medicine and Pharmacy, Cluj-
Napoca, Romania
Vitiligo is a cutaneous disease which, although it is asymptomatic and does not 
infl uences the general mortality and morbidity, it can determine lesions with major 
consequences on mental health of the pacient. The aim of vitiligo treatment is 
repigmentation and stabilization of the depigmentation process. Phenytoin, a widely-
used anticonvulsant, has been employed both topically and systemically in the 
treatment of some dermatological disorders. There are many immunological and non-
immunological efects that suggests that Phenytoin could be therapeutically effective 
against vitiligo.The objective of the study was to evaluate the effect of Phenytoin on 
cultures of normal human melanocytes, and to appreciate cellular viability using 
colorimetric methods.We used a line of normal human melanocytes (Sigma-Aldrich) 
cultivated with melanocyte growth medium and incubated for 24 hours at 37 C 
&#351;i 5%CO2. We exposed melanocyte cultures at 5,5 diphenylhydantoin powder 
at 17 different concentrations (0,1-1000 µg/ml). We appreciated the melanocyte 
viability using MTS Assay test, by measuring the absorbtion at 490 nm with ELISA 
plate reader. The statistic analysis revealed that at low concentrations (0.1 µg/ml, 0.5 
µg/ml), Phenytoin stimulates growth and cellular proliferation in melanocyte cultures. 
In conclusion, although there is still no therapeutic panacea for vitiligo, topical 
applications of Phenytoin may be a  treatment option that can lead to satisfactory results.




The effects of Rituximab on BAFF levels in epidermolysis bullosa acquisita
Baican A1, Chiriac MT2, Baican C1, Cosgarea R1, Macovei V1, Sitaru C3 1Department 
of Dermatology, University of Medicine and Pharmacy, Cluj-Napoca, Romania 
2Department of Experimental Biology, University of Babes-Bolyai, Cluj-Napoca, 
Romania 3Department of Dermatology, University of Freiburg, Freiburg, Germany
The B-cell activating factor (BAFF), a member of the TNF family, regulates the survival 
and proliferation of B cells. Rituximab, a chimeric monoclonal antibody that depletes 
CD20+ B cells, was originally approved for the treatment of B-cell malignancies. Recently, 
it has been used for treating B cell mediated autoimmune diseases like pemphigus 
vulgaris, systemic lupus erythematosus and rheumatoid arthritis. Here we investigated 
changes in BAFF levels in a rituximab-treated case of epidermolysis bullosa acquisita, an 
autoantibody-mediated  chronic subepidermal blistering disease, characterized by tissue-
bound and circulating antibodies against the type VII collagen of the dermal-epidermal 
junction. Our patient had been refractory at conventional treatments with prednisone and 
dapsone. Serum was collected twice before the initiation of treatment and at weeks 3, 
8, 26 and 52 after the fi rst of 4 weekly infusions of rituximab (375 mg/m2) and assessed 
for BAFF levels and for autoantibodies by indirect immunofl uorescence and ELISA using 
recombinant collagen VII. The circulating levels of BAFF were elevated as soon as 3 
weeks after the initiation of treatment, peeked at 8 weeks (>5 fold of the baseline level) 
had a slow decline thereafter (4x at 6 months) and tend to stabilize at 9 and 12 months 
(3x). The  titres of circulating autoantibodies also decreased up to 4 fold within 1 year, 
and we  recorded a partial clinical remission. The increase in BAFF level after rituximab 
treatment could have a promoting effects on antibody production by long-lived antigen-
specifi c plasma cells, which were not depleted by the Rituximab therapy. Therefore, a 
BAFF-antagonist treatment could be considered to prolong the period of clinical remission.
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The Immune Phenotype of Therapeutic IL-12/IL-23 Blockade in Psoriasis Patients 
Treated with Ustekinumab
Krueger J1, Kikuchi T1, Fidelus-Gort R2, Khatcherian A1, Novitskaya I1, Brodmerkel 
C3 1Rockefeller University, New York, USA 2Incyte Corporation, Wilmington, USA 
3Centocor Research and Development, Inc, Malvern, USA
Genes activated in psoriasis vulgaris skin lesions include lipocalin 2, defensins, S100 proteins, and 
CCL20, all modulated by IL-17, the defi ning cytokine of Th17 T-cells. We present data related to the 
immune phenotype of therapeutic IL-12/IL-23 blockade in psoriasis patients treated with ustekinumab. 
In the ACCEPT study, patients were treated with 45 mg or 90 mg of ustekinumab for 12wks. Skin biopsies 
were performed at baseline, wks 1 and 12 of treatment to assess the impact of p40 cytokine (IL-12/IL-23) 
blockade on resident and infl ammatory cells and on expression of gene circuits that may drive chronic 
immune activation and infl ammation in the skin. Two infl ammation-associated dendritic cell subsets;TIP-
DCs (CD11c+BDCA1) and mature/activated DCs (DC-LAMP (CD208+)) were highly expressed in 
active psoriasis lesions and reduced to normal levels by ustekinumab (p < 0.01) as were infi ltrating 
T cells. In contrast, resident populations of Langerhans cells (CD207+) and dendritic cells (BDCA1+) 
were retained in skin lesions at normal levels during ustekinumab treatment. Activation of infl ammatory 
DCs, Th1, and Th17 T-cells, as well as keratinocyte response to IL-17 was assessed by quantifi cation of 
mRNAs for gene products (IL-20, IL-23, IL-17, IL-22, interferon-gamma, lipocalin, defensins, CCL20, 
and MX-1). Genes in this axis may form a self-sustaining activation loop for Th17 T-cells through Toll-
like receptors 1 and 2 on infl ammatory DCs. Treatment with ustekinumab modulated expression of 
genes in this “autoinfl ammatory loop” and reduced activation of Th1 and Th17 T-cells to background 
levels found in non-lesional psoriatic skin (all effects p<0.01). Modulation of infl ammation-associated 
leukocyte subsets was confi ned to the skin, as circulating levels of Th1, Th2, Th17, NK-T and Treg T-cell 
subsets was not signifi cantly impacted during 12wks of ustekinumab treatment. Overall, these results 
suggest that interruption of p40 cytokine signaling in the skin causes collapse of pathogenic immune 
infi ltrates and cytokines, but T-cells and DCs of the normal skin immune system persist in treated skin.
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The mTOR inhibitor sirolimus augments melanoma cell apoptosis induced by the 
multikinase inhibitor sorafenib
Schwarz D1, Lasithiotakis K1, Niessner H1, Sinnberg T1, Vasseur S2, Iovanna JL2, Kulms 
D3, Schittek B1, Garbe C1, Meier F1 1University of Tübingen, Germany 2Centre de 
Recherche INSERM, Marseille, France 3University of Stuttgart, Germany
In melanoma, the RAF-MEK-ERK (MAPK) and the PI3K-AKT-mTOR (AKT) signaling pathways are 
constitutively activated and have key functions in tumor progression. However, clinical studies revealed 
that neither the RAF inhibitor sorafenib nor the mTOR inhibitor sirolimus have suffi cient antitumor activity 
in patients with metastatic melanoma. Recent experimental data suggest that in melanoma an effective 
treatment strategy must take into account more than one deregulated signaling pathway. We investigated 
whether combined targeting of both pathways with the RAF inhibitor sorafenib and the mTOR inhibitor 
sirolimus has therapeutic effects in melanoma. The effects on growth, survival and invasion of six human 
metastatic melanoma cell lines in monolayer and organotypic culture were investigated.Combination of 
sorafenib with sirolimus signifi cantly potentiated growth inhibition in all melanoma cell lines tested and 
led to an approximately 2-fold increase of apoptosis compared with sorafenib monotreatment (p< 0.05). 
Moreover, sorafenib in combination with sirolimus completely suppressed invasive melanoma growth in 
organotypic culture. To investigate the molecular mechanisms involved in the antitumoral action of these 
drugs we analyzed the gene expression profi le of melanoma cells in response to sorafenib or/and sirolimus. 
Data analysis showed a series of stress-associated genes that were upregulated after combination treatment 
with sorafenib and sirolimus. One of these genes was that encoding p8, a protein that belongs to the family 
of HMG-I/Y transcription factors and that is involved in the control of cell fate. Using real-time quantitative 
PCR, we confi rmed that sorafenib and sirolimus upregulates p8 mRNA levels in melanoma cells. Likewise, 
western blot analysis showed that sorafenib and sirolimus increases p8 protein levels in melanoma cells. 
Further analysis of the gene expression profi le has led to the identifi cation of three genes encoding the 
transcription factors ATF-3 and CHOP and the stress-related pseudokinase TRB-3 which have been proposed 
to be responsible for the execution of endoplasmic reticulum stress-induced apoptosis.The mTOR inhibitor 
sirolimus potently augments apoptosis induced by the multikinase inhibitor sorafenib in melanoma cells.
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Therapeutic Effect of Photodynamic Therapy With Aminolevulinic Acid Topical 
Solution and Blue Light on the Treatment of Precancerous lesions
Choi J, Hong S, Chun J, Kang J Busan Paik Hospital, Busan, Korea, Republic of
Actinic keratoses and Bowen’s diseases are precancerous lesions that are treated with 
local liquid nitrogen cryotherapy, topical fl uorouracil, or topical chemotherapeutic 
agents. Recently, photodynamic therapy with various kinds of light sources have 
been tried in treatment of precancerous lesions. We examined the safety and 
effi cacy of photodynamic therapy using topical 20% aminolevulinic acid in a 
solution formation and blue light to treat precancerous lesions in Korean patients.
Twenty fi ve Actinic keratoses lesions of 17 patients and 4 Bowen’s diseases lesions 
of 3 patients were enrolled in the study. They were prepared with application of 
topical 20% aminolevulinic acid solution for 2 hours and followed by exposure 
to 10 J/cm2 of blue light. The lesions were assessed at 48 hours and 2, 4 weeks 
following photodynamic therapy . Target lesions remaining at week 4 were re-
treated. For evaluation of response to aminolevulinic acid-photodynamic therapy , 
skin biopsies were done at 8 weeks. Complete remissions were achieved in 64.0% 
of Actinic keratoses lesions and 50.0% of Bowen’s lesions after 2 treatment sessions. 
Only 4 patients suffered from a stinging sensation when exposed to the light therapy. 
In conclusion, topical aminolevulinic acid-photodynamic therapy using a blue 
light source could be an effective treatment modality for precancerous lesions.
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Toll-Like Receptor-8 engagement in Artifi cial Antigen-Presenting Cell-expanded 
CD8+ T lymphocytes
Chatillon JF1, Abasq C1, Fauquembergue E2, Bayeux F1, Drouet A2, Latouche JB2, 
Musette P1 1INSERM U905, Rouen, France 2INSERM U614, Rouen, France
Adoptive transfer of in vitro activated and expanded tumor antigen-specifi c cytotoxic T lymphocytes 
(CTLs) is a promising approach to cure cancer but numerous diffi culties are encountered. The main 
problem is to obtain highly cytotoxic cells that could home to the tumor. Our team studied the 
impact of Toll-Like Receptor-8 (TLR8) engagement on peripheral CD8+ T lymphocytes expanded by 
co-culture with artifi cial antigen-presenting cells (AAPCs) (Latouche and Sadelain, Nat biotechnol, 
2000). These AAPCs have been transduced to recreate an A2.1 immunological synapse which 
presents MART-1, an auto-antigen which is overexpressed in melanoma, to CD8+ T cells. We defi ned 
the optimal conditions for proliferation and purifi cation of MART-1-specifi c CTLs from 6 A2.1+ 
healthy donors, using AAPCs and anti-MART-1 phycoerythrin (PE)-coupled pentamer staining. After 
a 2 to 3 week co-culture, we obtained, in a donor-dependent manner, 3 to 25% of specifi c CD8+ T 
cells. We found that CD8+ T cells express TLR8 at the cell surface and in intracellular compartments. 
MART-1 specifi c T cells activated by TLR8 agonist (CL075) were able to induce an increase of 
cytotoxic activity against MART-1-pulsed target cells, between 10 and 20 percent at each tested 
ratio for two donors, and at the highest ratio for two other donors. Unexpectedly, TLR8 engagement 
did not change signifi cantly the production of cytokines implicated in the cytotoxicity (TNF-α, IFN-γ 
and Granzyme B). Here we confi rmed a previous observation that TLR8 mRNA is present in CD8+ 
T cells population. Furthermore, we found that TLR8 expression level in intracellular compartments 
and cell surface as well as the increase in cytotoxity observed after TLR8 engagement both depended 
on the donors. We could not correlate this effect to an increase in the cytokine production. 
Further analyses are needed to understand the mechanism of TLR8 engagement in CD8+ T cells. 
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Traumatic release of mast cell mediators as an aetiology of skin tags
El Safouri O, Fawzy M, Abdel Hay R, Eissa A, Saad A, Rashed L, El Maadawi Z Faculty 
of Medicine, Cairo University, Cairo, Egypt
Skin tags are common benign tumors of the skin which arise in sites subjected to 
trauma or repeated friction. It was proved that mast cells are recruited to sites of 
skin trauma and increase their tumor necrosis factor-alpha (TNF-α) content. Based 
on these fi ndings, we hypothesized that mast cells, TNF-α and its family member, 
TNF related apoptosis inducing ligand (TRAIL) might play a role in the pathogenesis 
of skin tags as a response to trauma. Fifteen subjects were included in our study. A 
large skin tag, a small skin tag and a snip of normal skin (to be used as control) was 
obtained from the same area in each subject. We counted the mast cells in sections 
from each sample after toluidine blue staining. Enzyme-linked immunosorbent assay 
was used to measure TNF-α level while reverse transcriptase polymerase chain 
reaction was used to evaluate the level of TRAIL mRNA expression. Mast cell count 
in all skin tags was signifi cantly higher than that in control skin (P=0.0355). There 
was a highly signifi cant increase in the level of TNF-α in all skin tags as compared 
to control skin (P<0.0001). Expression of TRAIL mRNA was signifi cantly higher in 
skin tags as compared to its expression in control skin (P<0.0001). The results of our 
study suggest an important role of mast cells, TNF-α and TRAIL in the pathogenesis 
of skin tags. We propose that following friction to the skin, chemokines attract mast 
cells which in turn secrete TNF-α as well as other cytokines and mediators. Mast 
cell mediators and TNF-α are capable of stimulating epithelial hyperplasia and 
fi broblast proliferation which are the main pathological abnormalities in skin tags. 
The role of TRAIL could be related to chemokine release and mast cell attraction.
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Unilateral Nevoid Telangiectasia That Accompany With Neurological Disorders
Akman A, Kandemir H, Senol U, Unal A, Duman O, Ciftcioglu MA, Haspolat S, 
Alpsoy E Akdeniz University School of Medicine, Antalya, Turkey
Unilateral nevoid telangiectasia is a unique vascular dermatosis of ambiguous etiology. 
However, the role of neurological disorder in pathogenesis of the unilateral nevoid 
telangiectasia has not been investigated before.We investigated all consecutive six 
patients with unilateral nevoid telangiectasia between January 2004 and January 2009. 
Dermatological and detailed neurological examinations, magnetic resonance imaging 
(MRI) were done for each patient. If the patients had dysesthesia over the lesional area, 
electroneuromyography was performed to show probability of relationship between 
lesions and peripheral neuropathy. In all patients, there was hemihypoaesthesia over 
the lesional skin. In cranial MRI, there were subcortical hamartomatous lesions in one 
patient. Demyelinized plaques were on the corpus of the caudate nucleus and the 
pontin area on the cranial MRI in another patient. We did not detect any pathologic 
fi ndings in ENMG evaluation. In our case series study neurological disorders 
accompany with UNT.  We can speculate that neurological disorders might contribute 
to the development and/or progression of unilateral nevoid telangiectasia. Patients with 
unilateral nevoid telangiectasia should be encouraged for neurological investigation.
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Values of IL-13 in serum and synovial fl uid of psoriatic arthritis and rheumatoid 
arthritis patients: A potential therapeutical target
Solovan C1, Ciacli C2 1University of Medicine and Pharmacy, Timisoara, Romania 
2West university’Vasile Goldis’, Arad, Romania
Aim.Il-13 is an Il-4 like cytokine with anti-infl ammatory effects and a protective role on the infl ammed 
synovium. Il-13 is produced by Th0,Th1,Th2 and CD8 T lymphocyte; it inhibits the synthesis of 
Il-1,Il-6, TNF-α,IFN-γ as well as chemokines(Il-8) at this level. We determined pro-infl ammatory 
(IL-1, IL-6, TNF-α) and anti-infl ammatory (IL-4, IL-13) cytokines in serum and synovial fl uid at 27 
patients with psoriatic arthritis(PsA) and 21 patients with  rheumatoid arhtritis(RA).The cytokines 
were determined in blood and synovial fl uid by means of the ELISA immunoenzimatique sandwich 
tehnique. Serum levels in PsA patients were: IL-1: 4.6±2.45 pg/ml,IL-6:11.25±4.75 pg/ml,and TNF-
α:3.5±1.45 pg/ml. RA patients had following seric values:IL-1:6.6±2.48 pg/ml,IL-6:18.13±1.95 pg/
ml and TNF-α: 5.75±2.48 pg/ml. Level of pro-infl ammatory cytokines in the synovial fl uid of PsA 
patients was:IL-1: 4.8±2.46 pg/ml, IL-6:21.4±10.3 pg/ml and TNF-α :10.5±4.75 pg/ml. RA group 
had following values in the synovial fl uid: IL-1:5.2±2.48 pg/ml, Il-6:28.5±8.75 pg/ml and TNF-α 
:26.21±17.01 pg/ml. Seric levels of IL-4 was undetectable in majority of PsA and RA patients;in the 
synovial fl uid values between 0.20 and 0.50 pg/ml were detected in PsA patients and between 0.58 
and 0.70 pg/ml in RA patients.Seric level of IL-13 in PsA was between 2.67 and 4.99 pg/ml while 
in the synovial fl uid between 2.07 and 14.8 pg/ml.In RA patients seric and synovial fl uid Il-13 was 
higher than in PsA patients.Seric levels of Il-13 suggested that the activation of Th2 lymphocytes 
was lower in PsA than in RA patients.But the rate synovial fl uid/serum of Il-13 was higher in PsA 
than RA suggesting that Il-13 could be a therapeutical target. In the synovial fl uid the values of anti-
infl ammatory cytokines in PsA were much more reduced than in RA. This fact suggested that Th2 
lymphocytes were not activated in PsA and RA, and did not secret any anti-infl ammatory cytokines 
which would anihilate the effects of pro-infl ammatory cytokines produced by Th1 lymphocytes.
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Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous 
lipogenesis
Zouboulis CC1, Seltmann H1, Alestas T2 1Dessau Medical Center, Dessau, Germany 
2Charité Universitaetsmedizin Berlin, Berlin, Germany
Arachidonic acid (AA) activates the 5-lipoxygenase, induces leukotriene-B4 (LTB4) 
synthesis, enhances interleukin-6 (IL-6) release and increases intracellular neutral 
lipids in human sebocytes. Moreover, the enzymes of LTB4 biosynthesis are activated 
in acne-involved sebaceous glands. Zileuton, a 5-lipoxygenase inhibitor, reduces the 
number of infl ammatory acne lesions and lipogenesis in patients with acne. In this study, 
we investigated the activity of zileuton on LTB4 generation, lipid content and IL-6 and 
-8 release from human SZ95 sebocytes in vitro. Pre-treatment with zileuton partially 
prevented the AA-induced LTB4 and IL-6 release and the AA enhancement if neutral 
lipid content. IL-6 release and neutral lipid content were also reduced under long-term 
zileuton treatment. In conclusion, zileuton prevents the activation of the leukotriene 
pathway and the enhancement of lipogenesis by AA in human sebocytes in vitro.
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Investigation of cell therapy for generalized severe recessive dystrophic epidermolysis 
bullosa by intradermal allogeneic fi broblasts  randomized against placebo injections
Yan WF1, Venugopal S1, Frew JW1, Tran K2, Sturm M3, Fogarty J3, Marinkovich P4, Igawa S5, 
Ishida-Yamamoto A5, Murrell DF1 1St George Hospital, Univ of NSW, Australia 2SEALS, St 
George Hosp, Univ of NSW, Sydney, Australia 3Cell and Tissue Therapies WA, Royal Perth 
Hosp, Perth, Australia 4Stanford Univ, Stanford, USA 5Asahikawa Medical College, Japan
We designed a single institution, double blinded, intra-patient, placebo-controlled randomized controlled trial to 
determine the clinical response of intradermal cultured allogeneic fi broblast injections, from a healthy male donor, 
in chronic erosions of patients with RDEB-GS.  The trial was designed to determine whether intradermal injections 
with allogeneic fi broblasts could enhance wound healing and improve collagen VII synthesis compared with 
intradermal injections of placebo transport solution alone. Patients 18 years or older with RDEB-GS were screened 
by immunofl uorescence mapping for low positive collagen VII expression and a negative history of squamous cell 
carcinoma. Allogeneic fi broblasts from a healthy unrelated male donor were cultured from skin biopsies in a GMP 
facility. Up to 6 pairs of symmetrical wounds were randomly injected at baseline only and measured at baseline, 
2w, 4w, 8w, 12w, 16w, 20w and 24w to determine differences in healing of wounds and comparison of rate of 
change of healing between treatments. Subject and Investigator Visual Analogue Scores for appearance, pain and 
pruritus, Quality of Life in Epidermolysis Bullosa and non-invasive testing of epidermal fl uid content studies were 
performed. Skin biopsies were performed at baseline, 2w, 12 w, and 24w to determine Collagen VII expression, 
anchoring fi bril ultrastructure, presence of infl ammatory markers and fl uorescent insitu hybridzization (FISH). 
Indirect immunofl uorescence for anti-type VII collagen antibodies, ELISA, HLA typing and reverse transcriptase 
polymerase chain reaction to detect COL7A1 mRNA expression and source were performed. 12 RDEB-GS patients 
were screened: 7 patients were excluded and 5 patients (3 female and 2 male) were recruited; 4 have reached 
six months and 1 has reached 3 months post treatment.  FISH analysis for Y chromosome DNA was negative by 2 
weeks in the 3 female patients. The rates of wound healing in the treated sites using both the cultured cells and the 
transport media were signifi cantly greater than untreated sites within the same patient. QOLEB scores for emotional 
wellbeing improved during the trial. The methods used provide a feasible new potential long term therapy for RDEB. 
167
Comparison of cryotherapy and photodynamic therapy in treatment of  actinic 
keratosis
Lis-Swiçty A, Brzezinska-Wcislo L, Bergler-Czop B, Sygula E Silesian Medical 
University, Katowice, Poland
Photodynamic therapy (PDT) of actinic keratosis (AK) using methylaminolaevulinate 
(MAL) is an effective treatment option, but  actually clinical observations are not 
yet  suffi cient to state superiority of this method to conventional treatment. The aim 
of his study was to compare treatment results of AK using cryotherapy with liquid 
nitrogen and MAL-PDT. Cryosurgery and MAL-PDT was applied in 18 patients 
with mild to moderate AK (cryosurgery – 43 AK and MAL-PDT - 83 AK) localized 
symmetrically on scalp, forehead and temple. Side effects, response to treatment, 
cosmetic results and patient satisfaction were analysed. After 3 months total healing 
was stated in 87% of patients treated with MAL-PDT and in 93% patients, in whom 
crysurgery was applied. Esthetic effects, patients comfort during the treatment 
and cure period  speak  for benefi t of MAL-PDT versus cryosurgery. Number of 
estimations: satisfi ed and very satisfi ed with cosmetic effects of treatment gave by 
doctor and patients  was, as respectively: 78% and 89% for MAL-PDT and 56% and 
67% for cryotherapy. 89% of patients preferred MAL-PDT, when only 11% of them 
cryotherapy. MAL-PDT is an effective method in AK therapy, which makes possibility 
to achieve better cosmetic results, because it is less destructive and more selective.
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Effi cacy and Safety of Infl iximab Therapy in Psoriasis Patients Previously Treated 
with Etanercept: Interim Results from a Multicenter, Prospective Study
Gottlieb AB1, Kalb RE2, Blauvelt A3, Heffernan MP4, Sofen H5, Wang J6, Calabro S7, 
Chevrier M7 1Tufts Med Ctr & Tufts Univ School of Med, Boston, USA 2SUNY at 
Buffalo School of Med & Biomed Sciences Dept of Dermatol, Buffalo, USA 3Oregon 
Health & Sci Univ, Portland, USA 4Wright State Univ School of Med, Dayton, USA 
5Dermatol Assoc, LA, USA 6Johnson & Johnson Pharm R&D, LLC, Horsham, USA 
7Centocor Ortho Biotech Services, LLC, Horsham, USA
PSUNRISE  is  a multicenter, prospective, interventional study of the use of infl iximab(IFX)  in pts receiving treatment 
for plaque psoriasis with etanercept(ETN) with or without concomitant methotrexate (MTX) and cyclosporine (CYC). 
This open label trial will enroll approximately 210 ETN-exposed pts who have signifi cant disease despite treatment 
with ETN alone or in combination with MTX or CYC. Pts who have had 4 months+ of  ETN (25mg 2X/wk, 50mg 1X/
wk, or 50mg 2X/wk) were transitioned to IFX 2 wks after their last dose of ETN. IFX was administered at 5 mg/kg at wks 
0, 2, and 6 prior to the wk 10 effi cacy/safety assessment. Later doses at wks 14 and 22 support a secondary durability 
and safety assessment through wk 30. Pts included were 18+ years of age, currently receiving ETN (+/- MTX or CYC) 
with ongoing active psoriasis defi ned by a Physicians Global Assessment (PGA) score averaging >=2, combined 
with an inadequate response. The primary endpoint was the proportion of pts who received at least one dose of IFX 
and had a PGA of <= 1 at wk 10. Safety endpoints included a summary of all adverse events. A protocol-stipulated 
interim analysis for safety/effi cacy was performed when 50% of the target cohort completed the Wk 10 assessment. 
In the interim analysis population (105 pts received at least one dose of IFX), 64.4% of pts (mITT) achieved a response 
at wk 10. Static PGA assessments at screening (2.76/3 mean/median) and on Day 0 (2.82/3) were stable, refl ecting 
a lack of ETN withdrawal skin fl ares at wk 2 post-cessation. The majority of pts entered the study with a PGA of 
3+ while the incremental response in the responder population was a median of 2. There were no unexpected 
adverse events. PSUNRISE is designed to explore the incremental response and safety following a transition to IFX 
in pts who exhibit signifi cant psoriasis disease activity despite ETN therapy alone or in combination with other 
immunosuppressive agents. This interim safety/effi cacy analysis supports additional investigation as IFX appears 
generally well tolerated and effective in this interim population. A full analysis will be conducted through week 30.




High Dose Inhalation Interleukin-2 Therapy for Lung Metastases in Patients with 
Malignant Melanoma
Bartsch K, Weihsengruber F, Rappersberger K Hospital Rudolfstiftung, Vienna, Austria
The lungs are frequently affected by metastases in patients (pts) with advanced melanoma. 
Previous studies with inhalation interleukin (IL)-2 therapy have shown remarkable 
improvements of respiratory problems in such pts (1). Here we report our experiences with 
inhalation IL-2 therapy.13 pts (8 males/5 females), mean age 69.7y, all under a regular 
clinical and radiological screening were included. 10 pts developed pulmonary metastases 
after cessation or still under s.c. low dose interferon-á therapy. 12 pts received chemotherapy 
with dacarbazine and 6 pts with fotemustine as second line treatment. 8 pts had disseminated 
disease, in 5 pts metastases were restricted to the lungs. Therapy with 3x3 million IU 
inhalative IL-2 per day was applied via the “Jet Air Gamma 20 C”-inhalation system, both in 
a clinical- and out patient-setting. Clinical controls were performed monthly, radiological 
controls every third month. Three pts experienced complete remission of disseminated lung 
metastases (CR), observation period 9 months to 3 years, one pt  a partial response (PR), 
observation period 12 months. Six pts displayed a stabilization of their pulmonary disease 
(stable disease/SD), observation period 6.4 months and three pts developed progression of 
pulmonary metastases (PD). Therapy was applied continuously up to 2 years. Treatment 
was well tolerated by 12 pts with only mild cough as major side effect. In one pt inhalation 
induced dyspnoea and was therefore discontinued. The technical equipment allowed an 
easy handling for all pts. Our observation of stabilization and improvement of pulmonary 
metastases in 10/13 pts confi rms previous investigations. Inhalation IL-2 therapy also seems 
to be save and its application can be easily performed. Taken together with previous reports 
our fi ndings suggest a formal proof of the effi cacy and tolerability of this regimen in larger 
clinical studies.
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Oral supplementation with probiotic Lactobacillus paracasei ST-11 improves 
dandruff condition
Gueniche A1, David P2, Bastien P1, Buyukpamukcu E2, Reygagne P3, Castiel I1 
1LOREAL Recherche, Clichy, France 2Nestle Research Center, Lausanne, Switzerland 
3Centre Sabouraud, Paris, France
Dandruff is a common condition, affecting close to 50% of the adult population. It is 
often associated with an abnormal colonization of the scalp by Malassezia yeasts, a skin 
barrier defect and pruritus. In previous clinical trials, we showed that the oral intake of 
the specifi c probiotic, Lactobacillus paracasei (ST11) was able to induce a faster recovery 
of the skin barrier function (compared to placebo) after alteration by a repeated tape 
stripping, to modulate skin immune system and skin sensitivity. Since these parameters 
are known to be important events associated with dandruff, we decided to evaluate the 
clinical effi cacy of this probiotic in this area.A new randomized, double-blind, placebo-
controlled clinical trial was conducted with 66 healthy volunteers who have moderate 
dandruff status receiving either ST-11 (10 9 CFU/day) or placebo, during two months. It 
was demonstrated that daily consumption of ST11 resulted in a signifi cant decrease versus 
placebo, of scalp adherent and free dandruffs as assessed both by a dermatologist and the 
subjects (self-assessment). Moreover, it appears that the clinical improvement of dandruff 
status is associated with a decrease of scalp erythema as assessed by a dermatologist 
and confi rmed by the reduction of pruritus perception by the subject. Concerning 
perceived scalp greasiness, subjects reported a positive effect (tendency) following self-
assessment. As far as cutaneous ecofl ora is concerned, we fi nd that following ST11 intake, 
Malassezia yeast populations are also signifi cantly decreased versus placebo. Altogether, 
these clinical evidences highlight for the fi rst time the benefi ts of oral supplementation 
and more specifi cally of the probiotic ST11 for improving dandruff condition.
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Reactive Skin: Clinical effi cacy of a probiotic lysate is associated with specifi c 
changes in stratum corneum protein pattern
Gueniche A1, Delattre C1, Winstall E2, Bastien P1, Bernard D1, Castiel I1 1LOREAL 
Recherche, Clichy, France 2Centre Hospitalier Universitaire de Québec, Quebec, 
Canada
Reactive skin is characterized by a marked sensitivity to physical (heat, cold, wind) or chemical 
(topically applied products) stimuli and by an impaired skin barrier repair ability.  Clinical 
evaluation of a Bifi dobacterium lysate containing cream (10%) in a randomized double-blind 
placebo-controlled trial (66 volunteers, 2 month topical application) has shown a reduction of skin 
sensitivity and an increase in skin barrier resistance to physical aggression. To better understand the 
mechanisms involved in the action of the probiotic lysate, specifi c skin surface biomarkers were 
analysed in stratum corneum (SC) extracts. Skin proteins were extracted from SC strip samples taken 
using D-squam technique before and after 2 month lysate application. Selected biomarkers were 
analysed using mass spectrometry and peptide isobaric labeling method (ITRAQ).In the group treated 
by the lysate, data showed that some proteins (or their proteolytic fragments) involved in stratum 
corneum maturity and particularly those associated with the desquamation process increased such 
as proteins KLK7 (Uniref P49862), DSC1a (Q9HB01), Cathepsin L2 (O60911), DSG1 (Q02413), 
KLK5 (Q9Y337), and Corneodesmosin (N Q15517). Moreover, some antimicrobial defense proteins 
increased in the epidermis, eg  Ribonuclease 7 (Q9H1E1), Dermcidin (P81605), Prolactin inducible 
protein (P12273), S100-A8 and S100-A9 proteins (P05109 and P06702), and Histone H2B 
(Q5R2W0)).The present results confi rm the interest of tested Bifi dobacterium lysate in the treatment 
of reactive skin. Topical application of the extract for 2 months induced changes in the level of various 
surface protein biomarkers associated with epidermal differentiation, desquamation as well as skin 
antimicrobial defense.  Data from differential proteomic approach supports previous clinical results 
showing the benefi cial effects on the treatment and/or prevention of symptoms related to reactive skin.
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Relationship Between Psoriasis Activity Following a Period of Adalimumab 
Discontinuation and Subsequent Effectiveness of Adalimumab Retreatment
Menter A1, Sasso E2 1Baylor Psoriasis Research Institute, Dallas, Texas, USA 2Abbott 
Laboratories, Abbott Park, Illinois, USA
Effectiveness of adalimumab (ADA) retreatment was assessed for patients grouped by 
severity of psoriasis (Ps) at the start of retreatment. REVEAL was a 52-week, double 
blind, randomized, placebo controlled trial of patients with moderate to severe Ps. 
Patients randomized to ADA in period A (N=814) who achieved >/=PASI 75 response 
at end of periods A (wk 16) and B (wk 33) were re-randomized in period C (wks 33-52) to 
ADA (N=250) or placebo (N=240). Patients who completed period C or lost adequate 
response could then receive open label extension (OLE) ADA. A post hoc analysis 
of the 227 period-C placebo-treated patients who received OLE ADA determined: 1) 
PASI responses at OLE week 24 (relative to baseline) for patients grouped by PASI 
response at OLE week 0; and 2) Physician Global Assessment (PGA) at OLE week 24 
for patients grouped by PGA at OLE week 0 (nonresponder imputation). At OLE week 
0, PASI 75, 90, and 100 response rates for the 227 period-C placebo-treated patients 
were 45%, 19%, and 7%, respectively. At OLE week 24, patients with >/=PASI 75, 
PASI 50 to <75, or <PASI 50 responses at OLE week 0 had PASI 75, 90, and 100 
response rates of 89%, 70%, and 49%; 75%, 36%, and 13%; and 56%, 30%, and 
16%, respectively. At OLE week 0, 30% of 227 patients had PGA of clear or minimal. 
At OLE week 24, PGA clear or minimal was achieved by 87% of patients (60/69) who 
had PGA clear or minimal at OLE week 0, by 52% (69/133) who had PGA mild or 
moderate, and 24% (6/25) who had PGA severe or very severe.  Thus, ADA retreatment 
was most effective in patients who maintained high responses while off therapy.
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Using a structured image database how well can novices assign skin lesion images 
to the correct diagnostic grouping?
Brown H, Robertson K, Rees JL The University of Edinburgh, United Kingdom
The cognitive basis of expertise in dermatology has received little formal attention. Crucial to any 
such account is how experts recognise dermatological lesions—that is, how they attach semantics 
to images.  Insights into these processes might allow improved rates of skill acquisition and may 
be relevant to attempts to use computers to diagnose solitary skin lesions such as skin cancers. 
In order to pursue this question experimentally we examined whether experts and novices were 
able to assign images of lesions from three common diagnostic groups (basal cell carcinoma 
(BCC), squamous cell carcinoma (SCC) and seborrhoeic keratoses (SK)) to the correct group using 
a simple structured computer image database. Three studies were undertaken sequentially. For all 
experiments, subjects were shown a series of 6 index prints of skin tumours, 2 from each test 
diagnostic group (BCC, SCC, SK) and were asked to match each test lesion to either a group of 
images from a single diagnostic category (experiments 1 & 2) or to a single image (experiment 
3) using the computer database. The images differed for each experiment and subjects were not 
informed of the diagnosis of any image. Our only outcome was the number of correct scores for 
an index image, and we used a binomial test to examine whether the results obtained differed 
from p=1/3 (that which is attributable to chance). Scores for the correct diagnosis for the three 
experiments, experiment 1, 2 and 3, were 36/48 (75%), 50/54 (93%), and 38/42 (90%) respectively. 
If only novices are considered the respective fi gures were 36/48 (75%), 39/42 (93%) and 34/36 
(94%).  All these scores are highly signifi cant (p<10-6) with a large magnitude of effect.  Although 
there are limitations to our study, our results show that even when those with dermatological 
experience are excluded, a group of individuals with no specialist expertise were able to assign 
index images to one of three common diagnostic skin tumour groups with a high degree of accuracy.
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Betapapillomavirus infection and cutaneous squamous-cell carcinoma
Bouwes Bavinck J1, Neale R2, Abeni D3, de Koning M4, Pawlita M5, Pfi ster H6, 
Naldi L7, Harwood C8, Green A2, Feltkamp M1 1Leiden Univ Medical Center, 
Leiden, Netherlands 2Queensland Inst of Medical Research, Brisbane, Australia 
3Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome, Italy 4DDL Diagnostic 
Lab, Voorburg, Netherlands 5German Cancer Research Center (DKFZ), Heidelberg, 
Germany 6Inst of Virology, Univ of Cologne, Germany 7Dept of Dermatology & 
GISED Study Center, Bergamo, Italy 8Queen Mary Univ of London, UK
There is evidence to suggest that infection with human papillomaviruses from the beta genus 
(betaPV) play a synergistic role with ultraviolet (UV) radiation in the development of cutaneous 
squamous-cell carcinoma. We performed case–control studies in The Netherlands, Italy and 
Australia to evaluate the association between betaPV infection and cutaneous squamous-cell 
carcinoma in conjunction with measures of UV exposure and susceptibility. The presence of all 25 
known betaPV types in eyebrow hair follicles was determined using a highly sensitive genotyping 
assay, as well as serological responses to the 15 most prevalent betaPV types. Multivariable logistic 
regression models were used for case–control comparisons and interaction analyses.BetaPV 
infections were detected in the eyebrow hairs of more than 90% of the 1534 participants tested. 
The absence of infection was associated with a decreased risk of squamous-cell carcinoma in 
the Netherlands (OR=0.36; 95% CI 0.17;0.74) and Italy (OR=0.60; 95% CI 0.28;1.3), but not in 
Australia (OR=1.1; 95% CI 0.64;1.9). Seropositivity for betaPV in controls ranged between 52% and 
67%. A positive antibody response against 4 or more betaPV types was associated with squamous-
cell carcinoma in Australia (OR=2.2; 95%CI 1.4;3.3), the Netherlands (OR=2.0; 95%CI 1.2;3.4) 
and Italy (OR=1.4; 95%CI 0.88;2.2). The association between UV susceptibility and squamous-cell 
carcinoma was stronger in the presence of serological responses to betaPV, indicating interaction 
between these two variables.These data support the hypothesis that betaPV infection augments 
the carcinogenic role of UV radiation in the development of cutaneous squamous-cell carcinoma.
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Temporal patterns of disease in eczema: the failure of objective and subjective 
measures of disease activity to match
Murray CS, Rees JL
The University of Edinburgh, Edinburgh, United Kingdom
Diseases such as eczema do not just exist at particular time points such as at clinic 
visits but longitudinally in time. How is it best to measure this disease activity? We 
have previously shown that for groups of patients at a single time point subjective 
measures of itch (using visual analogue scales,’VAS itch’) do not correlate with 
objective measures of scratch using digital accelerometers worn at night. What is 
however of greater relevance is whether measures correlate for any single patient 
over time.  We studied 20 individuals over 42 nights with atopic dermatitis, in their 
own homes. Patients recorded nightly VAS itch scores and wore a limb accelerometer 
overnight. Surprisingly, there was little correlation (rho=0.08) between subjective 
and objective measures for the overall dataset. Plotting of the two measures for 
individuals over time also showed no convincing pattern. In order to examine the 
temporal pattern of scores we evaluated the data using a mixed effect model with 
accelerometer or VAS scores dependent on time. The accelerometer data showed 
little autocorrelation but VAS scores showed highly signifi cant (p<0.01) patterns of 
autocorrelation over 1-4 nights. We then performed time series analysis (using an 
ARMA model) and show that there is a highly signifi cant (p<0.001) autocorrelation 
at a lag of one night for VAS scores but not for accelerometer scores. These results 
are challenging: the accelerometer score has been demonstrated to be robust 
(against the ‘gold standard’ of video studies.) One possible interpretation is that 
widely used subjective measures such as VAS itch scores may not truthfully refl ect 
what they purport to measure but are instead infl uenced by other cognitive factors.
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Psoriasis is not associated with an increased risk of cardiovascular hospitalizations: 
results of a large population based Dutch cohort
Wakkee M, Herings R, Nijsten T Erasmus Medical Center, Rotterdam, Netherlands
Psoriasis patients may be more likely to have the metabolic syndrome, however it 
is less clear whether they also have an increased risk of myocardial infarction. A 
cohort study was conducted with data from hospital and pharmacy databases of 
prospectively collected data between 1997 and 2008 comprising approximately 
2.5 million Dutch residents. The risk of hospitalizations for acute ischemic heart 
disease (IHD) was compared between a cohort of patients with a defi nite psoriasis 
diagnosis and a reference cohort matched for age, gender and enrolment date. 
Additional adjustments were made for the use of healthcare and cardiovascular 
drugs. A total of 15,820 psoriasis patients and 27,577 reference subjects were 
included, showing an incidence rate of 611 and 559 IHD per 100.000 person-years, 
respectively. The age and gender adjusted risk of IHD was comparable between 
both cohorts (hazard ratio [HR]=1.10, 95% confi dence interval 0.99, 1.23). Prior to 
cohort entry, psoriasis patients used more antihypertensive, antidiabetic and lipid-
lowering drugs and were more often hospitalized. Adjusting for these confounders 
decreased the HR for IHD, but it remained comparable between both populations. 
There was no different risk of IHD between the subgroup of patients who only used 
topicals versus those who received systemic therapies or inpatient care for their 
psoriasis. Psoriasis patients may use more drugs associated with the metabolic 
syndrome, but psoriasis is no independent risk factor for IHD hospitalizations.
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A prospective case-controlled cohort study to assess pre-clinical cardiovascular 
disease in patients with moderate to severe psoriasis
Martyn-Simmons CL1, Ranawaka RR1, Crook MA2, Marber MS3, Chowienczyk PJ4, 
Smith CH1, Barker JN1 1St Johns Institute of Dermatology, London, UK 2University 
Hospital Lewisham and Guys Hospital, London, UK 3King’s College London, The 
Rayne Institute, UK 4King’s College London, UK 
Moderate to severe psoriasis is associated with a number of co-morbidities including cardiovascular 
disease (CVD).  This study investigates whether validated markers of CVD are more prevalent in 
patients with moderate to severe psoriasis, after exclusion of known CVD risk factors, to establish 
whether psoriasis per se is associated with pre-clinical CVD. Patients were recruited from a tertiary 
referral clinic. Exclusion criteria included established CVD and/or conventional risks for CVD. 
Cardiovascular disease was assessed by vascular endothelial function, using brachial artery fl ow-
mediated vasodilation (FMD), and carotid intima-media thickness (CIMT). Markers of CVD risk 
including high-sensitivity C-reactive protein (HSCRP) and BMI were also recorded.  A total of 282 
consecutive patients were invited to participate (204 male, 78 female, mean age 54.9 years). 218 
were excluded due to established CVD (n=16) or known risk factors (n=159; 25% had at least 2). 
Included patients totalled 60 (46 males, 14 females, mean age 50.1 years), with 30 healthy controls. 
HSCRP was elevated (>2.0mg/l) in 53% of patients in the psoriasis group (range 0.2-45mg/l, mean 
4.63). The mean BMI of the psoriasis patients was 26.42. There was no statistical difference in FMD 
(psoriasis 5.97% + 2.72, control = 5.83% + 1.93; mean+s.d) or carotid-IMT (psoriasis  0.7mm + 
0.13, control 0.82mm +  0.15; mean+s.d). This study indicates that there is no increase in pre-
clinical CVD in patients with moderate to severe psoriasis compared to healthy controls, even 
in the context of a raised HSCRP, suggesting that psoriasis per se does not increase the risk of 
CVD.  The high prevalence of confounding variables identifi ed in our excluded patient cohort has 
been previously reported, and may account for the excess risk of CVD in patients with psoriasis. 
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Analysis of risk factors in cutaneous malignant melanoma: an italian population-
based study
Campione E1, Paternò EJ1, Orlandi A2, Costantini S2, Diluvio L1, Ricozzi I1, Bianchi 
L1, Carboni I1, Chimenti S1, Medda E3 1Univ of Rome Tor Vergata, Dermatology, 
Italy 2Univ of Rome Tor Vergata, Pathology, Italy 3National Centre for Epidemiology, 
Surveillance & Health Promotion, Rome, Italy
Melanoma incidence continues to increase in white population and is higher in older man. Cutaneous 
malignant melanoma has a signifi cantly higher morbidity and mortality, resulting in 65% of all skin cancer 
deaths. Although the long-term survival rate for patients with metastatic melanoma is only 5%, early 
detection of cutaneous malignant melanoma carries an excellent prognosis, with surgical excision often 
being curative. The aim of our study  was to evaluate the relationship between the growth of primitive 
melanoma at different anatomic sites and the modality of sun exposure and other specifi c risk factors. This 
study also aimed to investigate whether melanomas nevus associated  or not associated have different risk 
factors distribution and the status of solar dermal elastosis. Case subjects (n=113) from a population-based 
study of cutaneous melanoma collected in a 2 ½ - year-period, admitted to the Dept of  Dermatology at 
the University of Rome “Tor Vergata”. The clinico-pathological melanoma types included 94 superfi cial 
spreading, 5 in situ, 6 nodular, 7 lentigo maligna melanoma. The hypothesis of an association between 
the different risk factors considered and melanoma were investigated by producing tables with percentage 
distributions of each variable (among the group comparing) and estimating the age-adjusted odds ratios 
(OR) and their confi dence intervals (95%CI).In our study we found a link among superfi cial spreading 
melanoma arose on the limbs in younger people, most females, and the histopathologic parameter of 
nevus associated melanoma with light dermal solar elastosis. On the other hand nodular melanoma 
and lentigo maligna melanoma were more frequent in older patients, used to chronic sun exposure, 
localized on the trunk with moderate-severe solar dermal elastosis, not nevus associated. The mean age at 
diagnosis of melanoma was 50 years. Our results confi rmed the hypothesis of the two distinct pathways 
of tumorigenesis in patients with melanoma on the basis of endogenous and environmental factors. 
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Changing delayed-type hypersensitizations to the standard series allergens over a 
decade at the Zurich University Hospital
Janach M1, Kuehne A1, Seifert B2, French LE1, Ballmer-Weber B1, Hofbauer GF1 
1University Hospital Zurich, Switzerland 2University of Zurich, Switzerland
Patch testing detects delayed-type sensitizations and may reveal changes in 
prevalence over time. Objectives: Sensitization prevalence in our standard series 
allergens during the years 2000–2004 and to results from 1990–1994. We analyzed 
standard series allergens patch tests from 2000 through 2004. 4094 standard patch 
test series (mean age 45.4 years, males 41.7%). The highest sensitization rates 
were found for nickel (19.3%), fragrance mix (10.4%) and balsam of Peru (7.8%). 
Compared to 1990–1994, methylchloroisothiazolinone (MCI) and neomycin 
sulfate sensitization decreased and wool alcohols, thiuram mix and mercury (II) 
amide chloride sensitization increased. Current sensitization rates are similar to 
those across Europe. Reduced sensitizations to MCI and neomycin and increased 
sensitizations to thiuram mix and mercury (II) amide chloride may well be due to 
changes in exposure. The current group comprises a higher proportion affected by leg 
dermatitis and may thus explain the higher sensitization to wool alcohols. Comparing 
patch results over time reveals important changes in sensitization prevalence.
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Dermatology Life Quality Index: measuring the change in scores and its clinical 
meaningfulness
Basra MK1, Sturkey RL2, Salek MS2, Finlay AY1 1Dept. of Dermatology, Cardiff 
University, Cardiff, United Kingdom 2Centre for Socioeconomic Research, Welsh 
School of Pharmacy, Cardiff, United Kingdom
The aim of this study was to determine the signifi cance to patients of changes in health- 
related quality of life (HRQoL) scores assessed by the Dermatology Life Quality Index 
(DLQI). In this longitudinal study, specifi cally designed for the stated purpose, a cohort 
of dermatology patients attending the out-patients and day-care centre of a secondary 
referral centre completed the DLQI at their fi rst visit before starting any new therapy, and 
the DLQI and a global rating of change questionnaire (GRCQ; -7 to +7; used as an anchor to 
measure the minimal clinically important difference or MCID) at the follow-up visit. For the 
patients who mentioned “a little change” (-3, -2, +2, +3) in the GRCQ, the corresponding 
difference was calculated in DLQI mean scores indicating the MCID. In order to determine 
the magnitude of the change in DLQI scores, effect size (ES) and standardised response 
mean (SRM) were calculated. A total of 79 patients suffering from 18 different skin diseases 
completed the DLQI at the fi rst visit while 30 patients completed the DLQI and GRCQ at the 
follow-up visit (mean interval=90 days). The mean change in the DLQI scores in these 30 
patients was 2.8 (SD=5.3). The ES of the change score was 0.37 indicating a small-moderate 
effect while SRM was 0.53 indicating a moderate effect according to Cohen’s criteria. 12 
patients out of 30 indicated “a little change” in the GRCQ either for better or for worse; 
the mean corresponding change in DLQI scores was 3.6 which could be regarded as the 
approximate MCID for the DLQI scores.The fi nal results will be published once the study is 
completed. However, the preliminary fi ndings are in conformity with previous data but are 
based on general dermatology rather than individual diseases. Greater clarity of the minimal 
important change can have substantial implications for the use of the DLQI in clinical trials.




Epidemiology of cutaneous melanoma in Austria 1996 and 2006. Preliminary results 
of a national histopathology-based survey.
Marculescu R1, Harold C2, Bartsch K2, Rappersberger K2 1Medical University of 
Vienna, Vienna, Austria 2Hospital Rudolfstiftung, Vienna, Austria
We attempted to obtain an accurate snapshot of the current melanoma epidemiology in 
Austria by evaluating all available histopathologic reports of the years 1996 and 2006. All 
departments of dermatology as well as the departments of pathology and private pathologic 
laboratories performing dermatohistopathology to any signifi cant extent were included. All 
available histopathologic reports of the index years were searched electronically and/or 
manually for the diagnosis of invasive or in situ primary cutaneous melanoma. In 2006 
1974 Austrian residents were diagnosed with an invasive melanoma and 708 with an in 
situ lesion. The crude incidence rates for invasive melanomas were 24.8 for males and 
22.8 for females per 100,000, corresponding to directly age-standardized rates based on 
the European standard population of 21.7 and 18.8. The corresponding incidence rates for 
in situ melanomas were 8.2 and 8.9 (ASR 6.9 and 7.1). For 1996 we counted 996 invasive 
melanomas and 385 in situ lesions. The incidence rates were 12.3 for males and 12.7 for 
females (ASR 12.0 and 8.4) for invasive and 4.2 for males and 5.4 for females (ASR 4.0 
and 3.3) for in situ melanomas. The proportion of thin (<1mm) invasive melanomas was 
72.6% in 2006 and 68.3% in 1996. The percentage of lesions with Clark level II was 28.3 
in 2006 and 35.1 in 1996, respectively. Our data suggest a faster increase in the incidence 
of invasive melanoma than estimated from hospital-based cancer registries. The incidence 
trend of in situ melanoma closely parallels that of invasive melanoma. This, together with 
the negligible increase in the proportion of thin invasive melanomas and the quite surprising 
decrease in the diagnosis of Clark level II lesions in 2006 as compared to 1996 reveals the 
necessity for additional public health effort in order to further improve early detection. 
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Ethnic variations in facial variations in facial skin neurosensitivity assessed by 
capsaicin detection thresholds.
Jourdain R1, Maibach HI2, Bastien P1, De Lacharriere O1, Breton L1 1l’Oreal Recherche, 
Clichy, France 2Department of Dermatology, University of California, School of 
Medicine, San Francisco, USA
Ethnic variations in sensitive skin syndrome have not been as thoroughly explored 
as irritant or allergic contact dermatitis and remain controversial.The goal was to 
objectively assess ethnic variations in facial skin neurosensitivity in women through 
individual detection threshold of topically applied capsaicin.The single-blind, 
controlled study was performed in 144 women from three ethnic backgrounds: 
Asian, African and Caucasian. Five aqueous solutions with increasing capsaicin 
concentration were successively applied to one side of nasolabial folds while the 
other side simultaneously received vehicle as control. The test was discontinued when 
the volunteer reported a specifi c sensation on capsaicin side. Each ethnic group was 
divided into 6 sub-groups according to the level of sensitivity to capsaicin, i.e. from 
detection of the lowest concentration up to no detection of the highest concentration, 
one hundred fold higher. Asian women tended to detect higher concentrations 
than Caucasians but lower concentrations than Africans. Nevertheless, the 
distribution did not greatly differ between the three ethnicities. The test was painless.
The capsaicin skin neurosensitivity test is painless and changes across individuals of 
different ethnic backgrounds appear minimal, with a trend toward lower threshold 
in Caucasian women.
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Prevalence of atopic dermatitis in urban and rural schools in Gabon and Ghana
Lavrijsen AP1, Amoah AS2, Adegnika AA1, Koelemij I1, Boakye D2, Bouwes Bavinck 
JN1, Yazdanbakhsh M1, Hartgers FC1, Hogewoning AA1 1Leiden University Medical 
Center, Leiden, Netherlands 2Noguchi Memorial Institute for Medical Research, 
University of Ghana, Legon, Ghana
Atopic dermatitis (AD), a common pruritic chronic infl ammatory skin disease, affects 15-20% of 
children in developed countries. The prevalence of eczema is considered to be less in developing 
countries. With the westernization in urban areas in developing countries it is believed that the 
prevalence will increase. The objective of this study was to determine the prevalence of atopic 
dermatitis among school children in different rural and urban schools in Ghana and Gabon. 
Cross-sectional studies were performed in Ghana in 2007 and Gabon in 2005, with respectively 
1394 and 454 children aged between 4-20 years. In Ghana the children were residing in 6 rural 
and 5 urban schools in the Greater Accra Region (Ghana) and in Gabon in one urban school 
in Lambarene and one rural school in a nearby region. All children were clinically examined 
for atopic dermatitis using the criteria as defi ned by Hanifi n and Rajka. The schools in Ghana 
were categorized as public, private and private rich to refl ect the average socioeconomic level 
of the children, respectively low, middle and high.  Statistical analysis was done with Pearson’s 
chi-square test. In Ghana 22 (1.6%) out of 1394 children and in Gabon 6 (1.3%) out of 454 had 
atopic dermatitis. In Ghana in the rural schools 10 (1.3%) out of 753 children had AD compared 
to 12 (1.9%) out of 641 children in the urban schools. In Gabon in the urban school only 
one child (0.4%) out of 245 children had atopic dermatitis, compared to 5 (2.4%) out of 209 
children in the rural schools. In Ghana in seven public schools 12 (1.2%) out of 967 children 
had AD compared to 10 (2.3%) out of 472 in private and private rich schools (OR 1.9; 95% 
CI 0.8:4.5).The prevalence of atopic dermatitis among school children in Ghana and Gabon is 
considerably lower compared to developed countries. No signifi cant difference between the 
prevalence of atopic dermatitis in rural versus urban schools was found in our study. Furthermore 
the socioeconomic level of the children did not appear to infl uence the prevalence of AD.
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Squamous cell carcinoma of the skin induces sustained considerable cost of care in 
organ transplant recipients
Rüegg C1, Graf N2, Mühleisen B1, Szucs T3, Surber C4, Hofbauer G1 1Dept of 
Dermatology, Univ Hospital Zürich, Switzerland 2Clinical Trials Center, Univ Hospital 
Zürich, Switzerland 3Institute for Social and Preventive Medicine, Univ of Zürich, 
Switzerland 4Dept of Dermatology, Univ Hospital Basel, Switzerland
Squamous cell carcinoma (SCC) is the most common cancer in organ transplant recipients (OTRs) 
with a 65- to 250-fold increased incidence compared to general population. SCC is known to cause 
considerable cost of care in general population. We therefore analyzed the cost of dermatological 
care in OTRs seen in our OTR specialty clinic retrospectively with a particular focus on SCC. Billing 
data for all OTR (n=198; 145 male) seen by the Department of Dermatology, University of Zürich, 
during an observation period (OP) of 4 years was collected. According to histology of biopsies ever 
taken, patients were assigned to either the group SCC (n=70) with SCC occurring within the OP, past 
SCC (n=40) with SCC before the OP, in-situ SCC (n=13) when only in-situ SCC had been diagnosed, 
biopsy-negative for SCC and in-situ SCC (n=49), and no biopsy ever (n=26) within the OP. Median 
(minimum-maximum) annual costs for dermatological care were USD 1398 (USD 110 – 18586) 
for SCC, USD 776 (USD 77 – 9285) for past SCC, USD 308 (USD 131 – 971) for in-situ SCC, 
USD 211 (USD 23 – 2519) for biopsy-negative, and USD 156 (USD 62 – 519) for no biopsy ever. 
Median annual costs for group SCC and past SCC were higher than for groups in-situ SCC (p<0.001 
and p=0.014, respectively), biopsy-negative (p<0.001) and no biopsy ever (p<0.001). Regression 
analysis showed male sex (p=0.006), age at transplantation (p=0.001) and time since transplantation 
(p<0.001) as independent cost factors. Dermatological care for OTRs is costly, in particular due to 
SCC. Once an invasive SCC has been diagnosed, costs increase compared to OTRs without a 
histologically confi rmed SCC. Interventions reducing the progression from in-situ SCC to SCC should 
lead to considerable fi nancial savings. In particular, sun protection as well as early recognition and 
intervention should be advocated to OTRs to minimize the considerable costs associated with SCC.
185
Use of the Day Reconstruction Method (DRM) as an experiential sampling tool to 
assess subjective symptoms in atopic dermatitis
Rees JL, Murray CS The University of Edinburgh, United Kingdom
We have previously demonstrated a poor correlation between objective and subjective 
itch scores, causing us to examine accepted methods of disease quantifi cation. It has 
been demonstrated - in cognitive science - that experiential sampling of subjective 
symptoms minimises recall bias and allows subjects to tap into episodic/experiential 
memory rather than semantic memory. We trialled a novel questionnaire, designed 
to access episodic memory in retrospect (the Day Reconstruction Method or DRM) 
alongside  episodic monitoring in the form of a daily VAS score.  We studied 20 
individuals with atopic dermatitis over 42 days. Patients recorded daily (previous day, 
blinded) VAS scores for itch, extent and insomnia. The DRM was completed on days 
0, 21 and 42. It required the participant to write an episodic diary of the previous day 
and then score symptoms and emotions for each episode. The whole day DRM data 
was summarized by deriving a score from the product of the symptom severity with 
respect to length of episode. Subjects recorded a mean of 11.7 (SD 4.52) episodes 
which, on average, monitored 15.4 (SD 1.56) waking hours. Correlation between 
the DRM itch score and VAS was 0.74 (p=0.01.) There was a positive correlation 
between DRM itch score and sadness (rho=0.639, p=0.01) but, a weakly negative 
one for DRM itch and happiness, which was not signifi cant (rho=-0.234, p=0.74.) 
Reassuringly, there was a negative correlation between happiness and sadness 
(rho=-0.36, p=0.01.)  In summary, we have demonstrated the use of a modifi ed 
DRM in itchy patients. It would appear to tap into episodic memory for symptoms 
and may yield insight into the relationship between itch and general well-being.
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A mutation in the histidase gene sensitizes mice to UVB-induced DNA damage: 
evidence for the photoprotective role of endogenously produced urocanic acid
Barresi C1, Stremnitzer C1, Mlitz V1, Kezic S2, Ghannadan M1, Buchberger M1, Mildner 
M1, Selden C3, Tschachler E1, Eckhart L1 1Medical University of Vienna, Vienna, Austria 
2Coronel Institute, Amsterdam, Netherlands 3UCL Medical School, London, UK
Urocanic acid (UCA) has been proposed to function as the main absorption factor of 
ultraviolet B (UVB) light in the stratum corneum and, thereby, to protect the epidermis 
against UVB-induced damage. However, experimental confi rmation of this role of 
endogenous UCA has been lacking so far. Here we utilized a mouse model, in which 
the gene encoding the UCA-forming enzyme histidase is mutated, to investigate the 
photoprotective role of UCA in vivo. Histidase mRNA was expressed in both normal 
and mutant mice whereas histidase protein was detected by immunohistochemistry 
and Western blot analysis in wild-type mice but not in mutant mice, suggesting 
that the mutation destabilized the histidase protein. In line with this hypothesis, the 
concentration of UCA in the stratum corneum of homozygous mutant mice was reduced 
by approximately 90%. Newborn mice and the shaved back skin of adult mice were 
irradiated with 25 and 250 mJ/cm2 UVB. The resulting damage of epidermal DNA was 
assessed by enzyme-linked immunosorbent assay (ELISA) for cyclobutane pyrimidine 
dimers (CPDs). Defi ciency in histidase was associated with a relative increase of UVB-
induced CPDs by approximately 30% in most experimental settings and by more than 
80% in the epidermis of newborn mice irradiated with 250 mJ/cm2 UVB. Statistical 
analysis showed that the histidase-dependent difference in DNA damage was 
signifi cant in both newborn and adult mice. In conclusion, this study provides, to the 
best of our knowledge,  the fi rst evidence for an important contribution of endogenous 
UCA to the protection of the epidermis against the damaging effects of UVB.
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Langerhans cells are required for UV-induced immunosuppression
Schwarz A1, Noordegraaf M2, Clausen B2, Schwarz T1 1University Kiel, Kiel, Germany 
2University Rotterdam, Rotterdam, Netherlands
Painting of haptens onto UV-exposed skin does not result in sensitization but induces 
regulatory T cells (Treg). The inhibition of sensitization by UV was explained by 
UV-mediated depletion of Langerhans cells (LC). In addition, there is evidence that 
migration of UV-damaged but still viable LC into lymph nodes is essential to induce 
Treg. Accordingly, the steroid mometasone, which kills LC, inhibits sensitization but 
unlike UV does not induce Treg. To further elucidate this phenomenon, we utilized 
Langerin-DTR mice in which Langerin-positive cells can be depleted via injection of 
diphtheria toxin (DT). LC-depleted mice could be successfully sensitized though less 
pronounced in comparison to wild type mice (WT). Surprisingly, the sensitization 
response was not suppressed by UV in LC-depleted mice. Likewise, T cells obtained 
from UV-exposed Langerin-DTR mice did not suppress sensitization when injected 
into naive recipients, indicating that Treg did not develop in LC-depleted mice upon 
UV exposure. Langerin is not only expressed in epidermal LC but also in some dermal 
dendritic cells (dDC). After depletion with DT Langerin-positive dDC repopulate 
within 10 days, whereas LC are still absent. Therefore, Langerin-DTR mice were treated 
with DT 10 days (10d-DT) before UV exposure and sensitization. 10d-DT Langerin-
DTR mice were still resistant to UV-induced inhibition of contact hypersensitivity in 
comparison to WT. Likewise, Treg did not develop in these mice, as demonstrated by a 
negative adoptive T-cell transfer. Since in 10d-DT Langerin-DTR mice only LC but not 
Langerin-positive dDC are absent, one can conclude that LC are essential for both the 
suppression of contact hypersensitivity and the induction of Treg by UV. This adds to 
the concept that LC, in contrast to previous assumptions, appear to be more important 
for the down-regulation than induction of immune responses generated in the skin.
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In vivo antagonism of the aryl hydrocarbon receptor prevents UV-induced 
immunosuppression
Schuller W, Schwarz T, Schwarz A University Clinics Schleswig-Holstein, Campus 
Kiel, Kiel, Germany
Ultraviolet B radiation (UV) suppresses the immune system via induction of regulatory T cells (Treg). 
Recently it was shown that the cytosolic aryl hydrocarbon receptor (Ahr) is a molecular target for 
UV and participates in UV-induced signal transduction. To address whether the AhR is involved in 
UV-induced immunosuppression, the murine model of contact hypersensitivity (CHS) was utilized. 
Mice which were hapten-sensitized through UV-exposed skin did not respond with an ear swelling 
response upon ear challenge, indicating UV-induced immunosuppression. In contrast, mice which 
were exposed to UV but were injected intraperitoneally with the Ahr antagonists resveratrol (before 
sensitization) or 3-methoxy-4-nitrofl avone (MNF; injected daily) revealed a normal CHS response. 
Administration of resveratrol or MNF alone did not infl uence CHS reaction. To investigate the 
impact of resveratrol and MNF on the development of UV-Treg, adoptive transfer experiments were 
performed. Injection of lymphocytes obtained from donors which were hapten-sensitized through 
UV-exposed skin, rendered naive recipient mice unresponsive to the hapten. In contrast, recipients 
of T cells from donor mice, which were hapten-sensitized through UV-exposed skin but in addition 
received resveratrol or MNF intraperitoneally, were not suppressed in their CHS reaction. This 
indicates that administration of Ahr antagonists prevents the development of UV-induced Treg. 
The agonistic effect of UV and the antagonistic impact of resveratrol and MNF on the Ahr were 
confi rmed by measuring the expression of CYP1A1, a down-stream enzyme of the Ahr cascade. RT-
PCR analysis of lymphocytes from mice UV-exposed revealed induction of CYP1A1. Lymphocytes 
from mice treated with resveratrol or MNF showed suppressed CYP1A1 level. Together, these data 
suggest that the Ahr appears to be involved in mediating UV-induced immunosuppression. Thus Ahr 
antagonists might represent a suitable tool to modulate the impact of UV on the immune system.
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The pro-apoptotic role of RAIDD in vitro and in vivo
Schuepbach-Mallepell S1, Roques S1, Logette E2, Tschopp J2, Gaide O1 1Geneva 
University Hospital, Switzerland 2University of Lausanne, Switzerland
PIDD is a recently identifi ed protein that forms a signaling complex triggered by 
UV-induced genotoxic stress. PIDD activation has been suggested to induce either 
NF-kB dependent pro-survival signals or RAIDD dependent Caspase-2 activation 
and apoptosis. The balance between these life and death signals has been proposed 
to act as a DNA damage/repair checkpoint. However, this assumption is based 
on in vitro studies only. We have investigated this hypothesis by looking at UV-
induced DNA damage and apopotosis, either by silencing RAIDD in vitro or in 
RAIDD defi cient mice. Surprisingly, we found that RAIDD defi ciency signifi cantly 
increases PARP cleavage, Caspase-3 activation and cell death, both in vitro an 
in vivo. Silencing caspase-2 in vitro, on the other hand, protected the cells from 
UV-induced apoptosis. Moreover, we could show that RAIDD defi cient mice are 
more prone to UV-induced skin cancers. Taken together, these results indicate 
that we must reconsider the role of RAIDD and propose a mechanism by which 
RAIDD blocks the activity of caspase-2 and prevents UV-induced apoptosis.
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Treg/Th17 axis in 8-methoxypsoralen plus ultraviolet-A response of a psoriasis-like 
skin disorder in mice
Singh TP1, Schön MP2, Michaelis K3, Wang XJ4, Wolf P1 1Dept of Derm, Med Univ of 
Graz, Austria 2Dept of Derm, Univ Med Ctr Göttingen, Germany 3Univ of Würzburg, 
Germany 4Dept of Path, Head & Neck Cancer Res, Univ of Colorado Denver, USA
TGF-beta induces the T regulatory (Treg) cell transcription factor FOXP3 and is required for the maintenance of 
induced Tregs (iTregs) in the peripheral immune compartment. However, addition of IL-6 to TGF-beta inhibits the 
generation of iTregs and induces Th-17 cells. We now used transgenic mice expressing human wild-type TGF-beta1 
(K5.hTGF-beta1) to elucidate the signifi cance of potential psoralen+UVA (PUVA)-induced CD4+CD25+Foxp3+ 
(iTreg) and Th17 cells in a murine disease model. K5.hTGF-beta1 mice develop skin lesions with epidermal 
hyperplasia and infl ammatory infi ltration, resembling features of psoriasis. K5.hTGF-beta1 transgenic Hsd:ICR(CD-
1R) mice were topically treated twice a week with 8-methoxypsoralen on their shaved back skin 15 min before 
exposure to a sub- or near-phototoxic dose (0.25J/cm2 and 0.50J/cm2) of UVA radiation (mimicking a clinical PUVA 
protocol). After 4 weeks of treatment mice were sacrifi ced and samples analyzed for CD4+CD25+Foxp3+ levels 
and function by FACS and H3-thymidine Treg cell suppression assay. We found that both PUVA doses signifi cantly 
increased the IL-10 producing Foxp3+Treg population and its suppressive activity in treated mice compared to 
untreated mice what was reversed by anti-CTLA-4 antibody treatment in vivo and vitro.  We also found that 
PUVA down-regulated increased expression of the transcription factor ROR-gammaT and STAT3 and abnormally 
elevated levels of IL-23p19, IL-12p70, IL-17, IL-6, IL-1a, IL-9, IFN-gamma, IP-10, MCP1, KC, RANTES, G-CSF, 
TGF-beta1, and TNF-alpha but up-regulated the level of IL-10, IL-13 and IL-4 in the skin and/or serum, in a dose 
dependent manner. In addition, we observed that PUVA did increase the production of IL-2 and IL-10 in culture 
supernatants of splenocytes upon TCR stimulation. We furthermore found a down-regulation of IL-17 mRNA 
expression in the skin that was partially independent of IL-23p19 regulation.  The observation that the effect of 
PUVA on cytokine levels and Treg levels and function was paralleled by signifi cant macroscopic and microscopic 
improvement of the psoriasis-like skin lesions in the mice suggests that induction of CD4+CD25+Foxp3+ IL-10 
producing Tregs and inhibition of the Th-17 pathway may be responsible for the therapeutic effect of PUVA.
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Antimicrobial peptides: possible key players between the innate and the adaptive 
immune response
Navid F, Hinrichsen K, Schwarz T, Schwarz A University of Kiel, Kiel, Germany
Ultraviolet radiation (UV) suppresses the immune system in an antigen-specifi c fashion via 
induction of regulatory T cells (Treg). In contrast to the adaptive immune response, the innate 
immune response appears to be induced by UV, as recently demonstrated for the release of 
antimicrobial peptides (AMPs), thereby fostering the defense against microbial attacks. Since 
there is recent evidence that AMPs can also modulate the adaptive immune response, we 
studied whether AMPs can infl uence photoimmunosuppression. C57BL/6 mice were UV-
irradiated for 4 days (150 mJ/cm2) and then sensitized with 2,4-dinitrofl uorobenzene (DNFB) 
through UV-exposed skin. This results in the induction of immunotolerance mediated by 
CD4+CD25+ T cells (UV-Treg). Five days after sensitization, CD4+CD25+ and CD4+CD25- 
T cells were isolated from lymph nodes and spleens and the expression of UV-Treg specifi c 
molecules (Foxp3, CTLA-4, neuropilin) was measured by FACS analysis. Upon incubation 
of CD4+CD25- T cells with murine beta defensin-14 (mBD-14), a remarkable induction of 
these markers was observed, implying that mBD-14 might switch CD4+CD25- T cells into 
a regulatory phenotype. To investigate the in vivo relevance of these fi ndings, mice were 
injected i.v. with mBD-14 before sensitization with DNFB. The ear swelling response was 
signifi cantly reduced upon injection of mBD-14. Disruption of the epidermal barrier by tape 
stripping is known to induce AMPs. Accordingly, application of DNFB on tape stripped skin 
did not result in sensitization. These data imply that AMPs either injected i.v. or induced by 
tape stripping inhibit the contact hypersensitivity response, presumably by inducing Treg. 
These fi ndings give rise to the speculation that AMPs may participate in the modulation 
of the immune response by UV and explain why T-cell-mediated immune reactions are 
suppressed upon UV exposure but not host defense reactions against bacterial attacks.
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Chronic UV-Exposure Induces Signifi cant Changes Of The Cutaneous Neurosensory 
System In Mice
Legat FJ1, Sepic G1, Quehenberger F1, Wang M2, Glass JD2, Armstong CA3, Ansel JC3, 
Wolf P1 1Medical University of Graz, Graz, Austria 2Emory University, Atlanta, USA 
3University of Arkansas for Medical Sciences, Little Rock, USA
Sensory nerve fi bers densely innervate all layers of the skin, including the epidermis. In this location 
sensory nerves are exposed to ultraviolet (UV) light during daily sun exposure. An increased number 
of nerve fi bers was found in chronically photodamaged human skin. We investigated how chronic 
broadband (BB) or narrowband (NB) UV-B exposure affects the cutaneous neurosensory system of 
hairless mice, and whether sunscreen administration is capable of protecting this system against 
chronic UV exposure. Hairless mice were exposed to subinfl ammatory BB-UVB or NB-UVB 3x/wk 
for 12 wks. Before each UV exposure mice were either pre-treated with a broad spectrum sunscreen 
(SPF20) or left untreated. After 12wks of repeated UV exposure the skin of mice was assessed for the 
number of epidermal nerve fi bers (ENF) immunoreactive for protein gene product 9.5 (a pan-neuronal 
marker) as well as for the neuropeptide calcitonin gene-related peptide (CGRP). Skin sections were 
also assessed for immunoreactivity (IR) for NGF and its high affi nity receptor tyrosin kinase A (Trk-A). 
We found increased numbers of PGP9.5-IR and CGRP-IR ENF in chronically BB-UVB as well as NB-
UVB exposed skin; the effect was greater for NB-UVB than BB-UVB. BB-UVB or NB-UVB similarly 
increased NGF-IR but decreased TrkA-IR within the epidermis. Application of sunscreen to the 
skin of mice before each UV exposure abolished or signifi cantly reduced the effects of BB-UVB or 
NB-UVB on the number of PGP9.5-IR and CGRP-IR ENF, and it reversed the increase of NGF-IR as 
well as the decrease of TrkA-IR, respectively. In summary, chronic exposure to BB-UVB or NB-UVB 
caused signifi cant changes to the neurosensory system in the skin of hairless mice. These changes 
were similar to those seen in chronically photodamaged human skin. Sunscreens were capable of 
protecting the cutaneous neurosensory system from chronic UV exposure and by this way may help 
to reduce photodamage and to prevent skin cancer development in chronically UV-exposed skin.




COP1, a p53 interacting protein, is strongly expressed by proliferating keratinocytes, 
its expression decreases as cells differentiate and after UVB irradiation
Kinyó Á1, Hambalkó Sz1, Bebes A1, Bata-Csörgõ Zs1, Széll M1, Nagy F2, Kemény 
L1 1University of Szeged, Szeged, Hungary 2Biological Research Center, Szeged, 
Hungary
UVB-light is one of the most important physical carcinogens in the environment, and 
the skin is its main target. Human COP1 (huCOP1) has been shown to be a tumor 
suppressor p53 interacting protein; it increases p53 turnover in an ubiquitin-dependent 
fashion. Our aim was (i) to investigate the changes of COP1 protein in normal skin 
after UVB-irradiation and (ii) to elucidate the effect of differentiation on huCOP1 
protein expression in human skin as well as in an in vitro differentiating keratinocyte 
model. HuCOP1 protein was detected in the nucleus of epidermal keratinocytes, 
the staining was most prevalent in the basal layers of the epidermis. In addition, we 
demonstrated that UVB-irradiation of human skin dramatically decreased huCOP1 
expression in the basal and immediate suprabasal layers of epidermis. HuCOP1 
expression changes in the in vitro differentiating keratinocyte model confi rmed the 
immunohistochemical staining results: huCOP1 was highest expressed in proliferating 
keratinocytes and its expression level decreased as keratinocytes differentiated. Our 
results suggest that besides UVB-irradiation the proliferation-differentiation states 
of keratinocytes have a regulatory effect on huCOP1 expression in human skin.
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Dual role of CSB protein in photoaging and photocarcinogenesis
Majora M, Franke S, Schroeder P, Krutmann J Institut für Umweltmedizinische 
Forschung (IUF), Düsseldorf, Germany
Eukaryotic cells have evolved various mechanisms to cope with environmentally-induced DNA 
damage. In this regard, removal of UV-radiation-induced DNA photoproducts occurs via nucleotide 
excision repair, which comprises two distinct mechanisms: global genome repair, which acts on the 
whole genome, and transcription-coupled repair (TCR), which serves to repair actively transcribed 
genes. It is generally assumed that maintenance of genomic integrity by DNA repair mechanisms 
provides protection against cancer as well as aging. In order to study the relative importance of TCR 
for the prevention of photoaging versus photocarcinogenesis of the skin, in the present study, TCR-
defi cient CSB-knockout mice were crossed into the hairless background and subsequently subjected 
to a chronic UVA irradiation protocol. To our surprise, CSB-defi cient mice were resistant against 
photoaging. After receiving a cumulative dose of 750 J/cm2 UVA, wildtype (Wt) littermates showed the 
formation of skin wrinkles, whereas CSB-defi cient mice did not. Wrinkle formation in TCR-profi cient 
mice was accompanied by a 3-fold upregulation of MMP-13 expression in irradiated skin areas, whereas 
the tissue specifi c inhibitor TIMP-1 was only slighty (=1.3-fold) elevated. In marked contrast, CSB-
defi cient mice showed a 2-fold upregulation of TIMP-1, but only a 1.3-fold induction of MMP-13. We 
also noted increased expression of other genes involved in photoaging (e.g. IL-6 and VEGF) in the skin 
of irradiated Wt-mice but not in the CSB-defi cient mice. The exact opposite was observed when UVA 
radiation exposures were continued and mice analyzed for tumor formation. After a cumulative dose 
of 1300 J/cm2 UVA, 80 % of the CSB-defi cient mice had developed one or multiple skin papillomas, 
whereas the skin of all Wt-mice was tumor-free. Accordingly, immunohistochemical analysis revealed 
the presence of cyclobutane pyrimidine dimers, a highly mutagenic form of DNA damage, in the skin 
of chronically irradiated CSB-defi cient mice. Upon continued irradiation, some of the papillomas 
underwent transformation to squamous cell carcinomas. These results indicate that TCR protects the 
skin against UVA-radiation-induced photocarcinogenesis, but allows or even promotes photoaging.
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Enhanced collagen degradation in a dermal skin equivalent model containing 
fi broblasts with large scale deletions of mtDNA
Schuermann BA, Majora M, Schroeder P, Krutmann J IUF, Düsseldorf, Germany
Aged tissues contain increased levels of large scale deletions of the mitochondrial 
(mt) DNA. Especially extrinsically aged skin has been shown to carry a signifi cant 
burden of mtDNA deletions along with several other structural and functional 
impairments. Until now the role of mtDNA deletions for functional and structural 
changes of aged skin is not understood. Therefore we studied how human skin cells 
harbouring mtDNA deletions affect their microenvironment by comparing normal 
human fi broblasts (NHF) to dermal fi broblasts derived from patients suffering from 
Kearns-Sayre syndrome (KSS) in 3D collagen gels resembling human skin (dermal 
equivalents, DE). KSS fi broblasts carry a 10.000 fold higher amount of mtDNA 
deletions exemplifi ed by quantitative measurement of the 4977 bp Common 
Deletion. We here examined the degradation of components of the extracellular 
matrix in DE during cultivation.Within six weeks we observed a less robust collagen 
lattice structure in dermal equivalents with KSS fi broblasts in comparison to NHF 
by picrosirius red staining of histological sections. In line with that, we could 
measure higher mRNA expression levels of the dominant collagen degrading enzyme 
matrixmetalloproteinase-1 (MMP-1) in KSS DE using realtime PCR and increased 
MMP-1 protein amounts over the whole cultivation time. Moreover we detected 
a higher MMP-1 activity via zymography.We conclude that increased levels of 
photo-inducible mtDNA deletions are functionally relevant for intensifi ed matrix 
degradation and are therefore responsible for detrimental changes in photoaged skin
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Epidermal Recruitment of Diverse Cell Subsets after UV skin exposure may 
participate to the Recovery of the skin Immune system Homeostasis
Achachi A1, Vocanson M2, Gaillard V2, Poyet G2, David P3, Buyukpamukcu E3, Bastien 
P4, Castiel I4, Nicolas JF2, Gueniche A4 1INSERM U851, Clichy, France 2INSERM U851, 
Lyon, France 3Nestle Research Center, Lausanne, Switzerland 4L’OREAL Recherche, 
Clichy, France
UV injury profoundly affects the skin immune homeostasis by promoting strong infl ammation 
and cellular immuno-modulation. In this study, we characterized the infl ammatory cell 
subsets that emigrate in the epidermis the days following UV exposure.  Therefore, the buttock 
skin of 27 healthy volunteers was exposed twice to 1.5 minimal erythema dose of UV. Blister 
roofs were then collected before and 1, 4 and 10 days after UV-exposure from un-exposed 
and exposed skin and the resulting epidermal cells were analysed by fl ow cytometry. We 
demonstrated that, along with the rapid activation and migration of Langerhans cells (LC), 
UV skin radiation exposure promotes the infi ltration into the epidermis of a monocytic 
CD14+ CD36+ and of a macrophagic CD14- CD36+ cell subsets that emerge 1 and 4 days 
post exposition, respectively. More importantly whereas classical CD1ahi CD207+ LC are 
the unique dendritic cell (DC) subset found in the epidermis of unexposed skin, we detected 
two new subsets of epidermal DC namely CD1alow CD207- and  CD1alow CD207+  that 
emerged 1 and 4 days post irradiation, respectively. These two distinct populations of 
epidermal DC (EDC) differ from classical epidermal LC by their activation/maturation profi le 
as assessed by the strong expression of CD86 and HLADR. Finally, 10 days post-exposure, we 
observed that LC represented almost the only haematopoietic cell population in the epidermis. 
These results suggesting that the UV-recruited EDC and monocytic/macrophagic subsets 
participate to the progressive recovery of the epidermal immune cell network homeostasis.
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Expression of cyclin D1 and P16 in psoriasis before and after phototherapy
Abou EL-Ela M, Nagui N, Mahgoub D, El-Eishi N, El-Tawdy A, Fawzy M, Abdel Hay 
R, Rashed L Faculty of Medicine, Cairo University, Cairo, Egypt
Psoriasis vulgaris is characterized by keratinocyte hyperproliferation. An abnormal resistance 
of keratinocytes to apoptosis may contribute to the epidermal hyperproliferation. The aim 
of the study is to assess the expression of cyclinD1 (as a positive regulator of the cell cycle) 
and P16 (as a cyclin D1 inhibitor and a negative regulator of the cell cycle) in psoriasis 
and evaluate the effect of phototherapy on their expression. The study included 25 patients 
with psoriasis vulgaris and ten healthy individuals. Patients were treated with either narrow-
band UVB or PUVA for 24 sessions. Skin biopsies were taken from affected skin of each 
patient before and after treatment to examine the mRNA expression, trough the reverse 
transcriptase polymerase chain reaction, of cyclin D1 and P16. A skin biopsy was also taken 
from the healthy controls to examine cyclin D1 and P16 expression. Before phototherapy, 
the mean value of cyclin D1 concentration in patients was signifi cantly higher (P<0.001) 
than that in controls and the mean value of P16 concentration in patients was signifi cantly 
lower (P<0.001) than that in controls. On comparing the levels of cyclin D1 and P16 in 
our cases before phototherapy, there was evident inverse correlation (r= -0.697) which 
was statistically highly signifi cant (p value ‹ 0.001), denoting a state of hyperproliferation 
of the studied area. Following treatment, we detected a statistically signifi cant decrease 
in cyclin D1 and signifi cant increase in P16 (P value 0.003 and 0.001 respectively). This 
fi nding might contribute to cell cycle arrest to prevent further DNA damage following 
ultraviolet radiation. As a conclusion, cyclin D1 upregulation and P16 downregulation 
may play a role in the pathogenesis of psoriasis. Normalization of the levels of both 
parameters may be a mechanism by which phototherapy induces remission in psoriasis.
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gammaH2AX, a marker of skin photo exposure and photoaging
Barnes L1, Dumas M2, Juan M2, Noblesse E2, Schnebert S2, Guillot B3, Molès JP4 
1University Hospital of Geneva, geneva, Switzerland 2LVMH Research, Saint Jean de 
Braye, France 3Laboratoire de dermatologie moléculaire, Montpellier, France 4Max 
Mousseron Institute of Biomolecules CNRS–UMR 5247, Montpellier, France
Chronic exposure to low levels of genotoxic stresses such as UV is recognized to 
be a mechanism involved in tissue ageing. Studying such ageing mechanisms is 
quite diffi cult, because mimicking chronic exposure to low doses of those genotoxic 
agents implies the use of very sensitive biological markers. The phosphorylated 
form of histone H2AX (gammaH2AX) appeared as a suitable marker to follow the 
effect of chronic genotoxic stresses, since some permanent gammaH2AX foci have 
been described to be associated with DNA damages which accumulate with aging. 
Thus, we immunostained gammaH2AX on frozen skin sections of 22 human donors 
to detect variations of basal expression of this marker according to the age of the 
individuals, but also according to the chronic photo-exposition. Our results show 
that in normal epidermis, relevant amounts of discrete nuclear gammaH2AX foci are 
present. These foci did not matched with detectable foci of Cyclobutane Pyrimidin 
Dimers (CPDs). In young donors (11 donors between 19 and 27 years old) the density 
of foci increased between a photo-protected area (Inner arm) and the photo-exposed 
one (external forearm). No such difference was observed in the older group (11 donors 
between 61-67 years old), but an increase of the size of the foci between the photo-
protected and the photo-exposed area. Thus we conclude that basal expression of 
gammaH2AX may be an indicator of the chronic photo-exposition in young skins. In 
the case of older donors, we observed only an increase of the gammaH2AX foci size.
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Imuunosuppression induced by psoralen photoproducts can be realized through 
generation of adhesive cells with specifi c suppressive functions and apoptotic cells
Kyagova A, Kozir L, Gorshkova N, Pyatnitskii I, Pavlova S, Kozlov I, Malakhov M, 
Potapenko A Russian State Medical University, Moscow, Russian Federation
Psoralens (PS) plus UVA-light photochemotherapy (PUVA or photopheresis) is used for treatment 
of a variety of skin and autoimmune diseases. It has been suggested that PS-photochemotherapy 
exerts its benefi cial effects via suppression of the T-cell immune response. Photolysis of psoralens 
occurs during PS-photochemotherapy. The role of PS photoproducts in immunosuppression is 
not still clear. We assessed effect of photoproducts of psoralen (Ps), 8-methoxypsoralen (8-MOP) 
and 5-methoxypsoralen (5-MOP) on contact hypersensitivity (CSH) in mice, the T-cell mediated 
immune response in vivo. PS photoproducts were produced by irradiating of PS solution. It was 
found that orally or intravenously introduced photoproducts of all investigated photosensitizers 
induced fl uence-dependent suppression of the CHS to 2,4-dinitrofl uorobenzene (DNFB) and 
oxazolone. Immunosuppressive effi cacy of PS-photoproducts was different: 5-MOP=8-MOP>Ps. 
Suppression of the CHS induced by Ps photoproducts was due to generation of spleen cells with 
specifi c suppressive functions. These cells possessed adhesive properties to plastic surfaces in 
vitro. Apoptosis was evaluated in adhesive spleen cells from DNFB-sensitized mice that have been 
orally treated with Ps photoproducts. Apoptosis was determined by fl ow cytometry after staining 
of adhesive spleen cells with propidium iodide. In vivo treatment of mice with Ps photoproducts 
lead to two-folder increase in apoptosis of adhesive spleen cells. In vitro treatment of lymph 
node cells from DNFB-sensitized mice with Ps photoproducts resulted in apoptosis increase 
in 18 hours. Our data show that suppressive activity of PS photoproducts on the CHS can be 
realized through generation of cells with specifi c suppressive functions and induction of apoptotic 
cells. Our results also indicate that immunosuppression by PS photochemotherapy may proceed 
through photooxidation of PS and generation of photoproducts, which can affect T-cell immunity.
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Infrared radiation exerts immunosuppressive effects in mice
Jantschitsch C, Schwarz T, Schwarz A Kiel University, Kiel, Germany
Infrared radiation (IR) constitutes the major part of the total solar irradiance reaching 
terrestrial surface. For a long time IR has been regarded as inert and any effects by 
IR were interpreted due to warming. However, there is recent evidence that IR can 
exert wave band specifi c effects. It is well known that ultraviolet radiation (UV) exerts 
immunosuppressive effects.  Here, we studied whether the same applies for IR. To 
address this issue, an IR-A source (780-1400 nm) with a water fi lter which minimizes 
the heating effects was used. C57BL/6 mice were exposed to IR-A (1350 kJ/m²) on 
4 consecutive days. In parallel, another group of mice was exposed to UV (0.8 kJ/
m²). Mice were sensitized with dinitrofl uorobenzene (DNFB) through irradiated skin. 
In comparison to positive control mice which were sensitized and challenged, both 
IR- and UV-exposed mice revealed a signifi cantly reduced contact hypersensitivity 
(CHS) response. Suppression of CHS was even slightly enhanced upon combined 
exposure to UV and IR. Adoptive transfer experiments revealed that recipient mice, 
which were injected intravenously with lymphocytes obtained from either IR-A or 
UV-irradiated donors, were suppressed in the CHS response, suggesting that IR-A like 
UV might induce regulatory T cells. Accordingly, FACS analysis of lymph node cells 
revealed an increase in the number of CD4+CD25+ T cells in IR-A-exposed mice. 
Taken together, these data indicate that IR-A similarly to UV can suppress T-cell-
mediated immune reactions and demonstrate immunosuppressive properties of IR-A.
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Keratinocytes overexpressing gammaH2AX undergo apoptosis upon UVB irradiation 
in a p53 dependent manner
Barnes L1, Dumas M2, Juan M2, Noblesse E2, Tesnière A3, Schnebert S2, Guillot B4, 
Molès JP3 1University hospital of Geneva, geneva, Switzerland 2LVMH research, Saint 
Jean de Braye, France 3Max Mousseron Institute of Biomolecules CNRS¡VUMR 5247, 
Montpellier, France 4Laboratoire de Dermatologie Moléculaire, Montpelleir, France
Several molecular markers can be used to detect genotoxic stresses on skin. Our work 
focuses on the phosphorylated form of the histone H2AX (gammaH2AX) in keratinocytes 
and in normal human epidermis. We show that the histone H2AX is rapidly phosphorylated 
after UVB exposure in either keratinocytes cultures or human epidermis, and that 
gammaH2AX positive cells harbour Cyclobutane Pyrimidin Dimers. The relevant properties 
of gammaH2AX as a tool to analyse genotoxic stresses mainly resides on its ability to defi ne 
the degree of cell damage and lethality after a UVB irradiation. We observed that after 
irradiation with a low dose of UVB a fi rst set of phosphorylation occurs which correlates 
with cells undergoing DNA repair. In this case, gammaH2AX appears as a sensitive and 
quantitative tool to follow the repair of DNA injuries induced by UVB. After irradiation 
with a high dose of UVB, a typical super-bright gammaH2AX pattern appears in cells which 
will undergo apoptosis. So, the super-bright pattern seems to correspond to a massive 
phosphorylation of H2AX, and allows an early detection of apoptotic keratinocytes. In 
human irradiated epidermis in vivo, this subset of ¡§super-bright¡¨ gammaH2AX stained 
cells also matches with the sunburn cells. We further studied the gammaH2AX response in 
HaCaT keratinocytes, cells expressing a defective form of p53. Even if HaCaT were still able 
to phosphorylate the H2AX histone under UVB exposure, the association between apoptosis 
and the super-bright gammaH2AX pattern is not observed, suggesting that when the apoptotic 
process is engaged the massive phosphorylation of H2AX is under control of p53. Finally 
our results show that gammaH2AX is a valuable tool to study se severity of the damages 
after UVB irradiation both in vitro on keratinocytes and in vivo in the human epidermis.
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Long UVA directly generate cyclobutane pyrimidine dimers in isolated and cellular 
DNA
Mouret S, Philippe C, Gracia-Chantegrel J, Douki T CEA, Grenoble, France
Solar ultraviolet (UV) radiation is a well known mutagenic and genotoxic factor involved 
in the pathogenesis of skin cancers. In the recent years, we have shown that cyclobutane 
pyrimidine dimers (CPD), a typical UVB-induced DNA damage, are also produced upon 
UVA irradiation and are more frequent than oxidative DNA damage. In contrast to UVB 
that is known to induce CPD in DNA by direct absorption, their mechanism of formation 
upon UVA irradiation remains to be determined. In order to fulfi ll to this lack of knowledge, 
we compared the photochemistry of isolated and cellular DNA to determine whether the 
induction of CPD by UVA requires an endogenous photosensitizer or results from a direct 
effect. For this purpose, we used isolated calf thymus DNA, primary cultures of human 
keratinocytes and a highly accurate and quantitative HPLC-mass spectrometry technique to 
quantify the formation of all possible bipyrimidine photoproducts after enzymatic hydrolysis 
of DNA. In order to rule out contamination of isolated DNA, purifi cation steps were performed 
before UVA radiation. The distribution of photoproducts found in this purifi ed DNA was the 
same than in cellular DNA, namely an overwhelming formation of CPD at TT sites and no 
(6-4) photoproduct. We then studied the effect of the wavelength on the nature of CPD and 
yield of formation obtained in both isolated DNA and human keratinocytes. For this purpose, 
samples were irradiated with a broadband UVA lamp through a set of fi lters exhibiting 
increasing cut-off wavelength. We showed that even the longest UVA wavelengths (>380 
nm) induced CPD without drastically modifying the yield of formation and the distribution 
of these lesions. Altogether, the obtained results could suggest that a direct mechanism 
rather than a photosensitized reaction is involved in the formation of UVA-induced 
CPD. Our data further emphasize the need for an effi cient photoprotection against UVA.
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Microarray analysis of microRNA expression in skin of Xpc+/− mice and wildtype 
mice
Luo D, Zhou B The First Affi liated Hospital of Nanjing Medical University, China
MicroRNAs (miRNAs) are non-coding RNA molecules of 21 to 24 nt that regulate the 
expression of target genes in a post-transcriptional manner. Evidence indicates that 
miRNAs play essential roles in embryogenesis, cell differentiation, and pathogenesis 
of human diseases including skin cancer. To investigate possible mechanisms of 
photocarcinogenesis, we describe a comparison between miRNA expression profi le 
of Xpc heterozygous partially repair-defi cient mice and WT repair-profi cient mice. 
We analyzed the miRNA expression profi les in 2 pairs of Xpc+/− mice and WT mice, 
using a mammalian miRNA microarray containing whole mice mature and precursor 
miRNA sequences. MiRBase and GO-analysis were employed for the prediction 
of miRNA targets. A total of 20 miRNAs were differentially expressed in which 13 
miRNAs down-regulated and 7 miRNAs up-regulated in Xpc heterozygous mice 
compared with WT counterpart. Differentially expressed miRNAs were predicted 
to have some relationships with several signaling pathway in skin cells, of which 
regulation of epidermal growth factor receptor signaling pathway and transforming 
growth factor beta receptor signaling pathway should be noted. Our data thus indicate 
that miRNAs were potentially involved in the pathogenesis of photocarcinogenesis, 
and miRNAs may help to diagnosis, treat and prevent UV-induced skin cancers.
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Oral supplementation with Lactobacillus johnsonii reinforces skin immune 
homeostasis following UV exposure and limits UV-induced damages
Gueniche A1, David P2, Achachi A3, Vocanson M3, Buyukpamukcu A2, Bastien P1, 
Nicolas JF3, Castiel I1 1LOREAL Recherche, Clichy, France 2Nestle Research Center, 
Lausanne, Switzerland 3INSERM U851, Lyon, France
Probiotics have immunomodulatory functions through their activities on immunocompetent 
cells. Previously it was demonstrated that supplementation with Lactobacillus johnsonii 
(La1, 10 10 CFU/day) reinforces skin immune homeostasis and regulates UV-mediated 
immune-suppression, by promoting a faster recovery of Langerhans cells (LC) functions and 
basal CD1a+ cells number). A new randomized, double-blind, placebo-controlled clinical 
trial was conducted with 54 healthy volunteers receiving either La1 (10 9 CFU/day) or 
placebo, during 57 days prior to UV (2 x 1.5 MED). Blister roofs, liquid and skin biopsies 
were collected 1, 4 and 10 days after UV exposure from non-irradiated and irradiated 
skin areas and used for identifi cation of cells involved in UV-induced immune response, 
quantifi cation of infl ammatory cytokines, a DNA damage marker (p53).While a similar 
decrease of LC for both groups was observed on day 1 after UV exposure compared to 
placebo, La-1 group presented a faster increase of a new subset of epidermal dendritic cells 
(DC), namely early LC precursors (CD1alow CD207-) associated with a minor recruitment of 
monocytes. Concomitantly, inhibition of IL-10 and a tendency to inhibit IL-6 was observed 
in La-1 group compared to placebo. On day 4, La-1 group presented a greater recruitment 
of early LC precursors and a trend to increase CD1alow CD207+ LC precursors compared 
to placebo. Additionally, a faster reduction of infl ammatory and immunosuppressive 
cytokines (IL-6, TNFα, IL-8, and IL-10) was observed in La1 group compared to placebo. 
We show that La1 limits UV-induced immune-suppression and skin infl ammation. This 
contributes to the recovery of the skin immune homeostasis, confi rming the previously 
observed benefi ts of La1 supplementation for photoprotection at a lower dose (1 log).




Patients with Xeroderma pigmentosum and Vitamin D levels
Hösl M, Röcken M, Berneburg M University of Tuebingen, Tuebingen, Germany
Keratinocytes, macrophages and fi broblasts synthesise active vitamin D de novo from 
cholesterol precursors by photochemical activation in the skin. Recently vitamin D 
levels have been implicated in skin carcinogenesis and it has been postulated that 
photoprotection may lead to clinically relevant reduction of vitamin D levels. In 
order to address this point vitamin D serum levels were investigated in 17 patients 
suffering from Xeroderma pigmentosum (XP). XP patients are required to apply 
stringent photoprotection to reduce the risk of developing skin cancer. This includes 
measures such as strict avoidance of direct sun-exposure, UV-protective screens on 
all windows, long sleeved protective clothing and application of sun protection with 
very high protection levels in the UVB as well as the UVA range. In order to assess 
stringency of UV-protective measures, questionnaires containing questions regarding 
age of diagnosis, types of UV-protection applied, self assessment of stringency 
(scale 1-10). Vitamin D serum levels (1,25-OH VitD) were normal in 76% (13/17), 
elevated in 6% (1/17) and reduced in 18% (3/17) of XP patients investigated. Effect of 
photoprotection type, self estimation of stringency, and age of diagnosis on vitamin D 
levels were not statistically signifi cant. Only the duration of photoprotection in years 
showed a signifi cant effect on measured levels of vitamin D. Due to this, 30 years of 
photoprotection as applied by XP patients will lead to a 50% risk of reduced vitamin 
D serum levels. These data indicate, that photoprotective measures as stringent as 
in patients with XP do not lead to a strong reduction of serum vitamin D levels.
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Photodynamic therapy with glycoconjugated chrolin effectively induces tumor 
reduction
Sakuma S1, Otake E1, Maeda A1, Yano S2, Morita A1 1Nagoya City University Graduate 
School of Medical Sciences, Nagoya, Japan 2Kyoto University, Kyoto, Japan
Photodynamic therapy (PDT) is a less invasive method to induce apoptosis in cancer cells. However, 
usual photosensitizers, such as NPε6, do not have enough tumor selectivity and photosensitivity. 
Cancer cells are well known to phagocytose glucose 3-20 times as effectively as normal cells. 
Therefore, we hypothesized that glycoconjugation may improve the tumor-localizability and 
glycoconjugated chlorin may be more suitable and effective candidate for a PDT drug. To test 
the effi ciency of PDT with glycoconjugated chrolin, HaCaT cells were incubated with H2TFPC 
(unconjugated chrolin), H2TFPC-SGlc (glycoconjugated chrolin) and NPe6, followed by irradiation 
of 16J/cm2 of 633nm LED light. PDT with 1µM of H2TFPC-SGlc induced signifi cant amount of 
apoptosis 12h after irradiation in HaCaT cells (annexinV+ cells: 94.2%) compared to PDT with 
H2TFPC (annexinV+ cells: 33.5%) and NPe6 (annexinV+ cells: 4.5%). Next, we determined IC50 
24h after PDT in various tumor cells. PDT with H2TFPC-SGlc (IC50: 0.2~0.8 µM) induced cell 
death more effi ciently in all cell lines, compared to that with NPe6 (11~18 µM) and H2TFPC 
(0.6~2.8 µM). To check ROS-induction by PDT, sodium azide (NaN3) was added during irradiation 
as a quencher of singlet oxygen. The PDT-induced apoptosis was signifi cantly suppressed by NaN3 
(cell survival: 2.7%→54%). Furthermore, co-incubation with deuterium oxide (D2O), enhancer 
of singlet oxygen, during irradiation enhanced PDT effi ciency (cell survival: 110%→69%). The 
analysis using confocal microscopy revealed that H2TFPC-SGlc accumulates in both lysosome and 
golgi body. Finally, to evaluate in vivo effi cacy of PDT, we utilized melanoma-bearing BL6 mice. 
Tumor-bearing mice were intravenously injected with H2TFPC-SGlc (0.14µM), followed by the 
irradiation of 150 J/cm2 633nm LED light. 48h after irradiation signifi cant reduction of tumor was 
induced in PDT-treated mice. Taken together, these fi ndings indicate that PDT with glycoconjugated 
chrolin is highly effective to induce apoptosis in various tumor cells via induction of singlet oxygen.
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Photodynamic therapy with glycoconjugated fullerene induces tumor-specifi c 
cytotoxicity via induction of singlet oxygen
Otake E1, Sakuma S1, Maeda A1, Yano S2, Morita A1 1Nagoya City University Graduate 
School of Medical Sciences, Nagoya, Japan 2Kyoto University, Kyoto, Japan
Photodynamic therapy (PDT) has attracted attention as a less invasive treatment for cancer. In PDT, 
the use of tumor-localizing photosensitizer together with light exposure effectively and preferentially 
induces apoptosis in cancer cells through the generation of reactive oxygen species (ROS). 
Fullerene has been well known to have a capacity of producing high ROS. Furthermore, cancer 
cells are well known to endocytose glucose more effectively compared to normal cells. Therefore, 
we hypothesized that glycoconjugation would improve tumor-localizability and glycoconjugated 
fullerene may enhance PDT. To study the cytotoxicity of PDT with these photosensitizers, HGC-27 
cells were cultured with 10µM C60-(Glc)1 (D-glucose residue pendant fullerene) and C60-(6Glc)1 
(a maltohexaose residue pendant fullerene) for 24h and subsequently irradiated with 5J/cm2 UVA1. 
PDT treatment induced signifi cant cytotoxicity (%survival C60-(Glc)1: 1.7%, C60-(6Glc)1: 63.0%). 
Next, the effect of PDT on normal fi broblasts was evaluated. PDT exhibited no signifi cant cytotoxicity 
against normal fi broblasts (%survival C60-(Glc)1: 99.5%, C60-(6Glc)1: 98.8%), indicating that PDT 
with glycoconjugated fullerene targets cancer cells. To investigate whether this PDT induces ROS, 
generation of ROS after PDT was evaluated by FACS. ROS was induced in HGC-27 cells by PDT with 
C60-(Glc)1 and C60-(6Glc)1. In contrast, PDT with these drugs induced only few ROS in normal 
fi broblasts, suggesting thatinduction of ROS by PDT is tumor-specifi c. In addition, to investigate 
whether singlet oxygen (1O2) is generated, 50mM NaN3 was added during UV irradiation on 
HGC-27 cells. PDT-induced apoptosis were extensively reinstated by NaN3 administration; from 
0.5% to 40.0% [10µM of C60-(Glc)1] and from 46.8% to 88.0% [10µM of C60-(6Glc)1], suggesting 
that PDT-induced cell death is due to the generation of 1O2. These fi ndings indicate that PDT with 
glycoconjugated fullerene exhibited the tumor-specifi c cytotoxicity via induction of singlet oxygen.
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PPAR delta is the dominant PPAR isoform in UV exposed in vitro differentiated 
primary human keratinocytes
Balogh A, Törõcsik D, Nagy L, Remenyik É University of Debrecen, Hungary
Nuclear receptors are transcription factors that bind directly to DNA. Upon activation by 
their lipid soluble ligands they alter the expression of their target genes, playing important 
roles in metabolic processes, proliferation, differentiation, apoptosis, and immune responses 
of the cells on the level of gene expression regulation.  Our aim was to examine the role of 
nuclear receptors that are known to be expressed in the skin such as Peroxisome Proliferator-
Activated Receptors (PPARs), Retinoic Acid Receptors (RARs), Retinoid X Receptors (RXRs) 
and Liver X Receptors (LXRs) in in vitro differentiated and in UV exposed keratinocytes.In 
the experiments we used primary keratinocytes differentiated by raising the Ca2+ levels 
of the culturing medium to 1.2mM in a 0-6 days period and exposed to UVB (30mJ/cm2)
on the last day of differentiation. The changes in the expression levels of the marker genes 
of differentiation (TGM1, INV, PI3) and in the expression levels of the nuclear receptors 
and their target genes were followed by Real Time Quantitative RT-PCR technique.After 
verifying the differentiation of the keratinocytes by detecting the induction of the marker 
genes we measured the mRNA expression levels of nuclear receptors. We found that mRNA 
levels of PPAR alpha, RAR beta/delta, RAR gamma, RAR alpha, RXR alpha RXR beta and 
LXR apha did not change markedly. Measuring the expression levels of the known target 
genes for the PPAR pathways (ADRP, CPT1, FABP4, ABCG1) it was found that while PPAR 
beta/delta and alpha could be activated, PPAR gamma was inactive when using specifi c, 
synthetic activators. Although in vitro UV exposure of the keratinocyte cultures resulted 
in decrease both in the expression levels of PPAR isotypes and in the expression levels of 
their target genes, the responsiveness of PPAR beta/delta to its activator was still at high 
levels. Our results further confi rm the role of PPAR beta/delta in keratinocyte homeostasis.
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Protection of normal human epidermal keratinocytes against the combined stress of 
methylglyoxal and UV irradiation
Corstjens H1, Declercq L1, Maes D2 1Estée Lauder Companies, Oevel, Belgium 2Estée 
Lauder Companies, Melville, USA
Glycation is the non-enzymatic reaction between sugars and proteins that leads to the 
reversible formation of intermediate products. At this stage of the Maillard reaction, reactive 
carbonyls like methylglyoxal (MG) are released. Further reactions give rise to the formation 
of heterogeneous, fl uorescent and cross-linked structures called advanced glycation 
endproducts (AGEs). AGEs have been shown to accumulate in skin with age and their 
formation is increased under pathological conditions such as diabetes. Glycation is expected 
to interfere with normal cellular function.We investigated the effect of short term exposure 
of normal human epidermal keratinocytes (NHEK) to MG in combination with low doses 
of UV irradiation. In conditions chosen such that separate exposure to MG and UV caused 
only minimal loss of cell viability, their combined exposure resulted in signifi cant loss of 
viability. Using a cDNA array for evaluating the expression of stress related genes in NHEK, 
it was shown that the combined stress of UV and MG up regulated genes associated with 
heat shock proteins, p53-dependent cell growth arrest and apoptosis, while the antioxidant 
defence capacity (metallothioneins, thioredoxin, SOD, ferritin) was impeded. Based on the 
identifi cation of these target genes, a rosavin and salidroside containing Rhodiola rosea 
extract was tested in the keratinocyte survival model. This Rhodiola extract, known to possess 
strong antioxidant activity and the ability to induce heat shock proteins, offered signifi cant 
protection against the combined stress of UV and MG. We conclude that exposure of NHEK 
to low levels of MG exacerbated the effect of UV irradiation on viability loss. The Rhodiola 
rosea extract was able to protect keratinocytes against the combined stress and is proposed 
as a compound that reduces the impact of glycation stress on the skin’s sensitivity to UV.
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Proteomic Profi ling Identifi es the protective effect of Ligustrazine on ultraviolet B 
induced photodamage in keratinocyte cell line
Luo D, Wei M, Bingjiang L The First Affi liated Hospital of Nanjing Medical University, 
Nanjing City, China
In this study, we aimed to investigate the proteomic changes of human epidermal 
keratinocytes (HEK) induced by Ligustrazine, one kind of Chinese herbal medicine 
with anti-infl ammatory and anti-oxidant property, and UVB irradiation. We used a 
proteomic method to study these responses. Keratinocytes were kept on culturing 
for 24h after that 200μg/ml of Ligustrazine was added into the medium and 
exposure to UVB irradiation. The total proteins were collected and separated by 
two-dimensional gel electrophoresis(2-DE). Differentially expressed proteins were 
processed through mass spectrometric analysis and database searches. Among all 
the protein spots detected, 25 were found to be different between the cells before 
and after Ligustrazine intervention. Of these spots, 19 were identifi ed by using mass 
spectrometry analysis. With the UVB irradiation, there were 33 differential protein 
spots compare to the simple Ligustrazine group, when 7 of them were identifi ed. These 
identifi ed proteins could be functionally classifi ed into several aspects: cell structure, 
cytoskeleton, stress response, cell proliferation, apoptosis, and unclassifi ed. Some 
fi ndings, including Heat shock protein beta-1 and Collagen alpha-2, were verifi ed 
by western blot analysis. In this study, some differential proteins related to the effect 
of Ligustrazine and UVB radiation were found. These results strengthen the notion 
that Ligustrazine act as potential agent to reduce risk of photodamage effect of UVB.
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PUVA inhibits Th17-migration into central nervous system in experimental 
autoimmune encephalomyelitis
Maeda A, Furuhashi T, Torii K, Saito C, Morita A Nagoya City University Graduate 
School of Medical Sciences, Nagoya, Japan
Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of central 
nervous system (CNS) infl ammatory demyelination, characterized by progressive paralysis 
and has directly led to the development of treatments for Multiple Sclerosis. Although the 
pathogenesis is incompletely understood, there is now growing evidence implicating the 
newly characterized Th17 cells in the pathogenesis of EAE. Previous our study shows that 
psoralen + UVA irradiation (PUVA) signifi cantly suppresses the progression of EAE although 
PUVA does not affect IL-17 mRNA expression in regional lymph nodes. To elucidate this 
discrepancy, regional lymph nodes obtained from PUVA-treated and untreated MOG35-
55-immunized mice were analyzed. Because pertussis toxin (PT) is known to facilitate 
the induction of EAE by opening up the blood-brain barrier and thereby facilitating the 
migration of pathogenic T cells to the CNS, we hypothesized that PUVA may suppress 
PT-induced migration of pathogenic Th17 cells. Th17 cells in regional lymph nodes from 
PUVA-treated and untreated mice were analyzed. FACS analysis revealed signifi cant 
expansion of Th17cells in regional lymph nodes from PUVA-treated immunized mice 
immediately after second immunization (Day7) in both MOG-immunized (10.5% in CD4+ 
T cells) and PUVA-treated mice (10.7%) compared to those of naïve (0.3%). While 72hr 
after 2nd immunization (Day9) Th17 cells signifi cantly reduced in immunized mice without 
PUVA (3.1% in CD4+ T cells) compared to Day7, any signifi cant reduction of Th17was 
not observed in PUVA-treated mice (14.68% in CD4+ T cells). Furthermore, infi ltration 
of lymphocytes in the brains obtained from PUVA-treated mice was signifi cantly reduced 
compared to EAE mice. Taken together, these fi ndings indicate that PUVA presumably may 
inhibit the migration of Th17 cells into CNS in EAE mice, leading to prevention of EAE.
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Real time imaging of UVB-induced keratinocyte apoptosis, and analysis of factors 
infl uencing cell-to-cell variation
Weatherhead SC, Jamieson D, Reynolds NJ Newcastle University, Newcastle-upon-
Tyne, United Kingdom
Ultraviolet B (UVB) is a potent inducer of apoptosis. Apoptosis is essential for the elimination 
of damaged keratinocytes and represents an important protective mechanism. This dynamic 
process is often measured as an endpoint assay which may lead to sampling errors associated 
with the timing of apoptosis.  Apoptosis also contributes to steady state turnover of cell 
populations, particularly in tumours, but this contribution is diffi cult to estimate from endpoint 
assays on human tissues as the percentage of cells undergoing apoptosis at any one time 
may be very low.  To understand the dynamic effect of apoptosis it is necessary to determine 
how long cells take to go through apoptosis and relate this to assays applied to tissues. We 
have used a high-content, real-time imaging system to measure the timing and duration of 
apoptosis in primary keratinocytes after irradiation with a range of clinically relevant doses 
of narrowband UVB (0-1000 J/m2). The median time a live cell remained caspase-3+ before 
dying was 20 min.  Apoptosis generally started from ~8h after irradiation with most caspase 
positivity occurring by 16-18h. A specifi c caspase-3 inhibitor blocked apoptosis/cell 
death further validating the assay and role of capsase-3 in UVB-induced apoptosis.  Flow 
cytometric analysis confi rmed that UVB-induced apoptosis occurred in transit amplifying 
cells and stem cells. Stage of cell cycle was also an important determinant of an individual 
cell undergoing apoptosis. These data demonstrate quantitative assessment of UV-induced 
apoptosis in populations of primary keratinocytes over time. We have shown that monolayer 
keratinocytes show signifi cant heterogeneity in both sensitivity to apoptosis (initiated at 
between 1h and 24h post UVB), and duration of caspase positivity prior to cell death which 
ranged from less than 10mins to over 9h.  Apoptosis was limited to proliferating cells only.
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Serum 25-hydroxyvitamin D levels in patients with psoriasis treated with UVB 
therapy
Podskarbi M, Brzezinska-Wcislo L Silesian Medical University in Katowice, Poland
Psoriasis is a common, chronic and recurrent infl ammatory dermatosis with abnormally exaggerated 
epidermal cellular turnover, which affects about 2,5% of the world’s population. One of therapeutic 
modalities for the treatment of moderate to severe psoriasis is phototherapy with UVB radiation. 
The 290–315nm UV radiation produces in the basal epidermis vitamin D of 7-dehydrocholesterol 
which is then hydroxylated in the liver into 25-hydroxyvitamin D. Vitamin D has been shown to 
inhibit hyperproliferation and to induce terminal differentiation of cultured human keratinocytes. 
Bibliography notes  many adverse reactions to phototherapy found during and after the end of the 
treatment which is possible connected to abnormal vitamin D metabolism in some patients with 
psoriasis. The aim of this research was to examine whether narrowband UVB therapy was able to 
induce vitamin D synthesis and thereby supply psoriasis patients with vitamin D, to found correlation 
between good response to the treatment with serum vitamin D levels and sun exposure/nutrition 
habits. The assessment included: serum concentrations of 25(OH)D3, BMI, skin phototype (Fitzpatrick 
scale), MED for UVB, PASI and questionnaire for patients and volunteers (habitual sun exposure, 
solar protection behaviors, using of tanning beds, nutrition habits).The serum concentrations of 
25(OH)D3 were measured using an radio immunoassay method (RIA).  The tests to measure MED for 
UVB were carried out using  TH-1 E lamp (Cosmedico Medizintechnik).The tested material were 22 
adult patients of the Dermatological Clinics, who were earlier qualifi ed to phototherapy with narrow 
band UVB radiation (311nm) due to moderate forms of psoriasis and 22 volunteers to compare 
baseline and concluding serum 25-hydroxyvitamin D levels. The parameters were measured before 
the fi rst dose of radiation, during the treatment and 2 and 8 weeks after the end of UVB therapy. 
The tests showed in most patients increased serum 25(OH)D3 levels in response to treatment (after 
the initial decrease after fi rst week of phototherapy), no tendency to decline in week 2 and 8 after 
the treatment was stopped, correlation between with serum vitamin D levels and reduction in PASI.
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Soluble growth stimulation gene-2 (sST2) contributes to the immunosuppressive 
effects of UV-radiation
Mlitz V, Mildner M, Hötzenecker K, Ankersmit HJ, Tschachler E Medical University 
of Vienna, Vienna, Austria
ST2, a novel member of the IL-1-receptor family, has recently been identifi ed as the 
receptor for IL-33. In addition, a soluble form (sST2), comprising only the extracellular 
part of ST2, exists. Whereas IL-33 activates Th2-cells, mast cells, eosinophils and 
basophils via binding to ST2, sST2 is known to have immunosuppressive properties 
by acting as a decoy receptor for this cytokine. We have thus asked whether sST2 
could contribute to the well-known, but poorly understood, immunosuppression 
occurring in UV irradiated skin. Exposure of primary human keratinocytes (KC) to 
UVB strongly induced the secretion of sST2. A similar effect was observed when 
KC were stimulated with hepatocyte growth factor (HGF), which is known to be 
up-regulated in dermal fi broblasts (FB) after UV-irradiation. In contrast, IL-33, 
the agonist of sST2, was not secreted by KC. To investigate the biological activity 
of KC-derived sST2, we analyzed its effect on IL-33 stimulated peripheral blood 
mononuclear cells (PBMC). IL-33, in combination with IL-12, is known to induce 
IFN-gamma production in these cells. We show here that pre-incubation of IL-33 
with either recombinant sST2 or supernatants of UVB or HGF-treated KC strongly 
inhibited IL-33 induced IFN-gamma release.In summary, we have demonstrated 
that high amounts of biologically active sST2 are secreted by KC after exposure 
to UVB or HGF. We therefore suggest that the UV-induced secretion of sST2 by 
KC might contribute to the immunosuppression observed in UV irradiated skin.
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The effect of baicalin on UVB-mediated miRNAs expression changes in mice skin
Zhou B, Luo D The First Affi liated Hospital of Nanjing Medical University, China
MicroRNAs (miRNAs) are non-coding RNA molecules of 21 to 24 nt that regulate 
the expression of target genes in a post-transcriptional manner. Evidence indicates 
that miRNAs play essential roles in embryogenesis, cell differentiation, and 
pathogenesis of human diseases including skin cancer.  To assess the effect of 
baicalin on UVB-mediated miRNAs expression changes in mice skin, we analyzed 
the miRNA expression profi les in 3 pairs of UVB irradiated mice, baicalin treated 
irradiated mice, and untreated mice. MiRBase and GO-analysis were employed 
for the prediction of miRNA targets. 3 miRNAs are down-regulated and 3 miRNAs 
are up-regulated in UVB irradiated mice compared with untreated counterpart. 
Differentially expressed miRNAs were predicted to have some relationships with 
photocarcinogenesis, hypomethylation and apoptosis. 3 miRNAs are down-regulated 
and 1 miRNA are up-regulated in baicalin treated irradiated mice compared with 
UVB irradiated mice. Differentially expressed miRNAs were predicted to have 
some relationships with DNA repair signaling. MiRNAs were potentially involved 
in the pathogenesis of photodamage, and differentially expressed miRNAs in 
baicalin treated group may help to treat and prevent UV-induced dermatoses.
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The use of nanosensors and mitochondrial DNA to investigate oxidative stress and 
aging in human skin
Birch-Machin M1, Henderson J1, Oyewole A1, Anderson A1, Boulton SJ1, Manning P1, 
Birket M2, McNeil C1, Swalwell H1 1Newcastle University, Newcastle Upon Tyne, 
United Kingdom 2Buck Institute, San Francisco, USA
The purpose of the study is to use mitochondrial DNA, electrochemistry and nanosensors 
to investigate the relationship between UVR induced oxidative stress and aging in human 
skin.  Mitochondrial DNA (mtDNA) mutations have been shown to accumulate with 
UVR exposure. We show that a T414G “aging” mtDNA mutation (previously observed 
in other tissues) accumulates in both normal and photo-aged human skin (n=108) and is 
linked to an UV-induced 3895bp mtDNA deletion thereby suggesting focal effects. Skin 
fi broblast cultures were sorted into young and senescent populations and there was a 
7-fold increase in ROS in the senescent cells which was associated with increased mtDNA 
damage (i.e. strand breaks) (t-test, P<0.01). This type of mtDNA damage can be abrogated 
by a range of anti-oxidants including the mitochondrial-targeted ubiquinone MitoQ 
as well as Tiron. The fl ow cytometery dyes DHR123 and MitoSOX, were used to detect 
cellular and mitochondrial ROS respectively in skin cells following UVA irradiation in the 
presence of respiratory chain inhibitors (e.g. rotenone, TTFA, antimycin for complexes I, 
II, III respectively).  A comparative study showed that complex II appears to enhance the 
oxidative stress to the greatest extent. This was further investigated by a novel application 
of a cytochrome c functionalised amperometric sensor to detect real time superoxide 
production in isolated mitochondria for the fi rst time in the literature. Additionally, we have 
developed intracellular nanosensors that encompass fl uorescent ROS probes which allow 
real time analysis of cell function.  One such ROS generating nanoprobe was achieved 
by entrapping a photosensitiser, TPPS4, within a polyacrylamide matrix. Together these 
investigations have implications regarding relative potency and synergy of anti-oxidants 
as well as the “vicious cycle of aging” components of mtDNA damage and dysfunction.




Uptake of aminolevulinic acid in keratinocytes by GABA transporter 3
Schulten R1, Stichel CC2, Luebbert H1, 2 1Ruhr-University Bochum, Bochum, Germany 
2Biofrontera Bioscience GmbH, Leverkusen, Germany
5-Aminolevulinic acid (ALA) is widely used as a photosensitizer in the treatment of skin cancer. Until 
today, the mechanism of its uptake into keratinocytes is not completely known. Primary keratinocytes 
(KC) and two KC cell lines, CCD 1106 KERT and A431, were incubated with ALA and competitive 
inhibitors to fi nd out more about the uptake mechanism in these cells. Protoporphyrin IX (PpIX) 
concentration was measured fl uorimetrically 2h after incubating the cells with 1.8 mM ALA for 30 
min. Inhibitors used were gamma-aminobutyric acid (GABA), beta-alanine, guvacine, betaine, glycyl-
glutamine (GlyGln), and (S)-SNAP-5114. Further, the expression of GABA transporters (GAT)-1, -2, 
and -3 was analyzed by reverse transcriptase (RT)-PCR. ALA-treated cells were irradiated with light 
(635 nm) and the ATP-release was analyzed. PpIX production was reduced after incubating A431 cells 
with GABA. Even stronger effects could be detected after incubating the cells with beta-alanine or the 
specifi c GAT-3 inhibitor (S)-SNAP-5114. No reduction of PpIX production could be measured after 
incubating the cells with betaine, guvacine or GlyGln. CCD cells showed a reduced PpIX production 
after incubation with beta-alanine or (S)-SNAP-5114 as well, but to a lesser extent compared to A431 
cells. The inhibitory effect on primary KC was even lower than in CCD cells. GAT-3 mRNA could be 
detected in all analyzed cell lines, whereas GAT-1 and GAT-2 mRNA could not be detected. The ATP-
release was measured in the supernatant after irradiating the cells. The cells incubated with ALA showed 
an intense release of ATP. This ATP-release could be signifi cantly reduced by applying beta-alanine in 
combination with ALA. These results show that ALA is taken up via GAT-3 in KC. The inhibitory effects 
were more prominent in A431 cells compared to CCD and primary KC. Normal KC and pathological 
cells could differ in the uptake mechanism by preferring different transporters. Future experiments 
will have to show if normal KC express other transporters. The reduction of ATP after irradiating cells 
incubated with beta-alanine and ALA shows that the ATP release is a consequence of PpIX formation 
after ALA incubation. Inhibition of ATP release could lead to a reduced pain sensation during PDT.
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A dynamic subpopulation of slow-proliferating JARID1B-positive cells is required 
for long-term self-renewal of melanoma but not for initial tumor formation
Roesch A1, Fukunaga-Kalabis M2, Schmidt B2, Zabierowski S2, Vogt T1, Herlyn M2 
1Regensburg Univ Medical Center, Germany 2The Wistar Institute, Philadelphia, USA
Malignant melanoma is famous for its phenotypic diversity and heterogeneous expression of biological 
markers. Recently, markers such as CD20, CD133, or ABCB5 have been used to defi ne melanoma 
subpopulations with tumor-initiating capacity. Our data indicate that melanoma contains a label-retaining 
subpopulation with increased stem cell-like self-renewal potential. We discovered a molecular marker for 
these cells, JARID1B. JARID1B is a member of the highly conserved JARID1 family of chromatin regulators 
which are involved in tissue development and stem cell biology. Demethylation of H3K4 by JARID1B is 
known to play a role in cell fate decision of embryonic stem cells by blockage of terminal differentiation. In 
both patient samples and cultured cells, we found JARID1B to be expressed on a small subpopulation (3-5%). 
Expression in metastases is lowest when compared to primary melanomas and nevi with scattered cells 
showing staining. We isolated the JARID1B+ population using a lentiviral construct which drives cytoplasmic 
EGFP expression controlled by the co-cloned human JARID1B main promoter. After isolation from melanoma 
spheres, J/EGFP+ cells at fi rst showed decreased BrdU incorporation and slow proliferation. However, after 10 
days, they gave rise to a highly proliferative progeny of J/EGFP+ and J/EGFP- cells and showed an increased 
potential to self-renew into daughter spheres. When long-term cultured, J/EGFP- cells gradually re-gained 
JARID1B expression depending on culture conditions; a fi nding that supports a dynamic model of ‘stemness’. 
Accordingly, both J/EGFP+ and J/EGFP- cells induced tumor growth in NOD/LtSscidIL2Rgamma-/- mice in 
xenotransplantation assays (100, 10, 1 cell injected). However, when melanoma cells were restrained from 
JARD1B expression by stable shRNA knock down (KD), cells exhausted over time in vitro and in vivo as 
indicated by decreasing colony formation and reduced tumorigenicity in serial xenotransplantation assays. 
When seeded at clonal density, the potential of JARID1B KD cells to form heterogeneous melanoma spheres 
also signifi cantly decreased. In summary, our data sustain the hypothesis that JARID1B is involved in long-
term maintenance of primary tumor growth and systemic disease progression but not initial tumor formation.
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Micro-array analysis reveals that melanocortin 1 receptor is down-regulated by 
SLC24A5 knock-down in normal human melanocytes
Wilson S, Askew SE, Lim FL, Gunn DA, Ginger RS, Green MR Unilever R&D, Bedford, 
United Kingdom
The SLC24A5 gene encodes a potassium dependent sodium-calcium exchanger 
(NCKX5) that plays a key role in vertebrate pigmentation. The NCKX5 A111T SNP 
alters exchanger activity and is associated with natural human skin colour variation. 
We have previously shown that siRNA-mediated knockdown of SLC24A5 signifi cantly 
disrupts melanogenesis in cultured normal human melanocytes (NHM) and reduces 
the level of the key melanogenic proteins, tyrosinase, Tyrp1 and pmel17. In order 
to identify potential interactions between this gene and other known genes and 
pathways we conducted whole genome micro-array analyses of mRNA isolated from 
SLC24A5 knock-down experiments with NHM. Five different SLC24A5 knockdown 
siRNAs were compared to control siRNAs and a list of genes selected whose mRNA 
expression was signifi cantly altered 5 days after SLC24A5 knockdown. The only 
known pigmentation gene in this list encodes the melanocortin 1 receptor (MC1R) 
and real time PCR has confi rmed that MC1R mRNA is signifi cantly reduced following 
SLC24A5 knockdown. This suggests that SLC24A5 interacts with the well documented 
melanocortin signalling pathway at the transcriptional level. In contrast, the infl uence 
of SLC24A5 on the expression of the other pigmentation genes appears to be elicited 
through post-translational mechanisms and is currently under further investigation.
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c-Kit Mutants Require Hypoxia-Inducible Factor 1 to Transform Melanocytes
Monsel G1, Ortonne N2, Bagot M2, Bensussan A1, Dumaz N1 1INSERM U976, Paris, 
France 2Hôpital Henri Mondor, Créteil, France
Although many studies have highlighted the critical role of c-Kit in normal 
melanocyte development, its role in melanoma development remains unclear. 
Whereas c-Kit expression is often lost during melanoma progression, a subset of 
melanoma has been found to overexpress c-Kit and mutations activating c-Kit have 
recently been identifi ed in some acral and mucosal melanoma. To address the role 
of these c-Kit mutants in the transformation of melanocytes, we characterized the 
physiological responses of melanocytes expressing the most frequent c-Kit mutants 
found in melanoma (K642E and L576P) and a novel mutant we identifi ed in an 
acral melanoma. We analyzed signaling pathways activated downstream of c-Kit 
and showed that all three mutants led to strong activation of the phosphatidyl-
inositol-3 kinase pathway but only weak activation of the Ras/Raf/Mek/Erk pathway, 
which was not suffi cient to promote uncontrolled melanocyte proliferation and 
transformation. However, these mutants cooperated with a constitutively active form 
of Hypoxia-Inducible Factor 1α (HIF1α) to activate the Ras/Raf/Mek/Erk pathway and 
transform melanocytes. Proliferation of melanocytes transformed by mutant c-Kit was 
specifi cally inhibited by imatinib. These results demonstrate for the fi rst time that 
melanocytes require a specifi c epigenetic environment to be transformed by c-Kit 
mutants and highlight a distinct molecular mechanism of melanocyte transformation.
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AP-1 inhibition identifi es cooperation of INK4 and Cip/Kip signaling pathways to 
suppress human melanoma
Jalili A1, Wagner C1, Mertz KD1, Pashenkov M1, Lupien M2, Brunet JP3, Ramaswamy 
S4, Golub TR3, Stingl G1, Wagner SN1 1DIAID, Dept of Dermatology, Medical Univ 
of Vienna, Austria 2Norris Cotton Cancer Center, Dartmouth-Hitchcock Med Center, 
Lebanon, USA 3The Broad Inst of MIT & Harvard, Cambridge, USA 4Massachusetts 
General Hosp Center for Cancer Research & Dept of Medicine, Charlestown, USA
In the past years, cell biologic analyses have uncovered serious gaps in our understanding of 
genes and pathways that function to constrain transformation of melanocytes into melanomas. In 
melanoma, oncogenic BRAF/NRAS mutations induce activation of AP-1, a fundamental regulator 
of cell proliferation and oncogenic transformation. Though of fundamental importance, the effects 
of AP-1 activity are largely unknown in human melanoma. We used the human melanoma cells 
LOXIMVI and UACC257 to establish lines allowing inducible expression of a c-Jun (AP-1) dominant 
negative mutant. Using these cell lines in cell cycle analyses, proliferation and colony formation 
assays in vitro, and an in vivo model of the disease, we show that AP-1 activity critically controls 
cell cycle progression at G1 and accelerates proliferation of melanoma cells. Western blot analysis 
and RNA interference of genes involved in cell cycle progression at G1 identifi ed repression 
of p18INK4c by AP-1. A series of functional studies employing promoter reporter assays, ChIP, 
immunofl uorescence, and (Co-)IP confi rmed that p18ink4c is a direct target of AP-1. Co-transfection 
and RNA interference in Western blot and promoter reporter analyses revealed also indirect 
repression of p21Cip1 by AP-1 via Tbx2. Finally, in silico analysis of generated mRNA expression 
profi les from human melanoma samples identifi ed c-Jun and JunD as potential heterodimerization 
partners, an observation supported by functional studies. These results, to the best of our knowledge, 
identify for the fi rst time p18INK4c as an important melanoma suppressor gene that, in cooperation 
with p21Cip1, can effectively repress AP-1-mediated oncogenic signals in human melanoma.
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Ebselen induces peripheral actin depolymerisation and inhibits melanosomal 
transfer through a melanocyte-dependent mechanism
Kasraee B, Nikolic D, Salomon D, Piguet V, Fontao L, Sorg O, Saurat JH Geneva 
University Hospital, Switzerland
Melanocytes synthesize melanin pigments in specialised organelles, melanosomes, 
which are eventually transferred into keratinocytes. The essential role of peripheral actin 
network in inter-cellular organelle transfer is well known in several cell types. Although 
much is understood about the intracellular traffi cking of melanosomes, the mechanism of 
melanosomal transfer to keratinocytes is still considered as a “black box”. Ebselen is a non-
proteic glutathione peroxidase mimic well-known for its capacity to reduce intracellular 
H2O2 levels.By histological, immunohistochemical and quantitative electron microscopic 
techniques we demonstrated that ebselen signifi cantly inhibited melanosomal transfer in 
melanocyte-keratinocyte co-cultures, in human reconstructed epidermis, as well as in 
black guinea pigs in vivo. We have then cross-cultured ebselen-treated B16 melanocytes 
with BDV-II keratinocytes and demonstrated that ebselen inhibits melanosomal transfer 
through a melanocyte-dependent mechanism. Thus untreated keratinocytes were 
not capable of receiving melanosomes from ebselen-treated melanocytes despite the 
direct contact of keratinocytes with melanosome-containing dendrites. We found by 
confocal microscopy of viable cultured melanocytes that 25 µM ebselen depolymerised 
the peripheral actin network already after 3 hours of exposure, while other cellular 
components (e.g. microtubules) remained intact even after 4 days of treatment.The 
currently accepted hypothesis regarding melanosomal transfer considers keratinocytes 
as the central cells in melanosomal transfer acting through phagocytosis of melanocyte 
dendrite tips. Melanocytes, on the contrary, are believed to be passive by-standers in 
the transfer process, having no more role once they have accomplished the intracellular 
traffi cking of melanosomes into dendrite tips. Our data indicate that melanocytes play an 
active role in the transfer of melanosomes, which can be mediated by the actin network.
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GLI2, A TGF-beta-Inducible Target, Promotes Melanoma Invasion and Metastasis
Alexaki VI, Javelaud D, Dennler S, Verrecchia F, Mauviel A INSERM U697, Paris, 
France
Cutaneous melanomas, which represent about 4% of skin cancers, are responsible for up 
to 80% of deaths from cutaneous malignancies.  The TGF-beta/SMAD pathway, which 
can exert both tumor suppressor and pro-oncogenic activities, is often constitutively 
active in melanoma and a marker of poor prognosis. Our work demonstrates that 
GLI2, a mediator of the Sonic Hedgehog pathway recently identifi ed as a TGF-
beta/SMAD target, is upregulated in the most aggressive melanoma cell lines, and 
promotes melanoma migration and invasion by controlling a mesenchymal transition 
characterized by loss of expression of E-cadherin and increased MMP secretion. GLI2 
expression is heterogeneous within human melanoma lesions, associates with tumor 
regions in which E-cadherin is lost, and is increased in the most aggressive tumors 
when compared to less aggressive tumors. Further, GLI2 knockdown in melanoma 
cells that express high levels of GLI2 signifi cantly inhibits the development of 
experimental bone metastases in mice. Together, our data provide functional evidence 
for a direct role for GLI2 in driving melanoma invasion and metastasis, and suggest 
that high GLI2 expression in tumors may be a marker for melanoma metastasis.
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Functional melanocortin 1 receptors are located in the melanosome of pigment cells
Jackson CL1, Singh S2, Robinson SJ1, Kumar P1, Page AM1, Friedmann PS1, Tobin DJ2, 
Healy E1 1University of Southampton, UK 2University of Bradford, UK
The melanocortin 1 receptor (MC1R) is a 7-pass transmembrane receptor which determines the 
amount and type of melanin synthesised by pigment cells.  Genetic alterations at the MC1R/Mc1r 
locus are associated with phenotypic variations in pigmentation in birds and animals and with 
hair colour/skin type in humans.  It has been known for a long time that MC1R is present at the 
cell surface and the established view is that activation of MC1R at that site results in intracellular 
signalling which directs the production of melanin within the melanosome.  We have previously 
noted colocalisation of MC1R with melanosomal markers on confocal microscopy of amelanotic 
B16G4F melanoma cells transfected with human MC1R, an observation which raised the question 
of whether MC1R is present in the melanosome.  Here we have investigated for the presence of 
melanosomal MC1R, and have transfected pigmented B16F10 melanoma cells with human MC1R 
tagged with eGFP.  In addition to MC1R colocalising with tyrosinase-related protein 1 along the 
dendrites following culture with IBMX, confocal microscopy demonstrated the presence of MC1R in 
pigmented melanosomes isolated from these cells by sucrose density centrifugation.  Immunogold 
electron microscopy using an anti-MC1R antibody, in conjunction with an anti-gp100 antibody, 
identifi ed the presence of MC1R in melanosomes in cultured primary human melanocytes. 
Cultures of melanosomes which had been isolated from FM55 melanoma cells, and separately 
from primary human melanocytes, with alpha-melanocyte stimulating hormone caused an increase 
in melanin within these extracellular melanosomes.  Furthermore, treatment of melanocytes with 
siRNA targeting MC1R prevented this subsequent induction of pigmentation by alpha-melanocyte 
stimulating hormone in melanosomes isolated from these cells, whereas control siRNA did not alter 
melanin synthesis.  The results demonstrate that MC1R is present in the melanosome of melanocytes 
and melanoma cells and that it plays a role in pigmentation through its location at this site.
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15d-PGJ2 (15-deoxy-D12,14-prostaglandin J2) inhibits melanoma progression by 
targeting HSP-90
Paulitschke V1, Gerner C2, Gruber S1, Pehamberger H1 1Dermatology, Vienna, Austria 
2Medicine I, Vienna, Austria
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear 
hormone receptor superfamily. The role of these receptors has originally been 
thought to be restricted to lipid and lipoprotein metabolism, glucose homeostasis 
and cellular differentiation. Recently, evidence is growing that PPARα ligands have 
inhibitory effects on tumor growth by regulating cell proliferation, differentiation 
and apoptosis. To shed light on the potential therapeutic effects on melanoma we 
tested a panel of PPARα (ciglitazone, troglitazone, 15d-PGJ2) agonists on a variety 
of melanoma cell lines (M24met, Mel Juso, A375, 1205LU) in vitro. Whereas most 
of the PPARα agonists showed only moderate effects on melanoma cell proliferation, 
15d-PGJ2 (15-deoxy-D12,14-prostaglandin J2) displayed profound anti tumor 
activity on all cell lines tested. Therefore we selected 15d-PGJ2 as the most potent 
PPARα agonist and further evaluated its anti neoplastic effects. 15d-PGJ2 treatment 
(25µM) exerted a dose dependent induction of the tumor suppressor gene p21, 
induced G1 cell cycle arrest and led to a total inhibition of tumor cell migration in 
a matrigel assay. In addition, 15d-PGJ2 totally abrogated tube formation of HUVECs 
(human umbilical vein endothelial cells) and LECs (lymphatic endothelial cells) at 
a concentration of 50µM, while there was no signifi cant reduction in cell growth 
at this concentration.Shot gun proteome analysis provided further support of these 
observations and revealed that 15d-PGJ2 might exert its effects via downregulation of 
HSP-90 (heat shock protein 90) and other related chaperones. In synopsis, 15d-PGJ2 
potently reduces proliferation, alters cell cycle and diminishes tumor cell migration, 
lymphangiogenesis and angiogenesis in vitro. Effecting all of these key strategies of 
tumor growth with the single compound 15d-PGJ2 suggests high therapeutic effi ciency.
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4-Methylumbelliferone inhibits hyaluronan synthesis and invasion in melanoma cells
Pasonen-Seppänen S1, Edward M2, Kultti A1, Pyöriä E1, Tammi M1, Tammi R1 1University 
of Kuopio, Finland  2University of Glasgow, Glasgow, UK
Malignant melanoma is one of the most deadly human cancers. The molecular mechanisms 
behind melanoma are not clear, but may involve the extracellular matrix molecule hyaluronan 
and its receptor CD44 in addition to the aberrant expression of RTKs and BRAF mutations. 
Hyaluronan overproduction in many cancers has been shown to enhance tumour cell invasion 
and metastasis leading to a worse clinical prognosis. Experiments with melanoma cells indicate 
that hyaluronan stimulates melanoma cell proliferation and migration, and facilitates invasion.
In this study, conventional submerged melanoma cell (A2058) cultures and 3D–cultures (C8161 
cell line) were utilized to study the infl uence of 4-methylumbelliferone (4-MU). 4-MU is known 
to inhibit hyaluronan synthesis and to retard cancer spreading in experimental animals. 4-MU 
decreased hyaluronan production in A2058 melanoma cell cultures as well as in 3D –cultures, 
as determined with an ELISA-like assay. 4-MU is actively glucuronidated leading to depletion 
of UDP-glucuronic acid pool, the precursor sugar of hyaluronan, thereby reducing hyanuronan 
synthesis for example in breast cancer cells. In line with these results the cellular content of 
UDP-glucuronic acid (UDP-GlcUA), was decreased by 70% after 24h 4-MU treatment in A2058 
melanoma cells. However, 4-MU (1 mM) also downregulated the mRNA levels of hyaluronan 
synthases (Has) in melanoma cells: Has2 was reduced by 90% and Has3 60%, indicating that the 
effect of 4-MU on hyaluronan synthesis is not mediated solely by the depletion of the precursor 
sugar. The effects of 4-MU on A2058 melanoma cell invasion and migration were studied using 
MATRIGEL™ invasion chamber and fi lter (8 µm) assay. The reduction of hyaluronan caused by 
4-MU was associated with a signifi cant inhibition of cell migration and invasion. In addition, the 
proliferation rate of A2058 cells was dose-dependently suppressed by 0.2-1.0 mM concentrations 
of 4-MU.Taken together, these results demonstrate that 4-MU may have potential as an anti-
invasive agent in melanoma, but also appears to be a potent inhibitor of tumour cell growth.
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A functional HERC2 variant is associated independently to pigmentation 
characteristics and melanoma risk in the French population
Soufi r N1, Guedj M2, Descamps V3, Bourillon A1, Dupin N4, Wolkenstein P5, Lebbe 
C6, Basset-Seguin N6, Grandchamp B1 1Hôpital Bichat Claude Bernard 2Prog CIT, Ligue 
Nationale Contre le Cancer 3Dermatologie, Hôpital Bichat Claude Bernard, 4Dermatologie, Hôpital 
Tarnier 5Dermatologie, Hôpital Henri Mondor 6Dermatologie, Hôpital Saint Louis: Paris, France
A functional polymorphism in the intron 86 of HERC2 (rs12913832) has been shown to be strongly associated 
to blue/brown eye color. In this study, we investigated whether this variant was also associated to other 
pigmentation characteristics and melanoma risk.One thousand patients affected by cutaneous melanoma and 
925 ethnic Caucasian controls skin cancer free were genotyped for this HERC2 polymorphism (Infi nium Illumina, 
Bead express). Statistical analysis was performed using the R computer package (version 2.7.1). Conformity of 
genotypes to Hardy-Weinberg equilibrium was tested in controls. The effect of rs12913832 on melanoma risk and 
on pigmentations characteristics (eye color – blue/grey, green/hazel, brown/black -; skin color – light, medium 
versus dark -; skin type - I-II versus III-IV-, nevi count - <50 versus 51-100; hair color – blond, red, brown, black- 
and ephelides - presence versus absence- was assessed using Fisher exact test and Odds Ratios (ORs) calculations. 
Logistic regression was also performed taking into account potential confounders.The SNP rs12913832 was 
strongly associated with eye color (P value = 6.49x10-90, OR 14.14, %95 IC [10.92-18.30]), hair color (P value 
= 1. 10-50), skin color (P value = 2.23. 10-13), skin type (P value = 1.1.10-8), ephelides (P value = 7.88.10-5). 
Interestingly, this SNP was also associated with melanoma risk (P value = 5. 10-4), and this association persisted in 
logistical regression analysis integrating eye color, skin type, hair color, and nevi count (P value < 0.0001, OR= 2.8 
%95 IC [1.96-3.94]).The HERC2 gene lies on chromosome 15q11 upstream OCA2, a gene previously associated to 
human albinism and tightly associated with human eye color. The HERC2 SNP rs12913832 was previously shown 
to be strongly associated to eye color and is localized in a conserved HERC2 regulatory element and has been 
shown to modulate OCA2 expression. Here, we show that in addition to eye color, this SNP is highly associated 
to hair color, skin type and melanoma risk, the latter association persisting in multivariate analysis. This SNP 
therefore adds to the growing list of low penetrant alleles associated to pigmentation and melanoma susceptibility.
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A novel potential therapy for melanoma by HVJ envelope
Kiyohara E1, Tamai K1, Katayama I1, Kaneda Y2 1Graduate School of Medicine, Osaka 
University, Japan 2Division of Gene therapy Science, Osaka University, Japan
Hemagglutinating virus of Japan envelope (HVJ-E), an inactivated Sendai virus 
particle, has been originally developed as a drug delivery vector. Recently, we 
discovered that HVJ-E effi ciently induces variegated anti-tumor immunity including 
dendritic cell maturation, NK cell activation, CTL generation and regulatory T cell 
suppression. We tested the therapeutic potential of HVJ-E in malignant melanoma 
tumor models. HVJ-E was injected three times into intradermal tumor mass derived 
from B16-F10 melanoma in C57BL/6 mice. At 48 h after the third injection, abundant 
infi ltration of CD8+ T cells, CD11c+ dendritic cells and DX5+ NK cells were detected 
in tumor tissues by real-time PCR and immunofl uorescence. On day 7 after the fi nal 
injection, ELLISPOT assay showed that the number of interferon-α-positive colonies 
increased 5 times by HVJ-E compared with that by PBS. Apoptotic cells were detected 
by TUNEL assay in HVJ-E treated tumors. Consequently, signifi cant suppression 
of tumor volume was observed by HVJ-E injection in a dose-dependent manner. 
These data indicated that HVJ-E activated adaptive and innate immune response 
against mouse melanoma. Human melanoma cell line Mewo cells were injected into 
intradermal space of SCID mice. HVJ-E dissolved in PBS was injected into tumors six 
times. Dose-dependent reduction of tumor volume was observed. Mouse survival 
was signifi cantly prolonged by the injection of high-dose HVJ-E. This data indicated 
that HVJ-E also had the anti-tumor effects on human melanoma in SCID mice. Thus, 
HVJ-E is a promising therapeutic tool for malignant melanoma. Clinical grade-HVJ-E 
has been prepared and preclinical safety tests have been done in mice, rats and 
non-human primates. Based on those results, we are going to start phase I/II clinical 
trial to test the safety and effi cacy of HVJ-E in Stage IIIc and IV melanoma patients.




A spectrophotometric method for simple quantifi cation of melanosomal transfer 
from melanocytes to keratinocytes: Combination of a novel co-culture method and 
an «ELISA-like» assay
Kasraee B, Fontao L, Sorg O, Saurat JH Geneva University Hospital, Switzerland
Several methods have been developed to evaluate melanosomal transfer from melanocytes to 
keratinocytes quantitatively. An optimal method should overcome three major diffi culties: (i) the 
long-term maintainance of confl uent co-cultures of melanocyte and keratinocytes to reassure the 
transfer, (ii) reliable separation of both cells and (iii) accurate melanosome quantifi cation in separated 
cells. The existing methods are either based on the evaluation of  keratinocyte phagocytotic activity 
in keratinocyte mono-cultures, or involve complicated methods such as fl ow-cytometry for both 
cell separation and melanosome determination after conventional co-cultures maintained no more 
than a few days.In our new approach, melanocytes (B16) and keratinocytes (BDVII) are cultured 
on opposite sides of a polyester porous membrane (Millipore; membrane thickness: 10 µm; pore 
diameter: 1 µm). Electron microscopic analysis showed that melanocytes, cultured on the bottom 
surface of the membrane, get in direct contact with keratinocytes, cultured on the upper surface 
of the same membrane, through their dendrites passing via the pores to accomplish melanosomal 
transfer. In this system, cells can be maintained in co-culture for two weeks. Simple trypsinisation is 
suffi cient to obtain pure populations of each cell. For melanosome quantifi cation in separated cells, 
we compared the fl ow-cytometric assay with a new ELISA-like method. In both methods, the specifi c 
melanosomal protein Rab-27 served as the detectable antigen. The ELISA-like assay, performed 
on paraformaldehyde fi xed cells, proved to be a highly specifi c and sensitive assay, showing 
comparable results with the fl ow cytometric method.Both methods permitted accurate and specifi c 
melanosome quantifi cation in melanocytes and keratinocytes. Our trans-membrane melanosome 
transfer system together with our simple melanosome determination assay represent, to the best of 
our knowledge,  the fi rst spectrophotometric method to evaluate melanosomal transfer quantitatively.
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An interplay between TGF-beta and PKA signaling inversely regulates the 
melanogenic differentiation program in melanoma cells
Pierrat MJ, Alexaki VI, Mauviel A, Javelaud D INSERM U697, Paris, France
The melanocyte-specifi c transcription factor M-MITF is involved in all aspects of 
melanoblast lineage biology including differentiation, survival and proliferation. In this 
study, we demonstrate that expression of M-MITF in human melanoma cell lines in culture 
is highly variable and always inversely correlated with that of GLI2, a Hedgehog mediator 
identifi ed as a TGF-beta/Smad target. The latter is critical for melanoma progression and 
metastasis. We demonstrate that the balance between M-MITF and GLI2 expression is 
controlled by two distinct pathways: the TGF-beta/Smad pathway favors GLI2 expression, 
while the protein kinase A (PKA)/cAMP pathway pushes the balance towards high M-MITF 
expression. Remarkably, despite reduced M-MITF levels, GLI2-expressing melanoma cells 
maintain signifi cant expression of the proliferative factors CDK2 and CDK4. In cell lines 
expressing M-MITF at high levels, expression of M-MITF and its gene targets involved in 
melanogenesis, TYR, TRP-1, DCT/TRP-2, was repressed after exogenous TGF-beta treatment 
and by overexpression of a constitutively active mutant form of TGF-beta receptor type I 
(TbetaR1) or that of a constitutively active mutant form of GLI2 induced a strong reduction in 
M-MITF and TYR promoter activity, as determined in transient cell transfection experiments. 
This effect was accompanied with a marked downregulation of protein kinase A activity and 
decreased melanin production by melanoma cells. Inversely, the TbetaRI inhibitor SB431542 
increased M-MITF expression. Remarkably, TGF-beta enhanced, while SB431542 inhibited, 
melanoma cell invasion into Matrigel™. Taken together, our data suggest an interplay 
between TGF-beta and PKA signaling in the regulation of the melanogenic differentiation 
program in melanoma cells, and that an imbalance in favor of TGF-beta results in 
increased invasive capacities of melanoma cells, associated with loss of pigmentation.
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Detection of a rare CDKN2A intronic mutation in a Hungarian melanoma prone 
family and its role in splicing regulation
Balogh K1, Széll M2, Pagani F3, Kemény L1, Oláh J1 1University of Szeged, Hungary 
2Dermatological Research Group of the Hungarian Academy of Sciences, Szeged, 
Hungary 3International Center for Genetic Engineering & Biotechnology, Trieste, 
Italy
Epidemiologic data suggest an increasing incidence of malignant melanoma thus 
the importance of identifying risk factors is growing. Approximately 10% of all 
melanoma cases are familial and in some of  these cases mutations of the cell cycle 
regulator cyclin-dependent kinase inhibitor 2A (CDKN2A) gene can be detetced. 
Recently, we have identifi ed a CDKN2A intronic mutation (IVS1+37 G/C) in a 
Hungarian melanoma prone family. The aim of our work is to fi nd out whether the 
detected intronic mutation has any effect on CDKN2A mRNA splicing regulation 
and whether it has a pathogenetic role in melanoma susceptibility. In order to prove 
our hypothesis we created a CDKN2A minigene which enables us to study in vitro 
the effects of the IVS1+37 G/C mutation on mRNA splicing. CDKN2A minigenes 
containing the wild type and the mutant intronic sequence were transfected to 
HeLa cells and we studied the mRNA transcripts of the minigene by RT-PCR. Our 
preliminary data showed that the mRNA transcribed from the minigene containing 
the IVS1+37 G/C mutation is different from that of the wild type which indicates 
that the mutation has an effect on splicing regulation. Thus we suggest that the 
aberrant transcript might have a role in the pathogenesis of familial melanoma.
232
Development of a Pigmented Human 3-dimensional Epidermis Model Integrating 
Human Primary Melanocytes
Becker B, Hopf S, Engelking O, Fuchs HW Cellsystems Biotechnologie Vertrieb 
GmbH, St. Katharinen, Germany
Novel cosmetics for skin tanning or bleaching are an important issue for cosmetic 
and chemical industry. The active ingredients used in these products have to be tested 
for effi cacy and product safety. The aim of this study was to create a 3-dimensional 
epidermis model harbouring melanocytes at the basal cell layer, their physiological 
localisation. Based on the technology of the epidermal skin test (EST-1000) we 
tested different ratios of melanocytes and keratinocytes for the production of the 
skin models. For testing effects on skin pigmentation an important feature of that 
epidermis models is the feasibility of cultivating the models for at least ten days 
without loss of viability. As endpoint analyses we determined the physiological 
behaviour of the melanocytes by analysing the melanin content. The vitality was 
assessed by standard MTT-test. We addressed the localisation of the melanocytes by 
immunohistochemistry using the HMB45 antibody. We could demonstrate a constant 
high viability for about 23 days of culture. High melanin content is displayed at 
an optimum ratio of melanocytes and keratinocytes. The immunohistochemical 
analyses showed the localisation of melanocytes in the basal cell layer.
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Effect of DNA repair host factors on temozolomide or dacarbazine melanoma 
treatment in Caucasians
Boeckmann L1, Schirmer M1, Rosenberger A1, Thoms KM1, Gutzmer R2, Kunz M4, 
Kuschal C1, Brockmöller J1, Emmert S1 1Georg-August-University Goettingen, 
Goettingen, Germany 2Hannover Medical School, Hannover, Germany 3University of 
Freiburg, Freiburg, Germany 4University of Rostock, Rostock, Germany
The effi cacy of temozolomide (TMZ) or dacarbazine (DTIC) in melanoma treatment 
depends on low O6-methylguanine-DNA-methyltranferase (MGMT) repair and 
on high mismatch repair (MMR). Our aim was to identify individual host markers 
for hematologic side effects and treatment effi cacy of TMZ or DTIC in melanoma 
treatment. Fifty-one Caucasian patients with metastasized melanoma were recruited. 
In each patient, the mRNA expression of MGMT and two essential MMR genes, MLH1 
and MSH2, was measured in peripheral blood. The coding gene regions including 
splice sites were sequenced to identify genetic variants and the promoter methylation 
status of the genes was determined. Either constitutively low or high mRNA expression 
of MGMT, MLH1, and MSH2 was signifi cantly associated with reduced hematologic 
side effects (p=0.008-0.020), but did not correlate with treatment effi cacy. We 
identifi ed 5 variants in the MGMT gene, 13 variants in MLH1, and 7 variants in MSH2, 
including 5 novel genetic variants in MLH1. Variations of the hosts’ gene expression 
of MGMT, MLH1, and MSH2 did not result from promoter methylation. Of note, one 
variant in MSH2 (rs2303428) was associated with increased hematologic side effects 
(p=0.017) and showed a tendency for better treatment response (p=0.071). Our 
results indicate that either low or high host expression of MGMT, MLH1, and MSH2 
may serve as a marker for reduced hematologic side effects of TMZ or DTIC but not 
for treatment effi cacy in melanoma. The genetic variant rs2303428 (MSH2) might 
serve as a predictive marker for hematologic side effects and treatment response.
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Enhancing PAR2 receptor expression modulates skin pigmentation
Bonnans M1, Labarrade F1, Plaza C1, Botto JM1, Gondran C1, Portolan F1, Garcia 
N1, Dal Farra C2, Domloge N1 1ISP Vincience Global Skin Research Center, Sophia-
Antipolis, France 2ISP  Corporate Research Center, Wayne, USA
Protease-activated receptor-2 (PAR2) belongs to the large superfamily of G-protein-coupled receptors, 
is implicated in melanosome transfer, and can thus modulate cutaneous pigmentation.In this domain, 
we used IV08.006, a designed molecule to act selectively on PAR2 receptor, and tested its ability to 
modulate skin pigmentation. Through immunofl uorescence (IF) staining of the PAR2 receptor, we 
observed an increase in PAR2 expression in NHK treated with 1% of IV08.006 for 48 hours. This 
result was confi rmed by Western blot.The effect of PAR2 modulation on melanosome uptake was 
evaluated by looking at fl uorescent microsphere ingestion by NHK. For this purpose, NHK were 
pretreated, or not, with the PAR2-inducing agent for 48 h. Fluorescent microspheres were added to 
the culture medium for the last 16 hours. Fluorescence observation and quantifi cation were then 
performed, and showed that microsphere ingestion was signifi cantly increased in NHK where PAR2 
was up-regulated.As this activity has been previously linked with actin cytoskeleton reorganization, 
we performed actin staining on NHK. This study showed cytoskeletal modifi cations in PAR2-
induced NHK, in association with extended membrane protrusions. This observation corroborated 
the phagocytosis mechanism implicated in the ingestion of melanosomes by keratinocytes. 
Furthermore, we investigated the effect of the association of IV08.006 with a previously described 
tanning compound on skin pigmentation. IF studies on normal human ex vivo skin showed that 
PAR2 is similarly up-regulated in skin samples treated with the PAR2 enhancer. Melanin intensity 
was revealed by Fontana-Masson staining of human skin sections, after 48 hours of treatment. 
The association of the two compounds enhanced skin pigmentation to a greater extent, compared 
to the effect observed with the tanning compound alone. In conclusion, these studies show that 
enhancing melanin transfer by PAR2 activation can be a useful approach to boosting skin tanning.
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Evaluation of Ethosomes for Delivery of siRNA into Cultured Primary Melanocytes 
and Skin
Geusens B1, Braat S1, Stuart M2, De Smedt S3, Sanders N3, Prow T4, Roberts M4, 
Lambert J1, Van Gele M1 1Ghent University Hospital, Ghent, Belgium 2University of 
Groningen, Groningen, Netherlands 3Ghent University, Ghent, Belgium 4University 
of Queensland, Woolloongabba, Australia
The skin is an important route for drug delivery as it allows non-invasive application 
of therapeutics for systemic as well as for local treatment. However, the very 
effi cient barrier properties of the skin, exerted by the stratum corneum, impede 
the penetration of topically administrated therapeutics in the skin. Our aim is to 
develop a system that can deliver siRNA into cells present in the human epidermis. 
More specifi cally, we wanted to block the expression of a specifi c Myosin Va 
exon F-containing isoform that is involved in melanosome transport in human 
melanocytes. By knocking down this isoform, we might be able to treat various 
forms of hyperpigmentation. Interestingly, some carrier systems such as ethosomes 
enhance the delivery of drugs or macromolecules to the skin. However, ethosomes 
have never been described as siRNA delivery systems. Therefore, we synthesized and 
characterized (particle size, surface charge, deformability) a new type of ethosomes, 
complexed them with siRNA to make ethosomes/siRNA complexes or ethoplexes, 
and investigated the effi ciency of this formulation as a siRNA delivery system in 
vitro on cultured primary human epidermal melanocytes. Results show that the 
ethoplexes are highly deformable, effi ciently deliver siRNA into primary melanocytes 
and maintain their stability for at least 3 weeks. Their penetration capacities through 
human skin are currently being evaluated by means of multiphoton microscopy.
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Germline mutational analysis of melanoma predisposing genes in an 
immunocompromised patient with multiple primary melanomas
Hatvani Z, Somlai B, Blazsek A, Szakonyi J, Hársing J, Bottlik G, Török S, Kárpáti S
Semmelweis University, Budapest, Hungary
Atypical nevi, environmental factors and genetic alterations are well known 
melanoma predisposing factors. Additionally immunosuppressive regimens might 
represent as independent risk factor with a signifi cant impact on the development 
of pigmented lesions and malignant melanoma (MM). A skin type I, blue eyed 
woman with skin signs of chronic sun damage developed multiple cutaneous MMs 
following a 3-7 year long combined immunosuppression and died in the 8th year of 
that due to multiplex metastases. In order to gain information about possible genetic 
background responsible for the extremely rare clinical picture we have performed 
mutational analysis in the melanoma predisposing gene CDKN2A and the genes 
PTEN, MC1R known to  contribute to MM formation in other ways.After isolation 
of DNA from peripheral lymphocytes, the entire coding region of PTEN, MC1R 
and CDKN2A , except CDKN2A exon 4, but including the CDKN2A deep intronic 
segments known to carry functional mutations, were amplifi ed by polymerase chain 
reaction (PCR), and were automatically sequenced.We did not fi nd any germline 
mutations neither polymorphisms in any of these sequences, that could have been 
related to the multiplex malignancies. Although immunosuppressed patients are at 
increased risk of secondary malignancies, multiple primary melanomas (MPMs) are 
rarely seen even in this subpopulation. While it is well known that genetic factors, 
epigenetic events and somatic mutations as well as acute and chronic sun damage 
could contribute to melanoma development, our clinical data further support the 
hypothesis that immunosuppression might have a major impact on MPM initiation.
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Glycyrrhetinic Acid: A Novel Modulator of Human Skin Pigmentation and DNA-
Repair
Hong M, Mahns A, Batzer J, Mann T, Gerwat W, Scherner C, Stäb F, Wolber R, Kolbe 
L Beiersdorf AG, Hamburg, Germany
Licorice extract is known for its broad spectrum of effects. Single active compounds, 
such as Licocalcone A and Glabridin can be addressed for its anti-infl ammatory and 
anti-oxidative or whitening effects, respectively. Glycyrrhizic acid is a compound 
of licorice extract that has previously been described to increase melanogenesis 
in B16 mouse melanocytes whereas its metabolite Glycyrrhetinic acid had no 
effect on melanogenesis. The purpose of this study was to investigate the effect 
of Glycyrrhetinic acid on human skin pigmentation, a compound that is only 
known to have anti-infl ammatory properties. We investigated both, the formation 
of melanin and the activity of Tyrosinase, the key-enzyme in melanin production. 
Here we demonstrate that Glycyrrhetinic acid increases melanogenesis in human 
primary melanocytes as well as in human skin. In human primary melanocytes 
the melanin content almost doubles within four days following Glycyrrhetinic 
acid treatment and the application of a formulation with 0.1% Glycyrrhetinic 
acid twice daily for two weeks increases Tyrosinase-activity signifi cantly in vivo. 
Furthermore, we demonstrate for the fi rst time to the best of our knowledge that the 
treatment with Glycyrrhetinic acid enhances the repair of UV-induced cyclobutane 
pyrimidine dimers in vivo signifi cantly. More precisely, Glycyrrhetinic acid treatment 
results in 50% less cyclobutane pyrimidine dimers 24 hours after UV-irradiation 
compared to vehicle treated control. In conclusion we show that Glycyrrhetinic 
acid increases not only melanogenesis but also exerts a UV-protective role as 
demonstrated with a signifi cantly enhanced repair of cyclobutane pyrimidine dimers.
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IL-1RA inhibits tumor growth and metastasis of melanoma. Molecular 
characterization of the underlying mechanisms
Zigrino P, Zamek J, Mauch C 1University of Cologne, Germany 2University of Virginia, 
Charlottesville, USA
Tumor invasion and metastasis of malignant melanoma requires both cell-cell and cell-
matrix interactions within the host tissue in order to activate cytokines and growth factors 
that directly or indirectly promote tumor growth and survival. Furthermore, proteolytic 
degradation of the extracellular environment plays also an important role in these processes 
and is achieved primarily by enzymes of the matrix metalloproteinases (MMP) family. 
We have previously shown, that increased enzyme activity is localized at the border of 
tumor cells and the adjacent peritumoral connective tissue emphasizing the crucial role of 
tumor-stroma interactions in the regulation of MMP activity. In addition, in vitro expression 
profi ling revealed a signifi cantly increased production of several soluble factors such as 
RANTES, MCP-1, ENA-78 next to IL-1a and bFGF, by invasive melanoma cells. To abrogate 
the enhanced signaling induced in tumor and stromal cells by the increased release of 
IL-1 by melanoma cells we treated BLM-tumors grafted in nude mice with recombinant 
IL-1RA and followed tumor growth and metastasis over time. We detected a signifi cant, 
by 30%, reduced tumor volume and decreased metastasis with 23,5 vs. 93 % to lymph 
nodes and 35,3 vs. 80% to the lungs in treated vs. untreated control animals. Histologically 
the tumors showed differences in tumor vascularization. Measurement of CD31 and LYVE-
stained vessels confi rmed that density of blood and lymphatic vessels was decreased in IL-
1RA-treated tumors. Whereas no differences in neutrophils and lymphocytes infi ltrates were 
observed in IL-1RA-treated versus untreated controls, a decreased macrophage infl ux into 
the tumor site was observed upon treatment. In conclusion, we identifi ed IL-1 as one key 
molecule activating stroma cells and thereby facilitating tumor growth and metastasis and, 
most importantly, that tumor invasion and metastasis can be inhibited by IL-1RA treatment. 
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Immunohistochemical markers as prognostic factors in primary cutaneous malignant 
melanoma
Emri G1, Várvölgyi T1, Bégány Á1, Hargitay Z2, Tóth L1, Emri E1, Remenyik É1 1University 
of Debrecen, Debrecen, Hungary 2Kenézy Hospital, Debrecen, Hungary
The aim of this pilot study was to investigate the predictive value of different 
immunohistochemical markers in cutaneous malignant melanoma (MM) whith a 
Breslow tumor thickness less than 2.00 mm. We examined Ki67, bcl-2, p53 and 
metallothionein (MT) expression by means of the Streptavidin-biotin peroxidase 
complex method on formalin fi xed and paraffi n-embedded tissue samples of MM 
removed at our department between 1990 and 2006 (T1-2, n=39). The average 
Breslow tumour thickness, localization, histological type, Clark level of the tumours 
or the average age of the patients were not signifi cantly different (p>0.05) between 
MM with different metastatic potency. We did not fi nd remarkable expression of p53 
and bcl-2 proteins in the primary tumours examined. Although the level of Ki67 
expression was higher in MM showing haematogenous spreading, the difference was 
not statistically signifi cant. The expression of MT was signifi cantly higher (p<0.0001) 
in tumours with haematogenic metastasis compared to MM with no metastasis 
or with lymphogenic metastasis only. The MT overexpression was associated 
with the presence of more Ki67 positive cells. This study supports the prognostic 
relevance of MT expression in cutaneous melanoma for haematogenic progression.
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Implication of c-kit gene in genetic predisposition of melanoma
Bourillon A1, Lacapere JJ2, Descamps V3, Lebbe C4, Basset-Seguin N4, Saiag P5, 
Grandchamp B1, Soufi r N1 1Laboratoire de Biochimie Hormonale et Génétique, 
Hôpital Bichat Claude Bernard, APHP; IFR02, Univers, Paris, France 2EA3516, Faculté 
de Médecine Paris VII, Bichat- Claude Bernard, Paris 7, Paris, France 3Dermatologie, 
Hôpital Bichat Claude Bernard, Université Paris 7, Paris, France 4Dermatologie, 
Hôpital Saint Louis, Université Paris 7, Paris, France 5Dermatologie, Hôpital Ambroise 
Paré, Université Paris Ouest, Boulogne Billancourt, France
KIT, receptor of SCF, is a kinase protein which plays a role in differentiation and migration of 
melanocytes. Activation germline mutations of gene predispose for tumor process as cutaneous 
mastocystosis or gastrointestinal stromal tumor. Loss-of-function constitutional mutations are 
responsible for piebaldism. The hypothesis of this work was that rare variants were implicated in 
predisposition of melanoma. We have sequenced all exons and adjacent junction introns–exons 
in 143 melanoma cases with familial history and/or multiple melanoma cases, without mutation 
in major genes, and 189 Caucasian controls. Founded missens variants were analysed in silico 
with Sift, Polyphen, Panther, SNPs3D sites and Pymol software. Synonym and intronic variants 
were analysed with SSF (Splicing sequences fi nder) sites in order to eventually determinate modi-
fi cation of splice. All functional missens variants predicted were compared in two populations 
with exact Fisher test.Ten new missens variants were found: fi ve in cases population and fi ve in 
control population. Variants were localised in extracellular , transmembranar and kinase domains. 
In cases, whole of variants were deleterious predicted in silico by at least two prediction sites, 
versus none observed variants in control population (Fisher exact test =0.01). These results were 
consolidated by effect study with Pymol software. These preliminary results suggest a role of c-kit 
missense variant in multifactor predisposition of melanoma. Functional complementary studies 
are necessary. They might cause activation function promoting a proliferation of melanocytes as in 
some melanoma. A loss of function might cause trouble in differentiation of melanocytes promot-
ing transformation of cell.





Molecular and functional characterisation of acrolentiginous and mucosal 
melanomas
Schönewolf NL, Zipser MC, Hoek KS, French LE, Dummer R University Hospital 
Zurich, Dermatology, Switzerland
Genetically acrolentiginous and mucosal melanoma are similar, including specifi c mutations 
and overexpression of cKIT; its product KIT is one target of kinase inhibitors such as Imatinib. 
On a transcriptional level, melanoma cell cultures demonstrate two opposing growth profi les, 
proliferative and invasive that translates into specifi c migration patterns in matrigel. We have 
established 30 cell cultures from 24 acrolentiginous and 6 mucosal melanomas, nine taken 
from primaries, 21 from metastases. Paraffi n embedded material of 40 primaries, 38 metastases, 
altogether 26 matching pairs were collected. Until now, KIT expression in nine primary tumours, 
eight from the foot sole, one from the hand, and seven corresponding metastases was studied 
by immunohistochemistry. Metastases originated from two distant, four in-transit and one lymph 
node metastases. Mutational status of KIT as well as BRAF was identifi ed for nine cell cultures 
by PCR and sequencing. Eight cell cultures were characterised, utilising matrigel, as previously 
established in our laboratory. After incubation of the cells on matrigel, proliferative or invasive 
phenotypes were distinguished.For one primary tumour out of seven, KIT staining was positive (+1), 
the corresponding metastasis was negative. A heterogenous and broad KIT staining was detected in 
in-transit-metastases (+4), especially at the tumour borders. Matrigel analysis revealed the invasive 
phenotype as the dominating cell signature (7 out of 8). The mutation at V600E for BRAF was 
found for three cell cultures. cKIT mutations of Exon 11 were not detected in any cell culture. 
Immunreactivity for c Kit showed variable expression intensity with pronounced expression in the 
peripheral tumor cell formations suggesting regulation by the microenvironment. Interestingly, 
only BRAF mutations were found, and no activating cKIT mutations for exons 9, 11, 13 and 17. 
Integrative analysis of genetic, transcriptional and functional features will result in a rational 
concept for the successful use of targeted therapies using kinase inhibitors in advanced melanoma. 
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Molecular events mediating ADAM9 regulation in melanoma cells by interleukin-
1alpha
Schönefuß A, Seyfarth B, Zigrino P, Mauch C University of Cologne, Germany
ADAM9 belongs to the family of the adamalysin proteases and contains a metal-
loprotease as well as a disintegrin domain, providing sheddase and adhesive activity 
of the protein. Increased expression of ADAM9 has been shown in several cancers 
including pancreatic carcinoma, breast cancer and in melanoma. In melanoma 
metastasis, ADAM-9 seems to be very little expressed whereas in malignant mela-
noma, ADAM-9 expression is localized more in the invading parts of the tumor, in 
the tumor cells and in the surrounding fi broblastic cells. In previous investigations, 
we have identifi ed interleukin-1alpha, a proinfl ammatory cytokine as a regulator 
of ADAM-9 synthesis.In this study we have investigated the molecular mechanisms 
by which ADAM9 is regulated by interleukin-1alpha in malignant melanoma cells. 
Stimulation of the high invasive melanoma cell line BLM with 10U/ml interleukin-1-
alpha resulted in down-regulation of ADAM-9 expression not only at transcriptional 
level but also on post-transcriptional level as determined by analysis of protein 
expression. On the contrary stable down-regulation of interleukin-1alpha by shRNA 
in BLM cells, which did not alter cell proliferation, lead to up-regulation of both, 
ADAM-9 transcript and protein level. Using a pharmacological approach, we have 
further investigated which intracellular pathway is involved in interleukin-1alpha-
mediated ADAM-9 regulation. Stimulation of melanoma cells with interleukin-1-
alpha in the presence of specifi c JNK or NFκB activity inhibitors lead to ADAM-9 
down-regulation in the presence of blockers for the NFκB complex, but not when 
inhibitors of JNK activity were present. These results indicate that interleukin-1alpha 
as the factor regulating the constitutive expression of ADAM-9 in malignant BLM 
melanoma cells and that down-regulation of ADAM-9 induced by increasing the 
interleukin-1alpha concentration in cellular supernatants is mediated by JNK.
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Multiparametric assay of angiogenesis and invasion gene expression in archival 
paraffi n-embedded tissues of melanoma
Lebbe C, Guedj M, Basset-Seguin N, Bougatef F, Verola O, Podgorniak M, Calvo F, 
Janin A, Mourah S Hôpital Saint-Louis, Paris, France
In a recent study we showed a signifi cant association between the presence of a micrometastasis 
and the expression of VEGF 121 and PAI1 in the sentinel lymph node. To extent these fi ndings 
to a wider biomarkers panel and a more important sample of tumors, we have developed a 
reliable and reproducible quantifi cation assay of these biomarkers in archival paraffi n-embedded 
tissues.Formalin-fi xed and paraffi n-embedded tissue specimens or frozen for the same tumor 
sections were available for 30 patients referred to our department with primary melanoma n=9, 
cutaneous metastasis n=5, lymph node metastasis n=16. The expression of 25 genes involved in 
angiogenesis and invasion was studied: VEGF isoforms, VEGF receptors, PDGF A and B, PDGF 
receptors, uPA, PAI-1, MMP1, 2, 9 and14, MMP inhibitors and inducer EMMPRIN, transcription 
factors HIF1a, PROX-1. After RNA extraction and quantifi cation by Ribogreen assay and Agilent 
capillary electrophoresis, the cDNA were synthesized. Quantitative RT-PCR were then performed 
on a lightCycler using sets of TaqMan®/probes and primers all designed for amplicons length less 
than 200 bp. Expression profi les normalization was based on six reference genes to correct for 
differences arising from variability in RNA quality and total quantity of RNA in each assay referred 
to the Cronin work (2004). Correlation of gene expression analyses was done using Person linear 
correlation. The adjusted Pearson correlation between paraffi n and frozen tissue for each gene 
assessed on the whole population was 0.88 p<0.0001. There was also a good correlation on an 
individual basis when the whole panel of genes was considered for 21/25 samples (p<0.05). This 
type of methodology allowed us to validate the quantifi cation of mRNA in FFPE samples for a panel 
of 25 genes involved in angiogenesis and invasion in more than 80% of samples tested and could 
allow us to discriminate informative samples through assessment of reference genes.
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New therapeutic attemps to improve survival in metastatic melanoma patients
Minutilli E Catholic University of Sacred Heart, Rome, Italy
To increase rates of recurrence-free-survival (RFS) and particularly overall survival (OS) 
in patients with stage III-IV melanoma compared to different post-surgical adjuvant 
treatments.  Patients with stage III melanoma are treated with s.c. pegylated interferon-
alpha (PEG-IFN-alpha = 3-6 μg/kg once weekly) for more than one year, while patients 
with stage IV melanoma with PEG-IFN-alpha (1-3 μg/kg/wk) plus oral temozolomide 
(TMZ = 100-200 mg/m2 per days 1-5 monthly) for some cycles with acceptable 
toxicity. The extent of sentinel node (SN) metastasis and visceral involvement is 
correlated with response rates to post-surgical adjuvant therapies respectively in stage 
III and IV melanoma. Patients with stage III-N1 (microscopic nodal involvement) 
take advantages of the high-dose PEG-IFN-alpha therapy in terms of RFS rather than 
OS, unlike patients with stage III-N2 (clinical nodal involvement), particularly in 
presence of signifi cant SN immune reaction. Patients with stage IVA (non-sentinel 
nodes involvement) take advantages of the biochemotherapy in terms of OS more 
than patients with stage IVB (visceral involvement).Higher doses of PEG-IFN-alpha 
(3-4 μg/kg twice weekly) in stage III-N1 and new chemoimmunotherapy protocols in 
stage III-N2 and IVA, eventually associated with tailored multitarget tyrosine kinase 
inhibitors (MTKIs), could further improve RFS and OS in selected melanoma patients.
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NFAT signalling in metastatic melanoma: a novel target for oncogenic B-RAF
Reynolds N, Flockhart R, Armstrong J, Lovat P Newcastle University, Newcastle upon 
Tyne, United Kingdom
Activating mutations in the BRAF gene are present in >70% of all melanomas 
and play a role in proliferation, migration, apoptosis and tumourogenesis but the 
mechanisms by which B-RAF signalling promotes melanoma development and/or 
progression to metastatic disease are not well understood. Deregulated or abnormal 
expression of the calcineurin-regulated transcription factor NFAT has been reported 
in a number of malignancies and we have recently shown that NFAT is preferentially 
activated by carcinogenic UVB radiation in keratinocytes.  We tested the hypothesis 
that NFAT may be a downstream target of oncogenic BRAF in melanoma and that 
NFAT is involved in regulating COX-2 expression.NFAT2 and 4 were expressed in 
human metastatic melanoma cell lines.  Both basal and inducible transcriptional 
NFAT activity was higher in B-RAF mutated A375 and WM266-4 cells compared 
to B-RAF wild-type CHL-1 cells (n=3, p=<0.001) and was inhibited by cyclosporin. 
Furthermore, in wild-type cells, over-expression of B-RAFV600E (the commonest 
activating mutation) increased NFAT activity which was blocked by the MEK inhibitor 
PD98059.COX-2 is a downstream target of NFAT shown to be partly responsible 
for the pro-carcinogenic role of NFAT in other cancers and in melanoma increased 
expression of COX-2 correlates with disease progression.  Using COX-2 luciferase 
reporter vectors that selectively lacked functional NFAT binding sites, calcineurin 
inhibitors and siRNA-mediated knockdown of NFAT2 and 4, we show NFAT 
is required for COX-2 promoter activation and protein induction in metastatic 
melanoma cells.To the best of our knowledge, these data show for the fi rst time that 
oncogenic B-RAF signalling increases NFAT activity and that NFAT is an important 
upstream regulator of COX-2 in metastatic melanoma. The potential to exploit 
NFAT signalling for therapeutic benefi t therefore warrants further investigation.
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Non-invasive visualization of melanin in the skin using two-photon microscopy
Sakai S1, Sugata K2, Nakagawa N1, Osanai O2, Kitahara T2, Watanabe S3, Takema Y2 
1Kanebo Cosmetics Inc., Odawara, Japan 2Kao Corporation, Haga-gun, Japan 3Teikyo 
University School of Medicine, Tokyo, Japan
Melanin plays important roles in protecting skin from UV damages, and its distribution varies 
in pigmented sites affected by conditions such as melasma and solar lentigo. Understanding 
this distribution is essential for the diagnosis of melanoma, but there are not yet any non-
invasive methods for observing melanin specifi cally. Two-photon microscopy enables non-
invasive visualization of the characteristics of fl uorescence lifetime in skin components. 
We used two-photon microscopy for the specifi c in vivo visualization of melanin in the 
skin. A human 3D skin model containing melanocytes was used for the validation. We 
analyzed the frozen sections using DermaInspect (JenLab, Jena, Germany). Excitation 
wavelength was 760 nm. Lifetime components T1 and T2 and corresponding amplitude 
a1 and a2 on each pixel were calculated using a bi-exponential fi tting. FLIM (Fluorescence 
lifetime imaging) was generated using these parameters. These sections were stained by the 
Masson-Fontana method to identify melanin. We also examined the 3D skin model, skin 
after UV irradiation and solar lentigo in vivo. Melanin in the frozen section had a very short 
lifetime (T1) and the amplitude of component (a1) was high. High-resolution images of 
melanin were obtained using a parameter, a1/a2 ratio. Melanin specifi c imaging was also 
confi rmed using an in vivo 3D skin model with other internal fl uorescence components 
like NADP(H) and FAD. FLIM demonstrated melanin signals in only the epidermal basal 
cells (high a1/a2) in the inner arm. After UV irradiation, basal cells containing melanin 
increased and melanin signals were detectable in the granular layer time-dependently. 
FLIM was able to demonstrate the individual variation of vertical melanin distribution in 
the epidermis of solar lentigo.FLIM using two-photon microscopy enables non-invasive 
specifi c observations of melanin in the skin, and is useful in diagnosing hyper-pigmentation.
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N-Propionyl-Cysteaminylphenol Suppresses Re-Challenge of Mouse B16F1 Tumor 
by Inducing Tumor-Specifi c Immune Response
Osai Y1, Tamura Y2, Sato N2, Wakamatsu K3, Honda H6, Okura M7, Yamashita T7, 
Jimbow K7 1Department of Dermatology, Sapporo Medical University, Sapporo, Japan 
2Department of 1st Pathology, Sapporo Medical University, 1, Japan 3Department of 
Chemistry, Fujita Health University, Toyoake, Japan 4Department of Chemistry, Fujita 
Health University, 4, Japan 5Department of Chemical Engineering, Kyushu University, 
Fukuoka, Japan 6Department of Biotechnology, Nagoya University, Nagoya, Japan 
7Department of Dermatology, Sapporo Medical University, 1, Japan
We have previously shown that N-propionyl-cysteaminylphenol (NPrCAP) is a good substrate 
for tyrosinase, selectively incorporated into melanoma tissues, and inhibits the growth of 
melanoma cells. In the present study, we examine whether NPrCAP can suppress transplanted 
re-challenged secondary mouse B16F1 tumors by inducing melanoma-specifi c host immune 
responses. From the 8th day after fi rst, primary transplantation, mice bearing B16F1 melanoma 
received three or fi ve intratumoral administrations of 24.4 mM NPrCAP. On the 14th day after 
NPrCAP administrations commenced, residual tumors were removed and B16F1 or RMA T-cell 
lymphoma cells were respectively re-transplanted on the opposite sides of the fl anks. Results 
indicated that the growth of primary as well as secondary B16F1 tumors was signifi cantly 
suppressed in mice treated with NPrCAP. In contrast, the growth of RMA T-cell lymphoma 
transplanted after the excision of the B16F1 tumor was not affected. In vitro depletion assay 
using anti-CD8 and CD4 mAb showed that CD8, but not CD4 T cells were involved in this anti-
melanoma immune responses. Furthermore, B16F1 cells, when cultured in NPrCAP-containing 
medium, showed evident sub-G1 fraction with an activation of caspase 3. These results suggest 
that NPrCAP has an anti-melanoma growth effect by causing apoptotic cell death that results 
in induction of tumor-specifi c host immunity consisting of CD8+ T cells. Thus, it is proposed 
that NPrCAP may be applicable to the development of a novel melanoma targeted therapy.
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Platelets interact with B16 melanoma cells to augment tumor cell adhesion and 
promote lung metastasis formation
Lonsdorf AS1, Enk AH1, Langer HF2 1University Hospital Heidelberg, Heidelberg, 
Germany 2University  Hospital Tübingen, Tübingen, Germany
Recently, fundamental aspects determining the molecular basis for the reciprocal relationship 
between metastasizing tumor cells and soluble components of the coagulation cascade have 
increasingly become understood. However, the involvement of platelets, the cellular component of 
thrombus formation, in the pathogenesis of cancer metastasis is still poorly comprehended. Here, 
we demonstrate that platelets are an important contributing factor in the early phase of the formation 
of lung metastasis in vivo. As determined by in vivo luciferase bioluminescence imaging and in vitro 
bioluminescence analysis of lung tissue, the depletion of platelets after i.v. inoculation of luciferase-
transduced murine B16 melanoma cells (B16M-luc) into syngeneic C57BL/6 mice resulted in a 
more than 30 % decrease in micrometastasis to the lung. Thus, we hypothesized that platelets may 
be critically involved in the multistep process of tumor metastasis. Evaluating tumor cell rolling 
(parallel-plate fl ow chamber), chemotaxis (wound assay) and migration (transwell chamber) we 
found no signifi cant platelet mediated effect on B16M behavior in vitro. However, we determined 
an up to 50fold augmentation in the adhesion of melanoma cells on immobilized platelets under 
static conditions. Furthermore, platelets substantially mediated an up to 6fold increase in B16 
melanoma cell (B16M) adhesion to endothelial cells under physiological shear stress conditions. The 
observed augmentation in tumor cell adhesion was signifi cantly abolished by blocking monoclonal 
antibodies (mAb) to alphaV integrin, an adhesion molecule highly expressed on 97.8% of B16M. 
Likewise, blocking mAb to GPIIbIIIa, the most abundant platelet adhesion receptor, and the integrin 
blocking peptide RGD both signifi cantly abrogated the observed platelet-mediated increase in B16M 
adhesion.We conclude that platelet-tumor interactions are critically involved in the early  formation 
of metastasis of melanoma cells to the lung and suggest that the specifi c targeting of adhesion 
molecules involved in this process may represent a promising strategy for therapeutic intervention.
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Polymorphisms in glutathione S-transferase and melanoma risk in Japanese 
population
Chiyomaru K, Nagano T, Masaki T, Kunisada M, Nishigori C Kobe University Graduate 
School of Medicine, Kobe, Japan
Members of the glutathione S-transferase (GST) supergene family, which consists of at least 
six gene subfamilies (GSTA, GSTM, GSTP, GSTS, GSTT and GSTZ), are known to utilize 
toxic products produced by ultra violet-induced oxidative stress, mostly by conjugation 
of glutathione to electrophiles but also by other specifi c mechanisms. Genetic variations 
at the GSTM1 loci have been shown to alter the susceptibility to basal cell carcinoma 
(BCC), squamous cell carcinoma (SCC) and malignant melanoma (MM) among patients in 
the United Kingdom. And the additional studies have implicated polymorphisms status of 
GSTM1 and GSTT1 as relevant for the development of non-melanoma skin cancers among 
Caucasian population. However, the genetic backgrounds and skin types are quite different 
between Caucasian and non-Caucasian. To investigate the differences, we analyzed the 
relationship between polymorphisms of GST supergene families and skin cancers in 
Japanese population. The study population was 164 patients with skin cancers and 53 
healthy individuals. The skin cancers included 21 actinic keratoses, 35 BCCs, 25 SCCs, 29 
Bowen’s diseases, 37 MMs and 17 extramammary Paget?Œs diseases. We used a polymerase 
chain reaction based genotyping assay to identify the polymorphisms of GSTM1, GSTP1 and 
GSTT1. To assess the differences of proportions between controls and disease groups, we 
calculated the odds ratios (OR) and the 95% confi dence intervals. Signifi cantly increased 
risk of MM associated with GSTM1 null genotype was observed. The pooled OR was 2.65 
(95%CI 1.09-6.43). The polymorphism at the GSTM1 locus could be an important factor 
in susceptibility to MM at least in Japanese population. Therefore, a better understanding 
of the factors that predispose to the MM will enable to identify causative factors and 
development of prevention strategies, especially identifi cation of high risk group for MM.
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Role of stroma derived ADAM-9 in tumour invasion and metastasis of malignant 
melanoma
Abety A, Zamek J, Mauch C, Zigrino P University Hospital, Köln, Germany
ADAM-9 is a member of the ADAM family (A Disintegrin and Metalloproteinase) and shares 
with the other members of this family a multidomain structure comprising a metalloproteolytic 
and a disintegrin-cystein domain. This protein has been involved in variours shedding 
events, such as that of the FGFRiii2b and of EphB4. However, in addition to the enzymatic 
function this protein mediates adhesive events by binding to integrin receptors. ADAM-9 
is expressed in various cancers and its expression is believed to correlate with disease 
progression. In human melanoma we have previously shown that ADAM-9 is strongly 
expressed at the tumour-stroma border where direct or indirect interactions between tumour 
cells and fi broblasts occur. Using mice lacking ADAM-9 we aimed to investigate the role 
of stroma-derived ADAM-9 in melanoma growth and metastasis. Murine melanoma cells 
injected intradermally in the fl ank of ADAM-9 knock out animals grew signifi cant larger 
than in wild type animals over 12 days. Interestingly, metastasis to different organs was 
similar in knock out and wild type animals being 60% of the lungs in both animals whereas 
60% and 44% of the lymph nodes were positive in the knockout and wild type animals, 
respectively. Analysis of tumour cell proliferation using Ki67 staining showed increased 
proliferation in knock out animals compared to wild type controls. In addition, we observed 
reduced phospho-caspase-3 activity in tumour sections from knock out as compared to 
control animals thus indicating that reduced cell apoptosis paralleled the increased 
proliferation.  In vitro, incubation of B16F1 cells with conditioned media from ADAM-9 
knock out but not control dermal fi broblasts resulted in increased cellular proliferation in 
melanoma cells thus suggesting that a soluble factor-mediated mechanism is responsible 
for the induction of proliferation in melanoma cells. In summary, these results suggest that 
ADAM-9 expression in stromal fi broblasts is important for the growth of melanoma in vivo. 
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Skin whitening and radiance control using orchidaceous extract
Bonte F, Archambault JC, Lazou JH, Cauchard JH LVMH Recherche, St Jean de Braye, 
France
The loss of skin radiance and spots are among the fi rst signs of aging in Asian women Pigmentation 
disorders are due to stress, UV light, or hormonal changes combined with epidermal differentiation 
modifi cations and lower cell turnover due to aging. Many genes are recognised involved in the 
synthesis, maturation, transport, transfer of melanin and in the control of epidermal architectural 
properties which govern skin-light interactions. Normal human melanocytes and keratinocytes 
cultures obtained from biopsies of healthy skin cultivated in K-SFM medium and DNA microarrays 
were used to determine the biological activity of a new natural active ingredient. After incubation 
4 and 24h with Brassocattleya Marcella (orchidaceae) purifi ed stem and leaves extract, total 
RNAs were then extracted by standard methods and the corresponding cDNAs produced by 
reverse transcription. These were then tested on DNA microarrays specifi cally designed for 
human keratinocytes and melanocytes. This active ingredient was then formulated for topical 
application and clinically compared to 3% Vitamin C serum. Formulas were emulsions made 
from C12-20 alkylglycosides, glycolipids, isohexadecane, caprylic/capric triglycerides, glycols 
and hyaluronate.Gene profi les modifi cations of keratinocytes and melanocytes by Brassocattleya 
extract reveal actions on the main genes involved in melanogenesis steps control and radiance. 
On melanocytes, Brassocattleya extract reduced activity of the gene encoding tyrosinase, MC1R, 
AP3B2, SILV, GPR143, VAMP 2, STOML2, and SNAP23. On Keratinocytes, it stimulated the 
gene encoding aquaporins 3 (AQP3), E cadherins, Ki67 but reduced the activity of the K16 and 
calgranulin A genes. The topical formulation containing 3% of this orchid extract was shown 
clinically to be as effective of a 3% Vitamin C (magnesium ascorbyl phosphate) - QD serum 
on skin spots and radiance.  The formula was shown in vivo to reduce defects of cutaneous 
pigmentation, to slow the process of aging and to allow the skin to have optimal optical properties. 




The anti-tumor effects of recombinant human Interferon-α and- on human 
melanoma cells in vitro
Roh M, Chung K, Rha S Yonsei Univ College of Medicine, Seoul, Republic of Korea
The incidence of malignant melanoma has increased at a faster rate than that of any 
other solid tumor due to the limited effi cacy of chemotherapy and immunotherapy 
of metastatic melanoma. Therefore, there has been substantial interest in the 
use of adjuvant therapy in patients with malignant melanoma. Interferons have 
antiproliferative activity against various tumor cells in vitro, and can induce 
differentiation or modulate surface antigen expression of cell. We investigated and 
compared the anti-tumor effect of human interferon-α(HuINF- α) and β (HuINF-β) 
against human malignant melanoma cells. In vitro study revealed that both HuINF- α 
and β not only inhibited proliferation of melanoma cell lines (two cell lines: SK-MEL-2, 
SK-MEL-24) but also induced apoptosis in a dose dependent fashion. However, the 
sensitivity to HuINF- α and β was different among cell lines. In addition, both HuINF- 
α and β is a potent inhibitor of angiogenesis in vitro and suppressed endothelial cell 
differentiation into tubular capillary structures and both HuINF- α and β inhibited 
invasion of melanoma cells in vitro. These results suggests that both HuINF- α 
and β inhibit both proliferative and invasive activity of human melanoma cells. 
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The role of Wnt/-catenin in melanocytes differentiation
Bellei B, Flori E, Maresca V, Picardo M IFO San Gallicano, Rome, Italy
Different pathways modulate the melanogenesis. Main pathway in human melanocytes through which 
signal from the melanocortin system reaches the melanogenesis enzymes tyrosinase, tyrosinase-
related protein-1 and dopachrome tautomerase is cAMP/PKA pathway. Through the activation of 
PKA, cAMP promotes an increase in the expression of microphthalmia-associated transcription 
factor (MITF), the master regulator of pigmentation. Among the pathways involved in the synthesis 
of melanin pigments, the Wnt/β-catenin was recently found to be involved in the development and 
differentiation of melanocytes. Even if MITF is a target for Wnt pathway, at the moment the regulatory 
role of components of Wnt pathway in the control of melanogenesis is not completely understood. 
We used an in vitro model of melanoma cells (B16) and primary human melanocyte differentiation 
to study Wnt/β-catenin-signaling pathway in melanogenesis. We demonstrated that exposure 
of melanocytes to GSK3β inhibitors, as well as specifi c siRNA-GSK3, resulted in stimulation of 
β-catenin accumulation and in a dose-dependent increase of the differentiation-associated markers 
level of melanoma cells such as melanin synthesis, tyrosinase activity and protein expression. In 
addition, treatment of B16 cells with α-MSH or forskolin, two activator of adenylate cyclase, increase 
the transactivation potential of Tcf/Lef-b-catenin complex which was abolished by pre-treatment 
with PKA inhibitor, H-89.  These results demonstrate the existence of a cross talk between the cAMP 
and Wnt/β-catenin pathways in melanocytes suggesting that β-catenin could play a role in cAMP-
induced melanogenesis. Although, the overexpression of β-catenin, is required for melanogenesis 
stimulation by GSK3β inhibition, a simple direct transcriptional control of MITF gene expression due 
to β-catenin-mediated transcriptional activation does not seem to satisfactorily explain the strong 
increase in melanin that is observed suggesting that abrogation of GSK3β activity could increase 
melanin synthesis through mechanisms probably not restricted to Wnt/?-catenin pathway activation.
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The skin depigmenting effect of retinaldehyde and its mechanism of action
Kasraee B, Kaya G, Sorg O, Saurat JH Geneva University Hospital, Switzerland
Melanin homeostasis in the epidermis is principally controlled by the rate of 
melanin production by melanocytes and the rate of melanin loss via keratinocyte 
shedding. Retinoic acid has long been used for several therapeutic purposes, 
including skin depigmentation. In newer approaches, epidermal retinoic acid 
delivery is targeted by the use of retinoic acid precursors such as retinaldehyde 
with better cutaneous tolerability. In this study we investigated the depigmenting 
properties of retinaldehyde using biochemical, genomic and cell biology analyses 
in cell culture models, as well as biochemical, immunohistochemical and electron 
microscopy methods in reconstructed epidermis and animal models.In B16 cultured 
melanocytes the analysis of tyrosinase and peroxidase activities, and gene expression 
by qPCR of melanogenic proteins could not provide a convincing explanation for 
the depigmenting activity of retinaldehyde. Co-cultures of B16 melanocytes and 
BDVII keratinocytes did not show any signifi cant effect on melanosomal transfer. 
In C57BL/6 mouse tail retinaldehyde was twice as effi cient as retinoic acid in 
decreasing epidermal melanin content. In guinea pig ears, quantitative electron 
microscopic analysis revealed a signifi cant reduction in the number of mature 
melanosomes in keratinocytes of retinaldehyde-treated skin, whereas the number 
of mature melanosomes within melanocytes remained close to control. Histological 
and electron microscopic analyses unequivocally confi rmed the skin depigmenting 
effect of retinaldehyde and excluded melanocytotoxicity as its mechanism of action. 
In CD44-/- mice, in which topical retinoids don’t increase the epidermal turnover, 
retinaldehyde failed to reduce epidermal melanin content, unlike to wild-type mice 
with the same genetic background.Taken together, our results favour the hypothesis 
of augmentation of epidermal melanosomal loss as the depigmenting mechanism of
retinaldehyde in mouse skin.
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Thymic Peptides Stimulate Hair Follicle Pigmentation and Protract the Onset of 
Catagen
Langan D1, Meier NT1, Bodo E1, Hilbig H2, Armbruster FP3, Paus R1 1University of 
Lübeck, Lübeck, Germany 2University of Leipzig, Leipzig, Germany 3Immundiagnostik 
AG, Bensheim, Germany
Several studies in rodents have indicated a potential modulatory role for some thymic peptides 
(Prothymosin a1, Thymosin b4 and Thymulin) in skin or hair follicle biology. However, the effects 
of defi ned thymic peptides on human hair growth remains to be studied systematically. Here, we 
have tested the effects of Prothymosin a1 (100 ng/ml and 1000 ng/ml), Thymosin b4 (100 ng/ml 
and 1000 ng/ml) and Thymulin (10 and 100 pg/ml) on key parameters of human hair growth and 
pigmentation in serum-free organ culture of normal human scalp hair follicles. During and after 9 
days of culture the growth kinetics, hair morphology, proliferation, apoptosis and melanisation of the 
treated hair follicles were analyzed. The numbers of hair follicles with a morphology characteristic 
of the anagen stage were increased after treatment with each of the thymic peptides. Despite 
this, treatment with Thymulin and Prothymosin a1, but not Thymosin b4, reduced the hair shaft 
elongation rate. The numbers of proliferating or apoptotic cells in the hair matrix of anagen follicles 
were measured by Ki67/TUNEL double-immunostaining, but were not changed signifi cantly after 
treatment with any of the thymic peptides tested. Interestingly, however, a stimulatory effect on hair 
follicle pigmentation: A signifi cant increase of melanin content as measured by Masson Fontana 
staining could be observed for hair follicles treated with the lower dose of thymulin. Quantitative 
immunohistomorphometry for the premelanosomal marker, gp100 (NKibeteb), and evaluation of 
the dendricity of gp100+ hair follicle melanocytes, showed an increase after treatment with each of 
the 3 peptides. These data provide the fi rst evidence that Thymosin a1, Thymosin b4 and Thymulin 
have indeed anagen-prolonging and pigmentation stimulatory effects on human scalp hair follicles, 
and introduce these peptides as novel regulators of melanocyte functions in human skin in situ.
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Tumor cell expression of programmed cell death 1 ligand 1 is a prognostic factor 
for malignant melanoma
Hino R1, Kabashima K2, Kato Y2, Yagi H3, Nakamura M1, Honjo T2, Okazaki T4, Tokura 
Y1 1University of Occupational & Environmental Health, Kitakyushu, Japan 2Kyoto 
University Graduate School of Medicine, Japan 3Hamamatsu University School of 
Medicine, Japan 4University of Tokushima Tokushima, Japan
Although malignant melanoma is a representative immunogenic tumor among various neoplasms, 
it tends to be refractory to immunotherapy. To investigate the mechanism underlining the 
immunosuppression of malignant melanoma patients, we focused on programmed cell death-1 
(PD-1)/ PD-1 ligand 1 (PD-L1) interaction between tumor cells and T cells.Melanoma specimens 
were collected from 59 primary tumors, 16 lymph nodes (LNs), and 4 lesions of intransit metastasis. 
Specimens were stained with anti-PD-L1 monoclonal antibodies and analyzed with digitalized 
pictures. To evaluate the intensity of PD-L1 expression, we used Adobe Photoshop CS histograms 
and obtained the red density (RD). PD-1 expression on T cells was analyzed in blood samples 
of 10 stage IV patients and 4 lesions of intransit metastases.Twenty-fi ve patients were defi ned as 
the “low” PD-L1 expression group (RD value < 90) and 34 were as the “high” (RD value >= 90) 
group. Breslow’s tumor thickness of the high group was signifi cantly higher than the low group. 
Univariate and multivariate analyses revealed the overall survival rate of the high group was 
signifi cantly lower than that of the low group. In all the stage IV patients examined, both CD8+ 
and CD4+ T cells had signifi cantly higher PD-1 expression levels in the peripheral blood. Tumor-
infi ltrating T cells expressed high levels of PD-1 and its expression was further elevated during 
the clinical course. We found that there is a correlation between the degree of PD-L1 expression 
and vertical growth of the primary tumors in melanoma.  Our multivariate analysis demonstrated 
that PD-L1 expression is an independent poor prognostic factor for malignant melanoma.
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Tyrosinase variants and mutations are associated to pigmentation characteristics 
and skin cancer risk in the French population
Guedj M2, Descamps V3, Bourillon A1, Dupin N4, Wolkenstein P5, Lebbe C6, Grandchamp 
B1, Basset-Seguin N6, Soufi r N1 1Hôp Bichat Claude Bernard, Paris 2Prog CIT Paris 3Hôpital Bichat 
Claude Bernard, Paris 4Hôpital Tarnier, Paris 5Hôp Henri Mondor, Créteil 6Hôpital Saint Louis, Paris
Tyrosinase (TYR) is an enzyme involved in melanin synthesis, and is mutated in occulocutaneous albinism 
I. A functional variant in exon 4 (rs1126809, R402Q) has been shown to be associated to melanoma and 
basal cell carcinoma (BCC) risks in European populations. In this study, we investigated whether this variant 
was also associated to pigmentation characteristics and skin cancer risk in French population, and whether 
other TYR mutations were also implicated in skin cancer risk.997 patients affected by cutaneous melanoma, 
216 patients with BCC and 925 ethnic Caucasian controls were genotyped for this SNP. Statistical analysis 
was performed using the R computer package. Conformity of genotypes to Hardy-Weinberg equilibrium 
was tested in controls. The effect of R402Q on melanoma risk and on pigmentation characteristics was 
assessed using Fisher exact test and Odd Ratio calculations. In addition, the TYR coding sequence was 
entirely sequenced in 73 patients having a familial history of melanoma, and 216 patients with BCC. SNP 
R402Q was strongly associated with skin type (P value = 9.32E-08) and moderately associated with nevi 
count (P value = 0.016) and eye color (P value = 0.023). In addition, it was also associated to skin cancer risk 
(P value = 0.023) for the homozygote subjects. Furthermore, it was also statistically associated to multiple 
melanoma (P value = 1E-03) and to familial melanoma (P value = 5E-03). 6 rare missens TYR variants were 
identifi ed in 1 melanoma and 6 BCC patients, but 4 missens TYR variants were also identifi ed in 5 controls 
(P value>0.05). However, 1 nonsense mutation (Y85X) and 2 variants affecting mRNA splicing (c.1037-7 
T>A, c.1366+4 A>G) were identifi ed in 1 familial melanoma and 2 BCC patients.The TYR gene is involved 
in human albinism. In this study, we confi rmed that the SNP R402Q is associated to skin cancer in French 
population, but also strongly associated to skin type and eye color. In addition, we show that it was particular 
associated to multiple melanoma and familial melanoma. This SNP therefore adds to the growing list of 
low penetrant alleles associated to pigmentation and melanoma susceptibility. In addition, multiple rare 
deleterious mutations may also play a role in skin cancer predisposition.
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Use of a manual dermatoscope with a compact digital camera in skin cancer triage
Zattra E1, Tonin E2, Belloni-Fortina A3, Pigozzi B2, Alaibac M1 1Unit of Dermatology, 
University of Padua, Padua, Italy 2Melanoma Unit, Istituto Oncologico Veneto (IOV), 
Padua, Italy 3Department of Pediatrics, University of Padua, Padua, Italy
Dermatoscopy  is  a  non-invasive  diagnostic  technique  that  allows  the  in-vivo 
visualisation  of morphological  structures  that  are  not  evident  with  simple  clinical 
examination.   Videodermatoscope  consists  of  a  digital  videocamera  incorporated 
into  a  probe  usually  with interchangeable  optics  connected  to  a  personal  computer. 
Lesions  are  visualized  through  a  conventional monitor. This system gives the possibility 
to acquire and store images in an easy way,  but   direct  visualization  of  the  lesion 
through optics is not possible.  This  system and other similar approaches used  to  archive 
digital  dermatoscopic  images  are  usually expensive in relation to the quality of optics 
and the hardware provided. We have investigated a  practical approach capable to save 
considerable time and money in the every-day practice of a pigmented  lesion clinic in 
order to archive digital images.  Our  method  is  based  on  a  hand-held  dermatoscope, 
a compact photocamera  and a common windows-based personal  computer  including  a 
simple  database  software  able  to  store  and  compare  images.  Leaning  the  retractable 
lens of  the photocamera  in extended position directly on  the dermatoscope viewfi nder 
and  setting the “macro” mode of the camera makes it possible to obtain very crisp, clear 
and bright  images similar to those obtained with much more expensive  devices.  In 
our study, we have evaluated the performance of our approach in comparison with the 
performance of different commercially available devices utilised to store  and  compare 
digital images. We have found that our  system is comparable in terms of quality of the 
images to other more sophisticated and expensive devices for the diagnosis of both 
melanocytic and non-melanocytic skin lesions. The  advantages  of    this  system  are  the 
very  low  cost  and  the  fact  that  single  routinely  used  components  can  be  utilised. 
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UVB regulation is both direct and indirect on TRP-1 mRNA, a melanocyte 
differentiation marker in human melanocytes
Kormos B1, Belsõ N1, Széll M2, Kemény L1, Bata-Csörgõ Zs1 1University of Szeged, 
Department of Dermatology and Allergology, Szeged, Hungary 2Dermatological 
Research Group of the Hungarian Academy of Sciences, Szeged, Hungary
Epidermal melanocytes (EMC) capable of pigment production are fully differentiated cells 
characterized by tyrosinase activity, tyrosinase-related protein 1 and -2 (TRP-1 and TRP-2) 
expressions, mature melanosomes and well-developed dendrites. We aimed to study the direct 
and indirect effect of UVB irradiation on melanocyte differentiation using in vitro cultured normal 
human adult epidermal melanocytes. For MC cultures we use a chemical-free medium (Mel-mix®) 
in which normal human MCs dedifferentiate (cells become bipolar, proliferate rapidly and loose 
their melanin content, TRP-1 and c-Kit expressions). We found that in our culture system TRP-1 
mRNA expression correlated with TRP-1 protein expression, indicating transcriptional regulation. 
We irradiated cells in 3rd passage with different UVB doses (0, 20.8, 31.2 and 41.6 mJ/cm2), and 
determined TRP 1 mRNA expressions 24 hours after irradiation. Values of TRP-1 mRNA expressions 
were normalized to 18S ribosomal RNA values. The viabilities of irradiated cells were determined 
by MTT assay. Keratinocytes (KC) from the same donors were also irradiated with similar doses 
of UVB. KC supernatants were collected 6 and 24 hours after irradiation and were given to 
autologous cultured melanocytes, 24 hours later TRP-1 mRNA expressions were determined. 
Direct UVB irradiation of melanocytes caused a dose-dependent decrease in TRP-1 expression. 
In opposition, treatment of EMC cultures with irradiated KC supernatants increased TRP-1 mRNA 
expression. TRP-1 mRNA expression increased more in cells that were treated with supernatants 
collected 24 hours after irradiation. These data suggest that UVB affects differentiation of EMCs 
indirectly through keratinocytes. Our result is in line with previous observations showing that 
UV effect on differentiation/pigmentation in EMCs can be regulated through keratinocyte factors. 
261
What are the objective determinants of tanning (facultative pigmentation)?
Wong TH, Rees JL The University of Edinburgh, United Kingdom
The majority of genetic studies of pigmentation and skin cancer use anamnestic 
measures such as Fitzpatrick phototyping. Although this has great ease of use a 
drawback is that it confl ates two measures, pigmentation and erythema, responses 
which whilst interrelated are clearly not the same. In the present study we have 
used objective measures of tanning using colorimetry following ultraviolet 
exposure and noradrenaline iontophoresis to remove the confounding effects of 
blood fl ow. An opportunistic sample of 98 adults, mostly students, median age 
22, comprising 86 Europeans and 12 Asians were recruited. Back and buttock skin 
was exposed to 300mJ (~8 Standard Erythemal Doses) using a bespoke TL12 UVB 
unit (courtesy of BL Diffey). Erythema was measured at 24 hours using refl ectance 
spectrophotometry and change in skin pigmentation (L) assessed objectively with 
a Minolta colorimeter at 7 days following iontophoresis of 0.1% noradrenaline.  As 
well as the expected factors such as freckling and hair colour the best predictors 
of L  were erythema (r2=0.21, p<10-6 for buttock) and Fitzpatrick skin type 
(r2=0.23, p<10-6). Multivariate models showed that once erythema was fi tted only 
skin type had an effect (r2=0.33, p<10-6). In general relations were stronger for sun 
protected (buttock) than the back.  These studies show that variation in erythemal 
response is the chief determinant of tanning and that once erythema is factored in, 
despite its anamnestic nature Fitzpatrick phototyping provides information superior 
to other measures of pigmentation such as hair colour, eye colour or skin colour.
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Both hematopoietic and mesenchymal stem cells contribute to the production of 
basement membrane protein in bone marrow transplantation treatment model 
mouse
Fujita Y1, Inokuma D1, Nishie W1, Nakamura H1, Akiyama M1, Sawamura D2, Shimizu 
H1 1Hokkaido University Graduate School of Medicine, Sapporo, Japan 2Hirosaki 
University Graduate School of Medicine, Hirosaki, Japan
Attempts to treat congenital protein defi ciencies based on the stem-cell plasticity of bone 
marrow cells have been reported. Our group has investigated the possibility of producing 
donor bone-marrow-cell-derived basement membrane zone proteins, especially collagen 
XVII (Col17). Bone marrow transplantation (BMT) treatment of adult Col17 knockout 
(Col17-/-) mice models of epidermolysis bullosa (EB) induced production of donor bone 
marrow cell-derived keratinocytes and expression of Col17, as well as improvement of 
the survival rate. Few reports have investigated BMT treatment in other EB models, and 
there is little data focusing on the nature of bone-marrow-derived stem cells. This study 
attempted to identify the types of stem cells that have the potential to differentiate into 
keratinocytes and contribute to the recovery of Col17 in a BMT treatment model. We 
sorted approximately 5-10x10^3 hematopoietic stem cells from GFP+ transgenic mice 
(Col17+/+) showing c-Kit+Sca-1+Lineage- by magnetic cell sorting and fl ow cytometry. 
We also prepared approximately 5x10^5 GFP+ mesenchymal stem cells  (Col17+/+) 
(passage>5). GFP+ stem cells of each type, mixed with 5x10^5 bone marrow cells derived 
from Col17-/- mice as supporting cells, were injected into recipient adult Col17-/- mice 
after total-body X-ray irradiation. After engraftment, the reepithelized skin areas were 
studied. We found that in this BMT treatment model, both hematopoietic and mesenchymal 
stem cells were able to differentiate into keratinocytes and produce Col17. These fi ndings 
indicate that both hematopoietic stem cell transplantation and mesenchymal stem cell 
infusion have signifi cant potential as systemic therapeutic approaches to EB treatment.
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Heterogenetic parabiosis and skin grafting murine models (Abcc6-/-) support the 
metabolic nature of pseudoxanthoma elasticum
Uitto J, Jiang Q Jefferson Medical College, Philadelphia, USA
Pseudoxanthoma elasticum (PXE), an autosomal recessive multi-system disorder characterized 
by ectopic mineralization of connective tissues, is caused by mutations in the ABCC6 gene. 
Several hypothesis have been proposed to explain the mineralization process in peripheral 
connective tissues. Specifi cally, ABCC6 protein has been postulated to serve as an effl ux 
transmembrane pump in the liver, raising the possibility that PXE is a metabolic disease. We 
have previously developed an Abcc6-/- knock-out (KO) mouse which recapitulates features 
of human PXE, including peripheral connective tissue mineralization. We have now used 
this animal model to test the hypothesis that PXE is a metabolic disease. First, grafting of 
muzzle skin from Abcc6-/- mice to their corresponding wild-type (WT) littermates, and vice 
versa, was performed. The results indicated that grafting of WT skin to KO mice did result 
in mineralization of connective tissues in the graft, while grafting of the KO skin to WT 
mice did not. WT to WT grafting as a control did not show mineralization. Secondly, we 
utilized parabiotic pairing, i.e., surgical joining of two mice to create a shared circulation 
between various Abcc6 genotypic mice. Circulation between the parabiotic animals was 
confi rmed by quantitative PCR of blood cell genotypes and by Evans blue dye injection into 
the tail vein of one of the mice one week after surgery. The results indicated that pairing of 
Abcc6-/- mice with their WT counterparts halted the connective tissue mineralization in 
the KO mice. Homogenetic WT/WT and KO/KO pairings were phenotypically unaffected 
by parabiosis. Consequently, these fi ndings support the notion that PXE is a metabolic 
disease, potentially due to absence of a systemic anti-mineralization factor(s) in the 
circulation. These observations raise the possibility that re-introduction of such factors 
into circulation would yield a potential treatment for this, currently intractable, disease.
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Filaggrin-defi cient mice have an inherent skin barrier defect and recapitulate key 
features of atopic eczema
Fallon PG1, Irvine AD1, Sasaki T2, Sandilands A3, Saunders SP1, Presland RB4, Fleckman 
P4, Kudoh J2, Amagai M2, McLean I3 1Trinity College Dublin, Dublin, Ireland 2Keio 
University, Tokyo, Japan 3University of Dundee, Dundee, United Kingdom 4University 
of Washington, Seattle, USA
Loss-of-function mutations in the fi laggrin gene (FLG), cause ichthyosis vulgaris and convey a 
major genetic risk to atopic dermatitis (eczema) and secondary allergic phenotypes. Several 
low frequency FLG null alleles occur in European and Asian populations, with a cumulative 
frequency of ~9% in Europeans, and are associated with a signifi cant cumulative burden of 
atopic disease. Here we report complete sequencing and assembly of the murine profi laggrin/
fi laggrin gene, fl g, in the C57BL/6 strain of mice.   We also report the full sequencing of fl g 
in the spontaneous mouse mutant fl aky tail (ft), and detection of the causative frameshift 
mutation 5303delA in fi laggrin repeat 6.  This allowed development of a rapid genotyping 
assay and facilitated backcrossing onto C57BL/6 and other inbred strains, as well as 
removal of other potentially confounding mutations in the original mixed-strain on which 
ft was maintained. The mutation is highly analogous to common human FLG mutations. 
Biochemical analysis showed that the defect leads to failure of profi laggrin-to-fi laggrin 
processing, destabilization of the truncated profi laggrin protein and ultimately, complete 
absence of mature fi laggrin in the epidermis. Importantly, we demonstrate that topical 
application of protein allergen to mice homozygous mutant mice results in signifi cantly 
increased cutaneous infl ammatory infi ltrates and enhanced cutaneous allergen priming 
with development of allergen-specifi c antibody responses compared to heterozygous and 
wild-type littermates. These data validate ft as a useful model of fi laggrin-related disorders 
and provide experimental evidence for the hypothesis that antigen transfer through a 
defective epidermal barrier is a key mechanism underlying elevated IgE sensitization 
and initiation of cutaneous infl ammation in humans with fi laggrin-related atopic disease.




Long term genetic correction of cancer prone xeroderma pigmentosum skin ex vivo 
and in vivo
Magnaldo T1, Warrick E2, Garcia M3, Bergoglio V4, Larcher F3, Del Rio M3,  Bernerd 
F5 1CNRS, FRE 3086, Faculté de Médecine, Nice, France 2CNRS, FRE 3086, Faculté 
de Médecine, L’oréal France, Nice, France 3CIEMAT-CIBER de Enfermedades Raras, 
Madrid, Spain 4CNRS, FRE 3086, Faculté de Médecine, Nice, Spain 5L’Oreal Advanced 
Research, Clichy, France
Xeroderma pigmentosum (XP) is a rare, recessively inherited genetic disorder characterized 
by an extreme sensitivity to sunlight and a severe predisposition to UV-induced skin cancers. 
Cells from XP patients are defi cient in the repair mechanism called nucleotide excision 
repair which removes UV-induced DNA lesions. Among the seven groups of genetic 
complementation (XP-A to XP-G), XP-C is the most common one in Europe and North Africa. 
In contrast to other groups, XP-C patients do no present with neurological problems. In the 
absence of any currative treatment,  ex vivo cutaneous gene therapy could help solving the 
susceptibility of XP-C patients toward skin cancer. As a prequisite toward ex vivo cutaneous 
gene therapy, we have set up a selection strategy compatible with specifi cations inherent to 
skin graft in vivo: absence of immune response against stem keratinocytes selected ex vivo 
for their effi cient genetic correction. The XPC gene was retrovirally transduced in activally 
dividing patients keratinocytes together with a natural cell surface marker (CD24) of post-
mitotic keratinocytes. This allowed the safe selection of corrected XP-C keratinocytes. In these 
cells, re expression of the XPC protein was accompanied by recovery of a full DNA repair 
capacity and cell survival properties after UVB irradiation. Corrected XP-C keratinocytes 
also retained a full capacity to regenerate a UV-resistant skin both ex vivo in organotypic 
cultures and in vivo after long term regeneration on the athymic mouse. Our results open 
the fi rst rational perspective toward ex vivo cutaneous gene therapy of the XP-C disease.
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In vitro Correction of COL7A1 Gene Mutations using RNA Trans-splicing
Murauer EM1, Gache Y2, Gratz IK1, Klausegger A1, Muss W3, Gruber C1, Meneguzzi 
G2, Hintner H4, Bauer JW1 1Laboratory for Molecular Therapy, eb-house Austria, Univ 
Hospital Salzburg, Austria 2INSERM U634, Faculty of Medicine, Univ of Nice-Sophia 
Antipolis, Nice, France 3Institute of Pathology, Univ Hospital Salzburg, Austria 4eb-
house Austria, Department of Dermatology, Univ Hospital Salzburg, Austria
Functional defects in type VII collagen, caused by premature termination codons on both 
alleles of the COL7A1 gene, are responsible for the severe autosomal recessive types of 
dystrophic epidermolysis bullosa (RDEB). In these phenotypes type VII collagen is unable 
to form stable anchoring fi brils at the dermal-epidermal junction (DEJ). By means of the 
RNA trans-splicing gene therapy we were able to correct the RDEB phenotype in an in vitro 
model. Trans-splicing provides intron-specifi c gene-correction at the pre-mRNA level.A pre-
trans-splicing molecule (PTM) is designed to exchange parts of the coding sequence of 
the endogenous transcript by the wild type sequence. In our gene therapy model we used 
primary keratinocytes from a RDEB patient, carrying two heterozygous nonsense mutations 
in COL7A1 exons 14 and 104 that provoke type VII collagen-defi ciency. These cells were 
retrovirally transduced with a 3’ PTM encoding COL7A1 wild type exons 65-118.Retroviral 
transduction of the cells resulted in correction of the 3’ portion of the endogenous COL7A1 
transcript via trans-splicing with consequent restoration of type VII collagen expression in 
cultured cells. Unlike parental RDEB keratinocytes, the transduced cells displayed normal 
morphology and reduced invasion capacity. The reverted keratinocytes also regained 
their ability to secrete and deposit type VII collagen at the basement membrane zone in 
skin equivalents. Anchoring fi brils-like structures were visualized at the DEJ by electron 
microscopy. Using 3’ trans-splicing we are able to correct type VII collagen expression 
in vitro, which marks an important step towards its application in gene therapy in vivo.
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Plectin expression in epidermolysis bullosa simplex (EBS) with muscular dystrophy 
vs. in EBS with pyloric atresia
Natsuga K1, Nishie W1, Akiyama M1, Ouchi T3, Ishiko A3, Hirako Y4, Owaribe K4, 
Bruckner-Tuderman L2, Shimizu H1 1Hokkaido Univ Graduate School of Medicine, 
Sapporo, Japan 2Univ Medical Center Freiburg, Germany 3Keio Univ School of 
Medicine, Tokyo, Japan 4Nagoya Univ Graduate School of Science, Japan
Plectin is a cytoskeletal linker protein that localizes at the interface between 
intermediate fi laments and the plasma membrane in epithelial and muscle cells and 
other tissues. Plectin has a unique dumbbell shape, with a rod-like central region, an 
N-terminal globular domain at one end and a C-terminal globular domain at the other 
end. Mutations in the gene encoding plectin (PLEC1) cause two distinct subtypes of 
epidermolysis bullosa (EB): EB simplex with muscular dystrophy (EBS-MD) and EB 
simplex with pyloric atresia (EBS-PA). To clarify how mutations in PLEC1 lead to the 
two clinical EB phenotypes, we analyzed 9 unrelated patients (6 with EBS-MD and 3 
with EBS-PA) in whom PLEC1 mutations had been confi rmed. Immunofl uorescence 
analysis using 5 antibodies directed to different plectin domains and immunoblotting 
of cultured fi broblast extracts demonstrated that in EBS-PA the expression of entire 
plectin domains was markedly attenuated or completely lost, whereas in EBS-MD 
the expression of the N- and C-terminal domains of plectin was detectable but 
the expression of the rod domain was reduced or absent. In EBS-MD, the PLEC1 
mutations were mostly confi ned to exon 31, which encodes the large plectin rod 
domain, whereas in EBS-PA most of the PLEC1 mutations were outside exon 31. 
Our data suggest that loss of full-length plectin together with maintenance of the 
rodless plectin transcript isoform leads to the EBS-MD phenotype and that complete 
loss or markedly attenuated expression of plectin causes the EBS-PA phenotype.
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Hereditary Painful Callosities, a form of Palmar-Plantar Keratoderma, is caused by 
Dominant Negative Mutations in the 2B Helix of Keratin K6c.
Easter TE, Ruge F, Bowden PE Cardiff University, Cardiff, United Kingdom
Hereditary painful callosities (HPC) was clinically defi ned over 20 years ago (OMIM: %114140) 
and can be considered a type of focal palmar-plantar keratoderma (FPPK). Patients have thickened 
skin at pressure points on the sole which blister and worsen in summer heat. We studied a three 
generation family with this disorder over 10 years ago and found mild epidermolysis and extensive 
hyperkeratosis, typical of keratin genodermatoses. However, screening for K9, K1, K6a, K6b, K16 
and K17 mutations failed to fi nd any defect. More recently, a third K6 gene (KRT6C) has been 
located on chromosome 12 between KRT6a and KRT6b. The expression pattern of K6c is presently 
unknown but this keratin remains a strong candidate gene for HPC. We therefore screened several 
FPPK families for mutations in KRT6c and identifi ed the fi rst known point mutation in exon 7 
of KRT6C in a family with HPC. Genomic DNA from both patients (father and son) as well as 
normal controls was screened for mutations in KRT6C using carefully defi ned primers specifi c 
for this gene which did not amplify either KRT6A or KRT6B. Sequencing data identifi ed two 
heterozygous point mutations in codon 472 (GAG to AAA) of the KRT6C gene in both patients 
which were not present in the normal controls examined. While one alteration represents a neutral 
polymorphism, the other alters this key glutamic acid residue which lies at position 117 in the 2B 
helix of the K6c protein to lysine in this HPC family (p.Glu472Lys). The point mutation altered a 
Mnl I site, allowing sequence data confi rmation by RFLP analysis. In addition, the son also had a 
heterozygous point mutation (AGT to AAT) in the H1 domain of K6c altering codon 143 from serine 
to asparagine (p.Ser143Asn). Both residues are highly conserved in all type II keratins and mutation 
of the glutamic acid at position 117 in the 2B helix has been identifi ed as causing pathology 
in several different keratin genodermatoses. Thus, we conclude that this heterozygous point 
mutation (p.Glu472Lys) in K6c is the likely cause of the pathology observed in this HPC family.
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Plectin mutations underlie epidermolysis bullosa simplex in patients with wild type 
KRT5 and KRT14 alleles
Bolling MC1, Jongbloed JD1, Smith FJ2, McLean WH2, Jonkman MF1 1University 
Medical Center Groningen, Netherlands 2University of Dundee, UK
Epidermolysis bullosa simplex (EBS) is a hereditary skin blistering disease characterized by 
fragility and rupture of basal keratinocytes mainly caused by dominant negative mutations 
in the KRT5 and KRT14 genes, encoding the basal epidermal keratins. However, in ~25% 
of EBS cases no mutation is found in one of these keratin genes. A Norwegian study has 
reported an autosomal dominant mutation in PLEC1 associated with non-syndromic EBS in 
two related families, a phenotype called EBS-Ogna. PLEC1 encodes the cytoskeleton linker 
protein plectin, which in skin anchors basal keratins to the hemidesmosomal plaque. The 
purpose of this study was to investigate whether plectin mutations may be underlying the 
KRT5 and KRT14 mutation-negative EBS cases. PLEC1 mutation analysis was performed 
in 14 EBS families in which KRT5 and KRT14 mutations had been excluded. In fi ve EBS 
families with a mild phenotype a heterozygous plectin missense mutation was found. Three 
mutations were located in the plectin rod domain, important for dimerization, and two 
mutations in the intermediate fi lament binding C-terminus. The mutations were excluded 
in the normal population, segregate with the phenotype in the families, and involve well 
conserved aminoacids. Two families carried the same plectin mutation as the original EBS-
Ogna families: p.R2000W. Immunofl uorescence microscopy showed diminished plectin 
expression with C-terminal and rod directed antibodies indicating protein degradation. 
Electron microscopic analysis showed a plane of cleavage just above the inner dense plaque 
of hemidesmosomes, of which some had normal appearance and others were hypoplastic. 
In summary, PLEC1 mutations were found in 36% of KRT5 and KRT14 mutation-negative 
EBS families (8% of total amount of EBS cases), making this gene the fi rst candidate 
gene to screen for mutations when KRT5 and KRT14 mutation analysis is negative.
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Functional Restoration of Inherited Epidermolysis Bullosa by Bone Marrow-Derived 
Adult Stem Cells
Ghoreschi K1, Huenefeld C1, Glocova I1, Mueller-Hermelink E1, Fehrenbacher B1, 
Biedermann T1, Amagai M2, Manz MG3, Schaller M1, Roecken M1 1Eberhard Karls 
University, Tübingen, Germany 2Keio University School of Medicine, Tokyo, Japan 
3Institute for Research in Biomedicine, Bellinzona, Switzerland
Desmoglein 3 (Dsg3) is a desmosomal transmembrane protein required for regular cell-cell 
adhesion and cellular function of keratinocytes in stratifi ed squamous epithelia. Genetically 
engineered mice with a targeted disruption of the Dsg3 gene (Dsg3-/-) develop a severe epidermal 
blistering disease characterized by runting, low body weight and telogen hair loss. Thus, the 
Dsg3 knockout mouse represents an ideal animal model for severe skin fragility disorders like 
inherited epidermolysis bullosa (EB) in humans, where no treatment is available. We established an 
experimental cell-based therapy to examine the ability of bone marrow (BM)-derived CD45+Kit+ 
adult stem (AS) cells to restore epithelial defects and Dsg3-expression in the skin and mucosa 
of Dsg3-/- mice after systemic application. After stem cell therapy (SCT) with BM-derived 
CD45+Kit+ AS cells from transgenic mice, expressing the enhanced green fl uorescent protein 
(EGFP), Dsg3-/- mice recovered from runting and telogen hair loss. Moreover, EGFP positive BM-
derived CD45+Kit+ AS cells selectively migrated to epithelial defects of Dsg3-/- mice and restored 
epithelial structure and Dsg3-expression in K5+ basal epithelial cells of the skin and oral mucosa. 
Statistically, 56% of all epithelial cells in Dsg3-/- mice were EGFP+ after SCT, compared to only 
6% of EGFP+ epithelial cells in transplanted heterozygous Dsg3+/- control mice. Ultrastructually 
the Dsg3-/- mice re-established normal desmosomal architecture after transplantation. Our results 
indicate that epithelial defects of Dsg3-/- mice constitute a unique microenvironmental niche 
for BM-derived CD45+Kit+ AS cells to immigrate and to restore Dsg3-expression and functional 
epithelial structure. Therefore, SCT with BM-derived CD45+Kit+ AS cells is a promising treatment 
for inherited epidermolysis bullosa and other severe inherited epidermal diseases in humans.
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Cross talk between p63 and IRF6 in the regulation of keratinocyte proliferation
Moretti F1, Spallone G1, Botti E1, Merlo G2, Chimenti S1, Alemà S3, Guerrini L4, 
Costanzo A1 1Dept of Dermatology University of Rome Tor Vergata, Italy 2Molecular 
Biotechnology Center, DTI, University of Turin, Italy 3Cellular Biology Institute, CNR, 
Rome, Italy 4Cellular and Developmental Biology, University of Milan, Italy
Mutations of IRF6 and p63 cause two groups of human congenital syndromes 
characterized by defects in development of structures derived from ectoderm-
mesenchimal interaction. Cleft-lip/palate and ectodermal dysplasia are present 
in both groups of diseases. p63 and Irf6 null mice display consistent phenotypes 
affecting the same tissues. Thus, p63 and IRF6 control tissue-specifi c transcription 
programs essential for the regulation of ectodermal cell proliferation and 
differentiation. We report that in keratinocytes IRF6 and p63 constitute a feed-
back regulatory cascade: íNp63 activates transcription of IRF6 and this, in turn, 
induces proteasome-mediated íNp63 degradation. This loop allows keratinocytes 
to exit the cell cycle, thereby limiting their proliferation. p63 mutations causing 
ectodermal dysplasias are unable to activate IRF6 transcription, and mice with 
mutated or null p63 show reduced Irf6 expression in palate and ectoderm. These 
results identify a novel mechanism regulating the proliferation-differentiation 
balance of keratinocytes essential for palate fusion and skin differentiation.
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Mutations in either the OSMR or IL31RA genes underlie familial primary cutaneous 
amyloidosis
Tsai S1, Lin M2, Lee D3, McGrath J4 1National Health Research Institutes, Zhunan, 
Miaoli County, Taiwan 2National Yang-Ming University, Taipei, Taiwan 3Taipei Veterans 
General Hospital, Taipei, Taiwan 4St John’s Institute of Dermatology, London, UK
Primary cutaneous amyloidosis (PCA) is an itchy skin disorder associated with amyloid 
deposits in the superfi cial dermis. The disease is relatively common in Southeast Asia and 
South America. Autosomal dominant PCA has been mapped previously to 5p13.1-q11.2 
and 2 pathogenic missense mutations in the OSMR gene, which encodes the interleukin-6 
family cytokine receptor oncostatin M receptor beta (OSMRβ), were reported. Here, 
we investigated 29 Taiwanese pedigrees with PCA and found that 10 had heterozygous 
missense mutations in OSMR: p.D647V (1 family), p.P694L (6 families), and p.K697T (3 
families). The mutation p.P694L was associated with the same haplotype in 5 of 6 families 
and  also detected in 2 sporadic cases of PCA. Of the other 19 pedigrees that lacked 
OSMR pathology, 8 mapped to the same locus on chromosome 5, which also contains 
the genes for 3 other interleukin-6 family cytokine receptors, including interleukin-31 
receptor A (IL31RA), which can form a heterodimeric receptor with OSMRβ through 
interleukin-31 signaling. In one family, we identifi ed a point mutation in the IL31RA 
gene, c.1562C>T, that results in a missense mutation, p.S521F, which is also sited within 
a fi bronectin type III-like repeat domain as observed in the OSMR mutations. PCA is a 
genetically heterogeneous disorder but our study shows that it can be caused by mutations 
in 2 biologically associated cytokine receptor genes located on chromosome 5. The 
identifi cation of OSMR and IL31RA gene pathology provides an explanation of the high 
prevalence of PCA in Taiwan as well as new insight into disease pathophysiology and 
management. The pathogenesis mechanisms of FPCA involving the two genes are under 
investigation by expressing mutant receptor components in the cell culture system.
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Microarray profi ling in EEC ectodermal dysplasia syndrome skin reveals increased 
fatty acid-binding protein FABP7 and reduced hair/nail keratin gene expression
Clements SE, Techanukul T, Mellerio JE, McGrath JA St Johns Institute of Dermatology, 
London, UK
EEC (ectrodactyly-ectodermal dysplasia-clefting) syndrome is an autosomal 
dominant disorder with developmental abnormalities affecting skin, hair, teeth and 
nails. Most cases result from missense mutations in the DNA-binding domain of 
the p63 gene, a key transcription factor in ectodermal formation and maintenance. 
The overall function of p63 in post-natal human skin, however, has yet to be fully 
characterized. To address this, we performed Illumina® microarray gene expression 
profi ling using RNA extracted from skin biopsies of 4 unrelated individuals with 
EEC syndrome (mutations: p.Arg279Ser, p.Arg304Gln (x2) and p.Ala307Asp) and 
12 normal controls. We identifi ed 104 down-regulated and 6 up-regulated genes 
with a differential fold change of ≥2 plus an expression difference score of ≥65 
(equivalent to a corrected p-value of 0.05). This included a 10-fold increase in 
mRNA expression of FABP7, a fatty-acid binding protein involved in gene regulation, 
differentiation and proliferation. The increase in FABP7 was verifi ed by qRT-PCR and 
immunofl uorescence microscopy in EEC skin. Furthermore, we identifi ed down-
regulation (6 to 16-fold) of several hair and nail keratins, including keratins 33B, 
34 and 35 as well as those known to be mutated in the human genetic disorders 
monilethrix (keratins 81 and 86) and ectodermal dysplasia with hair and nail defects 
(keratin 85). Ingenuity pathway analysis identifi ed TNF, NFκB and Wnt signalling 
pathways to be the most signifi cantly abrogated in our EEC syndrome patient cohort. 
This study extends the spectrum of known p63 target genes and provides new 
insight into the role of p63 in infl uencing expression of particular signalling and 
structural molecules relevant to healthy skin, hair and nails, selected abnormalities in 
which may underlie the cutaneous EEC ectodermal dysplasia syndrome phenotype. 
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High-throughput mutation profi ling of CTCL samples using OncoMap
Oberholzer PA1, Karpova MB2, Zipser MC2, Lin WM3, Girardi M3, MacConaill LE1, 
Kehoe SM4, Garraway LA1, Dummer R2 1Broad Inst of MIT & Harvard, Cambridge, 
USA 2Univ Hospital of Zurich, Switzerland 3Yale Univ School of Medicine,  New 
Haven, USA 4Dana-Farber Cancer Inst,  Boston, USA
Mycosis fungoides (MF) and its leukemic counterpart Sézary syndrome (SzS) are characterized by the 
accumulation of malignant CD4+ T-cells with memory phenotype in the skin. Molecular studies of 
Sézary tumor cells revealed existence of several genetic defects and isolated chromosomal aberrations, 
as well as disturbances on transcriptional level. Large scale genomic evaluations, such as mutations 
screening, have provided a comprehensive tool to reveal patterns of aberrations contributing to the 
cancer phenotype.In this study, 78 samples (44 skin biopsies and 34 blood samples) have been screened 
for somatic mutations using OncoMap (OM) technology to identify new genetic markers and therapeutic 
targets for these diseases. Patients group encountered 26 SzS and 52 MF plus other CTCL type patients 
with mean age of 52 years. OM is an extensive mutation profi ling platform which interrogates over 
500 mutations in 34 cancer genes, both oncogenes and tumor suppressors. OM workfl ow uses 
conventional PCR and primer extension approaches followed by two different mass spectrometry 
readouts in a 96-well format. First readout, called “iPLEX”, is a higher throughput approach which uses 
whole genome amplifi ed (WGA) DNA and suited for a large screen. Second readout, called “hME”, 
is a lower throughput and more sensitive approach which validates iPLEX results using unamplifi ed 
DNA to rule out WGA artefacts. 1 MF, 1 SzS and 2 other CTCL type samples, in total 4/78 (5.1%), 
harbored mutations across 2 different genes. Affected genes were KRAS and NRAS oncogenes. Mutation 
spectrum included 2 amino acid substitutions with 1 aggressive (newly discovered) and 6 conservative 
(predicted) calls. To the best of our knowledge this is the fi rst report that characterizes point mutations 
in CTCL. Interestingly, these genes represent druggable target candidates. This data might help to defi ne 
new disease-specifi c target(s) that may be implemented in the diagnostics and therapeutic interventions, 
which in turn can improve the quality of life, not only in CTCLs but also in other T cell malignancies.
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5’ trans-splicing in the Type VII Collagen Gene – Development of a mRNA based 
Gene Therapy Approach for Dystrophic Epidermolysis bullosa
Mayr E, Koller U, Murauer EM, Wally V, Klausegger A, Hintner H, Bauer JW Laboratory 
for Molecular Therapy, eb-house Austria, University Hospital Salzburg, Austria
Mutations in  COL7A1, the gene coding for type VII collagen, are the cause of 
dystrophic epidermolysis bullosa (DEB), a heritable mechanobullous skin disease. 
Because of its size the COL7A1 gene  exceeds the integration capability of most 
viral vectors commonly used for delivery in gene therapy. Furthermore endogenous 
regulation of expression is crucial in tissue with a complex differentiation program. 
Therefore we chose to use a mRNA based gene therapy  to repair defects in COL7A1. 
In this approach a wild type copy mRNA of the 5’part of COL7A1 is trans-spliced to the 
mutated type VII collagen gene, enabling the correction of any mutation in the 5´part 
of COL7A1. We tested rationally constructed pre-trans-splicing molecules (PTMs), 
which showed a trans-splicing effi ciency of about 50% in our test system, regarding 
their endogenous trans-splicing potential in HaCaTs. Functional endogenous trans-
splicing on mRNA level was detected by cDNA analysis using PCR methods and 
sequencing. With a fl uorescence based screening procedure we are maximizing 
effi ciency and spezifi city to much higher levels than 50%. The long term goal of 
this approach is ex vivo gene therapy, in which skin grafts taken from DEB patients 
are transfected with specifi c 5’ PTMs and are then transplanted back to the patients.
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A double blind phase III trial of afamelanotide in erythropoietic protoporphyria 
(EPP), preliminary data in a Swiss cohort and a model to determine effi cacy in EPP
Minder E1, Harms J1, Lautenschlager S1, Minder CE2 1Stadtspital Triemli, Zürich, 
Switzerland 2Horten Center, Zürich, Switzerland
EPP, a rare inherited disease, is due to defi cient ferrochelatase the ultimate enzyme of heme 
biosynthesis. EPP patients suffer from incapacitating skin pain upon sunlight exposure. 
Management of EPP is inadequate and effi cacy determination is diffi cult. Afamelanotide, an 
alpha-melanocyte-stimulating-hormone analogue capable of increasing light tolerance of exposed 
skin areas as shown in an open-label phase II trial, was further evaluated under daily routine in 
a randomized, double blind and placebo controlled multicentre trial. 16 mg sustained-release 
afamelanotide or placebo were applied subcutaneously every 60 days to 15 EPP patients in a 
crossover design. The following endpoints were recorded: daily: pain intensity, sunlight exposure 
time; every 30 days: adverse effects, skin melanin density (MD). Phototoxic reactions were 
recorded when the pain score exceeded 3/11 (Likert-scale). The effi cacy model was verifi ed by 
a questionnaire. Non-parameterical and multiple regression analyses were applied. Maximal 
intensity and severity of phototoxic reactions were signifi cantly higher during placebo than during 
active treatment (p=0.05 and 0.008, respectively). Conversely, sunlight exposure was signifi cantly 
longer during active treatment than during placebo (p=0.009). A new model comprised the 
interaction between these two variables: The product sunlight-exposure times freedom-from-pain 
(ETFP) correlated positively with afamelanotide treatment (p=0.004), pronounced in summer 
(p<0.001), corresponding with the seasonal variations of patients’ symptoms. ETFP correlated 
negatively with patients’ weight (p<0.0001). MD was signifi cantly higher during active treatment 
than during placebo (p=0.001). Among this limited number of patients, afamelanotide seemingly 
offered clinical benefi ts by reducing severity (intensity) of phototoxic reactions suffered under 
conditions of use. Further analysis showed that a refi ned protocol for assessment of pain in 
relation to sunlight exposure accounted for the interaction of environment and treatment effects.




A new germline FLNA mutation in a patient with Ehlers-Danlos syndrome and 
periventricular nodular heterotopia
Morin AS1, Goizet C2, Prost C3, Blom A3, Laroche L3, Fain O1, Caux F3 1CHU Jean 
Verdier, Bondy, France 2CHU Pellegrin, Bordeaux, France 3CHU Avicenne, Reference 
Center for Genetic Skin Diseases, Bobigny, France
The FLNA gene, located on Xq28, encodes F-actin-binding cytoplasmic phosphoprotein 
fi lamin A and is mutated in periventricular nodular heterotopia (PNH), a malformation 
of neuronal migration characterized by nodules lining the ventricular walls. Patients 
with PNH and Ehlers-Danlos syndrome (EDS) have recently been reported, some of 
them carrying FLNA mutations. Here we report a woman with PNH, EDS and a novel 
FLNA mutation. This woman presented with a history of seizures, PNH, pulmonary 
embolism and skin hyperlaxity. Skin analysis by electron microscopy revealed no 
abnormality of size or morphology of dermal collagen fi brils, neither fl ower-like cross 
section, nor dilated rough endoplasmic reticulum in fi broblasts. The 47 coding exons 
of FLNA were analyzed by high-resolution melting analysis or direct sequencing on 
her DNA. A heterozygous deletion of 11 nucleotides associated with a 4 nucleotides 
insertion (c.4812_4822delinsCCAG) was identifi ed in exon 29. The mutation results 
in a frameshift and premature truncation of the protein (p.Thr1605GlnfsX6).This 
novel FLNA mutation, located in the 14th Ig-like repeats (rod 1 domain), is clearly 
deleterious and is expected to cause loss-of-function of fi lamin A. To date, only 2 
missense and 4 truncation mutations have been reported in PNH combined with EDS. 
Such FLNA mutations may cause EDS by impaired regulation of the cytoskeleton or 
by decreasing the cellular adhesion to the matrix, resulting in loss of skin elasticity 
and strength of collagen. In conclusion we described an original FLNA mutation in a 
patient with a dual EDS-PNH phenotype, a new variant within the spectrum of EDS.
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A novel keratin 5 splice site mutation in a Filipino family resulting in epidermolysis 
bullosa simplex associated with ankyloblepharon
Halim I1, Yan WF2, King-Ismael D1, Tran K3, Melbourne W3, Figueira EC4, Chow CW5, 
Lloyd L6, Murrell DF2 1Dept of Dermatology, Jose R. Reyes Memorial Medical Center, 
Manila, Philippines 2University of NSW; Dept of Dermatology, St George Hospital, 
Sydney, Australia 3University of NSW; Dept of Anatomical Pathology, SEALS, St 
George Hospital, Sydney, Australia 4University of NSW, Sydney, Australia 5Dept of 
Anatomical Pathology, Royal Children’s Hospital, Melbourne, Australia 6Dept of 
Chemical Pathology, Royal Brisbane Hospital, Australia
Epidermolysis bullosa simplex has not been associated with ankyloblepharon previously; EBS with 
mottled pigmentation (EBS-MP) is typically caused by keratin 5 mutations in the head domain 
and has only once been reported in the tail domain. To investigate the genotype to phenotype 
correlation in the mother and two daughters with blisters, mottled pigmentation and congenital 
ankyloblepharon, we used immunofl uorescence mapping (IFM), electron microscopy, mutation 
screening of KRT5 and RNA analysis from skin and cultured fi broblasts. There was no clefting 
or features of AEC syndrome besides the ankyloblepharon; mottled pigmentation had developed 
by 3 years and remained in the mother. IFM showed blistering in the basal layer with reduced 
keratin 5 expression but normal keratin 14, plectin and alpha 6 beta 4 expression. A novel 
heterozygous KRT5 splice mutation c.1474+1 G>A at the exon 8 / intron 8 boundary was found 
in all three affected patients, which resulted in several different splice variants in each affected 
individual, including parts of exons 8 and 9 missing. The unaffected father had the whole of 
exon 8 missing in one allele. Heterozygosity for the in-frame absense of KRT5 exon 8 does not 
give a dominant phenotype. Shortening of the tail of keratin 5 caused by the absence of 129 bp 
from exon 9 is most likely responsible for EBS-MP and ankyloblepharon in this family. Another 
possibility is that the defect causing ankyloblepharon is linked to the Krt5 gene in this family.
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A novel missense mutation in GJB2, p.Tyr65His, causes severe Vohwinkel syndrome
van Geel M1, de Zwart-Storm EA1, Veysey E2, Burge S2, Cooper S2, Steijlen PM1, Martin 
PE3, van Steensel MA1 1Dept of Dermatology, Maastricht University Medical Center, 
Maastricht, Netherlands 2Dept of Dermatology, Churchill Hospital, Oxford, UK 3Dept 
of Biological & Biomedical Sciences, Glasgow Caledonian University, Glasgow, UK
Connexins are transmembrane proteins that assemble to form hexameric intercellular 
channels, gap junctions, which are permeable to small molecules. They are expressed 
in tissues that require rapid intercellular communication, such as the inner ear, brain, 
heart and skin. Many different inherited skin diseases are associated with the skin-
expressed gene GJB2 that codes for the gap junction protein connexin26. GJB2 and 
the associated disorders show a strong genotype-phenotype correlation that is poorly 
understood. Identifying new mutations may help to elucidate such correlations. In the 
present work, we report on a family with a novel mutation, p.Tyr65His, affecting the 
fi rst extracellular domain of connexin26, causing severe Vohwinkel syndrome. This 
disorder has so far only been associated with the mutation p.Asp66His. Functional 
analysis of the novel mutation p.Tyr65His suggests that while there is a protein 
transport defect, some residual functional gap junction channels are formed. This 
ability to form gap junction channels is improved by the presence of wild type 
connexin26. Gap junction intercellular communication is signifi cantly diminished 
for mutants compared to wild type. Our fi ndings expand the spectrum of mutations in 
GJB2. Based on our observations we doubt that diminished gap junction intercellular 
communication or the transport defect are causative for the phenotype. To the best 
of our knowledge, this is the fi rst report of mutations in neighbouring residues of 
the fi rst extracellular domain of connexin26 causing similar disease phenotypes.
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A Suicide Gene Therapy Approach Treating Epidermolysis Bullosa-associated 
Cancer
Gruber C1, Gratz IK1, Mayr E1, Murauer EM1, Bruckner-Tuderman L2, Hintner H3, Bauer 
JW1 1Laboratory for Molecular Therapy, eb-house Austria, Univ Hospital Salzburg, 
Austria 2Department of Dermatology, Univ Medical Center Freiburg, Germany 3eb-
house Austria, Dept of Dermatology, University Hospital Salzburg, Austria
Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited disease causing 
extensive blister formation within the basal membrane zone of the skin and mucous 
membranes. RDEB is associated with the development of highly aggressive squamous 
cell carcinomas (SCC) that display a life threatening complication within this 
patient group. Due to the fact that conventional radio- or chemotherapies remain 
unsuccessful, we developed a suicide gene therapy approach using spliceosome 
mediated RNA trans-splicing (SMaRT).SMaRT technology utilizes pre trans-splicing 
molecules (PTMs) that are able to replace a tumour target gene with the cDNA of a 
cell death inducing peptide. We already demonstrated the upregulation of MMP-9 
gene in a RDEB-SCC cell line and therefore we designed PTMs that specifi cally bind 
to intronic regions of the target gene MMP-9 and facilitate trans-splicing with the toxin 
streptolysin O (SLO) encoded by the PTM. As a result, the toxin will be expressed in 
malignant cells, induce specifi c cell death and tumour growth arrest. We can show 
trans-splicing between MMP-9 and the PTM generating a fusion mRNA of target gene 
exon 1 and the cell death inducing peptide SLO. Moreover, specifi c expression of this 
fusion protein, upon correct trans-splicing, caused cell death in RDEB SCC cells which 
was analyzed using in vitro cell culture assays. Therefore this work evaluates SMaRT 
technology as a novel tool for suicide gene therapy of highly malignant tumours.
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ABCA subfamily member expression in the epidermis is altered by knockdown of 
ABCA12
Long HA, Akiyama M, Yanagi T, Shimizu H Hokkaido University, Sapporo, Japan
ABCA12 is a large membrane spanning protein and a member of the ABCA subfamily 
of lipid transporters. Mutations in ABCA12 have been linked with harlequin ichthyosis 
(HI). The expression of other ABCA subfamily proteins in the epidermis has been 
poorly explored. Therefore, it is important to clarify whether any other ABCA subfamily 
members are expressed in the epidermis and if their function is redundant to ABCA12, 
because, if so, they may be able to compensate for the loss of function of ABCA12 in 
the epidermis and to act as alternate therapeutic targets for HI. We screened for the 
expression of all ABCA sub-family members in mouse and human keratinocytes using 
standard PCR. The expression of ABCA 1,3,5 and 7 were confi rmed and  investigated 
in human keratinocytes and in both wild-type and Abca12 disrupted (Abca12-/-) 
mouse keratinocytes using PCR and real-time PCR for mRNA expression, and further 
examined by western blotting and immunofl uorescence for the protein expression. A 
marked reduction in expression of ABCA1,3 and 7 was observed in Abca12-/- mouse 
keratinocytes compared to wild-type mouse keratinocytes. Interestingly, normal 
human keratinocytes incubated in high Ca2+ medium showed strong ABCA7 staining 
at the cell periphery and co-staining with ABCA12 at cell-cell contacts. In contrast, 
Abca12 -/- mouse keratinocytes showed disorganized ABCA3 and 7 staining. These 
results suggest that loss of ABCA12 alters the expression of ABCA subfamily members, 
particularly ABCA1 and ABCA7, at the mRNA level. This further suggests that ABCA12 
may act as a global regulator of ABCA subfamily member expression in the epidermis.
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Aberrant KRT16 – KRT5 protein interaction distort the equilibrium of KRT5-KRT14 
heterodimers which may lead to skin fragility in ageing skin and blistering diseases
Maier RH1, Maier CJ1, Hintner H2, Trost A2, Bauer JW2, Önder K1 1University of 
Salzburg, Salzburg, Austria 2Paracelsus Private Medical University Salzburg, Salzburg, 
Austria
Keratin 5 (KRT5) is known to form heterodimers with keratin 14 (KRT14) that assemble 
into the keratin fi lament network of basal keratinocytes in the epidermis. Disturbances 
of one of these keratin molecules through alterations can lead to skin fragility, 
manifested as Epidermolysis Bullosa simplex (EBS). Furthermore, it was reported that 
an equal and constitutive expression of keratin 16 (KRT16) with endogenous KRT14 
in transgenic mice shows an altered keratin fi lament network and decreased cell-cell 
adhesion which also causes skin fragility. In an earlier study we reported that KRT16 
is strongly induced in aged human skin, whereas KRT14 and KRT5 regulation was not 
infl uenced. To further characterize the molecular environment of KRT16 we performed 
a protein-protein interaction screen. In a genome-wide yeast two-hybrid (Y2H) screen 
we used KRT16 as bait and a comprehensive human skin cDNA library to identify new 
protein interactors. Surprisingly, KRT5 was found to interact directly and specifi cally 
with KRT16. Consistent with this fi nding, we could detect a strong upregulation of 
KRT16 mRNA in an EBS cell line, which harbours a mutation in KRT14 and leads to 
the breakdown of the intermediate fi lament cytoskeleton under mechanical stress. It 
is thinkable that excess of KRT16 molecules compete with reduced functional KRT14 
for heterodimerization with KRT5. In conclusion, the upregulation of KRT16 and the 
capability to interact with KRT5 could infl uence the balance between KRT5 – KRT14 
heterodimers, contributing to the ageing as well as EBS associated loss of skin integrity.
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Adipose derived stem cells up-regulate type VII collagen in the presence of recessive 
dystrophic epidermolysis bullosa keratinocytes.
Pourreyron C1, Cole CL1, McGrath JA2, Leigh IM1, South AP1 1University of Dundee, 
UK 2University of London, UK
Adipose tissue-derived stem cells (ADSC) are a population of pluripotent mesenchymal cells. 
ADSC can be isolated from subcutaneous adipose tissue and their low immunogenicity makes 
them an ideal candidate for use in cell therapy. Recessive dystrophic epidermolysis bullosa (RDEB) 
is a severe skin blistering disease caused by mutations in the gene encoding type VII collagen, 
COL7A1. Recently dermal fi broblast cell therapy has been explored as a treatment option for RDEB 
patients. As  ADSC have demonstrated in vitro and in vivo support of epidermal regeneration, 
differentiation and wound healing by up-regulating fi bronectin, collagen I and III expression and 
decreasing MMP1 expression we explored the possibility that ADSC may potentially represent 
a therapeutic advantage over dermal fi broblasts for RDEB cell therapy. In culture, ADSC express 
low levels of type VII collagen compared with dermal fi broblasts (4.3 fold less as determined by 
densitometry normalised against tubulin expression). When co-cultured with RDEB keratinocytes 
which express no detectable type VII collagen (p.R578X / p.R905X COL7A1 genotype), ADSC up-
regulate type VII collagen 4.6 fold and express 6.7 times more type VII collagen than identical co-
cultures of dermal fi broblasts and RDEB keratinocytes.We next examined the expression of matrix 
metalloproteinases in co-cultures of ADSC, dermal fi broblasts and RDEB keratinocytes. Equal levels 
of MMP1 protein were recovered from co-cultures of dermal fi broblasts and RDEB keratinocytes 
compared with co-cultures of ADSC and RDEB keratinocytes. Interestingly, dermal fi broblasts and 
RDEB keratinocyte co-cultures express 3.7 fold more MMP3 compared with identical co-cultures 
of ADSC and RDEB keratinocytes. As type VII collagen is a substrate of MMP3 and MMP3 activated 
collagenases, the high level of MMP3 in dermal fi broblast - RDEB keratinocyte co-cultures may 
explain the lower levels of type VII collagen. Our data indicate that ADSC are more suitable for 
RDEB cell therapy as a result of increased type VII collagen and decreased MMP3 expression.
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An in vitro disease model of lamellar ichthyosis
Li H, Valquist A, Törmä H Uppsala University, Uppsala, Sweden
Lamellar ichthyosis is the most common form of severe autosomal recessive congenital 
ichthyosis (ARCI). Mutations causing ARCI are found in the genes encoding e.g. 
transglutaminase-1, ichthyin or in enzymes that metabolize arachidonic acid into hepoxilin, 
i.e. ALOX12B and ALOXE3 that code for the enzymes 12R-LOX respectively eLOX-3. The 
possibility of studying the disease mechanisms and the effects of new treatments is limited 
by the number of available patients. We have therefore tried to establish an organotypic in 
vitro model that mimics lamellar ichthyosis.Primary human epidermal keratinocytes were 
cultured in serum-free keratinocyte medium containing growth factors and antibiotics. The 
cells were transfected with specifi c siRNA targeting the disease-causing genes, and 24 hours 
after transfection they were transferred to cell culture inserts. The transfected cells were grown 
at the air-liquid interphase and the organotypic epidermis was harvested after 10-13 days. 
Total RNA was isolated, cDNA synthesized and the gene expression quantifi ed using real-
time PCR. Biopsies taken from the organotypic epidermis were sectioned and stained with 
hematoxylin for histology and various antibodies for immunofl uorescence. The epidermal 
barrier function was monitored by measuring the penetration of Lucifer yellow.The mRNA 
expression of ALOX12B was reduced by 70-90% in ALOX12B-siRNA transfected epidermis 
at harvest, as compared to control epidermis. The transfected epidermis also exhibited 
an altered phenotype by premature expression of markers of keratinocyte differentiation, 
deeper penetration of Lucifer yellow and decreased protein expression of ALOX12B. 
We have established a short-term disease model for lamellar ichthyosis by transfecting 
disease-causing siRNA into normal keratinocytes. The transfected organotypic epidermis 
display an altered phenotype and functional changes. This model could be used to study 
the disease mechanisms and for studying the effects of various novel treatment options. 
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Analysis of the gene expression signature of cholesterol-depleted normal epidermal 
keratinocytes
Mathay C1, Pierre M1, Pittelkow MR2, Depiereux E1, Poumay Y1 1University of Namur 
(FUNDP), Namur, Belgium 2Mayo Clinic, Rochester, MN, USA
Cholesterol depletion by methyl-beta-cyclodextrin (MBCD) disrupts membrane 
lipid rafts and induces morphological and physiological alterations in confl uent 
keratinocytes. In order to get a close insight into the transcriptional regulation of 
cholesterol-depleted keratinocytes, we performed whole genome expression 
profi ling (Affymetrix HG_U133 Plus 2.0). Cholesterol-depleted and mock 
cholesterol-depleted cultures were analysed either immediately after the treatment, 
or after 1h or 8h of recovery to detect early and delayed responses to cholesterol 
depletion. Transcriptional regulation of genes is considered to be signifi cant when 
fold changes are above 2 or below -2 and the p value below 0.05 (adjusted for 
multiple testing). As expected, a huge number of genes are signifi cantly differentially 
regulated when cholesterol is extracted. Among the highly upregulated genes, we 
fi nd interleukin-8 (IL8), interleukin-1 alpha (IL1A), activating transcription factor 3 
(ATF3), urokinase type plasminogen activator receptor (PLAUR), prostaglandin-
endoperoxin synthase 2 (PTGS2 or COX2) and matrix metalloproteinases 1 and 
10 (MMP1 and MMP10). Interestingly, these genes are also involved in epidermal 
wound repair. Microarray-generated data for these genes are validated by real-
time PCR and we observe an excellent concordance of the two techniques. 
Further on, we identify the functional importance of IL8 and IL1A by detection of 
these interleukins in the extracellular medium. In addition, microarray data are 
currently being analysed by bioinformatic tools in order to cluster differentially 
regulated genes into groups with associated biological functions. Thus, our efforts 
establish a gene expression signature of cholesterol depletion which will help to 
determine the role of lipid rafts in the physiology of normal epidermal keratinocytes.
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Characterization of promoter elements regulating the expression of the psoriasis 
susceptibility allele HLA-Cw*0602
Bertoni A1, Capon F1, Matthews L2, Trembath RC1, Barker JN1 1Kings College London, 
London, UK 2Wellcome Trust Sanger Institute, Cambridge, UK
Psoriasis is an infl ammatory skin disorder with a strong genetic component. 
Genome-wide linkage and association scans have identifi ed HLA-C as a most 
likely disease susceptibility gene, with the HLA-Cw*0602 allele showing robust 
associations with psoriasis in a wide range of populations. The aim of this study was 
to characterize the genomic elements that regulate HLA-C expression, based on 
the notion that altered expression of this gene represents a plausible pathogenetic 
mechanism. In particular, we investigated whether genetic changes that are specifi c 
to the regulatory elements of different HLA-C alleles might affect gene expression 
levels. We used reporter assays to compare the promoter activity of HLA-Cw*0602 
with that of two non-risk alleles (HLA-Cw*0702, HLA-Cw*0304). We observed a 
signifi cantly increased promoter activity for Cw*0702 compared to Cw*0602 
and Cw*0304 (p< 0.0001). We hypothesized that this difference might be due to 
the presence of a genetic variant in the kB enhancer of Cw*0702. Site targeted 
mutagenesis of this variant resulted in a signifi cant decrease of promoter activity 
(p= 0.02), suggesting that polymorphism in the Cw*0702 kB enhancer confers 
increased binding affi nity for transcription factor NF-kB. Taken together, our fi ndings 
confi rm that promoter variants can result in the differential regulation of HLA-C 
alleles and pave the way for further studies of HLA-Cw*0602 specifi c changes. 
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Cockayne syndrome A and B interact in complexes with mitochondrial DNA and 
protect from mitochondrial aging of subcutaneous fat
Kamenisch Y1, Fousteri M2, Knoch J1, von Thaler A1, Schaller M1, van Steeg H3, Röcken 
M1, Krutmann J4, Mullenders L2, Berneburg M1 1University of Tübingen, Germany 
2MGC-Department of Radiation Genetics and Chemical Mutagenesis, Leiden, 
Netherlands 3MGO, Utrecht, Netherlands 4IUF, Duesseldorf, Germany
A defective DNA repair mechanism nucleotide excision repair (NER) either entails 
the skin cancer prone rare disease Xeroderma pigmentosum (XP) or premature aging in 
Cockayne syndrome (CS). Aging-associated reduction of subcutaneous fat is a hallmark 
of physiological aging, premature aging of CS patients as well as many other progeroid 
syndromes. While mutations of mitochondrial (mt)DNA have also been linked to aging, 
the functional involvement of NER-associated proteins in mtDNA mutagenesis and aging 
remains unknown. We could previously demonstrate the localization of CSA and CSB 
proteins in mitochondria and their mitochondrial enrichment upon oxidative stress as well 
as premature induction of mtDNA mutations in cells from patients missing CS-A and CS-B. 
This could be normalised by coincubation with quenchers (vitamin E) and stable transfection 
of CSA and CSB. Removal of oxidative mitochondrial DNA damage was impaired in 
cells of CS patients. Furthermore, we could show binding of the CSA and CSB protein to 
mtDNA in a complex by coimmunoprecipitation upon oxidative stress. Aged csbm/m-mice 
show a strong increase of mtDNA mutations in age-dependently reduced subcutaneous 
fat tissue which was not observed in other DNA repair defi cient mice - also not showing 
premature reduced subcutaneous fat. These data present a link between (I) the clinical 
premature aging symptom loss of subcutaneous fat in CS patients, (II) enhanced oxidatively 
induced mtDNA mutagenesis and (III) the mitochondrial localization of CS proteins 
interacting with mtDNA. This indicates a hitherto undescribed role of the NER-associated 
CS-proteins in protection from oxidatively induced premature aging of subcutaneous fat.
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Combining virotherapy and immunotherapy as a novel strategy for multi-modal 
treatment of malignant melanoma
Zanzinger K1, Mahnke K2, Enk AH2, Nettelbeck DM3 1Heidelberg Univ Hosp, 
2Heidelberg Univ Hosp, Germany 3German Cancer Res Center, Heidelberg, Germany
Novel treatment modalities for malignant melanoma are highly sought for and should ideally 
implement both a high degree of tumor-selectivity and multimodality. Virotherapy is a promising new 
tool for treatment of cancer by specifi c viral replication in tumor cells resulting in cell lysis and release 
of progeny viruses that spread in the tumor. Adenoviruses are leading oncolytic agents for virotherapy 
for which several clinical trials have demonstrated proof of principle and a favorable safety profi le. 
However, adenoviral oncolysis needs to be improved to achieve therapeutic benefi t in the clinic.We 
engineered the melanoma-targeted oncolytic adenovirus Ad5/3.2xTyr by (i) replacing the promoters of 
the essential early viral genes E1A and E4 with pigment cell-specifi c optimized tyrosinase promoters 
and (ii) by replacing the cell-binding capsid domain of adenovirus serotype 5 with the corresponding 
domain of serotype 3. This oncolytic adenovirus showed a strongly enhanced infection rate of freshly 
isolated melanoma cells and a block of their replication cycle in non-melanoma cells, thus establishing 
tumor-selectivity.The goal of this project is to establish a multi-modal melanoma therapy by combining 
the advantages of virotherapy (local killing of tumor cells) with immunotherapy (systemic anti-tumor 
immune response). So far it is not known if a specifi c anti-tumor immune response could be induced 
by oncolytic adenoviruses. We analyzed the profi le of chemokines expressed by melanoma cells 
before and after infection with Ad5/3.2xTyr on mRNA and protein level. In addition, we performed 
migration assays to analyze the effect of oncolysates on the recruitment of immune cells. Our data 
showed that infection of melanoma cells with melanoma-targeted oncolytic adenoviruses does not 
induce signifi cant changes in chemokine production and immune cell recruitment in comparison to 
non-infected melanoma cells. Based on these results we generated genetically engineered oncolytic 
adenoviruses expressing recombinant immunomodulators to induce the recruitment and activation of 
immune cells. We hypothesize that infection of melanomas with such genetically engineered oncolytic 
adenoviruses improves the anti-tumor immune response for an optimized immuno-virotherapy.




Compound heterozygous desmoplakin mutations result in a phenotype with a novel 
combination of skin, hair, heart and dental abnormalities
Peltonen S1, Sadowski S2, Brennan D2, Saukko P1, Wahl J3, Bruckner-Tuderman L5, 
Fertala A2, Uitto J2, Mahoney MG2 1University of Turku, Turku, Finland 2Thomas 
Jefferson University, Philadelphia, USA 3University of Nebraska Medical Center, 
Omaha, USA 4Turku University Central Hospital, Turku, Finland 5University Medical 
Center Freiburg, Freiburg, Germany
Desmoplakin (DP) anchors the intermediate fi lament cytoskeleton to the desmosomal 
cadherins and thereby confers structural stability to tissues. We present a patient with 
extensive skin and mucocutaneous blisters, epidermolytic palmoplantar keratoderma, 
nail dystrophy, enamel dysplasia and sparse woolly hair. The patient died at the age of 
14 from undiagnosed cardiomyopathy. The skin showed hyperplasia and acantholysis 
in the mid and lower epidermal layers while heart revealed extensive fi brosis and 
fi brofatty replacement in both ventricles. Immunofl uorescence revealed reduction of 
the C-terminal domain of DP in the skin and oral mucosa. Sequencing of the DP gene 
revealed undescribed mutations in the maternal and paternal alleles. Both mutations 
affected exon 24 encoding the C-terminal domain. The maternal mutation, c.7964 
C to A, results in a substitution of an aspartic acid for an alanine residue at amino 
acid 2655 (A2655D).  Structural modelling demonstrated that this mutation changes 
the electrostatic potential of the mutated region of DP, possibly altering functions 
that depend on intermolecular interactions. The paternal mutation, c.6310delA leads 
to a premature stop codon.  To conclude, we report a novel combination of DP 
mutation phenotypes affecting skin heart and teeth. This patient case emphasizes 
the importance of heart examination of patients with desmosomal genodermatosis. 
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Comprehensive analysis of the psoriatic transcriptome and comparison with 
previous studies and cytokine models
Gudjonsson JE, Ding J, Johnston A, Guzman A, Nair RP, Voorhees JJ, Abecasis GR, 
Elder JT University of Michigan, Ann Arbor, USA
Psoriasis is characterized by marked hyperproliferation and altered differentiation 
of the epidermis accompanied by complex immunologic, biochemical, vascular 
and neurologic alterations.  To elucidate molecular alterations in psoriasis, we 
performed a gene expression study on 58 paired lesional and uninvolved psoriatic 
and 64 control skin samples. This identifi ed 1,326 differentially regulated transcripts 
encoding 918 unique genes between psoriatic and normal samples with 549 genes 
being up- and 369 genes down-regulated.  Up-regulated genes included SERPINB4 
and PI3, DEFB4 and S100 family members.  Enriched gene-ontology categories 
included immune and defense response, and keratinocyte differentiation.  Down-
regulated genes included the Wnt-inhibitory factor-1 (WIF1), betacellulin (BTC) 
and CCL27.  Biological processes regulating fatty acid and lipid metabolism were 
enriched in the down-regulated gene set. Comparison with previously published 
psoriatic transcriptome sets revealed small overlap (<20%) with our dataset, with 
the majority of our genes never being previously described to be differentially 
regulated in lesional psoriatic skin.  To gain insight into the cytokine network in 
psoriasis we compared the psoriatic transcriptome to genomic maps of IL-17, 
IL-22, IFN-γ, TNF-α and oncostatin-M stimulated keratinocytes.  This revealed 
surprisingly small overlap with the psoriatic transcriptome suggesting limitations of 
current models.  This comprehensive analysis of differentially regulated transcripts 
in psoriasis identifi es a large group of genes which have not been described before, 
providing novel insights into the pathogenic mechanisms involved in psoriasis 
and more accurately defi ning the biochemical changes and pathways involved.
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Congenital paucity of bile ducts may be part of the NISCH phenotype
Nagtzaam IF, van Geel M, Steijlen PM, van Steensel MA Dept of Dermatology, 
Maastricht University Medical Center, Maastricht, Netherlands
Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome is a rare autosomal 
recessive syndrome associated with scalp hypotrichosis, scarring alopecia, 
ichthyosis, and sclerosing cholangitis. It is caused by homozygous mutations in the 
CLDN1 gene coding for the tight junction component claudin-1. It is rare, only fi ve 
patients having been reported so far. The fi rst report described four patients from 
two inbred Moroccan families, all carrying a dinucleotide deletion c.200_201delTT 
in the CLDN1 gene. Here, we report on three Moroccan brothers born from 
consanguineous (fi rst cousins) parents presenting with ichthyosis, hypotrichosis and 
congenital paucity of bile ducts. In our patients, we found the same dinucleotide 
deletion (c.200_201delTT) in the CLDN1 gene that had been previously reported. In 
our view, this is suggestive of a founder effect. Interestingly, our patients presented 
not with sclerosing cholangitis but with congenital paucity of bile ducts. Although the 
two conditions cannot always be easily distinguished, we would suggest that paucity 
of bile ducts could be a manifestation of NISCH. In addition, we propose that the 
syndrome may feature a recognizable facial phenotype.
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Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS 
show distinct chromosomal alterations and differential expression of chemokine 
receptors and apoptosis regulators
van Kester MS, Tensen CP, Vermeer MH, Dijkman R, Mulder AA, Szuhai K, Willemze 
R, van Doorn R Leiden University Medical Center, Leiden, Netherlands
Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is a cutaneous T-cell 
lymphoma (CTCL) that has a favorable prognosis. On the contrary, primary cutaneous 
peripheral T-cell lymphoma not otherwise specifi ed (PTL-NOS) displays aggressive 
clinical behavior. To identify genomic events relevant in the pathogenesis of C-ALCL 
and PTL-NOS, we performed array-based CGH analysis. Simultaneously, gene 
expression profi ling was conducted to gain insight into gene expression programs 
associated with the different clinical behavior of these CTCLs. Gene expression results 
were validated by qPCR and immunohistochemistry. C-ALCL was characterized by 
gains on chromosome 7q and 17q and losses on 6q and 13q. PTL-NOS similarly 
demonstrated gains on 7q and 17q, but was distinguished by frequent gains on 
chromosome 8 and loss of a focal overlapping region on 9p21. We identifi ed minimal 
common regions harboring candidate oncogenes and tumor suppressor genes in 
C-ALCL and PTL-NOS. Genes with a role in lymphocyte chemotaxis, apoptosis 
and proliferation were overrepresented in the set of genes differentially expressed 
between these lymphomas. C-ALCL demonstrated higher expression of chemokine 
receptors mediating skin-homing, which may explain their lower tendency to 
disseminate to extracutaneous sites. Furthermore, C-ALCL and PTL-NOS were 
characterized by aberrant expression of distinct sets of apoptosis-regulating genes, 
which may account for differences in disease progression and treatment resistance.
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Deletion of the LCE3B and LCE3C Genes on 1q21 is not Associated with Atopic 
Dermatitis
Bergboer J1, Zeeuwen P1, Kezic S2, Giardina E3, Weidingen S4, Irvine A5, Estivill 
X6, Postma D7, Armour J8, Schalkwijk J1 1Radboud Univ Nijmegen Med Centre, 
Netherlands 2AMC, Univ of Amsterdam, Netherlands 3Tor Vergata Univ of Rome, Italy 
4Technical Univ Munich, Germany 5Hospital Crumlin, Dublin, Ireland 6Centre for 
Genomic Regulation, Barcelona, Spain 7Dept of Pulmonology, Univ Medical Center 
Groningen, Netherlands 8Inst of Genetics & School of Biology, Nottingham, UK
Psoriasis and atopic dermatitis (AD) have common features like chronic cutaneous infl ammation 
and disturbed epidermal barrier function. Genome-wide analyses have shown an overlap of several 
susceptibility loci for these skin diseases, such as the chromosomal regions 1q21, 3q21, 17q25 and 
20p12. Recently, a deletion on 1q21 (LCE3C_LCE3B-del), comprising LCE3B and LCE3C, two members 
of the late cornifi ed envelope (LCE) gene cluster, was found to  be associated with psoriasis. Although the 
functional role of LCE proteins in psoriasis has not been identifi ed, these proteins are putatively involved 
in skin barrier formation and repair. Considering the possible genetic overlap  between the two diseases 
and the recent fi nding that mutations in the skin barrier protein fi laggrin are associated with AD, we 
investigated the association between LCE3C_LCE3B-del and AD. We evaluated four different cohorts of 
European ancestry, containing a total of 1075 AD patients and 1658 controls. In addition we analyzed 
a cohort of 307 patients with chronic irritant contact dermatitis (CICD) and 201 controls. Expression of 
LCE3C in normal and AD skin was examined by qPCR and immunohistochemistry. A weak, but signifi cant 
association was found in the Dutch discovery cohort, but this could not be confi rmed in Irish, German 
and Italian replication cohorts. Similarly, no association was found with concomitant asthma, nor did 
we fi nd an association in a group that had asthma without AD. In addition we failed to fi nd a signifi cant 
association in the CICD case-control cohort. Expression studies indicate that LCE3C is not expressed in 
normal skin but is induced in differentiated cells of lesional AD skin. Our data suggest that the potential 
roles of skin barrier defects in the pathogenesis of AD and psoriasis are based on distinct genetic causes.
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Detection of a Heterozygous c.1141G>A, p.E381K Mutation in Exon 6 of Keratin 14 
in Epidermolysis bullosa hereditaria simplex
Meissner C1, Kohlhase J2, Gollnick H1, Bonnekoh B1 1Clinic for Dermatology, Otto-
von-Guericke-University, Magdeburg, Germany 2Practice for Human Genetics, 
Freiburg, Germany
The hereditary forms of epidermolysis bullosa are categorized according to the 
anatomical level of tissue destruction into so-called i) simplex, ii) junctionalis and 
iii) dystrophica subgroups. We hereby report about the detection of a rare keratin 14 
mutation in a patient with the clinical features of epidermolysis bullosa hereditaria 
simplex. 71-year old patient who from birth was affected by increased vulnerability 
of the skin with formation of blisters with generally scarless healing. Same symptoms 
had been known for preceding three generations, i.e. the deceased mother, grand-
father and great-grand-mother, each from the mother´s side. The patient has two 
sons, one of them deceased, and two male and one female grandchildren without 
skin symptoms.The keratin 5 gene (Genbank NM_000424.2, NC_000012.10) was 
amplifi ed and seuqenced as previously described. The keratin 14 gene (Genbank 
NM_000526.3, NC_000017.9) was amplifi ed according to (reference removed) and 
a 5 kb product was directly sequenced by the methodology of (reference removed).
In our patient we found a c.1141G>A, p.E381K mutation in exon 6 of the keratin 
14 gene in a heterozygous state. No mutation was detected in the keratin 5 gene. 
Mutations in keratin 5 and keratin 14 are known to result in epidermolysis bullosa 
simplex. To our knowledge the mutation p.E381K has not yet been described. Given 
the fact that this represents a non-conservative amino acid exchange, the mutation 
is assumed to be of disease-causative importance in our case. The genetic study of 
other accessible family members is in progress in order to strengthen this conclusion.
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Different COL17A1 mutations cause in vivo reversion of the 2342delG mutation in 
patients with epidermolysis bullosa
Pasmooij AM, Nijenhuis AM, Jonkman MF University Medical Center Groningen, 
Groningen, Netherlands
Revertant mosaicism due to in vivo reversion of an inherited mutation has been described in the 
genetic disease epidermolysis bullosa (EB). Recently, we investigated a subgroup of 20 patients with 
non-Herltiz junctional EB for revertant mosaicism. Seven out of 20 patients (35%) had revertant 
skin patches without blister formation.Here, we demonstrate the presence of several different in 
vivo reversions, all correcting the germ-line COL17A1 mutation 2342delG, in three mosaic nH-JEB 
patients. All patients showed a severe reduction of type XVII-collagen expression in their affected 
skin. Patient 035-01 (2342delG/3781C>T) had clinically healthy skin on both knees and the right 
upper leg with normal expression of type XVII collagen. In his brother, 035-02 (2342delG/3781C>T), 
a revertant skin patch was identifi ed on his hand. In the third patient, who was unrelated (208-
01, 2342delG/2342delG), two patches were discovered on his wrist. DNA-analysis showed in 
revertant keratinocytes of distinct biopsy specimens different second-site mutations: 2344C>T, 
2368+2T>C and Del14 (2364-2368+9). The 2368+2T>C mutation was present in one biopsy of 
035-01, as well as in the biopsy of the hand of his brother, 035-02. Furthermore, 2342delG was 
absent in one of the revertant biopsies. The three compensatory second-site mutations -- 2344C>T, 
2368+2T>C and Del14 (2364-2368+9) -- affected splicing, by giving rise to an exon 30-deleted 
in-frame mRNA transcript. Outsplicing of the mutated exon 30, carrying the 2342delG mutation, 
resulted in a smaller but functional type XVII collagen protein. Our observations indicate that 
revertant mosaicism in non-Herltiz junctional EB is not rare. Two of the three patients had multiple 
correcting mutations in COL17A1, implying that there is not a single preferred mechanism for 
correction of the inherited 2342delG mutation. Special attention should be paid by physicians to 
homogeneously pigmented macular patches. Revertant mosaicism raises the possibility of revertant 
cell therapy with the use of the patient’s own naturally corrected cells for autotransplantation.
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Dowling Degos Disease – Diagnosis confi rmed by the identifi cation of a recurrent 
KRT5 mutation
Blazsek A, Virágh Zs, Glász-Bóna A, Wikonkál N, Hársing J, Mazán M, Hatvani Zs, 
Medvecz M, Kárpáti S Semmelweis University, Budapest, Hungary
Dowling-Degos Disease (DDD, OMIM No. 179850) is a benign, rare autosomal 
dominantly inherited genodermatosis, and has been recently proposed to be a 
haploinsuffi ciency disorder of keratin 5 (KRT5), the keratin intermediate fi lament 
cytoskeleton within the basal keratinocytes. DDD manifests as late onset reticular 
hyperpigmentation on fl exor surfaces that begins in the axillae and groin and later 
involves other body folds as well. The disease should be differentiated from Galli-
Galli , Kitamura’s and Haber’s diseases.  Two European studies identified early 
PTC causing mutations in the KRT5 as cause of the disease, while other studies 
performed on Asian patients found no association of the diseases and KRT5. 
Here we confi rm the diagnosis of DDD in the first described Hungarian case by 
demonstration of a previously identifi ed mutation of KRT5. The proband was 
heterozygous for the c.418dupA; p.Ile140AsnfsX39  mutation in the KRT5 gene 
previously identifi ed by Betz et al. in 2006.  Our report extends the limited number 
of DDD cases with completed KRT5 analysis and gives further evidence that KRT5 
and its mutation c.418dupA p.Ile140AsnfsX39 is responsible for this phenotype.
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Eight new ATP2C1 mutations and epigenetic regulation of microRNAs in Hailey-
Hailey disease
Hamada T, Ishii N, Sakaguchi S, Yasumoto S, Hashimoto T Department of Dermatology, 
Kurume University School of Medicine, Kurume, Japan
The autosomal dominant disorder Hailey-Hailey disease (HHD) results from mutations in the ATP2C1 
gene, which encodes the human secretory pathway Ca2+/Mn2+-ATPase protein 1. To date, over 
90 pathological mutations scattered throughout ATP2C1 have been described with no indication 
of mutational hotspots or clustering of mutations. We previously searched the pathogenic ATP2C1 
abnormality in eight unrelated Japanese and Korean patients with HHD and identifi ed six new 
mutations. In this study, we sequenced ATP2C1 in additional nine Japanese patients and one German 
patient with HHD in order to provide further contributions to the understanding of the molecular basis 
of this disorder. We have identifi ed eight new heterozygous missense, nonsense or frameshift mutations: 
p.Pro307His; p.Leu632Pro; p.Asn647His; p.Try483X; p.Gln504X; p.Gln505X; p.Gln706X; c.825delTA. 
In view of the ubiquitous expression of ATP2C1, it is not clear why skin lesions restrict to certain areas 
of the skin, such as intertriginous regions and the neck. The mechanism of haploinsuffi ciency might 
account for these manifestations. We then performed quantitative RT-PCR to compare ATP2C1 mRNA 
levels between lesional (inguinal) skin and uninvolved (abdominal) skin from four patients with HHD. 
The ATP2C1 expression signifi cantly decreased in lesional skin. On the other hand, microRNAs 
(miRNAs) bind to their target mRNAs, leading to mRNA degradation or its translational repression, 
based on the degree of complementarity. Upregulation of the specifi c miRNA expression could result 
in downregulation of ATP2C1. To assess this hypothesis, we subjected lesional and uninvolved HHD 
skins, and inguinal and abdominal normal skins to global miRNA expression profi ling on Gene Chip® 
miRNA Array. The data demonstrated upregulation of several miRNA expressions in lesional HHD 
skin and inguinal normal skin. We are currently studying about the possibility that ATP2C1 gene may 
be the target of posttranscriptional gene regulation of these miRNAs. Targeting these specifi c miRNAs 
may be a promising future therapy for HHD. Although many researchers are now working with 
miRNA for various skin diseases, miRNA study has just started in the research fi eld of genodermatosis.
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EKV mutant Connexin 31 associated cell death is mediated by ER stress
Tattersall D, Scott CA, Kelsell DP Bart and the London Medical School, London, UK
Connexin (Cx) proteins form gap junctions which allow the intercellular transfer 
of ions and small molecules between cells. Six Cx proteins assemble to make a 
hemichannel which can traffi c to the cell surface and dock with a hemichannel from 
an adjacent cell, forming a gap junction. The importance of gap junction intercellular 
communication is indicated by the association of mutations in Cx encoding genes 
with a range of diseases. The epidermis expresses at least ten Cx proteins of which fi ve 
are associated with inherited cutaneous disease, for example, Cx26 and Cx31. Distinct 
dominantly inherited mutations in Cx31 cause the skin disease erythrokeratoderma 
variabilis (EKV) and hearing loss with or without neuropathy. Functional studies 
reveal tissue-specifi c effects of these Cx31 disease-associated mutations. The Cx31 
mutants (R42P)Cx31, (C86S)Cx31 and (G12D)Cx31 are associated with EKV and 
the mutant (66delD)Cx31 with peripheral neuropathy and hearing loss, however the 
mechanisms of pathogenesis remain to be elucidated. Expression of (R42P)Cx31, 
(C86S)Cx31 and (G12D)Cx31 in vitro, but not (WT)Cx31 or (66delD)Cx31, cause 
elevated levels of cell-type specifi c cell death. Previous studies suggest that connexin-
associated cell death may be related to abnormal “leaky” hemichannels but we 
produced direct evidence against that being the major mechanism. Additionally, our 
immunocytochemistry showed upregulation of components of the unfolded protein 
response (UPR) in cells expressing the EKV-associated Cx31 mutants but not (WT)Cx31 
or (66delD)Cx31. We conclude that the endoplasmic reticulum (ER) stress leading to 
the UPR is the main mechanism of mutant Cx31 associated cell death. These results 
indicate that, in vivo, ER stress may lead to abnormal keratinocyte differentiation and 
hyperproliferation in EKV patient skin. Further studies are in progress investigating 
UPR as a possible disease-associated mechanism for other keratinisation disorders.
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Epigenetic profi ling of human keratinocytes
Szeverenyi I1, Eng GH1, Lunny DP1, Lane B1,2 1Institute of Medical Biology, Singapore 
2College of Life Sciences, University of Dundee, UK
Terminal differentiation of keratinocytes is a tightly regulated process in space and time that 
allows the formation of the epidermal barrier. During this differentiation the pattern of keratin 
expression changes from K14 and K5 in the basal, mitotically-active layer of the epidermis to K10 
and K1 in the suprabasal post-mitotic layers. Synthesis of basal keratins K5 and K14 is down-
regulated as cells are released from the basal lamina, and expression of suprabasal keratins, 
K10/K1, is simultaneously induced. Downregulation of K5 and/or K14 is also seen sporadically 
in squamous cell carcinomas, where it is associated with an invasive or metastatic behaviour 
and is often correlated with the appearance of expression of simple epithelial keratins K8 and 
K18. The mechanism of regulation control of these basal keratins is not known.We investigated 
K14 expression silencing in keratinocyte cell lines in which this phenomenon is observed. In a 
keratinocyte line derived from NEB-1 cells, we observed spontaneous progressive silencing of 
K14 expression over time and increasing passage number. Using organotypic air-liquid interface 
cultures we observed that these cells show abnormal stratifi cation and terminal differentiation. 
By immunohistochemistry we detected expression of differentiation markers such as K10 and 
loricrin, but their distribution was very different from the normal pattern seen with NEB-1 cells 
and primary keratinocytes in 3D organotypic culture. No mutation was identifi ed in the genomic 
DNA of K14 coding or promoter regions, but we found that KRT14 gene was silenced by epigenetic 
modifi cation. Reactivation of K14 expression was observed upon treating the cells with a DNA 
methyltransferase inhibitor, confi rming gene silencing by DNA methylation. Fine mapping of 
methylated CpGs in the KRT14 regulatory region revealed an inverse correlation between K14 
expression and methylation status of CpG dinucleotides. Our data suggest that DNA methylation 
may be a signifi cant factor regulating epidermal keratin gene expression, either by directly 
preventing binding of transcription factors or indirectly by inducing repressed chromatin structure.
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Familial chilblain lupus - a monogenic form of cutaneous lupus erythematosus due 
to a heterozygous mutation in TREX1
Günther C, Meurer M, Stein A, Viehweg A, Lee-Kirsch M Technical University 
Dresden, Germany
Chilblain lupus erythematosus is a rare form of cutaneous lupus erythematosus, 
characterized by bluish red infi ltrates on acral locations of the body mostly 
affecting middle-aged women. We recently described a familial form of chilblain 
lupus manifesting in early childhood associated with a heterozygous mutation in 
the TREX1 gene, which encodes a 3´-5´ DNA exonuclease. Thus, familial chilblain 
lupus represents the fi rst monogenic form of cutaneous lupus erythematosus. Here 
we describe the unusual clinical course of this newly defi ned genodermatosis 
in an 18 year-old female member of the family in which familial chilblain lupus 
was originally described. The clinical picture was characterized by the early 
beginning of the lesions at the age of 2 years and a progressive course during 
adolescence. Sudden changes in temperature, mental and physical stress as well 
as weight loss lead to exacerbations of the skin manifestations. Beside typical 
acral lesions the patient developed infi ltrated lesions on her tighs which were 
shown by histopathology to contain marked subcutaneous deposits of mucin. 
Laboratory investigation revealed hypocomplementemia with descreased C4- and 
C3-serum levels, slighly elevated serum concentrations of antibodies to ssDNA 
and the HLA haplotype B8 and DRB1. To the best of our knowledge, we show 
for the fi rst time the expression of TREX1 protein in lesional skin and describe the 
treatment of this genodermatosis with hydroxychloroquine and cold protection. 




Gene expression patterns of psoriasis and other chronic infl ammatory diseases
Mesko B, Poliska Sz, Szegedi A, Nagy L University of Debrecen Medical School and 
Health Science Center, Debrecen, Hungary
Chronic infl ammatory diseases are a substantial burden in social and economic terms worldwide, 
and because of frequent co-morbidity, several other disorders are also related to this group of 
diseases. Chronic infl ammmatory diseases include psoriasis, and the other conditions with similar 
background in pathomechanism such as infl ammatory bowel disease (IBD; including Crohn disease 
and ulcerative colitis) and rheumatoid arthritis (RA). Despite the importance of these diseases 
and intensive global research, there have been relatively few innovative breakthroughs into the 
description of their genetic background regarding common or different gene expression patterns.
The aim of our experiment is to fi nd disease- or infl ammation-specifi c genetic markers and to 
fi nd correlation between clinical parameters and gene expression patterns with special interest in 
the genomic background of the chronic-plaque form of psoriasis.We collected peripheral blood 
samples from patients with chronic infl ammatory diseases such as psoriasis, RA, and IBD; and 
also healthy controls after determining inclusion and exclusion criteria. We isolated RNA from 
mononuclear cells that are meant to be the precursors and key cells in infl ammation. Converted 
RNA into cDNAs and performed Real Time-QPCR analysis on Taqman Low Density Arrays.We found 
5 genes that differentiated all the chronic medical conditions from healthy controls. These genes 
may represent chronic infl ammation. We created gene panels that differentiated each diseased 
group from healthy patients. Regarding clinical markers, the gene expression levels of a set of genes 
signifi cantly separated psoriasis patients from patients with psoriatic arthritis. We also validated 
genes that had previously been associated with psoriasis such as ADM, ANXA3, PBEF and AQP9 
among others.To think in terms of personalized medicine, these gene panels that are based on gene 
expression profi les of peripheral blood samples can lead to the development of diagnostic kits.
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Genetic variants of the Endocannabinoid receptor type I (CNR1) gene: association 
with susceptibility to cutaneous T-cell lymphoma (CTCL)
Vasku V1, Bienertova-Vasku J2, Bienert P2, Vasku A2 1Masaryk University, Faculty 
of Medicine, 1st Clinic of Dermatovenerology, Brno, Czech Republic 2Masaryk 
University, Faculty of Medicine, Dept of Pathological Physiology, Brno, Czech 
Republic
Endocannabinoids are lipid mediators thought to modulate central and peripheral 
neural functions. Recently, the overexpression of the central and peripheral 
cannabinoid receptors CB1 and CB2 was reported in various types of lymphomas. 
Therefore, the aim of the study was to investigate potential associations of 3 common 
SNPs in CNR1 gene (rs1049353, rs12720071 and rs806368) with cutaneous T-cell 
lymphoma. The total of 97 patients with CTCL were recruited for the study along 
with 258 healthy Czech individuals of similar age and gender distribution. No 
signifi cant differences in genotype distributions as well as allele frequencies were 
observed between the CTCL cases and controls. Five common haplotypes in the 
CNR1 gene were identifi ed, whereas the frequencies of the haplotypes differed highly 
signifi cantly between the cases and the controls (Phap<0.001). In the multivariate 
modelling, the CNR1 4895 C/T (rs806368) expressed an independent prediction 
role for the CTCL staging (β=-0.27, P =0.05). Based on our results, the CNR1 
gene could be considered a susceptibility marker for cutaneous T-cell lymphoma.
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Genetic variants of the proopiomelanocortin (POMC) gene: association with 
psoriasis susceptibility
Bienertova-Vasku J1, Vasku V2, Vasku A1, Bienert P1 1Masaryk University, Faculty of 
Medicine, Department of Pathological Physiology, Brno, Czech Republic 2Masaryk 
University, Faculty of Medicine, Clinic of Dermatovenerology, Brno, Czech Republic
Psychological distress has been for long known to substantially aggravate 
infl ammatory skin diseases such as psoriasis. Alterations in functioning of the 
Hypothalamic-Pituitary-Adrenal (HPA) axis, where POMC plays the crucial role, 
have been previously suggested to be involved in development of psoriasis. However, 
there is little evidence of impaired response of the HPA axis on environmental 
stimuli due different individual genetic background. Therefore, the aim of the study 
was to investigate possible effects of RsaI (rs3754860) and C1032G (rs1009388) 
polymorphisms in the non-coding regions of POMC gene on psoriasis and its related 
factors. We examined the total of 433 patients with psoriasis vulgaris and 403 healthy 
controls of similar age and gender distribution. No statistically signifi cant differences 
were observed when genotype frequencies or allele distributions of the psoriatic 
group were compared to those of healthy controls. In the multivariate modeling, the 
RsaI polymorphism was signifi cantly associated with the early onset of the disease 
(β= -0.10, P = 0.04) and with the staging of the disease (β= -0.25, P < 0.00003); 
whereas the lowest staging was associated to the ‘--‘ genotype. Moreover, RsaI was 
also associated with the personal history of allergy (β= 0.15, P = 0.02), whereas the 
++ genotype represented the risk variant for personal allergy history. Furthermore, 
common haplotypes in POMC gene were identifi ed, with no case-control differences 
observed. The ‘-G’ haplotype was signifi cantly associated with the highest rate of 
recurrent tonsillitis in psoriasis cases (β= 0.13, P = 0.005).To conclude, our results 
indicate that the investigated POMC gene variants could act as specifi c risk factors for 
psoriasis-related anamnestic factors, relevant for susceptibility to psoriasis in general.
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Genome-transcriptome fusion analysis of the dominant clonal and reactive T helper 
subpopulations in Sézary syndrome
Karpova MB1, Okoniewski M2, Lazarevych LI3, Laine E1, Cozzio A1, French LE1, 
Dummer R1 1Univ Hosp Zurich, Switzerland 2Functional Genomics Center, University 
of Zurich, Switzerland 3Swiss Federal School of Technology, Zurich, Switzerland
Sézary syndrome (SS) is characterized by the presence of neoplastic Sézary cells (SCs) in blood, lymph 
nodes, and skin. Large scale evaluation of single nucleotide polymorphisms (SNPs), as well as expression 
profi ling, are comprehensive tools for a detailed analysis in human genome and transcriptome, revealing 
genomic aberrations and patterns of deregulated gene expression contributing to the cancer phenotype 
including identifi cation of epigenetic hot spots.We have screened peripheral blood of SS with mAb 
against various V-beta regions and identifi ed the individual dominant T-cell clones in 5 untreated SS 
patients. Thereafter, non-clonal CD4 and V-beta +/CD4 cells were sorted by MACS; DNA and RNA were 
extracted. We studied genomic and transcriptional features using high-throughput genomic profi ling with 
SNP mapping arrays (Mapping-500K Array Set, Affymetrix) and micro array profi ling (U133–Plus-2.0 Array, 
Affymetrix). Genome-transcriptome fusion analysis compared non-clonal CD4 and V-beta +/CD4 of fi ve 
SS patients. Algorithm of fusion analysis included RMA and BRLMM summarization, identifi cation of 
differentially expressed genes and differential SNP alleles and joint annotation processing using NetAffyx, 
ADAPT and Ensemble databases.We have not found any major chromosomal aberrations in these patients, 
on the other hand, expression analysis showed differential expression of approximately 2-10% of analyzed 
transcripts. Investigation of genotyping function of 500K array revealed up to 5% of differential SNP alleles 
between tumor and normal cells of a patient. Fusion analysis of genotyping and expression profi ling 
detected on average 160 genes, including CCL5, TGFBI, TLR8, RAB8B, and RAB31 where differential 
SNP allele was combined with differential expression on transcriptional level. Data obtained in this 
study provide an exceptionally detailed insight into the genome-transcriptome changes that are involved 
in the pathogenesis of SS. The results may help to initiate development of therapeutic strategies targeting 
specifi c properties of the tumor cell population without interfering with normal T helper cell functions.
305
Germllne PATCHED mutations impact both epidermal and dermal skin cells in 
patients with the BCC prone Gorlin syndrome
Magnaldo T1, Valin A2, Barnay-Verdier S2, Brellier F3, Chevallier-Lagente O2, Avril MF4 
1CNRS, Institut Gustave Roussy, Faculté de M, Nice/Villejuif, France 2CNRS, Institut 
Gustave Roussy, Faculté de M, Villejuif, France 3Friedrich Miescher Institute, Villejuif, 
France 4Dermatologie, Universite Paris 5, France
The Gorlin or nevoid basal cell carcinoma syndrome is a dominant genetic disease due to the mutation of 
one allelle of the PATCHED gene which encodes the receptor of the diffusible morphogen protein, SONIC 
HEDGEHOG (SHH). Gorlin patients suffer from variable developmental traits and a very high proneness to 
BCCs. Surprisingly, Gorlin BCC develop in both photo exposed and photo protected areas of the skin. To 
explore the extent to which PATCHED mutations affect human skin cells, we isolated primary keratinocytes 
and fi broblasts from non photo exposed skin biopsies of Gorlin patients with authenticated PATCHED 
+ /- mutations. In organotypic skin cultures ex vivo, PATCHED +/- keratinocytes spontaneously formed 
epidermal invasions within dermal equivalents. As observed in BCCs in vivo, these invasions showed high 
numbers of CYCLIN D1 positive nuclei compared to controls, suggesting abnormal activation of the SHH 
PATHWAY in PATCHED +/- keratinocytes. Expression of GLI2, a transcriptional effector of the pathway, was 
also found signifi cantly increased in patients keratinocytes. Then, we explored the possible contribution of 
the stroma in the development of BCCs in Gorlin’s patients by analysing the transcriptome of PATCHED 
+/- healthy fi broblasts in organotypic skin cultures. Patients’ fi broblasts proved to spontaneously express 
a transcriptional signature similar to that of activated fi broblasts associated with carcinoma associated 
fi broblasts described at the periphery of BCCs from the general population. Notably, MMP1 and 3, FGF7, 
CXCL12 (SDF1) and TNC were found signifi antly over expressed in patients fi broblasts, some features 
expected to promote keratinocytes proliferation and invasiveness. These observations indicates that 
PATCHED heterozygosity in human skin not only impacts epidermal cells from which BCCs develop, 
but also dermal fi broblasts that may actively contribute to tumoral development in Gorlin patients.
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Gradual expression of plectin defi ciency in a patient with epidermolysis bullosa 
simplex and adult-onset muscular dystrophy
Klausegger A1, Wadell L2, Grasern N1, Lloyd L3, Tran K4, Bauer JW1, North K2, Murrell 
DF4 1eb-house, Salzburg, Austria 2Westmead Hospital, Sydney, Australia 3Royal 
Brisbane Hospital, Brisbane, Australia 4St.George Hospital, Sydney, Australia 5Royal 
Children´s Hospital, Melbourne, Australia
Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) (OMIM 226670) is 
an autosomal recessive disorder caused by mutations of the human plectin gene on 
chromosome 8q24. We report on a 42y Caucasian father of two with EBS-MD who 
had developed blisters at birth with no prior family history of EB nor consanguineity. 
Slowly progressive muscle weakness manifesting in his 20s and recently slight ptosis 
(drooping of the eyelids) and ophthalmoplegia were obsevered. Antigen mapping 
of cryosections of the patient´s skin showed a very reduced fragmented staining of 
plectin antibody 121 above and below the blisters. Plectin staining in muscle fi bres 
pointed to a subtle difference in staining intensity compared to the control as a 
possible reduction of plectin in type 2 fi bres and a possible increase in type 1 fi bres. 
Staining of  desmin, known to be associated to plectin, displayed signifi cant reduction 
of the protein in sarcolemma as well as abnormal desmin inclusion in cytoplasma.
Plectin specifi c Real Time PCR revealed a 12-fold reduction of mRNA levels of patient 
fi broblasts compared to control fi broblasts. Mutation analysis disclosed a novel 
spontaneous paternally inherited heterozygous nonsense mutation (Q1644X) in exon 
31 and a well known maternal deletion of three amino acids (890del3) in exon 22.
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Harlequin ichthyosis: prenatal diagnosis and a review of the clinical outcome of 
survivors
Rajpopat S, O’Toole EA, Kelsell DP Barts and the London School of Medicine and 
Dentistry, Queen Mary University of London, United Kingdom
Harlequin ichthyosis (HI) is the most severe and often lethal form of autosomal recessive 
congenital ichthyosis and is caused by mutations in the ABCA12 gene. Affected foetuses 
display abnormal sonographic features late in the second trimester but identifi cation of 
these is technically challenging and operator dependent. A review of over 70 families 
worldwide showed that approximately 55% of affected HI neonates survive into childhood 
and beyond. However, little is known about the long term prognosis of survivors. This study 
aims to identify novel ABCA12 mutations to facilitate prenatal diagnosis and secondly 
to review a large cohort of survivors to assess clinical outcomes and prognosis. ABCA12 
mutations have been identifi ed by our group in over 70 families. This information has been 
used for prenatal diagnosis in the UK. Additionally, we successfully performed prenatal 
diagnosis in 2 HI families living in Turkey and Pakistan.  Chorionic villus biopsy DNA was 
sequenced and compared to the known founder mutations. Within days we confi rmed both 
foetuses were unaffected. In instances where termination of pregnancy is being considered, 
this test is desirable as it offers an earlier and more accurate result than ultrasound. To assess 
clinical outcome we used a retrospective questionnaire that was emailed to dermatologists 
worldwide. Initial results show neonatal mortality is associated with respiratory distress 
and sepsis. There are problems with motor development delay in infancy and arthritis in 
older children as well as visual problems due to persistent ectropion, keratitis and cataracts. 
A high calorie diet is needed to maintain weight. Initial patient dermatology life quality 
index scores surprisingly averaged below 10 but this does not refl ect the impact of the 
disease on the family. This study provides new insights into the care of patients with HI. 
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Hypotrichosis simplex of the scalp: an amyloidosis caused by fi brillar aggregates of 
mutated corneodesmosin
Caubet C1, Bousset L2, Clemmensen O3, Sourigues Y2, Bygum A3, Coudane F1, Betz R4, 
Melki R2, Simon M1, Serre G1 1CNRS-University of Toulouse, Toulouse, France 2CNRS, 
Gif-sur-Yvette, France 3Odense University Hospital, Odense, Denmark 4University of 
Bonn, Bonn, Germany
Heterozygous nonsense mutations in the CDSN gene encoding corneodesmosin, an 
adhesive protein expressed in cornifi ed epithelia and hair follicles, cause Hypotrichosis 
Simplex of the Scalp (HSS), a non-syndromic form of alopecia. Truncated mutants 
of CDSN (mutCDSN), which bear the N-terminal adhesive Gly/Ser–rich domain 
of the protein, abnormally accumulate as amorphous deposits at the periphery of 
hair follicles and in the papillar dermis of the patient skin. Based on histological 
similarities between HSS and the primary localized cutaneous amyloidosis, we 
hypothesized that HSS is a protein misfolding disease. Here, we present evidence 
that the mutCDSN deposits display an affi nity for amyloidophilic dyes, namely Congo 
Red and Thiofl avin T. We also detected the serum amyloid protein component in the 
dermis, including papillar dermis, of HSS patients. We demonstrated that recombinant 
forms of mutCDSN and of the Gly/Ser–rich domain assemble in vitro into ring-shaped 
oligomeric structures and fi brils. The amyloid-like nature of the fi brils was demonstrated 
by dye binding and Fourier transform infrared spectrometry measurements. We 
showed that the ring-shaped oligomers of mutCDSN, but not the fi brillar forms, are 
toxic to cultured keratinocytes. Finally, online algorithms predicted the Gly/Ser–rich 
domain of corneodesmosin to be a particularly disordered region in agreement with 
circular dichroism measurements. This identifi es HSS as a human amyloidosis related 
to the aggregation of natively unfolded mutCDSN polypeptides into amyloid fi brils.
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Hypoxia Inducible Factor-1alpha Regulates the Expression of Nucleotide Excision 
Repair Proteins in Keratinocytes
Rezvani H1, Mahfouf W2, Chemin C2, de Verneuil H2, Taieb A2, Bickers D3, Mazurier 
F2 1INSERM U876-Univ Bordeaux 2 and Columbia University 2INSERM U876-Univ 
Bordeaux 2, France 3Columbia University, New York, USA
We have previously reported that expression of hypoxia-inducible factor-1alpha (HIF-1alpha) 
is modulated after ultraviolet B (UVB) exposure and plays an important role in the regulation of 
cellular responses to this type of genotoxic stress. We brought out that UVB induce reactive oxygen 
species (ROS), which then in turn have a biphasic effect on HIF-1alpha expression. Furthermore, 
we have shown a pro-apoptotic effect of HIF-1alpha in irradiated cells, accompanied by p53 
modulation, which suggests a link between UVB-induced ROS production, HIF-1alpha variation 
and DNA repair. Among DNA repair systems, nucleotide excision repair (NER) is the major pathway 
for repairing numerous types of damage induced by UVB irradiation. Despite the functional and 
clinical importance of NER in maintaining genetic stability, little is known about the regulatory 
mechanisms underlying its expression. We have studied the regulatory effects of HIF-1alpha on 
the expression of the two NER factors (XPC and XPD) following exposure of human keratinocytes 
to UVB.Using electromobility shift assay (EMSA), quantitative chromatin immunoprecipitation 
(ChIP), and luciferase reporter system, we have demonstrated that HIF-1alpha is involved in the 
regulation of XPC and XPD. Early down-regulation of HIF-1alpha after UVB irradiation increased 
XPC mRNA expression. This was explained by an overcompetition of HIF-1alpha with Sp1 for 
overlapping DNA binding sites. Late UVB-induced enhanced phosphorylation of HIF-1alpha 
protein upregulated XPC mRNA expression by direct binding to a separate hypoxia response 
element (HRE) in the XPC promoter region. HIF-1alpha also regulated XPD expression by binding 
to a region of seven overlapping HREs in its promoter. Since it is well accepted now that HIF-1alpha 
is a factor not only regulated by oxygen level but also by various stress signals, we can truly consider 
a broader role of HIF into the maintenance of the genomic integrity under various stressors.
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Identifi cation of miRNAs that may Account for the Aggressiveness of Malignant 
Melanoma
Diederichs S2, Pscherer A3, Schadendorf D1, Eichmueller S1 1Skin Cancer Unit, German 
Cancer Research Center, Heidelberg & University Hospital Mannheim, Heidelberg & 
Mannheim, Germany 2Molecular RNA Biology & Cancer, German Cancer Research 
Center, Heidelberg, Germany 3Translational Tumor Immunology, German Cancer 
Research Center, Heidelberg, Germany
Malignant melanoma is the most aggressive form of skin cancer in human with still rising 
incidence. Present treatment modalities are unsatisfactory and the 5-year survival rate for distant-
stage melanoma is 16%. One of the unsolved questions in melanoma is the extremely fast 
progression once metastasized, although there are quite big differences between individual cases. 
MicroRNAs (miRNA) are small non-coding RNAs that control gene expression by translational 
repression or mRNA degradation. Functional studies indicate that miRNAs participate in the 
regulation of almost every cellular process investigated and that changes in their expression 
were observed in a variety of cancer types. In this study, we aimed to identify miRNAs whose 
dysregulation may account for the aggressiveness of malignant melanoma. We selected two 
groups of melanoma cell lines which were all derived from metastasis of stage IV patients, 
but differed strongly in their survival after fi rst diagnosis of stage IV melanoma. We performed 
miRNA profi ling on individual melanoma cell lines using Illumina miRNA chip. A number of 
miRNAs were found to be differentially expressed between the two groups. Expression of hsa-
miR-19a, hsa-miR-33b, and hsa-miR-138, which were down-regulated in the short survival group 
compared to the long survival group, was further confi rmed by Taqman real-time PCR. Pathway 
predictions for candidate miRNAs indicate potential modulatory roles in the progression of 
this disease. Selected miRNAs and predicted target 3’ UTRs have been cloned into vectors for 
ongoing target validation and functional studies. In summary, our data indicate that the expression 
level of certain miRNAs may be associated with the aggressiveness of malignant melanoma.
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Increased expression of the neurite growth factor Meteorin in lesional skin of 
individuals with familial primary localized cutaneous amyloidosis
Tanaka A1, Lai-Cheong J1, Van den Accer P2, Nagy N1, Palisson F3, McGrath J1 1St 
Johns Institute of Dermatology, London, UK 2University Medical Center Groningen, 
Groningen, Netherlands 3University of Chile, Santiago, Chile
Familial primary localized cutaneous amyloidosis (FPLCA) is an autosomal dominant disorder 
associated with chronic itching and skin lichenifi cation. In lesional skin there are apoptotic basal 
keratinocytes, epidermal keratin fi lament-associated amyloid material in the upper dermis and a 
reduced number of nerves within the epidermis and at the dermal-epidermal junction. The genetic 
basis of FPLCA involves mutations in the OSMR gene, encoding the IL-6 family cytokine receptor, 
oncostatin M receptor-β, the ligands for which are OSM and IL-31. Nevertheless, the pathophysiology 
of the clinical symptoms of pruritus and the histological signs of apoptosis are not currently known. 
To investigate this, we compared gene expression profi les between site-matched control skin (n=6) 
and OSMR mutant FPLCA lesional skin (n=4) using the Illumina Sentrix Human-6 Whole Genome 
Expression Beadchips. In FPLCA skin, two-fold or greater expression changes were noted for 77 
genes (34 upregulated, 43 downregulated). No signifi cant differences were noted in OSM, OSMR, 
IL-31 or IL-31RA gene expression. Consistent with epidermal hyperproliferation, FPLCA skin showed 
increased expression of KRT6E, KRT16, FABP5, SPRR2G, 2B, 2A and 1A. In addition, FPLCA skin 
showed a 2.1-fold increase in expression of METRNL, which encodes the neurotrophic growth factor, 
Meteorin. Real-time RT-PCR confi rmed a 2.0-fold increase in Meteorin in FPLCA whole skin cDNA. 
Little is known about Meteorin in human skin: it is mainly expressed in neural progenitors and 
has a role in glial cell differentiation and axonal network formation. Given the nerve pathology in 
FPLCA skin, it is possible that increased Meteorin expression may be a secondary response to nerve 
loss. Alternatively, it is plausible that Meteorin has a more critical role in FPLCA pathophysiology, 
contributing to the cutaneous pathology that underlies the major clinical feature of pruritus.
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Infl uence of age-associated hormone decline on human dermal fi broblasts
Makrantonaki E1, Adjaye J2, Brink TC2, Hermes B3, Vogel K3, Fimmel S3, Groth 
D2, Hultschig C2, Lehrach H2, Zouboulis CC1 1Dessau Medical Center, Dessau, 
Germany 2Max Planck Institute for Molecular Genetics, Berlin, Germany 3Charité 
Universitaetsmedizin Berlin, Berlin, Germany
Within the scope of the Explorative Project Genetic Etiology of Human Longevity supported by the 
German National Genome Research Network 2 (NGFN-2) an in vitro model of human hormonal 
ageing has been developed. Several skin cell lineages were maintained under a hormone-substituted 
environment consisting of growth factors (GH, IGF-I) and sexual steroids (17â-estradiol, progesterone, 
DHEA and testosterone) in concentrations corresponding to those circulating in 20- (f20) and in 60 
(f60)-year-old women. In order to decipher the effects of hormones and their decline occurring with 
age on skin dermis, the biological activity and the gene expression pattern of human dermal fi broblasts 
were analyzed using the in vitro model mentioned above. The corresponding hormone receptor 
expression was confi rmed by RT-PCR, Western blotting and immunocytochemistry. Fibroblast 
proliferation, measured by 4-methylumbelliferyl-heptanoate assay, was signifi cantly stimulated under 
the respective hormone treatments (p<0.001). In addition, f60-fi broblasts showed lower content of 
neutral lipids (p<0.01) in contrast to f20-fi broblasts by means of nile red microassay. Expression 
profi ling employing a cDNA microarray composed of 15,529 cDNAs identifi ed ca. 300 genes with 
altered expression levels at f20 vs. f60. Confi rmation of gene regulation was performed by real-time 
RT-PCR. The functional annotation of these genes identifi ed pathways related to cell metabolism 
and organization, cell cycle and growth, and oxidative stress. 34 common genes were found to be 
differentially expressed in hormonally aged SZ95 sebocytes and in dermal fi broblasts. Our data 
demonstrate that biological activity and transcriptome of dermal fi broblasts may be affected by the 
age-associated hormone decline, they illustrate hormone-dependent genes and signalling pathways 
in human dermal cells and display the importance of hormones in human endogenous skin ageing.




Involvement of DHCR7 and DHCR24 in the physiology of epidermal keratinocytes
Minner F, Ruban E, Mathay C, Herin M, Poumay Y University of Namur (FUNDP), 
Namur, Belgium
The epidermis is mainly composed of keratinocytes that proliferate in the basal layer and 
differentiate in the suprabasal layers, leading to keratinisation. Changes in epidermal 
differentiation or cholesterol composition lead to a disturbed epidermal barrier, which can allow 
immunological reactions and infl ammation. In serum-free autocrine culture conditions, the 
confl uence of keratinocytes in monolayer corresponds to a strong commitment toward epidermal 
differentiation. In this model, we show that the expression of genes implicated in cholesterol 
synthesis, such as hydroxymethylglutaryl CoA reductase (HMGCR), squalene epoxidase (SQLE), 
and 24-dehydrocholesterol reductase (DHCR24), but not 7-dehydrocholesterol reductase 
(DHCR7), increase with differentiation of keratinocytes. Since membrane cholesterol depletion in 
keratinocytes using methyl-beta-cyclodextrin (MbCD) induces an altered differentiation profi le and 
since the dysfunctions of enzymes involved in cholesterol synthesis lead to skin diseases, such 
as those observed in Smith-Lemli-Opitz Syndrome (SLOS) caused by dysfunction of DHCR7 or 
in Desmosterolosis provoked by a lack of functionality of DHCR24, we investigated potential 
specialized functions of DHCR7 and DHCR24 in the keratinocytes physiology. Both enzymes are 
implicated in the last steps of cholesterol biosynthesis pathway and recent data have shown that 
these enzymes play other functions such as the regulation of responses to oxidative stress. Therefore, 
we used both pharmacological inhibitors and siRNA approach in order to fi rst inhibit DHCR7 or 
DHCR24 in keratinocytes. Then, after an oxidative stress, we observe that the expression of keratin-
10 is decreased after DHCR24 inhibition by siRNA, but not after DHCR7 inhibition. However, in 
these conditions, we observe that the inhibition of DHCR7 induces an increase in the expression 
of genes identifi ed by microarray as being induced after membrane cholesterol depletion, e.g. 
interleukin-8. Our results suggest that DHCR7 and DHCR24 enzymes are regulated in keratinocytes 
and participate to the physiological response of this cell type against an oxidative stress.
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Leukotrienes and leukotriene-signaling in atopic dermatitis
Rühl R1, Mihaly J1, Szegedi A2 1Laboratory of Nutr Bioactivation and Bioanalysis, 
Dept of Biochem and Mol. Biol., Uni. Debrecen, Debrecen, Hungary 2Dept of 
Dermatology and Dept of Dermatological Allergology, Univ Debrecen, Hungary
Leukotrienes are a family of potent eicosanoids lipid mediators with importance for 
infl ammation and proliferation observed in atopic disease like atopic dermatitis (AD). 
Leukotriene B4 (LTB4) is generated via 5-lipoxygenase (5-LOX) pathway from arachidonic 
acid (AA) to 5-HETE and a following hydroxylation to the highly potent LTB4. This LTB4 could 
potently activate the leukotriene B4 receptors BLT1 and BLT2. BLT1 and BLT2 mediated 
signaling induces chemotactic activity and the recruitment of various pro-infl ammatory 
cells. Leukotriene B5 origins from the eicosatetraenoic acid (EPA) and is much less potent 
than LTB4. The aim of this study is to investigate the concentrations of LTB4 and LTB5 in 
the serum of patients with AD in comparison to healthy volunteers as well as in mice after 
allergic sensitization. In addition we determined the effects of n3-PUFA (DHA-enriched 
fi sh oil) treatments on leukotriene signaling in mice and humans. Using QRT-PCR we 
determined in human PBMCs and in mouse spleenocytes the expression of leukotriene B4 
signaling enzymes, binding proteins and receptors. Using our LC-MS-MS methodology we 
determined 5-HETE, 5-HEPE, LTB4 and LTB5 in serum (humans) and spleen (mouse). A strong 
up-regulation of 5-LOX expression in human PBMCs of atopic patients vs. healthy volunteers 
could be observed, this up-regulation could also be confi rmed in ovalbumine sensitized 
mice. The determination of various other LTB4/5 signaling molecules like 5-LOX activating 
protein (FLAP), LTA4-hydroxylase (LTBA4H), BLT1 and 2 is actually under investigation as 
well as the LC-MS-MS analysis of LTB4/5. We conclude that in AD patients LTB4 signaling 
is strongly increased in comparison to healthy volunteers and that the potential benefi cial 
effects of n3-PUFA treatments may result from ameliorated LTB4-mediated signaling.
315
Long-term follow-up and genotype-phenotype correlations in the Dutch cohort of 
patients with recessive dystrophic epidermolysis bullosa
van den Akker PC1, van Essen AJ1, Kraak MM1, Meijer R2, Nijenhuis M1, Meijer G1, 
Hofstra RM1, Pas HH1, Scheffer H2, Jonkman MF1 1Univ Medical Center Groningen, 
Netherlands 2Radboud University Nijmegen Medical Centre, Netherlands 
Recessive dystrophic epidermolysis bullosa (RDEB) is a heritable blistering disorder caused by mutations 
in the COL7A1 gene. The current consensus classifi cation of RDEB recognizes two major subtypes: 
(1) ‘severe generalized’ RDEB (RDEB-sev gen) with early-onset, extensive, generalized blistering and 
scarring, complete absence of type VII collagen, and bi-allelic COL7A1 null mutations; (2) milder 
‘generalized other’ RDEB (RDEB-O) with reduced-to-normal type VII collagen expression, and non-
null genotypes. The purpose of this study was to describe the genotype-phenotype correlations in the 
Dutch cohort of 33 RDEB families and to search for previously unrecognized ones. In this retrospective 
longitudinal cohort study we analyzed the extensive clinical follow-up data available for all patients 
up to 19 years, detailed type VII collagen immunostaining and genotypes, and correlated clinical 
phenotypes to molecular phenotypes and genotypes. In 14 of 15 RDEB-sev gen patients type VII 
collagen was completely absent, one had strongly reduced type VII collagen, and all carried bi-allelic 
null mutations. Five of 11 RDEB-O patients developed pseudosyndactyly of the fi ngers preceded by 
skin atrophy and fl exion contractures later in childhood and adolescence. All fi ve had esophageal 
involvement and growth retardation. In these RDEB-O patients with pseudosyndactyly type VII collagen 
immunostaining ranged from strongly reduced to slightly reduced, whereas in RDEB-O patients without 
pseudosyndactyly type VII collagen staining was slightly reduced to normal. The genotypes did not 
differ between both groups, although we unexpectedly found bi-allelic nonsense mutations in two of 
fi ve RDEB-O patients with pseudosyndactyly. In these patients, the polypeptides produced were not 
truncated and in-frame exon skipping was excluded as the rescue mechanism of protein production. We 
conclude that pseudosyndactyly could occur in approximately half of RDEB-O patients. The lower type 
VII collagen staining, the higher the chance of developing this more severe disease course. Moreover, 
the prognosis in RDEB cannot always be simply predicted from the COL7A1 genotype.
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Modifying effects of a novel fi laggrin mutation on X-linked Ichthyosis in an affected 
female
Chen H1, Ramesh R2, Kukula A3, Wakeling E3, McLean I1, Rustin M2 1University 
of Dundee, Dundee, United Kingdom 2The Royal Free Hospital, London, United 
Kingdom 3North West Thames Regional Genetics Service, Middlesex, United 
Kingdom
X-linked ichthyosis is a relatively common, recessive condition caused by mutations 
in the STS gene. This condition is characterised by dark scaly skin, corneal opacities 
and elevated levels of sulfated steroids the body. Here we report the fourth female 
case of X-linked ichthyosis in an Indian girl, who presented with an unusually 
severe phenotype in addition to eczema and mild childhood asthma. Molecular 
analysis revealed that she was homozygous for the common STS genomic deletion 
mutation.  Further investigation of the patient revealed a novel frame-shift mutation 
3672del4 in the gene encoding fi laggrin (FLG), leading to premature termination 
of fi laggrin translation. Interestingly, her father, who had a very typical mild 
presentation of X-linked ichthyosis did not carry this FLG mutation in addition 
to his STS deletion.  Her mother was a heterozygous carrier of the FLG mutation 
and consistent with this, had mild symptoms of ichthyosis vulgaris; she was also 
a heterozygous carrier of the STS deletion. Previous reports have established null 
FLG mutations as a cause of ichthyosis vulgaris as well as a signifi cant predisposing 
factor to eczema and asthma associated with eczema. The is the second reported 
case of the modifying effects of FLG null alleles on other genodermatoses.  It 
appears that disruption of independent epidermal differentiation pathways can have 
additive effects, causing severe impairment of skin barrier biogenesis and function
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Morpholino “knockdown” of the Abcc6a gene impairs zebrafi sh development – a 
model system for PXE
Sadowski S1, Varadi A2, Dean M3, Uitto J1 1Jefferson Medical College, Philadelphia, 
USA 2Hungarian Acad of Sciences, Budapest, Hungary 3NCIFCRDC, Frederick, USA
Pseudoxanthoma elasticum (PXE), characterized by ectopic mineralization of soft connective 
tissues in the skin, the eyes and blood vessels, is caused by mutations in the ABCC6 gene. The 
physiological function and natural substrate transported by ABCC6 are currently unknown. The 
development of an Abcc6-/- mouse that recapitulates features of PXE has suggested that the function 
of this transporter is conserved. The zebrafi sh (Danio rerio) has nearly the same complement of 
ABC genes as mammals and has an accessible and well-characterized embryo. To study the 
function of ABCC6 during zebrafi sh development, the full-length cDNA sequence of the zebrafi sh 
Abcc6a gene was determined and the mRNA expression levels in embryos over the fi rst week of 
development were measured using real-time qRT-PCR. The Abcc6a expression profi le showed a 
very high level of expression at 5 days post fertilization. Two morpholinos were designed to the 
Abcc6a gene, one at the ATG site to block translation and one at a splice donor site to prevent 
pre-mRNA splicing. Injection of the oligos into 1-4 cell zebrafi sh embryos was performed and the 
embryos followed for a visible phenotype. The ATG site and the splice donor site morpholinos were 
found to decrease Abcc6a expression by 54 and 81%, respectively. Both morpholinos induced a 
similar phenotype, cardiac edema and curled tail, and the splice donor site morpholino resulted 
in a more severe phenotype consistent with the expression levels. Microinjecting zebrafi sh larvae 
with full-length mouse Abcc6 mRNA completely rescued the knockdown phenotype. These results, 
which suggest that Abcc6a is an essential gene for zebrafi sh development, provide novel insight into 
the function of ABCC6, the gene mutated in PXE. The Abcc6a knockdown zebrafi sh model system 
enables us to test substrates of ABCC6 transporter and potential pharmacologic agents in vivo.
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Novel donor splice site mutation in KRT10 in a lethal case of recessive bullous 
congenital ichthyosiform erythroderma
Castiglia D1, Covaciu C1, Castori M2, De Luca N1, Ghirri P3, Zambruno G1 1IDI-IRCCS, 
Rome, Italy 2San Camillo-Forlanini Hospital, Rome, Italy 3Azienda Ospedaliera 
Universitaria Pisana, Pisa, Italy
Bullous congenital ichthyosiform erythroderma (BCIE) is a genodermatosis characterized by the 
coexistence of skin fragility and scaling. At birth, the disorder usually manifests with generalized 
erythema, easily breaking blisters, erosions and scaling. Later in life, hyperkeratosis becomes 
the more prominent feature. Classically, BCIE is caused by heterozygous missense mutations in 
either keratin 1 or 10 genes. However, autosomal recessive transmission has been molecularly 
documented in two pedigrees and associated with variable phenotypes. Here, we report the 
sporadic case of a male newborn son of consanguineous parents of North African origin and 
affected by a severe form of BCIE. Skin erosions covered 70% of body surface and death occurred 
72 hours after birth due to sepsis and hypernatremic dehydration. The diagnosis was fi rst confi rmed 
by light and electron microscopy of a skin biopsy. Keratin expression study revealed complete 
loss of keratin 10, normal levels of keratin 1, and strong upregulation of keratin 16 and 17 in the 
upper epidermal layers. These fi ndings prompted to search mutations in KRT10. The c.1155+5G>A 
splice site mutation in intron 5 was identifi ed at the homozygous state in the proband, while 
both healthy parents resulted heterozygous. RT-PCR analysis of the mutation effects revealed the 
utilization of a cryptic splice site within intron 5. This results in partial intron retention and stop 
codon formation at the beginning of the 2B helical domain. Our study adds a further mutation type 
involved in keratin 10 loss, thus rising to three the number of autosomal recessive BCIE pedigrees. 
In contrast to the two previously reported cases of recessive BCIE, the severity of the observed 
phenotype well mirrors the consequences of biallelic keratin 10 inactivation of the mouse model.
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PPARγ has different expression and signaling pattern in normal and pathologic 
sebaceous glands
Dózsa A1, Dezs B1, Tóth BI1, Bálint BL1, Zouboulis CC2, Bíró T1, Remenyik É1, Nagy 
L1 1University of Debrecen, Medical and Health Science Center, Research Center for 
Molecular Medicine, Debrecen, Hungary 2Dessau Medical Center, Germany
Peroxisome proliferation activated receptor gamma (PPARγ) has been implicated in lipid metabolism 
and also in infl ammation. PPARγ is expressed in lipid rich human sebocytes and it appears to have 
roles in their functions. The details of  PPARγ-regulated lipid metabolism in sebocytes are, however, 
not well understood. Therefore our aim was to characterize the expression patterns of PPARγ, its 
heterodimeric partner RXR and  target genes in normal and pathologic sebaceous glands in tissues 
and  in the SZ95 sebocytes . Therefore we applied formaldehyde fi xed parraffi n embedded skin 
samples of patients with sebaceous hyperplasia, sebaceous carcinoma for immunohistochemistry. 
From fresh frozen skin samples, we laser  microdissected normal sebaceous glands and isolated 
RNA for RT-PCR. We studied function of  PPARγ molecule in SZ95 sebocyte culture by adding 
PPARγ agonist rosiglitazone (RSG), RXRalfa agonist LG268 or arachidonic acid (AA). Viability 
of the cells was measured by MTT test. Nile red staining and quantitative fl uorimetric analysis 
were used to detect changes in polar and neutral lipid content levels as a differentiation marker 
of sebocytes. We found that PPARγ and RXRα proteins are present in normal and hyperplastic 
sebaceous glands, immortalized SZ95 cell line, but PPARγ is barely expressed in sebaceous 
carcinoma. We also demonstrated that mRNA of PPARγ and its lipid-metabolism associated 
target genes, ADRP and PGAR were present in both models, but only sebaceous glands in situ 
expressed FABP4. Target genes responded to activation or inhibition of PPARγ and RXRα in 
SZ95 sebocytes. These data suggest that PPARγ as a transcription factor is likely to play a role in 
normal and pathological sebaceous gland biology, thus possibly serving as a relevant target for 
further investigations in sebaceous gland-associated dermatoses and a potential target of therapy.
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PRINS, the psoriasis susceptibility related non-coding RNA interacts with the 
nuclear phosphoprotein, nucleophosmin and regulates the expression of G1P3 and 
cyclin D1
Széll M1, Szegedi K2, Antal M3, Németh I2, Sonkoly E2, Bebes A2, Bata-Csörgõ Zs2, 
Dobozy A2, Kemény L2 1Dermatological Research Group of the Hungarian Academy 
of Sciences, Szeged, Hungary 2University of Szeged, Szeged, Hungary 3Biological 
Research Center of the Hungarian Academy of Sciences, Szeged, Hungary
Expression data of the non-coding RNA gene, PRINS (Psoriasis Susceptibility-Related 
RNA Gene Induced by Stress) identifi ed and characterized by our workgroup, suggests a 
role for PRINS in psoriasis susceptibility and in cellular stress response. In order to asses 
the function of PRINS, we aimed to identify genes regulated by PRINS and intracellular 
molecules interacting with this stress-induced non-coding RNA. To identify PRINS regulated 
genes, we carried out gene specifi c silencing and gene expression profi ling experiments. 
These experiments identifi ed G1P3, an interferon-inducible anti-apoptotic gene that was 
down-regulated and cyclin D1 that was upregulated by PRINS silencing. To detect PRINS 
interacting proteins we applied ribonucleoprotein (RNP) purifi cation in HaCaT cells. With 
the help of Matrix-Assisted Laser-Desorption Ionization Time-of-Flight (MALDI-TOF) method 
we identifi ed nucleophosmin that physically interacted with PRINS RNA. Nucleophosmin 
is a ubiquitously expressed nucleolar phosphoprotein which shuttles continuously between 
the nucleus and the cytoplasm. The expression of nucleophosmin was signifi cantly 
elevated in psoriatic involved epidermis, localized to the dividing cells of the basal layer. 
Our data indicate that the non-coding PRINS RNA is a structural element of a molecular 
complex composed of nucleophosmin that regulates stress-induced and proliferation 
related cellular processes. We suppose that the abnormal functioning of this complex 
may result in the altered regulation of genes among them the anti-apoptotic G1P3 and 
the cell cycle regulatory cyclin D1 which can contribute to the pathogenesis of psoriasis.
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Psoriatic keratinocytes differ in 5 integrin response from healthy keratinocytes
Hambalkó Sz1, Belsõ N1, Széll M2, Kemény L1, Bata-Csörgõ Zs1 1University of Szeged, 
Szeged, Hungary 2Dermatological Research Group of the Hungarian Academy of 
Sciences, Szeged, Hungary
Psoriasis is considered to be a multigenic infl ammatory skin disease with characteristic 
hyperproliferation and abnormal differentiation of the epidermal keratinocytes. 
Although there is strong evidence that dysregulated infl ammation plays a pivotal role 
in disease development and maintenance, we present data indicating that epidermal 
abnormalities detectable in the normal appearing, non-lesional psoriatic epidermis 
contribute to disease susceptibility. We compared the expression of α5 integrin 
mRNA in healthy and non-lesional epidermis 6 hours after tape stripping. We found 
that the mRNA expression of α5 integrin was already 5.5 times higher in the non-
lesional epidermis compared to healthy epidermis. Tape stripping induced a 3 times 
increase in healthy and a 4 times increase in the non-lesional epidermis, indicating 
an inherent difference in α5 integrin mRNA expression response in the non-lesional 
psoriatic skin compared to normal skin.To study signal transduction processes 
regulating α5 integrin expression in keratinocytes we constructed an α5 integrin 
promoter - luciferase reporter chimaera and detected the effect of KGF on α5 integrin 
promoter activation. We found that KGF treatment induced α5 integrin promoter 
activity in HEK293 and HaCaT cells, but not in normal human keratinocytes. These 
data support the possibility that enhanced α5 integrin expression in the psoriatic non-
lesional skin could be due to an abnormal KGF response of the psoriatic keratinocytes.
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R434X mutation in ABCA12 causing Harlequin ichthyosis in consanguineous roma 
family
Mazán M1, Katona M1, Silló P1, Hatvani Zs1, Dobos M1, Noll J2, Medvecz M1, Szalai 
Zs2, Blazsek A1, Kárpáti S1 1Semmelweis University, Budapest, Hungary 2Heim Pál 
Children’s Hospital, Budapest, Hungary
Harlequin ichthyosis (HI, OMIM: 242500) is a rare congenital, autosomal recessively 
inherited cornifi cation disorder, belonging to the group of congenital ichthyoses, 
described by the extreme thickening of the stratum corneum caused by the abnormal 
formation of the lipid lamellae between corneocytes. Early nonsense mutations of 
ABCA12 were identifi ed as causative genetic factor of the disease. The proband 
with HI was referred to our department. He was born to a family with complicated 
consanguineous relationship from parents of roma ethnicity. It was diffi cult to determine 
the exact degree of relations due to poor compliance of the parents and relatives. 
Although the affected newborn condition improved under retinoid treatment, he died 
due to complications related to recurring infections. Genetic analysis of the DNA from 
the index patient revealed a homozygous PTC causing mutation of the 12nd exon of 
ABCA12 (g.C1300T, p.R434X), previously identifi ed in a Japanese case.   These data 
may suggest that the residue g.1300 could be prone to mutations in populations with 
different ethnic and geographic background and further increases the data available 
in genetic analysis of HI. Further it implies that ABCA12 is the major HI gene.
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Recurrent European missense mutation in the F12 gene underlying type III 
hereditary angio-oedema
Nagy N1, Greaves MW2, Tanaka A1, McGrath JA1, Grattan CE3 1St John’s Institute of 
Dermatology, King’s College London, London, United Kingdom 2Dep of Dermatology, 
Poole General Hospital, 3Guy’s and St Thomas NHS Foundation Trust, Poole, London, 
United Kingdom
Hereditary angio-oedema (HAE) is a non-allergic, bradykinin-induced form of 
angio-oedema that has been classifi ed into three subtypes. The classic forms, types 
I and II HAE, arise from mutations in the SERPING1 gene encoding C1-inhibitor. 
By contrast, type III HAE results from gain-of-function mutations in the F12 gene 
encoding coagulation factor XII. The latter sub-type almost exclusively affects 
females and can be associated with high oestrogen levels. The aim of this study was 
to investigate the molecular basis of type III HAE in a British family containing three 
affected females spanning three generations. The coding region of the F12 gene 
was sequenced using genomic DNA from affected and unaffected family members 
and 197 control subjects. All three affected individuals had the same heterozygous 
single nucleotide substitution, c.983C>A (p.Thr328Lys) in exon 9 of the F12 gene. 
This missense mutation was also present in two other clinically unaffected female 
family members and in two unrelated control subjects (both male). p.Thr328Lys 
has previously been reported in other Western European pedigrees with type III 
HAE and haplotype analysis showed that the mutant allele in our British family 
shared a common genetic background. This study has identifi ed a pathogenic 
mutation in a British family with type III HAE. Our observations suggest that the 
mutation p.Thr328Lys in F12 has arisen on a common ancestral Western European 
allele. Explanations for the lack of symptoms in some family members and the 
potential signifi cance of F12 mutations in males, however, are currently lacking.
324
Replication of Association between interleukin-23 receptor (IL23R) and its ligand 
(IL12B) Polymorphisms in Patients with Psoriasis in a Chinese population
Zheng J Ruijin hospital, Shanghai, China
Psoriasis (PS) is a chronic skin disorder characterized by infi ltration of infl ammatory 
elements and by keratinocyte hyperproliferation and altered differentiation. Despite 
the established infl uence of several environmental factors, epidemiological data 
and twin studies have long demonstrated a genetic basis for psoriasis susceptibility 
Recently, a number of groups have described psoriasis susceptibility loci obtained 
by whole-genome association (GWA) study, including IL12B (which encodes 
the p40 subunit common to both IL-12 and IL-23 )and the genes encoding the 
receptors of IL-23 (IL23R), We genotyped three representative variants in Chinese 
to further investigate the involvement of these polymorphisms in conferring 
susceptibility to psoriasis.Three SNPs (rs6887695, rs11465817, rs1343152) 
were genotyped in 217 patients with psoriasis vulgaris and 288 control subjects; 
for patients, 120 men and 92 women; for control subjects, 82 men and 191 
women through direct sequencing. Allele frequency OR of one SNP, rs6887695 
[OR=1.33(95% CI 1.031689~1.726659), p=0.027866 in IL12B was signifi cantly 
associated with psoriasis in the Chinese population. G allele£the risk allele of 
rs6887695 was fi t to dominant model, which means as long as the site contain G 
,even if heterozygous, it will greatly increase the risk of illness.This investigation 
confi rms there is the variant of IL12B on psoriasis in Chinese psoriatic populations.




SLCO1B3 expression in recessive dystrophic epidermolysis bullosa associated 
squamous cell carcinoma is reduced by recombinant type VII collagen
Cole CL1, Pourreyron C1, Foerster J1, Purdie K2, Salas-Alanis JC3, Murrell DF4, Bruckner-
Tuderman L5, McGrath JA1, Leigh IM1, South AP1 1University of Dundee, UK 2Cancer 
Research UK, London 3Hospital Univ Autonoma de Nuevo Leon, Monterrey, Mexico 
4St George Hospital, Sydney, Australia 5Univ of Freiburg, Germany
The genetic skin disease, recessive dystrophic epidermolysis bullosa (RDEB) predisposes patients 
to develop aggressive squamous cell carcinoma (SCC). Global gene expression studies identifi ed 18 
candidate genes which were differentially regulated in RDEB SCC (n=4) compared with non-RDEB SCC 
(n=5) primary keratinocyte cultures.  Validation of these genes by quantitative-PCR (Q-PCR) in replicate 
cultures of RDEB SCC (n=3), non-RDEB SCC (n=3) and control (n=1), deduced 5 genes to have statistically 
signifi cantly different mRNA expression.  Of these genes, SLCO1B3, is over expressed 7.5 fold in RDEB 
SCC keratinocytes (p < 0.001).  SLCO1B3 encodes the organic anion transporter OATP8, which is normally 
expressed on the basolateral membrane of hepatocytes.  Q-PCR revealed that the mRNA expression 
level of SLCO1B3 is reduced in RDEB SCC keratinocyte cultures when COL7A1, the gene mutated in 
RDEB patients, is re-expressed (average 14.2 fold change decrease); suggesting that COL7A1 expression 
regulates the expression of SLCO1B3. Immunofl uorescent staining of RDEB SCC tissue identifi ed OATP8 
expression, whilst Q-PCR using mRNA isolated from freshly frozen skin and SCC tissue samples from 
both RDEB (n=6) and non-RDEB individuals (n=5) identifi ed increased SLCO1B3 mRNA expression in 
RDEB SCC in vivo.  Over expression of SLCO1B3 and increased activity of OATP8 is associated with 
breast, colon and pancreatic cancer, and OATP8 is a known transporter of chemotherapeutic agents 
such as paclitaxel and methotrexate. These observations have led to speculation that, as a transporter 
over expressed in cancer and capable of introducing drugs into cells, SLCO1B3 represents a therapeutic 
target.  Preliminary data, using a Fluo-3 assay of OATP8 activity shows uptake of Fluo-3 in a dose 
dependent manner in RDEB SCC keratinocytes, suggesting that indeed OATP8 is an active transporter in 
RDEB SCC.  These results demonstrate that SLCO1B3 may be a potential therapeutic target in RDEB SCC.
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The expression pattern of the ABCC4 and ABCG2 proliferation-related xenobiotic 
transporters differs in psoriasis
Bebes A1, Nagy T2, Kurunczi A2, Polyánka H3, Bata-Csörgõ Zs1, Kemény L1, Dobozy 
A1, Széll M3 1Univ of Szeged, Hungary 2SOLVO Biotechnology, Szeged, Hungary 
3Derm Research Group of the Hungarian Acad of Sciences, Szeged, Hungary
Xenobiotic transporters of the ATP binding cassette (ABC) protein superfamily play an important role 
in maintaining the biochemical barrier of various tissues, however the precise role of these transporters 
in skin is not known to date. We determined the expression profi le of xenobiotic transporter genes 
in two in vitro keratinocyte differentiation models. High levels of ABCC4 and ABCG2 mRNAs were 
found in proliferating, undifferentiated normal human keratinocytes. Similarly, induction of ABCC4 
and ABCG2 genes were observed in synchronized HaCaT keratinocytes after releasing them from 
cell quiescence. Western blot and immunocytochemistry results further supported that ABCC4 and 
ABCG2 transporters have a possible function in keratinocyte proliferation/differentiation. Next, we 
examined their expression in healthy and psoriatic human skin, the latter characterized by keratinocyte 
hyperproliferation. ABCC4 protein was overexpressed in the basal layers of psoriatic lesional epidermis, 
parallel with the in vitro results, while in keratinocytes of normal and non-involved skin it was expressed 
at very low levels. The ABCC4 transporter may contribute to the pathogenesis of psoriasis since 
antiapoptotic/proliferation related cyclic nucleotides and important infl ammatory mediators are ABCC4 
substrates. The ABCG2 transporter was expressed in normal and psoriatic non-involved epidermis 
and its expression was restricted to basal layer keratinocytes. Increased levels of ABCG2 protein was 
detected in psoriatic lesions, however its highest level of expression was observed in keratinocytes 
in the abnormally differentiating granular layer. It is known that human epidermis is a constitutively 
hypoxic tissue, and hypoxia is more pronounced in psoriatic lesions. Hypoxia induces the generation 
of harmful porphyrins that are substrates of ABCG2, thus ABCG2 may protect keratinocytes from the 
accumulation of these compounds. The upregulation of ABCC4 and ABCG2 xenobiotic transporters 
in psoriatic lesions could signifi cantly modulate drug distribution and effectiveness in the skin.
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The H syndrome- Report of mutations in 30 patients
Zlotogorski A, Molho Pessach V Hadassah-Hebrew University Medical Center, 
Jerusalem, Israel
The H syndrome is a recently described autosomal-recessive genodermatosis with 
systemic manifestations. The term H syndrome is derived from its major clinical 
and laboratory manifestations including hyperpigmentation and hypertrichosis, 
hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism, low height 
and hyperglycemia/diabetes mellitus. Patients from 15 families with this set of 
clinical fi ndings were examined and tested in our center for the gene and mutations 
causing this disease. The clinical fi ndings were variable. Ninety percent of the 
patients presented with hyperpigmentation and hypertrichosis. Other combinations 
of the above fi ndings were found in some or most of the patients. Less common 
manifestations included camptodactyly or fl exion contractures of the hands and feet 
phalanges, ocular vascularization, arcus senilis, lipoatrophy of the lateral buttocks 
and malabsorption. Histological fi ndings included dermal infi ltrate consisting mainly 
of histiocytes, later replaced by dermal and subcutaneous fi brosis. Homozygosity 
mapping led to the identifi cation of various mutations (missense, compound and 
deletion) in the SLC29A3 gene, with no phenotype-genotype inter or intra familial 
correlation. Identifi cation of mutations in patients with variable clinical presentations 
including mild phenotype suggests that oligosymptomatic individuals might have 
this disorder and that H syndrome is more common than previously estimated.
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Therapy of dominant Epidermolysis bullosa vie Spliceosome Mediated RNA Trans-
splicing
Wally V, Brunner M, Koller U, Hintner H, Bauer JW Division of Molecular Therapy 
and eb-house Austria, Salzburg, Austria
Epidermolysis bullosa simplex Type Dowling-Meara (EBS-DM) arises due to mutations 
in the KRT14 gene. This type of EB is mostly inherited in an autosomal dominant 
way, rendering it a challenge for gene therapy.In our model, one heterozygous 
missense mutation (R125P) in exon 1 of the KRT14 gene leads to protein misfolding 
and subsequent self-aggregation, resulting in cytoskeletal instability and increased 
susceptibility to stress.We chose “Spliceosome Mediated RNA Trans-Splicing” 
(SMaRT) to replace the disease causing part of a KRT14 transcript.By replacing exons 
1 to 7 of the KRT14 gene during mRNA maturation, the level of the mutated allele can 
be signifi cantly reduced and the amount of functional protein increased. Necessary 
trans-splicing components are brought in by an engineered pre-trans-splicing molecule 
(PTM). Besides the wildtype gene portion to be replaced and essential splicing features, 
the PTM incorporates a binding domain (BD), which is crucial for the specifi city and 
effi ciency of the trans-splicing process. We developed a reporter based screening 
method to identify best BDs for a PTM which should specifi cally replace exons 1 to 
7 of the KRT14 gene. A PTM library including random binding domains specifi c for 
KRT14 exon 7 / intron 7 was produced. Library screening resulted in the isolation of 
highly functional PTMs. Best PTMs were adapted for endogenous trans-splicing and 
transfected into a R125P carrying EBS keratinocyte cell line. We showed specifi c trans-
splicing into exon 8 of the endogenous KRT14 gene. Subsequent real-time PCR revealed 
a decrease of unspliced KRT14 transcripts by 40 to 60%. Successful trans-splicing 
in this model constitutes a novel approach to treat autosomal dominant diseases.
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Toward enzyme substitution therapy of lamellar ichthyosis: liposomal encapsulation 
of recombinant transglutaminase 1
Aufenvenne K1, Zimmerling K2, Walker T1, Dathe M2, Traupe H1 1Univ Hospital, 
Münster, Germany 2Leibniz Inst for Molecular Pharmacology, Berlin, Germany
Lamellar ichthyosis (LI) is a genetically and clinically heterogeneous keratinisation disorder. 
In up to 45% of all cases it is caused by mutations in TGM1 coding for a key enzyme of 
cornifi ed cell envelope (CCE) formation, transglutaminase 1 (TG1). Patients are often born as 
collodion-babies. After shedding of the collodion-membrane they develop large dark-grey 
or brownish scales affecting the entire body. So far only symptomatic therapeutic modalities, 
making use of e.g. urea creams, are available. Enzyme replacement therapy has greatly 
benefi ted genetic skin diseases (e.g. Fabry disease). It holds great promise for lamellar 
ichthyosis due to transglutaminase 1 defi ciency and further genetic variants. Therefore, we 
intend to develop a topical approach for enzyme replacement therapy for TG1 defi cient LI. 
In a fi rst step we established high level expression of recombinant full length TG1 in insect 
cells and the purifi cation of the expressed enzyme via affi nity-chromatography. Because of 
the intracellular localisation of TG1 and the resulting necessity to deliver the recombinant 
protein across the cell membrane, we developed specialised liposomes for encapsulation of 
the purifi ed recombinant TG1. These liposomes were coupled with a special apolipoprotein 
E (ApoE) derived peptide which enables the cellular uptake of the TG1-liposome-complexes 
into primary keratinocytes in an energy-dependent manner. We could show indeed the 
internalisation of the TG1-liposomes into previously isolated primary keratinocytes 
of healthy individuals and TG1 defi cient LI-patients and demonstrate the specifi c 
intracellular activity of liposome-encapsulated TG1 after application on undifferentiated 
and differentiated primary keratinocytes.  In future work we intend to develop a skin 
humanized mouse model as an important milestone in the development of an enzyme 
substitution therapy to study the effects of TG1-liposomes on the human skin phenotype.
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Two Case Reports of Dystrophic Epidermolysis Bullosa
Cosgarea R1, Danescu S1, Senila S1, Popescu O2 1University of Medicine , Cluj-
Napoca, Romania 2University Babes-Bolyai, Cluj-Napoca, Romania
Dystrophic epidermolysis bullosa (DEB) is a genetic disease characterized by blistering 
and scarring of the skin and mucous membranes. DEB is caused by mutations in the 
type VII collagen gene (COL7A1) and is inherited either in autosomal dominant or 
recessive mode. We intended to identify mutations in two patients with DEB and 
understand their clinical phenotypes. We performed molecular diagnosis to a patient 
aged 45 who showed the typical severe generalized autosomal recessive EBD signs 
when admitted to the hospital. The clinical features included severe scars that caused 
mutilations of hands and feet, fi brosis of the oral cavity, weight loss, dystrophic teeth. 
The other patient is a 4-month old boy who showed nail dystrophy, milium on his 
hands and erosions on the thigh. Dystrophic changes were present in toes. There was 
a family history of nail dystrophy.After informed consent genomic DNA was extracted 
from a peripheral blood sample from the patients, using a DNA isolation kit according 
to the manufacturer?fs protocol. Polymerase chain reaction (PCR) amplifi cation was 
carried out. After that, the products were sequenced on a 8-capilary genetic analyzer. 
The molecular diagnosis disclosed in the fi rst patient the presence of a heterozygous 
mutation consisting of a nucleotide substitution that lead to a splice site mutation, 
namely 425-2 A>G, associated to a premature termination codon, in exon 5, namely 
c.553 C>T, p.R185X and in the second patient a heterozygous substitution at 
nucleotide position 6100 that converts a glycine amino acid to arginine (6100G?¨A). 
The mutation is designated G2034R. We conclude that molecular diagnosis is the 
conclusive EBD investigation, maps the phenotype of a patient with his genotype and 
thus allows a better understanding of the disease mechanism and the development 
of gene therapy. It also enables genetic counseling and prenatal diagnosis. 
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Activated Langerhans cells capture external antigens by sending their dendrites out 
through epidermal tight junctions
Kubo A1, Nagao K1, Yokouchi M1, Sasaki H2, Amagai M1 1School of Medicine, Keio 
University, Tokyo, Japan 2The Jikei University School of Medicine, Tokyo, Japan
The mammalian skin consists of two sets of epidermal barriers: stratum corneum 
(SC) and tight junctions (TJs). It has been long believed that epidermal Langerans 
cells (LCs) acquire foreign antigens encountered in skin, but how such antigens 
penetrate the epidermal barriers is completely unknown. In this study, we enabled 
3D visualization of epidermal TJs. Using this method, we monitored the behavior of 
LC dendrites in relation to TJs. In resting state, LCs projected their dendrites upward 
to the skin surface but stopped a cell layer short of TJs. Surprisingly, once activated 
by tape stripping or cytokine injection, elongated LC dendrites docked with TJs, 
and sometimes penetrated through, to reach to the SC. Of note, TJ formation was 
observed between LC dendrites and surrounding keratinocytes, indicating that the TJ 
barrier integrity was maintained during this dynamic process. Next, we investigated 
whether LC dendrites that penetrated TJ could engage in endocytic activity. To this 
end, we topically applied a protein biotinylation reagent or FITC-OVA on the skin. 
Remarkably, membrane biotinylation revealed endocytic activity that took place at 
the dendrite tip, which fl owed to perinuclear area. FITC-OVA application indicated 
that this endocytic activity was capable of antigen uptake by LC from outside of 
TJ environment. Both intra-dendrite and perinuclear signals co-localized with 
langerin, strongly suggesting that Birbeck granules were involved in this process. 
Thus, LCs stay below TJs under normal conditions, but are able to capture external 
antigens upon activation, by sending their dendrites out through TJs, without 
perturbing the integrity of epidermal barriers. These fi ndings will provide a new 
fundamental framework for the immunological behavior of dendritic cells in skin.
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Protein kinase C and AP-1-dependent upregulation of miR-203 is required for 
keratinocyte differentiation
Sonkoly E1, Loriè EP2, Törmä H2, Kato M3, Ståhle M1, Pivarcsi A1 1Molecular Derm Res 
Group, Stockholm, Sweden 2Dept of Medical Sciences, Uppsala Univ, Sweden 3Dept 
of Exp Pathology, Univ of Tsukuba, Japan
Protein kinase C and AP-1-dependent upregulation of miR-203 is required for keratinocyte differentiation. 
We aimed to explore the possible involvement of miRNAs in keratinocyte differentiation. To this end, we 
used miRNA expression profi ling, overexpression and inhibition of microRNAs in keratinocyte differentiation 
models and using transgenic keratinocyte cell lines expressing various components of the AP-1 transcription 
factor and transcription factor ELISA. Out of 365 miRNAs tested, 7 showed signifi cant change between 
keratinocytes cultured in low or high calcium concentration, representing undifferentiated and differentiated 
stages. The highest-ranked up-regulated gene was miR-203, with 8.3-fold upregulation in terminally 
differentiated keratinocytes in comparison to low-calcium controls. MiR-203 was signifi cantly upregulated 
in response to calcium and other inducers of keratinocyte differentiation such as 12-O-tetradecanoylphorbol-
13-acetate (TPA) and vitamin D3. In contrast to inducers of keratinocyte differentiation, epidermal growth 
factor and keratinocyte growth factor suppressed miR-203 expression in keratinocytes below the basal level. 
Differentiation-induced upregulation of miR-203 expression was blocked by treatment with selective inhibitors 
of protein kinase C (PKC), GF109203X and Ro31-8220. TPA-treatment increased JunB and decreased c-Jun 
activity in keratinocytes, thus altering the composition of AP-1 transcription factor complexes. Overexpression 
of the dominant negative mutant form of JunB in HaCaT keratinocytes resulted in decreased miR-203 expression. 
Overexpression of c-Jun suppressed miR-203 expression. In functional experiments, transient overexpression of 
miR-203 in keratinocytes enhanced terminal differentiation, while specifi c inhibition of miR-203 suppressed 
calcium-induced differentiation. These results identify a pathway in which differentiation-inducing agents 
increase miR-203 expression in keratinocytes through the activation of PKC and alteration of the composition 
of AP-1 transcription factor complex. MiR-203 in turn induces terminal differentiation of keratinocytes. These 
results establish miR-203 as a critical part of the keratinocyte differentiation program.
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IGFBP7, a biomarker defi cient in psoriatic plaques and induced by UVB 
phototherapy, regulates keratinocyte proliferation, differentiation and apoptosis.
Nousbeck J1, Sarig Of2, Avidan Ni3, Indelman Ma4, Bergman Re4, Ramon Mi4, Enk 
Cl5, Sprecher El6 1Technion-Israel Institute of Technology, Tel Aviv Sourasky Medical 
Center, Haifa,Tel Aviv, Israel 2Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 
3Technion-Israel Institute of Technology, Haifa, Israel 4Rambam Health Care Campus, 
Haifa, Israel 5Hadassah Hebrew University Medical School, Jerusalem, Israel 6Tel 
Aviv Sourasky Medical Center, Technion-Israel Institute of Technology, Tel Aviv, 
Haifa, Israel
Insulin-like growth factor (IGF)-binding protein (IGFBP) 7 has been shown to function as a potent 
tumor suppressor gene. Recently, a global gene expression study revealed that IGFBP7 is down-
regulated in the psoriatic epidermis, with UVB phototherapy restoring its expression to normal. In 
a large series of biopsies, we confi rmed these results at the protein level. These data suggest that 
IGFBP7 may be involved in the pathogenesis of psoriasis, and more generally, in the regulation of 
keratinocyte proliferation and differentiation, which are abnormal in psoriasis. To model IGFBP7 
down-regulation in vitro, we used lentiviral vectors expressing IGFBP7-specifi c shRNA and control 
shRNA in HaCat cells and in primary human keratinocytes. Down-regulation of IGFBP7 was found 
to enhance keratinocyte proliferation in both systems as assessed by MTT and BrdU incorporation 
assays. In addition, IGFBP7 down-regulation was associated with a marked decrease in keratinocyte 
susceptibility to TNF-α-induced apoptosis but lacked any effect on senescence.  Down-regulation of 
IGFBP7 was also found to block calcium-induced differentiation of human keratinocytes as assessed by 
KRT10 and involucrin expression and morphometry. Recombinant IGFBP7 was found to signifi cantly 
inhibit keratinocyte proliferation. Down-regulation of IGFBP7 was found to activate the MAPK 
pathway, which has previously been shown to be involved in the pathophysiology of psoriasis. These 
data position IGFBP7 as a major regulator of keratinocyte proliferation and differentiation, suggesting 
a potential role for this protein in the treatment of psoriasis and other hyperproliferative dermatoses.
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Identifi cation of Spink6 - a widely-expressed and selective Kallikrein-related 
Peptidase Inhibitor
Meyer-Hoffert U1, Kantyka T2, Hansmann B1, Gläser R1, Schröder JM1 1Department of 
Dermatology, Kiel, Germany 2Department of Biochemistry, Krakow, Poland
Kallikreins-related peptidases (KLKs) are serine proteases and have been implicated 
in the desquamation process of the skin.  Their activity is tightly controlled by 
epidermal protease inhibitors like the lympho-epithelial Kazal-type inhibitor (LEKTI). 
Defects of the LEKTI-encoding gene serine protease inhibitor Kazal type (Spink)5 
lead to the absence of LEKTI and result in the genodermatose Netherton syndrome, 
which mimics the common skin disease atopic dermatitis. Since many KLKs are 
expressed in human skin, we proposed that more inhibitors are present in human 
skin. Herein, we identifi ed Spink6 as a new member of the Spink gene family. 
Spink6 mRNA expression was detected in human skin and cultured keratinocytes but 
moreover in many other tissues. We expressed Spin6 recombinantly and generated 
polyclonal antibodies. Using an antibody affi nity column we purifi ed native Spink6 
from human stratum corneum extracts. Immunostaining revealed Spink6 expression 
throughout the epidermis and in the skin appendages. Recombinant Spink6 
was identifi ed as a potent inhibitor of KLK5 and KLK14 but exhibited only weak 
inhibition activity against KLK7.  Notable no other serine proteases were inhibited by 
Spink6. We suggest that Spink6 contributes to the regulation of KLKs in human skin.
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Flaky tail mouse as a possible model of atopic dermatitis
Moniaga C1, Chikuma M1, Kawasaki H2, Nakajima S1, Tanizaki H1, Egawa G1, 
Honda T1, Amagai M2, Miyachi Y1, Kabashima K1 1Kyoto University Graduate School 
of Medicine, Japan 2Keio University School of Medicine Tokyo, Japan
The permeability barrier abnormality, which was derived from the recent link between the incidence 
of atopic dermatitis (AD) and loss-of-function mutations in the gene encoding fi laggrin (FLG), could 
be an important factor in the pathogenesis of AD. To explore more about the roles of FLG mutation 
on AD, fi laggrin-defi cient fl aky-tail (ft/ft;a/a ma ft/ma ft/J) mice might be a useful model. However, 
the precise analyses on the immunological mechanistic aspect as well as their phenotypic analysis 
have not been revealed.In the steady states under specifi c pathogen free conditions, surprisingly, the 
majority of ft/ft mice showed eczematous skin lesions with acanthosis and enhanced lymphocyte 
and mast cell infi ltration in the dermis with age. Flow cytometric analysis revealed increased 
numbers of total cell, T cell, and dendritic cells in the draining lymph nodes and the skin. In 
addition, augmentation of total serum IgE level in ft/ft mice were detected by ELISA. Moreover, 
skin barrier defect in ft/ft mice were demonstrated by enhanced transepidermal water loss and the 
amount of fl uorescein isothiocyanate retaining in the skin after its skin exposure as a marker for 
inside to outside, and outside to inside barrier function, respectively. There results suggest that ft/ft 
mice show AD like manifestations even in the steady states. We then evaluated the responsiveness to 
foreign antigens in ft/ft mice. Enhanced irritant dermatitis induced by phorbol myristate acetate and 
contact hypersensitivity response sensitized and elicitated with dinitrofl uorbenzene was observed 
in ft/ft mice compared to wild type C57BL/6 mice. Clinically and histologically enhanced dermatitis 
accompanied with more scratching behavior (monitored using Sclaba Real), augmentation of 
transepidermal water loss and mite specifi c IgE levels after repeated exposure of ointments 
containing Dermatophagoides pteronyssinus were observed in ft/ft mice but not in C57BL/6 mice.
These results suggested that ft/ft mice could be proposed as a possible animal model of AD, and 
provide  evidences of skin barrier defect as an important component in the pathogenesis of AD.
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Increased murine Beta-defensin-1, -3, and -14 expression after acute and chronic 
skin barrier disruption is induced by cytokines and growth factors
Hinrichsen K1, Meingassner J2, Harder J1, Proksch E1 1University Hospital Kiel, Kiel, 
Germany 2Novartis Institut for BioMedical Research, Vienna, Austria
The permeability barrier and antimicrobial proteins protect the skin against 
microbiological infection. We asked whether the expression of murine Beta-defensins 
mBD-1, -3 and -14 which are orthologs of human Beta-defensins hBD-1, -2 and -3, 
respectively, is stimulated by acute (tape-stripped or acetone treatment) or chronic 
(essential fatty acid, EFA diet) skin barrier disruption. Also, we examined whether mBDs 
are stimulated by cytokines and growth factors. Defensin expression was determined 
by Realtime PCR and by immunohistology using specifi c antibodies. Acute and 
chronic permeability barrier disruption led to an upregulation of all three defensins, 
but the levels of increase were different. We found a slight induction of mBD-1, a 
moderate induction of mBD-14 and a pronounced induction of mBD-3 after acute 
barrier disruption. After chronic barrier disruption expression of mBD-14 was also 
markedly increased. This may be due to the upregulation of mBD-3 by cytokines TNF, 
IL-1-Alpha and IFN-Gamma, which is probably an acute response, whereas mBD-14 
is stimulated by growth factor TGF-Alpha, which may be a chronic response. Artifi cial 
barrier repair by occlusion with a latex foil reduced the increase in mBDs supporting 
interrelation between permeability and antimicrobial barrier. Together we demonstrate 
upregulation of mBD-1, -3 and -14 by acute and chronic disruption of the skin 
barrier. Expression of mBDs is specifi cally regulated by cytokines and growth factors. 
The upregulation of defensins may be an attempt to increase defense in the case of a 
reduced physical barrier which alleviates the invasion of microbes. A stimulation of 
the innate immune barrier may subside for the loss in the permeability barrier function.




A novel isoform of the psoriasis candidate gene CCHCR1
Tervaniemi M1, Elomaa O1, Sormunen R2, Tiala I1, Saarialho-Kere U1, Kere J1 
1University of Helsinki, Helsinki, Finland 2University of Oulu, Oulu, Finland
The PSORS1 candidate gene CCHCR1 has different expression patterns in psoriatic 
and healthy skin and is suggested to have a role in cell proliferation. A recent 
genome-wide association study on susceptibility variants for psoriasis indicated a 
very strong association to PSORS1 within the region where CCHCR1 is located, 
including one of the CCHCR1*WWCC risk allele SNPs earlier identifi ed by our 
group. In the present study, we have concentrated on a novel variant 1 of CCHCR1 
caused by an alternative transcription site. The 5’-UT region of variant 1 contains an 
SNP (rs3130453) that changes a stop codon into tryptophan, enabling the usage of 
an earlier methionine in the readingframe and leading to a longer transcript of 267 
nucleotides. Our aim was to investigate the role and expression of the variant 1 versus 
previously studied variant 3 of CCHCR1 in psoriasis. We demonstrated by western 
blotting that the variant 1 expression construct produces a bigger protein product 
than variant 3 in transfected COS7 cells. This indicates that the novel initiation 
codon of variant 1 is functional even if it doesn’t contain the Kozak consensus 
sequence. We also studied the cellular localization of variant 1 in comparison to 
variant 3 in transfected cells using immunofl uorescence microscopy. Both isoforms 
of CCHCR1 show cytoplasmic granular staining that does not co-localize with 
ubiquitin. Interestingly, the shape and size of particles formed by these two variants 
is slightly different. By immunoelectron microscopy (IEM) variant 3 does not seem to 
localize with membrane bound structures, i.e. organelles. We conclude that there 
exists a novel isoform of CCHCR1 that contains a 89 amino acids longer N-terminal 
domain than variant 3 and shows a divergent expression pattern in transfected cells.
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A novel Role of iASPP, a key regulator in skin development
Chikh A, Bergamaschi D Barts and The London School of Medicine and Dentistry, 
London, United Kingdom
iASPP (PPP13RL) is an inhibitory member of the ASPP family and is an evolutionarily 
conserved p53 inhibitor. Its expression is frequently up-regulated in human 
cancers. However, little is known about the role of iASPP in skin development. 
In the outermost component of the skin, the epidermis, p53 family members play 
an important role in protecting against UV-B induced DNA damage. Here, we 
investigate the role of iASPP in normal skin. At key murine embryonic time-points 
iASPP expression is detected in the proliferating layer of the epidermis. Our data 
also in human skin indicates expression of iASPP predominantly in the basal layer of 
epidermis where it interacts with p63, one of the master regulatory genes involved 
in epidermal development. We report that the silencing of iASPP in keratinocytes, 
using a retroviral shRNA, cause defects in several cellular compartments, and  affect 
expression of protein involved into cytoskeleton organisation  and cell adhesion, 
proliferation and apoptosis. To further investigate the physiological role of iASPP 
in the skin, 3D organotypic skin cultures were prepared with stable iASPP knock-
down keratinocytes cell lines.  Our data highlight for the fi rst time the molecular 
signalling pathway controlled by iASPP in basal keratinocytes and demonstrates that 
iASPP is a novel key regulator for epithelial integrity and epidermal homeostasis.
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A putative normoxic role for ARNT in the control of HDAC activity in human 
keratinocytes
Robertson D1, Weir L1, Wondimu A2, Mezentsev A2, Panteleyev A1 1University of 
Dundee, United Kingdom 2Columbia University, New York, USA
Precise orchestration of gene expression is essential for the formation of various 
layers of the epidermis and epigenetic mechanisms are potential candidates as a 
means for this control. The aryl hydrocarbon receptor nuclear translocator (ARNT 
or HIF1b) is a class II PAS protein involved in instigating cellular responses to stress 
such as hypoxia or exposure to toxicants. Previously we have demonstrated a role 
for ARNT in regulating expression of differentiation-associated genes in mouse 
epidermis. Mechanisms of this regulation remain to be elucidated. Here we show 
that in human keratinocytes in vitro, along with deregulation of differentiation 
markers, the level of ARNT expression dictates the level of HDAC activity. Using 
an immortilised keratinocyte cell model (N-TERT) with an shRNA-mediated stable 
suppression of ARNT (0.2-0.4 of normal level) we demonstrate that the depletion of 
ARNT results in an increase in total HDAC activity (~15% as assessed by fl uorometric 
HDAC activity kit). Examination of specifi c HDAC expression using qPCR shows 
upregulation (~1.5x) of HDAC2, HDAC6, SIRT1 and SIRT2 in N-TERT cells. Of 
interest, N-TERT cells induced to differentiate by calcium showed a signifi cant 
downregulation of HDAC3 suggesting a role for this protein in control of keratinocyte 
differentiation. Finally, immunocytochemistry in normal N-TERT cells grown under 
normoxic conditions showed ARNT clearly localised to the nucleus suggesting it has 
a putative normoxic role in human keratinocytes.  Taken together, our results imply 
a novel normoxic role for ARNT in control of total HDAC activity and expression 
of individual HDACs in differentiated human keratinocytes thus shedding further 
light on still elusive mechanisms of coordinated expression of epidermal genes.
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Alteration of tight junction proteins is an early event in psoriasis: putative 
involvement of proinfl ammatory cytokines
Kirschner N1, Poetzl C1, von den Driesch P2, Wladykowski E1, Moll I1, Behne MJ1, 
Brandner JM1 1University Hospital Hamburg, Hamburg, Germany 2Clinical Center 
Stuttgart, Stuttgart, Germany
Psoriasis is an infl ammatory skin disease characterized by hyperproliferation of 
keratinocytes, impaired barrier function and pronounced infi ltration of infl ammatory 
cells. Tight junctions (TJs) are cell-cell junctions which were shown to form 
paracellular barriers for solutes and infl ammatory cells. Altered localization of TJ 
proteins in the epidermis was described in plaque-type psoriasis. Here we show that 
localization of TJ proteins is already altered in early-stage psoriasis. Occludin, ZO-1 
and Claudin-4 are found in more layers than in normal epidermis, Claudin-1 and -7 
are down-regulated in basal and in the uppermost layers. In plaque-type psoriasis 
staining patterns of Occludin and ZO-1 do not change while Claudins are further 
down-regulated. Near transmigrating granulocytes, all TJ proteins except for JAM-A 
are down-regulated. Treatment of cultured keratinocytes with IL-1β  and TNFα which 
are present at elevated levels in psoriatic skin, results in an increase of transepithelial 
resistance at early and a decrease at later time points. Injection of IL-1β into an 
ex-vivo skin model leads to an up-regulation of Occludin and ZO-1 resembling TJ 
protein alteration in early psoriasis. Our results show that alteration of TJ proteins 
is an early event in psoriasis and is not the consequence of the more profound 
changes found in plaque-type psoriasis. Our data indicate that proinfl ammatory 
cytokines are involved in alterations of TJ proteins observed in psoriasis.
341
An approach for measurement of stratum corneum thickness by Raman spectra
Shimizu N1, Nakagawa N1, Bito K2, Naito S2, Sakai S1 1Kanebo Cosmetics INC., 
Kanagawa, Japan 2Kao Corporation, Tochigi, Japan
In vivo measurements of stratum corneum (SC) thickness from water concentration 
profi les measured by a confocal Raman spectrometer have been proposed. However, 
the validation of the methods based on the Raman signals from water molecules is 
diffi cult, since the precise water content in each skin compartment has not been 
determined. Under such circumstances, the measurement of SC thickness using 
Raman spectra of components localized in the SC is preferable. The purpose of 
this report is to develop a new approach for measuring SC thickness from Raman 
signals specifi cally derived from SC components.Raman spectra were obtained from 
the surface to interior of skin in healthy Japanese subjects by a confocal Raman 
spectrometer. We searched for Raman signals specifi cally derived from SC components 
in Raman spectra. In order to confi rm signal specifi city, we also carried out a Raman 
microscopy experiment using human skin sections and visualized localization of 
specifi c Raman signals. The same skin sections were stained by the Hematoxilin-
Eosin method to distinguish SC from viable epidermal layers and for use in the 
comparison with the Raman signal maps.The signal intensity of the SC at 2880[cm-1] 
decreased with increasing depth from the skin surface in vivo measurement. The 
signals at 2880[cm-1] from face and forearm disappeared at 10.8+/-3.0[um] and 
14.7+/-3.1[um], respectively. Furthermore, the signal at 2880[cm-1] was obtained 
almost exclusively from the SC region on skin sections. It is considered that this signal 
derives from the lipids forming lamellar structures, because the signal at 2880[cm-1] 
is assigned to the CH2 stretching mode, mainly attributable to lipid alkyl chains 
in the case of the skin.The assessment of the SC region based on the intensity of 
Raman spectra at 2880[cm-1] is useful for in vivo measurements of SC thickness.
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Analysis of factors that regulate ceramide production in the stratum corneum using 
a 3 dimensional keratinizing human keratinocyte model
Yoshida N1, Imokawa G2 1Tokyo University of Technology, Hachioji City, Tokyo, Japan 
2Tokyo University of Technology , Japan
Ceramides in the stratum corneum (SC) play an important role in maintaining its 
water-holding and barrier function, defi ciencies of which are highly associated with 
the pathogenesis of xerosis and atopic dermatitis. In this study, we examined factors 
that regulate ceramide production in the SC using a 3 dimensional keratinizing human 
keratinocyte (3DKK) model in which a layered SC can be induced within 1 week of 
culture. The addition of the UDP-glucose: ceramide glucosyltransferase inhibitor, 
PDMP (50 uM) during the 7 day keratinization phase signifi cantly diminished 
ceramide levels expressed as per SC protein, without affecting the formation of 
the SC, and concomitant with decreased glucosylceramide levels. An inhibitor of 
sphingomyelinase, DSP (25 uM) also signifi cantly reduced ceramide levels without 
decreasing acylceramides. Similarly, an inhibitor of beta-glucocerebrosidase, CBE (3 
mM), signifi cantly down-regulated ceramide levels with decreases in all ceramide 
species in concert with a signifi cant increase in glucosylceramide. The above results 
indicate that major metabolic pathways leading to ceramide synthesis through 
the interface between the SC and the granular layer occur in the 3DKK model as 
occurs in in-vivo. Surprisingly, all-trans retinoic acid (RA) at concentrations as low 
as 25 nM signifi cantly up-regulated ceramide levels with increases in all ceramide 
species without affecting formation of the SC, whereas RA at concentrations more 
than 1 uM markedly attenuated the SC formation and the ceramide production. Our 
results indicate a superiority of the 3DKK model for analyzing factors that regulate 
ceramide synthesis in the SC and suggest RA of low doses as a new therapeutic 
tool for treating ceramide defi cient-disorders of the SC such as atopic dermatitis.
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Aquaporin-3 is involved in cold stress resistance in normal human keratinocytes 
and human skin
Labarrade F1, Serre C1, Gondran C1, Botto JM1, Portolan F1, Garcia N1, Dal Farra C2, 
Domloge N1 1ISP Vincience Global Skin Research Center, Sophia-Antipolis, France 
2ISP  Corporate Research Center, Wayne, USA
One of the main functions of the skin is to protect the organism against environmental threats, 
such as thermal stress. Aquaporin-3 facilitates water and glycerol transport across cell membranes, 
and therefore regulates osmotic balance in different situations of stress. This mechanism seems 
to be particularly important for the resistance of different organisms to cold stress. Consequently, 
we were interested in investigating the effect of cold stress on AQP3 expression in normal human 
keratinocytes (NHK) and human skin, and its role in cold stress resistance. RT-PCR studies were 
performed in order to evaluate the expression of aquaporins 3, 5, and 7 in different human cell types 
(NHK, HaCaT, and fi broblasts).Then, NHK were submitted to a cold stress of 4 C for 4 hours, with 
or without pre-treatment with the AQP3-inducing active ingredient IV08.002. AQP3 expression was 
then analyzed by immunoblotting and immunofl uorescence staining. This study revealed that cold 
stress up-regulated AQP3 expression in all the cells.Moreover, we examined the effect of cold stress 
on cell morphology. Our results indicated that cold stress induced rounding of the cells, and that pre-
induction of AQP3 helped to preserve cell shape in cold-exposed cells. Furthermore, actin staining 
showed that induction of AQP3 by IV08.002 maintained the actin cytoskeleton in cold-stressed NHK, 
preserving cell morphology and preventing cells from rounding.These results were also confi rmed 
by transfecting NHK with AQP3-specifi c si-RNA.Ex vivo studies showed that, in human skin samples 
exposed to a cold stress at 4 C for 4 h, with or without pre-treatment with IV08.002, AQP3 expression 
increased. However, AQP3 pre-induced skin exhibited less damage, compared to control cold-
stressed skin.The implication of AQP3 in thermal stress resistance suggests that it plays an essential 
role in environmental stress resistance and in protecting the skin from cold-induced damage. 
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Cannabidiol inhibits lipid synthesis in human sebaceous gland-derived sebocytes - is 
cannabidiol a novel anti-acne agent?
Oláh A1, Tóth BI1, Czifra G1, Zouboulis CC2, Paus R3, Kovács L1, Bíró T1 1Dept of 
Physiol, Univ of Debrecen, Hungary 2Dept of Derm, Venereology, Allergol & Immunol, 
Dessau Medical Center, Germany 3Dept of Derm, Univ of Lübeck, Germany
We have previously shown that locally produced endocannabinoids (e.g. anandamide, AEA) 
constitutively stimulate lipid production and induce cell death in human sebaceous gland-derived 
SZ95 sebocytes (Dobrosi et al, FASEB J, 22:3685, 2008). In this study, we investigated the effects 
of Cannabidiol (CBD), a non-psychoactive component of Cannabis sativa, on biological functions 
of SZ95 sebocytes.CBD alone did not affect basal lipid synthesis of the sebocytes. However, of 
great importance, CBD markedly abrogated the effects of endocannabinoids to stimulate lipid 
synthesis. Intriguingly, higher concentrations (30-50 µM) of CBD induced apoptosis similar to the 
action of AEA. Of further importance, inhibition of cannabinoid receptors CB1 or CB2 did not 
prevent the effect of CBD. However, the decrease of extracellular Ca2+ concentration ([Ca2+]e) 
markedly suppressed the action of CBD to inhibit lipid synthesis. CBD was previously shown to 
modulate Ca2+-permeable transient receptor potential (TRP) channels, namely TRPV1, V2, M8, 
and A1. Among these, we have identifi ed the expression of TRPV1 and V2 on SZ95 sebocytes. 
Indeed, CDB increased [Ca2+]i which was prevented by ruthenium red, a non-specifi c inhibitor 
of TRP channels. Intriguingly, capsazepine, a blocker of TRPV1, was unable to inhibit the action 
of CBD to suppress lipid synthesis. These fi ndings (at least indirectly) suggest that the cellular 
effects of CBD on SZ95 sebocytes are mediated by Ca2+-permeable channels, most probably 
by TRPV2 (our currently running siRNA experiments intend to unambiguously identify the CBD-
target molecule). Collective, our data introduce CBD as a novel molecule with a signifi cant 
sebostatic function. Our fi ndings may therefore encourage one to systematically explore whether 
CBD can be exploited in the management of such a common skin disorder as acne, which is 
characterized by pathologically elevated lipid (sebum) production of the sebaceous glands.
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Caspase-14 plays a key role in DNA repair and protection
Bergeron L1, Labarrade F1, Amoyel A1, Serre C1, Gondran C1, Botto JM1, Garcia N1, 
Dal Farra C2, Domloge N1 1ISP Vincience Global Skin Research Center, Sophia-
Antipolis, France 2ISP  Corporate Research Center, Wayne, USA
Caspase-14 is involved in keratinocyte terminal differentiation cell death program of 
cornifi cation. Caspase-14 is involved in the processing of profi laggrin into fi laggrin, which 
is further degraded into free amino acids, constituting the NMF. Therefore, caspase-14 
plays a crucial role in protecting skin from dehydration, and from the harmful effects of 
UV.In the present study, caspase-14 expression in different cell lines was investigated by 
RT-PCR studies. Caspase-14 transcripts were detected in HaCaT cells and normal human 
keratinocytes (NHK), but not in human fi broblasts and melanocytes.Immunofl uorescence 
(IF) studies on NHK and human skin biopsies showed that caspase-14 expression could 
be induced selectively within 24 hours of treatment with our newly developed IV08.003 
active. By using si-RNA on caspase-14, we observed an inhibition of 30.6% in caspase-
14 expression that was signifi cantly restored by the induction of caspase-14 by IV08.003. 
Because pro-fi laggrin is considered a direct substrate of caspase-14, IF staining studies for 
pro-fi laggrin were performed on human skin biopsies, treated with caspase-14 inducing 
active ingredient for 24 to 72 hours. We observed an increase in pro-fi laggrin staining 
at the different time points studied. This increase could be the result of a compensation 
mechanism, resulting from an increase in pro-fi laggrin cleavage by caspase-14. Our studies 
also investigated the effects of UVB-irradiation on caspase-14 expression. As previously 
described, caspase-14 expression was up-regulated in NHK irradiated with a dose-effect 
of UVB. Comet assays showed that caspase-14 induction promoted DNA protection and 
repair, depending on whether the induction was performed before or after UVB irradiation.
In conclusion, these results indicate that caspase-14 can play an important role in preventing 
and repairing UVB-induced DNA damage, in addition to its effect on skin barrier function. 
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Characterization of human caspase-14 in vivo and in vitro: its relevance to DNA 
degradation
Yamamoto M1, Hosoi J2, Katagiri C2, Tsuboi R3, Hibino T2 1Tokyo Medical University, 
Shiseido Research Center, Tokyo, Japan 2Shiseido Research Center, Yokohama, Japan 
3Tokyo Medical University, Tokyo, Japan
We have previously purifi ed human caspase-14 from cornifi ed cells and determined cleavage 
sites for the activation.  This enables us to prepare: 1) cleavage-site directed antibody (D146 
Ab) that recognized only the active caspase-14, and 2) constitutively active caspase-14 by 
reverse genetics (revC14). ?@The revC14 was recognized with D146 Ab, and it showed 
hydrolytic activities on synthetic and protein substrates. In addition, we also developed 4 
clones of monoclonal antibodies against human caspase-14, one of which possessed strong 
neutralizing activity (C14 mAb-2).  When the revC14 was expressed in a growing phase of 
cultured keratinocytes using CMV promoter, it did not show any detectable changes.  In 
contrast, when the culture was prolonged after confl uency, some cells stained with C14 
mAb-2 and D146 Ab turned TUNEL positive, indicating that DNA degradation occurred 
in the active caspase-14 expressing keratinocytes only after differentiation.  We tested 
hydrolytic activities of the purifi ed caspase-14 and revC14 on the inhibitor of caspase-
activated DNase (ICAD).  These enzymes effectively degraded ICAD, and the degradation 
was suppressed by the addition of C14 mAb-2.  We also developed an ELISA assay system 
for the quantifi cation of caspase-14 using C14 mAb-3.  The cornifi ed cell extracts from 
healthy individuals contained approximately 1.41 microgram of caspase-14/mg total 
protein, whereas psoriatic scale extract showed signifi cant decrease (0.46 microgram/mg 
total protein). In addition, immunohistochemical study revealed that D146 Ab staining was 
hardly detectable in the parakeratotic skin with psoriasis.  Our results suggest that caspase-
14 may be involved in the process of DNA degradation and decreased expression as well 
as suppression of the activation may have relevance to the pathophysiology of psoriasis.
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Chromosomal passenger complex proteins and survivin regulate epidermal adult 
stem cells differentiation
Labarrade F1, Meyrignac C2, Lebleu A1, Botto JM1, Gondran C1, Garcia N1, Dal Farra 
C2, Domloge N1 1ISP Vincience Global Skin Research Center, Sophia -Antipolis, 
France 2ISP  Corporate Research Center, Wayne, USA
The epidermis and the hair follicle need to continuously generate new cells through proliferation 
of progenitor cells and subsequent differentiation.This renewal is permitted by adult stem cells 
(ASCs) originating from the bulge region of follicles. Under certain stimuli, ASCs are able to 
migrate towards interfollicular epidermal regions and/or the hair follicle, in order to replenish the 
loss of terminally differentiated cells (corneocytes and the hair shaft). This differentiation process 
is tightly controlled and the underlying successive mitosis is strictly regulated, particularly by the 
chromosomal passenger complex (CPC). The CPC is the key regulatory complex which is responsible 
for the correct development of cellular mitosis. The proteins survivin, borealin, aurora kinase B, 
and INCENP are the interacting components of the CPC. Survivin is a member of the Inhibitor of 
Apoptosis Proteins (IAPs) family. In order to study the role of CPC proteins in adult skin stem cell 
maintenance and protection from various stresses, we prepared several fractions of primary cells 
from human epidermis, corresponding to cellular enrichments at successive stages of differentiation 
(mainly transient amplifying and differentiated adult epidermal stem cells). Cell morphology 
observation, RT-PCR analysis, immunoblotting, as well as immunocyto, histological, and siRNA-
induced knockdown expression studies, were all approaches used to further evaluate and follow the 
implications of the four studied CPC components in correct stem cell differentiation, their subcellular 
localization, as well as several relevant markers (P63, beta-catenin, alpha-6 and beta-1 integrins, 
and KT15). In parallel, we investigated whether an induced upregulation of survivin expression, 
or its translocation into the nucleus, could have a protective role in the mitosis phenomenon. 
Together, these studies shed more light on the essential role and importance of ASC protection.
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Clinical effi cacy of a probiotic lysate on barrier function is associated with changes 
in stratum corneum aging related proteins
Gueniche A1, Delattre C1, Winstall E2, Bastien P1, Bernard D1, Castiel I1 1L’Oreal 
Recherche, Clichy, France 2Centre de recherche du Centre Hospitalier Universitaire 
de Québec, Canada
In a randomized double-blind placebo-controlled trial (66 volunteers, 30-65 years old, 2 month 
topical application twice a day), it has been shown that a novel probiotic (Bifi dobacterium) lysate 
improved the resistance of skin barrier to physical aggression as  assessed by  trans-epidermal water 
loss measurements following tape-stripping induced barrier disruption. Barrier function is known 
to play a major role in skin homeostasis and some recent studies brought out changes occurring at 
the skin barrier level with chronological aging. Moreover, proteomic analysis of stratum corneum 
proteins in post-menopausal women and in xerotic skin showed  that aging and/or dry skin  condition 
were associated with major changes in skin surface proteins patterns. The purpose of the study was 
to get deeper information on the mechanisms involved in the effect of tested probiotic lysate.Stratum 
corneum strip samples were  taken before and after 2 month treatment and differential proteomic 
analysis was carried out using isobaric labeling of peptides (iTRAQ analysis). In the group treated 
with  probiotic lysate, the level of some proteins (or of their proteolytic fragments) involved in 
stratum corneum maturity and particularly those associated with desquamation process increased 
eg: proteins KLK7 (n Uniref P49862), DSC1a (N Q9HB01), Cathepsin L2 (N O60911), DSG1 (N 
Q02413), KLK5 (N Q9Y337), and Corneodesmosin (N Q15517) while the quantity of some other 
proteins related to the SC immaturity such as Bleomycin hydrolase (Q13867), Enolase 1 (Q53FT9), 
TPI (Q6FHP9), GAPDH (Q2TSD0) decreased.Data from proteomic analysis confi rms the potential 
interest of tested bacterial extract on skin aging.  They indicate that topical application of the 
Bifi dobacterium lysate reverse the changes in specifi c aging-related proteins such as Desmoglein 
1 and reinforce the barrier function known to be impaired with skin chronological aging.




Decreased fi laggrin expression results in impaired epidermal barrier function in 
ichthyosis vulgaris
Gruber R1, Crumrine D2, Sandilands A3, Gunathilake R2, Hachem JP4, Presland RB5, 
Fleckman P5, Feingold KR2, Elias PM2, Schmuth M1 1Innsbruck Medical University, 
Innsbruck, Austria 2University of California, San Francisco, USA 3University of 
Dundee, Dundee, United Kingdom 4Free University of Brussels, Brussels, Belgium 
5University of Washington, Seattle, USA
It is widely suggested that fi laggrin (FLG) defi ciency results in abnormal permeability 
barrier function. However, direct evidence for this is lacking, and the structural 
basis is poorly known. In order to assess the relationship between FLG mutations 
and the epidermal permeability barrier, we characterized a total of 12 ichthyosis 
vulgaris patients with FLG defi ciency, and 29 age- and sex-matched controls at the 
molecular, functional, and morphological level. Although FLG defi ciency correlated 
with an increase in stratum corneum cell layers, in these patients we observed 
both trans epidermal water loss (TEWL) abnormalities and extracellular lanthanum 
leakage, as compared to control subjects. By electron microscopy analysis, 
FLG-defi cient corneocytes showed a normal ultrastructure with regular keratin 
aggregation and normal cornifi ed envelope dimensions. Instead of a corneocyte 
scaffold abnormality, the leaky extracellular space could be ascribed to impaired 
secretion and processing of lamellar body-derived extracellular lipids. Consistent 
with this, in the extracellular spaces of FLG-defi cient stratum corneum, we observed 
foci of irregularly shaped, loosely organized lamellar bilayers adjacent to regular 
lamellar membranes. This lamellar/non-lamellar phase separation suggests that FLG 
infl uences extracellular lipid organization, and sheds initial light on the pathogenesis 
of epidermal permeability barrier dysfunction in FLG-defi cient epidermis.
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Desmosomal genes stimulation by a biotechnological Adenium obesum extract
Dumas M, Archambault JC, Bonte F LVMH Recherche, Saint Jean De Braye, France
The stratum corneum protects skin form the evaporation of water thanks to desmosomes 
and tight junctions, closing intercellular spaces at the corneo epidermal junction. These 
proteins are also involved in the reinforcement of the skin mechanical barrier by linking 
adjacent keratinocytes and corneocytes. Sheets cells of Adenium obesum (apocynaceae) 
are cultivated in vitro by biotechnology, then washed, freeze-dried, fi nely crushed and 
fi ltered. The lyophilized fi ltrate is rich in proteins, lipids, glucose, fructose, and saccharose, 
vitamins (PP, B1, B5, B6, B8, B9) and membrane components. Normal human cultures 
of keratinocytes are cultivated classically in a SFM medium containing EGF and pituitary 
extract. Confl uent monolayer cultures are treated during 24h with solution of Adenium 
obesum 10% p/v in DMSO, the fi nal non cytotoxic concentration being 20 and 40 µg/ml, 
and with calcium chloride 1.5 mM, a differentiation inducer used as a positive control. 
Expression of desmosomal genes, desmoglein 1 and desmoplakin, is measured by RT-QPCR 
using G3PDH as the internal house keeping gene control.After treatment, the supernatants 
of keratinocytes cultures are eliminated, cells rinsed with PBS and then frozen at - 80 C. 
After extraction, total RNA are removed from any traces of DNA by treatment with DNAse 
and a quantitative RT-PCR was carried out with the Lightcycler (Roche Molecular System) 
using desmoglein 1, desmoplakin and G3PDH oligonucleotide starters.Adenium obesum 
biotechnological extract was demonstrated to reinforce the formation of desmosomes by 
stimulating the expression of desmoglein 1 (up to +43%) and of desmoplakin (up to 20%) at 
the mRNA level, the calcium treatment leading to +68% and +61% stimulation respectively 
for these two genes. Conclusion: Adenium obesum extract stimulates fundamental genes 
implicated in the cutaneous barrier formation mainly in charge of waterloss control 
through intercellular spaces, and can be therefore used in moisturizing cosmetic products 
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Differential roles of melanocortin receptor 1 and melanocortin receptor 5 in 
the human immortalized sebocyte biology in the presence of alpha-melanocyte-
stimulating hormone
Kim JM
Brain Korea 21 Project for Medical Science,Yonsei University College of Medicine, 
Seoul, Republic of Korea
The effect of alpha-melanocyte-stimulating hormone (alpha-MSH) as a regulator of sebogenesis 
and infl ammation on the human sebocytes via melanocortin receptors has been well recognized. 
Primary human sebocytes and immortalized humans sebocytes (SZ95 sebocytes) have 
melanocortin receptor 1 (MC1R) and melanocortin receptor 5 (MC5R) and MC5R is known to 
be a differentiation marker. However, the precise role of alpha-MSH in sebocyte biology and the 
differential function of MC1R and MC5R in sebocytes are not fully investigated. In this study, we 
investigated the effect of alpha-MSH on the expression of antimicrobial peptides (AMPs), matrix 
metalloproteinases (MMPs), and sebogenesis in SZ95 sebocytes with or without testosterone and 
linoleic acid treatment. Expression of MC1R, MC5R, MMPs, and AMPs was detected using real 
time quantitative PCR and western blotting. In addition, we detected lipid contents using nile-
red stain. SZ95 sebocytes showed MC1R expression and weakly detectable MC5R expression. In 
contrast, SZ95 sebocytes treated with testosterone and linoleic acid showed both MC1R and MC5R 
immunoreactivity suggesting of differentiated state. When 0.1μM alpha-MSH was treated on the 
SZ95 sebocytes the expression of MMP2, hBD2, and LL37 was increased and lipid content was 
increased with high polar/neutral ratio, suggesting the MC1R-induced proliferation. In the SZ95 
sebocytes treated with testosterone and linoleic acid, alpha-MSH stimulation also resulted in the 
increased expression of MMP2, hBD2, and LL37. Lipid content was also increased, however, the 
neutral lipid was more prominent in contrast to that of SZ95 sebocytes without treatment with 
testosterone and linoleic acid. From these fi ndings, we concluded that alpha-MSH induces up-
regulation of MMP2, hBD2, and LL37 in sebocytes via both MC1R and MC5R. We also concluded 
that alpha-MSH-induced up-regulation of sebaceous lipids is primarily mediated by MC5R.
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Differentiation of immortalized keratinocytes HaCaT cells compared with normal 
human keratinocytes using real time PCR and QuantiGene® technology
Hernandez-Pigeon H, Rigaudeau AS, Castex-Rizzi N Pierre Fabre Dermo-Cosmétique, 
Toulouse, France
Epidermal differentiation is a continuous process, constituting and renewing a 
protective layer at the skin surface: the stratum corneum, composed of cornifi ed 
keratinocytes, that is a mechanic and chemical barrier to the organism.  The kerati-
nocyte differentiation is tightly regulated and is generally associated with expression 
of epidermal differentiation markers, such as proteic markers (like involucrin, 
transglutaminases, fi laggrin and loricrin) and lipid markers (like ABCG1, ABCA12, 
beta-glucoceramidase, and sphingolipid C4-hydroxylase/delta-4 desaturase). 
Cell culture models for studying human keratinocyte differentiation are primarily 
normal human keratinocytes (NHK) obtained from skin surgery. However, these primary 
keratinocytes are diffi cult to work with because of the diffi culty of supplying, their 
few passages number under culture and the donor-dependent variability. Therefore, 
we proposed to evaluate the differentiation parameters on a cell line. Indeed, we 
have compared the results obtained between NHK and HaCaT cells, a spontaneously 
immortalized human keratinocyte cell line. For this comparison we have analyzed 
cell differentiation after incubation with high calcium concentration and/or reference 
molecules inducing differentiation. The proteic and lipid markers were quantifi ed by 
real time PCR and by QuantiGene Plex® 2.0 Reagent System (Luminex technology). 
This study allows us to show that QuantiGene® can also quantitatively measure 
multiple RNA targets simultaneously in our models. Both primary and cell line HaCaT 
keratinocytes are useful in vitro cell models for studying epidermic differentiation.
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Effect of Filaggrin gene mutations on biophysical and biochemical skin properties in 
individuals with pathological dry skin
Gardinier S1, Latreille J1, Mlitz V2, Guinot C1, Tschachler E2 1CERIES, Neuilly-sur-
Seine, France 2Medical University of Vienna, Vienna, Austria
The aim of the study was to examine the effect of FLG gene mutations on biophysical properties 
and stratum corneum (SC) composition in subjects with atopic dermatitis (AD). To reach this 
objective, a study was conducted on 196 French adults Caucasian subjects, 18 to 46 years old, 
classifi ed in two groups: atopic dermatitis subjects (AD group, n=97) and healthy skin subjects as 
controls (control group, n=99). The genotypes of four FLG variants (R501X, 2282del4, R2447X et 
3702delG) were analysed. The severity of AD was determined using the OSCORAD index. Raman 
measurements were performed on the forearm of each subject to assess in the SC the amount 
of lipids, lactate, NMF components (amino acids and derivatives), relative amount of water 
as well as the thickness of the SC. Moreover, capacitance, trans epidermal water loss (TEWL), 
temperature and pH parameters were also measured on the forearm. Fourteen subjects (AD: n=10; 
Control: n=4) were carriers of at least one mutation of the three FLG variants: R501X, 2282del4 
and R2447X. The 3702delG variant was not detected in our sample. The allelic frequencies of 
FLG mutations tended to be higher in the AD group than in the control group (p < 0.0993). The 
AD carriers of at least one mutation presented signifi cantly lower values of NMF components 
(amino acids and derivatives) than the AD subjects without mutations and than the control 
subjects. They also presented signifi cantly higher values of TEWL, of relative amount of water 
and a thinner SC than the control subjects. Besides, a signifi cant negative correlation was found 
between OSCORAD and the Ceramide 3 and NMF components, even if no signifi cant difference 
of Ceramide 3 was found with the mutation. The AD severity was also negatively correlated with 
the capacitance parameter. Our fi ndings support the role of fi laggrin protein in the maintenance 
of skin barrier function and suggest a diminution of Ceramide 3 correlated with the severity of AD.
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Effects of environmental stress factors on the level and subcellular localisation of 
Hif1a/Hif1b proteins in epidermal keratinocytes
Weir L1, Wondimu A2, Robertson D1, Panteleyev A1 1University of Dundee, Dundee, 
United Kingdom 2Columbia University, New York, USA
Skin has evolved complex mechanisms to cope with multiple environmental stresses (e.g., oxygen, 
UV, toxicants). Many adaptive mechanisms centre on ARNT (Hif1b) and its dimerisation partners 
like Hifa or AhR that regulate basic physiological processes in the cell. Here we set out to unravel 
the effect of environmental stressors upon the ARNT pathway in epidermal keratinocytes.Confl uent 
primary mouse (PMK) and human immortalised (N-TERT) keratinocytes were exposed to hypoxia 
(1% oxygen, 48 hours) or to UV light (300 Joules/m2), to mimic environmental challenge. Hif1a 
protein, assumed to be stabilised under hypoxia only, was detected (WB) not only in hypoxic 
keratinocytes but also under normoxia. Hypoxia resulted in prominent Hif1a decrease. In low 
calcium in normoxia, Hif1a was mostly cytoplasmic but some was nuclear suggesting a putative 
normoxic role for Hif1a in proliferating keratinocytes. In low calcium under hypoxia, Hif1a 
was exclusively nuclear. In high calcium in normoxia and hypoxia, Hif1a was not detectable 
in PMK and cytoplasmic in N-TERT cells. ARNT, usually assumed to be at steady state levels, 
was signifi cantly reduced under hypoxia in both PMK and N-TERT keratinocytes (WB). UV 
treatment of PMK also resulted in signifi cant downregulation of ARNT. This effect was equal 
in cells grown at high and low calcium suggesting UV suppressed ARNT in proliferating and 
differentiating cells. Our results demonstrate that environmental challenge can infl uence levels 
and subcellular localisation of both Hif1a and ARNT. Previously, we showed that changing 
ARNT levels produced severe alterations in epidermal development, differentiation and barrier 
formation. Together with our current results this provides a new link between environmental 
stress and epidermal differentiation and suggests that modulation of Hif1a/Hif1b levels 
may serve as a mechanism employed by epidermis to cope with environmental challenges.
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Epidermal insulin receptor (IR) and Insulin like growth factor-1 (IGF-1R) receptor 
are essential on maintenance epidermal morphogenesis and proliferative potential
Stachelscheid H, Schmitz A, Brüning JC, Niessen CM University of Cologne, Germany
Continuous renewal and the interaction of proliferative potential and differentiation 
in the epidermis is crucial for organisms to maintain and restore the skin barrier that 
protects them from external challenges and dehydration. In mice, the signals that are 
involved in regulating epidermal proliferative potential are largely unknown. Using 
epidermal specifi c insulin receptor (IR) and/or IGF-1 receptor knockout mice, we 
previously identifi ed isulin and IGF signalling as important regulators of proliferative 
potential in keratinocytes and this was associated with a progressively decrease 
of epidermal thickness that was fi rst obvious at embryonic day 16.5. Interestingly, 
expression of a known regulator of epidermal proliferative potential, p63, was reduced. 
Even though initial analysis did not show a difference in proliferation at E16.5, as 
judged by Ki67 staining, further examination revealed less anaphase spindles in IR/
IGF-1R epidermal knockouts (dko) compared to control, suggesting a G2/M block. This 
was associated with altered expression of key cell cycle regulators, such as stratifi n 
and cyclin G1 in the epidermis of newborn dko mice. In addition, the p38 Map kinase 
stress signalling is upregulated, which may be responsible for the induction of  cell 
cylce arrest. At the moment, we are confi rming the G2/M cell cycle arrest and ask if 
cells that undergo cell cycle arrest go into senescence. In addition, we are examining if 
upregulation of p38 Map kinase is a cause or consequence of the phenotypes induced 
by epidermal loss of IR and/or IGF-1R by blocking this pathway in vitro and in vivo.
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Evaluation of the protection from oxidative stress and UV-induced apoptosis by 
Flow Cytometric assessment
Botto JM1, Bauza E1, Gondran C1, Chabert R1, Garcia N1, Dal Farra C2, Domloge N1 
1ISP Vincience Global Skin Research Center, Sophia-Antipolis, France 2ISP  Corporate 
Research Center, Wayne, USA
Oxidative stress and UV irradiation are implicated in the alteration of cutaneous mitochondrial 
metabolism, leading to premature cell death. Moreover, coenzyme Q10 is known to play an 
essential role in mitochondrial energy synthesis and antioxidative stress protection. In this study, 
we further investigated the deleterious effects of hydrogen peroxide (H2O2) on mitochondrial 
respiratory functions and UV irradiation on skin fi broblast apoptosis. Additionally, we compared 
the chemopreventive effects of the IV08.004 compound, which we previously described to possess 
an effect on mitochondrial redox metabolism and apoptosis. We evaluated hydrogen peroxide 
cytotoxicity on cultured cells by following the level of the free radicals produced. Human skin 
fi broblasts were grown for 48h, treated for 30 minutes with H2O2, and then allowed to recover 
for 2h. For apoptosis induction, fi broblasts were UVB-irradiated (150 mJ/ cm2) after 36h, and then 
maintained in culture for 16h for recovery. In parallel, the same treatments were applied in the presence 
of the IV08.004 compound. After H2O2or UV treatment, cells were harvested and then submitted 
to ROS measurement with dihydroxy-ethidium, or to cell death measurement by annexin V-FITC 
labeling. Analyses were performed by fl ow cytometry. To evaluated apoptosis, cells were labeled 
with recombinant annexin V-FITC. Then, propidium iodide was added and samples were analyzed 
immediately by fl ow cytometry. The percentage of apoptotic cells corresponded to the total of annexin 
V positive and annexin V/PI double positive cells. The IV08.004 compound exhibited the property of 
signifi cantly reducing the level of free radicals produced in response to the H2O2application (-22%) 
and also of protecting from UV-induced apoptosis (-27%), compared to the control. These studies 
shed more light on the effects of oxidative stress and the essential role of mitochondrial protection.
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Expression analysis of hornerin, a member of the S100 fused-type protein family in 
oral mucosa with the disorders
Makino T1, Yamakoshi T1, Inoue S1, Noguchi M1, Shimizu T1 1University of Toyama, 
Toyama, Japan 2Okayama University Graduate School of Medicine, Okayama, Japan
Recently we identifi ed human hornerin gene on chromosome 1q21 by homology 
search using a sequence covering the EF-hand domain of mouse hornein. Human 
hornerin consists of an EF-hand domain at the N-terminus followed by a large 
repetitive domain. These structural features of human hornerin are most similar to 
those of human profi laggrin, an essential protein for keratinization. The hornerin 
protein was detected in the granular cells of regenerating skin and psoriatic skin, 
but not in the normal skins. In the present study, we investigated expression of 
human hornerin in oral mucosa using antibodies against the repetitive domain of 
hornerin. Hornerin was slightly expressed in the epithelium of hard plate, but not 
in buccal mucosa and tongue. On the other hand, profi laggrin was expressed in 
epithelium of in buccal mucosa, hard plate and tongue. Furthermore, we examined 
the expression of hornerin in oral mucosa with the disorders. The expression of 
human hornerin was markedly increased in the epithelium of oral mucosa with 
leukoplakia, lichen planus and dysplasia. The positive signals of hornerin were 
observed as granules, some of which were also positive for profi laggrin as revealed 
by a double staining method. These results showed that hornerin was expressed in 
oral mucosa under the pathological conditions similar to the expression profi le in 
skin, and might be involved in the pathogenesis of some disorders of oral mucosa.
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Expression of neuropeptide Y, Y1 and Y2 receptors in human epidermal layer of 
the skin
Dumont Y1, Duranton A2, Demaude J2, Bastianeto S1, Breton L2, Quirion R1 1McGill 
University, Montreal, Canada 2L’Oréal  Research, Clichy, France
Neuropeptide Y (NPY) and peptide YY (PYY) were isolated from porcine brain and intestinal 
tissues, respectively, are two structurally related peptides and mediate their effects through 
the activation of at least 5 receptor subtypes designated as Y1, Y2, Y4, Y5 and Y6. NPY-like 
immunoreactivity has been found in autonomic nerve terminals and fi bres of the normal 
human dermis while NPY and PYY were also detected in Langerhans cells located in the 
epidermal layer of the skin. Early studies have shown that NPY had an inhibitory effect 
on forskolin-induced cyclic AMP accumulation in keratinocytes, suggesting that NPY may 
have an inhibitory role on the proliferation in a human keratinocyte cells. However, the 
distribution of NPY receptor subtypes has not been investigated in human skin especially 
at the level of the epiderm. Human skin tissues were obtained from normal subjects 
undergoing for facial plactic surgery and NPY receptor distribution has been accessed 
using receptor autoradiography and immunohistochemistry from frozen and fi xed sections, 
respectively. NPY receptor autoradiography has been performed as previously reported 
and revealed strong labelling of specifi c [125I]GR231118/Y1 sensitive, [125I][Leu31, 
Pro34]PYY/Y1 sensitive and [125I]PYY3-36/Y2 sensitive binding sites at the level of the 
epidermal layer, while labelling of Y4 and Y5 sites were closed to background level. 
Immuno-histochemistry using antibody directed against NPY Y1 and NPY Y2 receptor 
subtypes have confi rmed the presence of both NPY Y1 and NPY Y2 receptor subtypes at 
the level of the epidermal layer of the human skin. These data suggest that either the NPY 
Y1 and/or NPY Y2 receptor subtypes may regulate the activity of human keratinocyte cells.
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Galanin regulates ionic secretion in the human sweat gland
Bovell D1, Odusanwo O1, Rauch I2, Kofl er B2, Lang R3 1Department of Biological 
and Biomedical Science, Glasgow Caledonian University, Glasgow, United Kingdom 
2Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical 
University, Salzburg, Austria 3Department of Dermatology, University Hospital 
Salzburg, Paracelsus Medical University, Salzburg, Austria
Galanin is a member of the galanin family of neuropeptides. There is immunohistochemical evidence 
fom human skin that galanin is not only present in nerve terminals around the sweat glands but 
also in ductal cells. Furthermore, galanin binding sites have been detected in human sweat glands 
suggesting a regulatory function for galanin on sweating.The present study examined the mRNA 
expression of galanin and of the three distinct galanin-receptor subtypes GalR1, GalR2 and GALR3 
in the human sweat gland cell line NCL-SG3. To further evaluate a possible physiologic function of 
galanin, we determined the effects of galanin on ionic secretion in this cell line by Ussing chamber 
experiments. RT-PCR analysis revealed that NCL-SG3 cells express galanin mRNA, GalR2 as well as 
GalR3 mRNA but not GalR1 mRNA. In Ussing Chamber experiments, application of á5µM galanin 
stimulated a signifi cant increase of the short-circuit current (Isc), when added to the basolateral 
side of the cells. The galanin evoked increase in Isc was not altered by the presence of the sodium 
channel blocker amiloride (10 µM), demonstrating no apparent contribution of sodium ions to the 
galanin induced changes in Isc. However, the presence of the chloride channel blocker 5-nitro-2-
(phenylpropylamino)-benzoate (NPPB) (100 µM) in the bath solution inhibited the response.The 
results of this study demonstrate that galanin mRNA and mRNA´s of two galanin-receptor subtypes are 
present in the sweat gland cell line NCL-SG3 and that stimulation of the receptors at the basolateral 
membrane of these cells can produce chloride secretion.In addition to the well documented 
effects of cholinergic, adrenergic and purinergic receptors galanin and its receptors may play a 
role in regulating transepithelial ion transport and fl uid secretion from the eccrine secretory coil.
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HSD11 is a novel candidate of homeostatic regulator on epidermal 
differentiation
Terao M, Ishikawa A, Kotobuki Y, Murota H, Katayama I Osaka University, Suita, 
Japan
11β-hydroxysteroid dehydrogenase (11βHSD) is an enzyme that modulates physiological 
actions of glucocorticoid within target cells. There are two isoforms of 11βHSD. One is 
HSD11β1 that is expressed in several organs including liver and adipose tissues. It is known 
to predominantly activate glucocorticoid and to be accelerated in obese people. The other 
is HSD11β2 that is mainly expressed in kidney and works as inactivator of glucocorticoid. 
Its mutations are responsible for mineral corticoid excess syndrome. Although there 
are some reports that describe of HSD11β1 and HSD11β2 expressions in epidermis, 
their functions are still unknown. In this study, we examined HSD11β1 and HSD11β2 
expressions in normal human skin and several skin diseases. We further differentiated or 
induced epithelial-to-mesenchymal transition (EMT) in normal human keratinocytes (NHEK) 
and examined the expression of HSD11β1 in vitro. To investigate the functions of HSD11β 
in keratinocytes we treated NHEK with small interfering RNA (siRNA) to investigate the 
functions of HSD11β in keratinocytes. In normal skin, HSD11β1 is mainly expressed from 
spinous to granular layer. Its expression is decreased in lichen planus, DLE and GVHD 
lesion. HSD11β2 was expressed only in the basal layer in normal skin. However, in the 
lesional skin of psoriasis, it is observed from basal to granular layer. In contrast to these 
data that HSD11β1 is expressed in differentiating cells and HSD11β2 is expressed in 
proliferating cells in normal skin, the keratinocyte differentiation marker, involucrin 
and K10 increased by transfection of human HSD11β1-specifi c siRNA and decreased 
by transfection of human HSD11β2-specifi c siRNA in NHEK in vitro. The expression 
of HSD11β1 decreased when NHEK is differentiated by adding 1.2 mM calcium and 
increased when EMT is induced by adding 10ng/ml EGF.  From these fi ndings, we conclude 
that HSD11β1 and HSD11β2 are homeostatic regulators of epidermal differentiation. 




Hypoxia affects differentiation patterns of epidermal keratinocytes in vitro
Weir L, Robertson D, Panteleyev A University of Dundee, Dundee, United Kingdom
Hypoxia is a potent modulator of cell differentiation, especially in developing tissues. 
Here we investigated the role of hypoxia in keratinocyte differentiation using primary 
mouse and immortalised human (N-TERT) cells. Confl uent keratinocyte cultures were 
stimulated with calcium to induce differentiation. In contrast to normoxia, phenotypic 
changes representative of differentiation were not observed in cells exposed to hypoxia 
(1% oxygen) even 48 hours after calcium switch. Expression of terminal differentiation 
markers (involucrin and transglutaminase-1) was reduced or abolished under hypoxia 
(WB, qPCR). The expression of a basal keratinocyte marker, cytokeratin 5, was severely 
reduced in hypoxia, similarly to psoratic epidermis. Embryonic basal cytokeratin 15 under 
hypoxic conditions was also reduced. Cytokeratin 15, a negative regulator of keratinocyte 
activation, is also known to be downregulated in psoriasis. The effects of hypoxia on 
expression of cytokeratin 6, a marker of keratinocyte activation and hyperproliferation, 
were highly dependent on time and calcium level. At low calcium, hypoxia resulted in 
brief downregulation of K6 followed by signifi cant increase in expression. All these 
expressional changes in keratinocytes were associated with activation of Hif1-mediated 
hypoxia pathways, as confi rmed by upregulation of VEGF (WB, qPCR).Exposure to hypoxia 
reduced proliferation in primary mouse keratinocytes but showed no effect in N-TERTs 
(cell counting, PCNA WB). Moreover, hypoxic cells displayed greater general reductase 
and lactate dehydrogenase activity in ELISA assays, confi rming that they are metabolically 
active and are not senescent. Then, we found no difference in the level of apoptosis between 
normoxic and hypoxic cultures.In general, our fi ndings showed that exposure of epidermal 
keratinocytes to low oxygen signifi cantly modulates expression of specifi c keratins and 
other differentiation markers in a pattern reminiscent of psoriasis suggesting an important 
role for hypoxia in control of epidermal differentiation in normal and pathologic conditions.
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Identifying compounds that modulate the behaviour of human epidermal stem cells 
in culture
Saintigny G1, Broad S2, Mulder K2, Watt F2 1CHANEL P B, 93694 Pantin Cedex, France 
2CRUK Cambridge Research Institute, Cambridge, CB2 0RE, United Kingdom
We have used a variety of techniques to screen compounds for their effects on 
cultured human epidermal stem cells. The primary screen was carried out in multi-
well plates and involved quantitating expression of terminal differentiation markers 
such as transglutaminase 1 and involucrin relative to the total number of cells per 
well. Positive hits were further screened by measuring growth at clonal cell density 
and by tracking the behaviour of living cells in order to detect changes in cell adhesion 
and motility. Tertiary screens involved fl ow cytometry and quantitative RT-PCR to 
evaluate expression of putative stem cell markers such as β1 integrins and Delta-like 
1. We tested a mix of hydroxymethionine calcium salt and 3-aminopropane sulfonic 
acid using the different assays and found that it stimulated terminal differentiation 
and promoted intercellular adhesion without depleting the stem cell compartment. 
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In vitro and in vivo studies of the anti oxidant role of cellular aconitase
Oberto G1, Guérif Y1, Gondran C1, Garcia N1, Bauza E1, Botto JM1, Bressier G1, Berghi 
A1, Dal Farra C2, Domloge N1 1ISP Vincience Global Skin Research Center, Sophia-
Antipolis, France 3ISP Corporate Research Center, Wayne, USA
Oxidative stress generates mitochondrial DNA alterations and damage, therefore 
compromising the cellular respiration process. In response to oxidant accumulation, 
cells have developed an “oxidative stress response” in which aconitase seems to 
play an important role by triggering survival functions. We evaluated hydrogen 
peroxide (H2O2) cytotoxicity on human skin fi broblasts in culture, grown for 48h 
with or without 1% of the IV08.001 compound, which has been previously shown 
to enhance total cellular aconitase expression and activity. After 30 minutes of 5 mM 
H2O2 treatment, fi broblasts were allowed to recover for 2h in medium containing or 
not containing compound IV08.001. Free radical production was then evaluated by 
dihydroxy-ethidium staining and subsequent analysis by fl ow cytometry. Aconitase-
stimulated cells showed a signifi cant reduction in the production of free radicals when 
fi broblasts were pretreated for 48h before the application of H2O2. In this study, the 
observed level of ROS production was less (-16%) than that of the control condition. 
An 8-day in vivo study was also conducted with IV08.001 compound, versus placebo, 
on 12 healthy volunteers. In vivo confocal microscopy (Vivascope) at D0, D6, and 
D7, 24h after UV (2 DEM of full spectrum solar light), allowed comparison between 
placebo and aconitase-induced epidermis. At D6 and D7, we observed nice conserved 
structure with an improvement of granular cell morphology on the aconitase-induced 
side, demonstrating skin with a healthier appearance, compared to the placebo-treated 
side. Moreover, UV-generated damage, such as sunburn cells, vacuoles, and oedema, 
was less apparent on the aconitase-induced side. A Vivascope was used to quantify 
results and revealed a 61% decrease of sunburn cells on the aconitase-induced 
side, which confi rmed the overall protective role of aconitase against UV damage.
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Indications to a novel neuroendocrine control of keratin expression: Cannabinoid 
receptor 1 agonist inhibits the expression of keratins K6 and K16 in human 
keratinocytes in situ and in vitro
Ramot Y1, Sugawara K1, Tiede S1, Biro T2, Paus R1 1University Hospital Schleswig-
Holstein, Campus Luebeck, Luebeck, Germany 2University of Debrecen, Medical 
and Health Science Center, Research Center for Molecular Medicine, Hungary
Endo- and exocannabinoids have been reported to have anti-infl ammatory and proliferation-
inhibitory effects that are primarily mediated via cannabinoid receptors (CBs). Since the latter 
are also expressed by human skin keratinocytes, CB agonists have been suggested as a potential 
new therapy for psoriasis, a hyperproliferative chronic infl ammatory disease characterized by 
upregulation of keratins K6 and K16. In the current study, we have studied the effects of the selective 
CB1 agonist, arachidonoyl-chloro-ethanolamide (ACEA), on K6 and K16 expression in situ and in 
vitro. Organ-cultured human scalp skin or isolated HaCaT cells were treated for 24h with ACEA. 
By quantitative immunohistomorphometry, ACEA caused a signifi cant downregulation of K6 and 
K16 immunoreactivity (IR) in suprabasal epidermal cells. This was partially reversed by the CB1 
antagonist AM-251. K6 IR expression by HaCaT cells in culture, as assessed by confocal microscopy, 
was also decreased by ACEA. In line with these results, Q-PCR of ACEA-treated HaCaT cells for 8h 
demonstrated signifi cant inhibition of K6 gene synthesis. In order to obtain indications how these 
effects of CB1 agonists are related to its anti-proliferative effects, double-immunostaining for K6 
and Ki-67 was performed. The downregulation of K6 IR was accompanied by decreased expression 
of Ki-67, suggesting that, at least in part, the keratin expression effects are related to decreased 
proliferation of basal epidermal cells. However, since the CB1 agonist also slightly downregulated 
K6 expression in non-proliferating epidermal compartments, CB1-mediated signalling may also 
directly downregulate K6 expression. This proposes that cannabinoids and their receptors may 
constitute a novel, as yet unstudied, neuroendocrine element in the control of keratin expression.
365
Infl ammatory mediators modulate the release of neurotransmittors from PC12 
cells
Stanila G1, Badea E1, Franchomme P1, Declercq L2, Yarosh D3 1Centre for Plant 
Research, Bucharest, Romania 2Estée Lauder Companies, Oevel, Belgium 3Estée 
Lauder Companies, Melville, NY, USA
Vanilloid receptor type 1 (VR1/TRPV1) is a non selective cationic channel permeable for Na+ 
and Ca2+. Activation of TRPV1 triggers the release of neurotransmittors from primary sensory 
neurons in response to capsaicin, heat, tissue acidifi cation or endogenous agonists. TRPV1 is 
expressed in a subset of primary small sensory neurons from dorsal root ganglia and trigeminal 
ganglia that terminate in free nerve endings in epidermal and dermal skin layers. The expression 
of TRPV1 is increased in infl ammatory conditions leading to sensitization of peripheral primary 
afferent terminals. PC12 cells like endocrine chromaffi n cells undergo neuronal like differentiation 
in response to nerve growth factor. In morphological undifferentiated state they synthesize, 
store and release catecholamine and acetylcholine (Ach) and expresses ionic channels involved 
in normal pain states or infl ammatory pain transduction such as TRPV1, P2X receptors, and 
ASIC (acid sensing ionic channel) receptors. The rate of secretion can be increased by a series 
of secretagogues factors like high K+, nicotine, calcimycin (calcium ionophore). We measured 
spontaneous and capsaicin-induced Ach release in morphological undifferentiated PC12 
cells cultivated in physiological and infl ammatory conditions (i.e. presence of bradykinin, 
histamine and prostaglandin PGE2). Quantifi cation of Ach release was made using 10-acetyl-
3.7 dihydroxyphenoxazine (Amplex Red Reagent). In physiological conditions treatment of PC12 
cells with 50ìM capsaicin and 60ìM nicotine increased the level of Ach release compared with 
spontaneous level of release. When the cells were cultivated in the presence of infl ammatory 
mediators the application of 50μM capsaicin stimulated the release of Ach even stronger, without 
affecting viability. We conclude that the PC12 cells are well suited for selecting compounds that 
can affect the storage and release of neurotransmitters in normal and infl ammatory conditions.
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Knock-down of (pro)-fi laggrin in an organotypic skin model reproduces some of the 
features observed in atopic dermatitis and Ichthyosis vulgaris
Eckhart L, Mlitz V, Ballaun C, Födinger D, Tschachler E, Mildner M Medical University 
of Vienna, Vienna, Austria
Loss-of-function mutations in the fi laggrin gene have been shown to be associated 
with skin diseases displaying impaired terminal keratinocyte differentiation such as 
ichthyosis vulgaris and atopic dermatitis.We have thus investigated whether knock-
down of fi laggrin in an organotypic skin model would also lead to morphological 
phenotypes reminiscent of these diseases. In addition, we asked whether fi laggrin 
knock-down in this system would have an impact on keratin-condensation/soubility. 
Human primary keratinocytes were transfected with siRNAs specifi c for fi laggrin, and 
seeded onto fi broblast-collagen suspensions to generate a multilayered epidermis. 
By H&E-staining we observed a complete loss of keratohyalin granules in fi laggrin 
knock-down organotypic skin cultures, whereas the stratum corneum was formed 
regularly. However, ultra-structural investigations showed that keratohyalin granules, 
although still present, were strongly reduced in size. We did not observe signifi cant 
differences in the expression of other important epidermal differentiation associated 
genes, including loricrin, involucrin, matriptase-1, caspase-14, and several keratins by 
Western blot analysis and immunostaining. In addition the solubility of keratin-1 and 
keratin-10 was not affected by fi laggrin knock-down, indicating a proper aggregation 
of keratin intermediate fi laments. Our fi ndings show that fi laggrin knock-down in 
an organotypic skin model does not affect the expression and solubility of other 
differentiation associated proteins, and that morphological alterations of the epidermis 
are restricted to the granular layers, without infl uencing stratum corneum formation. 
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Lef1 mediated regulation of sebaceous gland lipid metabolism regulates skin barrier 
function
Niemann C1, Fehrenschild D1, Galli U2, Breiden B3, Bloch W4, Schettina P1, Michels 
C5, Sandhoff K3, Niessen C5 1Center for Molecular Medicine Cologne (CMMC), 
Cologne, Germany 2DKFZ, Heidelberg, Germany 3LIMES, Bonn, Germany 4Sport 
University, Cologne, Germany 5University Cologne, Cologne, Germany
The transcription factor Lef1 is essential for development of mammalian skin and hair follicle 
regeneration and mutations in Lef1 are associated with human sebaceous skin tumours. In vivo 
expression of a dominant negative mutant Lef1, which inhibits Wnt/b-catenin signalling, promotes 
keratinocytes to differentiate into interfollicular epidermis and mature sebocytes. However, the 
molecular pathways by which mutant Lef1 regulates cell fate and differentiation programs are still 
unknown. Here we demonstrate that expression of mutated Lef1 results in severe impairment of 
skin barrier function by regulating lipid metabolism especially of the sebaceous gland. Loss of 
barrier function occurred without alterations in stratifi ed organisation of keratinocytes and tight 
junctions, but was associated with ultrastructural abnormalities in assembly and extrusion of 
lamellar bodies in the uper granular layer of the interfollicular epidermis. Lipid analysis revealed 
drastic changes in composition of ester-bound ceramides of the cornifi ed envelopes. Moreover, 
lipids of the sebaceous gland and essential lipid modifying enzymes, particularly SCD1, were 
abnormally regulated by mutant Lef1. Our experiments demonstrate that functional signalling 
by Lef1 plays a key role in maintaining epidermal barrier function by controlling important 
aspects of the lipid metabolism of the skin. The process of sebaceous gland differentiation as well 
as an appropriate composition of lipids and lipid modifying enzymes of sebocytes is important 
for skin barrier function and the results support the idea of strong interdependence of different 
keratinocyte compartments for function and maintenance of the mammalian epidermal tissue.
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Localization of the multidrug resistance proteins (MRP1-MRP4) in the human 
epidermis and physiological role of MRP in human melanocytes and keratinocytes.
Khazen W1, Dumas M2, Noblesse E2, Verbavatz Jm3, Garrigos M3 1CEA/salay,  Gif sur 
Yvette, France 2LVMH Recherche - Parfum Christian Dior, St. Jean de Braye, France 
3CEA/salay, Gif sur Yvette, France
The nine MRP (Multidrug Resistance–associated Proteins) protein isoforms constitute the majority 
of the members of the sub-family C of membrane transporters which possess an ATP-binding 
consensus motif (ATP Binding Cassette). MRPs are generally involved in cellular detoxifi cation 
processes and capable to transport numerous organic molecules, conjugated or not to glutathione 
(GSH), into various intracellular compartments or outside the cell depending on their cellular 
location. Little is known about the expression and function of MRP in the human skin. We have 
characterized the expression (by qualitative and quantitative RT-PCR) of MRP1-9 mRNA as well 
as their localization (by immunocytochemistry) in primary cultures of human keratinocyte or 
melanocyte and in human epidermis. Keratinocyte and melanocyte cells show a similar expression 
profi le of MRP1, 4, 5 and 7 genes. In contrast, MRP3 expression is only found in keratinocytes while 
MRP2 expression is only observed in melanocytes. Moreover, MRP2 was located in the perinuclear 
region of melanocytes. In order to characterize the role of MRPs in primary cultures of melanocytes 
and keratinocytes we have evaluated the doxorubicin cytotoxicity by MTT assays and studied 
the cellular distribution of doxorubicin, a substrate of MRP, by fl uorescence microscopy, in the 
absence or presence of MK-571, a MRP inhibitor. We fi rstly demonstrated the implication of these 
proteins in the doxorubicin resistance profi le of both cells, supporting a role of these transporters 
in the elimination of xenobiotics and detoxifi cation of epidermis cells. Secondly, we showed the 
involvement of MRP transporters in the effl ux of doxorubicin outside of the nucleus of melanocytes 
and keratinocytes. Interestingly we observed by quantitative RT-PCR studies and after treatment of 
melanocytes and keratinocytes primary cultures with a non-cytotoxic concentration of doxorubicin, 
a signifi cant stimulation of MRP2 mRNA expression in both cells of the human epidermis.
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lysyl oxidase silencing impairs keratinocyte differentiation
Le Provost G1, Debret R1, Cenizo V2, Kaniewski B1, Aimond G1, André V2, Sommer P1 
1CNRS, Lyon, France 2BASF, Lyon, France
Lysyl Oxidase (LOX) is not only an extracellular enzyme involved in maturation of 
connective tissues, but also acts in many cell types as a modulator of cell behaviour 
and phenotype through intracellular signalling pathways. Recently, LOX has been 
reported in human epidermis, but its functions remain unclear. In this context, 
LOX expression was silenced in the immortalized human keratinocyte cell line N/
TERT-1, by short hairpin RNA expressed from lentiviral-based vector. Keratinocyte 
differentiation was fi rst investigated in confl uent monolayer cultures, at mRNA 
and protein level. Then, a 3D- model of reconstructed epidermis was developed 
to further analyse terminal differentiation and global epidermal formation, using 
immunohistochemistry and functional tests. In N/TERT-1 monolayer cultures, LOX 
expression increased during the fi rst keratinocyte differentiation steps. LOX RNA 
interference delayed expression of early differentiation markers. In reconstructed 
epidermis model, LOX silencing did not counteract the stratifi cation process and 
the formation of the fi rst differentiated layers. However, terminal differentiation 
was strongly impaired, regarding to weaker expression of late differentiation 
proteins, and absence of stratum corneum. Therefore, LOX silencing perturbs the 
fi rst steps of keratinocyte differentiation and commitment to terminal differentiation, 
resulting in functional defects in reconstructed epidermis. Taken together, these 
results suggest that tight regulation of LOX expression is necessary for normal 
keratinocyte differentiation, as well as maintenance of epidermal homeostasis.
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Mechanism for moisturizing effects of potassium lactate on the stratum corneum
Nakagawa N1, Naito S2, Yakumaru M1, Shimizu N1, Sakai S1 1Kanebo Cosmetics Inc., 
Kanagawa, Japan 2Kao Corporation, Tochigi, Japan
Among natural moisturizing factors, we have previously demonstrated that the 
potassium lactate content of the stratum corneum (SC) in healthy subjects was well 
correlated with physical properties of the SC as well as skin conductance. However, 
the mechanism of the moisturizing effects of potassium lactate on the SC remains 
unclear. In this report, we have investigated the effects of potassium lactate on the 
interaction between water and SC components. We compared the moisturizing effects 
of potassium lactate and sodium lactate. The total SC water content after a topical 
application was examined by attenuated total refl ectance infrared spectroscopy (ATR-
IR). Differential scanning calorimetry was used to quantify the bound water of the 
lactate salts-treated plantar SC. In order to examine the interaction between water 
and SC components, the ratio of hydrogen deuterium exchange of the lactate salts 
treated-plantar SC was examined by ATR-IR. The topical application of potassium 
lactate signifi cantly increased SC water content and the amount of bound water of 
SC, indicating that potassium lactate was capable of altering the interaction between 
water molecules and SC components. The ratio of hydrogen deuterium exchange at 
the 1340 cm-1 band was signifi cantly increased by the potassium lactate treatment. 
Furthermore, the intensity of the 1340 cm-1 band of hydrogen deuterium exchanged 
serine was decreased compared with that of untreated serine, suggesting that the 1340 
cm-1 band is derived from the OH group of serine residues of cytokeratin, because the 
major SC components consist of cytokeratin. In conclusion, these fi ndings demonstrated 
that potassium lactate has effects on the increase in the amount of bound water in 
the SC. The potassium lactate in SC may have a role in regulation of the interaction 
between water molecules and the OH group of serine residues in cytokeratin.
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Mitochondrial mass plays a key role in the protection from UV-induced apoptosis
Botto JM1, Gondran C1, Garcia N1, Menon G2, McMullen R2, Bressier G1, Bauza 
E1, Dal Farra C2, Domloge N1 1ISP Vincience Global Skin Research Center, Sophia-
Antipolis, France 2ISP  Corporate Research Center, Wayne, USA
In eukaryotic cells, mitochondria are essential organelles in charge of ATP production through 
oxidative phosphorylation and lipid oxidation. Acquired or induced dysfunction of mitochondrial 
metabolism can participate in initiating cell programmed death and apoptosis. As oxygen 
metabolism generates reactive oxygen species and free radicals, mitochondria have developed 
several essential antioxidant systems, both enzymatic and non-enzymatic, such as MnSOD, 
catalases, and cytochrome C. When cytochrome C capacity to trap O(2) is reduced, for example, 
after stress or hypoxia, the cellular redox potential is altered, thus leading to the accumulation of 
electrons that induce the formation of ROS. Thus, we studied the effect of UV stress on cultured 
human skin fi broblasts, by measuring mitochondrial mass and membrane potential, as well as 
apoptotic cell death. We evaluated the mitochondrial mass of a population of skin fi broblasts by 
Fluorescence Activated Cell Sorting (FACS) after 10 nonyl acridine orange staining of mitochondria. 
We observed that the IV08.005 compound, already known for its ability to stimulate cytochrome 
C expression and cytochrome C oxidase activity, was able to increase mitochondrial mass. For 
apoptosis induction, fi broblasts were UVB irradiated (150 mJ/cm2, corresponding to 55% of 
induced apoptotic cells, 12h after UV irradiation), incubated for 36h in culture, with or without the 
cytochrome C inducer, and then cultivated for 16h, with or without cytochrome C induction. Cells 
were labeled with Annexin V-FITC and propidium iodide and then submitted to fl ow cytometry 
analysis. The percentage of apoptotic cells corresponded to the total of Annexin V positive and 
Annexin V/PI double positive cells. Signifi cant protection from UV-induced apoptosis was observed 
in cells where cytochrome C was induced by IV08.005 treatment. In conclusion, increase in 
mitochondrial mass correlated with better cell resistance to UV-induced apoptosis in skin fi broblasts.
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mRNA profi les of circumscribed palmo-plantar hypokeratosis skin lesions might 
reveal the nature of hyperkeratotic sole type skin differentiation.
Takahashi K1, Yasuda M2, Ishikawa O2, Miyachi Y1 1Kyoto University, Kyoto, Japan 
2Gunma University, Maebashi, Japan
Circumscribed palmo-plantar hypokeratosis (CPH) is a recently described keratoderma 
characterized by persistent, well-circumscribed, asymptomatic, depressed macules on palm or 
sole skin.  Histological examination showed a sudden and substantial decrease of the stratum 
corneum.  The hypokeratotic lesional epidermis exhibits thinner horny, granular and spinous layers 
with basket wave cornifi cation.  We found that the expression of palm and sole specifi c keratin 
K9 abruptly and completely disappears in the hypokeratotic lesional epidermis at the transition, in 
contrast, these keratinocytes showed robust K10 expression.  In addition, the expression of Cx26 
also diminished notably at the hypokeratotic lesions; meanwhile the expression of dickkopf1 did 
not show any alteration in the underlying dermis.   Based on these observations, we proposed 
that CPH is a unique keratoderma of mis-differentiation, in which lesional keratinocytes lose their 
sole specifi c differentiation pathway, and achieve or recover trunk-type keratinization.  As no 
pathological alteration or discontinuity was noted in dermal architecture, we suspect that the lesional 
keratinocytes lose their ability to receive signal(s) from the fi broblasts or to enter the sole skin-specifi c 
differentiation pathway.We recently had a chance to further analyze the mRNA profi les of other 
CPH cases.  RNAs captured from both hypokeratotic lesional and no-lesional adjacent skin by in situ 
laser micro-dissection were used for microarray analysis after amplifi cations.  Among many mRNAs 
altered there expressions, the hypokeratotic lesional skin are commonly loosing or diminishing the 
expression of CEACAM6, FGFR2, INTBL1 mRNA from keratinocytes as well as decreased TSPAN13, 
BMP8b, MMP28 mRNA expressions from underlying fi broblasts. These fi ndings are favorable for 
the understanding the pathogenesis of CPH, as well as for the further perspective on the palm 
and sole specifi c differentiation of keratinocytes as represented by K9 and Cx26 expressions.




Murine TLR2, 4 and 5 expression is increased after acute and chronic skin barrier 
disruption
Panzer R1, Hinrichsen K1, Meingassner JG2, Schmuth M2, Proksch E1 1UKSH, Campus 
Kiel, Germany 2Universitätsklinik für Dermatologie & Venerologie, Innsbruck, 
Austria
The innate immune system supports the physical skin barrier in antimicrobial 
defense. Human keratinocytes constitutively express various members of the toll-
like receptor (TLR) family, important for innate immunity including TLR2, TLR4, 
TLR5 and TLR9. These TLRs recognize pathogen associated molecular pattern such 
as lipoteichoic acid, lipopolysaccharide, fl agellin and microbial DNA, respectively. 
TLRs also interact with antimicrobial proteins, in particular defensins and cathelicidin 
LL37. We asked whether TLRs are constitutively expressed or inducible in mouse 
skin and if impairment of the physical barrier stimulates expression of TLRs in 
vivo. Acute barrier disruption in mouse skin was induced by tape stripping or by 
scraping the skin surface with a scalpel blade. Chronic skin barrier disruption 
was induced by an essential fatty acid-defi cient (EFAD). The expression of mouse 
TLRs was assessed by realtime PCR analysis, subsequent gel electrophoresis for 
verifi cation and by immunohistochemistry. Acute barrier injury by tape-stripping and 
by scraping enhanced expression levels of TLR2, TLR4 and TLR5 at 6 h following 
barrier disruption. In addition, severe skin barrier disruption by scraping induced 
TLR9 expression in a subgroup of mice, this increase occurred not before 48 h after 
treatment. EFAD mice also showed an enhanced TLR2, TLR4 protein expression 
when compared with untreated skin. In conclusion, acute and chronic skin barrier 
disruption induced TLR2, TLR4, TLR5, and partly TLR5 and TLR9 expression. These 
TLRs seem to play a crucial role as pathogen recognition receptor after a disruption 
of the physical barrier, which alleviates the invasion of pathogenic microorganisms.
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New in vitro skin models for psoriasis and dermatitis based on gene silencing and 
subsequent impairment of barrier function
Chrétien A, Belot N, Salmon M StratiCELL SA, Crealys Science Park, Gembloux, 
Belgium
Psoriasis, atopic eczema and contact dermatitis are skin diseases characterized 
by a disorganization of the barrier function of the epidermis and an increased 
transepidermal water loss. Alteration in the expression of key proteins involved in 
the cornifi cation and desquamation processes of corneocyte differentiation explains 
barrier impairment, sensitivity to environmental stresses, bacteria and fungi, and skin 
infl ammation. Models for drug screening are mainly based on animals, or on in vitro 
organotypic cultures like reconstruction of skin models, either from affected patients 
or treated with selected cytokines. However, these models are poorly standardized 
and/or subject to individual variability.In the present work, we sought to develop new 
in vitro epidermal models which display key molecular and structural characteristics 
of psoriasis or dermatitis, in a controlled manner. Using keratinocytes transfection 
with small-interfering RNAs and further organotypic 3D cultures at the air-liquid 
interface, we aim to knock-out protein targets involved in the control of skin barrier 
function, resulting in increased transepidermal water loss, acanthosis, parakeratosis 
and an infl ammatory secretory phenotype.First promising data suggest that these 
innovative in vitro models provide valuable alternative tools for drug screening, 
validation and delivery, as well as for the investigation of their mechanism of action.
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Oral supplementation with probiotic to improve skin conditions: In vitro evidences 
of benefi cial effects on barrier function and sensitive skin
Gueniche A1, Benyacoub J2, Bastien P1, Kuzy N2, Philippe D2, Buyukpamukcu E2, 
Blum S2, Castiel I1 1LOREAL Recherche, Clichy Cedex, France 2Nestle Research 
Center, Lausanne, Switzerland
Over the last decades the prevalence of persons presenting reactive skin has increased in developed 
countries. Reactive skin is characterized by a marked sensitivity of the skin to physical (heat, 
cold, wind) or chemical (topical product application) stimuli and impaired skin barrier repair 
ability. Probiotics are defi ned as live microorganisms that when consumed in suffi cient amount 
positively balance the host microbiota and benefi cially improve health. Previously, we have 
shown that oral supplementation with specifi c probiotic could improve reactive skin. The aim 
of our study was to elucidate, using in vitro testing, the mechanisms of action of probiotics on 
skin reactivity and skin barrier function. It is postulated that following interaction of probiotics 
with the gut epithelium, activated immune cells, bacterial compounds and/or cytokines will 
circulate through the blood vessels and may exert immunomodulatory effect at the skin level. In 
order to mimic these interactions a CaCo2/PBMC co-culture system was used. Culture medium, 
from the basolateral side of the cell-insert, was collected after stimulation with a probiotic strain, 
so-called conditioned medium. Using human abdominal plastic surgery skin tissue we show ex 
vivo that treatment with probiotic-conditioned medium down-regulates reaction of the skin after 
substance P stimulation. We found a statistically signifi cant decrease in mediator release compared 
to control. Moreover, we show that treatment with probiotic-conditioned medium signifi cantly 
faster barrier function recovery after tape stripping disruption, compared to control. Finally, using 
reconstructed skin model (Episkin®), we found that probiotic-conditioned medium improves 
barrier function as assessed by the penetration rate of various exogenous compounds. These results 
show a benefi cial effect of the probiotic strain on some biological processes associated with 
barrier function and skin reactivity. All together, these new in vitro fi ndings support the benefi t 
of oral supplementation with probiotic to improve sensitive skin and/or reactive related disorders.
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Patterns Of Epidermal Sphingolipids In Atopic Dogs
Popa I1, Osta B1, Thuy L1, Gatto H3, Haftek M1, Portoukalian J1 1University of Lyon-1, 
Lyon, France 2Veterinary School, Lyon, France 3Virbac, Nice, France
The major role of the skin is to protect the body against harmful agents and water loss. 
In several skin diseases, the lipid composition in the intercellular matrix of the stratum 
corneum is different from that of healthy human skin, especially in atopic dermatitis (AD). 
A comparable clinical picture of this illness can be found in atopic dogs of various breeds. 
Canine AD also presents evidence of lamellar lipids disorganization in the stratum corneum, 
similar to that described in humans. 12 tape strips were taken from the thorax of normal 
dogs and AD dogs. The epidermal free lipids were then extracted from these strips, then 
the protein-bound lipids were released by alkaline treatment. The lipids were separated 
in different classes and analyzed by thin-layer chromatography. Differences in the level 
of lipid components were found in each layer. In AD skin, we observed a higher amount 
of lipids in the upper strips with an increase of normal and hydroxylated fatty acids, but 
a marked reduction in the level of ceramides, both free and protein-bound. Furthermore, 
in the involved and non-involved skin of AD dog, gangliosides were present along with 
lactosylceramide. Skin biopsies of AD dogs which were examined by electron microscopy 
showed a marked absence of structured lipids in extracellular spaces. AD dogs were treated 
for two weeks with a mixture of fatty acids called Megaderm (Omegaderm in USA) provided 
by Virbac, Nice, France. Then, strips were taken on the thorax and the lipids were analyzed. 
The results show that free cholesterol was augmented, and ceramides were strongly increased 
in both free and protein-bound form. The content of normal fatty acids were slightly 
reduced, whereas protein-bound omega-hydroxylated long chain fatty acids were markedly 
increased. Electron microscope examination of skin biopsies showed a vast improvement 
over untreated AD skin, with the fi lling of extracellular spaces with structured lipids.
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Peptidylarginine Deiminases 1, 2 And 3 Are Differently Regulated During 
Differentiation Of Human Keratinocytes
Mechin MC1, Coudane F1, Adoue V1, Arnaud J1, Duplan H2, Charveron M2, Schmitt 
AM2, Takahara H3, Serre G1, Simon M1 1cnrs-ups umr-5165, Toulouse, France 
2PierreFabre Dermo-Cosmétique, Toulouse, France 3University of Ibaraki, Japan
Peptidylarginine deiminases (PADs) catalyze the deimination (or citrullination) of proteins, 
converting arginyl residues to citrullyl residues. In the epidermis, PAD1, 2 and 3 play a 
crucial role in keratinocyte terminal differentiation, targeting several major structural proteins 
like fi laggrin, a key actor for maintaining tissue hydration and an effective epidermal barrier 
against environmental stresses. Nonsense mutations of the profi laggrin gene cause ichtyosis 
vulgaris and are associated with atopic dermatitis. Moreover, alterations of deimination are 
observed in the epidermis of patients with psoriasis and bullous congenital ichthyosiform 
erythroderma. To investigate the regulation of deimination we used cultured keratinocytes 
induced to differentiate either by increasing cell-density or by treatment with vitamin D. High 
cell-density increased endogenous PAD1 and 3 but not PAD2, at the mRNA and protein levels 
and drastically up-regulated the deimination rate (by a factor of ~12). By contrast, vitamin 
D increased PAD1-3 mRNA amounts, with distinct kinetics, but not the protein levels or the 
deimination rate, suggesting an additional post-transcriptional regulation. We also showed 
that auto-deimination reduces PAD activity, and therefore might be an additional level of 
regulation. Producing topological three-dimensional models of PAD3 based on the crystal 
structure of PAD4, we observed that in silico substitutions of the most accessible arginyl 
residues by citrullyl residues increase i) the distances (~1Å; up to 38%) between Asp-472 
and the three other reactive amino-acids of the active site, Asp-350, His-470 and Cys-646 
and ii) the volume of the active site area (~20%). Our data demonstrate that in keratinocytes, 
deimination can be regulated at multiple levels by modulating transcription of the PADI 
genes, translation of the PADI mRNAs, and also the enzymatic activity by auto-deimination.
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Polyfunctional activity of aqueous Vanilla planifolia extract and boost of Vanilla 
planifolia oil activity on potential anti-aging targets
Bhatt P, D’Arcangelis A, Lasserre C Chanel, Inc., Piscataway, USA
Changes in growth factor expression, extracellular matrix protein integrity, and 
oxidative stress homeostasis are important characteristics of intrinsic and extrinsic 
skin aging. At the molecular level, upregulation of MMPs, increase of oxidative stress, 
and downregulation of certain cytokines involved in tissue homeostasis are associated 
with aging. The aim of our study was to assess if an aqueous Vanilla planifolia 
extract, alone or in combination with Vanilla planifolia oil, would modulate cellular 
processes associated with skin aging. Neonatal keratinocytes or fi broblasts were 
incubated in the presence or absence of extracts, individually or in combination. 
Effect of the plant extracts was evaluated in experimental and control samples by 
ELISA, antioxidant test, enzyme activity assays, and RT-PCR. The aqueous extract of 
Vanilla planifolia upregulates VEGF and TGF-β1 expression in cultured keratinocytes. 
We also observe an inhibition of MMP-2, MMP-3, and slight inhibition of MMP-9 
activity.  Further, the aqueous V. planifolia extract inhibits hydroxyl radical formation. 
Surprisingly, this aqueous extract, in combination with V. planifolia oil, is able to 
boost the expression of HB-EGF and PDGF in cultured keratinocytes, well above the 
level of upregulation observed with the oil alone. This multifunctional aqueous extract 
may be useful in the protection of skin against aging and damage from UV irradiation.
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Probiotic lysate applied to skin: in vitro evidences of benefi cial effects of 
Bifi dobacterium longum sp. on sensitive skin and aging
Gueniche A1, Castiel I1 1LOREAL Recherche, CLICHY CEDEX, France
Several lines of evidence suggest that beyond their capacity to positively infl uence 
the composition of intestinal microbiota some probiotic bacteria can modulate the 
immune system both at the local and systemic levels thereby improving immune 
defense mechanisms and/or down-regulating immune disorders such as allergy 
or intestinal infl ammation. Numerous recent human clinical trials clearly suggest 
that probiotic supplementation might be benefi cial to skin. Using a probiotic 
lysate, Bifi dobacterium longum sp. extract (BL), we showed that when applied 
onto skin this non-replicating bacteria form was able to improve sensitive skin as 
well as skin aging parameters in vivo.In order to get a deeper understanding of the 
mechanisms involved, we evaluated the effects of BL on 3 different in vitro and/
or ex vivo models.Using nerve cell cultures in vitro, we showed that after 6 hours 
incubation in culture medium (0,3-1%), the probiotic lysate signifi cantly inhibited 
capsaicin induced CGRP release by neurons. Using ex-vivo human skin explant 
model we found a statistically signifi cant improvement versus placebo in various 
parameters associated with infl ammation such as a decrease in vasodilation, mast 
cell degranulation and TNF-alpha release. Moreover, using keratinocyte cell cultures, 
we showed that BL signifi cantly inhibited IL8 stimulation induced by skin irritants. 
All together, these results indicate that observed clinical benefi ts of the probiotic 
lysate on skin sensitivity might be mediated via modulation of neuromediators 
release and neurogen infl ammation at the skin level. Moreover, the anti-infl ammatory 
effect of BL confi rms its potential to prevent some aging related disorders.
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Resveratrol up-regulated GLUT1 expression in epidermis
Duranton A1, Rathman-Josserand M1, De Potter A2, Breton L1 1L’Oréal  Research, 
Clichy, France 2Institute of Cellular Pathology, Brussel, Belgium
A growing number of studies suggest that natural extracts and phytochemicals have a 
positive impact on brain aging. This can be evidenced by exposure of  hippocampal 
cells to the nitric oxide (NO) donor sodium nitroprusside (SNP) which resulted in 
a decrease in cell survival and the protection by natural polyphenols against these 
events. More recently, it has been reported that neuroprotective effects of one of 
these compounds, resveratrol, may be mediated by specifi c binding sites in the 
brain.In this work we have  transposed to skin these results. Using immortalized 
keratinocytes cell lines HaCAT, we have here studied the effect of resveratrol in a 
model of toxicity induced by the nitric oxide (NO) donor, sodium nitroprusside 
(SNP). A 24-hour exposure SNP (0.3-10 mM) caused a concentration-dependent 
decrease of cell survival, as revealed by the MTT and calcein assays. A treatment 
with resveratrol (1-30 ?M) inhibited the toxic effect of SNP, the effect being signifi cant 
from 10 ?M. Moroever, resveratrol reduced the increased activity of caspase-3 
and the number of apoptotic cells, as estimated by the SYTO 16, suggesting that 
it protects keratinocytes cells through its anti-apoptotic action. Finally, we have 
identifi ed [3H]-resveratrol binding sites in HaCAT as well as in human skin sections. 
Taken together, these data suggest that as for brain resveratrol is a potent agent that 
offers anti-aging effetcs for human skin. Moreover a similar mechanism could be 
involved to explain the benefi cial effects resveratrol in skin and brain. This can be 
connected with the hormonal prevention of aging which has also been described 
to have benefi cial effects against age-induced damage in the CNS the liver and 
the skin through molecular mechanisms reducing oxidative stress and apoptosis.
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Simultaneous characterization of oxygen transport into and through porcine skin 
exposed to oxygen saturated water
Atrux-Tallau N1, Denis A2, Padois K1, Zahouani H3, Haftek M4, Falson F1, Pirot 
F1,2 1University of Lyon, Faculty of Pharmacy, EA4169, Lyon, France 2Laboratoire 
Dermatologique Bioderma, Lyon, France 3Ecole Centrale de Lyon, Ecully, France 
4University of Lyon, Laboratoire de Dermatologie, EA4169, Lyon, France
Oxygen skin delivery is a promising approach for treatment of dermatological 
diseases (e.g., ischemic wound healing). However, characterization of oxygen 
transport into and through the skin exposed to oxygen carrier formulations has 
not been reported. In the present study, we developed an original lab-made static 
diffusion cell mounted with porcine skin enabling the assessment of oxygen uptake 
into the skin (i.e., oxygen penetration) and passage through the skin (i.e., oxygen 
permeation). Oxygen penetration and permeation were recorded by using an optical 
probe implanted into the skin tissue and a Clark-type electrode plunged into the 
receptor solution of the diffusion cells. Permeability parameters (i.e., maximal and 
steady-state fl ux; permeability coeffi cient) of oxygen were determined after 2-hours 
application of oxygen saturated water to either skin surface (exogenous delivery) or 
dermis face (endogenous delivery). Similar experiments were performed by using 
intact or stripped skin in order to appreciate the role of the stratum corneum as oxygen 
barrier. Exogenous delivery of oxygen in skin tissue was found more effective than 
endogenous delivery through intact and stripped skin. However, exogenous oxygen 
permeation was found smaller than that determined from endogenous delivery. The 
upper layers of the skin would constitute a potential oxygen reservoir created by the 
high solubility of oxygen in epidermal lipids. Therefore, oxygen carrier formulation 
might signifi cantly improve oxygen status into the skin for further biological effects.
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Studies of transglutaminase isoforms modulation in normal human keratinocytes 
and skin
Gondran C1, Perrin A1, Botto JM1, Garcia N1, Portolan F1, Dal Farra C2, Domloge N1 
1ISP Vincience Global Skin Research Center, Sophia-Antipolis, France 2ISP  Corporate 
Research Center, Wayne, USA
Transglutaminases (TGases) are calcium-dependent enzymes that catalyze the formation of ε-(γ-
glutamyl) lysine bonds, conferring stability of cross-linked proteins. Among the TGases expressed 
in the skin, TGases 1, 3, and 5 take part in the formation of the cornifi ed envelope, whereas 
TGase 2, is implicated in matrix remodeling and the wound healing.In these studies, we tried 
to modulate the expression of these different types of TGases and their main substrates in human 
keratinocytes (NHK) and human skin biopsies. Analyses were performed by immunoblotting and 
immunofl uorescence staining (IF). Our results indicated that IV08.008, a newly developed active 
to selectively modulate TGases expression, increased the synthesis of transglutaminases 1, 3, 
and 5, as well as the substrate molecules involucrin and loricrin, confi rming their relatedness. 
Interestingly, an increase in TGase 1, involucrin and loricrin staining was also observed in cultured 
human skin biopsies induced in a similar fashion.Moreover, on the basis of the implication of 
TGase 2 in wound healing, fi broblast migration capacity was observed at different time points 
in a two-compartment chamber. This study revealed that fi broblast treatment with the TGase-
inducing active ingredient could enhance fi broblast migration and wound healing. In order to 
evaluate the effect of TGase selective induction on TGase activity, NHK were incubated in the 
presence of fl uorescein-labelled cadaverine, which acts as an amine donor for the TGase reaction. 
This study showed a signifi cant increase in TGase activity, with a 24 to 48 hour treatment. si-
RNA approach for TGase 1 showed that incubation with IV08.008 in the presence of si-RNA 
could, in part, reverse the si-RNA effect on TGase 1 expression, as confi rmed by IF.In conclusion, 
these studies showed a positive modulation of TGases that suggests a benefi cial effect on 
cornifi ed envelope assembly and skin barrier function, as well as matrix stability in wound repair. 
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Telomere-associated protein TRF2 plays an essential role in cell ageing
Amoyel A1, Bergeron L1, Gondran C1, Botto JM1, Garcia N1, Imbert I1, Dal Farra C2, 
Domloge N1 1ISP Vincience Global Skin Research Center, Sophia -Antipolis, France 
2ISP Corporate Research Center, Wayne, USA
Telomeres behave like “virtual aging clocks” by determining the number of times cells 
can divide. Some proteins associated with telomeres can stabilize the loss of genetic 
material by capping chromosome ends. This protection prevents deleterious events 
due to chromosome instability, which can lead to apoptosis or cellular senescence. 
The complex of telomeric proteins maintains the structure of telomere in the T-loop, 
the protective form of telomeres. Our studies focused on the expression of the TRF2 
protein, which plays an important role in telomere stabilization. Through RNA 
silencing experiments, using si-RNA directed to the TRF2 protein, we observed that 
TRF2 silencing led to an increase in p53 expression in human fi broblasts, as well as 
increased senescence-associated beta-galactosidase marker expression. However, we 
also observed that selective TRF2 induction by the newly developed active IV08.007 
could partially restore TRF2 expression, in fi broblasts transfected with TRF2 si-RNA, 
and hence, could compensate for increased senescence induced by TRF2 RNA 
silencing. Furthermore, we used a model of human dermal fi broblasts, aged in vitro by 
repeated subcultures, and treated with a TRF2-inducing agent throughout their aging 
in culture. By comparing these fi broblasts at different stages, we observed a decrease 
in TRF2 immunostaining as the aging of the fi broblasts progressed. Interestingly, TRF2 
expression in these aged cells was restored by selective treatment with IV08.007. 
These results were confi rmed by western blot. Moreover, staining of the senescence-
associated beta-galactosidase marker, which increased in aged fi broblasts, also 
decreased when TRF2 was induced.In conclusion, our results indicate that modulation 
of TRF2 telomeric protein expression in cells may play a key role in cell aging. 
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The activity of EGFR pathway in epidermal keratinocytes is modulated by the level 
of Arnt (Hif1b)
Robertson D1, Weir L1, Kalachikov S2, Panteleyev A1 1University of Dundee, Dundee, 
United Kingdom 2Columbia University, New York, USA
The epidermal growth factor receptor (EGFR) is a member of the erbB family of membrane 
receptor tyrosine kinases. Upon activation by a number of specifi c ligands EGFR triggers 
regulatory pathways that play a crucial role in control of growth and differentiation in 
normal and cancerous cells, including epidermal keratinocytes. Activation of EGFR is often 
associated with its internalization and accumulation in endosomes/multivesicular bodies. 
We previously showed that targeted attenuation of stress-mediating ARNT (Aryl hydrocarbon 
receptor nuclear translocator or Hypoxia-induced factor 1b) in mouse epidermis results 
in severe alteration of epidermal differentiation along with deregulation of most known 
EGFR ligands. To elucidate the possible role of ARNT in control of EGFR activity in human 
keratinocytes we generated a cell model (N-TERT) with stable suppression of ARNT (0.2-
0.35 of normal level) using a lentiviral RNAi approach. QPCR analysis showed an increase 
of EPGN and EREG gene expression along with downregulation of TGFA, EGF, and AREG 
in Arnt-defi cient cells relative to the control cells. The level of BTC and HBEGF appears to 
be unchanged. Immunocytochemistry with antibodies specifi c for phosphorylated EGFR 
revealed that downregulation of Arnt results in a signifi cant decrease in overall cytoplasmic 
EGFRp positivity. High intensity foci most likely representing EGFRp-rich endosomes were 
seen in both, the control and Arnt-depleted cells. Nevertheless, their number in Arnt-
defi cient cells was approximately two times lower as revealed by a blind counting test. In 
addition, high intensity foci in ARNT-defi cient cells were mostly superfi cial and associated 
with cell membrane, suggesting lower level of EGFRp internalization. Together, these results 
reveal a novel role for Arnt in control of the EGFR pathway in epidermal keratinocytes 
and suggest a link between environmental stress and EGFR activity in the epidermis.




The effect of smoking on matrix metalloproteinase activity in the skin
Langton AK, Sherratt MJ, Tsoureli-Nikita E, Griffi ths C, Watson R University of 
Manchester, Manchester, United Kingdom
Wrinkle formation in skin is in part due to the effects of exposure to environmental 
factors including ultraviolet radiation and tobacco smoke. Remodelling of the elastic 
fi bre network of the dermis, particularly degradation of the fi brillin-rich microfi brils 
at the dermal-epidermal junction (DEJ) appears to be a key determinant of skin 
wrinkling. The activation of matrix metalloproteinases (MMPs) is strongly implicated 
in the process of elastic fi bre remodelling. In this pilot study we have characterised 
the effect of smoking on the activation and localisation of MMP2 and MMP9 in young 
adult skin. MMP activity can be localised in tissue sections using in situ zymography. 
In situ zymography requires a dye-quenched gelatin substrate that is heavily labelled 
with FITC molecules to be brought into contact with a tissue section. The gelatinolytic 
activity of MMP2 and MMP9 cleave the substrate producing a fl uorescent signal which 
can be used to determine the precise location of the active MMP2 and MMP9. A 6mm 
diameter punch biopsy was taken from photoprotected buttock from non-smokers (n 
= 3; aged 26 - 31) and smokers (>40 cigarettes/day for > 5 years; n = 3; aged 25 - 30). 
By using photoprotected buttock skin the effect of UV radiation, a well characterised 
inducer of MMP activity, was negated. Although not statistically signifi cant, MMP2 
and MMP9 activity, measured by fl uorescent signal intensity, is markedly increased 
in the epidermis of 2 out of 3 smokers. In addition, active MMP2 and MMP9 signal 
is not detectable in the basal layer of the epidermis in all samples from smokers. In 
conclusion, although up-regulation of MMP2 and MMP9 is noted in the epidermis 
of smokers, the absence of in situ zymography activity at the basal layer suggests 
that these MMPs are not responsible for the degradation of elastic fi bres at the DEJ.
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The readings of WST-1 proliferation assays are highly affected by hypoxia in 
cultured keratinocytes
WEIR L, Robertson D, Panteleyev A University of Dundee, Dundee, United Kingdom
One of the most commonly used assays to quantify cell proliferation in vitro is based on cleavage 
of the tetrazolium salt WST-1[2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium] into chromogenic formazan by reductases and mitochondrial dehydrogenases. 
Expansion in the number of viable cells results in increased amounts of these enzymes and 
consequent accumulation of formazan dye which can be quantifi ed using spectrophotometry. 
Similar proliferation assays utilising other tetrazolium salts such as  MTT [3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide, XTT (2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-2H-
tetrazolium-5-carboxanilide),or MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium] are also widely available in the marketplace. Here we show 
that reductase/dehydrogenase activity greatly increases in epidermal N-TERT and primary mouse 
keratinocyte cultures subjected to hypoxia (1% oxygen, 24 hours) resulting in high positive 
readings by WST-1 assay. Similar hypoxia-induced increase in WST-1 assay readout occurred 
for tumourigenic epithelial cell lines MCF-7 (breast) and HCT-116 (colon). However for all cell 
types WST-1 assay values do not refl ect actual cell number. Counting MCF-7 and HCT-116 cells 
revealed that they grow slower in hypoxia. Keratinocyte cell numbers were additionally infl uenced 
by calcium such that cell number was higher in cells cultured in low calcium (0.4mM) compared to 
high calcium (1.2mM for mouse, 1.4 mM for human). Primary mouse cell number was reduced by 
hypoxia and by high calcium (differentiation) whilst N-TERT cell number was infl uenced solely by 
calcium but not by hypoxia. Proliferation marker PCNA was lower in hypoxic mouse keratinocytes 
further suggesting that hypoxia has a negative or no effect on cell proliferation.Thus, when using 
tetrazolium salt-based proliferation assays the level of cell hypoxia should be taken into account. 
Further, our results suggest that wst-1 assay can be an effi cient method for assessing hypoxia in 
vitro when combined with more specifi c proliferation assay to exclude effects of cell growth.
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Thermosensitive transient receptor potential vanilloid-3 ion channels regulate 
human keratinocyte biology
Borbíró I1, Lisztes E1, Ambrus L2, Tóth BI2, Czifra G2, Kovács L2, Bíró T2 1Abiol Ltd, 
Debrecen, Hungary 2Department of Physiology, University of Debrecen, Hungary
Recently, a thermosensitive member of the transient receptor potential vanillioid (TRPV) ion channel 
family, i.e. TRPV3, was implicated in the regulation of murine hair growth. Namely, a “gain-of-
function“ mutation in the trpv3 gene resulted in a hairless phenotype in rodents. In addition, we have 
shown that the activation of TRPV3 inhibits growth of human organ-cultured hair follicles. In the 
current study, we investigated the expression and function of TRPV3 on various human keratinocyte 
cultures, i.e. on normal human epidermal keratinocytes (NHEK), hair follicle-derived outer root 
sheath keratinocytes (ORSK), and immortalised HaCaT keratinocytes. The presence of TRPV3 was 
identifi ed both at the protein (immunolabeling) and gene (real-time Q-PCR) levels on all keratinocyte 
populations. Accordingly, the prototypic plant-derived (such as thymol, carvacol, eugenol) and 
synthetic (2-aminoethoxydiphenyl borate) TRPV3 agonists resulted in a dose-dependent, transient 
increase of intracellular Ca2+ levels (quantitative Fluo-4-based fl uorimetry) which was abrogated 
by the suppression of extracellular Ca2+ concentrations or by the RNA-interference-mediated 
silencing of TRPV3. The functional expression of TRPV3 on the keratinocytes was further supported 
by our fi ndings that the prolonged application of the above agonists markedly suppressed cellular 
proliferation (colorimetric MTT and fl uorimetric CyQuant assays), induced apoptosis (fl uorimetric 
Annexin-V and MitoProbe assays), and altered the expression of keratinocyte-specifi c differentiation 
markers (e.g. keratins).  These data provide the fi rst evidence that various epidermal and follicular 
keratinocyte populations express functional TRPV3 ion channels. In addition, our fi ndings 
introduce TRPV3-coupled signaling mechanisms as a novel player in human keratinocyte biology 
with potential anti-proliferative actions. Therefore, further studies are warranted to explore the 
importance of keratinocyte-localized TRPV3 channel in various hyperproliferative skin conditions.
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Tight junction-like structures contribute to the lateral contacts between corneocytes 
and protect corneodesmosomes from premature degradation.
Haftek M1, Callejon S1, Sandjeu Y1, Padois K1, Falson F1, Pirot F1, Brandner JM2 
1University of Lyon, CNRS, Lyon, France, 2University Hospital, Hambourg, Germany
Several tight junction (TJ) proteins are expressed in adult human epidermis and TJ -like membrane 
ridges can be observed at the top of the stratum granulosum (SG) in freeze-fracture studies. 
However, immunolocalization of ultrastructurally defi nable TJs in the SG keratinocytes has not 
yet been achieved, except in the foetal epidermis and organotypic keratinocyte culture. We 
applied standard and immunoelectron microscopy to look for TJs in human adult epidermis and 
cornifi ed envelopes purifi ed from the plantar stratum corneum (SC). Excised whole thickness 
abdomen skin was maintained ex vivo at 32 C for 6 hours with and without occlusion. Antibodies 
to claudin-1, -4, occludin, ZO-1, desmoglein-1 and corneodesmosin were used for single and 
double post-embedding immunogold labelling. Discrete points of contact immunolabelled with 
claudin-1 were detected in the SG. However, most of the cell membrane -associated immunogold 
could not be assigned to any structures reminiscent of typical TJ. Instead, claudin-1 labelling was 
consistently found in the proximity of SG desmosomes and of corneodesmosomes in the lower 
SC. Lateral but not horizontal walls of the corneocytes showed frequent points of molecular fusion 
between lipid envelopes. Moreover, these associations were very frequently localized at the top of 
the lateral corneocyte membranes, thus sealing extremities of the lateral intercorneocyte spaces. 
Claudin-1 and occludin were consistently detected in the cornifi ed envelopes. TJ-like points of 
fusion did not increase in number after 6h occlusion but could be detected between the laterally 
attached corneocytes from the SC disjunctum. We propose that TJ-like structures contribute to 
the reinforcement of lateral contacts and to the formation of membrane interdigitations between 
corneocytes. Their presence could explain differences in the degradation rates between the 
“central” and “peripheral” corneodesmosomes observed during physiological desquamation and 
contribute to subdivision of the SC extracellular spaces into consecutive horizontal compartments.
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TLR-2 mediated cytokine and chemokine secretion in human keratinocytes
Niebuhr M1, Baumert K1, Sigel S2, Werfel T1 1Hannover Medical School; Department 
of Immunodermatology and Allergy Research, Hannover, Germany 2University of 
Konstanz; Biochemical Pharmacology, Department of Biology, Konstanz, Germany
The human epidermis provides a fi rst line of defence against exogeneous pathogens. 
Resistance to bacterial skin infections, e.g. with Staphylococcus aureus (S. aureus), is 
based on the function of intact innate immune mechanisms in the epidermis, mainly 
provided by keratinocytes. They establish the local cytokine and chemokine milieu 
which is necessary for attracting other cells participating in an immune response. 
Toll like receptor (TLR)-2 recognizes components of S. aureus and is known to be 
expressed on keratinocytes. The aim of this study was to investigate TLR-2 mediated 
chemokine and cytokine secretion on human primary keratinocytes (HPKs) both on 
mRNA and protein level. As there is no selective TLR-2 ligand known so far, we chose 
Pam3Cys that acts via TLR-2 / TLR-1 heterodimers, lipoteichoic acid (LTA) that acts 
via TLR-2 / TLR-6 and peptidoglycan (PGN) which acts via TLR-2 and Nod. Pam3Cys 
stimulation yielded in an enhanced secretion of CCL20, CCL2, MMP9 and IL-8 in 
HPK whereas stimulation with PGN or LTA showed no or solely slight effects. Our 
fi ndings show evidence for a functional TLR-2 / TLR-1 signalling profi le in HPKs upon 
stimulation with Pam3Cys contributing to the defence against bacterial skin infections. 
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Transcriptional profi ling identifi es novel differentiation regulated genes in 
keratinocytes
Paragh G1, Ugocsai P2, Vogt T2, Schling P2, Liebisch G2, Orso E2, Remenyik E3, Mandl 
J1, Wikonkál N1, Schmitz G2 1Semmelweis University, Budapest, Budapest, Hungary 
2University of Regensburg, Regensburg, Germany 3University of Debrecen, Hungary
Undisturbed keratinocyte differentiation plays a pivotal role in the maintenance 
of normal skin barrier functions. Single keratinocyte differentiation-induced genes 
have already been studied, but many important constituents of this process may 
have been missed so far. The aim of our current study, therefore, was to identify 
whole genome changes during keratinocyte differentiation. Gene expression profi ling 
by microarray was carried out in cultured normal human epithelial keratinocytes 
(NHEK). Twelve candidate genes were also validated by quantitative RT-PCR and 
immunohistochemical analysis. We identifi ed 932 genes that were greater than 2.5 
fold upregulated and 629 genes that were greater than 2.5 fold downregulated during 
confl uence induced keratinocyte differentiation. Analysis of these lists and verifi cation 
of the data lead to identifi cation of potential novel redox signaling in differentiating 
human keratinocytes revealed by counter-regulation of heme oxygenase and biliverdin 
reductase as well as glutaredoxin and glutathione reductase. Others indicate a strong 
concert downregulation of interleukin-1 signaling at previously unidentifi ed extent 
during NHEK differentiation. We therefore believe that this study on the keratinocyte 
differentiation transcriptome will help us gain a more comprehensive understanding 
of the complicated processes that guide keratinocytes through their transformation 
to corneocytes, and will lead to better understanding of dermatological disease.
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Ultraviolet B irradiation induces secretion of hyaluronan and apoptosis in cultured 
rat epidermal keratinocytes
Rauhala L, Salonen P, Pasonen-Seppänen S, Tammi R University of Kuopio, Finland
Solar exposure, especially between wavelengths 280-315 nm (ultraviolet B; UVB), has several 
implications for the biology of the epidermis, causing irritation, apoptosis and tumorigenic 
mutations. It has also recently been reported to regulate hyaluronan metabolism in skin.In the 
work undertaken here these phenomena were addressed using UVB-irradiated rat epidermal 
keratinocytes (REK) in monolayer cultures and in an organotypic skin model. The latter set-
up mimics the situation in vivo and is an excellent substitute for skin biopsies. Accumulation 
of hyaluronan in the culture medium (both models) and the differentiated epidermis and the 
underlying collagen bed (skin model) were determined with an ELISA-like assay. Additionally, 
the organotypic cultures were prepared for histology and assayed for apoptotic cells.REK-cells 
growing in monolayers were irradiated with 2.5-10 mJ/cm2 of culture area. The highest dose 
elicited release of LDH, but no signifi cant increase in cell death nor decrease in the number of 
viable cells. Most importantly, within this setup, a UVB-dose dependent increase was observed 
in the amount of hyaluronan secreted into the culture medium. The organotypic cultures were 
irradiated with 10-40 mJ/cm2 of UVB. These intensities caused a dose dependent increase in the 
number of sunburn cells and caspase 3 -positive keratinocytes, while the overall structure of the 
differentiated epidermis remained intact. The effect on hyaluronan content was less unambiguous 
than in the monolayers, probably due to the confi guration of the skin model. The results strengthen 
the notion that hyaluronan production specifi cally responds to UV-exposure, although the exact 
mechanism is not known, and underline the responsiveness of the vital layers of the epidermis to 
UVB. The relevance of these and other similar fi ndings lies in peri- and extracellular hyaluronan 
having profound effects on the migration, proliferation and differentiation of keratinocytes. Our 
future studies will elaborate on these themes and extend the use of the current models to examine 
the signalling routes involved and the function of the permeability barrier under UVB-stress.
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Urea revisited: a well known molecule with previously unrecognized gene 
regulatory properties
Grether-Beck S1, Felsner I1, Brenden H1, Reinhold K1, Jaenicke T1, Rodriguez-Martin 
M2, Elias PM3, Trullas C4, Krutmann J1 1IUF, Düsseldorf, Germany 2Hospital Univ de 
Canarias, Tenerife, Spain 3VA Med Ctr, San  Francisco, USA 4ISDIN, Barcelona, Spain
Urea, because of its capacity to serve as a natural moisturizing factor, has been used for many decades to 
improve the surface properties of healthy and diseased human skin. Here we show that this well known 
molecule possesses previously unrecognized gene regulatory activities which can be used to enhance barrier 
function and innate immunity of human skin. Accordingly, in-vitro stimulation of primary human epidermal 
keratinocytes (KCs) with clinically relevant concentrations of urea induced an inceased transcriptional 
expression of (i) the KC differentiation markers transglutaminase-1, involucrin, fi laggrin and loricrin and (ii) 
the antimicrobial peptides ß-defensin 2 and cathelicidin. These effects were of in-vivo relevance because 
in a placebo-controlled, double-blinded study with 20 healthy human volunteers, a 4-week application 
of a 10 % urea containing topical preparation signifi cantly increased the expression of KC differentiation 
markers and antimicobial peptides (AMPs) in human skin. Increased KC gene expression was associated 
with an improvement of skin barrier function, as indicated by a signifi cant decrease of transepidermal 
water loss in urea treated skin areas. Also, enhanced in-vivo expression of differentiation markers and 
antimicrobial peptides was corroborated immunohistochemically.At a mechanistical level, urea induced 
gene expression in KCs was not due to a urea induced shift in osmolarity, but mediated by specifi c urea 
transporters. Primary human keratinocytes expressed the human urea transporters hUTA2 and hUTA1 and 
the urea transport inhibitors thiourea or phloretin (i) decreased 14C labelled urea uptake in KCs by 70% or 
20%, respectively, and, even more important, (ii) completely prevented urea induced upregulation of KC 
differentiation markers and AMPs on mRNA and protein level. Similary, KC expressed the aquaglyceroporin 
aquaporin-3 and inhibition of aquaporins with HgCl2 caused a 65% decrease in KC urea uptake and a 50% 
inhibition of urea induced upregulation of skin differentiation markers and AMPs.These studies show that 
urea actively improves the properties of human skin by virtue of its capacity to modulate KC gene expression.
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Differentiation of epidermal keratinocytes from mouse induced pluripotent stem 
cells
Nakamura M, Tokura Y University of Occupational and Environmental Health, 
Kitakyushu, Japan
Induced pluripotent stem (iPS) cells were established from mouse somatic fi broblasts through 
reprogramming by transduction of four transcription factors (Oct3/4, Sox2, Klf5, c-myc).  Mouse 
iPS cells have pluripotency of differentiation in vivo.  However, it has not been demonstrated 
whether mouse iPS cells can be differentiated into keratinocytes in vitro.  The aim of this study 
was to examine whether mouse embryonic stem (ES) cell differentiation system into epidermal 
keratinocytes can be successfully applied to mouse iPS cells.  Epidermal keratinocytes can 
be differentiated from mouse ES cells when cultured on stromal PA6 cells in a culture medium 
containing bone morphogenetic protein-4 (BMP-4) and fetal calf serum (FCS) for a defi ned 
period. By using this ES cell differentiation for iPS cell differentiation methodology, iPS cells were 
successfully differentiated into keratinocytes, as immunohistochemistry showed that 42% of the 
cells were positive for keratin 14 (Krt14) at 11 days after the induction of differentiation.  The 
frequency of this differentiation of iPS cells was comparable to the frequency of the differentiation 
of keratinocytes from ES cells (47%).  To ascertain the expression of Krt14 gene in the differentiated 
cells from iPS cells, we performed a real-time PCR assay and confi rmed the expression of Krt14 
mRNA only by the differentiation-induced cells.  To clarify the further differentiation ability of 
these cells, we cultured the Krt14+ cells in high Ca2+ medium.  Immunohistochemistry revealed 
that keratin 10 (Krt10) expression level was augmented by culture in high Ca2+ medium. Finally, 
transplantation of the Krt14+ cells with dermal papilla cells onto nude mouse back skin induced 
hair shaft elongation, suggesting its use for therapeutics. These results showed that the differentiation 
properties of iPS cells are almost identical to those of ES cells and that differentiated Krt14+ cells 
have similar characteristics and differentiation potentials to those of mouse epidermal keratinocytes. 
This differentiation system from iPS cells may lead to the development of a novel cutaneous 
regenerative medicine without any vigorous ethical controversy, confronted in the case of ES cells.
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Regeneration of hair and epidermis by the receptor activator of NF-kappaB
Mueller C1, Duheron V2, Hess E2, Amoasii L2, Paus R3 1University of Strasbourg, 
CNRS, Strasbourg, France 2University of Strasbourg, Strasbourg, France 3University 
of Lübeck, Lübeck, Germany
The receptor activator of NF-kappaB (RANK), a TNF-receptor family member, is 
known for its role in osteoclastogenesis, lymph node development and mammary 
gland formation. In view of its emerging importance in epithelial cell biology, 
there is growing interest to elucidate its function in the skin. We have previously 
shown that RANK regulates Langerhans cell numbers, and it has been reported that 
RANK-ligand is upregulated in human infl ammatory diseases and fosters formation 
of regulatory T cells. We fi nd that RANK is expressed by basal keratinocytes and 
hair follicle bulge cells but that RANK-ligand is expressed in hair follicles and 
activated suprabasal keratinocytes. Mice defi cient in RANK-ligand are unable to 
enter anagen and display reduced epidermal proliferation. On the other hand, RANK-
transgenic mice show additional hair follicle regeneration phases and epidermal 
hyperproliferation. Although gene profi ling shows activation of NF-kappaB signalling, 
there is surprisingly little cutaneous infl ammation in the RANK-transgenic mice. 
We fi nd that NF-kappaB p50, p52 and Bcl-3 are nuclear in the basal keratinocytes, 
and that RANK-transgenic mice defi cient for Bcl-3 display enhanced keratinocyte 
activation. These fi ndings concord with the interpretation that nuclear sequestration 
of NF-kapppaB by Bcl-3 represses keratinocyte activation to prevent immune-
pathology. The data demonstrate that RANK plays a critical role in skin homeostasis. 
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The role of 1 chain containing laminins for the formation and function of the 
dermo-epidermal basement membrane
Fleger-Weckmann A1, Bechtel M1, Reibetanz M1, Chen ZL2, Smyth N3, Nischt R1 
1Dermatology Department, Univ of Cologne, Germany 2Rockefeller University, New 
York, USA 3School of Biological Science, University of Southampton, UK
The major laminin isoforms in the dermo-epidermal basement membrane are laminin 511, containing 
the γ1 chain and laminin 332 containing the γ2 chain. To investigate the role of γ1 chain containing 
laminins in skin, mice with keratinocyte-specifi c deletion of the laminin γ1 chain (LAMC1EKO 
mice) were generated. These mice die postnatally showing severe hair and pigmentation defects. 
Histological analysis at postnatal day 10 revealed normal hair follicle elongation, however, many 
hair follicles were misshapen and irregularly orientated. No hair shafts were observed and the 
sparsely found hair fragments lacked the normal pigmentation pattern. The dermal papilla is known 
to be essential for hair follicle morphogenesis. We therefore analysed morphology of the dermal 
papillae at postnatal day 1, 6 and 10. Histological analysis revealed abnormally shaped dermal 
papillae in the skin of LAMC1EKO mice when compared to their wildtype littermates. Abnormal 
differentiation was also observed in the epidermis with thickening and signs of hyperproliferation. 
Furthermore, in contrast to control skin, differentiated, DOPA-positive melanocytes are found in 
the basal cell layer of the epidermis and dermis but not in the hair bulb of LAMC1EKO mice. To 
gain insight into the mechanisms underlying these phenotypes, the composition of the dermo-
epidermal basement membrane of LAMC1EKO mice was analysed by immunofl uorescence. 
While laminin α5 (laminin 511) staining was completely lost, we observed ectopic deposition 
of the laminin α2 chain (laminin 211) suggesting induction of a compensatory mechanism by the 
lack of laminin 511. In conclusion our data indicate that laminin 511 plays an important role not 
only for hair follicle induction but also for differentiation of hair follicles and epidermis. Our data 
also suggest that laminin 511 is critically involved in the control of skin pigmentation in mice.
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MicroRNAs regulation of keratinocytes differentiation during human skin 
embryogenesis
Nissan X, Denis J, Saidani M, Lemaitre G, Peschanski M, Baldeschi C INSERM U861, 
Evry, France
During the last years microRNAs (miRNAs), a class of noncoding small RNAs had 
been demonstrated to regulate at least one third of all human genes implicated in a 
variety of fundamental cellular processes including cell proliferation, differentiation 
and death. This newly type of endogenous gene regulation exerts their regulatory 
affects through the RNA interference (RNAi) machinery to modulate translation of 
targeted mRNA. During the last years the role of miRNA-mediated regulation of 
development, embryogenesis and stem cell division had been highlighted. Thanks to 
their unlimited potential of self renewal and differentiation, human Embryonic Stem 
Cells (hESC) represent a unique in vitro model permitting to modelyze the earlier 
steps of development. To identify the miRNA implicated in the molecular and cellular 
events occurring at the successive ontogenetic stages leading to the formation of 
the epidermis, we developed a protocol to differentiate hESC into a fully functional 
population of keratinocytes-like-cells (K-hESC).  Using TaqMan® Low Density Array 
analyze we had been able to identify a set of miRNAs implicated in the neural 
ectodermal switches and in the epidermal commitment. Based on these results we have 
examined the expression and the function of these new regulators by over expression 
or extinction during epidermal commitment and stratifi cation. Among these miRNA, 
we demonstrated the role of miRNA 203 during the epidermal commitment.Our 
results shown that miRNAs as well it was demonstrated in the development represent 
a major epigenetic mechanism regulating keratinocytes differentiation processes from 
the very fi rst steps of epithelial commitment to the last stage of epidermis stratifi cation.




Targeted deletion of DNase1L2 leads to defective degradation of nuclear DNA in 
hairs and nails
Fischer H1, Jäger K1, Rossiter H1, Szabo S1, Hermann M2, Tobin DJ3, Popescu C4, 
Wagner EF5, Tschachler E1, Eckhart L1 1Medical University of Vienna, Department of 
Dermatology, Austria 2Max F. Perutz Laboratories, Vienna, Austria 3Center for Skin 
Sciences, School of Life Sciences, Univ of Bradford, Austria 4DWI an der RWTH-
Aachen University, Germany 5Spanish National Cancer Centre, Madrid, Spain
Hairs and nails are formed by keratinocytes in a process that involves breakdown of 
cell organelles and the conversion of cells with highly active gene expression into 
dead, cornifi ed cell remnants. During this terminal differentiation process nuclear DNA 
is degraded by an as-yet-unknown mechanism. Recently, we showed that keratinocytes 
express the cell type-specifi c endonuclease deoxyribonuclease 1-like 2 (DNase1L2). Here 
we assessed the physiological role of DNase1L2 by generating DNase1L2 knockout mice 
and comparing their phenotype with that of wild-type mice. Virtually all cornifi ed cells 
of hairs and nails of DNase1L2-defi cient mice retained nuclei that were strongly labeled 
with the DNA dye Hoechst 33342 in situ, whereas DNA labeling was minimal in wild-
type hairs and nails. Quantifi cation by real-time PCR confi rmed that hairs and nails of 
DNase1L2 knockout mice contained more than hundred-fold higher amounts of nuclear 
DNA than control mice. Aberrant retention of nuclear DNA in differentiated keratinocytes 
was also detected in the epithelium of the tongue, which resembles hair and nail with regard 
to the expression of hair keratins. By contrast, the interfollicular epidermis of DNase1L2-
defi cient mice was orthokeratotic and morphologically not different from that of wild-type 
mice. Taken together, this study shows that DNase1L2 is essential for the breakdown of 
nuclear DNA during hard cornifi cation of keratinocytes and identifi es DNase1L2 as 
the fi rst specifi c mediator of differentiation-associated keratinocyte cell death in vivo.
398 [Oral 064]
AKT-dependent PP2A activity is required for epidermal barrier formation during 
late epidermal development
O’Shaughnessy RF1, Welti JC2, Byrne C2 1UCL institiute of Child Health, London, 
United Kingdom 2Centre for Cutaneous Research, Institute of Cell and Molecular 
Science, Barts and the London, London, United Kingdom
Acquisition of epidermal barrier function late in gestation is dynamic. At E16.5-
E17.5 a wave of barrier acquisition sweeps across fetal skin, converging on dorsal 
and ventral midlines. We investigated the molecular pathways active during 
epidermal barrier formation. Akt signaling increased as the barrier wave crossed 
epidermis and cJun was transiently dephosphorylated. Inhibitor experiments on 
embryonic explants showed that the dephosphorylation of cJun was both Akt and 
protein phosphatase 2A (PP2A)-dependent.  Inhibition of PP2A and Akt signaling 
also caused defects in epidermal barrier formation.  These data are compatible with 
a model for developmental barrier acquisition mediated by PP2A-regulation of cJun 
dephosphorylation, downstream of Akt signaling.Support for this model was provided 
by siRNA-mediated knockdown of PPP2R2A (PR55alpha or B55alpha), a regulatory 
subunit of PP2A expressed in an Akt-dependent manner in epidermis during barrier 
formation.  PPP2R2A reduction caused signifi cant increase in cJun phosphorylation 
and interfered with acquisition of barrier function. Our data provide strong evidence 
that PPP2R2A is a regulatory subunit of PP2A that targets this phosphatase to cJun, 
and that PP2A action is necessary for barrier formation. We therefore describe 
a novel Akt-dependent PP2A activity which acts at least partly through cJun to 
affect initial barrier formation during late embryonic epidermal development.
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A role for clock-related genes in human hair growth control?
Al-Nuaimi Y1, Philpott M2, Kloepper J3, Tóth B4, McKay I5, Biro T4, Paus R3 1The 
University of Manchester, Manchester, United Kingdom 2St Bartholomew’s and the 
Royal London School of Medicine and Dentistry, London, United Kingdom 3University 
of Lübeck, Lübeck, Germany 4University of Debrecen, Hungary 5St Bartholomew’s 
and the Royal London School of Medicine and Dentistry, United Kingdom
The molecular nature of the autonomous oscillator system (“hair cycle clock”) that drives hair 
follicle (HF) cycling is a clinically important but, as yet, unsolved chronobiological enigma. 
Since genes central to the control of circadian rhythms are expressed in isolated human skin in 
vitro and in murine skin in vivo, and may coordinate even supra-circadian events, we wished 
to elicit whether clock-related genes are differentially expressed in human anagen and catagen 
HFs. Human scalp HFs were micro-dissected and organ-cultured in serum-free medium. The gene 
and protein expression of morphologically identifi ed anagen VI or catagen HFs was characterized 
and compared using Q-PCR and/or immunohistology. HFs were found to transcribe Clock, 
Bmal1, Period1, Cry1 and Cry2 genes. Importantly, signifi cant hair cycle-dependent expression 
differences were observed; compared to anagen VI HFs, catagen HFs showed increased relative 
gene expression levels of Clock and Cry2 (p<0.05), but decreased expression of Cry1 (p<0.01). 
By immunohistology, protein expression for Period1 was seen in the outer root sheath and matrix 
keratinocytes of anagen and catagen hair follicles. The mean ratio of Period1 positive cells to 
total cell number, within the 530x800 reference area of the distal hair follicle, increased with 
progressing catagen development. This trend was in concordance with that of period1 expression 
in the Q-PCR results. We are currently investigating the effect of clock gene knock-down on 
human HF cycling in vitro. To the best of our knowledge, this is the fi rst report of signifi cant, 
differential, and hair cycle-dependent expression of clock-related genes and proteins in human 
HFs. Our fi ndings suggest not only a role for clock-related genes in human hair growth control, 
but also that scalp HFs provide a clinically relevant model for studying the role of clock-
related genes in complex human tissue interaction and organ transformation systems in situ.
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Adenosine is effective on hair diameter and hair density of male pattern hair loss 
in Caucasian
Iwabuchi T1, Ideta R1, Ehama R1, Iino M1, Nakanishi J1, Tsuji Y1, Kobayashi T2, Ohyama 
M3, Kishimoto J1 1Shiseido Research Center, Yokohama, Japan 2National Defense Med 
College, Saitama, Japan 3Keio Univ School Med, Tokyo, Japan
Adenosine is effective for male pattern hair loss (MPHL) in Japanese clinical study, and this compound 
is also effective for female pattern hair loss in Japanese.  Adenosine signifi cantly increases the rate of 
thick hair in both male and female pattern hair loss.  In this study, we analyzed the effect of adenosine 
on MPHL in Caucasian men who stay in Japan.  A single-blind, randomized, placebo-controlled 
study was conducted on 38 Caucasian men aged 35 to 52 years (mean, 41.4 years) for 6 months.  All 
subjects received a full explanation of this trial and signed a written informed consent prior to the trial. 
Subjects topically applied approximately 3 mL of a lotion containing adenosine or a lotion without 
adenosine (placebo), twice daily for 6 months.  Data were obtained at the beginning of the trial and 6 
months thereafter.  Scalp hairs of subjects were combed in the middle before taking pictures, and top 
views of scalps were photographed.  Nine well-trained investigators evaluated the extent of hair loss 
in each subject by comparing the calibration standard photographs which is a 12-point scale from 
stage 1 (no hair loss) to stage 12 (severe hair loss).  Hairs (approximate 6 mm x 6 mm square) in the 
hair loss region were clipped using ophthalmologic scissors.  And the area was digitally imaged using 
a video microscope.  The numbers of hair in this area were counted, and hair density was calculated 
as the number of hair shafts/cm2.  The density of hair in adenosine group was signifi cantly increased 
compared with that of placebo group.  Adenosine also increased the percentage of thick hair (over 
60 micro meter-diameter) in total hair.  Assessment by investigators on hair loss stage in two groups 
was not signifi cantly changed.  No causal adverse effect due to the lotion was found during this trial. 
These results indicated that adenosine is effective on hair density and diameter of hair shaft in MPHL 
of Caucasian.  This suggested that adenosine is useful for treating male pattern hair loss in Caucasian 
men.  We would discuss the difference of effi cacy of adenosine in Japanese and Caucasian men.
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An unlimited source of early human keratinocyte progenitors derived from 
embryonic stem cells
Feteira J, Nissan X, Peschanski M, Lemaitre G, Baldeschi C INSERM U861, Evry, France
The human epidermis is a constant self renewal tissue in witch keratinocyte stem 
cells are responsible of the skin homeostasis. To date, the limited capacity for the 
isolation and purifi cation of epidermal stem cells has hampered studies on these 
cells.  The ability to generate differentiated epidermal cells from a continuously 
growing human embryonic stem cells (hESC) population in vitro provides a unique 
system for the study of keratinocyte stem cells potential. To explore the “stemness” 
status of keratinocytes derived from human embryonic stem cells (K-hESC), we 
monitored the expression of the characteristic stem cells markers including integrin 
beta 1, integrin alpha 6, p63 and keratin 19. Among these epidermal stem cell 
markers, the Q-PCR analysis revealed a high expression of the transcript coding for 
the keratin 19 in keratinocytes derived from hESC compared to adult keratinocytes 
and hESC. Western blot, FACS analysis and immunofl uorescence labelling of the 
K-hESC confi rmed the enrichment of keratin 19 in the culture. Moreover, it has been 
observed that the number of K19 positive cells is regulated during skin embryogenesis 
and decrease after birth, confi rming that K19 is an important keratinocytes stem 
cells marker.We conclude that an unlimited source of early human keratinocyte 
progenitors expressing K19 is obtained from human embryonic stem cells.
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Analysis of sporadic FGF mutant mouse
Imaki J, Hamada T, Kobayasi Y
National Defense Medical Collage, Saitama, Japan
Fibroblast growth factor 5 (FGF5) is one of the 22 members of FGF family, which is 
known to regulate growth, differentiation, survival and migration of a wide variety of 
cell types.  FGF5 was originally identifi ed a 1987 report based on a screening approach 
for transforming oncogenes. Subsequently, FGF5 was characterized as a regulator of 
the hair growth cycle and the knock out mice of FGF5 showed a long hair phenotype.
In our laboratory, we have been breeding ICR mice with long hair (LL) for over 20years. 
Their phenotype is similar to that of FGF5 knock out mice reported previously. We 
analyzed therefore the structure of FGF5 allele and the confi guration of the skin and 
hair in LL. From tail skin DNA of LL, we amplifi ed sequence of FGF5 allele by PCR 
and determined its structure. We also analyzed the skin from their face and body 
with HE-stained paraffi n sections, and compared the hair from LL with that from wild 
type mice (WT) by scanning electron microscopy (SEM). We found that about 10kb 
sequence including exon3 was replaced by another sequence of 0.5kb in FGF5 allele 
of LL.  In the skin and hair, however, we did not observe any difference between LL and 
WT either by HE staining or SEM except hair length.  In a previous report from another 
group, an angora mouse line lacking exon1 region of FGF5 allele exhibited abnormal 
phenotypes of the skin and hair. The difference in the phenotypes between the angora 
mouse line and LL might depend on the difference of the deleted regions in the allele.
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Antibody-induced cicatricial alopecia in epidermolysis bullosa acquisita (EBA): 
Lessons on the immunopathology of epithelial stem cell deletion from a passive 
EBA mouse model
Uppalapati SK, Meyer KC, Hirose M, Mihai S, Zillikens D, Ludwig R, Paus R 
Department of Dermatology, University of Lübeck,, Lübeck, Germany
Cicatricial alopecia (i.e. permanent, scarring hair loss) results from irreversible destruction of hair 
follicle (HF) epithelial stem cells, which reside in an immunologically privileged niche (bulge). 
Cicatricial alopecia can also be seen in epidermolysis bullosa acquisita (EBA), which results from 
autoantibodies to type VII collagen. Since this is a prominent feature of EBA mouse models, cicatrical 
alopecia here offers an excellent experimental tool for investigating the mechanisms by which 
antibody-dependent immune responses damage and destroy adult epithelial stem cells. For this 
purpose, skin from the back of C57/Bl6 mice treated with rabbit-anti type VII collagen IgG antibodies 
or with appropriate controls was analysed by quantitative (immuno-)histomorphometry of the bulge 
region and other defi ned reference areas in test versus control skin after 12 days of treatment. 
Antibodies to type VII collagen induced a collapse of the bulge immune privilege (e.g., signifi cant up-
regulation of MHC-Ia molecules and down-regulation of immunoinhibitory CD200 expression) and 
up-regulated the number of perifollicular MHC class II+ cells, CD8+, CD4+ T cells and mast cells, 
but not of neutrophils or gamma/deltaTCR+lymphocytes in and around the bulge of injected mice 
compared to controls. Furthermore, the immunoreactivity for NGF-, αMSH and IL15, but not for 
TGF-ß 1, was signifi cantly increased in the HF epithelium of test mice. Interestingly, in bulge regions 
of EBA mice, the number of proliferating (Ki67+cells) was up-regulated. Besides their implications 
for the pathogenesis of EBA-associated cicatricial alopecia, these data suggest that auto-antibodies 
can lead to epithelial stem cell destruction by collapsing the immune privilege of the tissue niche 
these cells reside in. Immune privilege protection and restoration strategies may therefore be well-
advised in autoimmune phenomena characterized by irreversible damage to epithelial stem cells.
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Anti-infl ammatory effects of a vitamin C derivative, L-ascorbyl-2-phosphate, in 
human sebocytes
Ikeno H1, Apel M2, Luger TA2, Zouboulis CC3, Böhm M2 1Ikeno Clinic of Dermatology 
and Dermatologic Surgery, Tokyo, Japan 2University of Münster, Dept. of Dermatology, 
Münster, Germany 3Depts of Dermatology, Venerology, Allergology and Immunology, 
Dessau, Germany
A number of clinical observations point towards an anti-infl ammatory effect 
of vitamin C or vitamin C derivates such as L-ascorbyl-2-phosphate (APS). For 
example, it was recently demonstrated that topical application of APS can improve 
the course of infl ammatory acne. In order to inevstigate the direct effects of APS 
on human sebocytes, we utilized the human immortalized sebocyte cell line SZ95. 
APS at doses utilized in vivo in patients with acne did not affect the viability or 
metabolic activity of SZ95 sebocytes in vitro. However, APS dose-dependently 
suppressed the inductive effect of the proinfl ammatory cytokine IL-1beta on IL-6 
and IL-8 mRNA expression as shown by real-time RT-PCR. These effects of APS 
were corroborated at the protein level by ELISAs. Mechanistically, APS attenuated 
IL-1beta-mediated activitation NF-kB as measured by NF-kB promoter activity 
and IkBalpha phosphorylation / protein degradation. However, APS did not 
affect IL-1beta-induced p38 phosphorylation in SZ95 sebocytes upon IL-1beta 
treatment. In summary, our data demonstrate an anti-infl ammatory potential of 
APS and emphasize its usefulness as a novel treatment of infl ammatory acne.
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Antimicrobial peptides expressions and mast cell acne inverse in hidradenitis 
suppurativa
Emelianov VU1, Taungjaruwinai WM2, Bechara FG3, Gläser R4, Schröder JM4, Paus 
R5, Meyer KC1 1Dept of Dermatology, University of Lübeck, Germany 2Division of 
Dermatology, Chulalongkorn University, Bangkok, Thailand 3Dept of Dermatology & 
Allergology, Ruhr-University Bochum, Germany 4Dept of Dermatology, University of 
Kiel, Germany 5Dept of Dermatology, Univ of Lübeck, Germany
Hidradenitis suppurativa (HS, acne inversa) is a chronic infl ammatory skin disease that originates 
from the distal hair follicle (HF) epithelium. While the pathogenesis of HS remains ill-understood 
and controversially debated, we hypothesize that the excessive release of pro-infl ammatory 
signals from the distal outer root sheath plays an important role in HS initiation, subsequent 
follicular occlusion and the perpetuation of unchecked, chronic infl ammation. Since bacterial 
superinfection is a common feature of HS, we wished to clarify whether two key component of 
the HF’s innate immune system that can transmit potent pro-infl ammatory signals, antimicrobial 
peptides (AMPs) and perifollicular mast cells, show any abnormalities in HS. The expression of 
selected AMPs (psoriasin, lysozyme, cathelicidin, human beta defensin 3 (hBD3) was examined 
by immunohistochemistry or toluidine blue histochemistry in 76 skin samples from 18 HS 
compared to 10 normal skin specimens as control. These analyses revealed signifi cantly increased 
immunoreactivity (IR) for psoriasin in the epidermis and the HF outer root sheath of HS skin 
compared to controls. Lysozyme and hBD3 IR was increased in the epidermis, and cathelicidin 
in epidermis and dermis. These phenomena were most pronounced in active infl ammatory, 
as opposed to scarring, HS lesions. The total number and the percentage of degranulating mast 
cells were also increased in HS-affected skin, in particular in highly infl ammatory HS lesions 
compared to HS lesions in late stages of scarring. The observed enhancement of AMP expression 
in the distal HF and the increased number and activation status of perifollicular mast cells in 
HS lesions invite the hypothesis that AMP overexpression and extreme mast cell stimulatioin 
are involved in HS pathogenesis and that both are interesting future targets for HS therapy.
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Cannabinoid receptor 1-mediated signaling regulates the proliferation and activation 
of normal human skin mast cells in situ
Sugawara K1, 3, Biro T2, Paus R1 1University of Luebeck, Germany 2University of 
Debrecen, Hungary 3University of Manchester, United Kingdom
The neuroendocrine controls of mast cell (MC) functions in normal human skin are still 
ill-explored. Recent cell culture studies have identifi ed cannnabinoids as yet another 
class of candidate MC regulators, which may inhibit MCs degranulation in a cannabinoid 
receptor (CB) subtype-specifi c manner. Since we have previously shown that prototypic 
endocannabinoids (e.g. anandamide, AEA) markedly inhibit the growth of organ-cultured 
human hair follicles (HF) via CB1 (Telek et al, FASEB J, 2007), we have now investigated 
the effects of CB1 ligands on the number and activation status of human HF connective 
tissue sheath MCs (hCTS-MCs) in microdissected, organ-cultured human scalp HF, as a 
clinically relevant new model for studying skin MCs within their natural tissue context. 
Double immunostaining for CB1 and c-kit revealed that hCTS-MCs express CB1 in situ. 
AEA and the CB1-specifi c agonist ACEA did not signifi cantly change the number or 
degranulation of these MCs. In contrast, the CB1-specifi c antagonist AM251 markedly up-
regulated the number of MCs, stimulated their degranulation, and signifi cantly increased 
the number of c-kit+ cells within the CTS. Importantly, these effects were effectively 
abrogated by CB1 agonists. Furthermore, RNA interference-mediated knockdown of CB1 
in cultured human HF resulted in signifi cant increase in the number of degranulated and 
total MCs. These data suggest an important function of endocannabinoids in suppressing 
the activation of normal resident hCTS-MCs in situ and that CB1 signaling regulates not 
only human hair growth but also MC degranulation and proliferation. Furthermore, we 
show the fi rst evidence that gene knockdown works properly in human HF organ culture, 
which also deserves to be exploited by the MC research community as an excellent model 
for studying and manipulating primary human skin MCs within their natural environment.
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Colocalization of cystatin M/E and its target proteases suggests a role in terminal 
differentiation of human hair follicle and nail
van Vlijmen-Willems IM, Cheng T, Schalkwijk J, Zeeuwen PL Radboud University 
Nijmegen Medical Center, Nijmegen, Netherlands
The cysteine protease inhibitor cystatin M/E is a key regulator of a novel biochemical pathway 
that leads to epidermal terminal differentiation by inhibition of its target proteases cathepsin L, 
cathepsin V, and legumain. Inhibition of legumain might regulate the processing of (pro)-cathepsins, 
a process that is also under control of intra- and extracellular pH changes. Inhibition of cathepsin 
V regulates desquamation, as cathepsin V is able to degrade (corneo)-desmosomal proteins like 
desmoglein-1, desmocollin-1, and corneodesmosin. Inhibition of cathepsin L is important in 
the cornifi cation process of the skin, as we have recently demonstrated that cathepsin L is the 
elusive processing and activating protease for transglutaminase 3, an enzyme that is responsible for 
crosslinking of structural proteins in cornifi ed envelope formation. By using immunofl uoresence 
microscopy, we studied the localization of all players of this novel pathway in the human hair 
follicle and nail unit in order to elucidate their possible role in the biology of these epidermal 
appendages. We showed colocalization of cystatin M/E and cathepsin V in the inner root sheath 
of the hair follicle, especially in Henle’s layer. This colocalization is restricted to the infundibulum 
of the hair follicle around the opening of the sebaceous duct into the hair canal. Furthermore, 
we found that cathepsin L and transglutaminase 3 specifi cally colocalize in the hair bulb and the 
nail matrix, the regions that provide cells that terminally differentiate to the hair fi ber and the nail 
plate, respectively. Furthermore, transglutaminase 3 also colocalizes with the structural proteins 
loricrin and involucrin, which are established transglutaminase substrates.These fi ndings suggest 
that cathepsin L and transglutaminase 3 could be involved in the pathway that leads to terminal 
differentiation, not only in the epidermis but also in the human hair follicle and nail unit. The 
expression pattern of cystatin M/E and cathepsin V suggests that both proteins are involved in the 
degeneration of the inner root sheath, possibly through desquamation of the inner root sheath cells.
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Comparative genomics identifi es hair keratin homologs and novel cysteine-rich 
keratins in reptiles and birds
Eckhart L1, Jaeger K1, Dalla Valle L2, Szabo S1, Stremnitzer C1, Ghannadan M1, 
Alibardi L2, Hermann M3, Tschachler E1 1Medical University of Vienna, Vienna, Austria 
2Università di Padova, Padova, Italy 3Max F. Perutz Laboratories, Vienna, Austria
The evolutionary origin of hair is unclear because of an incomplete fossil record. 
However, the evolutionary history of the genes, that determine the structure of hair, 
can be inferred from the distribution of these genes among modern vertebrates. The 
main components of hair are the hair keratins which establish the hard properties of 
hair by inter-molecular crosslinking at multiple cysteine residues. Here we analyzed 
by comparative genomics the keratin genes of amphibians, reptiles, birds and 
mammals. Four groups of cysteine-rich keratins were identifi ed: high cysteine type 
I keratins specifi c for sauropsids (reptiles and birds), high cysteine type II keratins 
specifi c for birds, type I hair keratins and type II hair keratins. Strikingly, the hair 
keratins were not found in mammals only but also in sauropsids. The lizard, Anolis 
carolinenis, contained two type I and four type II hair keratins, and the chicken 
contained one type II hair keratin. For studies of protein expression, antibodies 
were raised against two hair keratin homologs of the lizard. Immunohistochemistry 
demonstrated that both proteins were specifi cally expressed in the claws of 
the lizard. In summary, this study shows that hair keratins are not restricted to 
mammals and, therefore, must have evolved with an original function that was 
not associated with hair. We propose that the claws of the last common ancestor 
of mammals and reptiles were the main sites of hair keratin expression before a 
change in the expression pattern of these proteins facilitated the evolution of hair.




Evidence that thyrotropin releasing hormone and 17--estradiol regulate prolactin 
and prolactin receptor expression in human skin and hair follicles
Langan* EA1, Hanning* A2, Ramot* Y3, Poeggeler B2, Bíró T4, Gaspar E2, Kromminga 
A5, Griffi ths CE1, 2, Paus R1, 2 *contributed equally 1Univ of Manchester, UK 2Univ of 
Lübeck, Germany 3Hadassah-Hebrew Univ Med Ctr, Jerusalem, Israel 4Univ  of Debrecen, 
Hungary 5Inst for Immunol, Clinical Pathol, Molec Med, Hamburg, Germany
Human scalp hair follicles (HFs) are both a non-classical target and an extra-pituitary source of 
prolactin (PRL) production, and PRL is a potent hair growth modulator.  However, the regulation 
of PRL and PRL receptor (PRLR) expression in human skin and HFs are as yet entirely obscure. 
Therefore, we have investigated whether two potent stimulators of pituitary PRL secretion, 
thyrotrophin releasing hormone (TRH) and 17-β-estradiol (E2), also modulate intracutaneous PRL and 
PRL receptor (PRLR) expression. Full-thickness frontotemporal female scalp skin or microdissected 
anagen VI HFs, was exposed in serum-free organ culture for 6 days to 100nM E2, TRH (1, 5, 10ng/
ml) or vehicle control only, and the. culture medium was analyzed for PRL levels by ELISA every 
48 hour.  Cryosections of TRH-treated HFs, and of E2-treated full-thickness human scalp skin were 
assessed for PRL and PRLR immunoreactivity by quantitative immunohistomorphometry of selected 
skin and HF compartments.  qPCR for PRL and PRLR was also performed on E2-treated, cultured 
human outer root sheath (ORS) keratinocytes.  In TRH-treated HFs, PRL immunoreactivity was 
signifi cantly up-regulated in the  ORS (p<0.05). This corresponded to an increase in PRL transcription 
(qPCR) in ORS keratinocytes.  ORS PRLR immunoreactivity was signifi cantly down-regulated by 
TRH (p<0.05).  In E2-treated skin, PRL immunoreactivity was signifi cantly up-regulated (p<0.05) 
in the epidermis and the HF ORS.  PRLR immunoreactivity in situ was signifi cantly up-regulated in 
sebaceous and eccrine sweat glands (p<0.05).  qPCR showed signifi cant up-regulation of both PRL 
and PRLR transcription in ORS keratinocytes (p<0.001).  However, ELISA showed no differences 
in PRL levels in the culture media after E2 stimulation. This preliminary study suggests that the 
intracutaneous regulation of PRL expression may mirror classical pituitary controls of PRL secretion.
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Hair abnormalities due to Rac1 defi ciency in the differentiated parts of the hair 
follicle
Behrendt K1, Brakebusch C2, Pofahl R1, Krieg T1, Haase I1 1University of Cologne, 
Germany 2Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark
The formation and maintenance of hair follicles in mice is dependent on the function of 
the small GTPase Rac1. Targeted deletion of Rac1 from all epidermal keratinocytes results 
in alopecia which has been attributed to the loss of hair follicle stem cells. Aside from the 
maintenance of the follicular stem cell population we want to reveal additional functions 
of Rac1 in hair follicle formation which could not be addressed by targeted deletion of 
Rac1 from all keratinocytes forming the epidermis and hair follicles. To achieve this 
we have generated a mouse model in which Rac1 activity is reconstituted in the basal 
epidermal layer and outer root sheath but not in the more differentiated parts of the 
epidermis and hair follicles. Hence we crossed transgenic mice expressing a constitutively 
active form of Rac1 (L61Rac1) only in the basal keratinocytes of the epidermis and hair 
follicles (K14L61Rac1TG) which show no abnormal phenotype with mice where Rac1 
has been deleted from all epidermal and hair follicle keratinocytes (Rac1 E-KO). In 
contrast to Rac1 E-KO mice the resulting K14L61Rac1TG Rac1 E-KO mice (referred to as 
rescue mice) showed no loss of hair indicating that Rac1 expression specifi cally in the 
basal layer of the epidermis and hair follicles is essential for hair follicle formation. But 
we assume further functions of Rac1 in the suprabasal compartments of the hair follicle 
since the rescue mice showed a modifi ed coat appearance, as surprisingly their hair was 
grey instead of black. In addition, hair follicle- and hair morphology showed structural and 
pigmentation abnormalities which were most obvious in the medulla and in the hair shaft. 
Analysis of proliferation, apoptosis and molecules involved in hair follicle differentiation 
like Foxn1 and CDP did not show changes as compared to the controls. We therefore 
conclude that Rac1 has important functions in hair shaft formation and -pigmentation.
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Hair follicle markers. Histological studies on human scalp skin grafts
Perrin A1, Meyrignac C1, Plaza C1, Gondran C1, Chabert R1, Garcia N1, Pinacollo 
S2, Dal Farra C3, Domloge N1 1ISP Vincience Global Skin Research Center, Sophia 
-Antipolis, France 2ISP  Corporate Research Center, Sophia-Antipolis, France 3ISP 
Corporate Research Center, Wayne, USA
Understanding the roles of different hair follicle components and the possibilities 
for acting on them are key challenges in hair biology. Working with cells isolated 
from the different compartments of the hair follicle fails to take into account the 
complexity of the interactions which take place within it. For this reason, in the 
present study, we used a model of human scalp skin grafts, placed in emersion on a 
culture insert, and fed with a previously described serum-free medium.In order to test 
the reactivity of this model, we applied two molecules; one activates cAMP, and the 
other ATP, on the top of scalp biopsies for 48 hours. At the end of the incubation, scalp 
grafts were paraffi n-embedded or frozen in OCT, to perform immuno-histochemical 
analyses. Our studies showed that stimulating cAMP in the samples induced an 
increase in keratin 14, keratin 15, and keratin 16 in the outer root sheath (ORS). This 
outcome could be relevant for hair growth, as well as the quality of the anchoring 
of the hair. We also observed an increase in collagen IV and laminin-332, indicating 
reinforcement of the basement membrane, and better communication between 
the ORS and dermal sheath. A different set of markers, including beta-1 integrin, 
fi bronectin, Ki67, and P63, was modulated by ATP induction. These results suggest 
an optimized cell-matrix adhesion and enhanced cell signaling in the hair follicle. 
Moreover, further study results on beta-1 integrin and p63 (identifi ed as potential 
markers for hair follicle stem cells) were in favor of a positive effect of hair follicle 
ATP induction on hair renewal and growth cycle maintenance.Consequently, this 
model of human scalp grafts seems appropriate to observe the modulation of different 
hair follicle components, which could be essential for hair vitality and regeneration. 
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Hair follicles from alopecia areata patients exhibit immune privilege defi ciencies 
in advance of hair loss
Kang H1, Lee SD1, Shapiro J2, McElwee KJ2, Park YM3 1St. Paul’s Hospital, College of 
Medicine, The Catholic University of Korea, Seoul, Republic of Korea 2University of 
British Columbia, Vancouver, Canada 3Seoul St. Mary’s Hospital, College of Medicine, 
The Catholic University of Korea, Seoul, Republic of Korea
Alopecia areata (AA) is a suspected autoimmune hair loss disease. The hair bulb is 
believed to retain immune privilege (IP) characterized by downregulation of major 
histocompatibility complex (MHC) class I expression, antigen presentation suppres-
sion, and immunosuppressive agent production. It has been hypothesised that IP 
failure may elicit AA. We generated a list of 18 immunoregulation associated genes 
based on previous reports, and quantifi ed their potential differential expression in 
AA patients’ hair follicles as compared to normal healthy controls. Scalp skin biop-
sies from the lesional margin (M) and perilesion (P) were obtained from 5 patients 
with active AA and 4 normal haired controls. Follicular bulb regions were microdis-
sected, RNA extracted, and cDNA transcribed. Primers were designed for the genes 
of interest and real-time RT-PCR was conducted to determine relative mRNA expres-
sion. A distinct gene expression pattern was identifi ed in the hair follicle bulbs of 
AA patients compared to those of normal healthy controls. Red/IK cytokine, which 
inhibits expression of MHC II antigens, was downregulated (M: 0.32 fold; P: 0.23 
fold) and the perilesion fold change reached statistical signifi cance. The mRNA ex-
pression of competitive IL-1 antagonist IL1Ra and costimulatory factor CD80 were 
highly upregulated in the marginal lesions (15.46 and 14.01 fold respectively) and 
perilesion (4.31 and 2.05 fold respectively).These results reveal candidates that may 
participate in the putative IP failure of AA hair follicles and suggests possible roles 
in the pathogenesis of AA development, particularly for Red/IK and IDO.
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Inhibition of Apoptosis-Driven Regression of Hair Bulb
Giuliani G1, Benedusi A1, Marzani B1, Carelli S2, Traversa M2, Di Giulio A2, Gorio A2 
1Giuliani SPA, Milan, Italy 2Laboratories of Pharmacology, Dept. Medicine, Surgery 
and Dentistry, University of  Milan, Italy
Hair exerts a range of functions including thermoregulation, physical protection, sensory activity. 
Mature and actively growing hair follicles become anchored in the subcutis, and regenerate by 
spontaneous repetitive cycles of growth (anagen), apoptosis-driven regression (catagen), and 
quiescence (telogen). HF regression is characterized by activation of pathways that induce apoptosis 
in HF cells. We focused our study on investigating the effect of new therapeutic molecules capable 
of counteracting  the regression phase. HFDPC cells, grown in culture, were incubated for 24 hours 
incubation with 1 μM staurosporin and apoptosis was monitored. There was a marked activation of 
Caspase-3 accompanied by cytoskeletal degradation, nuclear blebbing, and cellular fragmentation. 
The addition of spermidin or rutine in the micromolar range concentration reduced staurosporin-
induced caspase activity by over 50%, when the two agents were added simultaneously equal 
levels of caspase-3 inhibition was achieved with concentration 10 fold lower. Zeaxantine alone 
was ineffective, however when added to the combined spermidin and rutine treatment, the 
staurosporin-induced caspase activity was almost totally counteracted and the enzymatic activity 
was signifi cantly reduced. These combined treatment were also effective in preventing staurosporin-
mediated cellular damage. The extent of cell loss was greatly reduced with preservation of cell 
shape and actin-tubulin cytoskeleton. The combined treatment also counteracted staurosporin-
induced caspase-3 and PARP over-expression, and prevented the inhibition of  Akt/PKB and MAP 
kinase ERK1/2 activities. The protective effects of our agents was also observed in ex vivo bulbs. 
After 24 hours in vitro culture of bulbs there is a dramatic loss of Akt and ERK phosphorylation. 
This is  totally prevented by co-incubation with our combined treatment. Thus, here we report 
that concomitant exposure of spermidine, rutine and zeaxantine blocks the degradation of 
vital intracellular pathways and structure of vital importance for the prevention of catagen.
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Preliminary evidence that prolactin exerts gender and/or site specifi c effects on the 
human hair follicle
Ramot* Y1, Langan* EA2, Goffi n V3, Griffi ths CE2, Foitzik K4, Paus R2,5, *contributed 
equally 1Hadassah-Hebrew Univ Medical Center Jerusalem, Israel 2Univ of Manchester, 
Manchester, UK 3Inserm, U845, Research Center Growth & Signaling, and Université 
de Paris Descartes, Paris, France 4Department of Paediatric Dermatology, Childrens’ 
Hospital Wilhelmstift, Hamburg, Germany 5Univ of Lübeck, Germany
There is both intra- and interspecies variation in the response of the hair follicle (HF) to the 
neurohormone prolactin (PRL).  We previously demonstrated that PRL exerts a catagen promoting 
effect on human male occipital HFs, mirrored in  murine HFs.  We sought to investigate whether 
this effect displayed any gender and/or site specifi city in the human HF.Frontotemporal female 
scalp skin anagen VI HFs were obtained from 2 healthy females undergoing routine facelift 
procedures.  These were cultured in serum free organ culture medium for 6 or 9 days, with the 
addition of 400ng/ml PRL alone, or with a pure PRL receptor (PRLR) antagonist, every 48 hours. 
HF growth and hair cycle stage were measured.  Cryosections of the HFs were then stained with 
markers of proliferation and apoptisis (Ki67/TUNEL).  Microarray analysis of PRL treated female 
frontotemporal and occipital HFs was performed to identify any differential regulation of catagen 
associated genes. PRL treatment signifi cantly increased HF growth in female frontotemporal scalp 
HFs (p<0.01), partially reduced by the addition of PRLR antagonist.  There was no increased 
TUNEL positivity, indicating that PRL did not induce catagen in these HFs.  This was independently 
confi rmed by analysis of hair cycle scores.  Microarray data demonstrated down-regulation of 
catagen associated genes, including BMP2 and 4, and several site and/or gender specifi c changes 
in gene regulation, for example in connexin 44 and haem oxygenase. We provide preliminary 
evidence that PRL exerts gender and site specifi c effects on human HF growth in vitro.  These 
fi ndings may partially explain why hyperprolactinaemia in human females is associated with 
hirsutism, whilst associated with reduced facial and body hair growth in males.  These fi ndings 
invite a systematic re-examination of gender and/or site effects of PRL on the human HF. 
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Reconstruction of pluristratifi ed epidermis using human embryonic stem cells.
Guenou H1, Nissan X1, Larcher F2, Feteira J1, Lemaitre G1, Del rio M2, Barrault C3, 
Bernard FX3, Peschanski M1, Baldeschi C1 1INSERM U861, Evry, France 2Ciemat-
–CIBER-ER, Madrid, Spain 3Bioalternatives, Gencay, France
Human epidermis has been produced in vitro for decades using adult epidermal 
stem cells from donors to provide cell therapy and industrial use in pharmaceutical 
and cosmetic applications. As potential alternative, embryonic stem cells, immortal 
and pluripotent, have attracted major interest. However, available protocols do not 
allow producing keratinocytes capable of forming a fully differentiated epidermis out 
of human embryonic stem cells. We present here a successful and robust protocol 
for that purpose, the success of which is based upon replication in vitro of the 
successive ontogenetic stages leading to formation of the epidermis. This protocol 
of differentiation generates fi rst a homogenous population of keratinocytes with 
high proliferative capacity. Once seeded on an artifi cial matrix and either grown in 
vitro or else transplanted in immunodefi cient mice, these cells form a pluristratifi ed 
epidermis that exhibits normal human characteristics. This opens the path for use 
of embryonic stem cell lines in skin regenerative medicine and for industrial use.
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The anti-apoptotic activity of psittacofulvins in transplanted hair bulbs
Giuliani G1, Rinaldi F2 1Giuliani SPA, Milan, Italy 2International Hair Research 
Foundation, Milan, Italy
The anti-apoptotic activity of a new compound with a carotenoid-like structure was 
studied. This compound  has been  recently isolated chemically as a result of studies 
on the pigments present in a particular species parrots.This new class of pigment, 
which are also called Psittacofulvins, have been proved to possess interesting 
biological properties that differ from those that carotenoids are known to have. To 
evaluate the anti-apoptotic effi cacy on dermal papilla of this compound  we studied 
the effect on transplanted bulbs during hair transplants, like a model of induction 
of apoptosis  of hair bulbs, because the evidence of the hair follicle damage during 
a transplantation is clear. We made a double blind randomized clinical trial on 50 
men, volunteers, underwent an hair transplant (micro-mini grafts, FUE)  in androgenic 
alopecia and treated with a topic solution (nanospheres)  with psittacofulvin once a 
day, from 15 days before hair transplant   to 90 days after transplantation.To study the 
effect of psittacofulvins we used an experimental design evaluating: 1) the number 
of apoptotic fragments  2) changes in the mitotic activity in the hair follicles before 
and after transplantation. Quantifi cation of apoptotic fragments in transplanted hair 
follicles is a sensitive and accurate assay of hair follicle damage. Our results show a 
very important anti-apoptotic activity of psittacofulvin in transplanted bulbs. 
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Topical application of ketoconazole, Minoxidil and tretinoin to  stimulates hair 
growth in Albino-Wibster male mice
Aldhalimi M College of Medicine- University of Kufa, Najaf, Iraq
This study evaluated the effect of Ketoconazole, Minoxidil, and Retin-A on hair growth 
in mice. Twenty Albino-Wibster male mice were included in this study, divided 
randomly into four groups, each one included 5 mice. One day before starting the 
experiment the dorsal skin of each mouse was shaved by an electric shaver, then 
stained by using commercial dye , then the animals were photographed. Group I 
was considered as control group and received ethanol alcohol, group II received 
Ketoconazole, group III received Minoxidil 5%, and group IV received Minoxidil 
+Tretinoin 1% application daily for 21 days. At the end of treatment, the animals 
were photographed to asses the degree of hair growth, and histological sections were 
obtained from each mouse to asses the effect of drugs on the number and diameter of 
hair follicles. Signifi cant hair growth (P-Value<0.05) was occurred with Ketoconazole, 
Minoxidil, and with Minoxidil & Retin-A. Insignifi cant increase in the number of hair 
follicles occurred with Minoxidil, Ketoconazole, Minoxidil with Retin-A. Signifi cant 
increase in diameter of hair follicles occurred with Ketoconazole, Minoxidil, and with 
Minoxidil&Retin-A. Ketoconazole, Minoxidil, and Minoxidil & Retin-A can promote 
hair growth effi ciently, and can increase both number and diameter of hair follicles.
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Topical application of Unikamide-AA, a putative sphingosine kinase activator, 
stimulate hair growth in mice model
Park H, Park B, Kwon M, Kwak H, Jeong S NeoPharm Co., Ltd., Daejeon, Republic 
of Korea
Millions of people suffers unexpected hair loss but the exact cause or mechanism 
of hair loss is not yet fully understood. Among the various signaling moleculears 
so far reported as being involved in hair growth, sphingosine-1-phosphate has 
been recently reported as having hair growth regulating activity. Recently, we have 
also reported that the newly synthesized chemical, Unikamide-AA is a putative 
sphingosine kinase activator. In this study, we have investigated the effects of topical 
Unikamide-AA on the hair growth in C57BL/6 and C3H mice after hair removal. 
Topical minoxidil (3%) was used as a positive control and samples were treated 
for 4 weeks. Topical treatment of 1% and 3% Unikamide-AA showed stimulating 
effects on the hair growth in mice in a dose-dependent manner, which might be 
due to the premature entry into anagen and shortening of telogen phase. When 
compated with 3% minoxidil, the hair growth was similiar in both mice strains. 
Theses results suggest that S1P in involved in hair growth and Unikamide-AA, which 
is a putative sphingosine kinase activator, can be used as a hair growth stimulant.
419
Travoprost and minoxidil promote hair growth in C57Bl/6 mice through modulation 
of the same set of genes involved in hair follicle cycling.
Rethore S, Baudin K, Jomard A Galderma R&D, Sophia - Antipolis, France
The aim of the study was to evaluate whether travoprost, one of the most potent 
FPR agonist, had an activity on hair growth in the C57Bl/6 mouse model, and to 
compare its effect to minoxidil on the expression of a selected list of genes involved 
in hair follicle growth. Fur was removed by shaving in mice that were in the telogen 
phase. Mice were treated with a single topical application of tested molecules. 
Visual assessment of hair growth was performed daily up to day 22. Skin mRNA was 
prepared using RNeasy Qiagen Kit and then subjected to qRT-PCR using microfl uidic 
card technology (Applied Biosystems). One single application of minoxidil 2.5% 
accelerated the entry of telogen hair follicles into anagen compared to the control. 
Likewise, travoprost triggered telogen / anagen transition in a dose dependent 
manner.  Moreover, at the highest dose (0.01%), the activity of travoprost on hair 
growth was superior to that of minoxidil.The ability of minoxidil and travoprost to 
modulate the expression of a set of selected genes was monitored 6h and 24h post-
treatment. The main modifi cations were observed 6h post-treatment. Yet only 25 out 
of 96 genes were modulated by the treatments. 17 genes were similarly modulated 
by both minoxidil and travoprost. Among them, the modulation of BAMBI, Ihh, 
Lef1, and Bmp4 expression is consistent with the Hedgehog-BMP-Wnt signaling 
cascade during hair cycling, which correlates with the induction of anagen in mice. 
Although minoxidil and travoprost do not have the same mode of action, they are 
both able to promote hair growth in the mouse through the modulation of the same 
set of genes, which suggests that travoprost could be of interest to treat alopecia.
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IL-21-activated STAT3 upregulates microRNA-21 expression in CD4+ T cells: 
pathologically involved in cutaneous T cell lymphoma?
van der Fits L, van Kester MS, Out JJ, Smit F, Willemze R, Tensen CP, Vermeer MH 
LUMC, Leiden, Netherlands
MicroRNAs (miRNAs) are small RNAs that control gene expression, and are involved in regulation 
of fundamental biological processes including development, cell differentiation, proliferation and 
apoptosis. MiRNAs regulate gene expression in normal haematopoietic cells and aberrant miRNA 
expression may contribute to leukemogenesis. Specifi cally, miR-21 is abundantly expressed in 
various tumors including leukemia and lymphoma, and is functionally involved in oncogenic 
processes. In this study we investigated the functional role for miR-21 in Sézary Syndrome (SS), a 
primary cutaneous T cell lymphoma in which CD4+ tumor cells (SS cells) are present in skin, lymph 
nodes and peripheral blood. miR-21 is located in a genomic region that is amplifi ed in 80% of SS 
patients. Deep sequencing studies showed that miR-21 represented over 65% of all miRNAs present 
in the SS-derived cell line SeAx. Furthermore, increased expression of pri-miR-21 mRNA was 
demonstrated in CD4+ SS cells, when compared to CD4+ T cells from healthy donors and patients 
with benign erythroderma. Chromatin immune precipitation showed that miR-21 is a direct target of 
STAT3, a transcription factor that is constitutively activated in SS cells. In addition, stimulation of SS 
cells with IL-21, but not with other common-gamma chain cytokines, resulted in activation of STAT3 
and increased miR-21 expression. A positive correlation was observed between IL-21 and pri-miR-
21 mRNA expression in CD4+ T cells. Silencing of miR-21 by transfection of SS cells with miR-21 
siRNA resulted in increased apoptosis as assayed by AnnexinV/PI fl owcytometric analysis, thereby 
demonstrating a functional role for miR-21 in survival of SS cells. In conclusion, we demonstrate 
that in CD4+ T cells miR-21 expression is induced by IL-21, mediated via STAT3. Furthermore, 
increased expression of miR-21 is found in SS cells, probably as a consequence of increased IL-21 
expression and constitutive STAT3 activation. MiR-21 is involved in regulation of apoptosis in SS 
cells, suggesting a functional role for miR-21 in the leukemogenic process of SS. Consequently, 
miR-21 might represent a novel therapeutical target for the treatment of Sézary Syndrome.




Epithelial-mesenchymal transition (EMT)-like phenotype in GnT-V transgenic
Ishikawa A, Terao M, Nakahara S, Kimura A, Moriwaki K, Murota H, Taniguchi N, 
Miyoshi E, Katayama I Osaka University, Suita-shi, Japan
N-acetylglucosaminyltransferase-V (GnT-V) is a glycosyltransferase that catalyzes the 
formation of beta1-6 branching of N-acetylglucosamine on N-glycans. It is reported 
that expression of GnT-V was elevated during malignant transformation in various 
types of cancer. In GnT-V-defi cient mice, suppression of tumor growth and metastasis 
was observed. (Nature Med. 6, Dennis et al., 2000) However, it remains unknown 
how GnT-V induces the progression of cancer. To know the biological signifi cance 
of GnT-V in carcinogenesis, we established GnT-V transgenic mice (GnT-V Tg mice), 
which were regulated under beta-actin promoter. In the present study, we focused 
the abnormality in the skin of GnT-V Tg mice and found an epithelial-mesenchymal 
transition (EMT)-like phenotype of keratinocytes derived from GnT-V Tg mouse 
skin. When primary keratinocytes in culture were stimulated with EGF, remarkable 
suppression of E-cadherin expression and changes in E-cadherin localization 
were observed. Simultaneously, expression of snail and twist mRNA in epidermis 
was dramatically enhanced without any stimulus. These results suggest that an 
EMT-like phenotype of GnT-V transgenic mice is important to reveal relationship 
between GnT-V and malignant transformation and cancer progression. We have 
investigated detailed mechanisms in terms of aberrant EGF signaling pathway.
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Tumor-stroma interaction is essential in a primary human in vitro skin cancer model 
using a human cancer-associated dermal microenvironment
Commandeur S, De Gruijl FR, Willemze R, Tensen CP, Elghalbzouri A Leiden 
University Medical Center, Leiden, Netherlands
Squamous cell carcinomas (SCCs) of the skin represent a large clinical problem, which 
is particularly dramatic in immune-suppressed individuals. Since medical intervention 
is crucial against successive and recurrent SCCs, refi ned therapies are indispensable. 
Therefore, well-targeted therapeutics should be screened in representative human skin 
carcinoma models. Our goal is to generate and validate an in vitro human skin cancer 
equivalent that mimics human SCCs to reduce and refi ne the current exploitation of animal 
models. For this purpose, in vitro skin models were engineered directly from primary SCC-
biopsies of immune-suppressed individuals. These models reproduce important hallmarks 
of SCC, including invasion, hyperproliferation, aberrant differentiation and expression 
of putative SCC markers as determined by morphological and immunohistochemical 
analysis. In order to further mimic SCC behavior in vitro, the dermal microenvironment was 
modulated by introducing cancer-associated fi broblasts (CAFs) into the dermal compartment 
and by using human CAF-derived dermal matrix instead of rat-tail derived collagen. These 
CAFs infl uenced invasion and epidermal morphogenesis differently than normal human 
fi broblasts. Furthermore, CAFs presented with aberrant morphology, loss of contact-
inhibition, increased contractility and motility, and increased production of extracellular 
matrix components. Altogether, these observations emphasize the crucial role of the dermal 
microenvironment in tumor development. By using primary human carcinomas and primary 
carcinoma-associated fi broblasts, the natural heterogeneity of SCCs is refl ected by this in 
vitro skin cancer model. Ultimately, this work aims to contribute to the replacement of animal 
models for therapeutic, diagnostic and screening purposes towards human skin cancer.
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MK2 regulates the early stages of skin tumor promotion
Johansen C1, Vestergaard C1, Kragballe K1, Ronkina N2, Bohlmann L2, Kollias G3, 
Gaestel M2, Iversen L1 1Aarhus University Hospital, Aarhus C, Denmark 2Hannover 
Medical School, Hannover, Germany 3Biomedical Sciences Research Center 
“Alexander Fleming”, Vari, Greece
The association between infl ammation and tumorigenesis is well recognized. Mitogen-activated 
protein kinase-activated protein kinase-2 (MK2) is known to play a pivotal role in infl ammatory 
processes. The purpose of this study was to analyze the effect of MK2-defi ciency and TNF-α-
defi ciency on skin tumor development in mice using the two-stage chemical carcinogenesis 
model. We found that MK2 knockout mice developed signifi cantly fewer skin tumors compared 
with both TNF-α knockout mice and wild-type mice when induced by initiation with DMBA 
and by promotion with TPA. The TPA-induced infl ammatory response was reduced in both 
TNF-α knockout mice and MK2 knockout mice, but most pronounced in TNF-α knockout mice, 
indicating that a reduced infl ammatory response was not the only explanation for the inhibited 
tumorigenesis seen in MK2-defi cient mice. Interestingly, increased numbers of apoptotic 
cells were detected in the epidermis of MK2 knockout mice compared with TNF-α knockout 
mice and wild-type mice, suggesting an additional role of MK2 in the regulation of apoptosis. 
This was further supported by a): increased levels of the tumor suppressor protein p53 in MK2 
knockout mice after DMBA/TPA treatment compared with TNF-α knockout mice and wild-type 
mice, b): reduced phosphorylation (activation) of the negative p53 regulator, murine double 
minute 2 (Mdm2) in MK2-defi cient mouse keratinocytes in vitro and c): a signifi cant decrease 
in the DMBA/TPA induced apoptosis in cultured MK2-defi cient keratinocytes transfected with 
p53 siRNA. Taken together, these fi ndings demonstrate a dual role of MK2 in the early stages of 
tumor promotion through regulation of both the infl ammatory response and apoptosis of DNA-
damaged cells. These results also identify MK2 as a putative target for future skin carcinoma therapy.
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RAGE signaling promotes tumor-angiogenesis and controls endothelial cell-specifi c 
immune cell recruitment
Gebhardt C1, Kiessling F2, Delorme S3, Nawroth PP1, Bierhaus A1, Arnold B3, Enk AH1, 
Angel P3 1University Hospital Heidelberg, Germany 2University Hospital Aachen, 
Germany 3German Cancer Research Center (DKFZ), Heidelberg, Germany
The central role of chronic infl ammation in promoting tumor development is highlighted by a 
broad range of experimental and clinical evidence. However, the mechanisms that sustain a 
tumor-promoting microenvironment remain largely elusive.We have recently demonstrated 
that mice defi cient for the receptor for advanced glycation end-products (RAGE) are resistant to 
DMBA/TPA-induced skin carcinogenesis and that RAGE-defi cient mice show severely reduced 
infl ammatory response to treatment with TPA accompanied by impaired infi ltration with subsets 
of innate immune cells such as neutrophils, macrophages, mast cells and impaired upregulation 
of pro-infl ammatory genes, such as Ptgs2, MIPs, S100a8 and S100a9. Interestingly, tumors in 
RAGE-defi cient mice showed severly reduced vascular density and impaired perfusion using 
confocal microscopy and perfusion-ultrasound-sonography. Furthermore, aortic rings explanted 
from RAGE-defi cient mice were characterized by impaired microvessel outgrowth revealing an 
important role of RAGE signaling in endothelial cell migration and endothelial progenitor cell 
recruitment. In order to elucidate an endothelial cell-specifi c role of RAGE signaling, we generated 
wildtype bone marrow chimeric Tie2 promoter-driven RAGE-defi cient mice (RageΔEND) that 
show a signifi cantly altered infl ammatory response to TPA treatment characterized by impaired 
immune cell recruitment in the presence of epidermal hyperplasia thereby partly phenocopying 
non-conditional RAGE-defi cient mice. In conclusion, we demonstrate the complex role of RAGE 
signaling in driving the strength and maintenance of an infl ammatory reaction during tumor-
promotion and in promoting tumor angiogenesis. Moreover, we provide direct genetic evidence for 
a novel endothelial cell-specifi c function of RAGE in promoting infl ammation-induced skin cancer.
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Mice Lacking MSK1 and MSK2 Show Decreased Skin Tumor Development In a Two 
Stage Chemical Carcinogenesis Model
Chang S1, Iversen L1, Arthur JS2, Kragballe K1, Johansen C1 1Aarhus University Hospital, 
Aarhus C, Denmark 2University of Dundee, Dundee, United Kingdom
MSK1 and MSK2 are two kinases activated downstream of the p38 MAPK and ERK mitogen-
activated protein kinases. Besides playing an important role in infl ammatory processes, 
recent data also suggest a crucial role for MSK1 in cell transformation. The purpose of this 
study was to examine the role of MSK1 and MSK2 in skin tumor development in mice, 
using the DMBA/TPA skin carcinogenesis model.  We found that MSK1 and MSK2 double 
knockout mice developed signifi cantly fewer skin tumors compared with wild-type mice. 
This was seen from week 12 and until the experiment was terminated at week 21. We 
also examined the TPA-induced infl ammatory response in the mice. By quantitative RT-
PCR we demonstrated that the mRNA expression of the proinfl ammatory cytokines IL-
1β and TNF-α was signifi cantly increased in the skin of MSK1/2 double knockout mice 
compared with wild-type mice, whereas the TPA-induced mRNA expression of IL-6 was 
unchanged between the two groups of mice. To further characterize the infl ammatory 
response induced by TPA, the myeloperoxidase (MPO) activity was determined to assess the 
level of neutrophils in the skin. TPA signifi cantly increased the MPO level in biopsies taken 
from wild-type skin compared with vehicle treated skin, refl ecting elevated neutrophilic cell 
infi ltration into the skin. Furthermore, the MPO level in TPA treated skin from MSK1/2 double 
knockout mice was signifi cantly elevated compared with TPA treated wild-type mice. Taken 
together, these data provide in vivo evidence that MSK1 and MSK2 signaling represents 
a novel tumor-promoting axis in skin carcinogenesis and it seems this tumor promotion 
is mediated through mechanisms disassociated from those inducing infl ammation. MSK1 
and MSK2 targeting may therefore be of possible future interest in skin cancer treatment.
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Quiescent cultured keratinocytes derived from squamous cell carcinoma retain a 
cancer-specifi c gene expression signature capable of differentiating squamous cell 
carcinoma from normal skin in vivo
Pourreyron C1, Foerster J1, Hogan C1, Purdie K2, Bruckner-Tuderman L3, Proby C1, 
McGrath JA4, Leigh IM1, South AP1 1University of Dundee, UK 2Cancer Research UK, 
London, 3Univ of Freiburg, Germany 4University of London, UK
Non-melanoma skin cancer is the most common cancer in Caucasians. Squamous cell carcinoma (SCC) is 
estimated to affect over 11,500 people in the UK each year and is the primary cause of death in patients 
with recessive dystrophic epidermolysis bullosa (RDEB). In order to understand the molecular events that 
contribute to this carcinoma we compared global gene expression of primary keratinocyte cultures derived 
from SCC (n=9, 5 spontaneous SCC and 4 RDEB SCC) and normal skin (n=7, 4 unaffected and 3 RDEB 
patients). Analysis revealed that under culture conditions SCC-derived keratinocytes retained an expression 
signature of 435 genes clearly distinguishing them from non-cancer derived keratinocytes. Remarkably, 
both spontaneous and RDEB SCC cultured keratinocytes exhibited similar expression profi les indicating 
that common SCC-associated pathways are dysregulated downstream of distinct tumour initiating lesions.
We applied the 435 gene signature to rank all tumours according to their relative deviation from normal. 
This analysis separated keratinocytes derived from well differentiated tumours (n=3) from those designated 
as moderately or poorly differentiated (n=6) regardless of RDEB status. Xenograft tumours were readily 
established from 6 of 8 primary SCC cultures after sub-cutaneous injection into SCID mice. The histological 
classifi cation of xenograft resembled the tumour of origin. Ranking analysis also identifi ed highly aggressive 
SCC cells characterized by Transwell assay, again regardless of RDEB status (% of invading cells vs. number of 
highly dysregulated genes, r = 0.97). Next we analysed the expression of our 435 gene signature across three 
independent in vivo expression profi ling data sets (our own, 9 SCC vs 5 normal skin; and two published data 
sets, 5 SCC vs 6 normal skin and 11 SCC vs 4 normal skin). In each case ranking of expression level for all 
probes representing our 435 genes was able to exclusively segregate normal skin from SCC without exception. 
Across all data sets 80% of the 435 genes were expressed and 36% were expressed concordantly. 5 genes were 
statistically signifi cant in all three experiments (p<0.005; FC > 2); KRT6B, ID4, ALDH3A2, ANG and WDR66.
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Effects of the immunosuppressant rapamycin on skin carcinoma formation by 
chronic UV exposure
Voskamp P1, Koehl GE2, Rebel HG1, Bouwes Bavinck JN1, Geissler EK2, De Gruijl 
FR1 1Leiden University Medical Center, Netherlands 2University of Regensburg, 
Germany
Conventional immunosuppressants are known to enhance UV radiation-related skin 
cancer risk, whereas the newer generation drug rapamycin (Rapa) has been shown to 
impair angiogenesis and tumor outgrowth. Rapa’s impact on early and late stage UV 
carcinogenesis was assessed in daily irradiated (UVB, 0.5 MED) hairless SKH1 mice. 
Tumor-precursing microscopic clusters of cells overexpressing mutant-p53 were 13 
fold less frequent in the skin of Rapa-fed mice than in controls after 70 days of daily 
UV exposure (p = 0.003). Nevertheless, mice on the Rapa diet developed small skin 
tumors at a similar rate as control mice, which indicated that Rapa does not affect 
tumor onset. The rate at which larger tumors develop was clearly reduced by Rapa; 
4-mm tumors appeared with a median latency time of 190 (Rapa) versus 125 days in 
control mice. Interestingly, there was a signifi cantly smaller percentage of UV-signature 
p53 mutations in large tumors from the Rapa-fed group than from the control group 
(39% vs 90%, p = 0.005). This shift in mutation spectrum was not essentially linked to 
reduction in large tumors as Rapa in combination with another immunosuppressant, 
mycophenolate mofetil (MMF) showed the same reduction without a shift in the 
p53 mutation spectrum; this may be attributable to anti-oxidant effects of MMF. The 
known anti-angiogenic effect of Rapa may explain lower yields of large tumors, which 
could be attributed to signifi cantly less VEGF-positive tumor cells found in the Rapa-
fed group. In summary, these results indicate that a Rapa-insensitive subset of p53 
mutant cell clusters eventually form malignant tumors, and that Rapa-resistant large 
tumors tend to acquire a p53 mutational pattern atypical for UV-induced damage.
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A polymorphism in codon 1315 of the PTCH1 gene may accelerate the development 
of basal cell cancer
Wikonkal N, Farkas R, Kaszab C, Blazsek A, Paragh G, Karpati S Semmelweis 
University School of Medicine, Budapest, Hungary
The majority of basal cell cancers (BCC) occur as sporadic tumors, yet familial forms are 
also recognized as part of Gorlin-Goltz syndrome. The nevoid basal cell cancer syndrome 
is an autosomal dominant disease in which the PTCH tumor suppressor gene is mutated. 
PTCH1 is a member of the hedgehog signal transduction pathway that is also found mutated 
in over 90% of BCC’s. In exon 22 of the PTCH1 gene we earlier reported a polymorphism in 
codon 1315 where it actually leads to a change in the amino acid sequence: either Proline 
(CCC) or Leucine (CTC) is encoded. We assumed that with this amino acid change the 
tumor suppressor function of PTCH1 is somewhat altered that leads an increased chance 
of the development of basal cell cancers.In order to investigate this theory we identifi ed a 
set of patients 1.) Who developed BCC’s at at a young age, under 35, without having other 
criteria of Gorlin-Goltz syndrome or 2.) Who had a higher number of BCC’s compared 
to other individuals with the same age. The DNA sequence of 104 BCC patients were 
analyzed by sequencing to fi nd 49 heterozygous, 12 homozygous Proline, 43 homozygous 
Leucine coding allele sequences. Two hypotheses have been tested statistically: either 
group 1 and 2 were different when compared to each other or they were different when 
compared to the allele distribution the control group. Our data showed that early onset 
basal cell patients (group 1) showed no signifi cant difference when compared to the allele 
distribution of high number BCC group (group 2). Testing the other hypothesis in which we 
were looking whether any of these two groups differ in their allele distribution to the control 
group we found a strong statistically signifi cant difference by using chi2 test. Although 
further confi rmation is on the way, we raise the possibility that harboring the sequence 
that encodes Pro leads to the development of basal cell carcinoma at a younger age.
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A Rare Type of Dermal Granular Cell Tumor
Tsoukalas N1, Papakostidi A1, Barbounis V1, Efremidis A1, Barbati K2 1Saint Savvas 
Cancer Hospital, Athens, Greece 2Korgialenio-Benakio General Hospital, Athens, 
Greece
Description and analysis of a rare case of a primitive nonneural, granular cell tumor of the skin 
in a young adult. A 39-years-old man was presented with a nodule in the right supraclavicular 
fossa (diameter~1cm). One month later, the nodule was excised and the histological examination 
showed a cutaneous carcinoma of lower differentiation. The rest of the work-up with CT’s of the 
thorax-abdomen-cervix-skull, bone scan, U/S of the thyroid and the scrotum and gastroscopy, 
failed to reveal the primary site of the tumor. Previous medical history of the patient: numbness 
of the left temporal area. Family medical history: his father died of non Hodgkin lymphoma. 
A review of the biopsy was done, which showed an infi ltrating, nested, epithelioid carcinoma 
with prominent granular cytoplasm and moderate nuclear pleomorphism. Infi ltration of the fat 
and the fi broconnective tissue was observed. No lymph nodes or adnexa were identifi ed within 
the specimen, however small nerve rootlets and fragments of skeletal muscle were observed. 
These were consistent with a subcutaneous location of the neoplasm. The immunohistochemical 
analysis showed positivity for CD68, PAS, PAS-D and negativity for ck18, ck19, cam5.2, AE1:AE3, 
34be12, S-100, HMB45, A103, Myogenin, Myo-D1, Desmin, chromogranin, synaptophysin, 
TTF-1, Thyroglobulin, TFE-3, inhibin, CD163, HAM56. The Mib (Ki-67) was approximately 
40-50% of the neoplastic cells. Also 2  mitosis per 10 high power fi elds and apoptotic bodies 
were observed. Possibly the strongly immunoreactivity for CD68 in all of the neoplastic cells 
was refl ective of an abundance of lysozomes. In summary the above fi ndings were compatible 
with a rare entity of a skin carcinoma, the primitive nonneural granular cell carcinoma. The 
majority of these uncommon tumors are polypoid and well-circumscribed, however there 
are some case reports in the literature of S-100 negative granural cell tumors with malignant 
potential.The primitive nonneural granular cell carcinoma of the skin is a rare entity of benign 
neoplasms, which has an indolent natural history with rare relapses after clear margin excision.
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A role for the receptor tyrosine kinase Axl in regulating NF-B activity in cutaneous 
squamous cell carcinomas
Papadakis ES1, Storey A2, O’Toole EA1 1Centre for Cutaneous Research, Barts and The 
London School of Medicine and Dentistry, London, UK 2Department of Molecular 
Oncology, The Weatherall Institute of Molecular Medicine, Oxford, UK
Axl is a transmembrane receptor tyrosine kinase whose downstream targets include NF-
κB, a family of transcription factors which are aberrantly regulated in cancer. We have 
identifi ed by Affymetrix chip analysis, a 12-fold increase in Axl expression in a squamous 
cell carcinoma (SCC) cell line compared to a keratinocyte line and demonstrated that Axl 
is overexpressed in cutaneous SCC. In this study we examined the role of Axl in NF-κB 
regulation. Two SCC cell lines, derived from a recessive dystrophic epidermolysis bullosa 
patient (EBSCC) and an organ transplant recipient (MET1) were transduced using a retroviral 
shRNA non-targeting control sequence or an Axl-specifi c targeting sequence resulting 
in approximately 95% stable Axl protein knockdown as shown by immunoblot analysis. 
Activation of the canonical NF-κB pathway by TNF-α resulted in faster degradation of 
IκBα, an important inhibitor of NF-κB activation in the cytosol, in both EBSCC and MET1 
Axl knockdown SCC lines. This was accompanied by increased TNF-α-induced NF-κB 
transactivation in EBSCC and MET1 Axl knockdown cells as revealed by a sensitive luciferase 
reporter assay. NF-κB transactivation in response to TNF-α diminished in a keratinocyte line 
stably overexpressing wild-type Axl but not in keratinocytes overexpressing mutant kinase-
defective Axl. RelA, one of the main NF-κB pathway components, expression was increased 
in nuclear extracts from Axl knockdown compared to control SCC cells.  Overexpression 
of RelA in MET1 cells resulted in decreased Axl expression. These data support the 
notion of a reciprocal relationship between NF-κB and Axl, which may modulate tumour 
infl ammation and offer further insight for the development of Axl as a therapeutic target.
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Aberrant DNA Methylation associated with MTHFR C677T Genetic Polymorphism 
in Renal Transplant Patients
Laing M1, Cummins R2, Kay EW2, Murphy GM1 1Department of Dermatology, 
Beaumont Hospital, Dublin, Ireland 2Department of Molecular Pathology, Clinical 
Research Centre, Beaumont Hospital, Dublin, Ireland
Changes in genomic DNA methylation associated with cancer include global DNA
hypomethylation and gene specifi c hyper or hypomethylation. We have previously 
identifi ed a genetic variant in the MTHFR gene involved in the methylation pathway 
which confers risk for the development of squamous cell carcinoma (SCC) in renal 
transplant patients. This genetic variant has also been discovered to confer SCC risk in 
non transplant patients with low folate status. In this study we used pyrosequencing to 
evaluate global (using LINE 1) and gene specifi c (p 16 and MGMT) methylation status in 
47 SCC and 40 adjacent non neoplastic skin samples in those with (n=17) and without 
(n=16) the MTHFR polymorphism. Results of methylation analysis revealed that SCC 
was hypomethylated compared with adjacent non neoplastic skin, p<0.04. Patients 
with the MTHFR polymorphism had higher levels of global methylation in tumours 
and non neoplastic skin compared with those without the MTHFR polymorphism, p < 
0.002. Global hypomethylation appears to be a feature of SCC. Aberrant methylation 
of DNA appears related to polymorphisms of MTHFR. Such fi ndings suggest that 
intervention in the form of demethylating agents or folate supplementation may be 
benefi cial in the treatment or prevention of SCC. This is the fi rst report on the use of 
pyrosequencing technology to uncover details of the epigenetic profi le of cutaneous 
SCC, the  status of global DNA methylation in cutaneous SCC and  also its relationship 
to the MTHFR polymorphism. The results from this study extend our previous 
fi ndings that MTHFR polymorphism confers risk for SCC in a transplant population. 
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Chromosomal aberrations of the CDKN2A network components p16, p53 and RB1 
differ in subtypes of primary cutaneous B-cell lymphoma
Kaune KM1, Hallermann C2, Middel P3, Haller F4, Schön MP1, Neumann C1 
1Department of Dermatology, Venereology and Allergology, Georg-August-University 
Göttingen, Germany 2Department of Dermatology, Institute for Tumors of the Skin, 
University of Münster, Germany 3Department of Pathology, Clinical Center of Kassel, 
Germany 4Department of Pathology, Georg-August-University Göttingen, Germany
The cyclin-dependent kinase inhibitor 2A (CDKN2A) gene encodes the p16 (INK4A) inhibitor of the 
CDK4/retinoblastoma (RB1) cell proliferation pathway and, in addition, p14 (ARF) which controls 
p53 dependent pathways. Interestingly, in the group of primary cutaneous B-cell lymphomas 
(PCBCL), inactivation of p16 has previously been associated with primary cutaneous diffuse large 
B-cell lymphoma, leg type, the subtype with the worst prognosis. Aberrations of components of 
the CDKN2A tumour suppressor network other than p16, e.g. p53 and the RB1 gene have been 
implicated in the pathogenesis of several types of nodal lymphomas. However, the roles of  p53 and 
RB1 in PCBCL are still unknown. We investigated 9 primary cutaneous follicle center lymphomas 
(PCFCL), 7 primary cutaneous marginal zone lymphomas (PCMZL), and 6 primary cutaneous 
diffuse large B-cell lymphomas, leg type (PCLBCL, LT). Fluorescence in situ hybridization (FISH) 
was performed using specifi c probes for p16 (9p21), p53 (17p13) and RB1 (13q14). None of the 
PCFCL or PCMZL showed alterations of p16. However, FISH analysis revealed alterations of p16 
(2 biallelic deletions, 1 monoallelic deletion, 1 trisomy 9) in 4/6 PCLBCL, LT. Interestingly, this 
tumour type also most often showed deletions of p53 (3/6) and RB1 (3/6). In contrast, only 1/7 
PCMZL and none of the 9 PCFCL showed deletions of p53, and only 1/7 PCMZL and 1/9 PCFCL 
harboured a deletion of RB1. In conclusion, aberrations of the CDKN2A network components 
p16, p53 and RB1 seem to be largely absent in PCMZL and PCFCL. In contrast, PCLBCL, LT, 
which is characterized by an unfavourable clinical outcome, shows deletions of these genes 
in a considerable percentage. Verifi cation of these fi ndings on the protein level is in progress.




Genomic characterisation of blastic plasmacytoid dendritic cell neoplasms by array 
CGH
Thomas W, Obenauf AC, Speicher MR, Cerroni L Medical University of Graz, 
Austria
Genomic characterisation of blastic plasmacytoid dendritic cell neoplasms by array 
CGH. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare malignant 
proliferation of plasmacytoid dendritic cells, typically presenting with reddish-
brown skin lesions, followed by bone marrow, lymph node, and blood involvement. 
The clinical course is aggressive with a median survival of 12-14 months. Genetic 
aberrations are largely unknown in BPDCN, but could provide new insights into their 
evolution and will likely improve diagnosis and therapy. We analysed skin biopsies of 
14 patients using a high-resolution array-based comparative genomic hybridization 
(CGH) technique to identify DNA copy number changes containing candidate genes 
involved in tumour initiation and progression. Chromosomal aberrations were 
observed in all analyzed samples. Losses of chromosomes 9, 12, 13, 15, and 19 were 
detected most frequently. In 9 of 14 patients, a minimal common deleted region at 
chromosome region 12p13 was observed. This region contains the cell cycle control 
gene CDKN1B and the transcriptional repressor ETV6. In 7 of 14 patients, deletions of 
chromosome 9 were detected, and in one case a very distinct biallelic deletion of 500 
kb at 9p21 was observed. This deletion indicates a critical pathogenic involvement of 
the cell cycle regulating genes CDKN2A and CDKN2B, which are localised at 9p21. 
The genomic aberrations of chromosomes 13, 15, and 19 were predominantly losses 
of whole chromosomes, involving numerous candidate genes, and were found in 6, 5, 
and 4 cases, respectively. In conclusion, the genomic aberrations in BPDCN involve 
especially cell cycle checkpoint genes, which may have a signifi cant role in the 
malignant transformation and may partly explain the aggressiveness of this tumour entity.
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Complement System Components and Inhibitors in Cutaneous Squamous Cell 
Carcinoma
Riihilä P1, Ala-aho R1, Kallajoki M2, Grénman R3, Meri S4, Peltonen J5, Kähäri VM1 1Dept 
of Dermatology & Venereology & Medicity Res Laboratory, Univ of Turku, Finland 
2Dept of Pathol, Turku Univ Central Hospital, Finland 3Dept of Otorhinolaryngol, 
Head & Neck Surgery, Turku Univ Central Hospital, Finland 4Haartman Institute, 
University of Helsinki, Finland 5Dept of Anat & Cell Biol, Univ of Turku, Finland
The incidence of cutaneous squamous cell carcinoma (SCC) and its precancerous forms is 
increasing in western world. Infl ammation is a typical feature of cutaneous SCC. We have 
investigated the expression of complement system components in cutaneous SCC cell lines (n=8) 
and normal human epidermal keratinocytes (n=7) by Affymetrix based expression profi ling and 
quantitative real time RT-PCR (TaqMan). In addition, expression of compelent components was 
examined in tissue arrays generated from cutaneous SCCs (n=47) by immunohistochemistry (IHC). 
The mean expression level of complement components in Affymetrix data was increased in SCC 
cells compared to normal keratinocytes: C1s (133-fold), C3 (8-fold) Complement factor B (CFB) 
(6-fold). In addition, expression of complement inhibitors was increased in SCC lines as compared 
to normal keratinocytes: Complement factor H (CFH) (23-fold), Complement factor H like protein-1 
(CFHL-1) (18-fold) and Complement factor I (CFI) (23-fold). This was also confi rmed by TaqMan: 
C1s mRNA expression was increased by 6-fold, C3 5-fold, CFB 4-fold, CFH 9-fold, CFHL-1 22-fold 
and CFI 11-fold. The expression of CFH and CFHL-1 mRNA was also detected in RNA derived 
from skin SCCs (n=5).  IHC of  SCC tissue arrays showed that CFH was specifi cally expressed 
by tumor cells. The production of CFH and CFHL-1 by SCC cells was up-regulated by IL-1beta, 
IFN-gamma and TNF-alpha at mRNA and protein level, as detected by Western blotting. These 
results show that cutaneous SCC cells express several components of the complement system, 
which may play a role in progression of SCCs.  The results suggest complement components 
as putative diagnostic markers and as potential targets for anti-cancer therapy in skin SCCs.
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Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: 
surprising heterogeneity and indications for cadherin switching
Werling AM1, Doerfl inger Y1, Brandner JM2, Fuchs F2, Becker JC3, Schrama D3, Kurzen 
H4, Goerdt S1, Peitsch WK1 1Dept of Dermatology, Univ Medical Centre Mannheim, 
Univ of Heidelberg, Mannheim, Germany 2Dept of Dermatology, Univ Hospital 
Hamburg-Eppendorf,, Germany 3Dept of Dermatology, Univ of Würzburg, Germany
4Dermatological Practice, Freising, Germany
Merkel cell carcinomas (MCC) are rare but highly aggressive tumors mainly affecting elderly and 
immunosuppressed patients, which have recently been attributed to Merkel cell polyoma virus 
(MCV). As development and progression of several carcinomas can be promoted by changes in the 
repertoire of cell adhesion proteins, we have analyzed homo- and heterotypic cell-cell contacts 
of normal Merkel cells and 52 MCC using double-label immunostaining, immunofl uorescence 
and confocal laser scanning microscopy. Patterns of cell junction proteins were correlated to the 
clinical course of MCC and to MCV status (84% of our tumors harbored MCV as detected by real-
time PCR). In normal epidermis, Merkel cells were connected to keratinocytes by E- and P-cadherin 
and the plaque proteins of adherens junctions as well as by desmosomes comprising desmoglein 
2 and desmocollin 2. By contrast, the vast majority of MCC (90%) contained N-cadherin whereas 
E- and P-cadherin were only detected in a subset of tumors, i. e., 67 or 65% respectively. Assuming 
that MCC are derived from Merkel cells, our results are well in line with a “cadherin switch”, widely 
discussed as important prerequisite for the pathogenesis of many kinds of tumors. Interestingly, 
absence of P-cadherin was noted signifi cantly more frequently in lymph node metastases than in 
primary tumors and by trend in more advanced clinical stages. The only desmosomal cadherin 
detected in a major subset of MCC was desmoglein 2. Moreover, surprisingly, a large proportion 
of MCC contained components of tight junctions, most frequently, occludin and claudin 3 and 
5 together with proteins ZO-1 and ZO-2. Whether this surprising heterogeneity of cell junction 
proteins may indeed imply prognostic and therapeutic consequences remains to be examined.
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Constitutive activation of NF-kB in cutaneous T cell  lymphoma (CTCL): involvement 
of TCR pathway
Baraut J1, Jean Louis F1, Bachelez H2, Courtois G1, Michel L1 1INSERM, Paris, France 
2AP-HP, Paris, France
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of non-Hodgkin extra-nodal 
T cell lymphomas,  with mycosis fungoides (MF) and Sézary syndrome (SS) as the two major clinical 
variants. Our recent work demonstrates that tumor cells from CTCL exhibit constitutive activation 
of the classical NF-kappaB  pathway that is involved in resistance to apoptosis. However, the origin 
of NF-kappaB  constitutive activation in CTCL remains unknown. One hypothesis is deregulation of 
the TCR pathway and the aim of our work is to target altered molecular events in TCR-induced NF-
kappaB  pathway. CTCL cell lines (HuT-78, SeAx, MyLa) and CD4+ tumor lymphocytes isolated from 
peripheral blood mononuclear cells (PBMC) of patients with SS were used. CTCL cell lines were 
co-transfected with negative dominant molecules, specifi c for the TCR-linked NF-kappaB  pathway, 
and a plasmid reporter Ig?-luc which measures the NF-kappaB  activation level. Transfection either 
with negative dominants for Bcl10 and PKCtheta or with specifi c PKCtheta siRNA, inhibited NF-
kappaB  transcriptional activity in a dose-dependent manner. This clearly demonstrates that the 
pathway is deregulated at the level of CARMA1-Bcl10-MALT1 complex and/or PKCtheta. Addition 
of a specifi c inhibitor of PKCtheta, rottlerin, after Ig?-luc transfection, decreased luciferase activity. 
Rottlerin [1.56 to 50 µM] also inhibited constitutive NF-kappaB transcription activity, as shown by 
EMSA and immunocytochemistry (dose-dependent inhibition of p65 NF-kappaB  nuclear staining). 
Moreover, this inhibitor induced a greater apoptosis of CTCL cell lines and tumor cells from patients 
with Sézary syndrome, as compared with Jurkat cell line and PBMC from healthy donors. Rottlerin 
also inhibits NF-kappaB  (p65) and phosphorylated Bcl10 expression. Alteration of CBM status 
in CTCL tumor cells was established by immunoprecipitation assays. In conclusion, NF-kappaB 
constitutive activation in CTCL is associated with a molecular deregulation at CARMA1-Bcl10-
MALT1 and PKCtheta level in TCR pathway, offering new potential therapeutic targets for CTCL.
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Identifi cation of therapeutic and prognostic biomarkers in keratinocyte 
carcinogenesis
Gulati A1, Harwood CA1, Kelsell D1, Proby CM2 1Institute of Cell and Molecular 
Science, London, United Kingdom 2University of Dundee, United Kingdom
Keratinocyte skin cancers (KSC) comprising BCC and SCC are the commonest malignancies in 
humans with over 100,000 cases diagnosed in the UK each year. Up to 72% primary SCC arise 
in areas of precancerous keratinocyte intraepithelial neoplasia (KIN), clinically apparent as partial 
(Actinic Keratoses) and full (Bowens disease) thickness epidermal dysplasia. This study examines key 
molecular events in KIN and proposes to identify novel biomarkers through an integrated genome-
wide mapping approach using SNP and expression microarrays on skin samples representing 
sequential stages of KIN evolution including normal non-sun exposed (NSE), normal sun exposed 
(SE) and KIN skin, such as dorsum of hands or forehead, from 30 high-risk organ transplant recipients 
and 20 immunocompetent subjects with previous SCC. 30 of these subjects also received treatment 
of KIN with three widely used topical chemopreventive agents: 5-fl ourouracil; imiquimod and a 
COX II inhibitor followed by a post-treatment biopsy. Initial results have revealed several recurrent 
areas of chromosomal loss or gain, specifi cally loss at chromosome 1p, 3p, 4p, 9p and 19p and a 
gain at chromosome 8q containing several potential candidate genes, such as EPS15 and GATAd2A, 
an transcriptional repressor involved in methylation. Expression array data has provided lists of genes 
differentially regulated through the different stages of KIN evolution and indicated involvement of 
a number of important gene ontology pathways, such as Keratin fi lament cytoskeleton remodelling 
and IL10 signalling. In summary, this research will provide a comprehensive, integrated profi le 
of key genetic and expression changes in early skin carcinogenesis, permitting identifi cation of 
critical events in the evolution of KIN, development of diagnostic and prognostic biomarkers and 
identifi cation of novel therapeutic targets directed at KIN, Ultimately such information may be used 
to refi ne therapeutic strategies in attempts to stem the mounting incidence and burden of SCC.
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Cutaneous Metastases From Lung Cancer
Tsoukalas N, Papakostidi A, Lypas G, Papadimitriou C, Pistamalntzian N, Panopoulos 
C, Demiri S, Koumakis G, Barbounis V, Efremidis A Saint Savvas Cancer Hospital, 
Athens, Greece
The description and analysis of 2 cases of cutaneous metastases which developed 
from lung cancer (SCLC and NSCLC). 1st case: a 54-year-old man, smoker, presented 
with a febrile infection of the respiratory system, in September 2007. In the context 
of the workup/investigation, he underwent a bronchoscopy which revealed a small 
cell lung cancer (brushing). The staging showed limited disease. He received 6 
cycles of chemotherapy with cisplatin 80mg/m2 d1 and etoposide 100mg/m2 d1-d3 
and concurrent radiotherapy of the mediastinum, which were well tolerated. The 
patient developed a mass in the right, front axillary line, on the level of the 8th 
pleura, which was callous, fi xed and painless (2,5x2cm). The FNA was positive for 
metastatic infi ltration from SCLC. 2nd case:  a 47-year-old man, smoker was admitted 
to our clinic due to recently diagnosed NSCLC stage IV, with brain, bone and 
liver metastases. He received whole brain radiotherapy (WBRT) and consequently 
chemotherapy with the regimen carboplatin d1 plus paclitaxel d1, which was well 
tolerated. During radiotherapy, he developed a painless, fi brous, mobile mass. The 
FNA was positive for metastatic infi ltration from NSCLC.The cutaneous metastases 
of lung cancer are quite rare about 3%. More often they appear with the carcinoma 
of lerge cell whereas rarely appear with squamous carcinomas and small cell lung 
cancer. The most usual site of these metastases is the back and they appear as nodule 
approximately 1-5cm. When these skin metastases are confi rmed metastases in 
other sites are almost always present and for that reason are poor prognostic fastors.
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Immunosuppression affects CD4+ mRNA and induces Th2 dominance in the 
infl ammatory microenvironment of cutaneous squamous cell carcinoma in organ 
transplant recipients
Dziunycz P1, Kosmidis M1, Suárez-Fariñas M2, Mühleisen B1, Schärer L3, Läuchli S1, 
French LE1, Schmidt-Weber C4, Carucci JA5, Hofbauer GF1 1University Hospital Zurich, 
Switzerland 2Rockefeller Univ, New York, USA 3Dermatopath Gemeinschaftspraxis, Friedrichshafen, 
Germany 4Imperial College London, UK 5Weill Medical College of Cornell University, New York, USA
Squamous cell carcinoma (SCC) represents the most frequent tumor associated with drug-induced 
immunosuppression in organ transplant recipients (OTRs), however little is known about the local 
infl ammatory response in SCC. We analyzed quantity and quality of the peritumoral infl ammatory SCC 
microenvironment in immunocompetent patients and OTRs.We evaluated the fold change for SCC genes 
published in 8 lists relating to Th1 vs. Th2 response: GATA3, IL-12, TH1TH2, ST IL13, ST IL-4, IFN-ƒ× 
up/ down; IL-4. Next, SCCs from immunocompetent patients and OTRs as well as CD4, CD8, TBET, 
GATA-3, FOXP3, RORC, IFN-gamma, IL-4, TGF-beta, IL-10 and IL-17A mRNA expression was evaluated 
by qRT-PCR.Considerable infl ammation was seen in both patient groups. SCC in immunocompetent 
patients and OTRs was associated with a mixed Th1 and Th2 gene expression signature. CD4+ mRNA 
was diminished in immunosuppression. Skin adjacent to SCC in OTRs showed Th2 expression pattern 
as compared to immunocompetent patients. T-BET and INF-gamma mRNA expression was decreased in 
OTRs, while GATA-3 and IL-4 mRNA expression did not differ. Although the expression of RORC mRNA 
was unchanged, IL-17A mRNA level was markedly decreased with immunosuppression. Regulatory T cell 
response, characterized by FOX-P3 and TGF-beta mRNA level, was decreased in OTRs.The infl ammatory 
microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients was characterized 
by an attenuated state of local immune response comprising a lesser quantity of helper T cell response 
and a Th2 polarized quality. Our fi ndings support the hypothesis that non -tumor-bearing skin adjacent 
to SCC in OTRs is not necessarily normal and that the local microenvironment may contribute to a fi eld 
effect contributing to higher recurrence rates and more aggressive behavior observed in these patients.
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Depletion of Collagen XVII Disturbs the Expression of Other Hemidesmosomal 
Proteins and Cell Migration in Squamous Cell Carcinoma
Moilanen J1, Hurskainen T1, Manninen A1, Tahkola J1, Pihlajaniemi T1, Autio-
Harmainen H1, Bruckner-Tuderman L2, Tasanen K1 1University of Oulu, Oulu, Finland 
2University of Freiburg, Freiburg, Germany
Laminin-332, alfa6beta4-integrin and collagen XVII are the major components of hemidesmosomes, 
which connect epithelial cells with basement membrane. Laminin-332 and alfa6beta4-integrin 
are essential for the genesis of invasive squamous cell carcinoma (SCC) originating from stratifi ed 
epithelia of the skin. However, the role of collagen XVII in the process of SCC carcinogenesis 
is largely unknown.We studied the expression pattern of hemidesmosomal components in the 
DMBA-TPA carcinogen-induced skin tumors of mice using immonohistochemical stainings. Basal 
hyperplastic tissue and individual invasive cells give a strong intracytoplastic signal for laminin-332 
and collagen XVII while in normal skin they are expressed mainly in the basement membrane zone. 
The relative expression levels for hemidesmosomal components in SCC-15 and SCC-25 cell lines 
were investigated by quantitative RT-PCR. Collagen XVII, laminin-332 and alfa6beta4-integrin are 
highly overexpressed in SCC cells compared to normal HaCat keratinocytes. To study the effect of 
collagen XVII knockdown in SCC cells, we performed retrovirus-mediated RNA interference (RNAi). 
Collagen XVII mRNA levels were effi ciently suppressed, the average reduction with two different 
short hairpin RNAs was about 99,5% and, accordingly, no protein expression was detected. The 
collagen XVII RNAi also decreased signifi cantly laminin-332 and alfa6beta4-integrin mRNA levels 
and protein expression. The effect of collagen XVII suppression to the behaviour of SCC cells was 
studied with electric cell substrate impedance sensing (ECIS) instrument. The adhesion and migration 
of collagen XVII knockdown SCC cells was notably disturbed in ECIS analysis. Our data demonstrates 
that laminin-332, alfa6beta4-integrin and collagen XVII are upregulated in SCCs. Interestingly, the 
depletion of collagen XVII by RNAi in SCC cells suppressed also the expression of laminin-332 and 
alfa6beta4-integrin and, furthermore, resulted in impaired adhesion and migration of SCC cells. 
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Increasing Melanoma Cell Death Using Inhibitors of Protein Disulphide Isomerases 
to Abrogate Survival Responses to Endoplasmic Reticulum Stress
Lovat P1, Armstrong J1, Martin S1, Hill D1, Pagliarini V2, Piacentini M2, Redfern C1, 
Birch-Machin MA1 1Newcastle University, Newcastle upon Tyne, United Kingdom 
2Institute of infectious diseases, Rome, Italy
Exploiting vulnerabilities in intracellular signalling pathways of tumour cells is a key 
strategy for drug development. The activation of cellular stress responses mediated 
by the endoplasmic reticulum (ER) allows cancer cells to survive outside their normal 
environment. Many proteins that protect cells against ER stress are active as protein 
disulfi de isomerases (PDI) and the aim of this study was to test the hypothesis that 
apoptosis in response to ER stress can be increased by inhibiting PDI activity. The 
response of metastatic melanoma cell lines to fenretinide, velcade or PDI inhibitor 
was evaluated using biochemical markers of ER stress and assays for viability and 
apoptosis. The role of PDI inhibition was assessed by transfection with both wild-
type and mutant PDI. The novel chemotherapeutic drugs fenretinide and velcade 
induced ER stress-mediated apoptosis in melanoma cells. Both the stress response 
and apoptosis were enhanced by bacitracin, a macrocyclic dodecapeptide antibiotic 
which inhibits PDI activity. Over-expression of the main cellular PDI, procollagen-
proline, 2-oxoglutarate-4-dioxygenase-beta subunit (P4HB), resulted in increased 
PDI activity and abrogated the apoptosis-enhancing effect of bacitracin. In contrast, 
over-expression of a mutant P4HB lacking PDI activity did not increase cellular PDI 
activity or block the effects of bacitracin.  These results provide proof-of-principle for 
the concept that ER-stress-induced apoptosis can be enhanced using PDI inhibitors. 
We are currently evaluating small-molecule PDI inhibitors predicted to bind to the 
CXXC motif of the PDI active site both in vitro and in vivo which may have signifi cant 
potential for enhancing the effi cacy of chemotherapy in a wide range of cancers.
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Dermatomyositis as a Precursory Symptom of Lung Cancer
Tsoukalas N, Papakostidi A, Lypas G, Papadimitriou C, Pistamalntzian N, Panopoulos 
C, Demiri S, Koumakis G, Barbounis V, Efremidis A Saint Savvas Cancer Hospital, 
Athens, Greece
The description of an interesting case of dermatomyositis of paraneoplastic origin.A 60-year-old man was 
admitted to our department due to recently diagnosed SCLC, limited disease. The fi rst manifestation of 
the disease was three months before admission, and it included weakness, shoulder myalgia and non-
productive cough. Approximately two years before patient developed a skin rash in the upper-front thoracic 
wall and pruritus. It was considered as allergic and was treated with corticosteroids and antihistamine. The 
physical examination revealed violaceous eruption in the face and the neck, right upper eyelid edema, 
cracked nails and tips, and symmetric proximal muscle weakness, mostly in the upper limbs. The clinical 
suspicion of dermatomyositis was confi rmed by the laboratory fi ndings SGOT 284 IU/L, CPK 11083 IU/L, 
aldolase 76,3 IU/L (<7,6). The anti-jo-1 antibody was negative and the biopsy of skin and muscle was 
not typical for dermatomyositis. During hospitalization, there was a deterioration of the eyelid edema, 
the skin rash and the muscle weakness, with the addition of dysphagia. The patient was administered 
chemotherapy (cisplatin 80mg/m2 d1 plus etoposide 100mg/m2 d1-3) with the addition of prednisolone 
75mg daily. There was an impressive amelioration. Before the 2nd cycle of chemotherapy the laboratory 
fi ndings were SGOT 52 IU/L, CPK 643 IU/L and aldolase 9,1 IU/L. Overall, the patient was administered 
6 cycles of chemotherapy with cisplatin plus etoposide, with frequent relapses of the skin rash, the 
dysphagia, and the proximal muscle weakness, which were treated with corticosteroids. Dermatomyositis 
has a prevalence of about 5-10/100.000 per year. It is more frequent in women, and approximately 25% 
is related to malignant neoplasm, for example ovarian cancer, breast cancer, melanoma, colon cancer, 
non-Hodgkin lymphomas, lung cancer, myelohyperplastic syndromes and cancer of the nasopharynx. 
In about 1/3 of cases, dermatomyositis   proceeds the exhibition of neoplasia, 1/3 of the cases are 
synchronous and 1/3 of the cases of dermatomyositis follow the clinical presentation of cancer. Finally, the 
relative risk of developing cancer in the context of dermatomyositis is  2,4  for men and 3,4 for women.
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Infl ammation as a driver of Squamous Cell Carcinoma of the skin
Iotzova-Weiss G1, Dziunycz P1, Vogl T2, Gebhardt C3, Hofbauer GF1 1Dermatology 
Clinic,  Zurich, Switzerland 2Institute for Immunology, Muenster, Germany 
3Dermatology Clinic, Heidelberg, Germany
Squamous cell carcinoma (SCC) is a common skin tumor which is characterized by 
infi ltrative, destructive growth and metastasis. SCC is the most common malignant 
complication in organ transplant recipients on long-term immunosuppression and 
occurs 60-100 fold more frequently than in the general population. The aim of the 
present study is to investigate the function of the receptor for advanced glycation 
end products (RAGE) as a link between infl ammation and the development of 
human SCC. It was recently reported that RAGE defi cient mice are resistant to 
DMBA/TPA-induced carcinogenesis and exhibit a severe defect in sustaining 
infl ammation. Moreover, a relation between RAGE expression and the infl ammatory 
proteins S100A8 and S100A9 was proposed. These fi ndings increased our interest 
of investigating the role of RAGE and the S100 proteins in the development 
of human SCC.  We were able to induce the proliferation of human primary 
keratinocytes and primary patient keratinocytes derived from SCC tumors in 
response to exogenous S100A8/9 stimulation. In contrast, the proliferation of SCC 
cells originating from patient material decreased after blocking of RAGE. Using 
confocal microscopy we detected a colocalization of RAGE and S100A8/9, which 
proves that S100A8/9 acts by a direct binding to RAGE. This is the fi rst evidence 
that RAGE and S100A8/9 are involved in the proliferation of human keratinocytes. 
Based on these data we hypothesize that these infl ammatory factors are drivers of 
the progression to human SCC, thus linking infl ammation and cancer development.
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Detection of the Merkel cell polyomavirus (MCV) DNA in tumor samples of Merkel 
cell carcinoma patients
Varga E1, Kiss M1, Szabó K2, Kemény L1 1University of Szeged, Department of 
Dermatology and Allergology, Szeged, Hungary 2Hungarian Academy of Sciences, 
Dermatological Research Group, Szeged, Hungary
Merkel cell carcinoma (MCC) (neuroendocrine carcinoma of the skin, trabecular 
carcinoma) is a rare but aggressive tumor affecting mostly elderly individuals of 
Caucasian origin, developing frequently on sun-damaged skin areas of the head and 
neck region. MCC shows many similarities to Kaposi’s sarcoma (KS). Both of them 
are frequent among immunosuppressed individuals, their incidence are increasing 
in the last two decades, and they both may also have an infectious origin.Recently a 
new human polyomavirus have been detected in MCC tumor samples (Merkel Cell 
Polyomavirus – MCV) and suggested that the virus have a role in the pathogenesis of 
the disease. In order to investigate the role of the MCV in the pathogenesis of MCC 
in Hungarian patients, genomic DNA was obtained from formalin-fi xed paraffi n-
embedded tissue biopsy specimens, and subjected to PCR analysis using virus 
specifi c primers.Of the 9 MCC tumors, 6 were tested positive for viral sequences. Five 
tumors were positive for viral large T antigen (LT1 and/or LT2 amplifi cation) and also 
5 tumors were positive for the viral capsid protein (VP1). Sequencing of the amplifi ed 
PCR products proved that the amplimers were identical to the reference sequence 
in NCBI. Recent reports from different countries suggest that variations in the 
percentage of MCV positive MCC cases exist. In Australians the virus is less frequently 
found compared to North American and European cases, suggesting that regional 
differenced of the MCC pathogenesis might exist. Our data shows similarities to the 
data gathered by studying American and European populations.Based on these results 
we believe that these studies can have a great value and help to make a clearer picture 
about the involvement of the MCV in the development of Merkel cell carcinoma.




Inhibition of UVB-induced skin carcinogenesis by topical treatment with a Stat3 
inhibitor
Yokogawa M1, Takaishi M1, Miyoshi K1, Ikeda M1, DiGiovanni J2, Sano S1 1Kochi 
Medical School, Nankoku, Japan 2MD Anderson Cancer Center, Smithville, USA
Constitutive activation of Stat3 has been found in many human malignancies 
including skin cancer. Critical role of Stat3 signaling in the skin carcinogenesis was 
demonstrated by our previous studies using Stat3-defi cient (K5-Cre.Stat3 fl ox/fl ox) 
and –constitutive active mice (K5.Stat3C) by comparing with wild-type mice. K5-
Cre.Stat3 fl ox/fl ox mice were resistant to the two-stage chemical-induced and UVB-
induced skin carcinogenesis. In contrast, K5.Stat3C mice, through both carcinogenesis 
models of two-stage chemical and UVB, developed skin tumors with a shorter latency, 
increased incidence and multiplicity compared with wild-type mice. Their tumors 
rapidly progressed to squamous cell carcinoma (SCC), indicating that Stat3 activation 
contributed to early development of cancer. Our previous studies implicated that Stat3 
activation exerted an anti-apoptotic effect through the transcriptional regulation of Bcl-
xL or other molecules, and allowed mutations in the stem cells following genotoxic and 
mutagenic insults. Also, Stat3 activation is associated with keratinocyte proliferation 
in response to tumor promoting agents such as phorbol esters or UVB irradiation. 
Here we examined whether inhibition of Stat3 signaling affected the progression of 
UVB-induced cancer in K5.Stat3C mice. We used a small compound Stat3-inhibitor, 
named STA-21 (ochronomycinone), which was previously reported to inhibit the 
dimerization of Stat3 so that it could not translocate into nucleus. Topical STA-21 
treatment of UVB-induced cancer at the early stage prevented further progression. 
Furthermore, STA-21 markedly inhibited the  growth of cancer at the progressive 
stage, whereas acetone-treated control mice developed invasive cancer. This result 
implicated that Stat3 inhibition could be a novel therapy for solar keratosis, and SCC.
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Development of a Xenotransplantation Model Suitable for the Experimental Studies 
of the Physiological and Pathophysiological Processes of Human Oral Mucosa
Lukacs L, Szakall Sz, Redl P, Juhasz I University of Debrecen, Hungary
Our information regarding the progression of human oral mucosa tumors, or 
the pathogenesis of certain diseases affecting the oral mucosa is rather sparse. 
The possibilities of doing experiments on human oral mucosa, for example in 
vivo experiments on mucosal wound healing (wh) is very limited.  Our previous 
work with severe combined immunodefi ciency (SCID) mice xenografted with full 
thickness human skin made possible to model a number of skin conditions. The 
vasculature of the human skin graft is subject to infl ammatory transformation by 
locally administered cytokines. During wh the skin graft exhibits morphological 
signs and antigen expression characteristic to that of human tissue. It is now 
possible to closely examine the progression of human skin tumors, e.g melanoma 
or basal cell cancer (BCC) in the human skin. Our model utilizing human 
mucosal graft in SCID mice allows reproducible studies on the infl ammatory 
processes of human oral mucosa, and on the wound healing in  the mouth.
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MTHFR and VDR gene polymorphisms in patients with basal cell carcinoma from 
Central Poland
Lesiak A1, Wodz K1, Pawliczak R1, Rogowski-Tylman M1, Sobjanek M2, Wlodarkiewicz 
A2, Sysa-Jedrzejowska A1, Narbutt J1 1Medical University of Lodz, Lodz, Poland 
2Medical University of Gdansk, Gdansk, Poland
Basal cell carcinoma (BCC) is the most common form of skin cancer in white populations. 
Sun exposure is a major risk factor for all BCCs. In addition, folate and vitamin D, have been 
proposed to be infl uenced by UV radiation.. Folate metabolism is involved in DNA synthesis 
and repair, and vitamin D processes anti-proliferative effects. The functions of both nutrients are 
implicated in skin carcinogenesis.  Some literature data report an association between some VDR 
(vitamin D (1,25- dihydroxyvitamin D3) receptor) and MTHFR (5,10-methylenetetrahydrofolate 
reductase (NADPH) polymorphisms and BCC development. Thus, the aim of present study was 
to evaluate possible relationship between polymorphism in genes encoding VDR and MTHFR, 
and BCC  occurrence in the Polish population. The study group consist of 144 BCC patients 
and 144 healthy subjects with negative skin cancers history. Genomic DNA was isolated from 
the peripheral blood leukocytes. Fragments of VDR and MTHFR genes were amplifi ed by PCR 
technique, using specifi c primers and RFLP technique was utilized to detect SNPs (VDR rs7975232, 
rs2228570, MTHFR rs1801133 (665C/T) rs1801131 (1286A/C), using restriction enzymes ApaI, 
FokI, HinfI and MboII respectively.  In case of rs7975232 and  rs2228570 (VDR) and rs1801131 
(1286A>C) (MTHFR) no signifi cant associations were found between analyzed genotypes and 
alleles frequencies in studying population. In opposite, we found that in case of rs1801133 
(MTHFR), homozygote CC occurred in 62.9%, TT in 6.45% and heterozygote CT in 30.64% of 
BCC patients and CC in 81.25%, TT in 7.81% and CT 10.94% healthy subjects. MTHFR 665CT 
and 665TT genotype was signifi cantly associated with an increased BCC risk (p=0.02463, 
OR=2.506, CI 1.112-5.651) compared to 665CC genotype. Genetic variants in MTHFR gene 
might be associated with basal cell carcinoma development BCC patients living in Central Poland.
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Dual anticancer effects of the alkaloid Lamellarin-D in melanoma cells
Ballot C1, Kluza J1, Martoriati A1, Buche S2, Formstecher P1, Marchetti P1, Mortier L2 
1Centre de recherche JP Aubert, LILLE, France 2Clinique de Dermatologie, hopital 
Huriez & Centre de recherche JP Aubert, LILLE, France
The marine alkaloid Lamellarine D (LamD) shows interesting anticancer properties 
against a large panel of cancer cell lines, notably on melanoma cells. Initially 
identifi ed as a potent nuclear topoisomerase-1 poison, LamD can directly 
permeabilize cancer cells mitochondria. In this study, the antitumor effects of 
LamD were examined in vitro and in vivo using the human melanoma cell line, 
HBL. At doses in the micromolar range, LamD induced full-blown apoptosis of 
HBL characterized by a rapid mitochondrial dysfunction (drop in mitochondrial 
membrane potential, inhibition of the mitochondrial respiration and generation of 
mitochondrial ROS) followed by the activation of caspases culminating in nuclear 
apoptosis. Conversely, HBL Rho0 cells, devoid of mitochondrial DNA, were totally 
resistant to LamD-mediated apoptosis suggesting that functional mitochondria are 
required for Lam D cytotoxicity. At lower doses (nanomolar range), LamD was unable 
to kill HBL cells. However, upon Lam D exposure, we have observed in HBL cells, 
the apparition of early DNA damages, irreversible cell cycle arrest in G2-M phase 
and activation of the P53-P21 dependent pathway. Furthermore, LamD-treated cells 
displayed some morphological and biochemical (SA-beta Galactosidase activity) 
changes consistent with the development of a senescence-like phenotype in vitro as 
well as in vivo in a murine xenograft model of melanoma. This senescence phenotype 
was associated with the generation of extra-mitochondrial NADPH oxidase 
dependent ROS production. In conclusion, LamD acts as a promising anti melanoma 
drug displaying both senescence and apoptosis depending on its concentration.
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Notch – A Potential New Therapeutic Target for Cutaneous Lymphomas.
Kamstrup M, Gniadecki R Bispebjerg Hospital, University of Copenhagen, Denmark
Notch comprises a transmembrane receptor family activated by ligands Delta and 
Jagged. The ligand-receptor interaction initiates a series of proteolytic cleavages of 
Notch resulting in release of a signal-transducing intracellular domain, which acts as 
a transcription factor involved in regulation of cell differentiation, proliferation and 
apoptosis. Since Notch signalling is central for T-cell development and implicated in 
the pathogenesis of acute lymphoblastic T-cell leukemia and nodal anaplastic large 
cell lymphoma, we wished to investigate the importance of this pathway in cutaneous 
T-cell lymphomas. Preliminary data of immunohistochemical analysis of skin biopsies 
from mycosis fungoides patients (3 stage I, 3 stage II, 3 stage III and 2 stage IV) 
suggested that Notch1 expression is upregulated in late compared to early disease. 
g-Secretase inhibitors (GSI), which block Notch activation by inhibiting cleavage of 
the receptor, were applied to cell lines of cutaneous T-cell lymphomas (Hut, MyLa and 
SeAx). Apoptosis was assessed by caspase 3/7 assays and fl ow- cytometric analyses of 
annexin V-FITC/propidium iodide stained cells. Cell growth was determined by calcein 
assays and thymidin incooperation. GSI I demonstrated a pronounced effect in all cell 
lines with a 3 to 17- fold increase in caspase 3/7 activity strongest after 24 hours. 
Correspondingly, there was at least a 4-fold depression in cell growth in all cell lines. 
GSI IX, XX and XXI demonstrated most effect in SeAx, albeit much less pronounced 
than GSI I. Immunoblot analysis of GSI I treated cells showed downregulation of 
the major cleaved products of Notch 1, 2, 3 and 4. Confocal microscopy after GSI I 
treatment suggested an inactivation of Nfkb.  In conclusion these data support a role 
of Notch signalling in cutaneous T-cell lymphomas and suggest that Notch could be a 
potential new therapeutic modality for the treatment of cutaneous T-cell lymphomas.
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Expression of MMP-10, -21, -26 and -28 in Merkel cell carcinoma
Suomela S1, Koljonen V1, Skoog T2, Kukko H1, Böhling T3, Saarialho-Kere U1 1Helsinki 
University Central Hospital, Helsinki, Finland 2Karolinska Institutet at Novum, 
Huddinge, Sweden 3University of Helsinki, Helsinki, Finland
Merkel cell carcinoma (MCC) is an aggressive cutaneous tumor with poor outcome and 
rapidly increasing incidence. We examined by immunohistochemistry the expression of 
three most recently cloned matrix metalloproteinases (MMPs) - MMP-21, MMP-26, and 
MMP-28 - in MCC (n=44) and their metastases (n=6) as well as that of MMP-10 serving 
as a positive control. Their mRNA expression was also studied in the UISO MCC cell 
line basally and after various stimulations using quantitative TaqMan PCR. MMP-28 was 
observed in tumor cells (15/44 samples) especially in tumors less than 2 cm in diameter 
(p=0.015).  20/44 specimens showed MMP-28 in the tumor stroma. Expression of MMP-21 
was demonstrated in tumor cells (13/44) but stromal expression was rare (8/44). MMP-26, 
instead, was positive in stromal cells (17/44) and its expression associated with tumors 
larger than 2 cm in diameter (p=0.006). However, only 7/44 MCCs expressed MMP-26 
in tumor cells. MMP-10 was detected in tumor cells (17/44) more often in stage 2 or 3 
MCCs than in stage 1 MCCs (p=0.006). Stromal expression of MMP-10 was the most 
frequent fi nding of the studied samples (31/44). Most of the metastasis samples expressed 
MMP-10 and MMP-26, while two expressed MMP-21 and one expressed MMP-28 in only 
stromal cells. MMPs -10, -21, and -28 mRNAs were basally expressed by the UISO cell 
line and the corresponding proteins were detectable by immunostaining of cultured cells. 
IFN-alpha and TNF-alpha downregulated MMP-21 and -28 expression while VEGF did not 
affect the expression of the studied MMPs. Our results suggest that also more novel MMPs 
may have a role in MCC: especially MMP-26 is associated with larger tumors that have a 
poor prognosis. MMP-28 and MMP-21 seem to be associated with the tumors of lesser 
malignancy. We confi rm the previous fi nding on the role of MMP-10 in MCC pathogenesis.
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Progression of cutaneous squamous cell carcinoma in immunosuppressed patients 
is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic 
infl ammatory infi ltrate
Mühleisen B1, Petrov I2, Kurrer M3, Schärer L4, Dummer R1, French L1, Hofbauer G1 
1Univ Hospital Zurich, Switzerland 2Tokuda Hospital, Sofi a, Bulgaria 3Cantonal Hosp, 
Aarau, Switzerland 4Dermatol Gemeinschaftspraxis, Friedrichshafen, Germany
Squamous cell carcinoma of the skin (SCC) increases dramatically in organ transplant 
recipients (OTRs). We assumed that qualitative and quantitative differences in perineoplastic 
infl ammation in OTRs contribute to the increased carcinogenesis. We studied perineoplastic 
SCC infl ammatory infi ltrate assessing depth, density and phenotype (CD3, 4, 8, FOXP3, CD123, 
and STAT1) by immunohistochemistry in paired biopsies of intraepithelial and invasive SCC 
in immunocompetent patients and OTRs. Considerable infl ammation was observed in all 
intraepithelial SCC (infl ammatory infi ltrate depth 2.80 mm ±2.21 immunocompetent pts, 2.15 
mm ±2.95 OTRs). Infl ammation was more pronounced in invasive SCC of immunocompetent 
patients (4.60 ±4.67 mm) and OTRs (3.30 ±5.90 mm) respectively (p<0.005). The density of 
perineoplastic infl ammatory infi ltrates increased from intraepithelial to invasive SCC (p=0.005). 
OTRs show a lower density of perineoplastic infl ammatory infi ltrate (p=0.041). OTRs also show 
reduced CD3+ T-lymphocyte and CD8+ cytotoxic T-lymphocyte proportions in intraepithelial 
SCC (p=0.025 and 0.027, respectively). FOXP3+ regulatory T-lymphocyte proportions in OTRs’ 
invasive SCC are markedly diminished (p=0.048). CD123+ plasmacytoid dendritic cells increase 
in the progression from intraepithelial to invasive SCC in immunocompetent patients (p=0.040). 
CD123+ cells are reduced in all SCC of OTRs (p=0.036). Perineoplastic infl ammation in 
intraepithelial SCC is pronounced both in immunocompetent patients and OTRs. Infl ammation 
increases further in invasive SCC. OTRs show reduced proportions of FOXP3+ regulatory T 
cells and CD123+ plasmacytoid dendritic cells. This distinct infl ammatory infi ltrate may result 
in the increased cutaneous carcinogenesis and more aggressive behaviour of SCC in OTRs.
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Promoter methylation profi ling of 28 genes in human cutaneous squamous cell 
carcinoma
Sakiyama M1, Furuta J1, Ishii Y1, Nakamura Y1, Fujisawa Y1, Kawachi Y1, Tajima 
S2, Otuka F1 1Graduate School of Comprehensive Human Sciences, University of 
Tsukuba, Tsukuba city, Ibaraki, Japan 2National Defense Medical College, Tokorozawa 
city, Saitama, Japan
Aberrant methylation and demethylation of promoter CpG islands leads to inactivation 
of tumour suppressor genes and abnormal expression of cancer¨Crelated antigens, 
respectively. Epigenetic abnormality has been well studied in many human malignant 
tumours. However, it has been poorly studied in human cutaneous squamous cell 
carcinoma (SCC). In this study, we evaluated the methylation status of promoter CpG 
islands of 28 genes in 50 cases of human cutaneous SCC using methylation-specifi c 
polymerase chain reaction method.¡¡The 28 genes comprised 18 tumour-suppressor 
genes, 4 genes that are not considered as tumour-suppressors but are frequently 
methylated in human cancers and 6 normally methylated melanoma antigen genes 
(MAGEs). Ten tumour suppressor genes and 4 non-tumour suppressor genes were 
methylated in at least 1 case. The frequency of methylation of tumour suppressor genes 
was as follows: CDH1 (26%), p16 (10%), TM (10%), RARB (6%), RASSF1A (4%), 
BRCA1 (4%), APC-1A (4%), TERC (4%), FHIT (2%) and PRDX2 (2%). The frequency of 
methylation of non-tumour suppressor genes was as follows: 3-OST-2 (42%), HAND1 
(18%), HRASLS (6%) and FLNc (4%). The frequency of demethylation was as follows: 
MAGE-A1 (2%), A2 (14%), A3 (30%), B2 (32%), C1 (20%) and C2 (20%). At least 1 
gene was methylated in 37 (74%) cases, and at least 1 gene was demethylated in 29 
(58%) cases. These results showed that both methylation and demethylation occur 
widely in human cutaneous SCC and potentially contribute to skin carcinogenesis.
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Serpin peptidase inhibitor clade a member 1: a novel potential marker for cutaneous 
squamous cell carcinoma
Farshchian M1, Ala-aho R1, Grenman R2, Peltonen J3, Kähäri VM1 1Department of 
Dermatology and Venereology, and Medicity Research Laboratory, University of 
Turku, Finland 2Department of Otorhinolaryngology, Head and Neck Surgery, Turku 
University Central Hospital, Finland 3Department of Anatomy and Cell Biology, 
University of Turku, Finland
Cutaneous squamous cell carcinoma (SCC) is the second most common form of skin 
cancers with high potential to metastasize. At present, there is no molecular marker 
available for early diagnosis and prevention of this invasive neoplasm. The aim of this 
study was to investigate the expression and role of novel genes in SCC. Analysis of SCC 
specifi c genes was performed by Affymetrix based expression profi ling of cutaneous 
SCC cell lines (n=8) and normal human keratinocytes (n=5). Further analysis was 
performed by quantitative real-time RT-PCR (Taqman) of cutaneous SCC cell lines, 
as well as cell lines and RNA derived from head and neck SCCs. The Affymetrix 
microarray analysis of cutaneous SCC cell lines revealed high expression of Serpin 
Peptidase Inhibitor Clade A Member 1 (SerpinA1), also known as alpha1-antitrypsin or 
alpha1-proteinase inhibitor, compared to normal human epidermal keratinocytes. The 
results of Real-time PCR revealed signifi cantly (50 fold) enhanced expression level of 
SerpinA1 in 8 cutaneous SCCs, while the gene was silent in normal human epidermal 
keratinocytes. The expression of SerpinA1 was also up-regulated (4 fold) in 40 head 
and neck SCC cell lines compared to normal human keratinocytes. The results of Real-
time PCR showed clearly up-regulation (4 fold) of SerpinA1 in 64 head and neck SCC 
tumors compared to healthy oral mucosal tissue samples. These fi ndings are consistent 
with the possibility of role of SerpinA1 as a novel diagnostic or prognostic marker for 
cutaneous and head and neck SCC to be considered also as a potential target for therapy.
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Skin Metastases From a Melanoma of the Chorioidea
Tsoukalas N, Papakostidi A, Lypas G, Papadimitriou C, Pistamalntzian N, Panopoulos 
C, Demiri S, Koumakis G, Barbounis V, Efremidis A Saint Savvas Cancer Hospital, 
Athens, Greece
The description and analysis of an interesting case of choroidal melanoma with late 
skin metastases which macroscopically resembled to blue nevi. A 70-year-old lady, 
with no medical history, was diagnosed with an ocular tumor, in 2002. The disease 
presented with visual problems and the work-up revealed a choroidal melanoma 
located radially. The patient was treated with brachytherapy and underwent a regular 
follow-up. In 2008 (approximately 6 years from diagnosis) an U/S of the upper-
abdomen revealed multiple liver lesions. The fi ne needle aspiration (FNA) and the 
cytology examination that followed showed metastatic infi ltration from malignant 
melanoma. Consequently, she was administered 5 cycles of chemotherapy with 
temozolamide, without signifi cant response. In May 2008 the patient exhibited 
skin nodules, three located in the scalp and two in the anterior thoracic wall. These 
nodules where painless, approximately 0,5-1cm large, and resembled to blue nevi. 
The patient reported mild pruritus. The FNA and the cytology exam revealed metastatic 
infi ltration from malignant melanoma. Concequently, the patient was administered 
2nd line chemotherapy with deticene. Skin metastases from chorioidal melanoma are 
rare. They can appear even when no other metastatic lesions are present, changing the 
prognosis. Medical history and clinical examination are important for early diagnosis. 
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The relationship between skin Cancers and 24-hour urine melatonin level
Ghaderi R,  Sehatbakhsh S, Zardast M, Sharifzade G, Amini A
Birjand University of Medical Sciences, Birjand, Islamic Republic of Iran
It has been postulated that in industrialized societies, rapid light exposure at night 
by suppressing melatonin production, poses a new risk for the development of breast 
cancer and, perhaps, other cancers like skin cancers as well. Therefore we decided to 
compare 24 -hour urinary melatonin level in skin cancers with control group. In this 
Case-Control study (studied group comprised 70 patients with skin cancer and control 
group comprised 70 healthy volunteers) we matched each group according to age and 
sex. After we collected testimonial from persons that attended in study, information 
of each person including: History of smoking, amount of daily sleeping, daily 
exercise and BMI recorded in a questionnaire that was admitted by a Dermatologist. 
The subjects collected the total volume of urine excreted during a 24-hour period. 
Melatonin in urine was calculated using ELISA method.Then data was analyzed using 
SPSS software, t, Manvitni, Kruskal Wallis and chi-square tests.The studied group 
comprised 70 patients with skin cancer including 49 patients with BCC (70%), 15 
patients with SCC (22%) and 6 patients with malignant melanoma (8%). Average and 
mean of 24 -hour urinary melatonin level in case group was 15.9 ± 8.1 and 15.5, and 
in control group was 52.3 ± 50.4 and 47.4, that test showed signifi cant deference 
between two groups.(Z=8.42, P<0.001). Average of BMI in case group was 25.1± 
2.3 and in control group was 26.7 ± 2.8. (P=0.001 T=3.6 DF=138) Sleep duration 
(P=0.001), History of smoking (P= 0.02) and amount of daily exercise (P=0.003) was 
a signifi cant deference between two groups. In this study, there was a signifi cant 
relationship between skin cancers and low level of 24- hour urinary melatonin 
level that can set forth role of melatonin in prevention or treatment of skin cancer.
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The Role of  Papillomavirus Infection in Oral cancers
Máthé M1, Suba Z2,  Németh Z2,  Tátrai P3, Füle T4, Kárpáti S1,  Kovalszky I4 1Department 
of Dermatology, Dermatooncology and Venerology, Semmelweis University, 
Budapest, Hungary 2Department of Oral and Maxillofacial Surgery, Semmelweis 
University, Budapest, Hungary 3II. Department of Pathology, Semmelweis University, 
Budapest, Hungary 41st Institute of Pathology and Experimental Cancer Research, 
Semmelweis University, Budapest, Hungary
Numerous lines of evidence indicate that head and neck squamous cell carcinomas 
associated with human papillomaviruses form a distinct subgroup. However, HPVs’ 
role in the pathogenesis of oral cavity cancers is still a matter of debate. Our aim was 
to analyze the presence of HR-HPVs in oral cancers. Fifty-seven oral carcinomas 
were assayed for HPV by PCR, and parallelly by E6 protein immunohistochemistry. 
HPV 16/18 E6 gene and  protein were found in 20/57 cases. In these cases E6 
immunostaining was localized within the tumor cells. In ten additional cases the 
immunohistochemistry following the positive E6 ORF PCR has shown that the 
viruses reside in the surrounding epithelium.Our results are consistent with the idea 
that the HR-HPV-associated subgroup of head and neck carcinomas-included oral 
cancers- is to be regarded as a distinct pathological and clinical entity, although not 
all PCR positivity means a real causative relationship between virus and malignancy.




Valrubicin in a New Topical Formulation Treats Skin Cancer
Andersen S1, Rosada C1, Dagnaes-Hansen F2, De Darkó E3, Dam TN4, Stenderup K1 
1Aarhus University Hospital, Aarhus, Denmark 2Aarhus University, Aarhus, Denmark 
3Valderm A/S, Lyngby, Denmark 4Roskilde Hospital, Roskilde, Denmark
Anthracyclines are effective and widely used cytostatic drugs used in cancer treatment, 
however they are not considered for topical use since their effect is associated to skin 
toxicity. Differently, valrubicin, a second generation anthracycline, is characterized 
by an excellent safety profi le, and does not induce skin toxicity and necrosis. The 
aim of the present study was to investigate the effect of applying valrubicin, in a 
new topical formulation, on development of skin cancer, and to investigate how 
valrubicin affects cellular proliferation and apoptosis “in vivo” and “in vitro”. We 
used the “in vivo” two stage DMBA/TPA carcinogenesis mouse model where tumors 
as papillomas develop; tumor formation was observed in the presence or absence of 
applied topical valrubicin. In cultures of squamous cell carcinoma cell lines HSC-1 
and DJM-1, we studied the effect of valrubicin on cell proliferation and on apoptosis 
by measure of caspases 3 and 7 activity. Western blot analysis was used to measure 
the pro- and anti-apoptotic markers Bax and Bcl-2, and the proliferation marker 
PCNA from both “in vivo” and “in vitro” studies. Valrubicin signifi cantly inhibited 
tumor formation “in vivo” as also shown by decreased PCNA expression. Moreover, 
valrubicin signifi cantly decreased cell proliferation of squamous skin cancer cell 
lines “in vitro” as measured by cell viability and PCNA expression. Apoptosis was 
increased as shown by elevated levels of caspases 3 and 7 “in vitro”. However, 
Bax and Bcl-2 were not found to be regulated by valrubicin neither in mouse skin 
nor in squamous skin cancer cell lines.In conclusion valrubicin, in a new topical 
formulation, was found to be very effective in the treatment of skin cancer in this model.
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Fetal cells persist in maternal chronic wounds, form blood vessels and enhance healing
Nassar D, Droitcourt C, Parant O, Mathieu-d’Argent E, Oster M, Uzan S, Khosrotehrani 
K, Aractingi S UPMC Univ Paris 6, INSERM UMRS 938, centre de recherche Saint 
Antoine, Fetal stem cells unit, Paris, France
Cutaneous wound healing is a complex multistep phenomenon that recruits cells from the marrow. 
Alteration(s) in any of the implicated pathways may lead to chronic wounds that can induce signifi cant 
morbidity. Several studies have demonstrated that fetal cells are transferred through pregnancy to 
the maternal circulation and niche in the marrow. These cells include progenitors of mesenchymal, 
hemopoietic and endothelial lineages. They can persist decades after delivery and develop in tissues 
affected with infl ammation or tumours. They are also able to rescue maternal defi ciencies. We asked 
here whether fetal cells transferred through pregnancy may be found in maternal wound bed.  We also 
questioned whether fetal cells of placental origin could intervene in would healing.Wild type mice 
were mated with GFP transgenic mice. Surgical wounds were performed on the back after delivery 
on normal skin or on fi brotic skin secondary to local injections of bleomycin to mimic acute and 
chronic wounds respectively. Injections of placental cell suspensions were also performed on acute 
wounds. At day 7, fetal cells were detected in all acute and chronic wounds. At day 18, fetal cells were 
found in 10/11 chronic wounds but only 5/11 of acute wounds. Of note, healing had ended at day 
18 in 11/11 acute wounds but only in 4/11 chronic wounds (p<0,01). At day 18, the number of fetal 
cells detected by quantitative PCR was 185 versus 1.4 out of 104 maternal cells (p<0,01). In chronic 
wounds, fetal cells were essentially CD45+ leukocytes at day 7, but endothelial cells at day 18. Vessels 
fully constituted of fetal GFP cells were found that appeared connected to maternal circulation. 
Pregnancy did not modify angiogenesis and acute wound parameters while injection of placental cells 
accelerated healing and increased lymphatic angiogenesis.These results strongly suggest that fetal 
progenitors are mobilized to the wound where they participate to infl ammation and angiogenesis. 
Although the transfer of cells through pregnancy did not infl uence the healing of acute wounds, 
injections of higher number of placental cells was able to intervene in the healing phenomenon.
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Promotion of lymphatic integrity by Angiopoietin-1
Kajiya K1, Kidoya H2, Sawane M1, Yamanishi H1, Takakura N2 1Shiseido Innovative 
Science Research & Development Center, Yokohama, Japan 2Osaka University, 
Japan
The cutaneous lymphatic system plays a major role in tissue fl uid homeostasis and 
infl ammation of the skin. Although several lymphangiogenesis factors were identifi ed 
to be involved in the formation of lymphatic vessels, the molecular control of 
lymphatic integrity resulting in the functional drainage of interstitial fl uid has been 
completely unknown. Here we fi rst describe the promotion of lymphatic integrity 
and function by Angiopoietin-1 (Ang-1). Ang-1 transgenic mice under the control 
of keratin-14 (K14-Ang1) showed the attenuated UVB-induced edema formation 
and infl ammation as compared to the wild-type (WT) mice. Immunofl uorescence 
analyses demonstrated lymphatic vessels of WT mice were pronouncedly enlarged 
after UVB irradiation, whereas K14-Ang1 mice revealed collapsed lymphatic vessels 
together with the enhanced lymphatic vascularization. Surprisingly, we found 
that the expression of an endothelial-specifi c tight junction molecule, claudin-5 
and ZO-1, was strongly downregulated in the infl amed lymphatic vessels of WT 
mice, whereas K14-Ang1 mice showed the increased expression of claudin-5 after 
infl ammation. Moreover, in vitro studies revealed that the activation of Tie2 on 
lymphatic endothelial cells (LEC) by Ang1 induced migration and cord-formation 
in a dose-dependent manner. The specifi c knockdown of Tie2 diminished the Ang1-
induced cord-formation, whereas Tie1 knockdown had no effect by Ang1 in LEC. 
Finally, permeability assay demonstrated that the stability of lymphatic endothelial 
cells was promoted in the presence of Ang1 presumably by the upregulation of 
claudin-5 as well as ZO-1. Collectively, our data strongly indicate that Ang1/
Tie2 signaling promotes lymphatic integrity during cutaneous infl ammation.
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Pregnancy promotes melanoma lymph node invasion by enhancing VEGF dependent 
lymphangiogenesis
Khosrotehrani K1, Nguyen Huu S1, Prignon A1, Oster M1, Avril MF2, Boitier F2, 
Aractingi S1 1Pierre et Marie Curie University-Paris6, Paris, France 2Tarnier Hospital, 
Paris, France
The infl uence of pregnancy on the evolution of melanoma has been a matter of 
debate. Early reports of poor event free survival being contradicted by more recent 
studies indicating that pregnancy is not an independent prognosis factor at least 
in thin melanomas. Our aim was to easily assess the infl uence of gestation on the 
course of melanoma in a well accepted mouse model of tumour progression.
B16 mouse melanoma cells were injected in non pregnant or pregnant mice at day 
5 of gestation. Tumour growth, metastasis and mortality were signifi cantly increased 
among pregnant mice that also displayed a reduction of necrosis in tumours by 
FDG-PET. Evaluation of tumour angiogenesis by computerized morphometric 
analysis revealed an increase in intratumoural lymphangiogenesis during gestation 
that was also reproduced in a separate murine melanoma cell line, S91, injected 
in syngenic DBA/2 recipients. Similar results were found in a case control series of 
pregnant and non pregnant women affected with melanoma and matched for age 
and Breslow index. Tumours from pregnant mice expressed signifi cantly increased 
levels of VEGFa at the mRNA and protein level. Treatment with bevacizumab 
completely abolished the difference in tumour size and lymphangiogenesis between 
pregnant and non pregnant mice. Finally, serum from pregnant mice induced VEGFa 
expression in B16 cells in vitro. However estrogens, chorionic gonadotropins or 
mouse prolactin failed to reproduce such effect. In conclusions, our results show 
that pregnancy associated circulating factors induce VEGFa expression in melanoma 
cells, increasing lymphangiogenesis and subsequent metastasis and mortality.
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Fibroblast-based VEGF-gene-delivery - A trojan-horse approach to promote 
neoangiogenesis in wound healing
Mueller CK, Schultze-Mosgau S Friedrich-Schiller-University, Jena, Jena, Germany
The effect of exogenous Vascular Endothelial Growth Factor (VEGF) overexpressed 
by transgenic, autogenous fi broblasts, on neovascularization of allogenous tissue 
replacement materials was studied. Fibroblasts were isolated from oral mucosal 
biopsies in 30 rats and used as gene-sphere following nucleofection with the 
pcDNA3.1/nV5-DEST VEGF-plasmid. Transfection-effi ciency, persistency, cytokine 
release as well as transgene functionality were determined using in-vitro assays. 
Allogenous collagen membranes were implanted at the rats groins. Groin regions 
received intraoperative injection of autogenous either VEGF-transgenic (group 
1, n=10), GFP-transfected (group 2, n=10) or non transfected (group 3, n=10) 
fi broblasts. Biopsies from the membranes, surrounding tissue, brain, lung, liver as 
well as peripheral blood samples were obtained at days 7 and 14 post operation. 
Samples were investigated for distribution of transgenic fi broblasts, VEGF-expression 
as well as vessel morphology. Functionally active VEGF-transgene was released up 
to day 12 in vitro. In vivo transgenic fi broblasts were localized in the membranes 
surrounding tissue with a high density. They did not show traffi cking into blood, 
brain, lung or liver. A signifi cant (p=0.001) VEGF-overexpression was detectable in 
the membrane area of group 1 resulting in signifi cantly (p=0.001) enhanced vessel 
density in the membranes in  those specimens. Vessel pathologies, like aberrant 
bulbous structures or even angioma, were neither detectable in the membranes 
nor surrounding tissue nor brain, lung or liver. Our study results demonstrate that 
fi broblast-based VEGF-gene-delivery is a potential nonviral therapy to enhance 
neovascularization in wound healing, while side effects are not obvious so far.
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Lymphatic hyperpermeability and persistent infl ammation induced by cutaneous 
delayed-type hypersensitivity reactions in angiopoietin-related growth factor 
transgenic mice
Hirakawa S1, Sato E1, Okazaki H1, Shudou M1, Oike Y2, Hashimoto K1 1Ehime 
University Graduate School of Medicine, Toon, Japan 2Kumamoto University, Japan
Angiopoietin-related growth factor (AGF), a pleiotropic orphan ligand, induces epidermal hyperplasia 
and angiogenesis in the skin. However, its potential role in promoting infl ammatory tissue response 
remains unclear. To directly investigate the biological importance of AGF in infl ammation, 
we subjected experimental delayed-type hypersensitivity reactions to the ear skin of mice that 
overexpress AGF in the epidermis and to the wild-type controls. Marked infl ammation persisted for 
more than one month in AGF overexpressing mice, whereas in control mice, infl ammation returned 
to baseline levels within 10 days. Targeted overexpression of AGF in the skin revealed remarkable 
hyperplasia and increased levels of AGF in the epidermis 7 day after the challenge by oxazolone as 
compared with control groups. Enhanced vascular leakage and marked enlargement of blood and 
lymphatic vessels were observed in the ear of AGF overexpressing mice. Importantly, dermal injection 
of colloidal carbon revealed that lymphatic vessels in infl amed ears of AGF transgenic mice leak the 
macromolecule, demonstrating insuffi cient transport of fl uids by the lymphatic vessels. Furthermore, 
a considerable number of mast cells was observed in the infl amed skin of AGF overexpressing mice 
compared to control groups. Transmission electron microscope identifi ed that those mast cells 
undergo marked degranulation, indicating persisted release of proinfl ammatory mediators such as 
histamine. Moreover, cultured lymphatic endothelial cells from human skin stimulated by histamine 
showed increased levels of intracellular free Ca2+, indicating that histamine can alter the contract 
of lymphatic endothelial cells. Together, these results demonstrate that AGF, a proinfl ammatory 
cytokine, likely induces hyperpermeability of blood and lymphatic vessels by positively mediating 
histamine release from mast cells, leading to persistent infl ammation in the skin. Thus, our present 
study identifi ed lymphatic vessels as a novel target for the control of infl ammatory skin disease.
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NPY, a novel major actor in vascular lip morphology
Boisnic S1, Duranton A2, Branchey-Gumilla MC1, Demaude J2, Breton L2 1**GREDECO 
Hôpital Pitié Salpêtrière, Paris 75651, France 2L’Oréal  Research, Clichy, France
Skin blood fl ow is controlled through a vasoconstrictor system and a vasodilator 
system. Sympathetic vasoconstrictor nerves secrete a variety of substances 
(cotransmitters) in addition to norepinephrine. The best-characterized sympathetic 
cotransmitters include ATP and neuropeptide Y (NPY). There is good evidence 
to support the conclusion that sympathetic cotransmitters participate in refl ex 
vasoconstrictor responses in humans. Little is known about morphological role 
of NPY in skin vascular adaptability and the effect of NPY on vascular response 
to warm and cold. Lips are exposed to ambient temperature most of the time. We 
recently reported the presence of NPY in lip epidermis and a high level of NPY 
fi bers in lip dermis. The aim of this study was therefore to assess the effects of NPY 
on ex vivo lip biopsies. We used a previously described alternative method to study 
neurogenic infl ammation of the skin based on organ culture of human skin. Even 
though such skin pieces in culture are not connected with systemic blood circulation, 
substance P has been shown to induce a dose-dependent edema and vasodilatation. 
Here, this morphological and quantitative method was used to show that contrary 
to substance P, NPY induced a strong vasconstrictive response of lip blood vessels. 
This effect may explain the morphological aspects and suggest a control of NPY 
on lip morphology and reactivity to warm and cold. This could be an interesting 
approach considering that refl ex-mediated cutaneous vasoconstriction, a critical 
thermoregulatory response to cold, is impaired in the elderly.  As lip pieces from 
surgery are used, it could also provide a way to identify new substances able to 
modulate local vasculature with immediate visible dermocosmetic effects as a result.
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Pharmacologic preconditioning of random pattern skin fl aps with local FK506 in 
nicotine-treated rats: Interaction with nitric oxide system
Rahimpour S, Nezami BG, Sianati S, Kalbasi Anaraki D, Sadeghi M, Ghasemi M, 
Dehpour AR Pharmacology Department of Tehran University of Medical Sciences, 
Tehran, Islamic Republic of Iran
Cigarette smoking decreases skin fl ap survival presumably by perturbing endothelial 
function and tissue viability, mediated by nicotine. We looked for the effect of acute 
FK-506 on blocking this effect of nicotine, and investigated the modulatory effect of 
nitric oxide pathway. Seventy-two male Sprague-Dawley rats were randomly assigned 
into 12 groups. The nicotine groups received the drug subcutaneously (4 mg/kg/day), 
for 1, 2 and 4 weeks before fl ap elevation and 1 week post-operatively. Pharmacologic 
preconditioning groups underwent fl ap surgery on 28th day of nicotine treatment 
and received local injection of FK-506 (0.01, 0.03 or 0.1 pmol/fl ap), while nicotine 
treatment continued afterward. At the seventh postoperative day, the survival of the fl aps 
was measured. Interaction with nitric oxide synthase inhibitor LNAME as well as nitric 
oxide precursor L-arginine was also studied. The 4 weeks nicotine treated animals had 
mean fl ap survival values of 42.9±3.5%, which was signifi cantly lower than control 
group (60.5±4.5%, P<0.05). While FK-506 (0.03 pmol/fl ap) effectively increased 
fl ap survival compared to placebo control, this protection was abolished by systemic 
L-NAME (10 mg/kg, 30 min before fl ap elevation). Co-administration of subeffective 
doses of FK-506 (0.01 pmol/fl ap) and sub-effective systemic L-arginine (100mg/
kg) signifi cantly improved fl ap survival (P<0.01). Pharmacological preconditioning 
with local, single low doses of FK-506 effectively blocks the deleterious effect of 
nicotine on skin fl ap survival. The mechanism seems to be nitric oxide mediated and 
administration of nitric oxide precursor L-arginine potentiates this effect of FK-506.
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Role of the vascular system in infl ammatory skin diseases
Detmar M, Huggenberger R ETH Zurich, Zurich, Switzerland
The chronic infl ammatory skin disease psoriasis is characterized by extensive (lymph)
angiogenesis. There is increasing evidence that inhibiting angiogenesis may serve as a 
novel strategy to treat psoriasis and other skin disease.  In contrast, the implications of 
lymphatic vessels in cutaneous infl ammation are unclear. We investigated the relative 
contribution of each individual VEGF receptor, and of lymphangiogenesis versus 
angiogenesis in the pathogenesis of skin infl ammation. To this end, we induced 
delayed-type hypersensitivity (DTH) reactions in the ears of K14-VEGF-A and 
K14-VEGF-A/VEGF-C transgenic mice. To dissect the effects of the VEGF receptors 
on (lymph)angiogenesis, we blocked the three VEGF-receptors - individually or in 
combination - in VEGF-A transgenic mice which develop a chronic, psoriasis-like 
skin infl ammation.We found that systemic blockade of VEGF-A potently reversed 
the pathological angiogenesis and also ameliorated psoriasis-like skin infl ammation, 
epidermal hyperplasia and abnormal epidermal differentiation. In the VEGF-A 
transgenic mouse model of chronic skin infl ammation, inhibition of angiogenesis 
via blockade of VEGFR1 and VEGFR2 resolved the psoriatic phenotype. In contrast, 
blockade of VEGFR3 prolonged the course of infl ammation. Conversely, stimulation 
of lymphatic function by VEGF-C counteracted the proinfl ammatory role of VEGF-A in 
double transgenic K14-VEGF-A/VEGF-C mice, leading to the resolution of psoriasis.
Together, these fi ndings indicate that inhibition of angiogenesis and/or stimulation of 
lymphangiogenesis might serve as novel strategies to treat chronic skin infl ammation.
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Rosacea: physiology and regulation pathways
Chanteloube F1, Loiseau A1, Tenca G2 1Bayer Sante Familiale Division Serdex, Lons / 
Pau, France 2Bioalternatives, Gencay, French Guiana
To date, few therapeutic treatments cope with a real improvement of rosacea, for instance for 
infl ammatory or even acneic rosacea. Many scientifi c searches and publications have tried to 
explain the rosacea causes, which are mainly: -an over-expression of active forms of antimicrobial 
peptides such as cathelicidins, involved in the maintenance of an infectious status leading to skin 
chronic infl ammation. -a vascular defect, which contributes to impaired capillary neoangiogenesis 
with frequent hemorrhagic characteristics, leading to the weakening of a skin that naturally tends 
to be thin and reactive. -an infl ammatory process initially elusive but steadily increasing to become 
persistent with fl ush and blush phenomena, and that often can aggravated by some environmental 
conditions such as UVs or free radicals.The fi rst step of our research, consisted to develop an 
available rosacea model, marked by an both over-expression of cathelicidin gene (CAMP) and 
related enzyme genes (SCTE & SCCE) capable to transform the pro-peptide form (hCAP-18) in 
its active form (LL-37). In accordance with several recent scientifi c publications, we have tested 
several inductors well known to induce the over-expression of cathelicidin, like calcitriol, IL-17, 
IL-22, AMPc… The originality was to associate some of them, and the best synergic result was 
obtained with a calcitriol ans IL-17 mixture. The second step, was to develop a vegetal extract 
capable to modulate some specifi c aspect of rosacea disease;  A madagascan plant Tambourissa 
trichophylla has been selected owing to its traditional use in healthcare and its phytochemical 
composition – in particular the presence of catechic tannins renowned for anti-infl ammatory and 
anti-hemorrhagic properties. A titrated extract of leaves of Tambourissa trichophylla has been shown 
to impact the main pathways of rosacea etiology:-infection modulation owing to the signifi cant 
reduction of LL-37, the active form of cathelicidin in keratinocytes, and of the related enzymes 
(e.g. kallikreins) -global anti-infl ammatory activity with the modulation of both prostaglandins
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The density of functioning skin lymphatics around human melanoma in vivo is 
decreased relative to normal skin
Akhras V, Stanton AW, Mellor R, Levick R, Mortimer PS St George’s University 
London, London, United Kingdom
Histological lymphatic density (and by implication the potential for lymphatic metastasis) 
is reportedly increased around melanomas compared with normal skin (Shields et al., 
2004). Histologically demonstrable lymphatics are not necessarily functional however. We 
used fl uorescence microlymphangiography in vivo to quantify the density of functional 
lymphatics near melanomas (potentially metastatic) and benign naevi (non-metastatic) 
prior to excision.In 32 melanoma patients and 17 benign naevus patients, 5 μl fl uorescein 
isothiocyanate (FITC)-dextran (Mw ~150 k) was injected intradermally ~2 mm from the 
edge of the pigmented lesion (perilesion site). Functioning lymphatics that had taken up 
dye were imaged for 30 minutes by fl uorescence video-microscopy. A montage of all 
imaged lymphatics was analysed stereologically. The process was repeated at a mirror 
image (control) site on the opposite side of the body. Lymphatic length densities 280ìm 
and 560μm away from the mole edge were determined. Diagnosis was confi rmed later 
by standard histology.At the perilesion site in the melanoma group, 280μm length density 
(5.3±1.4cm-1, mean±SE) and 560ìm length density (6.2±1.3 cm-1) were unexpectedly 
lower than normal skin at the control site (11.6±2.9 cm-1, P=0.001, and 11.8±3.3 cm-1, 
P=0.009 respectively, paired t tests). In the benign naevus group there was no difference 
between perilesion and control 280ìm length density (9.7±2.2 cm-1 v. 12.6±3.7cm-1, 
P=0.5) or between perilesion and control 560ìm length density (11.9±3.3 cm-1 v. 
11.8±3.4 cm-1, P=0.6). The principal new fi nding is that functional lymphatic density 
is surprisingly decreased around melanomas, relative to normal skin, but unchanged 
around benign naevi. This implies that the malignant nature of the mole rather than 
the presence of a lesion has an effect on peritumoural functional lymphatic densities.
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The role of beta-adrenoceptors in wound angiogenesis
Pullar C, OLeary A University of Leicester, Leicester, United Kingdom
Angiogenesis is an essential process in wound healing and aberrations have been 
associated with both chronic wounding and scarring. Beta-adrenoceptors (B-AR’s) 
are G protein-coupled receptors that are widely expressed on all cell types in the 
skin. Previously, our lab has shown that Beta-adrenoceptors (B-AR’s) have a role in 
wound healing, however their role in wound angiogenesis is currently unknown.
A variety of in vitro and in vivo models have been used to study the effect of non-
specifi c and selective B-AR agonists and antagonists on human dermal microvascular 
endothelial cell (HDMEC) migration, proliferation, tubule formation and blood vessel 
development in the chick chorioallantoic membrane assay (CAMs). A transgenic (B2-
AR +/+ and -/-) mouse wound model was also used to study wound angiogenesis in 
vivo. Both B-AR and B2-AR agonists decreased HDMEC single cell migration rate 
by 37% and 26%, respectively and a B-AR agonist decreased HDMEC proliferation, 
after 96 hours, by 47%. In addition, a B2-AR agonist delayed HDMEC-mediated 
tubule formation by 75% and inhibited blood vessel development by 70% in the 
chick allantoic membrane assay (CAMs). In contrast,  a B2-AR antagonist enhanced 
tubule formation by 50% and promoted capillary development and branching four-
fold in CAMs. ELISA studies demonstrated that activation or blockade of B-AR’s can 
alter the amount of VEGF secreted from keratinocytes, a major source of VEGF in 
skin wounds. Finally, topical application of a B2-AR agonist decreased angiogenesis 
by 50%, while application of a B2-AR antagonist increased angiogenesis by 31% 
in murine skin wounds. To conclude, the data demonstrates a role for the B-AR’s 
in wound angiogenesis. Further work will hopefully reveal the therapeutic potential 
of B-AR agonists and antagonists as modulators of wound angiogenesis and repair. 




HIF-1alpha knockdown keratinocytes cannot reconstruct a viable epidermis
Rezvani H1, Varon C2, Pain C1, Taieb A1, De Verneuil H1, Mazurier F1 1Inserm U876 - 
Univ. Bordeaux2 , France 2CNRS UMR5164- Univ. Bordeaux2, France
Hypoxia-inductible factor-1 (HIF-1) is a heterodimeric transcription factor composed of two 
constitutively expressed subunits, alpha and beta which is also named aryl hydrocarbon receptor 
nuclear translocator (ARNT). HIF-1alpha is the major factor regulated by the cellular response 
to oxygen level changes in the body. It plays a central role in regulating the expression of over 
100 genes involved in biological and physiological processes such as glycolysis, apoptosis, 
adhesion, and cell migration. Our previous studies of the role of HIF-1alpha in keratinocyte 
responses to UVB irradiation suggested an important role of this transcription factor in skin 
physiology. In order to investigate this hypothesis in more detail, we examined whether HIF-
1alpha-knockdown keratinocytes (HIF-1alphaKDNHK) were able to develop into a fully stratifi ed 
epidermis following seeding on dead dermis, using the Prunieras model. To this end, we fi rst 
inhibited the expression of HIF-1alpha using a lentiviral vector expressing a shRNA against HIF-
1alpha. Our results showed that HIF-1alphaKDNHK cells were unable to form a reconstructed 
epidermis. To explain this phenomenon, we speculated that down-regulation of HIF-1alpha might 
promotes failure of keratinocyte adhesion on dead dermis. Therefore, we investigated the effect 
of HIF-1alpha on expression of the genes implicated in keratinocyte adhesion and spreading. 
Among different genes, we found that HIF-1alphaKDNHK were defi cient in mRNA and protein 
expression of laminin-5(322) and collagen IV. Immunofl uorescence staining confi rmed a decrease 
of focal adhesion plaques, which was associated with decreased expression of vinculin and 
laminin5. We next demonstrated that adhesion defi ciency of HIF-1alphaKDNHK cells triggered 
apoptotic cell death. Taken together, our results show a key role of HIF-1alpha in adhesion of 
human keratinocyte through the regulation of laminin-5 expression, suggesting that adhesion 
defi ciency of HIF-1alphaKDNHK impairs the formation of reconstructed epidermis, and that this 
phenomenon may have important implications in wound healing physiology and pathophysiology.
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Cytoskeletal protein Flightless I affects Cellular Adhesion and Blister Formation in 
Epidermolysis Bullosa
Kopecki Z1, Arkell R2, Ludwig R3, Zillikens D3, Murrell D4, Cowin AJ1 1Women’s & 
Children’s Health Research Inst, North Adelaide, Australia 2Molecular Genetics & 
Evolution Group Australian Nat Univ, ACT, Australia 3Dept of Dermatology Univ of 
Lubeck, Germany 4Dept of Dermatology St. George Hospital, Sydney, Australia
Our previous studies have shown that the cytoskeletal protein Flightless I (Flii) negatively regulates wound 
healing via processes including reduced proliferation, migration and adhesion. Flii indirectly affects 
hemidesmosome formation and integrin-mediated keratinocyte adhesion and plays a role in adhesion-
signalling pathways. Therefore the aim of this study was to determine the role of Flii in Epidermolysis Bullosa 
(EB) blister formation. Using immunohistochemistry of human EB patient samples and a mouse model of 
EB aquisita (EBA) we have investigated the function of Flii in EB. Flii immunohistochemistry in blistered 
skin of 30 patients with different EB subtypes including: Junctional EB, EB Simplex, Dystrophic EB and 
Kindler Syndrome revealed signifi cantly elevated Flii activity both at the dermal epidermal junction and 
at the blister site. This was particularly pronounced in certain recessive subtypes of Dystrophic EB where 
patients have defects in ColVII production. Using the autoimmune ColVII murine model of EB aquisita 
(EBA); which mimics the characteristics of human Dystrophic EB; we subsequently induced EB in wild-
type and Flii over-expressing mice. Blisters from wild-type EBA mice showed increased expression of Flii 
compared to non-blistered skin. Over-expressing Flii EBA mice had signifi cantly elevated expression of 
Flii compared to both wild-type and IgG control mice and a signifi cantly higher histological blister score. 
Primary keratinocytes and fi broblasts extracted from Flii over-expressing and wild-type EBA induced 
mice were cultured on different extracellular matrix substrates, including: Laminin, Collagen I and 
Fibronectin. Decreased fi broblast adhesion was observed on all substrates yet no signifi cant difference 
was observed in adhesion of keratinocytes suggesting a cell specifi c effect of Flii. We conclude that 
Flii is a key factor involved in EB and we suggest that modulation of its activity will lead to improved 
wound healing thereby improving the quality of life and reducing the complications associated with EB.
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Cadherin mediated regulation of the tight junctional skin barrier function
Michels C, Buchta T, Niessen C University of Cologne, Cologne, Germany
Intercellular junctions, such as adherens and tight junctions, are crucial contributors 
to the skin barrier. The formation and maintenance of these junctions is highly 
coordinated and depends on the engagement of specifi c intercellular adhesion 
receptors and Recent results from us and others have shown that engagement of 
suffi cient classical cadherins is a crucial requirement for the formation of functional 
tight junctions, and thus the skin barrier. However, the mechanisms by which 
cadherins regulate these junctions is unclear. Using E-cadherin-/- keratinocytes 
we found that membrane recruitment of key tight junctional proteins, such as 
claudin-1 and ZO-1, and is unaffected by the loss of E-cadherin. Nevertheless, these 
junctions were unable to form a functional ion- and size barrier, as assessed by 
TER measurements and dye exclusion assays. Thus, cadherin regulate a late step in 
junction formation. Differential incorporation of claudins determines the strength of 
the ionic and size barrier. To examine if loss of E-cadherin alters claudin expression 
pattern we did semi-quantitative RT-PCR analysis and identifi ed claudin-14 as a 
potential candidate. Reduced claudin-14 expression in E-cadherin-/- keratinocytes 
was confi rmed by real time RT-PCR and, more importantly, was also observed in 
E-cadherin-/- epidermis compared to control. Reexpression of either E- or P-cadherin 
rescued tight junctional barrier formation in E-cadherin-/- keratinocytes and also 
appeared to upregulate claudin-14 expression. Thus, our results show that the 
cadherin dependent capacity to form functional tight junctions correlates with 
levels of claudin-14 expression. At the moment we are testing if barrier function 
in E-cadherin-/- keratinocytes is induced by restoring claudin-14 expression.
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Novel fi bronectin (FN) peptide protects adult human dermal fi broblasts (AHDF) 
from oxidative- and cytokine-induced death and inhibits burn injury progression
Clark R, Macri L, Tonnesen T Stony Brook University, Stony Brook, USA
A hallmark of burn injury to the skin is progression of the injury secondary to continuing tissue 
cell death by means of both apoptosis and necrosis over several days.  Most acute injury, including 
burns, is accompanied by oxidative stress and cytokine stress that are thought to lead to cell death 
by necrosis and apoptosis, respectively.  Using AHDF cultures we have demonstrated that oxidative 
stress from H2O2 leads to cell necrosis as determined by LDH assays, not apoptosis as judged 
by TUNEL assay.  In contrast, tumor necrosis factor-α (TNF-α) induces apoptosis, not necrosis. 
At the IID meeting we showed that FN contains 4 FN growth factor-binding (FN-GFB) sites that 
bind PDGF and that mouse FN-null fi broblasts failed to survive and grow in the absence of FN-
GFB sites.  Now we report that a FN-GFB peptide (P12) from one of these FN-GFB sites prevents 
AHDF death induced by oxidative stress and/or TNF-α and prevents burn injury progression 
in a rat hot comb burn model. Within 24 hrs, most (>90%) AHDF died by necrosis and none 
by apoptosis in the presence of ≥500 µM H2O2, while 20-30% AHDF died by apoptosis and 
none by necrosis in the presence of 1,000 ng/ml TNF-α.  Although little, if any, toxic effect was 
observed when AHDF were exposed to lower doses of either agent, AHDF exposed to 200-300 
µM H2O2 in combination with 500 ng/ml TNF-α, died by a combination of necrosis (60%) and 
apoptosis (40%), indicating a synergistic effect. FN-GFB peptide (in concentrations as little as 15 
µM) completely protected AHDF from cytotoxic doses of H2O2 alone, or in combination with 
TNF-α, regardless of whether the death pathway was necrosis, apoptosis or both.  Using a rat 
hot comb burn model we found that intravenous administration of P12 at 1 hour and 24 hours 
after burns inhibited injury progression in a dose-dependent fashion up to 90% inhibition at the 
optimum dose of 10 mg/kg.  Such therapy would fi ll an unmet need for patients with extensive 
burns and might prevent conversion of partial-thickness burns to full-thickness burns thus decrease 
the need for excision and grafting, reduce hospitalization, and attenuate scarring and contractures.
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The role of the receptor tyrosine kinase, Axl, in intercellular adhesion and signalling 
in cutaneous squamous cell carcinoma
Cichon MA, Papadakis ES, Mackenzie IC, O’Toole EA Barts and the London SMD, 
Queen Mary University of London, London, United Kingdom
Axl is a receptor tyrosine kinase that is overexpressed in a variety of tumours such as 
cutaneous squamous cell carcinoma (SCC) and breast cancer. Recent studies reveal its 
fundamental role in cancer progression through the regulation of cell survival and invasion. 
We hypothesised that Axl might play a role in epithelial mesenchymal transition (EMT), 
a crucial step in tumour progression, causing disruption of cell-cell adhesion to allow 
invasion. To investigate this further, we used two different short hairpin RNAs (shRNAs) 
targeting Axl in a retroviral delivery system to achieve stable knock-down of Axl in 
cutaneous SCC and breast cancer cell lines. We then studied colony morphology, expression 
of junctional proteins and related signalling pathways, including epidermal growth factor 
receptor (EGFR) and Wnt pathway. Depletion of Axl in cutaneous SCC and breast cancer 
cell lines led to the formation of tight colonies in vitro. Immunofl uorescence staining 
demonstrated decreased expression of beta-catenin and altered distribution of zonula 
occludens-1 in cells with Axl knock-down. Altered distribution of desmoplakin within cell 
compartments, as well as nuclear translocation of beta-catenin were observed on Western 
blotting in the Axl knock-down cells compared to controls. Three-dimensional organotypic 
experiments revealed that loss of Axl caused decreased expression of vimentin and MT1-
MMP (membrane type 1-matrix metalloproteinase), known markers of EMT.  Furthermore, 
Axl knock-down cells displayed decreased expression and phosphorylation of the EGFR, 
suggesting that the observed phenotypic changes may be secondary to attenuation of EGFR-
ERK signalling. In summary, Axl suppression leads to increased cell-cell adhesion and 
loss of EMT markers with decreased EGFR expression, confi rming Axl as a possible small 
molecule kinase inhibitor target in cutaneous SCCs and other Axl overexpressing cancers.
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The mTOR inhibitor everolimus is a potent suppressor of collagen synthesis in vitro 
and skin and lung fi brosis in mice - perspectives for new treatments of fi brotic 
diseases
Böhm M1, Kokot A1, Luger TA1, Scharffetter-Kochanek K2, Sindrilaru A2 1University 
of Münster, Dept of Dermatology, Münster, Germany 2University of Ulm, Dept of 
Dermatology and Allergic Diseases, Ulm, Germany
Treatment of fi brotic diseases including those of the skin remains a therapeutic 
challenge. Here, we investigated the effect of the mTOR inhibitor everolimus on 
collagen synthesis of human dermal fi broblasts as well on skin and lung fi brosis in 
the bleomycin mouse model. At present, everolimus is approved for the clincial use 
as a preventive treatment of allograft rejection in transplant patients. Everolimus dose-
dependently suppressed bFGF-induced metabolic activity and proliferation of human 
dermal fi broblasts in vitro. The drug also signifi cantly attenuated TGF-beta1- and 
bleomycin-induced collagen synthesis in vitro. These effects were closely related to 
inhibition of mTOR activity of human dermal fi broblasts as measured by phosphorylation 
of S6RP. However, everolimus did not induce the autophagy markers Beclin-1 and 
LC3B-II. Importantly, everolimus administered orally twice daily at doses used for the 
prevention of allograft rejection potently suppressed skin and lung fi brosis in adult mice 
exposed to bleomycin. In summary, these data highlight a novel treatment avenue for 
the treatment of fi brotic skin (and lung) diseases with the mTOR inhibitor everolimus.
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Laminin-332 and perlecan are crucial regulators of the plasminogen activation 
cascade: implications for epithelial homeostasis and tumor formation
Gagnoux-Palacios L, Botta A, Delteil F, Estrach S, Meneguzzi G INSERM, Nice, France
Among the variety of proteases involved in the remodelling of the extracellular matrix 
(ECM), the serine proteases of the plasminogen (Plg) activation system play a crucial 
role in the generation of pericellular proteolysis, in tissue remodelling and in tumor 
progression. Using a comparative proteomic approach of keratinocyte ECM extracts, 
we show that PAI-1, the major inhibitor of the Plg activation cascade, is highly 
accumulated in the ECM during keratinocyte growth arrest and differentiation. PAI-1 
accumulation results in the down-regulation of the Plg cascade, which facilitates 
the formation of the basement membrane. Our data also show that: - 1) increased 
expression and targeting of PAI-1 to the ECM is mediated by perlecan, an extracellular 
matrix proteoglycan, which also accumulates in the ECM during keratinocyte 
differentiation; - 2) Lm-332 mediates deposition of perlecan to the ECM via a Rho-
Kinase-dependent mechanism; - 3) absence of perlecan deposition in Lm-332 null 
keratinocytes impairs FGFs dependent signalling and results in the activation of the Plg 
activation cascade; - 4) inhibition of the Plg cascade increases perlecan deposition to 
the ECM and enhances the adhesion capacity of keratinocytes in culture. Our results 
disclose a novel function of perlecan in the control of the Plg activation cascade by 
controlling the expression of PAI-1 and by stabilizing PAI-1 into the ECM via a direct 
interaction. Indeed, the deregulation of Perlecan deposition/function, by activating 
the Plg dependent proteolytic pathway, may contribute to hamper the keratinocyte 
adhesion capacity, alter wound-healing processes and predispose to cell invasion.
476 [Oral 086]
Collagen-binding integrins alpha2beta1  and alpha11beta1 - key determinants of 
scar matrix remodeling?
Hallinger R1, Blumbach K1, Gullberg D2, Krieg T1, Eckes B1 1Dermatology, U.of 
Cologne, Cologne, Germany 2Physiology, U. of Bergen, Bergen, Norway
Integrins alpha2beta1 and alpha11beta1 are collagen receptors with highest affi nity 
for collagen I. By gene targeting, mice were generated with constitutive ablation 
of both receptors. Animals were smaller, but their skin appeared normal. Primary 
fi broblasts isolated from their dermis showed impaired adhesion to collagen I 
substrates and contraction of collagen I lattices. These results suggested major 
roles in dermal remodeling, and accordingly we investigated healing of full-
thickness wounds. Re-epithelialization, epidermal differentiation and ingression 
of mast cells and macrophages were unaltered. The amount of granulation tissue 
was reduced in double mutants, but unexpectedly, appearance of myofi broblasts 
and wound contraction were comparable to wildtype mice.To focus our analysis 
on matrix remodeling, we analyzed mechanical properties and breaking strength of 
scar tissue resulting from incisional wounds. Extensibility of scar tissue was similar 
in wildtype and double mutant mice, but the force required for extension was 
signifi cantly smaller in mutants. Equally, the force required to induce tissue rupture 
was signifi cantly reduced. These differences were not detected in mice lacking 
only integrin alpha2beta1, but impaired stability of scar tissue from mice lacking 
integrin alpha11beta1 was similar to that of double mutants. Our results indicate 
that myofi broblast differentiation and function proceeds unimpaired in absence of 
the major receptors for collagen I, suggesting that direct contact of fi broblasts with 
collagen I fi bers is no prerequisite for this process. By contrast, fi broblast-dependent 
remodeling of scar tissue depends in part on direct contact of the cells with the 
surrounding collagen fi bers that is established largely by integrin alpha11beta1.
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Collagen XVII in hemidesmosomes is involved in keratinocyte-collagen IV adhesion 
and p38-MAPK-dependent cell migration and signaling
McMillan JR1, Qiao H2, Shibaki A2, Long HA2, Wang G2, Nishie W2, Akiyama M2, 
Shimizu H2 1Hokkaido University, The University of Queensland, Herston, Brisbane, 
Australia 2Hokkaido University, Sapporo, Japan
Collagen XVII (COL17), a transmembrane collagen, is thought to be involved in 
keratinocyte adhesion and possibly migration, as COL17 defects disrupt keratinocyte-
basal lamina adhesion and underlie the disease non-Herlitz junctional epidermolysis 
bullosa (n-HJEB). COL17 is involved in keratinocyte adhesion and migration. 
Using siRNA to knockdown COL17 expression in HaCaT cells, we assessed cell 
characteristics including adhesion, migration and signaling. Control and siRNA 
transfected keratinocytes showed no difference in adhesion on plastic dishes after 
incubation for 8 hours in serum-free keratinocyte-growth medium, however when 
grown on collagen IV alone or BD matrigel (containing collagen IV and laminin 
isoforms) COL17 defi cient cells showed signifi cantly reduced adhesion compared to 
controls (P<0.01), and MEK1/2 and MAPK demonstrated reduced phosphorylation in 
COL17 depleted cells. Furthermore, COL17 defi cient HaCaT cells plated on plastic 
exhibited reduced motility that was p38MAP kinase dependent (after addition of the 
p38MAPK inhibitor SB203580). Conversely, keratinocyte adhesion was independent 
of p38MAPK signaling. Taken together, these results suggest COL17 has signifi cantly 
wider signaling roles than were previously thought, including the involvement of 
COL17 in keratinocyte adhesion to collagen IV, in p38MAP kinase-dependent cell 
migration, and multiple cell signaling events pertaining to MEK1/2 phosphorylation.
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A novel chemical screening method to identify compounds that block tumour-
associated fi broblast-driven matrix remodelling and cancer cell invasion
Hooper S1, Gaggioli C2, Meneguzzi G2, Sahai E1 1Cancer research UK, London, 
United Kingdom 2INSERM U634, Nice, France
Cancer associated fi broblasts (CAF) play a crucial role in tumour development and metastatic 
spreading. Their ability to remodel the extra-cellular matrix can generate an environment 
which enables the invasion of cancer cells by involving matrix metalloproteinases, integrins 
and the actin cytoskeleton. In vitro matrix reconstitution is a unique and powerful tool to 
study CAFs matrix remodelling, which, at a microscopic level, results in holes within the 
extra-cellular matrix, the expression and the deposition of new matrix proteins and the 
formation of matrix fi bres. Interestingly, matrix re-organisation can also be followed on 
a macroscopic level by contraction of collagen gels. Analysis of new and existing results 
shows a strong correlation between CAF-induced matrix contraction and CAF-dependent 
cancer cell invasion. Thus, we hypothesized that macroscopic gel contraction by CAF 
could be used to screen for compounds that prevent matrix contraction and hence reduce 
fi broblast-stimulated squamous cell carcinoma cells invasion. To identifying new chemical 
inhibitors that could prevent matrix remodelling and to verify our hypothesis, we performed 
a chemical screening of 182 compounds mainly including tyrosine kinase, cell cycle, and 
signal transducer inhibitors. The development of the screen methodology relied on a 96 
well plate contraction assay taken over a 4-day period with the media containing inhibitors 
added on the top of the gel. Among the compounds screened, we found two statins, 
lovastatin and simvastatin, that effi ciently block matrix remodelling by CAFs, and strongly 
reduce squamous cell carcinoma cells invasion in vitro.  This work validates a method 
suitable for the rapid screening of drugs endowed with an anticancer potential, and also 
allows for the identifi cation of potential clinical targets which could be useful to in a long-
term goal of developing novel strategies to counteract cancer cell invasion and metastasis.
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Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166/MEMD), a sensor of 
cell density that controls melanoma invasion
van Kilsdonk J, van Kempen L, Schalkwijk J, Swart G Radboud University Medical 
Centre, Nijmegen, Netherlands
The invasive potential of melanoma correlates among others with a gain of activated 
leukocyte cell adhesion molecule (ALCAM/CD166/MEMD). Paradoxically, ALCAM 
expression promotes clustering of tumor cells. Changing ALCAM status by soluble 
ALCAM fragments or by truncated ALCAM, respectively, reduced or increased cell-
migration in vitro and lung metastasis in nude mice. To test the hypothesis that 
ALCAM introduces a rate-limiting step in a metastatic cascade, we have applied 
above mentioned anti-ALCAM strategies in metastatic melanoma cells grown as 
monolayers, in reconstructed skin  and in nude mice. Combining these approaches 
with gene profi ling technologies (gene-chip, qPCR) we have identifi ed proteins highly 
responsive to cell crowding and relevant to progressive malignancy.  Impairment of 
ALCAM-mediated adhesion decreases the proteolytic activation of MMP-2 via its 
membrane bound activator MT1-MMP (MMP14). In addition we identifi ed C1r and 
C1s, two proteases of the classical complement pathway, as secreted and functionally 
active proteases depending on ALCAM status in melanoma cells. Furthermore we 
found that interfering with the ligand binding of ALCAM by a soluble ALCAM fragment 
decreases the expression of L1 cell adhesion molecule (L1CAM/CD171), a progression 
marker of several cancers including melanoma. The loss of L1CAM expression could 
contribute to the impaired invasion, implicating a correlation between ALCAM 
status and L1CAM expression.The protease and cell adhesion responses upon cell 
crowding and ALCAM clustering support and delineate the postulated role of ALCAM 
as a cell-surface sensor to balance local tumor growth and melanoma invasion. 
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AhR pathway as a novel pharmacological target for wound healing
Barouti N, Fontao L, Pardo B, Sorg O, Saurat JH Geneva University Hospital, 
Switzerland
A tetrachlorodibenzodioxin (TCDD)-intoxicated human case under treatment in our 
department showed dramatically rapid wound healing after dermatologic surgical 
procedures. Complete healing after dermabrasion, for example, taking usually more 
than one week, occurred in less than 48 hours in this patient.The whole genome 
expression profi le of skin biopsies of our patient taken at several time points was 
performed and analysed using Ingenuity software biological function analysis of 
microarrays data. This revealed that many genes related to wound healing, including 
matrix metalloproteinases, growth factors, infl ammatory cytokines and intracellular 
cell signalling kinases, were signifi cantly up-regulated. We then used an animal 
model to confi rm the effect of TCDD on wound healing: topical TCDD (0.2 µg/ml) 
signifi cantly increased the healing process in BALB/c mice following full-thickness 
excisions on the back. TCDD being a potent agonist of the aryl hydrocarbon receptor 
(AhR), we used the scratch wound assay in cultured human keratinocytes to assess the 
effect of TCDD and other AhR agonists on wound closure. TCDD (0.1 nM), indirubin-
3-oxime (10 nM) and 6-formylindolo[3,2-b]carbazole (100 nM; a tryptophan 
photoproduct) signifi cantly enhanced wound closure after 24 h. The involvement 
of AhR in this process was then analysed using siRNA transfection. The effect of 
TCDD on wound closure was inhibited by 70% following down-regulation of AhR. 
In this study we demonstrate that AhR agonists enhance the wound healing process 
and introduce AhR pathway as a new pharmacological target for wound healing.




Assessment of tensile strength benefi cial effects in an in vitro model of cutaneous 
wound healing
Rolin G1, Robin S2, Tauzin H1, Grandmottet F1, Tiberghien P3, Viennet C1, Binda D1, 
Humbert P4 1Univ of Franche Comté Inserm UMR 645 Cutaneous Engineering & 
Biol Team, IFR 133, Besançon, France 2Bioexigence, Besançon, France 3French Blood 
Establishment of Bourgogne Franche-Comté, Inserm UMR 645, IFR 133, Besançon, 
France 4Univ Hospital St Jacques, Dept of Dermatology, Besançon, France
Skin is a naturally tensed organ whose functions, and mainly its barrier role, are essential 
to maintain the homeostasis of the organism. Many publications focus  on the involvement 
of mechanical properties in the quality of wound healing. The aim of the present study was 
to assess the effects of tension in an in vitro model of cutaneous wound healing. Human 
dermal fi broblasts were loaded in an uniaxial loading system (Flexercell® FX4000) and 
cultured until confl uence before the monolayer was wounded. The cyclical mechanical 
load was applied or not (control) to fi broblasts (10% radial strain at a frequency of 0.5 Hz 
for up to 72h). The process of healing was followed taking numeric photographs (at 0, 4, 
8, 16, 24, 36, 48, 60 and 72h) to compare the kinetics of wound healing in mechanically 
stressed cutaneous fi broblasts and unstressed fi broblasts. Fibroblasts migration and 
proliferation were assessed by computer – assisted analysis of cell colonized surface in 
stressed and unstressed conditions. Moreover, supernatant were collected at the fi nal 
stage of woung healing to quantify synthesis of proinfl amatory cytokines, MMP’s and their 
inhibitor (TIMP’s). The complete healing occurred signifi cantly earlier in wounded cell 
monolayers submitted to tensile strength compared to controls. In addition, mechanical 
tension acts on the synthesis of cytokines and factors secreted during in vitro wound 
repair process. The results clearly show that tension has benefi cial effects on cutaneous 
wound healing and suggest that tensile strengths could be used to improve wound healing. 
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Blister-inducing autoantibodies from patients with epidermolysis bullosa aquisita 
recognize multiple epitopes on murine collagen VII
Csorba K, Sesarman A, Oswald E, Feldrihan V, Fritsch A, Bruckner-Tuderman L, Sitaru 
C University of Freiburg, Department of Dermatology, Freiburg, Germany
Epidermolysis bullosa aquisita (EBA) is an autoimmune subepidermal blistering disease of mucous 
membranes and skin caused by autoantibodies against collagen VII. The passive transfer of 
purifi ed IgG from EBA patients into mice reproduced the subepidermal blister formation. Patient 
autoantibodies posses genuine specifi city and effector functions that  make them ideal tools for 
gaining relevant pathomechanistic insights, but not all patient autoantibodies cross-react with mouse 
skin. In addition, the epitopes on the murine antigen recognized by pathogenic EBA autoantibodies 
have not yet been characterized. Therefore, the aim of the present study was to investigate the 
cross-reactivity of blister-inducing EBA patient autoantibodies with murine collagen VII. For this 
purpose, we expressed 7 overlapping recombinant fragments of murine collagen VII spanning the 
non-collagenous (NC)1 and NC2 domains of the antigen. Indirect immunofl uorescence microscopy 
revealed that IgG of EBA patients (n=5) cross-reacts with the mouse skin. By immunoblotting 
and ELISA autoantibodies from EBA patients recognized multiple epitopes of murine collagen 
VII. While collectively, EBA patient sera reacted with several epitopes of the NC1 domain of 
collagen VII, the antigenic determinants recognized by individual sera were not identical among 
the tested EBA patients. However, autoantibodies from all EBA sera fi xed complement at the 
dermal-epidermal junction of mouse skin sections. Importantly, when incubated with cryosections 
of murine skin, these EBA autoantibodies recruited and activated granulocytes and induced 
dermal-epidermal separation of both human and murine skin. Our present results demonstrate 
for the fi rst time that blister-inducing EBA autoantibodies recognize multiple epitopes on murine 
collagen VII. These fi ndings should greatly facilitate the generation of standardized reagents such 
as blister-inducing monoclonal EBA patient autoantibodies for improved disease models relevant 
for the human disease pathogenesis as well as the development of novel therapeutic strategies.
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CD98hc (SLC3A2) is a Key Regulator of Keratinocyte Adhesion
Feteira J1, Stella A2, Baldeschi C1, Vaigot P3, Feral Cc4, Martin Mt3, Monsarrat B2, 
Waksman G1, Lemaitre G1 1INSERM/UEVE U861, Evry, France 2IPBS/CNRS UMR5089, 
Toulouse, France 3CEA/IRCM/SCSR, Evry, France 4INSERM U634, Nice, France
Adhesion of keratinocytes is crucial for maintaining the integrity of the skin, as 
demonstrated by the number of dermatological disorders of genetic origin that 
are associated with a defect of basal keratinocyte adhesion. Integrins are the main 
component of the molecular networks involved in this phenomenon, but there 
are many others. In a recent description of proteins associated to caveolae at the 
plasma membrane of basal epidermal cells, we demonstrated that CD98hc is 
localized with beta1 integrin. Whether CD98hc may be a co-factor of integrins in 
keratinocyte adhesion is suggested by their association in other cell types. In the 
present study we show, using co-immunoprecipitation, that CD98hc indeed forms 
molecular complexes with beta1 and alpha4 integrins in primary keratinocytes 
and, using immunofl uorescence, that these complexes are localized at the plasma 
membrane, in keeping with a role in adhesion. Extinction of CD98hc gene expression 
using specifi c short hairpin RNA or over-expression of CD98hc lacking the beta1 
integrin binding site confi rmed that this protein is a key player of keratinocyte 
adhesion. In the latter cells, beta1 integrin failed to translocate from the cytoplasm 
to the plasma membrane, strongly suggesting that CD98hc is involved in integrin 
traffi cking and by consequence, in keratinocyte adhesion and differentiation.
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Collagen-binding integrins alpha2betaa1 and alpha11beta1 control bone 
development and mechanical properties
Blumbach K1, Schmitz M1, Hallinger R1, Hillebrand U1, Gullberg D2, Krieg T1, Niehoff 
A3, Eckes B1 1Dermatology, U.of Cologne, Cologne, Germany 2Physiology, U. of 
Bergen, Bergen, Norway 3German Sport University Cologne, Cologne, Germany
Besides their importance in proliferation, polarity, motility, differentiation and survival, integrins 
play key roles in mechanotransduction, connecting the cytoskeleton with extracellular matrix 
proteins. Collagen I is a high affi nity ligand for integrins alpha2beta1 and alpha11â1. We 
have previously shown that no spontaneous phenotypes were seen in the dermis of mice with 
constitutive ablation of either alpha2beta1 or alpha2beta1 + alpha11beta1, but tensile strength in 
scar tissue from the dermis was found to be reduced. Since alpha2beta1 and alpha11beta1 are also 
expressed in fi broblasts of the perichondrium and periosteum and have been reported to infl uence 
osteoblast activity we studied structural and mechanical properties of bones in mice lacking one or 
both receptors. In comparison to wildtype mice, size and weight were signifi cantly reduced in all 
animals lacking alpha11beta1. X-ray analysis of their skeletons and inspection of dissected organs 
revealed proportional dwarfi sm. To exclude an indirect systemic defect, IGF serum levels were 
assessed. Further analysis concentrated on properties of femora at 3 months, which ranged in size 
from wildtype > alpha2 null > alpha11 null > double null. X-ray and pQCT analysis (peripheral 
quantitative computed tomography) showed progressively decreasing bone mineral content and 
density with highest values in alpha2 null and lowest in double mutants. Functionally, mutant 
femora displayed reduced bone stiffness and failed in three-point bending tests with less breaking 
force applied than wildtype femurs.The data demonstrate that the lack of collagen binding integrins 
results in reduced tensile strength of skin collagen and decreased stability of bones. We also conclude 
that bone development and stability are controlled in part by direct cell interactions with collagen 
I via integrins alpha2beta1 and alpha11beta1. We cannot completely rule out a contribution of 
hormonal defects arising from receptor ablation, leading to secondary bone instability and dwarfi sm.
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Connexin mimetic peptides increase cell migration in scrape-wounded human 
organotypic skin models and alter gene expression of dermal fi broblasts
Wright CS1, Flint D2, Martin PE1 1Glasgow Caledonian University, Glasgow, United 
Kingdom 2University of Strathclyde, Glasgow, United Kingdom
Signifi cant increases in skin wound healing rates occur by reducing connexin (Cx) mediated 
communication (CMC). We analysed effects of Gap27, a connexin mimetic peptide directly 
targeted to the extracellular loop of Cx43 and known to reduce CMC, on cell migration during 
wound closure of an in vitro organotypic human skin model, and expression of extra-cellular matrix 
(ECM) and adhesion genes during dermal fi broblast migration in eugylcaemic and hyperglycaemic 
conditions. Organotypic living skin equivalents derived from primary dermal fi broblasts and 
epidermal keratinocytes were created. Immunocytochemistry determined connexin expression 
profi les. Migration studies revealed rates of scrape-wound closure over 78 hours in the presence 
or absence of 100 uM Gap27. Dermal fi broblasts were cultured in 5.5 mM or 25 mM glucose 
and treated for 24 hours with 100 uM Gap27, or scrambled peptide (control) in triplicate. mRNA 
from migrating cells was subjected to PCR array analysis (SABiosciences), with gene expression 
fold changes greater than 2 considered regulatory. Keratinocytes stratifi ed in the model, expressing 
Cx43 in basal proliferating cells and limited Cx26 predominantly in upper layers refl ecting profi les 
seen in vivo. Gap27 increased cell migration rates of keratinocytes and fi broblasts (P < 0.01). In 
euglycaemic migrating fi broblasts Gap27 upregulated thirty-four genes and downregulated 1 gene. 
Collagen1 alpha1, connective tissue growth factor, integrin beta1 and matrix metalloproteinase 1 
were signifi cantly upregulated (P < 0.05). By contrast, under hyperglycaemia, Gap27 upregulated 
one gene and downregulated 9 genes including collagens, integrins, fi bronectin-1 and versican. 
Connexin mimetic peptides blocked CMC and increased cell migration rates in this organotypic 
model. In euglycaemic conditions during fi broblast migration Gap27 induced upregulation of 
genes associated with ECM remodelling, but in high glucose these mechanisms appear impaired. 
Connexin mimetic peptides can improve migration and have therapeutic potential in wound healing.
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Effect of a new hexapeptide on the SMA expression, in adipose precursor cells.
Pellicier F1, Galitsky J2, Schnebert S1, Franchi J1 1LVMH Research, Saint Jean De 
Braye, France 2INSERM U586, Toulouse, France
The stromal-vascular fraction (SVF) of adipose tissue contains regenerative precursors 
which are able to proliferate in vitro and may differentiate along several lineages 
(osteogenic, chondrogenic, neurogenic).Cell subpopulation termed ADSC (adipose 
derived stromal cells) was  studied  here  for its contractile abilities (myofi broblastic 
phenotype like).We have shown, in this study, using RT-PCR, that these cells presented 
the ability to express the phenotypic smooth muscular cells marker αSMA (alpha 
Smooth Muscle Actin), abundant in the ADSC fraction after 10 days in culture and 
increased in presence of a selected hexapeptide: + 54, 79 and 97% respectively versus 
control, at doses: 0.5-1.5 and 3%. In parallel, αSMA expression was characterized 
by immunofl uorescence (videomicroscopy), fi rstly in the precursor cells which we 
engaged in adipose maturation (adipogenic medium) and secondly in cells which 
we maintained at fi rst in a non adipogenic medium before the phase of adipose 
differentiation. The experience was done in presence or not of the hexapeptide (1%).
The fl uorescence corresponding to the protein expression of αSMA had been then 
quantifi ed by image analysis. When cells are directly cultivated in an adipogenetic 
environment, the hexapeptide leads to more than a 50 fold increase of αSMA, that 
strengthens their capacity to make a commitment in a differentiation of myofi broblastic 
type, cells become able to exercise contractions on the surrounding cellular matrix. 
As well, when cells are maintained fi rstly in a non adipogenic medium, we observe 
a retardation of the lipid droplets’ apparition and meanwhile, an increase of α SMA. 
This peptide seems to be a good actor for sliming and fi rming cosmetic compositions.
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Enhanced Connexin 43 expression mediates cell proliferation and migration 
independent of connexin mediated communication
Johnstone SJ1, Wright CW2, Errington RJ3, Martin PE2 1University of Virginia School of 
Medicine, Charlottesville, Virginia, USA 2Glasgow Caledonian University, Glasgow, 
United Kingdom 3Cardiff University, Cardiff, United Kingdom
Acute wound healing is associated with a reduction in the expression of the gap junction protein 
Connexin 43 (Cx43) at the leading wound edge. By contrast in chronic non-healing wounds Cx43 
expression is signifi cantly upregulated and associated with delayed wound closure. Thus targeting 
Cx43 with specifi c peptides or SiRNA strategies presents an attractive therapeutic target. Whether 
changes in cell proliferation and migration are linked with altered Cx43 expression or function 
remains unresolved. To address this we used two pharmacological tools, the histone deacetylase 
inhibitor sodium butyrate (0.5mM NaBu) and the Cx43-specifi c  enhancing peptide AAP10 (50nM) 
to enhance Cx43 expression over 24 hour time periods in HeLa cells transfected to express Cx43 
(HeLa43) and in primary human dermal fi broblasts (HFF) derived from child foreskins with parental 
consent and ethical approval. Connexin 43 function was blocked using 18-alpha-glycyrrhetinic acid 
(GA). Exposure of the cells to NaBu or AAP10 induced Cx43 expression with an associated increase in 
channel function, determined by the ability of cells to transfer small fl uorescent dyes. Treatment with 
GA blocked channel function but maintained Cx43 expression levels irrespective of induction. Time-
lapse microscopy and fl ow cytometry of HeLa43 cells demonstrated that enhanced Cx43 expression 
resulted in reduced cell proliferation following a stall in the G1 stage of the cell cycle. This was linked 
to an increase in expression of the cell cycle inhibitor p21waf/cip1 and cyclinD1. Reductions in Cx43 
channel activity did not abrogate these responses, indicating that connexin mediated communication 
was not a critical factor in reducing cell proliferation. Parallel studies in HFF cells illustrated that 
exposure to AAP10 was also associated with increased expression of Cx43 and p21waf/cip and 
delayed migration rates in in vitro scratch assays. Taken together we conclude that enhanced Cx43 
expression and not communication is involved in regulation of cell migration and proliferation rates.
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Gene Regulation and Dose-Dependent Restoration of Skin Atrophy by Retinaldehyde 
and Defi ned Size Hyaluronate Fragments In Dermatoporosis
Ziori C, Kostaki M, Fontao L, Saurat JH, Kaya G University Hospital of Geneva, 
Geneva, Switzerland
Dermatoporosis, the holistic word for human skin fragility is an emerging clinical 
problem due to chronological aging, long-term sun exposure and chronic use of 
corticosteroids. We have previously shown that topical retinaldehyde (RAL), a natural 
retinoid immediate precursor of retinoic acid, and intermediate size HA fragments 
(HAFi) had repairing action in dermatoporosis. In this study we examined the 
effect of topical RAL and HAFi on the expression of genes potentially involved in 
the pathogenesis of dermatoporosis by quantitative RT-PCR. We also explored the 
effect of different concentrations of HAFi on the skin thickness by ultrasonography. 
Before treatment, the expression of genes potentially involved in skin atrophy such 
as CD44, HAS3, HB-EGF, collagen I, collagen III, and PCNA was lower in the skin 
of dermatoporotic patients when compared to young controls. After treatment, a 
signifi cant increase in HAS2, Hyal2, cyclin D1, collagen I and collagen III expression 
was observed in young controls and patients. The reduced expression of CD44 and 
HAS3 in patients was specifi cally restored in dermatoporotic patients after treatment. 
No difference in skin thickness was observed in controls after treatment. However, 
the treatment caused a signifi cant increase in skin thickness in dermatoporotic 
patients, which was more signifi cant with 1% HAFi when compared to 0.2% HAFi, 
and a signifi cant decrease in the number of senile purpura on the affected sites. 
Our results indicate that topically-applied RAL and HAFi regulate gene expression in 
dermatoporosis and show a dose-dependent effect on the correction of skin atrophy.
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Global action of active ingredients in the management of stretch marks
Naaimi D1, Baudouin C1, Meloni M2, Msika P1 1Laboratoires Expanscience, Epernon, 
France 2Vitroscreen, Milan, Italy
Stretch marks, common in pregnancy (70-90%) are the result of many factors: hormonal 
impact, mechanical and physiological stress. These lesions form an atrophied scar. Firstly, 
infl ammatory changes are signifi cant with dermal edema and afterward, an epidermal 
atrophy and thinning are observed. We investigated effi cacy of a cream specifi cally 
formulated to reduce stretch marks using a mimicking injury model. Previously, we 
have examined effi cacy of the main patented ingredients (lupeol, soya peptide and 
arabinogalactane) to counteract tissue infl ammation and to stimulate extracellular matrix 
(ECM) remodelling. In fi broblasts cultures, we analysed ingredients effects on expression 
regulation of collagens, elastin and HSP47 by quantitative RT-PCR. Proteins (collagens, 
elastin) or cytokine (Il1β) secretions were evaluated by ELISA or immunolabelling (HSP47). 
A dermal injury model that mimics ECM changes as they occur in the formation of stretch 
marks was conduced on reconstructed full-thickness skin. Collagen VII, elastin, integrin β1 
gene expression was analysed different time after injury by QRT-PCR. In fi broblasts, lupeol 
stimulated collagen I production (X2 to X4.4) through a targeted action on HSP47 that was 
increased at mRNA and protein level. Arabinogalactane inhibited signifi cantly the release 
of Il1β (-21%) and was able to restore and stimulate collagen I expression in deleterious 
hormonal condition (+37%). Soy peptide induced signifi cantly collagens and elastin neo-
synthesis (+ 60%, +34%). In skin injured model, from day 8, the cream topical treatment has 
signifi cantly upregulated elastin, collagen VII and integrin β1 (X2.2; X3, X1.7 respectively). 
This effect has been extended and increased until day 16 for collagen VII and integrin 
β1.These results demonstrate the wound healing effi cacy of the ingredients combination 
to counteract alteration at DEJ and ECM levels and to promote tissue regeneration, 
supporting the cosmetic relevance of this cream for the management of stretch marks.
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Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of 
type VII collagen
Martins VL1, Chen M2, Purdie K1, McGrath JA3, O Toole EA1 1Centre for Cutaneous 
Research, ICMS, Barts and the London SMD, London, UK 2Dept of Dermatology, 
Univ of Southern California 1, Los Angeles, USA 3St John’s Institute of Dermatology, 
Guys, Kings College & St Thomas School of Medicine 2, London, UK
Type VII collagen (ColVII) is the main component of anchoring fi brils, attachment structures within 
the basement membrane. Mutations in the ColVII gene cause the severe blistering disorder, recessive 
dystrophic epidermolysis bullosa (RDEB), associated with increased risk of metastatic squamous cell 
carcinoma (SCC). We have previously shown that knock-down of ColVII (siCOL7) in SCC increased cell 
migration/invasion, and siCOL7 cells showed disorganised epithelial differentiation, increased epithelial-
mesenchymal transition (EMT) in 3-D organotypic cultures as well as increased chemokine (CXC) 
expression (gene expression arrays and immunostaining). In this study, we explored further the mechanism 
of invasion using 3-D organotypic cultures and tumour samples. Immunostaining of RDEB skin and a tissue 
array of sporadic cutaneous SCCs confi rmed that loss of ColVII correlates with decreased differentiation in 
vivo. Intradermal injection of recombinant ColVII protein into siCOL7 3-D cultures was suffi cient to restore 
involucrin and E-cadherin expression to a normal pattern. Expression of the chemokine receptor, CXCR3, 
which was increased in the basal layer of siCOL7 3-D cultures as well as in RDEB skin, was signifi cantly 
reduced by injecting recombinant ColVII into siCOL7 3-D cultures. Ingenuity Pathway analysis of the 
array data, connected ColVII with the chemokine pathway through hubs around TGF-beta and NFkB. 
Data-mining for genes involved in TGF-beta signalling revealed signifi cant changes in CTGF (+3.7), VIM 
(+2.1), MMP2 (+1.5), MMP3 (+1.6), LTBP1 (+1.6), LTBP2 (+3.9), and SMAD6 (-2.1).  Increased expression 
of p-Smad2/3 was observed in siCOL7 invading cells suggesting a role for TGF-beta signalling in their 
invasion.  Inhibition of MMP2, a downstream target of the TGF-beta pathway, with a neutralising antibody 
reduced siCOL7 cell migration.  Our fi ndings suggest that loss of ColVII increases cutaneous SCC invasion 
through the TGF-beta pathway and provides a possible explanation for the accelerated metastasis in RDEB.
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Interplay between MT1-MMP and MT3-MMP regulates melanoma cell invasion
Tatti O, Arjama M, Keski-Oja J, Lehti K University of Helsinki, Helsinki, Finland
Membrane-type matrix metalloproteinase 1 (MT1-MMP) is essential for tumor invasion 
and metastasis. Many cells co-express MT1-MMP with the other MT-MMPs, but their 
potential co-operation at the cell surface has remained poorly defi ned. MT3-MMP 
is usually upregulated in tumors which grow in collagen type I -poor environment, 
while MT1-MMP is upregulated in almost all highly invasive solid tumors. MT3-
MMP has very limited collagenolytic activity towards collagen type I, while MT1-
MMP degrades it effi ciently. Both of these enzymes cleave readily fi brin. Current 
research has been focused to elucidate the interplay between MT1- and MT3-MMP in 
melanoma cells. We explored the roles of overexpression and silencing of these MT-
MMPs, and investigated their effects on cell invasion in established melanoma cell 
lines (ML852 and Bowes) and COS cells. For this purpose we explored melanoma 
cell invasion into collagen type I, fi brin and Matrigel, and monitored the possible 
interactions and changes in the levels of MT1- and MT3-MMP. We observed that 
MT-MMPs regulated each other´s levels at the cell surface by proteolysis.  Depending 
on the expression of either of them melanoma cell invasion into these matrices 
varied considerably. Our results revealed that MT3-MMP modulates the proteolytic 
functions of MT1-MMP in a substrate-dependent manner. These results help in 
part to explain the functional consequences of differential MT-MMP expression 
in melanoma cells growing in collagen type I –rich versus -poor environment. On 
the basis of the current results we present a new model for MT-MMP interplay. 
Modulation of MT-MMP profi le at the melanoma cell surface is likely to play a 
major role in melanoma progression and change toward an invasive phenotype.
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Mechanical properties and antioxidant status of fi broblasts from keloids and 
surrounding normal skin
Lebcira L, Binda D, Muret P, Tiberghien P, Robin S, Humbert P UMR Inserm U645, 
Besançon, France
Keloids preferentially arise on high skin tension areas and their development seems to 
be closely related to an abnormal activity of dermal fi broblasts due, between others, to 
their intrinsic mechanical properties. The purpose of this study was to compare both 
the mechanical behavior and the antioxidant status of fi broblasts from keloids (KFs) 
and surrounding normal skin (NFs). Primary fi broblast cell lines were established from 
biopsies of keloid scar as well as from the surrounding normal tissue. Migration was 
followed by measuring the contraction of free fi broblasts populated collagen lattices 
during 10 days. Extracellular matrix remodeling capacities were investigated by 
ELISA quantifi cation of alpha 1 procollagen (P1P), MMPs and TIMPs levels. Kinetics 
of intrinsic contractile strengths developed by fi broblasts was evaluated in tensed 
lattices by the mean of our patented Growing Lattice Study box (GlaSbox®) system. 
Antioxidant status was investigated by the measurement of glutathione rates (GSH), 
glutathione peroxidase and glutathione reductase activities (GPx and GRed), catalase 
activity (CAT), superoxide dismutase activity (SOD) and lipid peroxidation (TBARs). 
Migratory capacities, MMPs and TIMPs levels of KFs were different from NFs. Intrinsic 
strengths generated by KFs presented a lower intensity compared to NFs. SOD activity, 
GSH rates and GPx activity were signifi cantly higher in KFs, while GRed activity was 
lower in NFs. No signifi cant difference was found in CAT activity. Lipid peroxidation 
appeared lower in KFs. The antioxidant status of KFs is clearly different from that of 
NFs. This may contribute to explain their different intrinsic mechanical properties. 
Further investigations will be performed in order to study the relationships between 
oxidative stress and cells mechanical behaviour in the pathogenesis of keloids.




New Aryl-alkyl-beta-C-xylopyranoside  derivative, a novel anti aging ingredient
Pineau N1, Cavezza A2, Dalko-Csiba M2, Breton L1 1L’Oréal, Clichy 92583, France 
2L’Oréal, Aulnay sous Bois, France
Severe structural changes, including deterioration of the mechanical properties of the dermis, occur 
during skin aging. Whereas many studies have been devoted to age-related alterations of collagen 
fi brils, far less attention has been paid to another major family of extracellular matrix components, 
the proteoglycans (PGs), which may have important functions in the maintenance of skin elasticity. 
Because heparan sulphate-proteoglycans (HS-PGs), a subclass of the PG family, decreases during 
aging, we used it to demonstrate the effi cacy of Aryl-alkyl-beta-C- xylopyranoside (2-hydroxy-4- 
(4-hydroxy-3-methoxyphenyl) butyl-beta-C-xylopyranoside) derivative using atrophic skin model. For 
histological studies, human skin samples were obtained from 12 patients undergoing plastic surgery 
(Caucasian women, 35-55 yrs old). This skin was atrophied by applying Diprosone® to the surface 
of epithelium. Skin samples were stained with an immunohistochemical technique using antibodies. 
Histological evaluation was performed by semi quantitative grading using scores from 0 (negative) 
to 4 (maximum).Our experimental model of atrophic skin induced alterations of syndecan-1 and 
syndecan-4 at cell surface level of keratinocyte. When Aryl-alkyl-beta-C-xylopyranoside  derivative 
was applied onto atrophic skin samples, syndecan-1 and syndecan-4 depositions increased 
signifi cantly (3.65 and 3.2 versus 2.4 and 2.68 before treatment). In the same way we observed a 
decrease in CD44 expression at the level of keratinocyte in atrophic skin samples (1.8 versus 2.8 in 
normal skin). The treatment of skin samples with Aryl-alkyl-beta-C-xylopyranoside derivative increase 
expression level in atrophic skin from 1.8 to 3.06. At the level of dermal-epidermal junction atrophic 
skin induced alterations of perlecan and ECM1 depositions. When Aryl-alkyl-beta-C-xylopyranoside 
derivative was applied onto atrophic skin samples perlecan and ECM1 expression increased (1.9 versus 
1.00 and 1.5 versus 1). In conclusion,  Aryl-alkyl-beta-C-xylopyranoside derivative may improve the 
cohesion of both the epidermis and the dermal-epidermal junction through increased expression of 
HS-PGs. Aryl-alkyl-beta-C-xylopyranoside derivative is an effective anti aging ingredient.  
494
Prevention of Atrophy and Induction of Differential Gene Expression by Defi ned 
Size Hyaluronate Fragments in Corticosteroid-Treated Mouse Skin
Kaya G, Fontao L, Barnes L, Tran C, Sorg O, Grand D, Hotz R, Carraux P, Saurat JH
University Hospital of Geneva, Geneva, Switzerland
Selective suppression of CD44 expression in mouse epidermis leads to skin atrophy. 
Topical application of intermediate size hyaluronate fragments (HAFi) results in 
an epidermal hyperplasia accompanied by an increase in CD44 and hyaluronate 
expression in mouse skin. In this study, we examined the effect of topically applied 
HAFi on atrophy and gene expression in corticosteroid-treated SKH1 hairless mouse 
skin by histological analysis and quantitative RT-PCR, respectively. Dorsal skin of 
mice was treated twice daily for 5 days with vehicle, steroid (0.05% clobetasol 
propionate or 0.1% desonide) or steroid plus 1% HAFi. Topical application of steroid 
caused an epidermal (0.018±0.004 mm) and dermal (0.137±0.026 mm) atrophy 
when compared to epidermal (0.054±0.005 mm) and dermal (0.245±0.079 mm) 
thickness of vehicle-treated mouse skin, and a decrease of CD44, HB-EGF, erbB1 
and col1A1 gene expression. Topical application of HAFi prevented steroid-induced 
epidermal (0.134±0.023 mm) and dermal (0.206±0.042 mm) atrophy and inhibited 
the reduction of CD44, HB-EGF, erbB1 and col1A1 gene expression. Our results 
show that topically-applied HAFi prevent corticosteroid-induced skin atrophy 
by regulating the expression of genes potentially implicated in its pathogenesis.
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TGF1 regulation by fi broblasts in a 3D collagen lattice by cyclic deformation
Peters A1, Brunner G2, Scherr G1, Gullberg D3, Krieg T1, Eckes B1 1Dermatology, U. 
of Cologne, Köln, Germany 2Fachklinik Hornheide, Münster, Germany 3Physiology, 
Bergen, Norway
Fibroblasts in the skin are predominantly single cells without cell-cell contacts, surrounded by 
the extracellular dermal matrix rich in collagen type I. Several experimental models are in use 
today taking this 3-dimensional collagen environment into account, e.g. freely contracting or 
tethered lattices. We showed previously that human dermal fi broblasts assume strikingly different 
phenotypes depending upon the type of collagen lattice: an “infl ammatory” phenotype is induced 
by the dense collagen network of contracting lattices, while a “synthetic” phenotype results from 
culture in lattices which are not contracted and which represents mechanically stressed fi broblasts.
Here we subjected murine dermal fi broblasts, seeded in tethered collagen lattices, to intermittent 
cyclic stress (0.1 Hz, 24 hours, FlexerCell), thereby simulating the intermittent bending/relaxing 
forces acting on fi broblasts in the skin in many regions of the body. Such “fl exed” lattices become 
very thin with cells arranged as single layer, while those in tethered lattices are distributed in 
different focal planes.TGFbeta1 mRNA was increased in “fl exed” versus tethered cultures in wild 
type fi broblasts. Culture media were analyzed for secreted total (latent plus active) and active 
TGFbeta1 protein. Total TGFbeta1 did not differ signifi cantly between “fl exed” and tethered cells, 
however, active TGFbeta1 was signifi cantly elevated by cyclic stress. CTGF mRNA levels were 
high in “fl exed” and low in tethered lattices accordingly. By contrast, we found unregulated, high 
TGFbeta1 mRNA levels in “fl exed” and tethered cultures of fi broblasts lacking either of the integrins 
alpha1beta1, alpha2beta1 or alpha11beta1, which mediate cell-collagen interactions. These cells 
maintained high CTGF mRNA levels only in “fl exed” culture.We conclude that (i) activation of 
TGFbeta1 is regulated differently by intermittent versus static mechanical stress, possibly via 
induction/activation of proteases cleaving the latent form, or by inducing conformational activation, 
or by downregulating LTBP1; (ii) regulation is controlled by collagen receptors; and (iii) CTGF 
regulation correlates with type of force and is independent of TGFbeta1 and of collagen receptors.
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The role of versican in wound healing and keloid formation: analysis using a new 
ex vivo keloid model
Araki E1, Motoko N1, Aota S2, Matsui S1, Suzuki S1, Miyachi Y1 1Kyoto University, 
Kyoto, Japan 2Center for Developmental Biology, Kobe, Japan
Keloids are a refractory human-specifi c disorder and are characterised by excessive extracellular matrix 
(ECM) deposition in the skin. The mechanism by which keloids develop is unknown, largely because of the 
lack of an appropriate animal model. We previously found that increased expression of versican, a large 
chondroitin sulfate proteoglycan, was one of the key features that characterise keloid tissues as well as 
cultured keloid cells (KL cells). In this study, versican expression in normal skin wound healing process was 
fi rst studied by immunohistochemistry using C57BL mice. When the skin of mice was wounded, versican 
expression was induced, peaking 5-7 days post-wounding, after which its expression declined. Next, we 
performed a cre-loxP system-based cell-lineage tracing study using transgenic mice harboring the versican 
promoter-Cre;Rosa26r gene. After skin wounding, LacZ-positive (i.e. versican promoter-active) cells emerged 
transiently, peaking 5-7 d post-wounding. Since versican is stably deposited in massive amounts in keloid 
lesions, these results suggest that keloid cells may be derived from the versican-producing mesenchymal 
cells that normally disappear promptly once wound healing has fi nished.  RT-PCR and promoter analysis 
analysis indicated that cultured KL cells retained the versican-overproducing characteristics of keloid 
tissue and that PI3K signaling is involved in versican regulation in both normal fi broblasts and KL cells. 
Exogenous IL-1β treatment was found to inhibit versican expression of both cell types.We then generated 
a keloid model by subcutaneously implanting nude mice with a KL cell-seeded collagen sponge. Collagen 
sponges with keloid cells (keloid sponges) were less translucent and signifi cantly heavier than those with 
normal fi broblasts (normal fb sponges)  after 4 weeks. Immunohistochemistry showed keloid sponges 
deposited more versican than normal fb sponges did, which suggested that this model refl ected the ECMs-
producing characteristics of keloids. Administration of IL-1b and chondroitinase ABC to keloid sponges 
for one month successfully suppressed the deposition of glycosaminoglycan as well as the increase 
in weight. This novel mouse model should be useful for developing anti-keloid therapeutic reagents.
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Tropisetron attenuates collagen synthesis in human dermal fi broblasts and reduces 
tissue fi brosis in a mouse model of scleroderma
Kokot A1, Sindrilaru A2, Scharffetter-Kochanek K3, Fiebich B4, Luger TA1, Boehm 
M1 1University of Muenster, Muenster, Germany 2University of Ulm / University of 
Muenster, Ulm / Muenster, Germany 3University of Ulm, Ulm, Germany 4University 
of Freiburg, Freiburg, Germany
Many observations point towards a role of serotonin (5-Hydroxytryptamin, 5-HT) or 5-HT-mediated 
pathways in the pathogenesis of fi brotic diseases. 5-HT is a neurotransmitter, which exerts its biologic 
effects via at least 15 different receptor-subtypes. Tropisetron (TRO), a 5-HT3-receptor antagonist, has 
been suggested to improve symptoms of progressive systemic sclerosis in humans. TRO treatment also 
appears to have benefi cial effects in diseases such as rheumatoid arthritis and fi bromyalgia. Here, we 
investigated the effect of TRO on transforming growth factor-beta1 (TGF-beta1)- and bleomycin (BLM)-
induced collagen synthesis in human dermal fi broblasts (HDF). Moreover, we used a BLM mouse model 
of scleroderma to investigate the effect of TRO on tissue fi brosis. We also examined the impact of TRO 
on SMAD-signaling, a pathway involved in TGF-beta1-mediated collagen synthesis. In addition, we 
analysed the expression of 5-HT receptor subtypes in HDF. Our data disclose a suppressive effect of 
TRO on both TGF-beta1- and BLM-induced collagen synthesis in HDF. In accordance to these in vitro 
results we also found a reduction of BLM-induced tissue fi brosis in mouse skin after TRO treatment. 
However, the SMAD2/3 signaling pathway is not involved in the mechanism of TGF-beta1-induced 
collagen synthesis in HDF as SMAD2/3 phosphorylation, nuclear translocation, and promoter activity 
was unaffected by the drug. Surprisingly, expression of 5-HT3-receptors was undetectable although 
5-HT1B, 5-HT2A/B and 5-HT7 receptors were found in HDF suggesting that TRO presumably acts in a 
5-HT3 receptor-independent manner. In summary, our results highlight a potent antifi brogenic activity 
of TRO in vitro and in vivo and shed light into the possible mechanism of TRO-mediated effects 
in HDF. These data are encouraging for a detailed investigation of the 5-HT system in fi brotic skin 
diseases and furthermore may point to novel therapies in the treatment of patients with such disorders.
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Versican and migratory determinants of Sézary cells
Karpova MB, Georgiev O, Hemmi S, Laine E, Dummer R, Maiwald-Urosevic M 
University Hospital Zurich, Zurich, Switzerland
Sézary syndrome (SéS) is an aggressive variant of cutaneous T cell lymphoma 
defi ned by erythroderma, lymphadenopathy and the presence of neoplastic T 
lymphocytes, so called Sézary cells (SéCs) in the skin, lymph nodes and peripheral 
blood. Gene expression profi ling has been employed on several occasions to 
expand the understanding of the pathogenesis of SéS by using peripheral blood 
mononuclear cells or bulk CD-4+ T cells. To gain more insight in the biology of SéCs, 
we previously performed microarray analysis on CD-4+ clonal T cells additionally 
sorted according to patient-specifi c TCR V-beta expression (V-beta+). The expression 
profi le of clonal CD-4+ T cells (V-beta+) from 5 patients were compared to those 
of non-clonal CD-4+ T cells obtained from the same patients (V-beta-). Using HG-
U95Av2 Affymetrix arrays, we identifi ed versican as the highest up-regulated gene in 
clonal CD-4+V-beta+ T cells. Versican is a large chondroitin-sulphate proteoglycan 
and has at least 4 isoforms (V0-V3). Further investigation of expression pattern 
revealed preferential expression of versican V1 isoform in the clonal CD-4+V-
beta+ T cell population as compared to the other isoforms.To describe in details 
the infl uence of versican V1 overexpression in SéS in this study we generated two 
lentiviral constructs containing human versican isoform V1 coding sequence and 
sequences for VSV-G or FLAG peptide epitope tags. Introduction of these tags 
eased consequent determination of the introduced protein. Using real-time PCR, 
immunoblotting and fl uorescent microscopy we show overexpression of versican V1 
after lentiviral infection and possibility to use generated vectors in mammalian cells.
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Identifi cation of a novel microRNA regulator of keratinocyte migration and 
proliferation in wound healing
Bertero T1, Bourget-Ponzio I1, Loubat A1, Techer N1, Mari B2, Barbry P2, Meneguzzi 
G1, Ponzio G1, Rezzonico R1 1INSERM U634, Nice, France 2CNRS UMR 6097, 
Sophia-Antipolis, France
MicroRNAs (miRNAs) are endogenous post-transcriptional repressors of gene 
expression involved in the regulation of multiple biological processes including 
cell proliferation, differentiation or migration. miRNAs have been suspected to 
play a role in the control of wound healing, but so far this hypothesis has not been 
substantiated. In keratinocyte cell cultures (NHK) submitted to scratch wounding, 
we have identifi ed a set of miRNAs with an altered expression pattern that we have 
functionally characterized. Specifi cally, we observed upregulation of miR-483, 
whose expression in the skin had been reported but without any known function. 
In our hands, miR-483 accumulates at the terminal phase of the wound closure 
process, which suggests a specifi c involvement in the “healing” arrest signal. In line 
with this hypothesis, we demonstrated that over-expression of miR-483 in NHK, 
inhibits cell migration and cell proliferation through blockade in the G1 phase. 
Transcriptome analysis of pre-miR-483-transfected NHK identifi ed 122 down-
regulated genes known to be linked to cancer, cell growth and cell migration; of 
these, 33 corresponded to putative miR-483 targets. Using luciferase reporter 
assays, and Western blot analysis, we confi rmed that miR-483 directly targets 
MAPKAPK2, MKI67 and ASH2L transcripts. Accordingly, RNA interference targeting 
MAPKAPK2 and MKI67 inhibited NHK proliferation, which suggests that the anti-
proliferative properties of miR-483 is associated with down-regulation of these targets 
genes. Our results have identifi ed a miRNA involved in the arrest of keratinocyte 
migration and proliferation at the terminal stage of the reepithelialization process.
500 [Oral 083]
Dimethylfumarate inhibits Macrophage Inhibitory Factor induced proliferation of 
keratinocytes
Gesser B, Rasmussen MK, Rosada C, Johansen C, Kjellerup K, Kragballe K, Iversen L 
Aarhus University Hospital, Aarhus C, Denmark
Macrophage Migration Inhibitory Factor (MIF) is elevated in the serum of patients with 
severe psoriasis. The p38 MAPK and ERK signalling pathways as well as the downstream 
target Mitogen and Stress-Activated Kinase 1 (MSK1) are activated in lesional psoriatic skin. 
Recently, we demonstrated that the anti-psoriatic drug Dimethylfumarate (DMF) specifi cally 
inhibits IL-1b induced phosphorylation of MSK1 (S376) in cultured human keratinocytes. In 
this study the effect of MIF on the MAPK signalling pathways of cultured human keratinocytes 
was tested and the effect of DMF on MIF induced activations was studied, by phospho-
specifi c antibodies, Western Blotting and ELISA. Incubation with MIF induced a biphasic 
activation of ERK1/2 and JNK1/2 and p38 MAPK, which were not regulated by DMF. On 
the contrary, the MIF induced phosphorylation of MSK1 and the p90 kDa Ribosomal S6 
kinase (RSK1) were inhibited by DMF. RSK1 is a downstream target of ERK. Because ERK 
activation via RSK1 regulates c-Fos expression and cell proliferation, we then studied the 
effect of MIF on the proliferation of cultured keratinocytes. Incubation with MIF lead to 
increased keratinocyte proliferation after 96 hours and this was signifi cantly inhibited by 
pre-incubation with DMF or with the MSK1/2 and RSK1 inhibitor Ro-318220, possibly 
through the induction of the tumour suppressor protein p53. Furthermore pre-incubation 
with DMF increased nuclear expression of c-Jun and p-c-Jun (S63). DMF inhibited also the 
MIF induced phosphorylation of the transcription factor CREB which is activated through 
MSK1 and RSK1. DMF inhibited the MIF induced Cox-2 expression which is regulated by 
CREB. Our results suggest that the inhibitory effect of DMF on MSK1 and RSK1 activations 
and the inhibition of Cox-2, contributed to the induction of p53 protein and to the inhibition 
of keratinocyte proliferation. These can in part explain the anti-psoriatic effect of DMF.
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STAT4 serine phosphorylation during keratinocyte mitosis
Ferreli C, Pickard C, August S, Buggy Y, Ardern-Jones M, Friedmann PS, Healy E 
University of Southampton, Southampton, United Kingdom
Signal transducer and activator of transcription proteins (STATs) are a group of transcription 
factors involved in a variety of cellular functions, primarily through phosphorylation of 
a tyrosine residue which allows the formation of homo / heterodimers and subsequent 
entry into the nucleus.   Within the nucleus, phosphorylation of a serine residue on 
certain STATs (STAT1, 3, 4 and 5) augments transcription from STAT responsive genes. 
Using immunofl uorescence microscopy we observed a widespread extranuclear/
intracellular distribution of phosphoserine (pSer) STAT4 in a subset of HaCaTs in culture 
(n=5 experiments).  Further analysis with confocal laser microscopy (n=5) of HaCaTs and 
primary keratinocytes indicated that these pSerSTAT4 bright cells were undergoing mitosis. 
Conversely, in the mitotic cells phosphotyrosine (pTyr) STAT4 expression was predominantly 
located at the DNA (n=5).  Flow cytometry (n=3) and confocal microscopy (n=3) of 
cells synchronised in mitosis, by mitotic detachment and by nocodazole, confi rmed the 
upregulation and altered sub-cellular distribution of pSerSTAT4 in M phase.  Investigation 
of the phosphorylation status of STAT1 and STAT3, both of which can heterodimerise 
with STAT4, by confocal microscopy (n=3) and fl ow cytometry (n=3) suggested that 
pSerSTAT4 is not signifi cantly heterodimerised with either of these STAT protein during 
mitosis.  Inhibition of pSer-STAT4 phosphorylation by lisofylline demonstrated an increase 
in the number of cells remaining in telophase on confocal microscopy (n=3) and reduced 
frequency of cells completing cytokinesis during live-cell time-lapse microscopy (n=3). 
Enhanced expression of pSerSTAT4 was also seen in mitotic cells in murine testis (n=2), 
in normal human skin (n=5) and in cutaneous squamous cell carcinoma (n=10).  The data 
suggest that pSer-STAT4 plays a role in the normal division of keratinocytes during the 
later stages of mitosis and that interfering with this function adversely affects cell division.
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Regulation of tissue inhibitor of matrix metalloproteinases-1 and -3 in fi broblasts by 
mitogen-activated protein kinase pathways and zinc binding protein 89
Hieta N1, Ala-aho R2, Merchant JL3, Kähäri VM2 1Turku University Hospital, Turku, 
Finland 2University of Turku, Turku, Finland 3University of Michigan, Ann Arbor, USA
Tissue inhibitors of metalloproteinases (TIMPs) inhibit the active forms of matrix 
metalloproteinases (MMPs), but they also have a role in inhibiting angiogenesis, tumor 
cell invasion and metastasis. TIMP-1 expression is upregulated by a variety of external 
stimuli, such as growth factors like transforming growth factor-beta1 (TGF-beta1) and 
cytokines. It has been shown, that up-regulation of TIMP-1 expression by TGF-beta1 is 
mediated by ERK1,2 pathway and Sp1 in human fi brosarcoma cells. We show here, that 
also up-regulation of TIMP-3 expression by TGF-beta1 is mediated by ERK1,2 pathway. 
In normal dermal fi broblasts, TIMP-1 and TIMP-3 expression is potently enhanced by 
activation of ERK1,2 by adenoviral expression of constitutively active MEK1. Also, TIMP-3 
protein expression is potently induced by activation of ERK1,2. Enhancement of TIMP-1 
and TIMP-3 expression by the activation of ERK1,2 MAPK pathway by constitutively active 
MEK1 is decreased by adenoviral overexpression of wild-type zinc binding protein 89 
(ZBP-89). ZBP-89 is a widely expressed four-zinc fi nger transcription factor that functions 
as both a transcriptional activator and repressor. In many instances, ZBP-89 represses the 
promoter activity by opposing the effect of Sp1.  Here, also the enhancement of TIMP-3 
expression by TGF-beta1 is partly inhibited by overexpressing wild-type ZBP-89. Also, the 
enhancement of TIMP-1 and TIMP-3 protein production by TGF-beta1 is partly inhibited 
by the simultaneous overexpression of wild-type ZBP-89. Activation of p38beta by co-
infection of MKK3bE and wildtype p38beta completely inhibits the up-regulatory effect of 
MKK3 on TIMP-3 expression, while having no effect on TIMP-1 expression. These results 
show, that the expression of TIMP-1 and -3 is regulated by ZBP-89 transcription factor in 
dermal fi broblasts, which may have a role in proteolysis in, e.g., wound repair and cancer.
503
Activation of AMP-activated protein kinase prevents premature senescence in 
cultured human keratinocytes
Duranton A1, Chen TC2, Persons K2, Holick H2, Breton L1, Ruderman N2 1L’Oréal 
Research, Clichy, France 2Biomedical Research Center Boston University School of 
Medicine, Boston MA, USA
It has been demonstrated that the NAD-dependent protein deacetylase, SIRT1 mediates the delay in 
aging caused by caloric restriction. Recently, another line of investigation suggested that SIRT1 activity 
is closely linked to the energy sensing enzyme, AMP-activated protein kinase (AMPK). Thus, we reported 
that SIRT1 deacetylates and activates the AMPK kinase, LKB1.  In this study, we investigate whether this 
SIRT1-LKB1-AMPK system plays a role in keratinocyte senescence. Human primary keratinocytes, passages 
1 to 4, were cultured in serum-free low calcium medium. Premature senescence was induced by exposure 
to 50 µM hydrogen peroxide and assessed by SA-galactosidase staining. Cell viability (mitochondrial 
function) was measured by ALAMAR blue reduction. Exposure to hydrogen peroxide for 1 to 2 hr 
resulted in a 3-5 fold increase in the number of cells positive for SA-galactosidase and a 30% reduction 
in mitochondrial function. Immunocytochemical staining also revealed that the expression of LKB1 was 
lower in SA-galactosidase positive cells. Incubation of the cells for 1 hr with 1 mM AICAR (aminoimidazole 
carboxamide ribonuleotide), a widely used AMPK activator increased phosphorylation of AMPK (T172) 
and its substrate acetyl-CoA carboxylase (Ser89), indicating that it activated AMPK in keratinocytes. Co-
incubation with AICAR completely prevented the increase in SA-galactosidase staining and the decline 
in mitochondrial function caused by hydrogen peroxide. Conversely, suppression of AMPK by dominant 
negative AMPK adenovirus infection caused senescence-like morphological changes and positive staining 
for  SA-galactosidase. The  putative SIRT1 activator, resveratrol (25 µM) also activated AMPK and prevented 
hydrogen peroxide-induced senescence.   SIRT1 expression was not altered by hydrogen peroxide treatment; 
however its  expression was greatly diminished in cells that became senescent after multiple  passages. 
These studies demonstrate that keratinocyte senescence is associated with impaired SIRT1-LKB1-AMPK 
activity. They also suggest that activation of  this cascade may offer a novel means to prevent aging in skin.
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Alternative proteolytic processing of hepatocyte growth factor controls skin repair
Hoffmann D1, Buchstein N1, Smola H2, Paulsson M3, Niemann C4, Krieg T1, Eming SA1 
1Dept of Dermatology Univ of Cologne, Germany 2Paul-Hartmann AG  Heidenheim, 
Germany 3Center for Biochemistry Univ of Cologne, Germany 4Center for Molecular 
Medicine Cologne Univ of Cologne, Germany
Genetic deletion of c-Met in the murine epidermis demonstrated that the Hepatocyte growth factor 
(HGF)/c-Met pathway plays an essential role in skin repair. However, little is known on the function of 
this ligand-receptor complex during cutaneous repair in humans. We examined expression, integrity 
and function of the HGF/c-Met pathway in normal healing and non-healing human skin wounds. In 
healing wounds expression and phospohorylation of c-Met was most prominent in the epithelium at 
the wound margin and several dermal cell types. In contrast, in non-healing wounds phosphorylation 
of c-Met was absent in the wounded epidermis and merely detected in the dermal compartment, 
suggesting limited c-Met activation. In wound exudates obtained from non-healing, but not healing 
wounds, HGF protein was a target of substantial proteolytic processing, which was different from 
the classical activation pathway by known serine proteases. Western blot analysis of rhHGF and 
comprehensive protease inhibitor analysis revealed that in non-healing wounds, HGF is a target of 
neutrophil elastase and plasma kallikrein. Proteolytic processing of HGF by each of these proteases 
signifi cantly attenuated keratinocyte proliferation, wound closure capacity and signal transduction. 
Interestingly, HGF processing by neutrophil elastase generated an NK4-like fragment that antagonized 
c-Met-mediated HGF effects in an experimental model of tumor growth. Our fi ndings reveal 
a novel pathway of HGF processing in the human system. Furthermore, our results indicate that 
these unconventional proteolytic processing events of HGF have fundamental consequences on skin 
homeostasis. Under conditions in which infl ammatory proteases are imbalanced and tipped towards 
an increased proteolytic activity, such as in chronic non-healing wounds, this event might compromise 
HGF activity due to the inactivation of the HGF molecule and/or the generation of HGF fragments that 
ultimately mediate a dominant negative effect. Overall, these studies provide new mechanistic insights 
in HGF/c-Met function and suggest a novel molecular pathomechanism underlying chronic wounds.




Analysis of transcription factors involved in T-plastin synthesis in Cutaneous T Cell 
Lymphoma
Bégué E, Jean-Louis F, Bachelez H, Courtois G, Michel L INSERM, Paris, France
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of non-Hodgkin extra-
nodal T cell lymphomas presenting two major clinical variants; mycosis fungoides (MF) and Sézary 
syndrome (SS). Transcriptome analysis allowed the identifi cation of T-plastin as an upregulated gene 
in CTCL cells from SS patients not expressed in normal T lymphocytes. Herein, we studied T-plastin 
expression in a large cohort of CTCL patients, compared with a wide range of T-cell lymphoproliferative 
disorders, and searched for involved transcriptional factors.Peripheral blood lymphocytes (PBL) were 
isolated from circulating blood of patients with CTCL (n=36), MF (n=12), unidentifi ed erythroderma 
(n=10), hypereosinophilic syndrome (n=8), other lymphoproliferative disorders (n=10) and healthy 
donors (n=56). The expression levels of T-plastin and L-plastin was quantifi ed by quantitative 
real-time polymerase chain reaction assay and CTCL cell lines (SeAx, MyLa) as well as in control 
leukemic Jurkat cells. Our results showed that T-plastin mRNA were detected in 80% of SS patients, 
while no expression was detectable in patients with MF, idiopathic erythroderma, hypereosinophilic 
syndrome with clonal T-cell subset, and healthy donors. Hut-78 cells constitutively express T-plastin 
whereas SeAx and MyLa cells (derived from one SS and one MF patient respectively) express 
T-plastin only after PMA+ionomycin (Io) stimulation. T-plastin transcription was induced in PMA+Io 
stimulated T-cells of 4/5 T-plastin negative-SS patients, but interestingly also in PMA+Io stimulated-
control healthy PBLs. Calcineurin inhibitors reduced constitutive and PMA+Io-induced transcription 
of T-plastin by 30-45% and 50-100% respectively. EMSA and gene reporter assays demonstrated 
that activation of nuclear factor of activated T cells (NFAT) was responsible, at least partially, for 
T-plastin expression in tumor T cells. Our experiments strongly suggest the accuracy of T-plastin 
as a specifi c marker for Sézary syndrome diagnosis, and bring evidence of NFAT involvement 
in T-plastin expression, leading to new perspective for the prognosis and treatment of CTCLs.
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Characterization of AhR ligands by new DR-CALUX bioassays utilizing the dual 
luciferase reporter system in keratinocytes and hepatocytes
Barouti N, Sorg O, Leuba F, Piguet V, Saurat JH, Fontao L Faculty of Medicine, 
University of Geneva, Switzerland
DR-CALUX (Dioxin Responsive-Chemical Activated LUciferase gene eXpression) is a bioassay 
used to assess toxic equivalents of dioxin and related compounds in a variety of sample matrices. 
Most of the DR-CALUX bioassays use genetically modifi ed hepatoma cell lines incorporating 
the fi refl y luciferase gene coupled to xenobiotic responsive element (XRE) as reporter gene. The 
tested compound or its derivatives binds to the Aryl Hydrocarbon Receptor (AhR) and induces 
its translocation into the nucleus where it associates with Ah receptor nuclear translocator 
(ARNT) and activates reporter gene by binding to XRE. Since the metabolic machinery is likely 
cell type dependent, we assessed whether AhR ligands gave similar results when tested in DR-
CALUX assays established in keratinocyte and hepatoma cell lines. DR-CALUX assays using the 
Dual Luciferase Reporter (DLR™) system were performed on newly established hepatoma and 
keratinocyte cell lines. Both cell lines were generated by lentiviral transduction and express 
the fi refl y luciferase gene coupled to XRE as a reporter gene for the presence of dioxin and the 
renilla luciferase coupled to the constitutively active EF1promoter as a reporter for cells number 
and viability. In addition, P450-Glo™ assays were conducted to assess cytochrome P450-1A1 
activation.The limit of detection for 2,3,7,8-tetrachlorodibenzo-p-dioxine (TCDD) was within the 
same range (0.3-0.6 pg TCDD) for both cell lines. However, hepatoma cells were 4 time more 
sensitive than keratinocytes. A linear regression could be established between the ratio of fi refl y 
and renilla luciferases activities and TCDD concentration in both cell lines. With this approach we 
found that, AhR ligands such as resveratrol, 6-formylindolo[3,2-b]carbazol and quercetin activate 
AhR and induce cytochrome P450-1A1 in a cell type dependent manner.We have established 
and characterized two new DR-CALUX bioassays based on two different cell lines. AhR ligands 
may be characterized by their response in both bioassays to assess skin specifi c activation of AhR.
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Cloning Of The Human Gli2 Promoter: Transcriptional Activation By Tgf-Beta In 
Keratinocytes Via Smad3/-Catenin Cooperation
Dennler S, Andre J, Verrecchia F, Mauviel A INSERM U697, Paris, France
GLI-Kruppel family member 2 (GLI2), a zinc-fi nger transcription factor that mediates 
Hedgehog signaling, is implicated in the progression of an ever-growing number 
of human malignancies, including basal cell carcinoma of the skin. Its expression 
is upregulated by Transforming Growth Factor-beta (TGF-beta) in a variety of cell 
types, both normal and transformed. We report that TGF-beta-driven GLI2 expression 
in HaCaT keratinocytes is transcriptional and does not result from stabilization of 
GLI2 transcripts. We describe the characterization of the 5’-fl anking sequence of 
human GLI2 mRNA, the identifi cation of a transcription start site, the cloning of 
~1600bp of the regulatory promoter region and the identifi cation and functional 
analysis of a TGF-beta-responsive region mapped to a 91bp sequence between 
nucleotides -119 and -29 of the promoter. This region harbors putative SMAD 
and LEF/TCF binding sites that allow a functional cooperation between SMAD3 
and beta-catenin, recruited to the promoter in response to TGF-beta, to drive 
GLI2 gene transcription. Relevance to skin tumorigenesis is being investigated.
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Control of epidermal barrier function and cutaneous homeostasis by FGF receptors 
1 and 2
Müller A1, Yang J1, Meyer M1, Böhm F1, Grose R2, Partanen J3, Ornitz D4, Werner S1 
1ETH Zurich, Zurich, Switzerland 2Queen Mary`s School of Medicine & Dentistry, 
London, United Kingdom 3Viikki Biocenter, Helsinki, Finland 4Washington University 
School of Medicine, St. Louis, MO, USA
Fibroblast growth factors (FGFs) and their receptors are crucial regulators of 
development, repair and disease of several tissues and organs, including the skin. 
However, the roles of individual FGFs and their receptors in the skin and their 
mechanisms of action are largely unknown. To determine the roles of FGF receptors 
1 and 2 in this tissue we generated mice lacking both receptors in keratinocytes. 
These animals develop progressive loss of appendages, acanthosis, cutaneous 
infl ammation and dermal fi brosis. As the underlying mechanism we identifi ed 
a loss of tight junction proteins in keratinocytes, and we show that this is a direct 
consequence of the loss of FGFR1 and 2. Consequently, a defect in the epidermal 
barrier occurs, resulting in progressive infl ammation with production of cytokines and 
growth factors by stromal cells. This leads to stimulation of keratinocyte proliferation 
through a double paracrine mechanism. Our data reveal a novel role of FGFs in the 
maintenance of the epidermal barrier and in the protection from skin infl ammation.
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Control of growth factor networks by a new C-xylopyranoside derivative
Pineau N, Breton L L’Oréal, Clichy, France
C-xylopyranoside derivative improves dermatan sulphate synthesis and heparan 
sulphate-proteoglycan (HS-PG) synthesis, a subclass of the proteoglycan family that 
decreases during aging. Glycosaminoglycans and proteoglycans   participate in a 
variety of functions, including binding multiple growths factors and promoting their 
activities.   The purpose of this study is to show that C-xylopyranoside derivative 
is capable of promoting the synthesis of growth factors.Human skin samples were 
obtained from 12 patients undergoing plastic surgery (Caucasian women from 
35 to 55 years old). Atrophic skin model was achieved by applying Diprosone® 
(bethamethasone at 0.05%) to the surface of skin sample. These skins are then treated 
during 4 days with 3 mM of C-xylopyranoside derivative. Total RNA isolated from 
skin biopsies was retrotranscribed by reverse transcriptase. We analysed the effects 
of C-xylopyranoside derivative on FGF-2, FGF-7, EGF and FGFR2IIIb expression. The 
FGF-2 mRNA expression was signifi cantly up regulated in atrophic skin treated by 
C-xylopyranoside derivative compared to non treated skin (118 vs 82). The results 
are much more marked with FGF-7 and EGF (100 vs 44 for FGF-7 and 109 vs 55 for 
EGF). The FGF-2 receptor (FGFR2IIIb) also is up regulated in atrophic skin treated by 
C-xylopyranoside derivative (88 vs 65).  In conclusion, dermatan sulphate is abundant 
in the wound environment and binds and activates growth factors which are present 
during the wound repair process. C-xylopyranoside derivative, by its capacity to 
activate the synthesis of dermatan sulfate, allows a better healing of cutaneous tissues.
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Double and triple silencing of D type cyclins downregulates the mRNA expression 
of G2/M phase genes and results in aberrant mitosis in HaCaT keratinocytes
Belsõ N, Bebes A, Hambalkó Sz, Széll M, Kemény L, Bata-Csörgõ Zs University of 
Szeged, Szeged, Hungary
It is well known that D type cyclins have a key role in regulating the progression 
through late G1 into S phase of the cell cycle. Previously we have found that 
double or triple knocking down of D type cyclins results in the formation of large 
multinucleated cells, S phase arrest and moderate growth suppression in HaCaT 
keratinocytes, suggesting that the presence of at least two D type cyclins is needed 
for normal G2/M transition. To determine the genes interacting with D type cyclins 
during the G2/M transition, we applied SuperArray PCR in the double and triple 
silenced cells. We examined the expression of 90 genes (cyclins and their associated 
cyclin-dependent kinases (CDKs), CDK inhibitors, CDK phosphatases, and cell cycle 
checkpoint molecules involved in the control of cell growth and division). The most 
dramatic decreases occured in the mRNA expressions of BIRC5 (survivin), CDC2, 
CDC20, GTSE1 and MKI67 in the silenced cells compared to siControl treated 
cells. These genes are expressed and interact during the G2 and M phase of the 
cell cycle and they are mostly involved in mitotic processes. Our results reveal that 
D type cyclins have important functions during mitosis in HaCaT keratinocytes.
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Epidermis-specifi c loss of Neuropilin 1 delays wound healing and increases 
apoptosis of keratinocytes
Riese A, Meyer Y, Eming SA, Krieg T, Kurschat P University of Cologne, Germany
Neuropilin 1 (NRP1) is expressed on several cell types including neurons and 
endothelial cells, where it functions as an important regulator in development and 
during angiogenesis. As a cell surface receptor, NRP1 is able to bind to both members 
of the VEGF family of growth factors as well as to secreted class 3 semaphorins. 
Neuropilin 1 is also highly expressed in keratinocytes, but the function of NRP1 
in epidermal physiology and pathology is still unclear. Therefore we generated an 
epidermis specifi c Neuropilin 1 knock out mouse to study the function of NRP1 in 
skin. These mice show no spontaneous phenotype. Furthermore, in vitro migration of 
NRP1 defi cient keratinocytes and in vivo wound healing until day 5 is not disturbed. 
Nevertheless, at later time points (from day 8 on) we detected a delay in wound 
healing, as compared to wild type animals. Additionally, NRP1 defi cient keratinocytes 
show signifi cantly higher rates of apoptosis after 24 hours of growth factor starvation. 
Apoptotic cells were quantifi ed by annexin staining and FACS analysis. To explain 
these phenotypes, we analyzed VEGF-A expression in keratinocytes by qRT-PCR 
and detected that NRP1 defi cient cells secrete lower amounts of VEGF-A. Our 
results indicate that Neuropilin 1 is dispensable for normal skin development, but 
may play an important role during wound healing. A possible explanation for this 
phenotype could be a reduction of autocrine and paracrine effects mediated by VEGF.
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Inhibition of heat-induced reactive oxygen species and apoptosis of cutaneous 
lymphoma cells by platinum nanoparticle
Yoshihisa Y1, Zhao QL1, Wei ZL1, Miyamoto Y2, Kondo T1, Shimizu T1 1University of 
Toyama, Toyama, Japan 2University of Tokyo, Chiba, Japan
Platinum nanoparticles (nano-Pts) are a superoxide dismutase (SOD)/catalase 
mimetic and they may have utility as antioxidants to reduce reactive oxygen 
species in living organisms. Here, the effects of nano-Pts on hyperthermia (HT; 44 
oC, 30 min)-induced apoptosis and the underlying molecular mechanism were 
investigated in human cutaneous T-cell lymphoma HH cells and U937 lymphoma 
cells. Pretreatment of the cells with nano-Pts caused signifi cant inhibition in HT-
induced O2- formation in both cell lines, being complete in U937 cells. The 
pretreatment inhibited signifi cantly HT-induced apoptosis in a dose-dependent 
manner. Apoptosis endpoints, namely, Fas externalization, loss of mitochondrial 
membrane potential and increase in intracellular Ca2+ concentration induced 
by HT were also attenuated. Pretreatment with nano-Pts decreased both the 
truncation of Bid and the cleavage of caspase-3. These results indicate that nano-
Pts suppress HT-induced apoptosis because of quenching of O2- induced by HT in 
human lymphoma cells, and suggest usefulness of the compound as antioxidant.
513
Insulin resistance of keratinocytes contributes to the manifestation of the psoriatic 
phenotype
Buerger C, Hardt K, Diehl S, Malisiewicz B, Boehncke WH Goethe University, 
Frankfurt, Germany
Besides insulin’s well known effects on classic metabolic tissues, such as liver, 
muscle and adipose tissue, several reports suggest a role in non-metabolic tissues 
such as the skin.  Psoriasis patients show systemically and locally (dermal) elevated 
levels of infl ammatory cytokines, such as TNFα, which are known to confer insulin 
resistance contributing to the development of co-morbidities such as atheriosklerosis, 
coronary heart disease and diabetes. Therefore we examined whether psoriasis-
associated cytokines e.g. IL-1, Il-12, IL-17 and Il-23 contribute to similar effects in 
the skin. The exact signaling mechanisms and phenotypic consequences of insulin 
exposure were analyzed in keratinocytes. Using immunohistology we found that 
components of the insulin signal pathway show altered activation patters in psoriatic 
lesions compared to non-lesional skin in the same patients. We found that insulin 
induces expression of cytokeratin 1 and 10, markers of terminal differentiation, 
suggesting that insulin drives differentiation of healthy keratinocytes. This effect is 
blunted under conditions of chronic cytokine treatment, resembling the infl ammatory 
situation in psoriasis, where keratinocytes differentiation is abnormal and shifted 
towards hyperproliferation. Under these conditions activation of Akt/PKB, the 
target of the insulin receptor and insulin receptor substrate (IRS) is ablated. Our 
results indicate that psoriasis associated cytokines induce insulin resistance in 
the skin and in turn contributes to the manifestation of the psoriatic phenotype.
Thus, controlling impaired insulin signaling in the skin might represent a novel anti-
psoriatic strategy.
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Merkel cell Carcinoma: the Swiss Experience
Mangana J1, Dziunycz P1, Civenni G2, Contassot E1, Dummer R1, Cozzio A1 
1University Hospital of Zurich, Zurich, Switzerland 2University of Zurich , Irchel, 
Anatomy, Zurich, Switzerland
Merkel cell carcinoma is a malignant neuroendocrine neoplasm which shares 
structural and immunohistochemical features with neuroectodermally derived 
cells. It arises from Merkel cells which are highly innervated neuroendocrine 
cells involved in mechanoreception. The incidence rate of this cancer increases 
with age, sun exposure and after immunosuppression. Within the last 20 years of 
time its incidence has been tripled and exceeds that of cutaneous cell lymphoma 
with a mortality rate of 30 %. Despite its impact, little is known about its biology. 
The aim of the study was the characterization of cell lines derived from fresh 
tumor samples in our department. Additionally we wanted to determine the 
expression of surface and stem cell markers from formalin-fi xed paraffi n embedded 
specimens. Two cell lines have been established from Merkel cell carcinoma 
patients. One of them was established from primary excisions and one from a 
metastatic lesion. Both cell lines grow as suspension cultures, form spheres and 
were tested for the expression of the typical neuroendocrine markers. To evaluate 
the immunophenotypic and stem cell characteristics of Merkel cell carcinoma we 
performed immunohistochemistry on 73 Merkel cell carcinoma samples using tissue 
micro arrays. As control groups we used 5 melanoma, 5 basal cell carcinoma, 5 
squamous cell carcinoma and 5 normal skin samples. Here we report on our results.
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Neurotrophins and their receptors stimulate fi broblast differentiation, migration 
and tensile strength
Palazzo E1, Marconi A1, Truzzi F1, Lotti R1, Dallaglio K1, Borroni R1, Dumas M2, Pincelli 
C1 1Dermatology, Modena, Italy 2LVMH Recherche, St. Jean de Braye, France
Neurotrophins (NGF, BDNF, NT3 and NT4) belong to a family of growth factors that 
are involved in the control of skin homeostasis. These proteins act through two kinds 
of receptors: the low-affi nity receptor p75 (p75NTR) and the high-affi nity receptors 
TrkA, TrkB and TrkC. Previous studies have shown that skin cells express NTs and 
their receptors. Because fi broblasts are critical in many physiopathologic processes, 
including wound healing, we wanted to evaluate the expression and function of 
NTs and their receptors in these cells.  Here we show that dermal fi broblasts and 
myofi broblasts, obtained by stimulation with TGF-beta, express Trks and p75NTR both 
at the mRNA and protein level, as shown by RT-PCR and Western Blot, and secrete all 
NTs, as shown by Elisa. In particular, myofi broblasts present higher levels of p75NTR 
and TrkB than fi broblasts. On the contrary, they express TrkA at lower levels and both 
cellular types don’t express TrkC. Fibroblasts and myofi broblasts also secrete NGF 
and NT3 at higher levels than NT4 and BDNF.  As TGF-beta, NGF, BDNF, NT3 or 
NT4 (100 ng/ml) promote fi broblasts differentiation into myofi broblasts, as shown by 
the induction of alpha-sma expression at 24 and 48 hours, by immunofl uorescence 
and Western Blot. Moreover, NGF or BDNF statistically increase the tensile strength 
in a dose dependent manner, as measured through the Glass Box Device. The major 
effect is obtained with the highest concentration (100 ng/ml) of NTs.  Scratching assay 
at 24 hours demonstrates that NGF, BDNF or NT3 (100ng/ml) also induce fi broblasts 
migration in statistically signifi cant manner, the effect being more evident at 48 hrs. 
These results suggest that paracrine or autocrine NTs play an important role in tissue 
remodeling and wound healing, by inducing fi broblast differentiation and migration. 
516
Neutrophil-dominant psoriasis-like skin infl ammation induced by epidermis-specifi c 
Raf expression in mice
Tarutani M, Imai Y, Tsuda T, Nakanishi K, Yamanishi K Hyogo colledge of medicine, 
Nishinomiya, Japan
Raf is one of the downstream effectors of signal transduction mediated by Ras GTPases. 
In transgenic mice bearing the 4-hydroxytamoxifen (4OHT)–responsive mutant ER 
ligand binding domain-Raf fusion gene under the control of keratin 14 promoter, the 
epidermis-specifi c Raf expression induced by topical 4OHT application caused not 
only epidermal hyperplasia but also neutrophil-dominant infl ammation of the skin. 
The expression of IL-18, IL-15 and MCP-1 and the infi ltration of infl ammatory cells into 
the skin were observed as early as 8 hr after the treatment. Administration of an anti-
Gr-1 antibody reduced the numbers of those infi ltrating cells and partially reversed 
the epidermal hyperplasia. These results suggest that Raf might be involved in the 
formation of psoriasiform skin infl ammation via the recruitment of Gr-1 positive cells.




Potentiation of neuritogenesis emphasizes lypolysis in a PC12 / 3T3-L1 cell culture 
model
Frechet M, Prouheze P, Nicolay JF Exsymol, Monaco, Monaco
White adipose tissue (WAT) innervation is participating in lipolysis regulation along with 
several humoral substances (catecholamines, hormones). Efferent sympathetic nerve endings 
deliver a neuronal signal to adipose tissue, while afferent sensory endings may behave as 
local sensors for lipid stores. Besides, adipocytes release neurotrophic factors that promote 
growth and survival of nerve endings. Taken together, these data underlie the importance of 
the interplay between neurons and adipocytes in lipolysis regulation.In order to study the 
neurotrophic effect of adipocytes on neuronal cells, we set up a two-compartment coculture 
system containing 3T3-L1 adipocytes and undifferentiated PC12, a model of peripheral 
neurons. Scoring of PC12 neurite length enabled the monitoring of neuritogenesis induced 
by adipocytes. The reference neurotrophin Nerve Growth Factor (NGF) was used as a 
positive control. We found that 3T3-L1, through secretion of soluble factors (NGF or other 
adipokines), supported PC12 differentiation and neurite outgrowth.In addition, the effect of 
neuromediators released by PC12 cells on lipolysis was determined. For this purpose, PC12 
cells were treated with NGF to induce differentiation and neuritogenesis. Culture medium 
conditioned using these cells was deposited on 3T3-L1 mature adipocytes and glycerol 
release was assessed. Conditioned medium from NGF-treated PC12 cells could stimulate 
lipolysis. Interestingly, cells treated during 4 days and presenting a limited neuritogenesis 
induced less lipolysis than cells treated during 11 days, with a very dense dendritic network. 
Here, we showed that enhancement of neuritogenesis is favourable to lipolysis. Finally, we 
present preliminary results obtained using a bioavailable molecule capable of potentiating 
NGF and adipocyte-derived neurotrophins effect on neuritogenesis. These results suggest that 
promotion of adipocyte – neurons crosstalk may be a new approach for lipolysis improvement. 
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PPAR binding protein (PBP/Med1) is involved in signaling for quiescence of follicle 
stem cells
Nakajima T, Kitagawa Y, Fushimi T, Inui S, Itami S Osaka University, Suita, Japan
PPAR binding protein (PBP: also named as TRAP220/DRIP205/Med1/RB18A) is a 
coactivator of nuclear receptors, including PPARγ and vitamin D receptor (VDR). 
PBP also regulates cell cycle and apoptosis as a cofactor of p53. PBP is expressed and 
functions as a coactivator of VDR in human epidermal keratinocytes (KC). However, 
the biological role of PBP in KC has not been fully clarifi ed because PBP null mice 
are embryonic lethal. In this study, we established keratinocyte specifi c PBP null mice 
(PBPepi-/-) using K5-Cre-LoxP system to analyze its function in KC. Development 
of the epidermis and appendages of PBPepi-/- mice was macroscopically and 
microscopically normal. Wound healing of the PBPepi-/- is also comparable to the 
wild type (WT) counterparts. However PBPepi-/- mice showed rapid progression 
of hair cycles after the second telogen, hair structural abnormalities, dermal cyst 
formation, hyperplastic sebaceous glands. The number of CD34 positive bulge 
cells of PBPepi-/- reduced more rapidly than the WT counterparts. Some of those 
phenotypes of PBPepi-/- mice are shared with not only VDR-null or RXRalpha-null 
mice but also K14-Noggin transgenic mice and KC specifi c BMP4 disrupted mice, 
indicating the relationship between BMP signaling and PBP. Some of the phenotypes 
of PBPepi-/- mice are also observed in the skin of Lhx2 and Clims defi cient mice. 
These results suggest that PBP plays roles in the maintenance of KC stem cells.
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Precursor nerve growth factor (proNGF) induces apoptosis in cultured human 
keratinocytes. Cutaneous neuropeptides may prevent cells from entering the 
apoptotic cycle
Kiss M1, Dallos A2, Kormos B1, Dobozy A1, Husz S1, Kemény L1 1University of Szeged, 
Szeged, Hungary 2Dermatological Research Group of the Hungarian Academy of 
Sciences, Szeged, Hungary
Nerve growth factor (NGF) is produced as a precursor called proNGF which is secreted by 
many tissues. NGF promotes cell survival via binding to the tyrosine kinase receptor A (TrkA). 
Its precursor, proNGF has a distinct functionality, interacting with p75NTR and sortilin receptors 
on the cell surface form a molecular complex that is capable to activate an apoptotic cascade. 
In our previous work, we demonstrated that cultured human keratinocytes secrete proNGF and 
express sortilin receptors on their surface which is modulated by cutaneous neuropeptides. The 
aim of the present work  was to study whether proNGF cause apoptosis in keratinocytes and to 
investigate the infl uence of neuropeptides substance P (SP), calcitonin gene-related peptide 
(CGRP), vasoactive intestinal polypeptide (VIP) and galanin (GAL) on keratinocyte apoptosis 
induced by proNGF. Normal human keratinocytes were cultured in keratinocyte-serum-free 
medium in 96-well plates. After 24 h, the cells were induced with proNGF (100 ng/ml) alone, 
and together with the combination of proNGF and SP, or CGRP, or VIP or GAL, respectively. 
Each of the neuropeptides was used at the concentration of 10-8 M. Cells left without treatment 
served as control. After 48 h, the extent of apoptosis was detected by using an in situ apoptosis 
detection kit (TiterTACSTM, R&D Systems). The cell cultures treated with only proNGF exhibited 
a considerable increase in apoptotic cell index (1.4) compared to the untreated cultures (1.0). In 
each of the keratinocyte cultures treated with proNGF supplemented with one of the four different 
neuropeptides above, a signifi cant decrease  was demonstrated in the apoptotic index relative to the 
cells induced with proNGF alone (0.7-0.9 vs. 1.4). Our results suggest that all players of the NGF/
proNGF pathway are present in the keratinocytes and cutaneous neuropeptides can modulate their 
expressions and actions. NGF/proNGF balance seems to be very important in skin homeostasis. 
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The heparin-binding EGF-like growth factor (HB-EGF) is part of the keratinocyte 
response at long term after different stressing conditions.
Giltaire S, Poumay Y University of Namur (FUNDP), Namur, Belgium
The Heparin-Binding EGF-like Growth Factor (HB-EGF) is an autocrine/paracrine 
growth factor for epidermal keratinocytes. HB-EGF plays a critical role during the re-
epithelization of skin by its binding to the EGF receptor, stimulating proliferation and 
migration of keratinocytes. Like other members of the EGF-family of growth factors, 
HB-EGF is synthesized as a precursor transmembrane protein (proHB-EGF) that can 
be shed enzymatically by metalloproteases to release the soluble growth factor in 
the extracellular environment. Here, we hypothesize that stressing conditions induce 
the expression and release of HB-EGF by keratinocytes, likely in order to restore the 
epidermal tissue. We have induced cellular stressing conditions in autocrine cultures 
of human keratinocytes by disrupting cell layer using mechanical treatment (scratch 
wounds), by cholesterol-depletion using the molecule methyl-beta-cyclodextrin 
(MbCD) in order to extract cholesterol from plasma membrane, by oxidative stress or 
by phorbol ester. We have analysed the cellular HB-EGF mRNA and protein levels and 
report that stressing conditions induce long term (1-8h) expression of HB-EGF. The 
metalloprotease ADAM17 is concomitantly upregulated. Moreover, we demonstrate 
that all stressing conditions initiate the release of HB-EGF, a process partly inhibited 
by addition of inhibitor of metalloproteases GM6001. Previous studies have shown 
that extracellular ATP regulates proliferation and differentiation in keratinocytes. In 
the culture medium, we also found that cellular ATP is early released after these 
treatments and observed that keratinocytes stimulated with ATP-gamma-S induce 
HB-EGF expression and activate EGFR and ERK1/2. These results strongly suggest 
that stressing conditions release ATP which probably activates purinergic receptor 
in order to induce HB-EGF expression and release, promoting epidermal healing.
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Autoantibody-induced intestinal infl ammation and weight loss in experimental 
epidermolysis bullosa acquisita
Ishii N1, Recke A2, Mihai S2, Hirose M2, Hashimoto T1, Zillikens D2, Ludwig RJ2 
1Kurume Univ School of Medicine, Kurume, Japan 2University of Lübeck, Germany
Type VII collagen (COL7) is a major constituent of the cutaneous basement membrane. Loss of tolerance 
to COL7 leads to the blistering skin disease, epidermolysis bullosa acquisita (EBA). Antibodies to COL7 
have also been noted in patients with infl ammatory bowel disease (IBD). Yet, reports on the expression 
of COL7 in the gut are controversial and a pathogenic relevance of anti-COL7 autoantibodies in IBD 
has not been demonstrated. In a fi rst set of experiments, we therefore characterized expression patterns 
of COL7 in murine gastrointestinal organs by RT-PCR and indirect immunofl uorescence microscopy. 
These studies demonstrated COL7 expression in oral mucosa, esophagus, stomach, duodenum, and 
colon, with the strongest expression in oral mucosa and the lowest in duodenum.  To study if anti-
COL7 antibodies induce an infl ammatory response in the gut, mice were injected with a previously 
characterized rabbit antibody to murine COL7 (passive EBA mouse model) or with a fragment of 
murine COL7 (active EBA mouse model). After induction of EBA, organ samples were analyzed by H&E 
straining, direct immunofl uorescence microscopy and by immunohistochemistry. As expected, in both 
passive (n=10) and active (n=8) animal models, mice developed extensive skin blistering. Interestingly, 
in most mice, autoantibodies to COL7 also bound to the gastrointestinal mucosal basement membrane 
assessed by indirect IF microscopy, fi xed complement, and lead to the recruitment of leukocytes. Blister 
formation in esophagus (40% of passive and 37.5% of active model, respectively), stomach (40% of 
passive and 62.5% of active model), duodenum (20% of passive and 12.5% of active model), and 
colon (20% of passive and 12.5% of active model) was also observed. In line, we observed a signifi cant 
weight loss in both the active and passive EBA model compared to mice injected with a control rabbit 
antibody or a control peptide, respectively, suggesting that the autoantibody-induced gastrointestinal 
infl ammation is of functional relevance. Our results provide strong evidence that COL7 is expressed 
in different portions of the gut and that anti-COL7 antibodies induce tissue damage in the gut.
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IL-21, a new player in pathogenesis of psoriasis
Botti E1, Caruso R2, Sarra M2, Diluvio L1, Pallone F2, Chimenti S1, Monteleone G2, 
Costanzo A1 1University of Rome Tor Vergata Dermatology, Rome, Italy 2University of 
Rome Tor Vergata Gastroenterology, Rome, Italy
Psoriasis is a chronic infl ammatory skin disease affecting 2-3% of caucasian population 
and causes relevant reduction in quality of life. Although the exact pathogenetic 
mechanisms underlying the development of this disease are not fully understood yet, 
T cells seem to be crucial mediators of the skin damage in psoriasis. T-cell induced 
damage is mediated by the secretion of several cytokines including TNF-α, IFN-γ, IL-22 
and IL-23. Recently CD4 positive T cells characterized by secretion of  IL-17A (Th-17 
cells) were described in discrete population in dermis of psoriatic plaques. These cells 
are thought to be a major player in psoriasis pathogenesis being important producers 
of  IL-22 and other infl ammatory cytokines in response to IL-23. Interestingly IL-21, 
a “ γ chain cytokine “ was recently involved in differentiation of naïve CD4 positive 
T cells to Th-17 cells acting upstream IL-23 and found to be important mediator in 
pathogenesis of autoimmune infl ammatory disorders. Therefore we investigated the 
role of IL-21 in the pathogenesis of psoriasis by studying its expression in skin and 
peripheral blood of psoriasis patients and by blocking its activity in human psoriasis 
skin grafts transplanted onto severe combined immunodefi cient (SCID) mice. 
We have found that IL-21 is highly expressed in the skin and peripheral blood of 
psoriatic patients, and causes psoriasis-like hyperplasia when injected intradermally 
into mice.  IL-21 directly induces keratinocytes proliferation in a MAPK dependent 
manner. In the human psoriasis-xenograft mouse model antibody-mediated blockade 
of IL-21 activity leads to a resolution of infl ammation and reduces keratinocyte 
proliferation. IL-21 mediated proliferation is independent from IL-23/IL-22 axis. 
These results support an important role for IL-21 in the pathogenesis of psoriasis.
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Identifi cation of a novel skin homing V9V2 T cell subset and its potential 
implication in the immunopathogenesis of psoriasis
Laggner U, Di Meglio P, Hundhausen C, Perera G, Smith CH, Barker J, Hayday A, 
Nestle F King’s College London, London, United Kingdom
γδ T cells are key players in skin immunology in mice. However, little is known 
about their function in human skin under homeostatic and infl ammatory 
conditions. In this study we aimed to investigate the role of Vγ9Vδ2 T cells in skin 
immunosurveillance and in a major skin pathology such as psoriasis. We analysed 
expression of skin homing markers and skin associated chemokine receptors on 
γδ T cells using fl ow cytometry. We found a distinct population of Vγ9Vδ2 T cells 
expressing CLA and CCR6 indicating T cells specialised for entry into cutaneous 
sites. CCR6 receptor was functional as demonstrated by transwell migration and 
receptor downregulation assay. Upon activation skin homing Vγ9Vδ2 produced 
the pro-infl ammatory cytokines IFNγ and TNFα as well as chemokines associated 
with attracting infl ammatory cells (IL-8, RANTES). Subsequently we investigated the 
potential implication of Vγ9Vδ2 T cells in the pathogenesis of psoriasis. Analysing 
peripheral blood of psoriasis patients (n=62) and controls (n=31) by fl ow cytometry 
we found a highly signifi cant decrease of Vγ9Vδ2T cells in psoriasis patients as 
compared to controls. This decrease was associated with increased disease severity. 
Interestingly, skin homing CLA+Vγ9Vδ2 T cells were preferentially decreased while 
the CLA- subset was equivalent in patients and controls. Using immunofl uorescence 
microscopy we detected Vγ9Vδ2 T cells in psoriatic lesions but not in healthy skin 
indicating a redistribution of skin homing Vγ9Vδ2 T cells from blood during skin 
infl ammation.We identify a novel skin homing Vγ9Vδ2 T cell subset with a pro-
infl ammatory cytokine profi le and establish its potential signifi cance in psoriasis.
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Non-allergenic mediators from pollen induce mast cell dependent skin 
infl ammation
Metz M1, Gilles S2, Heydrich S1, Traidl-Hoffmann C2, Maurer M1 1Charité - 
Universitätsmedizin Berlin, Berlin, Germany 2ZAUM-Center for Allergy and 
Environment, HelmholtzCenter/Technische Universität München, Munich, Germany
Allergic individuals sensitized to birch or artemisia can suffer from seasonal allergic rhinoconjunctivitis, 
mediated by pollen-derived allergens which induce an IgE-dependent activation of mast cells (MC). It 
has recently been shown that pollen not only release allergens but also bioactive lipids which are able 
to activate human neutrophils and eosinophils in vitro. Herin, we followed the hypothesis that non-
allergenic pollen-derived mediators induce immediate infl ammatory reactions in non-allergic mice. 
To address this hypothesis, we fi rst prepared aqueous pollen extracts (APE) from birch pollen and 
administered them i.d. into the ears of naïve mice. This resulted in a rapid, dose-dependent and strong 
infl ammation, as assessed by measuring changes in ear thickness. Since the kinetics of the ear swelling 
response resembled MC-dependent infl ammatory skin reactions, we next compared the ear swelling 
response to APE in MC-defi cient KitW/KitW-v and the corresponding Kit+/+ wildtype mice. In contrast 
to Kit+/+ mice, even at the highest concentration of APE from birch pollen no signs of infl ammation were 
observed in MC-defi cient mice. To confi rm that this infl ammatory reaction is indeed MC mediated and 
not due to other defi ciencies in the Kit mutant mice we selectively repaired the MC-defi ciency in the 
ears of KitW/KitW-v mice by i.d. engraftment with bone marrow-derived cultured MC. MC engraftment 
completely restored the infl ammatory response following injection of 100µg APE from birch pollen, 
thus proving a MC-dependent skin infl ammation by birch pollen APE. Similar experiments performed 
with APE from Artemisia also exhibited a strong MC-dependent skin infl ammation, indicating that 
various pollen have the ability to release MC activating substances in nonsensitized mice. Our data 
show that water soluble, non-allergenic mediators from birch and artemisia pollen effectively induce 
MC-dependent skin infl ammation. It is tempting to speculate that under natural exposure conditions 
these mediators could serve as adjuvant in sensitization to allergens or aggravation of allergic responses.
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Identifi cation of a Novel Receptor For S100a8/A9, A Key Mediator of Infl ammation 
in Human Skin
Hibino T1, Sakaguchi M2, Ehama R1, Yamamoto M3, Motoyama N1 1Shiseido Research 
Center, Yokohama, Japan 2Okayama University Graduate School of Medicine, 
Okayama, Japan 3Tokyo Medical University, Dept of Dermatology, Tokyo, Japan
S100A8 and S100A9 are known to be up-regulated in hyperproliferative skin diseases such as psoriasis. 
It is suggested that two proteins form a heterodimer in vivo and the heterodimer plays a critical role 
in various infl ammatory conditions.  Recently we have reported the presence of a positive feedback 
loop between S100A8/A9 and the infl ammatory cytokines in human keratinocytes.  When S100A8/
A9 were applied to the cultured keratinocytes, they induced expression of a number of cytokine genes 
such as CXCL1, CXCL2, CXCL3, CCL20, IL-6, IL-8 and TNFalpha that are known to be up-regulated in 
psoriatic epidermis.  In addition, the S100A8/A9-induced cytokines in turn enhanced production and 
secretion of S100A8 and S100A9 by human keratinocytes.  However, signal transduction pathways 
from S100A8/A9 to cytokine induction are still obscure.  In this study, we tried to identify a receptor for 
S100A8/A9 involved in this positive feedback mechanism. Using LS/MS/MS-based shotgun proteomics, 
we identifi ed CD147 in the immunoprecipitates of S100A8/A9-treated human keratinocytes using 
anti-S100A9 antibody.  In order to investigate the interaction between S100A8, S100A9 and CD147, 
these molecules were over-expressed in 293 cells using CMV promoter.  We found that S100A9 and 
CD147 were specifi cally co-immunoprecipitated. In addition, induction of IL-6, IL-8 and TNFalpha by 
S100A8/A9 was signifi cantly suppressed by down-regulation of CD147 using siRNA in the cultured 
keratinocytes.  We concluded that CD147 is a novel receptor for S100A8/A9.  Immunohistochemical 
analyses showed that S100A8/A9 heterodimer was hardly detectable in normal human epidermis, and 
weak staining of CD147 was found in the upper layer.  In contrast, both were strongly up-regulated in 
the lesional epidermis with psoriasis.  A proximity ligation assay suggested that S100A8 and S100A9 
as well as S100A9 and CD147 would be present in proximate positions each other in the psoriatic 
epidermis.  These lines of evidence indicate that CD147 is a novel receptor for S100A8/A9 and the 
interaction plays a pivotal role in the pathophysiology of infl ammatory skin diseases including psoriasis.
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Characterization of functions and egress mechanism on skin regulatory T cell us-
ing Kaede-transgenic mice
Honda T1, Tomura M2, Otsuka A1, Tanizaki H1, Kanagawa O2, Miyachi Y1, Kabashima 
K1 1Kyoto University, Kyoto, Japan 2RIKEN, Yokohama, Japan
Dynamic immune cell movements and interactions cause skin immune response. 
However, it remains uncertain whether skin-infi ltrated lymphocytes move from 
skin into draining lymph nodes (DLNs) under pathophysiological conditions. 
Here we succeeded in analyzing the lymphocyte movements from the skin using 
transgenic mice expressing Kaede, a photoconvertible protein changing from 
green to red by violet light. Even in the steady state, CD4+ T cells migrated from 
skin to DLNs, which was more enhanced in contact hypersensitivity reactions. In 
addition, a high proportion of Kaede-red CD4+ T cells migrating from the skin were 
Foxp3+ regulatory T cells (Tregs). These Kaede-red Tregs inhibited DNBS-induced 
proliferation of LN cells sensitized with DNFB in vitro and contact hypersensitivity 
response in vivo more extensively than Kaede-green LN-resident Tregs. In addition, 
these Kaede-red Tregs showed higher expressions of CD25, CD44, CD69, CD103, 
CCR4, and CCR5, and lower expressions of CD62L and CCR7 than Kaede-green 
Tregs, and had an ability to migrate back to the skin. These results suggest that skin-
infi ltrated Tregs egress into DLNs and then circulate to attenuate immune responses.
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Isolation and characterization of autoreactive human Mabs from pemphigus 
vulgaris patients
Di Zenzo G1, Di Lullo G2, Calabresi V1, Sinistro A1, Didona B3, Cianchini G4, Eming 
R5, Hertl M5, Zambruno G1, Lanzavecchia A2 1Molecular and Cell Biology Laboratory, 
IDI-IRCCS, Rome, Italy 2Inst for Research in Biomedicine-IRB, Bellinzona, Switzerland 
3I Derm Division, IDI-IRCCS, Rome, Italy 4V Dermatology Division, IDI-IRCCS, Rome, 
Italy 5Dept of Dermatology & Allergology, Philipp’s University, Marburg, Germany
Pemphigus vulgaris (PV) is a life-threatening autoimmune blistering disease of skin and mucous membranes 
associated with autoantibodies against the cadherin-type adhesion molecules desmoglein (Dsg)3 and Dsg1. 
The binding of IgG antibodies to Dsg on epidermal keratinocytes leads to intraepithelial blister formation. At 
present, the involvement of anti-Dsg antibodies in PV pathogenesis is well-established, while the mechanism 
of blister formation is only partly defi ned. In addition, autoantibodies against other epithelial antigens have 
been described, suggesting the occurrence of epitope spreading phenomena. To gain a better insight into 
PV pathophysiology, we have used a previously developed method for the effi cient immortalization of IgG+ 
memory B cells with Epstein Barr virus and a Toll-like receptor agonist. By applying this methodology to samples 
from 3 patients with active PV, we have isolated 13 human monoclonal antibodies (hMabs) specifi c for Dsg3 
ectodomain, 3 hMabs cross-reactive for Dsg1 and 3, as well as 20 hMabs reactive with intracellular epithelial 
antigens and 1 hMabs recognizing a membrane antigen. Four of 16 anti-Dgs3 hMab showed pathogenic 
activity and recognized a calcium-dependent conformational epitope. Cross-competition experiments 
suggested that the epitopes recognized by 2 pathogenic hMabs are located in the NH2-terminal region of 
the Dsg3 ectodomain. The sequencing of the variable portions of the heavy and light chain immunoglobulin 
genes of 10 Dsg-specifi c hMabs isolated from a PV patient showed restricted patterns of heavy and light chain 
gene usage. Immunoblotting and immunoprecipitation studies indicated periplakin and a 100 kDa protein 
as possible targets of 2 hMabs that did not react with Dsgs. In conclusion, we isolated pathogenetic and non 
pathogenetic hMabs recognising Dsg1 and Dsg3, as well as other epithelial antigens, that could represent 
valuable tools for disease diagnosis and for investigating mechanisms of blister formation in pemphigus.
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Self-peptide treatment prolongs survival in murine autoimmunity via CD8/Valpha2-
(co)receptor tuning and reduction of both IL2-/IL7-induced STAT5-signaling and 
effector cytokines
Gutermuth J, Nograles K, Nelson E, Miyagawa F, Cho YH, Katz SI National Institutes 
of Health, Bethesda, USA
While the pathogenic role of B cells and CD4 T cells has been studied extensively, less is known 
about the role of CD8 T cells in autoimmunity and self-tolerance.  To evaluate the role of CD8 
T cells in autoimmunity and their potential modulation, we utilized mice expressing ovalbumin 
under control of the keratin-14 promoter in the skin, tongue, esophagus and thymus (sOVA mice). 
To generate a spontaneous model of autoimmunity, sOVA mice were crossed to OT-I mice, whose 
CD8 T cells carry a transgenic T cell receptor with specifi city for the OVA257-264-peptide (OVAp). 
80-85% of F1 (sOVA/OT-I) mice die by d21, due to infl ammation in multiple organs and diminished 
food intake. Prophylactic ip OVAp injections on both d5 and d9 after birth induced a dose dependent 
increase of sOVA/OT-I survival of 98% (100?g OVAp) and 60% (10μg) by day 21, whereas 1?g 
OVAp or PBS led to death of all mice. Furthermore, therapeutic injections on day 10 of life, when F1 
mice show overt signs of disease (growth restriction and neurological signs) still increased survival 
to 58% compared to PBS-treated mice that uniformly died. FACS analysis of skin draining lymph 
nodes of healthy survivors (either spontaneous or OVAp-treated) at d35 revealed reductions of 
(i) CD8 T cells (-95.4% to -98.5%), (ii) CD8 cell surface expression (-63% to -68%), (iii) Valpha2 
expression (47% to 60% of CD8 T cells were V alpha 2-negative), and (iv) reduced production 
of effector cytokines (IFN-gamma, TNF-alpha) as compared to OT-I controls or sick F1 mice. In 
addition, CD8 T cells from healthy mice failed to proliferate when cultured with OVAp-pulsed 
splenocytes. Nor did these cells proliferate in the presence of IL-2. FACS analysis of pSTAT5 protein 
showed a block of IL-2/IL-7 mediated signaling, thus providing a basis for low CD8 expression and 
failure of IL-2 to break anergy in CD8 T cells of healthy F1 mice. Thus, prophylactic and therapeutic 
self-peptide injections trigger multiple tolerance mechanisms and attenuate disease in sOVA/OT-I 
mice, making this treatment approach a potential paradigm for modulating autoimmune diseases.




Association study between auto-immunity genetic markers, melanoma susceptibility and prognosis
Guedj M1, Descamps V2, Dieude P2, Dupin N3, Wolkenstein P4, Saiag P5, Lebbe C6, Basset-Seguin 
N7, Grandchamp B2, Soufi r N2 1Programme CIT 2Hôp Bichat Claude Bernard 4Hôp Tarnier 5Hôp 
Henri Mondor 6Hôp Ambroise Paré Boulogne Billancourt 7Hôp Saint Louis: France
Auto-immunity has been shown to be associated with a better outcome and in interferon alpha-treated 
melanoma patients. In addition, polymorphism in NALP1 has recently been shown to be associated to vitiligo, 
a symptom often associated with an immune response in melanoma patients. Considerable progresses have 
been made in knowledge of genetic basis of auto-immunity. In this work, we performed for the fi rst time an 
association study between numerous autoimmune genetic markers, melanoma susceptibility and prognosis.
Thirteen SNPs belonging to 10 genes implicated in auto-immunity (FCRL3-rs7508684, NALP1-rs6502867, 
TLR5-rs5744168, TYK2-rs12720270, TYK2-rs2304256, PTPN22-rs2488457, PTPN22-rs2476601, PDCD1-
rs11568821, PDCD1-rs2227981, SUMO4-rs237025, ZFP36-rs3746083, IFIH1-rs1990760, TNFRSF1B-
rs1061622) were genotyped in 700 melanoma patients (MelanCohort) and respectively 150 (TLR5, TYK2, 
PTPN22, PDCD1, SUMO4, ZFP36, IFIH1, TNFRSF1B), 465 (FCRL3), and 937 (NALP1) Caucasian controls. For 
each genetic variant, we fi rst compared genotypes in patients and controls with a Fisher exact test according 
to the additive model. Stratifi ed analyses were conducted to test for any genotype association with melanoma 
genetic subgroups (familial, multiple, associated to skin carcinoma), histological subtype, and tumor location. 
Tumor progression was investigated according to two parameters: Breslow index (analysis of variance) and 
sentinel lymph node invasion (positive versus negative).Two SNPs (IFIH1-rs1990760, FCRL3-rs7508684) had 
a protective effect on melanoma risk (P value= 0.027, OR= 0.76 (0.60-0.97), P value = 0.032, OR= 0.83 
(0.70-0.98). In addition, NALP1 genotype was associated with Breslow index (P value= 0.008), and FCRL3.
rs7508684 was moderately associated with lymph satellite node invasion (P value=0.03). Our result suggest that 
genetic variants in genes belonging to auto-immunity pathways may infl uence the occurrence of melanoma. 
In addition, some of these variants may also have an impact on melanoma progression and prognosis, 
independently of interferon therapy. Our data are comforted by previous observations: the appearance of clinical 
or biological autoimmunity signs (vitiligo, antibodies) during treatment with interferon alfa-2b is associate
530 [Oral 096]
T cell labelling modalities for non invasisve in vivo T cell tracking
Griessinger C, Bukala D, Wiehr S, Ehrlichmann S, Kehlbach R, Bantleon R, Reichl G, 
Pichler B, Röcken M, Kneilling M Eberhard Karls University, Tübingen, Germany
Non invasive imaging of cell traffi cking is an important tool for pre-clinical studies to get a better 
understanding of the effector phase of T cell mediated autoimmune diseases. To get a better 
understanding about the migration properties of T cells, high sensitive multimodality imaging is 
an important tool for preclinical studies. T cell migration kinetics, homing or proliferation sites in 
infl ammation models are still unknown. In comparison, T cell labelling was performed by small iron 
particles for visualization, by magnetic resonance imaging by a fl uoroprobe for optical imaging, by 
radio labelling with [Cu-64]PTSM and [In-111]oxine for positron emission tomography (PET) or 
single photon emission tomography (SPECT), respectively. We compared all four different labelling 
methods by using interferon-γ (IFN-γ) producing ovalbumin (OVA) specifi c Th1 cells and assessed 
viability (Trypan blue staining), OVA-specifi c T cell functioning (specifi c IFN-γ expression by ELISA) 
and double strand brakes (phosphorylated histone H2AX-γ) of the cells at different time points after 
labelling. For each experiment 106 Th1 cells were incubated for 6 hours with iron particles, for 1 
up to 5 minutes with Cy5 dye, for 15 minutes up to 4.5 hours with [Cu-64]PTSM (740 – 2260 kBq), 
and for 15 minutes with [In-111]oxine. Labelling of the Th1 cells with iron particles (SPIOS)and Cy5 
did not infl uence specifi c IFN-γ secretion or viability. 24 hours after [Cu-64]PTSM and [I-111]oxine 
(740 kBq) labelling specifi c IFN-γ expression was reduced to 20%. A signifi cant increase (factor of 
10 compared to unlabeled cells) of double strand brakes was measured for the radiolabeled cells. 
Although radiolabelling of Th1 cells infl uence specifi c cell functions, in vivo high sensitivity nuclear 
imaging is still possible for the fi rst 48 hours after cell labelling. microPET studies using [Cu-64]
PTSM labelled cells were performed in an animal model for delayed-type hypersensitivity reaction 
and lung infl ammation analyzing the dynamic of cell migration into single lymph nodes, in vivo. 
Thus, non invasive in vivo investigation of T cell traffi cking using [Cu-64]PTSM labelled T cells and 
microPET provides an important tool gain important information about the mode of T cell traffi cking.
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Activation of PPAR delta in vivo replicates major elements of psoriasis
Romanowska M, Reilly L, Palmer C, Foerster J University of Dundee, UK
We previously reported that the nuclear hormone receptor peroxisome proliferator 
activator receptor (PPAR) delta is overexpressed in psoriasis. PPAR delta is a key 
regulator of adipogenesis and glucose metabolism. In adult mice, PPARd is not 
normally expressed in the skin. Here, we show that activation of PPAR delta in 
murine skin triggers a skin disease resembling psoriasis, including epidermal 
acanthosis, basal-cell hyperproliferation, endothelial activation, and  T cell infl ux. 
The phenotype is induced within 14 days upon administration of a PPAR delta-
specifi c agonist and shows  maximal severity at sites of mechanical friction. Th17 
cells are involved in disease pathogenesis and their elimination signifi cantly reduces 
disease severity. Expression profi ling showed signifi cant overlap between gene 
dysregulation in PPAR delta transgenic mice and that characteristic of psoriasis, 
suggesting that several gene expression programs characteristic of psoriasis can 
be explained by PPARd activation, including, e.g., IL-1 signalling and adipocyte 
differentiation. Our results indicate that PPAR delta may contribute to the psoriasis 
pathogenesis. In particular, the known effect of glucose turnover and caloric intake 
on PPARd expression suggests a molecular linke between metabolic disease and 
psoriasis. Moreover, several features of the novel mouse model (rapid onset, Th17 
dependence, immunocompetent background, responsiveness to therapy, complete 
reversibility) suggest that it may be useful to explore novel therapeutic strategies.
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Analysis of Allylisothiocyanate and Capsaicine-induced Neurogenic Infl ammation
Jain A, Brönneke S, Kühnl J, Kolbe L, Stäb F, Neufang G Beiersdorf AG, Hamburg, 
Germany
The natural plant-derived products allylisothiocyanate (AITC) and capsaicine (CPC) 
are used interchangeably to induce equivalent symptoms of pain and neurogenic 
infl ammation. AITC- and CPC-evoked effects are mediated by the transient 
receptor potential ankyrin 1 (TRPA1) channel and the transient receptor potential 
vanilloid 1 (TRPV1) channel, respectively. Here, we investigate the infl ammatory 
symptoms and the molecular mechanisms evoked by topical application of 
AITC and CPC on human skin in vivo and in vitro. Our results demonstrate that 
treatment with CPC -but not with AITC- provokes axonrefl ex erythema, edema 
and mechanical allodynia. Therefore, CPC and AITC trigger different kinds of 
infl ammatory reactions even though sharing certain similar symptoms (e.g. pain, 
primary erythema, heat-hyperalgesia). Analysis of the molecular mechanisms of 
AITC- and CPC-mediated neurogenic infl ammation provided evidence that AITC 
and CPC induce different secretion patterns of the lipid mediators PGE2 and LTB4 
in vivo and in vitro. Furthermore, we observed the expression of functional TRPV1 
and TRPA1 channels on human dermal fi broblasts and keratinocytes suggesting 
a role of non-neuronal skin cells in the activation or sensitization of peripheral 
nociception. Taken together, our data demonstrate a discriminative modulation of 
sensory perception and induction of neurogenic infl ammation by AITC and CPC.
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Anti-Fas Ligand neutralizing antibodies prevent acantholysis both in vitro and in vivo
Marconi A1, Lotti R1, Truzzi F1, Dallaglio K1, Borroni R1, Palazzo E1, Kitajima Y2, 
Pincelli C1 1University of Modena and Reggio Emilia, Modena, Italy 2Gifu University, 
Gifu, Japan
While anti-desmoglein (dsg) antibodies are essential for the development of pemphigus, the 
molecular mechanisms underlying cell-to-cell detachment (acantholysis) are still to be fully 
clarifi ed. We had fi rst proposed an important role for apoptosis in the pathomechanisms 
of blister formation. In this study, we have analyzed in details the apoptotic process and 
the role of Fas Ligand (FasL) in relation to acantholysis. Here, we present evidence that the 
effector caspase-3 is activated in lesional and perilesional skin of pemphigus. Untreated 
pemphigus sera contain signifi cantly higher levels of FasL than sera from healthy controls 
and treated sera. Moreover, untreated but not steroid-treated pemphigus sera induce 
apoptosis in normal human keratinocytes in culture, with the activation of caspase-8. 
Because caspases can cleave adhesion molecules in many cell settings, we evaluated 
whether pemphigus sera can cleave dsg. Indeed, sera from untreated patients induced the 
cleavage of both dsg-1 and 3. Moreover, recombinant FasL cleaves dsg-1 and 3 in a dose 
and time-dependent manner. Anti-FasL neutralizing antibodies and caspase-8 inhibitor 
prevent both dsg cleavage and keratinocyte dissociation induced by untreated pemphigus 
sera. Caspase-8 and caspase-3 activation occurs at 2 and 4 hrs, respectively, while dsg 
cleavage and keratinocyte dissociation take place at 6 and 24 hrs, respectively, indicating 
that apoptosis precedes acantholysis in vitro. Finally, using the “passive transfer” pemphigus 
mouse model, we were able to prevent apoptosis and blister formation, by injecting anti-
FasL neutralizing antibody 3 hours after PVIgG administration, as measured by counting 
the number of clefts/blisters in histology sections from treated vs. untreated mice and 
TUNEL staining. This strongly indicates that FasL plays a pivotal role in blister formation.
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Autoantibodies in IPEX Patients Recognize Keratin 14
Huter EN1, Natarajan K2, Torgerson TR3, Glass DD2, Shevach EM2 1University of 
Heidelberg, Heidelberg, Germany 2NIAID, Natl. Institutes of Health, Bethesda, USA 
3Dept. of Pediatrics, University of Washington, Seattle, USA
For many autoimmune disorders the nature of the antigenic targets are unknown. The 
Scurfy mouse spontaneously develops autoimmune disease due to a loss-of-function 
mutation in the foxp3 gene, a transcription factor important for the development and 
function of regulatory T cells. The skin is one of the main organs affected in Scurfy 
mice and we have previously shown, that several keratins, including keratin 14, are 
targets for autoreactive B cells in the skin.Patients with the rare “Immunodysregulation, 
Polyendocrinopathy, Enteropathy, X-linked syndrome” (IPEX) suffer from generalized 
autoimmunity due to the same mutation in the FOXP3 gene and often present with 
severe atopic-dermatitis-like skin disease.The purpose of this study was the evaluation 
of keratin 14-reactivity in IPEX patients with or without skin disease. We used sera 
from IPEX patients for western blot analysis: Two patient sera showed reactivity to 
keratinocyte extract, and interestingly one of the patients with skin disease yielded 
the strongest signal. We used the serum of this patient for a 2D-gel electrophoresis 
followed by Protein Identifi cation and identifi ed keratin 14, keratin 10 and keratin 
1 as targets recognized by the autoantibodies. To conclusively demonstrate that the 
autoantibodies target keratin 14, we expressed 3 protein fragments covering the whole 
keratin 14 protein and used them for western blot analysis with the IPEX patient 
serum. As in Scurfy mice, the C-terminal fragment of keratin-14 was predominantly 
recognized by the patient serum. In summary we show that autoantibodies from 
IPEX patients recognize different keratins including keratin 14 and conclude that 
keratin 14 is an antigenic target in autoimmune skin disease in IPEX patients. 
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Autoantibody against Caspase-3, an Executioner of Apoptosis, in Patients with 
Systemic Sclerosis
Okazaki S1, Ogawa F1, Iwata Y1, Hara F1, Muroi E1, Komura K1, Takenaka M1, Shimizu 
K1, Fujimoto M2, Sato S1 1Nagasaki University Graduate School of Biomedical 
Sciences, Nagasaki, Japan 2Kanazawa University Graduate School of Medical 
Science, Kanazawa, Japan
To determine the presence or levels of antibodies (Abs) against caspase-3 and their 
clinical relevance in systemic sclerosis (SSc). Anti-caspase-3 Ab was examined by 
enzyme-linked immunosorbent assay and immunoblotting using human recombinant 
caspase-3. Caspase-3 activity was evaluated by fl uorometric detection of cleavage 
from 7-amino-4 trifl uoromethyl coumarin-labeled Asp-Glu-Val-Asp, a substrate of 
caspase-3. IgG but not IgM anti-caspase-3 Ab levels in SSc patients were higher than 
in normal controls. SSc patients positive for IgG anti-caspase-3 Ab had signifi cantly 
longer disease duration, more frequent presence of decreased %VC and %DLco, 
and elevated levels of serum immunoglobulin and erythrocyte sedimentation rates 
than those negative. Furthermore, IgG anti-caspase-3 Ab levels correlated positively 
with serum IgG levels, renal vascular resistance determined by color-fl ow Doppler 
ultrasonography, and serum levels of 8-isoprostane, a marker of oxidative stress. 
Immunoblotting analysis confi rmed the presence of anti-caspase-3 Ab in sera from 
SSc patients. Caspase-3 enzymatic activity was inhibited by IgG isolated from SSc 
sera containing IgG anti-caspase-3 Ab.These results suggest that autoantibody against 
caspase-3, one of executioners of apoptosis, is generated in SSc and that this Ab is 
related to the severity of pulmonary fi brosis, vascular damage, and infl ammation.
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Benefi cial and dramatic effects on the regulatory T cell compartment resulting from 
mast cell defi ciency and majority
Mrabet-Dahbi S, Latuske AM, Loddenkemper C, Maurer M Charité-Universitätsmedizin 
Berlin, Berlin, Germany
Regulatory T cells (Tregs) are markedly reduced in atopic dermatitis skin lesions but in striking 
contrast accumulated at sites of chronic infections. Since mast cells (MCs) critically determine 
allergic reactions and MC-defi ciency, as characteristic for KitW/KitW-v mice, promotes 
susceptibility to pathogens, we hypothesized that MCs can modulate Treg numbers and functions. 
Using the MACS separation technology CD4+CD25+ T cells (Tregs) were positively selected from 
splenocytes of naïve C57BL/6 mice (purity: > 90%), subjected to anti-CD3/anti-CD28 activation 
and then cocultured with peritoneum-derived cultured MCs (PCMCs) at a 1:1 and 100:1 ratio for 
3 days. FACS analyses revealed a pronounced decline in Treg numbers paralleled by a dramatic 
decrease of CD25 expression of Tregs in cocultures performed with 1:1 but not 100:1 Treg-MC 
ratios (CD4+ cells: “Treg” 8476 vs “Treg-MC 1:1” 1484; p=0.02, vs “Treg-MC 100:1” 6932; 
p=0.50 and fl uorescence intensity CD25: “Treg” 4016 vs “Treg-MC 1:1” 450; p=0.01, vs “Treg-
MC 100:1” 1935; p=0.15). Moreover, Tregs derived from 1:1, but not 100:1Treg-MC cocultures, 
failed to inhibit IL-6 production during activation of conventional T cells (Tconv) (IL-6: “activated 
control Tconv” 625 pg/ml vs “Tconv plus Treg-MC 1:1” 956 pg/ml; p=0.006 and vs “Tconv plus 
Treg-MC 100:1” 288 pg/ml; p=0.007). Contrary, immunohistochemistry of spleens derived from 
MC-defi cient KitW/KitW-v mice revealed a predominance of larger, Foxp3-enriched T cell regions 
(Foxp3+ cells KitW/KitW-v: 3545 vs Foxp3+ cells Kit+/+: 1795; n=5) accompanied by higher 
Treg proliferation and IL-10 production upon TCR signaling ex vivo when compared to wildtype 
Tregs (BrdU+Foxp3+ KitW/KitW-v: 12% vs BrdU+Foxp3+ Kit+/+: 3.6%; p<0.001, and IL-10 KitW/
KitW-v: 227 pg/ml vs IL-10 Kit+/+: 30 pg/ml; p=0.006, n=4). Collectively, this novel MC function 
may be relevant for the pathogenesis of diseases with abnormal Treg numbers and/or activity.
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Caspase-5 is upregulated in psoriasis
Salskov-Iversen M, Johansen C, Kragballe K, Iversen L Aarhus University Hospital, 
Aarhus, Denmark
Caspase-5 belongs to the family of infl ammatory caspases. Caspase-1 is a well-
described member, responsible for the activation of the proinfl ammatory cytokines 
IL-1betaand IL-18. The role of caspase-5 is less clear, but it has been suggested that 
caspase-5 might be an upstream activator of caspase-1. Infl ammatory caspases are 
believed to play a pivotal role in innate immune responses and may link innate 
immunity to auto-infl ammatory diseases like psoriasis. The purpose of this study was 
to characterise caspase-5 in psoriatic skin including stable psoriatic plaques and acute 
guttate elements. Finally, we studied the induction of caspase-5 mRNA.Paired biopsies 
were taken from nonlesional psoriatic skin, stable plaques and guttate elements 
from 6 patients with moderate to severe psoriasis. Caspase-5 mRNA and protein 
was analysed using quantitative RT-PCR and Western blotting techniques. Cultured 
normal human keratinocytes were stimulated in 3-24 hours with IFN-gamma, 10ng/
µl before caspase-5 mRNA was measured in RNA extracts by RT-PCR.We found a 23-
fold upregulation (p<0.05) of caspase-5 mRNA in stable plaque psoriasis compared 
with nonlesional psoriatic skin. Guttate elements revealed 36-fold increase (p<0.05) 
compared with nonlesional psoriatic skin. We found no statistically signifi cant 
difference in caspase-5 mRNA between plaques and guttate elements in these 6 
patients. Protein studies revealed a 1.4 fold increase (p<0.05) in caspase-5 in lesional 
psoriatic skin compared with nonlesional skin. RT-PCR analysis on IFN-gamma 
stimulated human keratinocytes showed a signifi cant and time dependent upregulation 
of caspase-5 mRNA during 3-24 hours stimulation. In conclusion, we found signifi cant 
upregulation of both caspase-5 mRNA and protein expressions in lesional psoriatic skin 
compared with nonlesional psoriatic skin. Furthermore, in vitro studies in keratinocyte 
cultures suggest an important role of IFN-gamma in the regulation of caspase-5.
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Characterization of 14-3-3 isoforms in Psoriasis, Basal Cell Carcinoma, Atopic 
Dermatitis and Contact Dermatitis
Raaby L, Otkjær K, Johansen C, Kragballe K, Iversen L Aarhus University Hospital, 
Aarhus, Denmark
14-3-3 are highly conserved proteins involved in a number of cellular processes 
including cell signalling, regulation of cell cycle and transcription. Seven isoforms of 
the protein have been identifi ed; β, ζ, γ, η, υ, τ and σ. The expression profi le of the 
various isoforms in skin diseases is unknown. The aim of this study was to investigate 
the expression of the different 14-3-3 isoforms in lesional skin and nonlesional skin in 
patients with psoriasis, atopic dermatitis, contact dermatitis (induced by nickel) and 
basal cell carcinoma. Punch biopsies from lesional and nonlesional skin were analyzed 
with quantitative reverse transcription-polymerase chain reaction to determine the 
mRNA expression of the 14-3-3 isoforms. The protein level of the 14-3-3 isoforms 
was measured by Western blotting technique in keratome biopsies from patients with 
psoriasis. We demonstrated a signifi cant (p<0.05) 2 fold increase in mRNA expression 
of 14-3-3σ and ó in lesional psoriatic skin compared with nonlesional skin (n=9). 
However, at protein level only the expression of 14-3-3σ was increased signifi cantly. 
Patients with allergic contact dermatitis (n=3) had a signifi cant 2-3 fold increase in 
the mRNA expression of 14-3-3σ in lesional skin compared with nonlesional skin. 
No signifi cant differences were found for the other 14-3-3 isoforms. The mRNA 
expression of 14-3-3ζ was signifi cant increased 1.5-2 fold in basal cell carcinomas 
compared with nonlesional skin from the same patient (n=3). In atopic dermatitis 
(n=3) no signifi cant difference between the lesional and nonlesional skin was found 
for any of the isoforms. These results demonstrate a disease specifi c expression profi le 
of the 14-3-3 isoforms. The importance of these fi ndings requires further studies.
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Characterization of adult patients with atopic dermatitis with common fi laggrin 
gene loss of function mutations
Wichmann K1, Uter W2, Mommert S1, Werfel T1 1Hannover Medical School, Hannover, 
Germany 2University of Erlangen/ Nürnberg, Erlangen, Germany
Mutations in the fi laggrin gene, fi rst described in ichthyosis vulgaris, were identifi ed as 
a risk factor for atopic dermatitis. So far it is not clear if these mutations are associated 
with severity or sensitizations to food and aeroallergens in adult patients. We aimed to 
investigate two common loss of function mutations in the fi laggrin gene in a cohort of well 
characterized adolescent and adult patients with atopic dermatitis regarding disease severity 
and sensitization levels. We analysed a group of 97 adolescent and adult patients with atopic 
dermatitis for the two described mutations in the fi laggrin gene R501X and 2282del4 by real 
time PCR and compared patients with or without mutations in disease severity measured by 
SCORAD, IgE mediated sensitization to aeroallergens and food allergens measured by CAP-
FEIA and eczematous reactions in the atopy patch test. Mutations in the fi laggrin gene were 
found in 24 % of the patients. 10 patients were heterozygous for R510X, 12 patients were 
heterozygous for 2282del4, one patient in each case was homozygous. Disease severity 
measured by SCORAD did not differ between patients with one of these mutations and 
patients with the wild type. Both groups did not differ in the frequency of sensitizations to 
common inhalative allergens or in the frequency of positive patch test reactions to common 
inhalative allergens, food allergens, as well as to staphylococcal superantigens. 24 % of our 
patients showed mutations in the fi laggrin gene which confi rms previous data in larger cohort 
studies with infants and children. Surprisingly, no difference was found in the phenotype of 
the disease in our well characterized adult cohort. Although loss of function mutations in 
the fi laggrin gene clearly are a risk factor for developing atopic dermatitis in childhood, in 
a cohort of adult patients no difference in disease severity or sensitization levels were seen.
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Characterization of CD4+CD25+ regulatory T cells by FoxP3+ and CD127low/- 
expression levels in human peripheral blood
Kretz CC1, Klein S1, Krammer PH1, Kuhn A2 1German Cancer Research Center, Divi-
sion of Immunogenetics, Heidelberg, Germany 2University of Muenster, Department 
of Dermatology, Muenster, Germany
The capacity of CD4+CD25+ regulatory T cells (Treg) to suppress pathologic immune 
responses in autoimmune diseases has been demonstrated in the mouse and human system. 
Recently, it has been suggested that a lack of CD127 expression can be used to identify 
human CD4+ Treg, especially when combined with CD25. Therefore, we wanted to 
analyze CD4+CD25+CD127low/- cells in normal healthy donors and patients with systemic 
scleroderma (SSc) and to compare the frequency and expression pattern to FoxP3+ Treg using 
multiparameter fl ow cytometry analysis. We obtained human peripheral blood mononuclear 
cells from 20 normal healthy donors and determined the number of CD25+CD127low/- 
cells as percentage of the CD4+ T cells in the same panel used for CD4+CD25+FoxP3+ 
cells. In contrast to CD4+CD25+FoxP3+ cells, gating of a clear CD4+CD25+CD127low/- 
population was diffi cult. Moreover, we demonstrate that there was a high percentage 
(34.0% ± 15.1%) of CD127low/- cells that did not express FoxP3, and conversely, that there 
was a high percentage (30.3% ± 7.4%) of CD127+ cells that expressed FoxP3, suggesting 
that these markers did not represent the same population of Treg. These data were also 
confi rmed in blood samples from 12 patients with SSc. In addition, statistical analysis 
revealed that the number of CD4+CD25+CD127low/- cells (7.4%, range 5.7% to 17.7%) 
in the SSc patients was slightly lower compared to the number of CD4+CD25+FoxP3+ 
cells (8.2%, range 4.5% to 14.0%); however, this was not statistically signifi cant. Thus, 
isolation of pure Treg populations for in vitro functional studies is a challenge, explaining 
the various results by different groups in clinical studies. The data of this study have 
important implications for carrying out a quantitative analysis of Treg in human samples.




Characterization of the mapk phosphatases in skin infl ammation
Kjellerup R, Johansen C, Kragballe K, Iversen L Aarhus University Hospital, 
Denmark
The p38 MAPK pathway plays an important role in infl ammatory processes. The 
MAPK phosphatases (MKPs) are regulators of p38 MAPK activity. Three MKPs 
denominated DUSP1, 2 and 10 seem to be of particular interest. The purpose of 
this study was to investigate and characterize the expression level of DUSP1, 2 and 
10 in skin infl ammation using biopsies from psoriasis and atopic dermatitis patients 
and in a TPA mouse model of skin infl ammation. Mice were treated with TPA on the 
ears, and punch biopsies were taken after six hours or three days. In patients, punch 
biopsies were taken from nonlesional and lesional plaque-type psoriatic skin (n=17), 
guttate psoriatic skin (n=6), and atopic dermatitis skin (n=6). The mRNA expression 
was analyzed by quantitative RT-PCR. In TPA-treated mice the mRNA expression of 
DUSP1 and DUSP2, but not DUSP10, were signifi cantly (p<0.05) upregulated after 
six hours with 3.4 fold and 21 fold, respectively. In contrast, three days after the fi rst 
TPA application DUSP1 and DUSP10 were signifi cantly downregulated with 0.21 
fold and 0.15 fold, respectively. No signifi cant difference was seen for DUSP2. In 
lesional plaque-type psoriatic skin the DUSPs all displayed signifi cantly (p<0.05) 
altered expression as compared with nonlesional psoriatic skin. DUSP1 and DUSP10 
were both downregulated with 0.74 fold and 0.63 fold, respectively, whereas DUSP2 
was upregulated with 1.7 fold. In lesional guttate psoriatic elements the same trend 
was seen; however, only DUSP2 and DUSP10 mRNA levels showed a signifi cant 
change with 1.8 fold upregulation and 0.70 fold downregulation, respectively. In 
atopic dermatitis we found no signifi cant difference between nonlesional and 
lesional skin. In conclusion, our fi ndings suggest that dysregulation of the DUSP1, 
2 and 10 expression may contribute to the sustained infl ammation seen in psoriasis.
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Correlation of IgG4 and IgE antibodies against desmoglein 3 with disease activity 
in pemphigus vulgaris
Nagel A1, Stauber A2, Rühl D2, Hunzelmann N3, de Pita O4, Borradori L5, Hertl M1, 
Uter W2 1Philipps University Marburg, Marburg, Germany 2Friedrich-Alexander-
University Erlangen-Nürnberg, Erlangen, Germany 3University of Cologne, Cologne, 
Germany 4Istituto Dermatico dell´ Immacolata, Rome, Italy 5University Hospital, 
Berne, Switzerland
Pemphigus vulgaris (PV) represents a severe potentially life-threatening autoimmune 
bullous skin disorder characterized by extensive blisters and erosions of the 
mucous membranes and the skin. The autoantibody response against the major 
autoantigen, desmoglein 3, results in loss of cell-cell adhesion between epidermal 
keratinocytes. Since it has been previously suggested that T helper 2 (Th2) cells 
have a great impact on disease induction and perpetuation, aim of the present study 
was to assess serum levels of the Th2-related IgG4 and IgE autoantibodies with 
regard to disease activity. Thus, levels of dsg3-specifi c IgG, IgG1, IgG4, IgA and IgE 
were quantifi ed in the sera of 93 patients with defi ned clinical stages of PV, i.e. 
acute-onset (n=37), chronic active (n=42) and remittent (n=14) PV. High titers of 
IgG, IgG1, IgG4 and IgE autoantibodies were detected in acute-onset PV and were 
signifi cantly diminished in remittent PV. Noteworthy, the observed decline of IgG and 
IgE autoantibodies was not attributed to varying disease duration between patients’ 
groups. Furthermore, dsg3-reactive IgG4 and IgE levels were strongly related to 
each other in patients with acute-onset PV but not in patients with chronic active 
or remittent PV, respectively. Thus, the presence of IgE and IgG4 autoantibodies 
was primarily associated with acute-onset PV which strongly supports the 
pathogenetic role of Th2-driven autoantibody isotypes in the induction phase of PV.
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CXCL-16 an epidermal transmembrane chemokine: induction of secretion and 
implication in leukocyte adhesion
Franchi J1, Savary L1, Marteau C1, Lamerant N2, Schnebert S1, Kieda C1 1LVMH 
Research, Saint Jean De Braye, France 2UPR 4301 CNRS, ORLEANS, France
Chemokines play an important role as paracrine and autocrine mediators in healthy 
and diseased skin. They are implicated in homeostatic and infl ammatory processes, 
because they are mainly produced in infl amed tissues where they control the 
migration of blood cells. CXCL16 was recently discovered in the skin, this chemokine 
is expressed as a membrane molecule and can be released as a chemoattractant. In 
this study, we investigated the conditions of the release of this chemokine by human 
normal keratinocytes. We found that cultured keratinocytes produce a signifi cant 
amount of CXCL16 as determined by ELISA. Stimulation with the proinfl ammatory 
cytokine TNFα (50 and 10ng/mL) and UVB (20 and 11mJ/cm²) enhance CXCL16 
production. UVB radiation at the dose 11mJ/cm2 leads to an increase superior to 
10-fold of the soluble form of CXCL16 within 24h. A prominent feature of chronic 
infl ammatory skin diseases is the accumulation of activated leukocytes in epidermal 
and dermal compartments. In particular cytokine-activated keratinocytes become an 
important source of chemotactic factors that direct the recruitment of specifi c leukocyte 
populations and thus regulate the quality, magnitude and duration of the infl ammatory 
response. We highlighted the ability of the CXCL16 to mediate leukocyte recruitment 
by keratinocytes. As TNF α  and H2O2, CXCL16 increases the adhesion of leucocytes 
(CEMT4) on human keratinocytes as determined by fl ow cytometry. Thus our data 
indicate that CXCL16 may act as a novel actor of the skin physiology. Understanding the 
role of CXCL16 in the epidermis, may be crucial in chronic infl ammatory skin diseases 
and in skin photodamage where the presence of immune cells as been described.
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Decreased skin innervation in NC/Nga atopic mice during chronic mild stress
Lönndahl L, Lonne-Rahm S,Nordlind K, Theodorsson E, El-Nour H Dermatology and 
Venereology unit, Stockholm, Sweden
A connection between chronic mild stress and altered innervation in an atopic 
mouse strain, NC/Nga, was studied. We used three groups, stressed control 
(SC), non-stressed eczematous /NSE) and stressed eczematous (SE). There was a 
decrease of protein gene product (PGP) 9.5 positive nerve fi bres in SE compared 
to SC mice, in both epidermis and dermis (p<0.01 and p<0.001, respectively), 
also in SE compared to NSE mice (p<0.01). Also a decrease in growth associated 
protein (GAP)-43 positive nerve fi bres was seen in SE compared to SC, in 
both epidermis and dermis (p<0.001 and p<0.05, respectively).Chronic mild 
stress in atopic mice leads to decreased innervation in eczematous lesions.
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Dendritic cells  and psoriasis: more evidence on their pathogenetic role
Prignano F, Ricceri F, Bianchi B, Lotti T Florence University, Florence, Italy
Psoriasis is a common immune-mediated skin disease characterized by a complex 
interplay of T-cells, NK-cells, keratinocytes, endothelial cells, dendritic cells, 
cytokines and chemokines. Dendritic cells (DCs), for their central position in the 
immune system as antigen presenting cells, are  driver in the immune mechanism 
of psoriasis. The activation of DCs, the  cytokines production (IL-12, IL-23), induced 
by the DC,  DCs antigen presentation to T-cells and, subsequently, the Th-1 cells 
activation with release  of TNF-α and IFN-γ  play essential roles in the formation 
of chronic plaques psoriasis. Moreover, DCs are central players in the potentially 
self-substaining type-1 infl ammatory network. Due to the importance of DCs in 
psoriasis we used a panel of monoclonal antibodies and an electron microscopy 
study in order to better highlight their presence, morphology, distribution and 
number in lesional psoriatic skin before and after biological therapies (with both 
Anti-CD11a and Anti-TNF-α). Before therapy DCs (Langerhans cells Langerhin +, 
and mature mDCs CD83+,CD86+,BDCA-1/3+, DC-LAMP, and pDCs BDCA-2+) 
were signifi cantly increased in the epidermis, but also in the dermis, of lesional skin. 
Immunohistochemistry of diseased skin after treatment (4 months of therapy) showed 
an important decrease of all types of DCs. Ultrastructural examination demonstrated 
two distinct subtypes of DCs: DCs with mature phenotype, as the Langerhans cells 
(LCs), and immature DCs. The results provide more evidence, that  psoriasis is an 
immune-mediated dermatitis where the DCs play a pivotal role in the pathogenesis 
and that DCs and DC-T cell interactions are  potential target for  biologic therapies.
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Dendritic cells are the main source of TNF- in plaque-type psoriasis
Brunner P, Koszik F, Kalb M, Stingl G Medical University of Vienna, Vienna, Austria
In psoriasis, data on the spectrum of tumor necrosis factor (TNF)-α producing cells 
and their response to TNF-α antagonists are inconsistent, suggesting a role for 
various cell types including T cells, dendritic cells and monocytes/macrophages. 
In order to better understand which cell type is the principle TNF-α producer 
and thus may exhibit sensitivity towards TNF-α antagonists, we immunostained 
cryo-sections from lesional psoriatic skin. Using a tyramide amplifi cation system 
we obtained reproducible and fi rm signals of TNF-α in situ. In our study, the vast 
majority of TNF-α positive cells were present in the dermis. TNF-α was exclusively 
found on CD45+ cells, detecting a leukocyte subpopulation as the only TNF-α 
positive cell type in our setting. This population was characterized as being largely 
CD11c+HLADR+. Additionally, CD68+ macrophages accounted for about 10% of 
TNF-α positive cells. We did not fi nd TNF-α colocalization on mast cells (CD117+), 
T cells (CD3+), neutrophils (CD15+HLADR-), endothelial cells (vWF+), pDCs 
(BDCA-2+) or Langerhans cells (langerin+). Normal skin from healthy individuals 
was devoid of any TNF-α signal. At a functional level, we found evidence that the 
TNF-α antagonist infl iximab is able to induce apoptosis, complement killing and 
antibody-dependent cellular cytotoxicity on TNF-α producing cell lines in vitro, 
consistent with published data. However, there was no in situ evidence of apoptosis 
or change in dendritic cell number/phenotype in lesional psoriatic skin 24 hours 
after the infusion of infl iximab. Our data suggest that dendritic cells, but not T 
cells, are the main source of TNF-α in stable plaque-type psoriasis. So far, we could 
not fi nd evidence that infl iximab affects these cells in the initial phase of therapy.
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Development of psoriasis is dependent on IL-12/23p40, and partially on IL-17A in 
a mouse model
Takaishi M1, Nakajima K1, Digiovanni J2, Iwakura Y3, Sano S1 1Kochi Medical School, 
Nankoku, Japan 2MD Anderson Cancer Center, Smithville, USA 3University Of Tokyo, 
Tokyo, Japan
We previously found that Stat3 signaling of keratinocytes played an essential role in the 
development of psoriasis with a distinct crosstalk to T cells. Recent studies revealed that 
Th17 contributed to the crosstalk through their secreting IL-17A and IL-22, which activates 
Stat3 of keratinocytes. Furthermore, it was found that IL-23, which promoted activation and 
maturation of Th17, was also involved in the pathogenesis of psoriasis, evidenced not only 
by laboratory studies but also by favorable therapeutical effect of anti-IL-12/23p40 treatment. 
Here we studied the relative contributions of the IL-23/Th17 axis to the development of 
psoriasiform lesions in K5.Stat3C transgenic mice, an animal model of psoriasis showing a 
distinct skin phenotype following wound healing, topical TPA treatment or tape stripping. 
Real-time RT-PCR revealed that transcript levels of IL-17A, IL-17F, and IL-22 were elevated 
in the psoriasiform lesion of K5.Stat3C mice, suggestive of contribution of the IL-23/Th17 
similar to human psoriasis. Intraperitoneal administration of anti-IL-12/IL-23p40 antibody 
completely inhibited the development of psoriasiform lesions of K5.Stat3C mice. In treated 
mice, the transcript levels of IL-6, IL-17A, IL-17F, IL-20, IL-22, S100A8, S100A9 and keratin 
16 were markedly reduced in the skin compared with the lesions of control IgG-treated mice. 
Furthermore, K5.Stat3C mice defi cient in IL-17A presented a weak but not completely reversed 
skin phenotype, which was further abolished by anti-IL12/23p40 antibody treatment. We 
conclude that the development of psoriasiform lesions in this model is completely dependent 
on IL-12/23p40, but only partially on IL-17A. This result also suggests that psoriasis might 
require more than one pathway, including IL-17A-dependent and –independent pathways.
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Differential epitope recognition of desmoglein 3 by paraneoplastic pemphigus and 
pemphigus vulgaris sera
Brandt O1, Rafei D1, Podstawa E1, Niedermeier A2, Jonkman M3, Terra JB3, Messer G2, 
Hertl M1, Müller R1 1Department of Dermatology and Allergology, Philipps University 
of Marburg, Marburg, Germany 2Department of Dermatology and Allergology, 
Ludwig-Maximilians-University of Munich, Munich, Germany 3Department of 
Dermatology, University of Groningen, Groningen, Netherlands
Paraneoplastic pemphigus (PNP) is a mostly lethal autoimmune bullous disease 
characterized by severe polymorphous mucocutanous lesions, which is commonly 
associated with hematologic malignancies. In contrast to pemphigus vulgaris (PV), 
autoantibodies of PNP sera target several autoantigens including desmoglein (Dsg), 
desmoplakin, periplakin, envolakin, and bullous pemphigoid  antigen 1 (BP 230), and 
yet not characterized 170 kD protein. Despite in vitro evidence for a pathogenicity of 
anti-Dsg3 IgG from PV and PNP sera, the epitope specifi city of these autoantibodies 
needs to be determined. Recombinant proteins expressed in a baculovirus system 
were used as antigens for the detection of autoantibodies in PNP sera of 15 patients 
and compared to those of PV sera. Overall, sera from 12 of 15 PNP patients displayed 
IgG reactivity with the Dsg3 ectodomain, preferentially with epitopes located in the 
COOH-terminal EC4/EC5 domains, while autoantibodies from PV sera primarily 
recognized the NH2-terminus of Dsg3. Additionally, 5 of the 15 PNP sera exhibited IgA 
reactivity against the Dsg3 ectodomain. Furthermore, eight PNP, but none of the PV sera 
showed IgG reactivity against desmocollin (Dsc)1 (n=1), Dsc2 (n=1), and Dsc3 (n=6). 
In contrast, neither IgG directed against BP 230, nor IgE autoantibodies reactive with 
Dsg, Dsc or BP230 were detectable in PNP sera. These immunoserological differences 
may help to establish the diagnosis of PNP based on the autoantibody profi le.
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Differential expression of RANKL in infl ammatory skin diseases
Toberer F1, Sykora J2, Göttel D3, Schmitt V4, Loser K4, Beissert S4, Joos S3, Krammer 
PH1, Kuhn A4 1German Cancer Research Center, Division of Immunogenetics, 
Heidelberg, Germany 2University of Heidelberg, Department of Internal Medicine, 
Heidelberg, Germany 3German Cancer Research Center, Institute of Molecular 
Genetics, Heidelberg, Germany 4University of Muenster, Department of Dermatology, 
Muenster, Germany
Recently, it has been shown that RANKL expression plays an important role in the maintenance 
of peripheral CD4+CD25+ regulatory T cells. To investigate the role of RANKL in human 
infl ammatory skin diseases, we investigated the expression of RANKL in skin lesions of patients 
with cutaneous lupus erythematosus (CLE), psoriasis, and lichen planus. Skin biopsy specimens 
from 162 patients, including 119 patients with CLE, 25 patients with psoriasis, and 18 patients 
with lichen planus were analyzed by immunohistochemistry using the tissue microarray (TMA) 
technique. For evaluation of RANKL expression in skin biopsies, the relative proportion of positive 
cells (level of positivity: 0=0%, 1= up to 1%, 2=2-10%, 3=11-50%, 4=>50%) was multiplicated 
with the value for staining intensity (level of intensity: 0=negative, 1=low, 2=medium, 3=strong). 
Only 12 (10.1%) patients with CLE and 7 (38.9%) patients with lichen planus revealed expression 
of RANKL compared to 19 (76.0%) patients with psoriasis. Therefore, RANKL was signifi cantly 
higher expressed in skin lesions of patients with psoriasis (median: 4, range: 0-5) compared to 
skin lesions of patients with CLE (p<0.001) and lichen planus (p<0.05) as well as compared to 
normal healthy donors (p<0.05). However, RANKL expression in skin lesions of patients with 
CLE (median: 0, range: 0-4) or lichen planus (median: 0, range: 0-4) differed not signifi cantly 
from skin biopsies of normal healthy donors (median: 0, range: 0-0). There were no signifi cant 
differences in RANKL expression between the different subtypes of CLE. Together, these data 
show that expression of RANKL might be important for the development of skin lesions in CLE 
rather than psoriasis or lichen planus. If RANKL is important for the regulation of infl ammatory 
skin diseases or possibly provides a therapeutic alternative needs to be analyzed in future studies.
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Differentiation of Linear IgA bullous dermatosis from Epidermolysis bullosa 
acquisista mediated by IgA using laser scanning confocal microscopy
Wozniak K1, Kowalewski C1, Hashimoto T2, Huczek M1 1Medical University of 
Warsaw, Warsaw, Poland 2Kurume University, School of Medicine, Kurume, Japan
The presence of circulating and linear deposits of IgA at the BMZ was considered to 
be characteristic for linear IgA bullous dermatosis (LABD) until lately. Recently there 
has been published a growing number of case reports of patients with in vivo bound 
IgA located below lamina densa of the  BMZ in direct immunoelectron microscopy 
(dIEM) and circulating IgA react with 290kD protein - antigen of epidermolysis 
bullosa acquisita (EBA). Those cases are named “IgA-EBA”. The aim of the study 
was to investigate whether it is possible to distinguish IgA-EBA from LABD using 
overlay antigen mapping method by laser scanning confocal microscopy (LSCM) on 
the basis of comparison of the localization of in vivo bound IgA to the localization 
of collagen IV (marker of lamina densa). We studied 20 patients characterized 
by the presence of both, in vivo bound IgA at the BMZ as well as circulating IgA 
antibodies directed against BMZ antigens. In 15 out of 20 cases LSCM study showed 
the presence of in vivo bound IgA above the collagen IV, which corresponds to their 
ultrastructural localization within lamina lucida and is characteristic for LABD. Serum 
studies performed in those patients revealed the reactivity of IgA autoantibodies 
with LAD-1 and other epitops of BP180 by immunoblot. Whereas in 5 out of 20 
cases, IgA were localized below the collagen IV, typically for EBA (IgA-EBA). In 2 
out of 5 patients diagnosis of IgA-EBA was confi rmed by IB or dIEM. In 3 out of 5 
patients sera were negative by immunoblot. This study showed that LSCM allows 
the differentiation LABD from IgA-EBA and can be useful as a routine diagnostic 
tool especially in cases with undetectable circulating anti-BMZ antibodies.
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Effect of anti-IL-6 receptor antibody in a mouse model of bleomycin-induced 
scleroderma
Kitaba S, Murota H, Terao M, Azukizawa H, Katayama I Osaka University, Suita-shi, 
Japan
Serum levels of IL-6 are reported to be elevated in scleroderma patients and murine of 
dermal sclerosis. As IL-6 may contribute the skin symptoms of scleroderma, we investi-
gated whether an anti-IL-6 receptor monoclonal antibody (anti-IL-6R mAb) could inhibit 
dermal sclerosis in a bleomycin-induced murine model. To verify the above hypothesis, 
the effective of anti-IL-6R mAb was evaluated in a preventive model and a treatment 
model.To make a preventive model, C57BL/6 mice were administered bleomycin (BLM) 
for 4 weeks every day to induce a model mouse of systemic sclerosis (SSc) and were 
treated simultaneously with anti-IL-6R mAb or rat IgG injections. Additionally, to make a 
treatment model, C57BL/6 mice were administered BLM for 4 weeks every day to induce 
a model mouse of SSc and then, were treated with anti-IL-6R mAb or rat IgG injections. 
The effect of anti-IL-6R mAb was evaluated by measuring skin hardness, dermal thickness 
and immunohistochemical staining with alpha smooth muscle actin (alpha-SMA) and 
mast cells around the injection site.In results, the dermal thickness (p<0.01) and hardness 
(p<0.01) signifi cantly increased in the BLM-induced skin sclerosis model, as did a number 
of alpha-SMA positive fi broblasts (p<0.01), a marker of myofi broblasts, and mast cells 
(p<0.01). Anti-IL-6R mAb signifi cantly suppressed BLM-induced skin hardness (p<0.01 in 
preventive model and p<0.03 in treatment model), dermal thickness (p<0.01 and p<0.01, 
respectively) and the amounts of myofi broblasts (p<0.02 and p<0.03, respectively) and 
mast cells in both models (p<0.05 and p<0.01, respectively). Our results suggest that anti-
IL-6R mAb may be applicable as a new treatment for patients with SSc, and indicate that 
IL-6 may play an important role in the BLM-induced skin sclerosis model.
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Epidermal (eTG) and tissue (tTG) transglutaminase ELISA studies through the follow 
up of dermatitis herpetiformis patients
Blazsek A, Silló P, Kornséé Z, Losonczy V, Kósnai I, Erdοs Á, Mazán M, Pintér D, Sárdy 
M, Kárpáti S Semmelweis University, Budapest, Hungary
Dermatitis herpetiformis (DH), an autoimmune blistering skin disease, characterized by granular 
IgA epidermal transglutaminase (eTG) precipitates at the tips of the papillary dermis. There 
is growing evidence, that DH should be considered as gluten sensitivity of the skin developing 
only in certain patients with gluten sensitive enteropathy (GSE) who produce eTG autoantibodies 
of high avidity and affi nity. Endomysium antibodies (EMA), similarly to  tissue transglutaminase 
(tTG) autoantibodies are sensitive and specifi c markers of GSE associated with the skin condition. 
Although there is a body of information on changes of EMA and tTG autoantibodies in GSE under 
gluten-free diet, there are still limited data available on the correlation between changes of eTG, 
tTG IgA antibodies and EMA in log-term studies. To study parameters of DH patients followed 
through years of treatment, counseling and follow up.23 DH patients followed and monitored 
for 5 or more years at our department were selected for this study. In all cases the diagnosis has 
been confi rmed by skin immunofl uorescence and histology. Archived and collected samples 
were assayed on heTG ELISA (Immundiagnostik, Bensheim, Germany for eTG and on the Athena 
Multi-Lyte Celiac IgA Plus system (Zeus, Princeton, US) for tTG and gliadin IgA autoantibodies 
and determining a possible IgA defi ciency.In all 23 patients eTG IgA levels were elevated, while 
two of the 23 DH patients were EMA and tTG negative. Introduction of gluten free diet (GFD) 
slowly reduced the EMA, lowered the tTG and gliadin IgA levels, whereas eTG showed a slower 
decrease in titer. In 17 cases although tTG IgA autoantibodies became normal under the GFD 
or treatment, eTG IgA autoantibodies remained elevated. IgA type eTG autoantibodies seem to 
be sensitive markers of DH and are more characteristic for the skin disease than for the GSE.




Epidermolysis bullosa acquisita associated with IgM paraproteins directed to 
collagen VII and p200 pemphigoid antigen.
Mignot S1, Prost C2, André C3, Aucouturier F4, Dandurand M5, Barrientos L1, Le Roux 
C2, Laroche L2, Caux F2 1CHU Bichat, Paris, France 2CHU Avicenne, Reference Center 
for Bullous Diseases, Bobigny, France 3CHU Mondor, Créteil, France 4CHU Saint 
Louis, Paris, France 5CHU Caremeau, Nîmes, France
Epidermolysis bullosa acquisita (EBA) and p200 pemphigoid are autoimmune bullous 
diseases characterized by IgG antibodies directed to collagen VII and gamma 1 
laminin respectively. Here we report an EBA patient with circulating IgM directed to 
290 kDa and 200 kDa target antigens. A 63-year-old woman presented with clinical 
features of classical EBA. Direct immunofl uorescence (DIF) demonstrated linear 
IgM and IgA deposits on skin basement membrane zone (BMZ). Immunoelectron 
microscopy revealed IgM and IgG deposits on anchoring fi brils zone but also 
under lamina densa of vascular BMZ. Indirect immunofl uorescence showed high 
levels of IgM kappa directed to skin and dermal vessels BMZ and recognizing the 
dermal side of salt split skin. Immunoblotting using amniotic extract demonstrated 
IgG, IgA and IgM directed to a 290 kDa protein comigrating with collagen 
VII and IgM against a 200 kDa protein comigrating with gamma 1 laminin. Two 
IgM paraproteins (kappa predominant) of 22 g/L with cryoglobulinemia activity 
were present. Several features are unusual in this case report: i) EBA is associated 
to IgM directed to collagen VII, ii) IgM antibodies recognized a 200 kDa protein 
which may be gamma 1 laminin as suggested by vessel BMZ staining and results 
of immunoblotting, and iii) monoclonal IgM may have specifi c activities directed 
against two different BMZ antigens. This observation is the fi rst with IgM directed 
against p200 pemphigoid antigen and the second of IgM EBA. Moreover it suggests 
that IgM paraproteins may have specifi c affi nity for cutaneous BMZ epitopes.
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Epigenetic regulation of killer cell immunoglobulin-like receptor (KIR) expression 
in lichen planus
Fujiwara H Niigata University, Niigata, Japan
Lichen planus is a chronic infl ammatory condition, characterized by the lichenoid 
reaction in basal layer of the epidermis infi ltrated by CD8+ lymphocytes expressing 
cytotoxic molecules, e.g. granzyme B. Herein we demonstrate that the infi ltrating 
lymphocytes also express another cytotoxic molecule, killer cell immunoglobulin-like 
receptor, KIR2DL2. Methylation state of KIR2DL2 gene promoter was analyzed with 
methylation-specifi c PCR and bisulfi te sequence in genomic DNA extracted from the 
lichen planus tissues and the peripheral blood lymphocytes. On the tissue specimens 
KIR2DL2 immunostain and methylation detection with in situ hybridization was 
performed. DNA Promoter analysis of KIR2DL2 gene revealed that the promoter DNA 
was always methylated and KIR2DL2 protein expression was suppressed in normal 
T cells. In lichen planus skin lesion, the promoter of KIR2DL2 gene was partially 
demethylated. In situ detections demonstrated that KIR2DL2 promoter was demethylated 
in a part of the infi ltrated T cells; mRNA and KIR2DL2 protein were expressed in 
these cells.The expression of KIR was under the epigenetic regulation in lichen planus 
skin lesions. The fi nding may lead the different approach for treating lichen planus.
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Evaluation of PAR-2 antagonist using in vitro assay systems
Jeon J1, Kwon M1, Choi H1, Kwak H1, Park B1, Jeong S1 1NeoPharm Co., Ltd., Daejeon, 
Republic of Korea 2Yonsei University College of Medicine, Seoul, Republic of Korea 
Protease-activated receptor (PAR)-2 belongs to the G-protein coupled receptor 
(GPCR) family, and recent studies have suggested that expression of PAR-2 is 
upregulated in atopic dermatitis skin lesions. Since the PAR-2 in known be to related 
to the infl ammation, pruritus and pigmentation, upregulation of PAR-2 in AD skin 
lesions suggests that PAR-2 specifi c antagonist can be a potential therapeutic target 
for AD. Recently, we have reported that topical application of NP-003, as a PAR-2 
antagonist, alleviated the AD-like sympotoms in oxazolone-induced AD animal 
model. Lower effi cacy of NP-003, however, hampered its pracitcal application. In 
this study, we have evaluated the antagonistic actvity of newly synthesized PAR-2 
antagonist, LCB07-0541, using various in vitro systems and also investigated 
its in vivo activity using oxazolone induced AD model. Intracellular calcium 
infl ux measurement assay using FLIPR Calcium 4 assay system, and beta-arrestin 
accumulation measurement assay using PathHunter assay system was used to evaluate 
IC50 value against PAR-2 specifi c activator, and KNRK-PAR-2 cell line was also used 
to confi rm the antagonistic activity of LCB07-0541. As a results, LCB-0541 showed 
more than 10-fold increased antagonistic activity, compared with NP-003. In vivo 
evaluation of LCB-07-0541 also confi rmed its alleviating activity against AD. These 
results suggest that LCB-07-0541, as a PAR-2 antagonist, can be used to treat AD.
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Expression of the 27 and 90 Heat shock proteins in psoriatic skin
Mairhofer D1, Lobo A2, Nazarian R2, Mihm M2, Trautinger F1 1Karl Landsteiner Institute 
of Dermatological Research, St.Pölten, Austria 2Departement of Pathology, Harvard 
Medical School , MGH, Boston, MA, USA
Heat shock proteins (hsp) are a heterogeneous group of highly conserved proteins 
that are essential in cytoprotection and cell physiology. Although hsp have been 
shown to be involved in infl ammation and keratinocyte differentiation their role in 
psoriasis is largely unknown.In the current study a collection of 16 archival samples 
from various stages and various clinical variants of psoriasis was investigated 
for the expression of hsp27 and hsp90 by immunohistochemistry.As in normal 
skin hsp27 in the epidermis was associated with keratinocyte differentiation.In 
addition, most samples showed highly positive staining in the basal cell layer and 
in subcorneal areas of neutrophil aggregation.A striking fi nding in the dermis was 
the strongly positive staining of endothelial cells that was specifi cally absent in 
the characteristic dilated and tortuous capillaries of the papillae.Hsp90 was found 
to be expressed throughout the epidermis with many nuclear staining pattern and 
increasing intensity towards the upper layers.In the dermis hsp90 was expressed 
in all nucleated cells including infi ltrating leukozytes. Our fi ndings indicate that 
hsp27 and hsp90 might be induced in psoriatic skin in response to infl ammation 
and - as specifi cally shown for hsp27 - probably also through reactive oxygen 
species released by neutrophils.Furthermore,the differntial expression of hsp27 in 
capillary versus postcapillary endothelium points to a role of hsp27 in angiogenesis 
and pathological endothelial function associated with psoriasis.Based on these 
fi ndings further studies are warranted to investigate the functional role of these and 
other hsp in psoriasis and the possible therapeutic use of hsp modifying agents.
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Formation of peroxynitrite and poly(ADP-ribose) in the skin: implications for 
dermatopathophysiology
Virag L1, Szabo E2, Erdelyi K1, Brunyanszki A1, Gergely P1 1Dept. Medical Chemistry, 
Medical and Health Science Center, University of Debrecen, Debrecen, Hungary
2 Dept. Dermatology, Medical and Health Science Center, University of Debrecen, 
Debrecen, Hungary
Peroxynitrite (ONOO-) is a cytotoxic oxidant produced in the reaction of nitric 
oxide (NO) and superoxide anion. Whereas the role of the parent molecule nitric 
oxide has been extensively documented in numerous skin diseases including 
wound healing, burn injury, psoriasis, irritant and allergic contact dermatitis, 
ultraviolet (UV) light-induced sunburn erythema and the control of skin infections, 
the intracutaneous role of peroxynitrite has not been fully explored. Peroxynitrite 
may cause tissue injury via protein nitration, lipid peroxidation and DNA breakage. 
Peroxynitrite has also been shown to activate the nuclear nick sensor enzyme, 
poly(ADP-ribose) polymerase (PARP-1). Overactivation of PARP-1 depletes the 
cellular stores of NAD+, the substrate of PARP, and the ensuing “cellular energetic 
catastrophy” or PAR-mediated translocation of apoptosis inducing factor (AIF) may 
result in cell death. Moreover, PARP may regulate the transcription of infl ammatory 
cytokines, chemokines and other mediators such as inducible nitric oxide synthase 
(iNOS). We have demonstrated peroxynitrite production, DNA breakage and PARP 
activation in a murine model of contact hypersensitivity, and in sulfur mustard-
induced vesication. Moreover, we have data indicating the role of this pathway in 
human venous leg ulcers and in human malignant melanomas. Here we discuss 
the possible roles played by peroxynitrite and PARP in various skin diseases and 
outline potential therapeutic applications targeting the peroxynitrite-PARP pathway.
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Granular immunoglobulin and complement depositions in the basement membrane 
zone in pemphigus erythematosus contain the ectodomain of desmoglein 1
Oktarina D, Kramer D, Diercks GF, Jonkman MF, Pas HH Center for Blistering Diseases, 
University Medical Center Groningen, the Netherlands, Groningen, Netherlands
Pemphigus erythematosus (PE) is a localized form of pemphigus foliaceus (PF) that 
clinically shares some features with lupus erythematosus as scaly crusted lesions in 
the malar region of the face and seborrheic areas. Immunofl uorescence of PE skin 
biopsies demonstrate in addition to the typical granular intercellular IgG depositions 
(ICS), also granular deposits of IgG and C3c in the epidermal basement membrane 
zone (EBMZ). In the literature it has been suggested that in PE also antibodies to 
BP230 antigen and 190 kDa periplakin antigen are present. The purpose of the 
present study was to analyze the composition of the granular EBMZ deposits in 
patient’s skin, and to analyze if additional autoimmune targets are indeed present 
in PE. Biopsies and corresponding sera of 22 PF patients were included. Double 
immunofl uorescence staining on biopsies was performed for IgG, C3c and selected 
adhesion molecules. Additional techniques included ELISA and immunoblot. Three 
PF patients had clinically PE, and only their skin biopsies showed a granular EBMZ 
deposition of IgG and C3c in addition to the ICS pattern. These EBMZ clusters 
however had a different composition than the ICS clusters. Plakoglobin was absent 
but Dsg1 was present although not as the full-length molecule but rather as a spliced-
off part of the ectodomain. ELISA demonstrated anti-BP230 IgG in these three patients 
and two of these also reacted to periplakin by immunoblot. We conclude that PE 
is a subform of PF with unique granular EBMZ immune deposits with a molecular 
make-up that indicates the presence of a to PF additional pathogenic mechanism.
jid2009232.indd   Sec1:93 7/31/2009   6:36:26 PM
ABSTRACTS
S94  Journal of Investigative Dermatology (2009), Volume 129 
559
HLA class II risk alleles in Croatian patients with pemphigus vulgaris
Marinovic B1, Lipozencic J1, Dogic V2, Lakos Jukic I1 1Zagreb University Hospital 
Center, Zagreb, Croatia (Hrvatska) 2Croatian Institute of Transfusion Medicine, 
Zagreb, Croatia (Hrvatska)
Pemphigus vulgaris is autoimmune blistering disease caused by autoantibodies against 
keratinocyte adhesion molecules desmoglein 3 and 1. It is widely accepted that 
pemphigus vulgaris (PV) is HLA associated disease. We started a prospective study of 
association of HLA class II alleles and haplotypes in patients with pemphigus in Croatia. 
During last 12 months we were performed a pilot study of HLA genotyping in 12 patients 
with PV and compared results with control group of blood donors at Croatian institute 
of transfusion medicine. HLA typing was performed using high resolution PCR-SSP 
method (Olerup-SSP, Qiagen, Germany) In our results we observed high frequency 
of DRB1*0402 (AF 0.375) , DQB1*0302 (AF 0.375)  and DQA1*030101 (AF 0.333). 
Frequency of these alleles is signifi canty higher than in control group (AF 0.018; 0.061; 
0.245 respectively). Frequency of associated haplotype DRB1*0402-DQA1*030101-
DQB1*0302 is 0.25 vs. 0.020 in control group. Most of presented patients are from 
central part of Croatia. In our prospective study we will also focus on patiens from 
Mediterranean part of Croatia (patients from along a cost of Adriatic see) in which, 
acording to fi rst results we could expect completely different HLA class II alleles.
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Human 6-SulfoLacNAc+ (slan) dendritic cells, a novel proinfl ammatory cell type in 
lupus erythematosus
Hänsel A1, Günther C1, Baran W1, Rieber E1, Meurer M1, Schäkel K2 1Faculty of 
Medicine of the Technical University of Dresden, Dresden, Germany 2University 
Hospital, Heidelberg, Germany
Lupus erythematosus (SLE) is characterized by high levels of serum TNF-α and IFN-γ, as 
well as activated dendritic cells (DCs), B cells and T cells. In this study we asked for the 
role of 6-sulfoLacNAc expressing DCs (slanDCs), which have an outstanding capacity 
to produce proinfl ammatory cytokines and to programme Th1 cells, in human SLE. 
Immunohistochemical studies of affected skin samples (SLE n = 7, CDLE n = 8, SCLE 
n = 6) revealed increased numbers of slanDCs in the dermal infl ammatory infi ltrate. 
SlanDCs specifi cally clustered within pseudo follicular structures with CD3+ T cells 
and CD20+ B cells. A common proinfl ammatory signalling pathway in SLE is induced 
by autoimmune complexes containing single stranded ssRNA which bind to toll-like 
receptors(TLR) 7 and 8. Quantitative and qualitative PCR analysis of FACS-sorted 
slanDCs revealed the expression of TLR7 as well as of TLR8. This combined expression 
is in contrast to CD1c+ DCs and to pDCs that either express TLR7 or TLR8. In line with 
this, only slanDCs displayed a strong production of TNF-α and IL-12 after stimulation 
with selective ligands for TLR7 as well as for TLR8. SlanDCs also produced by far 
superior levels of the proinfl ammatory cytokines TNF-α, IL-6, IL-12/IL-23p40, IL-12p70 
but not IFN-γ after stimulation with the dual TLR7/8 ligand. Hence, slanDCs showed 
a massive response to ssRNA, the natural ligand of TLR7 and TLR8.Taken together 
these data provide strong evidence for slanDCs as being a novel proinfl ammatory 
effector cell type that may play an important role in the pathogenesis of human SLE.
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IL-31 expression by infl ammatory cells is unique to atopic dermatitis
Nobbe S1, Dziunycz P1, Mühleisen B1, Bilsborough J2, French LE1, Hofbauer GF1 
1University Hospital Zurich, Department of Dermatology, Zurich, Switzerland 
2Zymogenetics, Department of Immunology, Seattle, USA
Interleukin-31 (IL31) is a recently discovered cytokine expressed in many 
human tissues. Preferentially, activated CD4+T cells produce IL31 which signals 
through a heterodimeric receptor consisting of IL31 receptor alpha (IL31RA) and 
oncostatin M receptor (OSMR). Earlier studies showed involvement of IL31 and 
its receptor components IL31RA and OSMR in atopic dermatitis, pruritus and 
Th2-weighted infl ammation on the mRNA level. The purpose of the study was to 
detect IL31 protein in atopic dermatitis, Th2-weighted and pruritic skin diseases to 
delineate a more general or more concise involvement of IL31 in such conditions. 
Immunohistochemical staining for IL31, IL31RA and OSMR of the infl ammatory 
infi ltrate in formalin-fi xed paraffi n-embedded biopsy specimens of Th1-, Th2-
weighted, pruritic and non-pruritic skin diseases was performed. We found an 
increased IL31 expression in the infl ammatory infi ltrate of atopic dermatitis compared 
to most of the other skin diseases (p=0.05 and lower). Other Th2-weighted and pruritic 
skin diseases were not associated with increased IL31 protein immunoreactivity, 
nor did IL31RA or OSMR immunoreactivity differ between diseases. Our results 
suggest a specifi c relationship between IL31 expression and atopic dermatitis.
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Immunomodulatory properties of skin probiotics
Giuliani G1, Benedusi A1, Mascolo A1, Castagliuolo I2, Brun P2, Elli M3 1Giuliani SPA, 
MILANO, Italy 2Università di Padova, Italy 3AAT-Advanced Analytical Techonlogies 
Srl, Piacenza, Italy
The aim of the work was to investigate the ability of some selected lactobacilli to induce 
detectable immuno-responses in human keratinocytes. Several skin alterations are 
currently associated with cutaneous infl ammation due to altered immune-regulation. 
In recent years, the interaction between host and probiotics has been extensively 
investigated for its anti-infl ammatory and immunomodulatory implications. 
Monolayers of human primary keratinocytes were challenged with stationary phase 
lactobacilli, belonging to six different species of human origin, at different time 
frames. Experiments were done in duplicate and a pre-treatment of keratinocytes 
with bacterial LPS was also performed prior to challenge. Treated keratinocytes were 
then lysed for the evaluation, by SDS-PAGE and fl uorescent immune-microscopy, 
of PPAR-α, PPAR-β and PPAR-γ expression. Cytochines profi le of supernatants (Il-1, 
IL-6, IL-10 and TGF-beta) was also determined by Elisa kits. IL-1 was not affected by 
probiotic treatment conversely to IL-6 and IL-10 that were signifi cantly increased 
following probiotic exposure. TGF-β was also induced, leading to speculate about 
a presumptive probiotic involvement in the promotion of skin lesions repair and 
riepitelisation. Furthermore, while PPAR-β and PPAR-γ were not signifi cantly altered 
by bacterial challenge, PPAR-α expression was signifi cantly triggered, suggesting 
a potential role of skin probiotics in maintaining pH omeostasis of the skin. This 
hypothesis was strengthened by the observation that some of the tested lactobacilli 
were able to decrease the level of COX-2 expression. Overall data confi rm the ability 
of selected lactobacilli to maintain cutaneous immune-omeostasis, supplying a 
scientifi c rationale for their application in the treatment of human skin infl ammation.
563
Impact of thrombin on murine mast cell function via proteinase-activated 
receptors
Suender CA1, Grusser M1, Seeliger S2, Steinhoff M3, Maurer M1, Dudeck A4 1Charité-
Universitätsmedizin, Berlin, Germany 2University of Münster, Münster, Germany 
3University of Münster, Münster, Germany, University of California San Francisco, 
San Francisco, USA 4Technical University Dresden, Dresden, Germany
The activation of proteinase-activated receptors (PARs) via proteolytic cleavage by several serine 
proteases such as thrombin contributes to infl ammatory skin reactions and immune defense 
mechanisms. Thrombin activating PAR1, 3, and 4 in mice is upregulated during vascular and 
tissue injury. As mast cells (MCs) are preferentially localized around blood vessels and critically 
contribute to skin infl ammation and wound healing, we sought to investigate the expression and 
function of PARs on primary murine MCs. Therefore, we used two different in vitro models of 
murine MCs, immature bone marrow derived mast cells (BMCMCs) and peritoneal cultured MCs 
(PCMCs), i.e. mature connective tissue type MCs. We analysed the expression levels of PAR mRNA 
via RT-PCR as well as the degranulation and the release of IL-6, TNF, and MCP-1 by ELISA upon 
stimulation of MCs by thrombin. Furthermore, we investigated the induction of ear swelling by 
intradermal injection of thrombin in vivo in mast cell-defi cient mice (C57BL/6 KitW-sh/W-sh) and 
their C57BL/6 Kit+/+ wt littermates. Both murine MC subtypes expressed mRNA for all four PARs. 
The stimulation of MCs with thrombin resulted in a dose-dependent increase of β-hexoaminidase 
release demonstrating MC degranulation. Furthermore, we detected a dose-, and time-dependent 
increase in IL6, TNF, and MCP-1 release by MCs upon incubation with thrombin. The intradermal 
injection of thrombin in mouse ears resulted in a signifi cant swelling in C57BL/6 mice. 
Surprisingly, the ear swelling was even more pronounced in MC-defi cient C57BL/6 KitW-sh/W-sh 
mice. These fi ndings suggest that mast cell degranulation, cytokine and chemokine production 
can be induced by thrombin via PAR activation. PAR induction by thrombin may be a novel 
mechanism underlying MC-dependent skin infl ammation, immune defense and wound healing.
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In vivo detection of hypoxia during early stages of experimental arthritis even 
before visible joint infl ammation
Fuchs K1, Bukala D2, Grießinger C2, Schmid A2, Mannheim J2, Judenhofer M2, Reischl 
G3, Pichler B2, Röcken M1, Kneilling M1 1Dermatology, Univ of Tübingen, Germany 
2Laboratory for Preclinical Imaging and Imaging Technology, University of Tübingen, 
Tübingen, Germany 3Radiopharmacy, Univ of Tübingen, Germany
Early detection of arthritis is essential to prevent bone destruction by means of interventional anti-infl ammatory 
treatment. Hypoxia can induce angiogenesis via stabilization of the transcription factor hypoxia inducible 
factor (HIF)-1α and might be one of the early indicators of infl ammation. Under hypoxic conditions HIF-
1α/2α induces angiogenesis by upregulation of pro-angiogenic mediators such as bFGF and VEGF. We 
investigated hypoxia during early stages of experimental arthritis in vivo, using the Positron Emission 
Tomography (PET)-tracers 18F-Fluoromisonidazole ([18F]FMISO) and 18F-fl uoroazomycin-arabinosid ([18F]
FAZA), which selectively accumulate in hypoxic tissue. The aim of this study was to investigate a new tool to 
examine initial phases of angiogenesis in autoimmune diseases such as rheumatoid arthritis (RA) by detection 
of hypoxia, before incidence of clinical symptoms and histologicaly visible joint infl ammation. We induced 
arthritis in Balb/c mice via i.p. injection of auto-antibodies against Glucose-6-phosphate-isomerase (GPI). 
Mice underwent [18F]FMISO-, or [18F]FAZA in vivo PET investigations and magnetic resonance imaging (7 
Tesla MRI) 6, 12, 48 and 52h after induction of RA. In addition, we performed H&E-staining and real-time 
PCR analysis of gene expression patterns of joint tissue 6 and 12h after onset of arthritis. In vivo PET images 
confi rmed accumulation of hypoxia tracer shortly after arthritis induction. At 6h after GPI serum injection 
tracer uptake in arthritic joints was 1,5-fold higher than in joints of control mice, showing infl ammation in 
H&E-stained joint sections. In line with the PET-data, RT-PCR analysis showed a 7,5-fold enhanced expression 
of HIF-2α mRNA, and up to 12-fold up regulated mRNA expression of pro-infl ammatory mediators, such as, 
IL-1β and IL-6, 6h after a single GPI serum injection. Interestingly, bFGF and VEGF were not elevated at the 
mRNA level at this early time point. Thus, non invasive in vivo examination of hypoxia-induced angiogenesis 
using [18F]FAZA and [18F]FMISO seems to be a new  tool to detect RA before joint infl ammation is visible. 
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Increased expression of tumor necrosis factor-related apoptosis inducing ligand and 
its receptors in lichen planus lesions
Peternel S, Kastelan M, Prpic-Massari L, Kurilic M Medical Faculty , Clinical Hospital 
Center Rijeka, Rijeka, Croatia (Hrvatska)
The hallmark pathohistological change in lichen planus lesions is damage to the 
epidermal basal layer, considered to be mediated by dermal mononuclear cell 
infl ammatory infi ltrate. The purpose of our study was to investigate whether this 
damage might be mediated by tumor necrosis factor-related apoptosis inducing 
ligand (TRAIL) and its two death receptors TRAIL-R1 (DR4) and TRAIL-R2 (DR5). 
The pattern of tissue expression of TRAIL and its receptors was analyzed by 
immunohistochemical analysis performed on lesional skin samples of patients 
with lichen planus as well as skin samples of healthy volunteers. TRAIL and both 
of its receptors were found to be strongly expressed among cells comprising 
the dermal infi ltrate in lesional skin. The epidermal expression of TRAIL was 
only slightly increased in lichen planus lesions when compared to healthy skin. 
Interestingly, a signifi cantly stronger expression of DR4 and DR5 was observed in 
the epidermal basal layer of lichen planus lesions when compared to healthy skin 
in which the expression was low or even absent. These results indicate that TRAIL/
DR4/DR5 -mediated signalling might be involved in the pathogenesis of lichen 
planus, especially in the basal cell layer degeneration typical of this dermatosis.
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Increased IFN-, IL-12p40 and IL-8 production by P. acnes treated peripheral 
blood mononuclear cells from acne patients
Sugisaki H, Yamanaka K, Kakeda M, Kitagawa H, Kurokawa I, Mizutani H Mie 
University Graduate School Of Medicine, Tsu, Japan
Acne starts as a non-infl ammatory lesion and forms pustules with infl ammatory 
reactions.  However, the mechanism of this infl ammatory change and the role of 
Propionibacterium acnes (P.acnes) in this reaction have not been elucidated. The 
present study aimed to answer the question associated with acne pathology: which 
factor mainly contributes to the severe infl ammation on acne pathology, P. acnes 
species or host PBMC  P.acnes isolated from various acne lesions and healthy 
volunteers were cultured. The peripheral blood mononuclear cells (PBMC) from acne 
patients and healthy volunteers were stimulated with viable P.acnes from healthy 
and acne skin. The cytokine m-RNA expression of PBMC was evaluated by RT-PCR. 
The cytokine level in the culture supernatant was measured by specifi c ELISA. IFN-β, 
IL-12p40 and IL-8 mRNA expression and their protein productions were signifi cantly 
increased in PBMC from acne patients compared with those from normal donors 
stimulated with the same P.acnes. In contrast, there was no signifi cant difference 
between P.acnes species from normal skin and acne lesions, in PBMC cytokines 
induction activities. Present results strongly suggest that the infl ammatory response 
in acne appears to be attributable to individual differences in host immune response 
to P.acnes than differences in P.acnes species. Present study confi rmed importance of 
modulation of host immune responses to P.acnes as well as extermination of P.acnes.
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Interleukin-25 in Atopic Dermatitis
Hvid M1, Vestergaard C2, Christensen G3, Kemp K3, Deleuran B1, Deleuran M2 1Institute 
of medical microbiology and immunology, Aarhus C, Denmark 2Department of 
Dermato-venereology, Aarhus University hospital,Aarhus C, Denmark 3Leo Pharma, 
Ballerup, Denmark
Interleukin-25 (IL-17E) has recently been speculated to play a role in atopic 
diseases like asthma, where IL-25 is localized to affected lung tissue. Furthermore, 
IL-25 administration induces the production of Th2 associated cytokines IL-4, 
IL-5 and IL-13, in addition to eosinophilia and IgE production in a murine 
asthma model. The purpose of this study is to examine if IL-25 is involved in the 
pathogenesis of atopic dermatitis (AD). We examined serum samples from 22 
AD patients using an IL-25 ELISA (detection range: 60-2000 pg/ml). Additionally, 
formaldehyde fi xed, paraffi n embedded punch biopsies from AD patients, as 
well as psoriatic patients and healthy controls, were examined for the presence 
of IL-25.Using ELISA we were unable to detect IL-25 in AD serum. We therefore 
evaluated the expression of IL-25 locally in the skin by immunohistochemistry. In 
healthy controls IL-25 positive cells are nearly absent, whereas in involved skin of 
AD and psoriasis IL-25 is predominantly expressed by large mononuclear cells in 
the dermis and in the basal keratinocytes of the epidermis.These results indicate 
that IL-25 could play a potential role in AD and psoriasis locally in the skin. 
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Intrathymic beta2 integrin defi ciency generates  unconventional memory-like 
CD44+ TCRab+ CD4-CD8- (DN) T cells
Oreshkova T1, Sindrilaru A1, Wang H1, Varga G2, Grabbe S3, Scharffetter-Kochanek 
K1, Peters T1 1Ulm University, Ulm, Germany 2Münster University, Münster, Germany 
3Mainz University, Mainz, Germany
Thymus is the specialised organ where maturation of conventional and unconventional T cells occurs. 
But distinct sets of unconventional T cells develop extrathymically. We previously demonstrated 
that beta2 integrin defi cient (CD18-/-) mice accumulate unconventional TCRalpha/beta CD4-CD8- 
(DN) T cells expressing a characteristic memory-like CD44+ phenotype in their periphery driven 
by homeostatic expansion under lymphopenic conditions in CD18-/- mice. We here investigate the 
differential contribution of selective beta2 integrin defi ciency on T progenitors and the intra- and 
extrathymic hematopoietic environment (since beta2 integrin are only expressed on hematopoietic 
cells) in the primary generation of unconventional TCRalpha/beta DN T cells before they undergo 
homeostatic expansion. We found that peripheral memory-like CD44+ TCRalpha/beta DN T 
cells physiologically occur also in spleens of CD18wt mice at low numbers, whereas they were 
not convincingly detectable in spleens from native athymic nude mice. This suggested that their 
development required the presence of a functional thymus. However, functional TCR rearrangement 
was also required, since in thymus-competent RAG2-/- mice, CD44+ TCRalpha/beta DN T cells 
were also not detectable. Further establishing a key role for thymus in the generation of CD44+ 
TCRalpha/beta DN T cells, we detected signifi cantly higher numbers of these cells in thymi from 
CD18-/- as compared to CD18wt mice. Furthermore, the inability to recover CD18-/- TCRalpha/
beta DN T cells in bone marrow-reconstituted athymic nude mice showed that beta2-integrin 
defi ciency of hematopoietic progenitor cells was not the reason for their excessive production in 
CD18-/- mice. Collectively, these data reveal that absence of beta2 integrins during intrathymic 
T cell development plays a critical role in the generation of memory-like CD44+ TCRalpha/
beta DN T cells that accumulate in periphery of CD18-/- mice while they progress with age. 
570
Intravenous Immunoglobulin Therapy is Effective and Acts Independently of the 
Neonatal Fc-receptor in Experimental Epidermolysis Bullosa Acquisita
Kasperkiewicz M, Ishii N, Hirose M, Freitag M, Schmidt E, Recke A, Zillikens D, 
Ludwig RJ University of Lübeck, Lübeck, Germany
Epidermolysis bullosa acquisita (EBA) is a severe autoimmune skin disease 
characterized by autoantibodies against type VII collagen, the major component 
of anchoring fi brils. Currently, response of EBA patients to treatment is often 
unsatisfactory and relies on immunosuppressive agents. To evaluate the therapeutic 
effi cacy of intravenous immunoglobulines (IVIG), experimental EBA was induced in 
mice by immunization with murine type VII collagen. After clinical manifestation 
of EBA, mice were randomly assigned to one of the following treatment groups: 1) 
methylprednisolone (MP) (daily 20mg/kg i.p.), 2) IVIG 2g/kg (every second day) or 
3) IVIG weekly, or 4) untreated. All treatment options signifi cantly inhibited further 
disease progression, but it was most pronounced in both IVIG groups. In line, IVIG 
was more effective in decreasing subepidermal autoantibody deposition than MP, and 
IVIG had a more pronounced impact on neutrophil extravasation (MPO-assay). IVIG’s 
mode of action is still a matter of debate. However, it is hypothesized, that IVIG acts 
through inhibition of the neonatal Fc-receptor (FcRn). By inhibition of IgG degradation, 
the FcRn is mainly responsible for the long half-live of IgG. Hence, blockade of the 
FcRn by IVIG, is believed to shorten the half-live of pathogenic autoantibodies. To 
test this hypothesis, FcRn-defi cient and control mice were injected with pathogenic 
rabbit anti-mouse type VII collagen antibodies, and treated with IVIG or PBS. IVIG 
treatment was effective in wild type and FcRn-defi cient mice, indicating, that IVIG 
acts independently of FcRn expression. In summary, our data demonstrate that IVIG 
is an effective treatment for experimental EBA. Having excluded a role of the FcRn, 
further studies will aim at dissecting other mechanisms that mediate the effect of IVIG. 
Eventually, this may lead to a more targeted therapy in autoantibody-mediated diseases.
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Lipidomic analysis of intact components in human sebum. signifi cance for the 
identifi cation of lipid alterations in acne
Camera E, Galante M, Ludovici M, Tilgher S, Mastrofrancesco M, Briganti S, Sinagra 
JL, Capitanio B, Ottaviani M, Picardo M San Gallicano Dermatological Institute, 
Rome, Italy
Sebum, a key component of the skin’s surface structure, prevents water loss and shields 
environmental aggressions, and its qualitative and/or qualitative alterations have been 
addressed as triggers of skin infl ammation. Complexity of sebum composition and lack 
of suitable analytical methods; allowing for the identifi cation of the intact lipids have 
hampered perfection of knowledge around the structures and the biological signifi cance 
of individual components. Lipid profi ling can provide the basis for the acquisition of 
lipidomics data of human sebum in health and disease. To characterize the structure of 
human sebum, we have undertaken their systematic analysis based on time-of-fl ight mass 
spectrometry (TOF-MS) following separation of mixture by rapid resolution HPLC. The 
analysis of lipid profi les performed on 30 normal subjects has led to the identifi cation of 
averagely 700 species. Tandem MS/MS analysis has allowed for the structural elucidation 
of components populating the main classes of sebum lipids, i.e. free fatty acids, squalene, 
waxes, cholesterol and glycerol esters. Among the glycerol esters group ca. 300 species 
have been identifi ed with an unsaturation degree ranged from 0 to 6, and a chain length of 
the substituent fatty acyls from 4 to 26 carbon atoms. A wide variability was detected among 
different triglyceride groups. Sebum profi le was compared between 20 acne subjects and 20 
age-matched controls. Discriminate multivariate analysis revealed a signifi cant difference in 
the distribution of specifi c esters of glycerols mainly containing C18:1 fatty acid moieties and 
alterations in the levels of squalene. Our data demonstrates a great variability of sebum profi le 
probably as expression of individual lipid metabolism and indicates alterations of specifi c 
lipid compounds in acne patients that can play a role in the pathogenesis of the disease
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Low expression level of GATA3, a key regulator of keratinocyte proliferation and 
differentiation, is upregulated by narrow-band UVB phototherapy in psoriasis.
Racz E1, Kurek D1, Florencia E1, Kant M1, De Ridder D2, Mourits S1, Laman JD1, Van 
der Fits L1, Prens EP1 1Erasmus University Medical Center, Rotterdam, Netherlands 
2Delft University of Technology, Delft, Netherlands
Psoriatic skin lesions are characterized by hyperproliferation and activation of epidermal keratinocytes 
and by infi ltration of Th1 and Th17 cells. The transcription factor GATA3 fulfi ls important regulatory roles 
in both keratinocyte and T cell differentiation. GATA3-/- mice express a psoriasis-like skin phenotype. 
We therefore questioned whether GATA3 expression was altered in psoriasis. GATA3 expression was 
lower in lesional psoriatic skin than in non-lesional samples. This decreased expression was probably 
not due to suppression by pro-infl ammatory mediators, since its expression could not be suppressed by 
IFN-γ, IFN-β or IL-22 in ex vivo cultured healthy human skin biopsies. Comparison of gene expression 
profi les of human psoriatic skin with skin of GATA3-/- mice showed great similarity. This suggests 
that GATA3 defi ciency may be causatively involved in the skin barrier impairment, disturbed lipid 
metabolism and cell proliferation that are observed in psoriasis. To functionally dissect the association 
between GATA3 expression and skin infl ammation, we used the imiquimod (IMQ)-induced psoriasis-
like dermatitis mouse model. GATA3 expression was clearly decreased in IMQ-treated mouse skin. In 
addition, low GATA3 expression was detected in skin wounds in mice, demonstrating the association 
of low GATA3 expression with the regenerative epidermal phenotype. We assessed whether GATA3 
expression in psoriasis was infl uenced by the effective psoriasis therapy, narrow-band UVB (NB-
UVB). GATA3 expression showed signifi cant upregulation during NB-UVB, inversely correlating with 
the clinical improvement of psoriasis. In addition, NB-UVB-induced improvement of IMQ-induced 
psoriasis-like dermatitis in mice was accompanied by an upregulation of GATA3.  In conclusion, 
epidermal GATA3 expression is decreased in psoriasis and in a psoriasis-like dermatitis mouse model, 
whereas the expression level is restored upon successful NB-UVB treatment. The attenuated GATA3 
expression might be causative to the altered skin barrier function, lipid metabolism and cell proliferation. 
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Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the 
use of overlapping peptides
Adler J, Recke A, Freitag M, Schmidt E, Ludwig RJ, Zillikens D University of Luebeck, 
Luebeck, Germany
Pemphigus vulgaris (PV) is a severe autoimmune blistering disease associated with 
autoantibodies to desmoglein 3 (Dsg 3), a transmembrane glycoprotein of the 
cadherin family. By the use of recombinant fragments of Dsg 3 and a competition 
ELISA, previous analyses have identifi ed major B cell epitopes on the extracellular 
domain (EC) 1 of Dsg 3 in PV patients. Here, we generated 254 overlapping synthetic 
peptides of 14 amino acids length covering the entire Dsg 3 ectodomain. Each 
peptide was N-terminally biotinylated and subsequently bound to streptavidine-
coupled 96-well plates. Sera of PV patients (n=10) and healthy volunteers (n=10) 
were then tested for reactivity with the peptides by ELISA. Heuristic data analysis 
identifi ed 6 major antigenic sites harbored within the EC1 and EC3 domain of 
Dsg 3. In order to validate these results, ELISA was performed with larger peptides 
of 25-30 amino acids in length that covered the initially recognized smaller 
immunodominant peptides. Sera of 17 additional PV patients and 20 healthy blood 
donors were tested and a peptide within EC3 was confi rmed with the strongest 
reactivity. To explore the pathogenic relevance of this fi nding, the identifi ed 
peptide will be used to purify and preadsorb anti-Dsg 3 autoantibodies for further 
analysis in the keratinocyte dissociation assay and neonatal mouse model of PV. 
Our results may be helpful to design more specifi c therapeutic approaches for PV.
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Mechanisms of anti-infl ammatory activity of azelaic acid:effects on PPAR 
activation
Ottaviani M1, Mastrofrancesco A1, Cardinali G1, Aspite N1, Graupe K2, Zouboulis CC3, 
Camera E1, Picardo M1 1San Gallicano Dermatological Institute, Rome, Italy 2GCD, 
Intendis GmbH, Berlin, Germany 3Depts. of Dermatology, Venereology, Allergology 
and Immunology, Dessau Medical Center, Dessau, Germany
Azelaic acid; a naturally occurring dicarboxilic acid employed in the treatment 
of acne has proved benefi cial in treating rosacea as well. The common feature 
of these diseases is the development an infl ammatory reaction in response to 
different endogenous and exogenous stimuli. To elucidate the mechanism of anti-
infl ammatory activity of AzA, we have investigated its effects on the infl ammatory 
response of normal human keratinocytes (NHK) to UV; a trigger factor for rosacea. 
AzA at 20 mM showed a signifi cant suppressing effect on the UVA induced ROS 
generation and IL6 production and UVB-induced expression of TNF-α, IL-1β, and 
IL-6 at mRNA and protein levels. AzA limited the UVB-induced nuclear translocation 
of Nf-kB subunits associated with a decreased phosphorylation of p38 MAPK. 
Based on recent evidence pointing to PPARγ as a crucial player in the control of 
infl ammatory processes through trans-repression of NF-kB nuclear translocation and 
cosidering that natural PPAR ligands are lipids and their peroxidation products, we 
further investigated the kinetic of AzA-induced activation of PPAR-γ. we observed 
a signifi cant but transitory activation of PPAR-γ transcription by AzA up to 6h by 
means of mRNA expression and PPRE-luciferase reporter gene assay. Downstream 
effects of PPAR-γ activation such as inhibition of cell proliferation, were evident in 
the following 48 and 72 h, as demonstrated by the Ki67 expression. In conclusion 
these data contribute to understanding the mechanism of anti-infl ammatory 
activity of AzA and possibly explaing its theraputical effects in acne and rosacea
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Meranzin : A new COX-1 / COX-2 inhibitory
Renimel I, Fanton L, Andre P LVMH research, Saint Jean de Braye, France
Limnocitrus littoralis is a plant of the Rutaceae family, mainly located in Vietnam.
In traditional medicine, it’s used as an expectorant as well as to threat asthma attack 
and more widely as anti-infl ammatory. Meranzin, a coumarin derivative characterised 
by an epoxide group, was identifi ed as one of the main component. A fi rst study, on 
keratinocytes showed a strong inhibitory effect of the limnocitrus extract on the PGE2 
liberation (25% at 2µM) compared at the reference molecule indomethacin (17% at 
2 µM).In a second step, a virtual biological profi ling was carried to out. A database of 
2000 protein targets was tested. Three targets were held: Cyclooxygenase 1 (COX-1), 
Peroxisome proliferator activated receptor gamma (PPAR γ) and Cyclooxygenase 2 
(COX-2). The tree targets were submitted to in vitro validations along with two other 
proteins which were not selected: 5 lipoxygenase (5-LOX) and elastase, as negative 
control. The decision to test on 5 LOX was taken because this enzyme has a similar 
binding site as COX and is involved into the infl ammatory effect. The results of the 
in vitro assays showed clearly than Meranzin inhibited COX-1 and COX-2(IC50 less 
than 40µM and 0.4µM respectively). Meranzin was confi rmed, had no signifi cant 
activity on 5-LOX at 100 µM, neither on pancreatic elastase at 1mM.In vitro assays 
showed good correlations with the reverse pharmacognosy predictions either with 
positive and negative controls.With these studies we explained the traditional used. 
As this molecule can be purifi ed in huge quantity from readily available sources, 
a rapid industrialisation of a new Non steroidal Anti Infl ammatory Drug (NSAID) 
can be expected with a possible sustainable development with local population.
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Possible role of  the nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase 
pathway in chronic wounds
Szabo E1, Bodnar E1, Erdelyi K2, Hegedus C2, Bakondi E2, Remenyik E1, Virag L2 
1Dept Dermatology, Medical and Health Science Center, University of Debrecen, 
Debrecen, Hungary 2Dept Medical Chemistry, Medical and Health Science Center, 
University of Debrecen, Debrecen, Hungary
The wound-healing process has been well described at the histological level, but the underlying 
molecular mechanisms are still poorly defi ned. Chronic wounds (venous ulcers, pressure ulcers 
and diabetic ulcers) are a health problem of enormous magnitude affecting many hundreds of 
thousands of patients with health care costs amounting to billions of dollars annually in the United 
States alone. These human chronic wounds can be traced back to a combination of four major 
pathogenetic factors: persistent infl ammation, local tissue hypoxia, bacterial colonization and 
ageing-related alteration in the stress response. We set out to investigate the role of peroxynitrite 
(reaction product of NO and superoxide) and poly(ADP-ribose) polymerase-1 (PARP-1) in normal 
and in delayed wound healing. Examinations in the animal model: In murine incision wounds we 
detected iNOS (main source of NO) expression by immunohistochemistry. iNOS was most intense 
at the wound edges. Our previous work and other data in the literature also prove that peroxynitrite 
may also be formed from NO in the skin.Examinations on cultured HaCaT keratinocytes: In cell 
culture experiments, exposure of HaCaT keratinocytes to peroxynitrite induced alterations in 
the expression pattern of infl ammatory cytokines and chemokines as determined by low density 
arrays.Studies on human samples:Serum, wound fl uid, skin biopsies obtained from chronic venous 
leg ulcer patients. We detected eleveted nitrotyrosine (footprint of ONOO) level in serum and 
wound fl uid  by dot blot. Intense nitrotyrosine staining, PARP-1 expression and PAR accumulation 
could be detected in skin biopsies by immunohistochemistry.Our results demonstrate that the 
nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway is active in chronic wounds. 
Further examinations are necessary to establish the functional contribution of poly(ADP-
ribosyl)ation in the regulation of the production of infl ammatory mediators in chronic wounds.




Propionibacterium acnes extracts improve Corticotropin Releasing Hormone 
expression in the skin
Isard O1, Knol AC1, Castex-Rizzi N2, Khammari A2, Charveron M2, Dréno B2 1Nantes, 
France 2Toulouse, France
Propionibacterium acnes extracts improve Corticotropin Releasing Hormone 
expression in the skin. Propionibacterium acnes plays a major role in the development 
of acne especially on the infl ammation stage. The Corticotropin Releasing Hormone 
(CRH) is a neuropetide also produced by the skin through an equivalent of the 
Hypothalamic-Pituitary-Adrenal axis under the infl uence of a stress. CRH had been 
reported to have a role in the regulation of cell proliferation and differentiation 
representing an important step in the development of acne lesions. Our objective was 
to study the modulation of CRH expression by keratinocytes with P.acnes extracts and 
its modulation by Zinc. Zinc is known to act on acne lesions with still partially known 
mechanisms. Immunohistochemical analysis of CRH was conducted on frozen 
sections of cutaneous explants obtained from 3 healthy donors after 3 incubations 
(3h, 6h, 24h) with different P.acnes extracts (membrane fraction, cytosolic fraction) 
or Zinc gluconate. We observed an induction of CRH expression by keratinocytes 
particularly after incubations with the membrane fraction which was maximal after 3h. 
Gluconate Zinc salts decreased CRH expression since 3h. As it has been shown that 
P.acnes extracts could induce fi laggrine expression, by increasing CRH expression, 
this bacteria could thus indirectly have an effect on keratinocytes proliferation and 
differentiation. This induction was observed both with the membrane fraction and the 
cytosolic fraction. In conclusion, this work suggests that P.acnes could play a role since 
the comedo formation and not only on acne infl ammatory stage. Moreover it enlightens 
a potentially new mechanism of zinc action in acne through CRH modulation.
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Selective depletion of macrophages reveals distinct roles during the early and late 
phase of skin repair
Lucas T1, Piekarek M1, Waisman A2, Krieg T1, Eming S1 1University of Cologne, 
Cologne, Germany 2University of Mainz, Mainz, Germany
Infl ux and activation of macrophages represent an early defense mechanism after 
skin injury. The primary function of this process is to mount an immune response that 
effectively kills invading pathogens, and at the same time, induces successful repair 
and homeostasis of damaged tissue. Our previous work provides substantial evidence 
that an altered infl ammatory response at the wound site can lead to both benefi cial 
and harmful effects on cell functions essential for repair. In the presented project we 
took this work further by unraveling the dual role of the innate immune response in 
skin repair and homeostasis. We used a mouse model of Cre-inducible diphteria toxin 
receptor-mediated cell ablation to specifi cally eliminate macrophages at different time 
points after inducing skin injury. Depletion of macrophages during the early phase of 
repair signifi cantly attenuated the formation of a cellular and vascularized granulation 
tissue and the rate of wound closure was severely delayed. Notably, after wounds 
completed epithelialization the newly formed dermal tissue revealed minimal scar 
formation. In contrast, depletion of macrophages during the late phase of repair did not 
impact the overall amount of granulation tissue deposition. However, late granulation 
tissue was highly hemorrhagic, indicating reduced vascular stability. To the best of our 
knowledge, this data provides the fi rst evidence that functionally different populations 
of macrophages exist during the diverse stages of skin repair and play crucial and 
distinct roles during the phase of granulation tissue formation and tissue remodeling.
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Serum levels of Ficolin-2 correlated with C4 in systemic lupus erythematosus
Nishibu A1, Kato Y1, Nakamura K2, Endo Y1, Yamamoto T1 1Fukushima Medical 
University, Fukushima, Japan 2Saitama Medical University, Iruma, Japan
Complement activation or defi ciency within the classical pathway predisposes for 
systemic lupus erythematosus (SLE). Ficolin-2, a lectin which recognizes carbohydrate 
molecules on pathogens and apoptotic or necrotic cells, and to initiate activation of 
the lectin complement pathway, is thought to participate in autoimmunity. To confi rm 
whether Ficolin-2 is concerned with the clinical condition of SLE, we investigated 
correlations between the levels of fi colin-2 and various laboratory values in the 
sera from patients with SLE. Serum levels of Ficolin-2 were measured in 24 patients 
with SLE and age and sex matched 24 healthy controls by using ELISA. As a result, 
fi colin-2 from the patients with SLE (7.5±8.8 microgram/ml) was signifi cantly lower 
than that from the controls (15.7±9.9 microgram/ml) (p<0.001). In the comparison 
with the clinical inspection values, Ficolin-2 and C4 presented a negative correlation 
(correlation coeffi cient -0.44, p=0.02), and presented a negative correlation 
tendency with C3. On the other hand, it did not correlate to CH50. Furthermore, 
fi colin-2 and the erythrocyte sedimentation rate showed a weak, positive correlation 
tendency, but it wasn’t correlated with the number of red blood cells, and 
hematocrit, albumin and C-reactive protein values. These results indicate that not 
only classical complement pathway but also lectin pathway takes part as a decline 
of complements in SLE, and fi colin-2 is implicated in the pathophysiology in SLE.
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Skin mast cells express galanin receptors
Hakim-Rad K1, Metz M1, Rauch I2, Kofl er B2, Maurer M1 1Charité, Berlin, Germany 
2University Hospital Salzburg, Salzburg, Austria
Sensory nerve activation and neurogenic mediators have long been suspected to 
be able to elicit immunomodulatory effects. The underlying mechanisms, however, 
are far from clear. Due to recent studies using mouse models the neuropeptide 
galanin is suspected to be involved in the suppression of infl ammation. Speculating 
that its suppressive mode of action includes direct effects on mast cells, we asked 
whether mast cells express galanin receptors. Real time PCR analyses of murine 
bone marrow cultured mast cells showed that mast cells express galanin receptor 
3 (GalR3). DNP-IgE sensitisation and subsequent challenge with DNP resulted in 
a 4-fold up-regulation of GalR3 gene expression. GalR3 up-regulation was also 
observed in human cutaneous mast cells challenged with anti-IgE. Up-regulation 
of GalR3 appears within the fi rst hour after mast cell stimulation and rapidly 
returns to baseline after 2 hours. Interestingly, galanin does not induce mast cell 
degranulation or proliferation, i.e. mast cell responses that induce or promote 
infl ammation. Our ongoing studies will clarify whether or not galanin can prevent 
or modulate mast cell activation via GALR3. If this were the case, this novel 
pathway could be targeted for new approaches to treat skin infl ammatory disorders.
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Successful Treatment of Severe Pemphigus with the Combination of 
Immunoadsorption and Rituximab
Shimanovich I, Bohmke AK, Westermann L, Kramer J, Zillikens D, Schmidt E 
University of Luebeck, Luebeck, Germany
Standard regimens may prove inadequate in severe pemphigus and cause dangerous 
side-effects. Novel treatment options include immunoadsorption (IA) and rituximab. 
While IA rapidly reduces circulating autoantibody levels, rituximab has a delayed 
onset of action but exerts a long-term effect in the majority of pemphigus patients. 
Therefore, in addition to dexamethasone pulses (100 mg i.v., day 2, 3, 4, 22, 23, 
and 24) and azathioprine (2.5 mg/kg/d from day 1), 15 patients with severe and/or 
refractory pemphigus (vulgaris, n=12; foliaceus, n=3) were subjected to the adjuvant 
combined treatment with IA (day 1, 2, 3, 21, 22 and 23) and rituximab (1 g, day 4 and 
24). When lesions regressed by more than 80%, IA was discontinued and intervals of 
dexamethasone pulses were extended according to disease activity. All 15 patients 
showed a sharp decline of circulating autoantibody levels by a median of 62% and 
85% after 3 and 6 weeks of treatment, respectively. After a follow-up of 3 to 19 months, 
clinical remission was achieved in 8 patients, minimal disease in 6 and partial remission 
with healing of more than 50% of lesions in one patient. One patient suffered a relapse 
after 10 months and was retreated with rituximab. In summary, the combination of 
adjuvant IA and rituximab induced a rapid and durable remission in patients with 
severe pemphigus previously resistant to treatment. These results warrant a larger 
clinical study on the use of the combination of IA and rituximab in severe pemphigus.
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TARC/CCL17 and CTACK/CCL27 are Differentially Expressed in Infl ammatory Skin 
Diseases
Riis J, Johansen C, Kragballe K, Iversen L Aarhus University Hospital, C Aarhus, 
Denmark
TARC/CCL17 (thymus- and activation-regulated chemokine) is a Th2 type chemokine, 
which binds to the CC chemokine receptor 4 (CCR4). It is constitutively expressed in the 
thymus and is produced by dendritic cells, endothelial cells, keratinocytes, and fi broblasts. 
CTACK/CCL27 (cutaneous T-cell attracting chemokine) is a skin-specifi c CC-chemokine 
continuously expressed by keratinocytes. CCL27 binds to the chemokine receptor CCR10 
and mediates Th1 and Th2 lymphocyte migration into the skin. The purpose of our study 
was to review the differences in the expression of the chemokine CCL17 and CCL27 in 
the three infl ammatory skin diseases: psoriasis, atopic dermatitis (AD) and nickel allergic 
contact dermatitis (Ni-ACD). We determined the expression of both CCL17 and CCL27 
in the skin at mRNA level using quantitative RT-PCR and at protein level by ELISA. 
Interestingly, a pronounced (~100 fold) and statistically signifi cant raise in CCL17 mRNA 
was found when comparing lesional Ni-ACD with non-lesional Ni-ACD affected skin. 
This result was also seen at CCL17 protein level (~50 fold). In lesional psoriatic skin 
only a minor increase in CCL17 mRNA was measured when compared to non-lesional 
psoriatic skin. Surprisingly, our studies revealed that the expression of CCL27 mRNA and 
protein in psoriatic skin lesions was markedly and statistically signifi cantly decreased 
compared to non-lesional psoriatic skin. This fall in CCL27 mRNA and protein was also 
found in lesional skin from patients with Ni-ACD when compared to non-lesional skin 
although to a lesser degree. No alterations in either CCL17 or CCL27 were seen in AD 
skin. Overall, our principal fi ndings were a marked upregulation of CCL17 in lesional Ni-
ACD skin and a distinct decrease in CCL27 in lesional psoriatic skin. These fi ndings may 
explain the different recruitment of T-cells into the skin in these infl ammatory diseases. 
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Thalidomide Inhibits Activation of Infl ammasomes
Beer HD, Keller M, Sollberger G ETH Zurich, Switzerland
Thalidomide is an anti-infl ammatory, immunomodulatory, and anti-angiogenic drug, 
which is extensively tested and used for the treatment of infl ammatory skin diseases 
and cancer. Inspite of the signifi cant pharmacological potency of thalidomide, its 
therapeutic use is problematic due to a strong teratogenic activity. The molecular 
mechanisms, by which thalidomide exerts its pharmacological and/or teratogenic 
activities, are mainly unknown. In this study we asked whether thalidomide might 
inhibit infl ammation and angiogenesis via inhibition of caspase-1. Caspase-1 is 
required for the activation of the pro-infl ammatory cytokines proIL-1β and proIL-
18. In addition, we could recently demonstrate that the protease’s activity is also 
necessary for unconventional secretion of leaderless proteins such as proIL-1α, IL-
1β and FGF2. Caspase-1 itself is activated in recently discovered innate immune 
complexes, called infl ammasomes. Here we show that pharmacological doses of 
thalidomide prevent the secretion of leaderless proteins from different human 
primary cells. For example, the drug strongly reduced secretion of IL-1β from 
UVB-irradiated keratinocytes and from activated macrophages, and the release 
of FGF2 from UVA-irradiated fi broblasts. In line with these results, thalidomide 
inhibited activation and activity of caspase-1 in cultured cells but not in vitro. The 
latter fi nding indicates that the pharmacological activity is exerted by a metabolite 
of the drug. Results obtained with caspase-1-defi cient mice strongly suggest that 
the anti-infl ammatory activity of thalidomide is also mediated via this protease in 
mice.These fi ndings revealed a novel mechanism by which thalidomide exerts its 
pharmacological activity and suggest that inhibition of the activity of caspase-1 
or of IL-1 might represent a novel strategy to substitute this problematic drug.
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The characteristic granular IgG deposition in pemphigus patients’ skin is caused by 
the bivalent character of IgG
van der Wier G, Oktarina D, Diercks G, Jonkman M University Medical Center 
Groningen, Groningen, Netherlands
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are auto-immune blistering 
diseases caused by antibodies against the desmosomal cadherins desmoglein (Dsg) 
1 en 3. We analyzed the in vivo deposition patterns in pemphigus patients’ skin. We 
also investigated in an in vitro pemphigus model if these patterns are caused by the 
bivalent character of IgG and if they are a requirement for acantholysis. Biopsies of 11 
mucosal PV patients and 12 PF patients were selected. For the in vitro experiments, 
normal human skin biopsies were incubated for 24 hours with IgG and Fab fragments 
derived from PV and PF patients’ sera. Cryostat sections of the biopsies were stained 
by immunofl uorescence. The IgG deposition pattern in patients’ skin differs from the 
normal distribution of the immunological desmoglein targets. In both PV and PF the 
pathogenic IgG induces an aberrant desmoglein distribution that is visualized as a 
granular deposition pattern in the epidermis. This is more prominent in the lower 
epidermal layers both in PV as well as PF. The in vivo clustering of the desmogleins 1 
and 3 followed the specifi c reactivity of the patient’s serum IgG. Apart from desmoglein 
also plakoglobin becomes redistributed, which is more prominent in unaffected PF 
skin than in mucosal PV skin. Experimental in vitro incubations of normal human 
skin with patient derived IgG demonstrated that this granular appearance is due 
to the intrinsic bivalent character of the IgG. Monovalent Fab fragments did not 
result in a change of the desmoglein distribution patterns but nonetheless resulted 
in blistering, either suprabasal when PV Fab fragments were used or subcorneal 
when PF Fab fragments were used. This suggests that the observed apparent 
desmosomal redistribution of desmoglein is not necessarily coupled to acantholysis. 
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The role of PPAR receptors in the control of dermatological infl ammatory 
processes: the effects of a novel compound (GED507D) as an agonist
Camera E1, Mastrofrancesco A1, Ottaviani M1, Kovacs D1, Aspite N1, Giuliani GM2, 
Zouboulis CC3, Picardo M1 1San Gallicano Dermatological Institute, Rome, Italy 
2Giuliani Pharma, Milan, Italy 3Depts. of Dermatology, Venereology, Allergology and 
Immunology, Dessau Medical Center, Dessau, Germany
The peroxisome proliferator-activated receptors (PPARs) control important cell 
functions, such as cell proliferation and differentiation, growth factor and cytokine 
secretion, and lipid synthesis. The confl icting published data on different tested 
molecules indicate that specifi c targeting of the receptors can offer strategies for 
treating infl ammatory skin diseases. In order to assay its effects in limiting infl ammatory 
responses and sebum synthesis a new chemical entity (GED507D) designed as a 
selective PPARγ agonist has been investigated in human primary keratynocytes and 
in the sebocyte cell line SZ95. Keratinocytes were primed to infl ammation with 
oxidative and biological stresses, such as hydrogen peroxide and IFN-γ. GED507D 
specifi cally induced PPARγ mRNA expression and the PPRE-luciferase reported 
gene activity, and signifi cantly inhibited the induction of TNF-α and IL-6 at mRNA 
and protein levels. The effect was dose dependent between 0,01 and 1,0 mM and 
correlated with the inhibition of the trans-activation of NF-κB. Moreover reduction of 
cell proliferation associated with induction of differentation markers such as fi llagrin 
were observed. In sebocytes, a signifi cant inhibition of the sebum synthesis induced 
by insulin or by the combination linoleic acid/testosterone, was demonstrated by 
nile red incorporation assay and Liquid Chromatography-Mass Spectrometry analysis. 
These results confi rm the need to investigate the PPARγ activation mechanisms 
and place in prospective a possible application of GED507D in the control of the 
major pathogenetic factors involved in infl ammatory skin diseases including acne. 
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The Many Faces of Epidermolysis Bullosa Acquisita
Buijsrogge JJ, Diercks GF, Pas HH, Jonkman MF University Medical Center Groningen, 
Groningen, Netherlands
Epidermolysis bullosa acquisita (EBA) is a clinically heterogeneous disease with 
autoantibodies to type VII collagen, that may be characterized by either an infl ammatory 
or mechanobullous phenotype. The infl ammatory phenotype comprises the bullous 
pemphigoid (BP)-like, mucous membrane pemphigoid (MMP)-like, bullous systemic lupus 
erythematosus (BSLE) and IgA-EBA subtypes. The mechanobullous phenotype comprises 
the classical mechanobullous EBA (cMB) and the Brunsting-Perry (BrPr)-like EBA subtype. 
Aim of the study was to correlate the clinical phenotype of EBA to immunoreactivity as 
witnessed by immunofl uorescence microscopy (IF). 42 patients were included according 
to the criteria: 1) Blisters and erosions on the skin or mucous membranes and 2) U-serrated 
immunodepositions along the epidermal basement membrane zone (n=40) by direct IF or 
autoantibodies to type VII collagen (n=2) by immunoblot.  IgG-EBA was found in 14 cases: of 
these 5 were infl ammatory BP-like, 6 cMB and one Br-Pr-like. IgG-BSLE patients presented as 
one BP-like and one cMB-like. IgA-EBA was found in 11 cases; of these 10 were infl ammatory 
subtypes of which 9 vesicular pemphigoid (VP)-like and one BP-like, and one cMB-like. 
Mixed IgG/IgA-EBA was present in 15 cases; of these 8 were infl ammatory of which 6 BP-like 
and 2 MMP-like, and 3 mechanobullous of which 2 cMB-like and one BrPr-like. Four mixed 
IgG/IgA-BSLE patients were 2 cMB-like and 2 BP-like. Pure IgM-EBA was seen in 2 cases 
with a prurigo-like phenotype. Clinically EBA presents with various clinical presentations; 
the IgG-EBA subtype is mainly mechanobullous, the mixed IgG/IgA-EBA is mainly 
infl ammatory BP-like and the IgA-EBA is mainly infl ammatory VP-like. BSLE was present as 
IgG-BSLE or mixed IgG/IgA-BSLE. This study using the u-serrated clue to diagnosis recruted 
a relative large number of EBA patients, and extends our knowledge of its clinical diversity.
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The Molecular Profi le of Psoriatic Skin in Responders to Ustekinumab or Etanercept 
Following Twelve Weeks of Treatment: Results from the ACCEPT Trial
Krueger J1, Baribaud F2, Suarez-Farinas M1, Brodmerkel C2 1Rockefeller University, 
New York, USA 2Centocor Research and Development, Inc, Malvern, USA
We assessed the impact of p40 cytokine (IL-12/IL-23) or TNF-alpha blockade on 
resident and infl ammatory cells and on the expression of gene circuits that may drive 
chronic immune activation and infl ammation in the skin.In ACCEPT, a randomized, 
active-controlled study, the effi cacy of etanercept and ustekinumab were compared 
in 903 patients with moderate-to-severe plaque psoriasis through wk12. Skin biopsies 
were performed in a subset of patients at baseline, wks1 and 12. Microarray analyses 
(Affymetrix U133+2 array) comparing non-lesional skin (n=85) to lesional skin (n=85) 
at baseline showed several thousand probe sets differentially expressed (>2-fold 
change FDR, p<0.05) in lesional skin.Patients responding to each agent (>=PASI75, 
n=21 for etanercept, n=19 ustekinumab) had signifi cant changes in approximately 
4000 transcripts compared to untreated lesions, indicating signifi cant resolution of 
pathological gene circuits. A set of 2922 transcripts, which included S100 genes, 
keratins 6/16, and innate defense products (cytokine-modulated genes in keratinocytes), 
were commonly regulated by ustekinumab or etanercept.  The top ten genes down-
regulated at wk12 by ustekinumab overlap with nine of the top ten genes down-
regulated by etanercept at wk12; only two of the top ten genes up-regulated overlap 
(NTRK2, THRSP) in this comparison. The genes up-regulated by ustekinumab include 
a number of keratin structural proteins indicating a unique effect of ustekinumab 
on keratinocytes. Elucidation of common and unique effects of ustekinumab and 
etanercept defi ne critical pathways involved in psoriasis pathogenesis and a successful 
therapeutic response.  Broad genomic assessments provide an independent way to 
judge the extent to which disease pathology can be reversed by effective therapeutics.




The Overexpression of Keratin 17 as a Putative Psoriasis Autoantigen is Coupled to 
Hyperproliferation of Keratinocytes Due to Interleukins 22 and 23 in vitro.
Böckelmann R 1Otto-von-Guericke University Magdeburg, Magdeburg, Germany
The notion of the pathogenesis of psoriasis as an infl ammatory T cell-driven chronic, 
systemic disease has been shifted from a Th1 to a Th17 paradigm. In this scenario keratin 
17 has been discussed as a putative major psoriasis autoantigen in a subpopulation 
of psoriasis patients. The possible linkage between Th17 cytokines and keratin 17 
expression was studied in a HaCaT keratinocyte cell culture model. Incubation with 
IL-22 and IL-23 at 50 µg/L for 72 hours induced a signifi cant hyperproliferation 
(158±29 % and 142±35 %) and keratin 17 overexpression (374±14 % and 467±62 %), 
respectively, as compared to untreated controls (set to 100 %). These data substantiate 
the existence of a hitherto unrecognized Th17 cytokine / keratin 17 autoimmune 
loop as a precised mechanism of the vicious circle theory of psoriasis pathogenesis.
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The release of interleukin 8 induced by a sensitizer in keratinocyte depends on EGF 
receptor signalling and hydrogen peroxide
Frankart A1, Coquette A2, Schroeder K3, Poumay Y1 1University of Namur (FUNDP), 
Namur, Belgium 2SGS Life Science, Wavre, Belgium 3Henkel, Duesseldorf, Germany
Discrimination of chemical irritants and sensitizers can be obtained by the study of cultured 
human keratinocytes embedded in a reconstructed human epidermis (RHE). Here we 
have analysed the cell response in such model in order to identify cellular mechanisms 
involved in the behaviour of keratinocytes. Using ELISA assays, we fi rst confi rm our previous 
study demonstrating that a sensitizer (2,4-dinitrofl uorobenzene: DNFB) and an irritant 
(benzalkoniumchloride: BC) induce different profi les of interleukin-1alpha (IL-1alpha) 
and interleukin-8 (IL-8) release. We have investigated potential mechanisms involved 
in this release, using analyses of cell signalling pathways. In our model, activation and 
phosphorylation of EGFR, ERK1/2 and p38 MAPKs were obtained after stimulation with 
DNFB. These activations were not similar after treatment with BC. In order to demonstrate 
the involvement of these signalling proteins, we incubated the RHE with specifi c inhibitors 
of EGFR, ERK1/2 and p38 MAPK kinase activities. The inhibitor of EGFR reduces IL-8 
release in RHE treated with DNFB, suggesting a role of EGFR in IL-8 release. Similar 
profi les of interleukins were observed studying RHE treated with DNFB or with H2O2. 
The involvement of H2O2 as an intermediate in the response of RHE towards DNFB was 
investigated using the anti-oxidant agent N-acetyl cysteine (NAC). NAC inhibits the IL-8 
release from RHE treated with the sensitizer. Altogether, our observations demonstrate 
that the release of IL-8 induced by a sensitizer in RHE depends on EGFR signalling and 
H2O2 production. In view of these results, we could hypothesize that DNFB induces 
some oxidative stress which may in turn affect particular signalling pathways required 
for the induced IL-8 release. Our results suggest that accurate studies of keratinocyte 
response towards chemicals may refi ne in vitro investigation of epidermal toxicity.
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The role of FcgRs in neutrophil activation in ex vivo and in vitro models of bullous 
pemphigoid
Ludwig R, Kasper B, Holdorf K, Hänsel M, Zillikens D, Petersen F Reseach Center 
Borstel, Borstel, Germany
Bullous pemphigoid (BP) is an autoimmune bullous disease associated with 
autoantibodies to the hemidesmosomal proteins. It is characterized by chronic 
infl ammation and subepidermal blister formation in the skin. Activated neutrophils 
and their release products, e.g. oxygen radicals and granule constituents, play an 
essential role  in the pathogenesis of the disease. Neutrophil activation is triggered 
by the binding of FcgRs  to immune complexes. However, the role of individual 
Fcg receptors in this process is still not clear. In this study, we investigated the 
role of Fcg receptors in the activation of neutrophils by determining neutrophil 
degranulation and oxygen radical formation in an in vitro model of BP disease. 
Furthermore, direct pathological consequences of neutrophil activation in 
terms of dermal-epidermal separation were evaluated in an ex vivo model of BP. 
Our results show that FcgRII and FcgRIII are involved in neutrophil activation 
mediated by immobilized immune complexes. While both, FcgRII and FcgRIII are 
essential for dermal-epidermal separation as well as for neutrophil degranulation, 
production of reactive oxygen species is predominantly triggered by FcgRII. 
Our study shed some new light on the pathogenesis of bullous pemphigoid.
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The Role of IL-17 in Activity of Behcet Disease
Sayin N, Alpsoy E, Akman A, Buyukkara S, Yegin O Akdeniz University, Antalya, 
Turkey
Behcet disease (BD) is a chronic, relapsing, systemic vasculitis of unknown aetiology. Patients 
with BD exhibit elevated levels of pro-infl ammatory cytokines and the affected organs show a 
signifi cant neutrophile and lymphocyte infi ltration. Current evidence suggest that the activated 
lymphocytes contribute to neutrophile and endothelial cell activation in these patients. Th 17 cells, 
and IL-17 has recently been reported to be responsible for the enhanced infl ammatory reaction 
in BD patients with active uveitis. Forty-fi ve patients with BD (24 women, 21 men; mean age, 
40 years) and 33 age- and sex-matched healthy volunteers (17 females, 16 males; mean age, 36) 
were enrolled in the study. Serum IL-17 levels were examined by ELISA. In vitro IL-17 response 
of peripheral mononuclear cells of patients with BD and controls after stimulation with S. 
sangius, E. coli and PHA were evaulated by ELISPOT method. The proportion of Th 17 cells in 9 
patients with active organ involvement and 9 healthy volunteers was detected by fl owcytometry 
with intracellular cytokine staining method.Serum IL-17 levels of BD patients (20,16±12,9) were 
signifi cantly higher than healthy controls (11,82±3,4) (p=0,011). Active BD patients (28.73±12.8) 
showed signifi cantly higher levels of IL-17 compared with inactive patients (11.18±2.7) and healthy 
controls (p<0,001). Serum levels of IL-17 in BD patients with active stages of uveitis (p=0,003), 
oral ulcers (p<0,001), genital ulcers (p<0,001) and articular symptoms (p=0.002) were signifi cantly 
higher than patients with each inactive symptoms. Compared to the control group, a signifi cant 
increase was observed in the number of IL-17 producing cells obtained from BD patients after 
stimulation with S. sangius (p=0.003), E. coli (p<0.001) and PHA (p=0.008). Flowcytometry 
data also showed a signifi cant increase in the percentage of IL-17, CD4(+) IL-17(+) and CD4(-) 
IL-17(+) T cells after S. sangius (p=0,73), E. coli  (p=0.004) and PHA (p=0.006) stimulation. 
Our results suggests that IL-17 and Th17 cells have an important role in acute attacks of BD.
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The role of single nucleotide polymorphisms of pro-infl ammatory genes in the 
pathogenesis of acne
Szabó K1, Szegedi K2, Theodorescu-Brinzeu D3, Diószegi Cs2, Koreck A3, Széll M1, 
Kemény L2 1Dermatological Research Group of the Hungarian Academy of Sciences, 
Szeged, Hungary 2University of Szeged, Department of Dermatology and Allergology, 
Szeged, Hungary 3Victor Babes University, Timisoara, Romania
Acne is a common infl ammatory disease of the pilosebaceous follicles. As genetic predisposition 
plays a role in the pathogenesis of the disease, we investigated the function of single nucleotide 
polymorphisms (SNP) of pro-infl ammatory genes in the pathogenesis of acne.To investigate the 
role of polymorphisms of pro-infl ammatory and related genes (TNFA, IL-1A and IL-1RN) in the 
pathogenesis of the disease, we conducted case-control studies using DNA collection of 126 control 
individuals and 226 acne patients by PCR-based methods. Our results show that a SNP in the TNFA 
promoter ( 857C>T) might act as a protective factor (chi2 test p=0.01), whereas the A allele of the 
-308G>A SNP has a predisposing role in females patients of our study population (chi2 test p=0.022). 
The frequency of the genotypes containing the -857C or the -308G alleles are increasing parallel to 
the increases of the severity of infl ammation in the various acne subgroups. These polymorphisms 
might function by changing the regulation of the TNFA gene in response to various stimuli.We have 
also studied the polymorphisms of IL-1 family members. We did not fi nd any association among 
the alleles of the IL1RN gene (a natural antagonist of IL-1 receptor) and acne when we studied the 
variable number of tandem repeats (VNTR) polymorphism. The frequency of the mutant T allele of 
the +4845G>T SNP in the IL-1A gene, however, was higher in the acne group compared to controls 
(chi2 test p=0.0404). The data indicates that in the presence of the minor T allele the cleavage 
of the pre-IL-1a that results in the mature IL-1a is increased and thus an imbalance of the two 
isoforms is possible. These results suggest that functional polymorphisms of pro-infl ammatory genes 
might play a role in the orchestration of the innate immune events in the pathogenesis of acne.
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Three cases of pemphigoid nodularis associated  with autoantibodies to the NC16A 
domain of BP180
Preisz K, Silló P, Blazsek A, Kárpáti S Semmelweis Med Univ, Budapest, Hungary
Authors report three cases of pemphigoid nodularis. Patient 1 (54-year-old female) 
had generalized prurigo nodularis-like eruption for more than six years, when the 
fi rst bullous lesions appeared. First routine histology revealed prurigo simplex. 
The second histology raised the possibility of bullous pemphigoid, and direct and 
indirect immunohistological studies, as well as ELISA for BP180 NC16a confi rmed 
the diagnosis of nodular pemphigoid. Patient 2 (50 -year-old female) was referred to 
our clinic with the diagnosis of pityriasis lichenoides et varioliformis acuta (PLEVA). 
No defi nite blister formation was seen during the course of the disease, erythematous 
papules and some little superfi tial erosions were seen on the trunk and extremities. 
Routine histology revealed prurigo simplex. The diagnosis was confi rmed with 
immunohistology and ELISA techniques. Patient 3 (72-year-old female) had generalized 
pruritus and excoriated nodules since several months without blister formation. 
She got local treatment for scabies 2 times. Routine histology showed non-specifi c 
infl ammation, immunohistology as well as ELISA techniques proved the diagnosis. 
One of the rarest variants of bullous pemphigoid is pemphigoid nodularis, which 
is characterized by features of both prurigo nodularis and BP. Although BP180 and 
BP230 were identifi ed as target antigens in this variant, the fi ne specifi city of the 
autoantibodies and the pathomechanism is still not known.  
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Topical Application of Valrubicin Cream Treats Psoriasis
Rosada C1, Stenderup K1, De Darkó E2, Dagnaes-Hansen F3, Kamp S4, Dam TN4 
1Aarhus University Hospital, Aarhus, Denmark 2Valderm A/S, Lyngby, Denmark 
3Aarhus University, Aarhus, Denmark 4Roskilde Hospital, Roskilde, Denmark
This study investigated the effect of daily topical application of valrubicin cream 
in treating psoriasis “in vivo” in a psoriasis xenograft transplantation model. 
Valrubicin is a cytostatic drug currently used in bladder cancer therapy where it has 
demonstrated an excellent therapeutic potential with minimal toxicity.  Especially 
skin toxicity, defi ned as ulceration or necrosis, is not found upon tissue contact with 
valrubicin, rendering a chemotherapeutic drug available for topical usage.  We thus 
studied the cytostatic potential of valrubicin on epidermal keratinocytes.  “In vivo”, 
the valrubicin cream treatment of psoriatic skin after twelve days application resulted 
in a normalization of the epidermal morphology, a reduction of the epidermal 
thickness, along with a reduction of the dermal vessel pattern, and a regaining 
of the stratum granulosum.  These benefi cial changes were accompanied by a 
reduction in proliferation as visualized by staining for the regenerative proliferation 
marker K16, and by the induction of apoptosis in scattered epidermal cells.  “In 
vitro”, valrubicin was shown to localize solely to the cell cytoplasm in cultured 
keratinocytes and to reduce keratinocyte proliferation as well as to increase apoptosis 
by activation of caspases 3, 7, and 9.  Our results demonstrated that valrubicin 
successfully treats psoriasis in this xenograft transplantation model suggesting 
that topically applied valrubicin may be an upcoming treatment for psoriasis.
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Transient receptor potential vanilloid 3 (TRPV3) has a role in the development of 
allergic dermatitis and pruritus
Yoshioka T, Imura K, Hikita I, Hirasawa T, Yasui K, Shichijo M Shionogi & Co., Ltd., 
Toyonaka, Japan
DS-Nh mice, derived from a colony of the DS inbred strain in 1976, develop 
spontaneous dermatitis and hairless phenotypes. We have recently shown that both 
of these phenotypes are inherited in an autosomal dominant fashion and are not 
segregated during sequential crossing procedure. Positional cloning analysis revealed 
that the cause of hairlessness in DS-Nh mice was a Gly573Ser substitution in the 
transient receptor potential vanilloid 3 (TRPV3), a non-selective cation channel, 
which is activated by warmth and highly expressed in basal keratinocytes in the skin. 
Using ear epidermal sheets from DS and DS-Nh mice, we demonstrated that this 
substitution in TRPV3 led to the increased ion channel activity. We thus speculated 
that TRPV3Gly573Ser could also cause dermatitis in DS-Nh mice. To elucidate 
the involvement of TRPV3 in the development of a certain type of dermatitis, 
TRPV3Gly573Ser transgenic mice with the transgene including putative promoter 
sequence in the 5?Eregion of TRPV3 gene were investigated pathologically and 
serologically. Our data revealed that the transgenic mice spontaneously developed 
allergic and pruritic dermatitis in addition to the hairless phenotype, whereas wild-type 
mice did not display these phenotypes when maintained under the same conditions. 
We next used general breeding methods to construct C57BL/6-Nh congenic mice 
to investigate the penetrance of the TRPV3Gly573Ser gene in respect of dermatitis. 
Interestingly, these mice developed spontaneous scratching behavior separately 
from dermatitis. We proposed that TRPV3Gly573Ser is a cause of pruritus and/or 
dermatitis associated with scratching. We also suggested that TRPV3 may represent 
a therapeutic target for allergic dermatitis, pruritus and a certain type of alopecia.
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Two monozygous twin pairs discordant for dermatitis herpetiformis and celiac 
disease
Blazsek A, Losonczy V, Kósnai I, Silló P, Zágoni T, Mazán M, Tullassay Zs, Preisz K, 
Kárpáti S Semmelweis University, Budapest, Hungary
Dermatitis herpetiformis (DH) is a gluten sensitive skin disease associated in a ma-
jority of cases with gluten sensitive enteropathy (GSE). In multifactorial autoimmune 
diseases such as GSE studying twin cases allow us a deeper insight onto the signifi -
cance of the respective genetic and enviromental factors of the pathomechanism. 
Here we examined two monozygotic twin pairs with dermatitis herpetiformis (DH) 
where the second twin has neither DH nor celiac disease (CD). Monozygosity was 
proved for both twin pairs by microsatellite markers, HLA typing, and by identity of 16 
blood groups and polymorphism loci. Both twin pair carried the HLA DQA1*, *0501-
DQB1 *02 heterodimer, characteristic for GSE and DH. DH was diagnosed by skin 
immunofl uorescence in twin 1A and 2A, while the skin of twins 1B and 2B remained 
repeatedly  negative. In twin 1A biopsy of the small intestine showed partial villous 
atrophy while he was already  under gluten-free diet. In the asymptomatic 1B biopsy of 
the small intestine was also normal. CD was verifi ed in the son of 1B at the age of fi ve. 
In the second pair of twins, twin2A with DH proved to have subtotal villous atrophy 
in the small intestinal mucosa, was tTG, eTG and EMA positive and had articular 
hydrops in both knees. In the symptom free twin 2B no abnormality was shown 
neither by skin nor by small bowel biopsy. None of the symptom free twins showed 
EMA and tTG or eTG ELISA positivity by repeated testing. The fact that a monozygotic 
DH twin pair can be discordant for gluten sensitive diseases for year does not exclude 
the possibility to develop GSE in the other. Both twin 1A and 1B were being able to 
pass on the inherited factors to their offsprings that provide genetic background for 
GSE - indicates that non-genetic factors also determine the inititation of the disease.
598 [Oral 003]
An amplifying circuit of the innate immune sensing of Staphylococcus aureus: Monomeric 
peptidoglycan functions as NOD2 ligand and aggravates TLR mediated infl ammation
Volz T1, Nega M2, Buschmann J2, Kaesler S1, Guenova E1, Röcken M1, Götz F2, 
Biedermann T1 1Department of Dermatology, University Hospital Tübingen, Germany 
2Department of Microbial Genetics, Eberhard Karls University, Tübingen, Germany
Staphylococcus aureus is an emerging cause of severe acute infections, life-threatening sepsis, and a co-factor of 
chronic infl ammatory diseases such as atopic dermatitis (AD). In AD skin, colonization with S. aureus activates 
innate immunity mediating harmful infl ammation. Understanding innate immune sensing of S. aureus is still 
limited but crucial to develop new therapeutic strategies. During innate immune sensing cell wall components 
of S. aureus are recognized by pathogen recognition receptors (PRR). The most important S. aureus PRR ligands 
are peptidoglycan (PGN), lipoteichoic acid (LTA), and lipoproteins (LPP) but their exact role and interactions have 
not been characterized. To this end, polymeric PGN was purifi ed from wildtype S. aureus and S. aureus defi cient 
in either LPP or LTA. Surprisingly, NFkB reporter assays revealed that PGN mediated activation depended on the 
presence of LPP or LTA, indicating that PGN itself remains mute or needs interaction with other PRR ligands. To 
investigate the latter question, pure PGN preparations devoid of LPP or LTA activity were needed. Therefore, PGN 
was enzymatically digested into fragments that are also naturally released from bacteria and a monomeric PGN 
was purifi ed by HPLC. We then analyzed for the fi rst time this monomeric PGN for its role in innate immune 
sensing. In contrast to stimulation with other PRR ligands, dendritic cells (DC) remained immature and produced 
no cytokines after incubation with monomeric PGN alone. However, natural monomeric PGN signifi cantly 
enhanced IL-6 and IL-12p70 levels induced by all TLR ligands that signal via MyD88. To defi ne the coactive 
pathway utilized by monomeric PGN, DC defi cient in NOD2 proteins were analyzed. Strikingly, amplifi cation of 
IL-6 and IL-12p70 production by monomeric PGN was completely abolished in DC lacking NOD2 identifying 
monomeric PGN as a natural NOD2-ligand. These data demonstrate that monomeric PGN is an active and 
potent S. aureus PAMP and acts in a newly discovered amplifying circuit of S. aureus innate immune sensing. 
In addition, these data disclose a new level of regulation within the innate immune system: Innate sensing may 
remain mute in response to one single PRR ligand but the responses are markedly enhanced upon dual signalling.
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HIV-1 induces cdc42-dependent fi lopodia formation to facilitate dendritic cell-t 
cell trans-infection
Nikolic DS, Lehmann M, Garcia E, Blanchet FP, Piguet V Department of Dermatology 
and Venereology, University Hospitals, Geneva, Switzerland
Dendritic cells (DC), due to their unique localization at mucosal surfaces, coupled 
with their known profi ciency in capturing antigens, are among the fi rst potential tar-
gets for HIV-1 during transmission. One of the limiting steps for HIV-1 propagation 
is the transfer of virus at an infectious synapse (IS) between DC and CD4+ T cells.
Bacterial pathogens can hijack the host actin cytoskeleton to facilitate invasion and 
propagation. We report here the evidence that a virus, HIV-1, induces the formation 
of fi lopodia in DC through activation of the Rho GTPase Cdc42. We provide direct 
evidence that fi lopodia are obligate components of the HIV-1 induced DC-T cell 
infectious synapse and required for transfer of HIV-1 infection to target CD4+ T cells. 
HIV-1 at the surface and near the tip of fi lopodia was observed by confocal microscopy, 
electron microscopy and live imaging. Silencing of Cdc42, a key controller of fi lopodia 
formation, in DC by RNAi dramatically reduced number of fi lopodia on DC and 
decreased HIV-1 transfer to CD4+ T lymphocytes but did not alter infectious synapse 
formation. Finally, we show that fi lopodia play an essential role in the transfer of virus 
when a low number of DC are co-cultured with T cells, a situation that mimics DC-T 
cell ratios in mucosal tissues or lymph nodes. In conclusion we identify a critical 
role for Cdc42-dependent fi lopodia induction by HIV-1 in the transfer of HIV-1 from 
DC to T cells thereby identifying a novel pathway for HIV-1 cell-to-cell propagation.
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Mast cells regulate the magnitude and the cytokine microenvironment in HSV 
infection
Aoki R1, Kawamura T1, Goshima F2, Nishiyama Y2, Shimada S1 1University of 
Yamanashi, Yamanashi, Japan 2Nagoya University Graduate School of Medicine, 
Nagoya, Japan
Mast cells are known as immunoregulatory cells in both innate and adaptive immune 
responses. Recent studies have revealed their importance in immune suppression; 
mast cell-derived IL-10 limits skin pathology in contact dermatitis and chronic UV-B 
irradiation. The involvement of mast cells in regulating virus-inducing infl ammation 
is unknown. Here, we have evaluated the role of mast cells in herpes simplex virus 
(HSV) infection in vivo. Mast cell-defi cient Kit W/W-v (W/W-v) and wild-type (WT) 
mice were infected intradermally with HSV-2 (strain 186). HSV-induced zosteriform 
lesions in W/W-v was much severer than that in WT and the mortality in W/W-v was 
signifi cantly higher than that in WT. Furthermore, the severe mortality in W/W-v was 
recovered by the reconstitution of bone marrow-derived mast cells of WT. We next 
analyzed the production of proinfl ammatry or inhibitory cytokines using the skin 
lysates of HSV-infected or uninfected sites at day 3 p.i. Interestingly, IL-6, but not 
TNF-α, was signifi cantly increased in W/W-v than that in WT, whereas IL-10 was 
signifi cantly reduced in W/W-v than that in WT. As CD8+ dendritic cells (DCs) play 
a signifi cant role in priming virus-specifi c cytotoxic T cells, we next investigated 
CD8highCD205+ DCs and CD4+CD25+Foxp3+ regulatory T cells (Tregs) in 
draining lymph nodes at day 3 p.i. by fl ow cytometry. There was no signifi cant 
deference in the number of Treg and DC in the lymph nodes of W/W-v compared 
with WT. Thus, we for the fi rst time describe that mast cells were involved in 
immune response against HSV. Our fi ndings suggest that mast cells may participate 
in the reduction of HSV-induced infl ammation through production of IL-10.




A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in normal human 
keratinocytes and in HaCat cells
Bozzo C1, Tiberio R2, Pertusi G2, Graziola F1, Small PL3, Leigheb G2 1Laboratory of Cell 
Biology, University of Eastern Piedmont A. Avogadro, Novara, Italy 2Dermatologic 
Clinic, University of Eastern Piedmont A. Avogadro, Novara, Italy 3Department of 
Microbiology, University of Tennessee, Knoxville, USA
The pathogenicity of Mycobacterium ulcerans, the agent of Buruli ulcer, depends 
on the cytotoxic effect of its exotoxin mycolactone. Data about damage on 
infl ammatory cells, fi broblast cell lines and adipocytes were reported but few 
data exist on human keratinocytes. Since apoptosis plays a fundamental role in 
epidermal homeostasis, we explored the apoptotic effect of  mycolactone A/B on 
two human keratinocyte populations, stem cells (KSC) and transit amplifying cells 
(TA), and on keratinocytes cell line. Human keratinocytes were isolated from skin 
biopsies and separated in KSC and TA cells through their different adhesion capacity. 
Treatment of TA cells with mycolactone A/B induced severe apoptosis in dose-
dependent manner: about 90% of cells underwent apotosis after treatment with 10 
ng/ml toxin. KSC were more resistant than TA: 100 ng/ml mycolactone A/B were 
able to induce about 80% apoptosis. Some experiments were also performed on a 
human keratinocytes cell line, HaCat. High mycolactone A/B /toxin concentration 
(1000 ng/ml) induced severe apoptosis if only added before cell adhesion. 
Apoptotic nuclei were quantifi ed by laser scanner confocal microscopy after 
propidium iodide staining. We also showed that the toxin interferes with adhesion 
and proliferation of HaCat cells. These results suggest that also the epidermis, like 
the subcutaneous tissues, is directly damaged by the toxic action of mycolactone.
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Clinical study of 97 cases with Trichophyton tonsurans infection in Nagasaki 
prefecture from 2003 to 2008
Takenaka M, Nishimoto K, Sato S Nagasaki University Hospital, Nagasaki, Japan
In Japan, Trichophyton tonsurans (T.tonsurans) infection increased in recent years, 
and especially, it is abounding for the combative sports competition players.  A 
total of 97 cases (81 males and 12 females) with T. tonsurans infection examined 
in Nagasaki prefecture from 2003 to 2008 was surveyed.  In all cases, the growth 
of T. tonsurans has been mycologically confi rmed.  The patients included 68 high 
school students, 18 junior high school students, and 5 primary school students or 
kindergarteners.  Most patients were Judo practitioners (81cases), but 5 cases had 
no relation to combative sport. Twenty-two cases had multiple lesions.  Localization 
of the lesions was as follows : 14 cases on the head, 34 cases on the face, 26 
cases on the neck, 29 cases on the arms, 18 case on the trunk and 2 cases on the 
legs.  Hair brush sampling method was applied to the cases without symptomatic 
lesions on the head but had lesions on the other part of the body surface. The 
presence of T.tonsurans on the scalp was proved with 40.2% of the cases (53.8% 
of the cases with the lesions on the face, 37.5% on the neck, 27.2% on the arms, 
37.5% on the trunk, and 50.0% on the legs).  The treatment with oral antifungal 
agents had been carried out with over 60% of the cases. Especially, cases with the 
symptom on the head and those with repeated occurrence, treatment by the oral 
use of antifungals was carried out in most cases according to recommendation. 
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Dermal-type macrophages show inherent resistance to dengue virus growth
Mueller C1, Kwan WH2, Navarro-Sanchez E3, Vachon H1, Decossas M1, Harris E4, 
Schaeffer E1, Despres P5 1University of Strasbourg, CNRS, Strasbourg, France 2INSERM 
U872, Paris, France 3Insitut Pasteur, Paris, France 4University of Berkeley, Berkeley, 
USA 5Institut Pasteur, Paris, France
An important question in dengue pathogenesis is the identity of immune cells 
involved in the control of dengue virus infection at the site of the mosquito bite. 
There is evidence that infection of immature myeloid dendritic cells (DC) plays a 
crucial role in dengue pathogenesis and that the interaction of the viral envelope E 
glycoprotein with CD209/DC-SIGN is a key element for their productive infection. 
Dermal macrophages (Mö) express CD209, yet little is known about their role in 
dengue virus infection. We have found that dermal Mö bound recombinant envelope 
E glycoprotein fused to GFP but not control GFP. We generated dermal-type Mö from 
monocytes to study their infection by dengue virus. The Mö were able to internalize 
the virus, but progeny virus production was undetectable in the infected cells. 
The inability of dengue virus to grow in the Mö was attributable to accumulation 
of internalized virus particles into poorly-acidifi ed phagosomes. Aborting infection 
by viral sequestration in early phagosomes would present a novel means to curb 
infection of enveloped virus and may constitute a prime defense system to prevent 
dengue virus spread shortly after the bite of the infected mosquito. A means for the 
virus to escape sequestration within dermal Mö may be to await Mö to DC conversion, 
for which there is indirect evidence. We have therefore established a culture system 
which allows us to study the differentiation of Mö to DC. If confi rmed, blocking 
DC formation from infected Mö could provide long-lasting protection against the 
infection. Our fi ndings have important implications for better understanding the 
early infection events of dengue virus and of other skin-penetrating pathogens. 
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Detection and Typing of Human papillomavirus in Common Warts by Multiplex 
Polymerase Chain Reaction
Park Y1, Choi S2, Hong J1, Kang H1 1Department of Dermatology, College of 
Medicine, The Catholic University of Korea, Seoul, Republic of Korea 2Department 
of Biotechnology, College of Life Science & Nanotechnology, Hannam University, 
Daejeun, Republic of Korea 3Department of Dermatology, Chung-Ang University 
Yongsan Hospital, Seoul, Republic of Korea
Human papillomavirus (HPV) is classifi ed into cutaneous, mucosal, and epidermodysplasia 
verruciformis type according to their location and clinical context. Although epidemiological studies 
show that common warts are closely related to HPV-1, -2, -3, and -4, there have been few reproducible 
data in the Korean population. In this study, we aimed to develop a specifi c one-step multiplex PCR 
method that permits the identifi cation of six different HPV genotypes related to common warts ( 
HPV-1, -2, -3, -4, -27, and -57). Using computer-mediated HPV DNA sequence analysis, six pairs 
of specifi c primers were designed from the intergenic regions between genes L1 and E6, or between 
genes E2 and E6. The detection of each HPV type depends on distinguishing six amplifi cation 
products of different sizes on agarose gels following PCR with multiple primer sets. Multiplex PCR 
was run with HPV DNA isolated from 129 samples from the patients with common warts. In 109 
wart samples, HPV-1, -2, -3, -4, -27, and -57 were identifi ed without any cross amplifi cation. The 
specifi city of HPV-positive samples identifi ed by the multiplex PCR assay was confi rmed by DNA 
sequencing analysis with the L1 gene sequence. The clinical sensitivity and specifi city of the six sets 
of specifi c primers for detecting six types of HPV were 85% and 99.5%, respectively which were 
signifi cantly higher than those of PCR using the consensus sequence primers MY09/11. The most 
frequently observed HPV type in common warts was HPV-2. Further investigation of 20 unidentifi ed 
samples by multiplex PCR using different HPV primer sets revealed that seven samples were 
positive for HPV-7 or -65. These results imply that the newly designed intergenic-specifi c multiplex 
PCR can specifi cally detect different types of HPV involved with common warts with high accuracy.
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Eosinophilic fasciitis triggered by Mycoplasma infections
Silló P, Pónyai K, Ostorházi E, Hársing J, Mazán M, Pintér D, Szathmáry Zs, Stipkovits 
L, Blazsek A, Kárpáti S Semmelweis University, Budapest, Hungary
Eosinophilic fasciitis (EF) is a rare scleroderma-like disease with a still obscure 
etiology and pathomechanism, while in few cases Borrelia infection could have 
been identifi ed in the background. A 23-year-old man consulted us for progressive 
generalized tightening of the skin, restricted joint movement and venous furrowing 
for 19 months. He had been on low dose corticosteroid for 1 year. He presented 
with eosinophilia, an increased serum IgG and a moderate infl ammatory syndrome. 
The diagnosis of EF was confi rmed by skin biopsy. To identify new etiological 
or triggering factors in EF extended microbiological culturing and infective 
serological markers were performed. Cultured strain subspecies were identifi ed 
by PCR. Mycoplasma (M) cultures both from urethra and peripheral blood were 
intermittently positive and identifi ed as an avian M. and M. hominis by PCR. Serum 
ELISA test was available only for M. pneumonia and showed IgM positivity, while 
was repeatedly negative for Borrelia. The patient repeatedly received parenteral or 
oral erythromycin and clarythromycin as well as intermittently methylprednisolon, 
and showed a signifi cant improvement. Most patients with EF well respond to 
corticosteroids, but some of them are non-responding. Here we report a non-
responding EF case associated with chronic, multiple M strain infections. This case 
report clearly showed a correlation between EF and M infections. Steroid treatment 
alone not, but together with antibiotics (macrolids) selected for M infection led 
to normalization of the laboratory values and improvement of the clinical status. 
Although the mechanism by which M could contribute to the pathogenesis of EF 
remains obscure, our results provide new information about a possible connection 
of M infection and EF, and indicate latent M infections as disease provoking agents.
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Merkel cell polyomavirus is prevalent in normal and lesional skin and mucosa of 
individuals without Merkel cell carcinoma
Wieland U1, Mauch C2, Kreuter A3, Krieg T2, Pfi ster H1 1Insitute of Virology, Köln, 
Germany 2Deprtartment of Dermatology, Köln, Germany 3Department of Dermatology, 
Bochum, Germany
Merkel cell polyomavirus (MCV) is a novel polyomavirus that has recently been 
found in Merkel cell carcinoma (MCC). Using nested and single round PCR, we 
have analyzed 355 normal and lesional samples from different body sites for the 
presence of MCV-DNA. We could confi rm a high MCV-prevalence in primary 
MCC (88%) and MCC-metastases (100%). On the other hand, MCV-DNA was 
prevalent in non-MCC skin tumors of immunocompetent patients (16%), in healthy 
perilesional skin biopsies (24%), in anogenital and oral samples (31%) and plucked 
eyebrow-hairs (50%) of HIV-positive men, on the skin and mucosa of a patient 
with an immunosuppression-syndrome, and also on the forehead skin of healthy 
controls (62%). This shows that MCV is widespread in the normal population and 
in immunosuppressed individuals without MCC. Since MCV was less common in 
premalignant and malignant lesions than in normal mucosa and benign lesions 
of HIV-positive men, MCV probably does not play a role in the development of 
papillomavirus-induced anogenital dysplasia. Similar MCV-prevalence in non-
MCC skin tumors and in healthy perilesional skin and lower viral load than in MCC 
suggest that MCV is also not involved in development of non-MCC skin tumors.
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Models for the development of topical products for the treatment of 
onychomycosis
Hsia E1, Lenn J1, Donaldson M2, Chern W1, Hofl and H1 1Stiefel Laboratories, Inc., Palo 
Alto, CA, USA 2Stiefel Laboratories, Inc., Palo Alto, CA, United Kingdom
Onychomycosis, a dermatophyte  infection of  fi nger and or  toe nails, affects 6-8% of the adult 
population. Effective topical therapy is a clear unmet medical need, especially  for people who 
cannot take oral therapy. Albaconazole is an emerging triazole antifungal agent that, like other 
azoles, inhibits 14alpha-demethylase, thereby interfering with the formation of the fungal cell 
wall through inhibition of lanosterol synthesis. The purpose of this study was to evaluate models 
which might predict the effi cacy of topical therapies for onychomycosis. Using a standard 
microdilution method the antifungal activity of albaconazole was determined against various 
strains of dermatophytes, such as Trichophyton rubrum, T. mentagrophytes, and Epidermophyton 
fl ucossum. This susceptibility testing showed that MICs and MFCs ranged from 0.008 - 0.5 ug/mL 
and 0.06 - 8.0 ug/mL, respectively, thereby confi rming the high potency of albaconazole against T 
rubrum which is commonly associated with onychomycosis. To examine the ability of albaconazole 
to penetrate full thickness human nail, the drug content in the nail was measured following a 
single topical application. The nail was divided into three distinct layers (ventral, intermediate, and 
dorsal) using a nail-drilling technique from which the albaconazole was extracted and analyzed. 
It was shown that albaconazole reached the ventral side of the nail at levels of approximately 
0.5 ug/mg nail, suggesting that suffi cient levels of drug penetrate the nail. To evaluate potential 
effi cacy, albaconazole was applied to full-thickness human nail sections infected with T. rubrum, 
and the viability of the organisms was determined after two weeks of once weekly dosing. Topical 
application (two doses) of albaconazole resulted in complete eradication of T. rubrum after only 
two weeks, demonstrating that albaconazole is effective in the nail. Taken together, these results 
suggest that this model was able to document in vitro effi cacy of a topically applied antimycotic.
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Molecular pathogenesis of Staphylococcus aureus infections: comparing methicillin-
resistant and sensitive strains in relation to frequency of genes encoding adhesins 
and exfoliative toxin
Kocsis E1, Lagler H2, Pesti N1, Kristóf K1, Stich K2, Graninger W2, Rozgonyi F1 
1Semmelweis University, Budapest, Hungary 2Medical Univ of Vienna, Austria
The purpose of our study was to examine the presence of genes encoding adhesive proteins and exfoliative 
toxins of Staphylococcus aureus strains cultured from dominantly invasive clinical samples originating 
from Hungary and Austria using polymerase chain reaction (PCR).  After the phenotypical identifi cation 
performed by classical microbiological methods, the S. aureus strains were confi rmed genetically by the 
detection of nucA gene responsible for the thermostabile endonuclease and 23S rDNA. According to the 
presence of mecA gene responsible for methicillin resistance, 110 Hungarian (HU) methicillin-resistant 
(MRSA), 94 methicillin-sensitive (MSSA) S. aureus and 48 Austrian (AT) MRSA and 128 MSSA strains 
were examined. The genes responsible for adhesins and exfoliative toxins (eta, etb) were detected by 
PCR. The epidemiological independency of strains was confi rmed by pulsed-fi eld gel-electrophoresis. 
The HU MRSA, MSSA and AT MRSA, MSSA carried the gene of collagen-binding protein (cna) in 
24%, 34% and 15%, 52%, respectively. The fnbA gene responsible for fi bronectin-binding protein was 
detected in 93%, 97% and 38%, 59% in HU MRSA, MSSA and AT MRSA, MSSA strains. The spax gene 
coding for proteinA was harboured by 90%, 80% and 100%, 99% of HU MRSA, MSSA and AT MRSA, 
MSSA strains. The icaA gene responsible for intercellular adherence was found in HU MRSA, MSSA 
and AT MRSA, MSSA strains in 93%, 90% and 98%, 98%, respectively. The eta gene was carried by 
HU MSSA, AT MRSA and AT MSSA in 1%, 2% and 5.5%, respectively. The etb gene was only found in 
AT MSSA in 1.5%.The frequency of cna and fnbA genes revealed signifi cant difference in comparison 
of HU and AT MRSA and MSSA (p<0.01). The exfoliative toxin gene carriage was characteristic in low 
percentage with no statistical difference. In conclusion, the adhesion of MSSA strains can be infl uenced 
by collagen-binding protein in higher percentage compared to MRSA. The adhesive capacity of 
Austrian strains can be less infl uenced by fi bronectin-binding protein compared to Hungarian ones.
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Mycoplasma genitalium is an emerging pathogen in the Rotterdam STI outpatient 
clinic
Lanjouw E, Ossewaarde JM, Roorda L, Van der Meijden WI Erasmus MC, Rotterdam, 
Netherlands
To determine the incidence of M. genitalium (Mg) infection and characteristics of the positive 
patients. DNA was isolated from all specimens using the easyMAG. Primers and probe were 
previously validated. When the Mg Ct value was >35, specimens were fully retested. Addition 
of phocine herpes virus (phHV) to the clinical specimens was used as an internal control. A 
phHV Ct value of >35.7 (historical mean plus 1.5xSD) was regarded as inhibition. Of 1362 
specimens, 8.4% had a phHV Ct value >35.7 and Mg Ct value of >50 and were regarded as 
inhibited. Of these, 85 were self-collected vaginal swabs, 15 cervical/urethral swabs, and 4 
urines. Of the remaining specimens, 6 had a Mg Ct value of >35, but were negative upon 
retesting. Thirty-two specimens had a Mg Ct value of >35 and were positive on retesting. 
Thirty-fi ve specimens had a Mg Ct value between 25 and 35. These 67 specimens (4.9%) 
were regarded as positive: 1 throat specimen, 5 penile swabs, 7 cervical/urethral swabs, 
10 rectal swabs, 21 urines, and 23 vaginal swabs. From 42 Mg positive patients (21 males 
and 21 females; age 18 to 62 years) further data were available. Twenty-fi ve (60%) had 
no concurrent STI and 21 (50%) no history of other STIs. Twenty-nine (69%) reported no 
symptoms and 10 (24%) one or more symptom. Thirty-three (79%) reported vaginal sex only, 
seven (17%) anal sex only, and one both types. In all but one case the sex was unprotected. 
Mg is an emerging pathogen, that is claiming its place. In this study we have shown that 
the incidence of infections is at least 4%. Only one in every three patients will report 
symptoms. All infections are the outcome of unprotected sex. Thus, in empiric syndromic 
therapy the physician should take the possibility of an infection with Mg into account, 
especially when standard therapy for Chlamydia trachomatis fails to cure the symptoms.
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Mycoplasma infection – a possible etiological cofactor in morphoea and lichen 
sclerosus et atrophicus
Pónyai K1, Bognár P1, Pintér D1, Mazán M1, Szathmáry Zs2, Ostorházi E1, Blazsek E3, 
Stipkovits L3, Blazsek A1, Kárpáti S1 1Semmelweis University, Budapest, Hungary 2Rt. 
Europe Kht, Budapest, Hungary 3VMRI, Budapest, Hungary
Skin localized forms of scleroderma (SC) are connective tissue disorders characterized by thickening of 
the dermis after an initial infl ammatory reaction. One triggering factor of this autoimmunity could be 
Borrelia infection supported by skin or blood PCR, antibody seropositivity and by benefi cial effect of 
systemic penicillin therapy in some patients. Mycoplasma (M) infections have been associated with some 
autoimmune disorders, due to their symptom-free colonization, long latency, immunomodulatory and 
immunosuppressive effects on the hosts. Their molecular mimicry and phenotypic plasticity ensure the 
bacteria to evade immune detection and also induce autoimmunity. There are uncontrolled studies on long 
lasting tetracycline-minocycline administration inducing remission in few cases of SC.   To investigate the 
presence of M species in patients with localized forms of SC.  71 patients, 20 with morphea (Mo), and 51 
with lichen sclerosus et atrophicus (LSA) have been selected for this study and were compared to a control 
group of 40 healthy people matched in age and gender. Serum samples were taken before treatment and 
were evaluated by: (i) PCR for detection of Mycoplasma DNA in all the patients (23S rRNS based Myc23), 
(ii) Enzyme immunoassay (ELISA-ANI LABSYSTEM) 57 patients (LSA 40, Mo 17) and in 26 controls.A M. 
infection without further species specifi cation was based upon the serum PCR and was supported by M. 
pneumonia seropositivity. Results: Serum M PCR was positive in 65/71 patients and in 12/40 controls 
presenting a signifi cant difference with p<0.01. Almost every LSA patient was M PCR positive (48/51) and 
the majority of Mo cases (17/20) too. The M. pneumoniae ELISA was positive in 30/57 localized SC patients 
(22/40 LSA, 8/17 Mo). All the 30 ELISA positive patients were also PCR positive. Both PCR and ELISA proved 
a signifi cant presence of M when compared to controls in patients with LSA (PCR positivity: 48/51 vs. 12/40, 
p<0.01; ELISA positivity 22/40 vs.5/26, p<0,01), while only PCR data showed signifi cant difference between 
Mo patients and controls (17/20 vs. 12/40,p<0.01):  these cases had no signifi cant M antibody positivity
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Production of proinfl ammatory cytokines without invocation of cytotoxic effects 
by an Epstein-Barr virus-infected NK cell line established from a patient with 
hypersensitivity to mosquito bites
Suzuki D, Tsuji K, Yamamoto T, Fujii K, Iwatsuki K Okayama Univ Graduate School of 
Medicine, Dentistry & Pharmaceutical Science, Okayama, Okayama, Japan
Cumulative evidence supports that EB virus (EBV)-infected NK cells induce severe 
systemic as well as cutaneous infl ammation in patients with hypersensitivity to 
mosquito bites (HMB). In order to understand the pathogenesis of the NK cell-
mediated infl ammation in HMB, we established an EBV-infected cell line and 
characterized the cytological profi les. A novel EBV-infected NK cell line, designated 
NKED, was established from a patient with HMB and used for the present study with 
two other NK cell lines, KAI3 and KHYG-1. NKED expressed the latency II-related 
transcripts including EBER1, EBNA1 and LMP1 mRNA. NKED cells were positive for 
CD2 and CD161, and negative for CD3, CD16, CD34, CD56, T cell receptors α and 
β antigens. Although NKED cells contained cytotoxic molecules, the cells had an 
extremely poor cytotoxic activity. The majority of NKED cells were negative for MHC 
class I-restricted NK cell receptors, CD94/NKG2A and KIR2D, and an activating 
receptor, NKG2D. NKED cells, however, secreted higher levels of TNF-α. Stimulation 
with PMA or TNF-α induced the expression of BZLF1 mRNA in the NKED and KAI3 
cells, indicating the transition from the latent- to the lytic-cycle infection These data 
suggest that an EBV-infected NK cell clone, NKED, revealed a very low cytotoxic 
effect probably because of low expression of NKG2D, but had the ability to release 
proinfl ammatory cytokines including TNF-α, which in turn might induce the lytic 
cycle-related viral antigens targeted by EBV-specifi c cytotoxic T-cells. These cascades 
might be responsible for the abrupt onset of systemic infl ammations in HMB.
612
Propionibacterium acnes stimulates the proinfl ammatory cytokines and matrix 
metalloproteinase expression through activation of protease-activated receptor-2 
in keratinocytes and sebocytes
Lee S, Kim J, Jung M Yonsei Univ College of Medicine, Seoul, Republic of Korea 
Propionibacterium acnes (P. acnes) has been implicated in the pathogenesis of infl ammatory acne 
by stimulating keratinocytes and sebocytes to produce  proinfl ammatory cytokines. It has been 
demonstrated that P. acnes induces toll-like receptor (TLR) expression and that this mechanism could 
play an essential role in acne-linked infl ammation. P. acnes induces delayed type hypersensitivity 
response by producing lipases, proteases, hyaluronidases, and chemotatic factors. Recent reports 
demonstrated that protease-activated receptor-2 (PAR-2) activation has proinfl ammatory effects 
and plays a pathogenic role in the various infl ammatory diseases.The purpose of our study was to 
investigate whether serine protease from P. acnes can activate PAR-2 and induce the expression of 
proinfl ammatory cytokines and matrix metalloproteinase (MMP) in keratinocytes and sebocytes 
via the pathway involving PAR-2 activation. We found that 2.5uM PAR2 agonist (SLIGKV-NH2) or 
24hr P. acnes supernatant (2.5%) induced calcium signals which was dose dependently inhibited 
by increasing concentrations of PAR-2 antagonist (ENMD-1068) in immortalized keratinocytes 
(HaCaT cells) and SZ95 sebocytes. Desensitization of PAR-2 by repetitive PAR-2 agonist or P. acnes 
stimulation suggested that P. acnes-mediated calcium signals were mediated by PAR-2 activation. 
In addition, PAR-2 agonist or P. acnes treatment resulted in the increased mRNA expression of 
proinfl ammatory cytokines, such as IL-1alpha, IL-6, IL-8, TNF-alpha, and MMP-2 in HaCaT cells 
and SZ95 sebocytes. Inhibition of PAR-2 by PAR-2 antagonist resulted in a decreased P. acnes-
induced expression of proinfl ammatory cytokines and MMP-2 in HaCaT cells and SZ95 sebocytes. 
From these results, we fi rst demonstrated that serine protease from P. acnes activates PAR-2 in 
keratinocytes and sebocytes. We also showed that P. acnes induces the expression of proinfl ammatory 
cytokines and MMP-2 via PAR-2 activation as well as TLR-2/4 in keratinocytes and sebocytes.




The epidermal expression of antimicrobial peptides psoriasin and human beta 
defensin-2 is highly induced in the border region of chronic leg ulcers
Dressel S1, Cordes J1, Wittersheim M1, Meyer-Hoffert U1, Harder J1, Beissert S2, 
Sunderkötter C2, Gläser R1 1University Hospital of Schleswig-Holstein, Campus Kiel, 
Kiel, Germany 2University Hospital Münster, Münster, Germany
The role of antimicrobial petides (AMP) in the pathogenesis of chronic leg ulcers still remains 
unclear. AMP represent a part of the chemical barrier of skin playing an important role in fi rst 
line defense against invasive microorganisms. It was recently shown that these molecules 
may also be involved in the reepithelialisation process. Aim of this study was to perform 
a systematic analysis of different classes of epithelial AMP in the border area of chronic 
wounds.  The epidermal expression of psoriasin (S100 A7), RNase7, human beta defensins 
(hBD)-2 and-3 and the cathelicidin LL-37 was investigated by immunhistochemistry in tissue 
samples. These were taken under local anaesthesia in 1 cm distance from the wound border 
of chronic leg ulcers caused by venous or arterial vessel problems (n=7; 1f/6m; 61-82 years). 
Samples of healthy controls (n=5; 2f/3m; 66-73 years) derived from the same localization 
served as controls. Immunoreactivity was determined by two independent investigators for 
each epidermal layer using a standardized scoring system.Immunohistochemical analysis 
showed a clear induction of psoriasin and hBD-2 expression in all samples compared to 
healthy controls whereas the expression levels of RNase 7 did not differ between both 
groups. LL-37 was only detectable in one sample, hBD-3 was detectable in two samples, 
one with a weak staining activity, in another tissue high expression was remarkable. In 
summary, this study demonstrates that psoriasin and hBD-2 are induced in the border region 
of chronic wounds in contrast to RNase 7, LL-37 and hBD-3. Both latter AMP are known 
to be involved into the process of epithelialisation. Further investigations are needed to 
determine the role of AMP in regard to wound healing and infection in chronic leg ulcers.
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The neurocutaneous environment of warts in HIV infection
Meys R1, Mantovani C2, Asboe D3, Hawkins DA3, Gotch FM4, Terenghi G2, Bunker 
CB1 1Dept of Dermatology, Chelsea & Westminster Hosp, Imperial Coll, London, UK 
2Blond McIndoe Labs, Tissue Injury & Repair Group, Univ of Manchester, UK 3Dept 
of Genitourinary Medicine, Chelsea & Westminster Hosp, Imperial Coll, London, UK 
4Dept of Immunology, Chelsea & Westminster Hosp, Imperial Coll, London, UK
Treated HIV infected patients have a higher prevalence of warts than the general population, despite 
substantial or partial immune reconstitution. Previous work has shown that cutaneous nerves may be 
affected by HIV infection and by anti-retroviral therapy:  HIV is a neurotropic virus.  Cutaneous nerves 
support the epithelium and modulate local cutaneous immunity. We hypothesise that damage to the 
cutaneous innervation may contribute to the persistence or emergence of warts in treated HIV patients. 
The neurocutaneous environment of warts has not previously been investigated. Cutaneous (hand/foot) 
and genital warts from HIV infected, treated and untreated individuals were studied.  Saucerised/snipped 
wart tissue specimens were fi xed in Zamboni’s solution, sectioned and stained with antibody for protein 
gene product 9.5 (PGP9.5).  A secondary fl uorescent anti-PGP9.5 antibody was applied to allow qualitative 
assessment of the density of nerve fi bres contained in the epidermis, papillary dermis and deeper dermis 
(primarily peri-adnexal and peri-vascular regions).  Examination of the cutaneous wart specimens (n=9 
from seven individuals) was technically limited as they contained very little dermis.  Therefore, it was 
not possible to compare cutaneous specimens.  All genital wart specimens examined (n=6 from six 
individuals) included suffi cient dermis, although a further two were not examined and excluded on the 
basis of small size.  A qualitative assessment of nerve density in treated HIV infected anal warts compared 
with HIV uninfected anal warts showed a trend towards decreased nerve density in HIV treated patients, 
HIV infection duration and anti-retroviral treatment duration.  The number of specimens, however, was 
too small to draw defi nitive conclusions.In summary, we have qualitatively examined the neurocutaneous 
environment of cutaneous and genital warts from HIV infected and HIV uninfected individuals.  Further 
work is now required to determine if this trend can be substantiated in greater numbers of patients.
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The seborrheic dermatitis associated Malassezia indoles induce the Aryl-
hydrocarbon receptor (AhR) dependent genes in HaCaT cells
Gaitanis G1, Pappas P2, Magiatis P3, Mexia N3, Galanou M2, Stathopoulou K3, Skaltsounis 
AL3, Marselos M2, Velegraki A4, Bassukas ID1 1Department of Skin and Venereal 
Diseases, Medical School, University of Ioannina, Greece 2Dept of Pharmacology, 
Medical School, University of Ioannina, Greece 3Dept of Pharmacognocy & Natural 
Products Chemistry, Faculty of Pharmacy, Univ of Athens, Greece 4Mycology 
Laboratory, Microbiology Department, University of Athens, Greece
The production of the Aryl-hydrocarbon receptor (AhR) agonists malassezin, indolï[3,2-b]carbazol 
(ICZ) and indirubin by Malassezia furfur seborrheic dermatitis (SD) strains has been shown 
previously. Aims of the present study were: 1)To quantify malassezin, ICZ and indirubin production 
in extracts of L-tryptophan grown M. furfur strains; 2)To investigate the biosynthesis of AhR ligands 
in all currently established Malassezia species; 3)To evaluate in HaCaT cells the activation of the 
intracellular AhR downstream pathway by M. furfur extracts. The quantifi cation of malassezin(2.3-
40.9 ìg/mg), ICZ (1.2-6.0 ug/mg) and indirubin (0.1-1.7 ug/mg) in ethyl acetate extracts of an array 
of M. furfur stains of different origin grown on L-tryptophan agar was performed with HPLC-DAD 
using the chemically synthesized compounds as standards. This demonstrated the wide production 
of signifi cant quantities of indolic compounds particularly in extracts from Malassezia strains 
isolated from diseased skin. In addition malassezin, indirubin and ICZ were identifi ed, in extracts 
of L-tryptophan grown Malassezia species other than M. furfur (M.japonica, M. sympodialis and 
M.yamatoensis). The concentration of the measured compounds was signifi cantly lower compared 
to M.furfur clinical strains. Furthermore, expression of the AhR-induced battery of enzymes 
assessed by Reverse Transcriptase Real-Time PCR (exposure for 24h) showed statistically signifi cant 
alterations in AhRR, CYP1A1, CYP1B1, GSTT1 and GSTP1 mRNA. In conclusion, biosynthesis of 
bioactive indolic compounds  is not restricted to M. furfur species but probably is a Malassezia genus 
characteristic. As AhR is a multipotent transcriptional factor, activation of the down-stream cascade by 
the aforementioned bioactive indoles, could contribute to Malassesia species pathogenic potential.
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